Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.8233913675326087,2.0244466173191253,0.0,0.3746613954169412,0.13,10/23,12.22%,RYK;MAP2;MDGA2;TOX;GRID2;OPHN1;MDGA1;CHD5;AGTPBP1;PROX1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7156042055307357,1.9383047063932988,0.0,0.6444176001171389,0.39,13/41,9.50%,IL1RAPL2;LRFN4;SYNDIG1;NLGN1;PDLIM5;IL1RAPL1;NRXN1;GPC4;SLIT1;GRID2;WNT7A;LRFN5;MDGA1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.8009251432510888,-1.9211293054669916,0.0,0.0,0.0,62/102,15.15%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RBM8A;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;PNRC2;RPL7A;RPS28;RPL41;RPL15;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;CASC3;RPLP0;NCBP1;RPS4X;RPS20;UPF3B;MAGOHB;RPL18A;UBA52;RPL35;RPS7;UPF3A;RPS6
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.8172527216369976,-1.9136759261615106,0.0,0.0,0.0,49/83,10.31%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;RPL7A;RPS28;RPL41;RPL15;ZFAND2B;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;RPLP0
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.8072763995563033,-1.9015876165926073,0.0,0.0,0.0,48/86,10.31%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;RPL7A;RPS28;RPL41;RPL15;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;RPLP0
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.7468622904587128,1.8850660175773233,0.0,0.7892866730116894,0.58,9/24,13.39%,RAB31;SPTBN1;NSF;RAB10;SEC16A;GGA1;BLZF1;ARFRP1;KIF13A
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.8075357324374274,-1.8815710180825125,0.0,0.0,0.0,57/84,15.15%,RPS14;TMA7;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;RPL7A;RPS28;RPL41;RPL15;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;RPLP0;RPS4X;RPL22L1;RPS20;RPL18A;UBA52;ZC3H15;RPL35;RPS7;RPS6
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.7895313203371971,-1.8781658836905628,0.0,0.0,0.0,58/94,15.15%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;RPL7A;RPS28;RPL41;RPL15;ZFAND2B;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;RPLP0;RPS4X;RPS20;RPL18A;UBA52;CHMP4B;SPCS2;RPL35;RPS7;RPS6
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.8481118392562061,-1.853253990376002,0.0,0.0026777549979305633,0.02,5/35,3.37%,CD44;IFI6;VEGFA;NOL3;BEX3
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.8780286916511,1.8522990963009738,0.0,0.854227981550626,0.68,5/14,4.96%,NLGN1;NLGN4X;ASTN1;NCAM2;NRXN1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.755597981984309,-1.8437220165420325,0.0,0.002295218569654768,0.02,65/154,15.15%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;DXO;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RBM8A;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;POLR2G;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;PNRC2;RPL7A;RPS28;RPL41;DDX5;RPL15;RPS21;RPL36;RPL4;RPL18;RPS13;RPL9;CASC3;RPLP0;NCBP1;RPS4X;RPS20;UPF3B;MAGOHB;RPL18A;UBA52;RPL35;RPS7;UPF3A;RPS6
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.8605051680035167,-1.827778639631215,0.0,0.0020083162484479224,0.02,16/44,9.03%,CD44;B2M;HLA-F;HLA-B;HLA-C;TRIM5;TRIM25;RPL13A;IFNGR2;IRF1;HLA-A;OAS3;MT2A;GAPDH;OAS1;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.8450111170025808,-1.8043310860158355,0.0,0.004462924996550939,0.05,4/31,3.37%,CD44;IFI6;VEGFA;BEX3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.909909928812187,1.8031872385616499,0.0,1.0,0.84,2/10,1.28%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.8484264124896863,1.7975267911909942,0.02631578947368421,1.0,0.85,1/10,0.01%,CPA1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.7425991860177262,-1.7851240887298667,0.0,0.005623285495654183,0.07,51/136,8.81%,RPS14;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;MRPS18C;RPS15;RPL13A;RPL23A;RPL14;RPS16;COPS5;RPL23;RPL7A;RPS28;RPL41;RPL15;MRPS7;MRPL27;RPS21;RPL36;MRPL51;RPL4;RPL18;RPS13
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.740037778925304,1.7802873181358825,0.0,1.0,0.89,15/38,15.43%,IL15;ERBB4;EPHA3;ABL1;FER;IGF1R;ABL2;EGFR;ABI1;RELN;MAPK3;AATK;FLT1;TTBK1;FYN
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.7623060220014779,-1.7546432066697892,0.0,0.013145342717113675,0.18,4/49,3.37%,CD44;IFI6;VEGFA;BEX3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.8843129913019613,1.7525686301202645,0.0,1.0,0.96,4/10,5.37%,PKP2;NEDD4L;ANK2;GPD1L
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.8450880763231683,-1.7519893132852,0.0,0.013388774989652817,0.19,1/28,0.01%,CD44
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.8723007484489599,-1.747763963756011,0.0,0.013594756143339784,0.21,14/31,9.03%,CD44;B2M;HLA-F;HLA-B;HLA-C;TRIM5;TRIM25;IFNGR2;IRF1;HLA-A;OAS3;MT2A;OAS1;CAMK2A
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.9151716687392704,-1.7463809244810584,0.0,0.014345116060342302,0.22,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.864290895784483,1.7431117806504848,0.03333333333333333,1.0,0.97,3/9,5.92%,ACACB;CPT1A;ACACA
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.7051478838512364,-1.7398315096113097,0.0,0.017673182986341716,0.26,69/186,15.15%,RPS14;TMA7;RPS8;RPS23;RPL12;RPL31;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;MRPS18C;RPS15;RPL13A;RPL23A;RPL14;RPS16;COPS5;RPL23;RPL7A;RPS28;RPL41;NARS1;RPL15;MRPS7;MRPL27;RPS21;RPL36;MRPL51;RPL4;RPL18;RPS13;RPL9;RPLP0;RPS4X;AIMP1;RPL22L1;WARS1;RPS20;RPL18A;UBA52;ZC3H15;RPL35;RSL24D1;SARS1;RPS7;MRPL16;RPS6
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.6710724954671315,1.735704180962848,0.0,1.0,0.98,7/29,7.95%,SHROOM2;PBX3;PBX1;MYO7A;CHD7;SMOC1;MEIS1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.8049860316691377,-1.729894203902909,0.0,0.023597715919263088,0.31,2/37,1.06%,CD44;ITGA4
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.7801389480595203,1.7217921749555756,0.0,1.0,1.0,6/11,13.48%,SOX11;TCOF1;WNT7A;PTPRC;SOX8;KLHL12
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.7296017236283673,1.7183538265752019,0.0,1.0,1.0,1/25,0.01%,CPA1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.7205200304149628,-1.715432537637567,0.0,0.034495784973340785,0.42,57/141,15.15%,RPS14;RPL12;RPL31;RPLP1;RPS24;DHX37;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPL32;RPLP2;RPL29;DDX27;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;LAS1L;RPL7A;RPS28;RPL41;IMP3;RPL15;UTP15;RPL36;RPL4;RPL18;NOP58;RPL9;NOB1;RPLP0;NOL6;EMG1;NOP56;NOP14;UTP3;RPL18A;UBA52;RPL35;WDR12;RPS7;RPS6
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.5432665832985312,1.7043980575913225,0.0,1.0,1.0,24/108,8.96%,PLD1;ASXL3;NOVA2;ERC2;CSRNP3;RGS7BP;ADGRB3;ASTN1;NCS1;PCLO;MAP2;PLD2;NRXN1;ANK2;SLC8A2;LSAMP;CDC42BPA;GUCY1A2;MAPK10;CACNA2D1;CNTN1;KCTD16;UNC5D;CLVS2
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.6069233810798481,1.702993646034089,0.0,1.0,1.0,18/40,20.96%,ARFGEF2;RAB31;SPTBN1;NSF;RAB10;OSBPL5;GGA1;STXBP6;BLZF1;ARFRP1;EXOC2;KIF13A;ARL3;EXOC6;EXOC4;EXOC6B;GOLPH3;ANK3
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6951500632211015,-1.699382812926035,0.0,0.05355509995861126,0.56,63/175,16.44%,RPS14;RPL12;RPL31;RPLP1;RPS24;DHX37;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPL32;RPLP2;RPL29;DDX27;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;LAS1L;RPL7A;RPS28;RPL41;IMP3;RPL15;UTP15;RPL36;RPL4;RPL18;NOP58;RPL9;NOB1;RPLP0;NOL6;HNRNPA2B1;EMG1;NOP56;NOP14;UTP3;RPL18A;UBA52;RPL35;WDR12;SARS1;RPS7;RPS6;SRRT;ADAR;DKC1;TRPT1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.883173052529444,-1.6986574183364818,0.0,0.051159213907831284,0.57,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.6943244927171309,-1.6976391647430022,0.0,0.04940457971181889,0.57,60/154,16.34%,RPS14;RPL12;RPL31;RPLP1;RPS24;DHX37;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPL32;RPLP2;RPL29;DDX27;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;LAS1L;RPL7A;RPS28;RPL41;IMP3;RPL15;UTP15;RPL36;RPL4;RPL18;NOP58;RPL9;NOB1;RPLP0;NOL6;EMG1;NOP56;NOP14;UTP3;RPL18A;UBA52;RPL35;WDR12;RPS7;RPS6;RSL1D1;DKC1;RIOK2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6932329529934337,-1.6941735815998995,0.0,0.054320172815162854,0.62,71/170,18.82%,RPS14;RPL12;RPL31;RPLP1;RPS24;DHX37;RPS2;RPL30;RPL35A;RPL3;RBIS;RPL34;RPL13;RPL19;RPL32;RPLP2;RPL29;DDX27;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;RPS15;RPL13A;RPL23A;RPL14;RPS16;RPL23;LAS1L;RPL7A;RPS28;RPL41;IMP3;RPL15;UTP15;RPF2;RPL36;RPL4;GLUL;RPL18;NOP58;RPL9;NOB1;RPLP0;NOL6;EMG1;NOP56;NOP14;UTP3;RPL18A;UBA52;RPL35;WDR12;SURF6;RPS7;RPS6;MRPL36;DKC1;RIOK2;UTP18;EIF2A;MALSU1;RPL6;RPL21;POP4;RPL5
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.9273017932900096,1.6929541355428122,0.0,1.0,1.0,2/7,1.28%,DPYD;DPYSL5
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.9359427245780496,-1.6865705131785342,0.0,0.06280552631509867,0.66,1/9,0.01%,CD44
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.5824015542928563,1.6864422324506678,0.0,1.0,1.0,30/99,10.04%,ASXL3;FAM149A;LMO3;CSRNP3;CNTN3;RGS7BP;ERBB4;UNC5C;SORBS2;PCLO;TOX3;MAP2;PCP4;PBX1;ESRRG;NRXN1;FGF12;ANK2;NOL4;NOVA1;PDZRN4;GUCY1A2;MAGI1;MAPK10;CNTN1;MEIS1;FGF14;NFIB;LONRF2;ADGRA1
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.7933882527536061,1.6834789483629133,0.0,1.0,1.0,3/15,5.92%,ACACB;CPT1A;ACACA
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.9773471528158357,1.6827947775390726,0.0,1.0,1.0,2/6,1.28%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.8189250726060544,-1.6717970195754603,0.0,0.07683992602757268,0.77,3/26,1.53%,CD44;HES5;DDRGK1
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.8068950326417754,1.667665194331627,0.0,1.0,1.0,7/17,9.50%,IL1RAPL2;LRFN4;IL1RAPL1;GPC4;WNT7A;LRFN5;MDGA1
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.8068950326417754,1.667665194331627,0.0,1.0,1.0,7/17,9.50%,IL1RAPL2;LRFN4;IL1RAPL1;GPC4;WNT7A;LRFN5;MDGA1
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.7434007606891673,-1.656524553677986,0.0,0.0967338993002416,0.81,23/52,18.06%,NDUFA1;COA6;NDUFS5;UQCRQ;NDUFB2;NDUFB11;COX4I1;NDUFA12;NDUFC1;UQCR10;NDUFB9;NDUFA6;NDUFAF1;COX7C;COX5B;UQCRB;NDUFS7;CYC1;COX7B;COX6C;UQCC3;NDUFB7;NDUFA3
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8211090457816631,-1.6537066906213636,0.0,0.09330946262019578,0.83,17/33,8.45%,IFI6;HLA-F;HLA-B;MX1;IFIT1;HLA-C;ISG15;IFITM3;IFI35;IFIT3;IFIT5;PSMB8;IRF1;HLA-A;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8211090457816631,-1.6537066906213636,0.0,0.09330946262019578,0.83,17/33,8.45%,IFI6;HLA-F;HLA-B;MX1;IFIT1;HLA-C;ISG15;IFITM3;IFI35;IFIT3;IFIT5;PSMB8;IRF1;HLA-A;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8964840813202426,1.6512379354526296,0.03125,1.0,1.0,3/9,4.91%,NLGN1;NLGN4X;IL1RAPL1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.610425826298512,1.6498513441195284,0.0,1.0,1.0,14/43,18.00%,BCAR1;ATP2C1;RICTOR;GAB1;FER;MYH9;CDC42BPA;AUTS2;NRP1;RAP2A;MCU;SIPA1L1;RALA;THSD7B
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.735734241701687,-1.6480786117778001,0.0,0.10145716158825802,0.83,22/51,18.06%,NDUFA1;NDUFS5;UQCRQ;NDUFB2;NDUFB11;COX4I1;NDUFA12;NDUFC1;UQCR10;NDUFB9;NDUFA6;NDUFAF1;COX7C;COX5B;UQCRB;NDUFS7;CYC1;COX7B;COX6C;UQCC3;NDUFB7;NDUFA3
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.6618864032643995,1.6441538081874536,0.05263157894736842,1.0,1.0,13/34,14.53%,ADGRB3;HECW2;CAMSAP2;NEDD4L;SEMA4D;CSMD3;VLDLR;DCC;BMP7;NEDD4;SDC2;COBL;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.7570568240870028,-1.6415694641751513,0.0,0.10816217509498094,0.86,7/53,6.41%,CD44;VEGFA;PFN2;CAMK1;TGFB1;HAX1;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.8433151054665932,-1.6411795281392092,0.0,0.10554048147015978,0.86,1/20,0.01%,CD44
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.7624541719797364,-1.6399946609456422,0.0,0.10389689391970584,0.86,9/30,7.48%,NDUFA1;NDUFS5;NDUFB2;NDUFB11;NDUFA12;NDUFC1;NDUFB9;NDUFA6;NDUFAF1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.7438879755302374,1.6366238882378195,0.043478260869565216,1.0,1.0,2/15,1.28%,DPYD;DPYSL5
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.7643202097177733,1.6328422547762114,0.0,1.0,1.0,6/16,10.81%,CRB2;PARD3;LRRC7;ERBIN;DLG2;PARD3B
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.8098195378017299,-1.6296145088352512,0.012987012987012988,0.12023983732643044,0.92,4/30,4.27%,CD44;HES5;DDRGK1;TGFB1
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),0.7437287945894638,1.6272673756346112,0.029411764705882353,1.0,1.0,4/15,11.01%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),0.7437287945894638,1.6272673756346112,0.029411764705882353,1.0,1.0,4/15,11.01%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8856628298787432,1.6231668296022979,0.02631578947368421,1.0,1.0,4/10,6.49%,NLGN1;NLGN4X;NRXN1;WNT7A
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.8677132671947445,-1.6221346486542614,0.0,0.1343061491149548,0.95,9/20,8.87%,DUOX1;FMO6P;IL20RA;FMO3;CFTR;CP;CLCA4;TMC4;VWA2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,-0.7516452877149007,-1.6205939492814627,0.0,0.1341311821690673,0.95,1/42,0.01%,CD44
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.7576329211324233,1.619716590570911,0.0,1.0,1.0,7/16,14.78%,PARD3;FERMT1;OPHN1;MSN;CLASP1;RAP2A;CYTH1
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.7524770662239914,1.6193690933581697,0.0,1.0,1.0,5/12,15.59%,ANK2;CACNA2D1;STIM1;BCL2;ORAI1
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),0.8935975106334446,1.6177218605919081,0.0,1.0,1.0,3/6,10.25%,ABL1;MAP2K6;MAPK3
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.902815306300994,-1.6175796589706875,0.0,0.13869195739281534,0.95,2/10,2.75%,CD44;FLOT1
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.7684875883933384,1.6157043604391583,0.0,1.0,1.0,5/14,11.79%,LRFN4;LRRC4C;GPC4;LRFN5;PTPRS
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),0.743073471812378,1.615530092746665,0.043478260869565216,1.0,1.0,5/11,16.94%,SOX11;TCOF1;SOX8;KLHL12;CDH2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.9180367289932623,1.6138477859327445,0.0,1.0,1.0,3/8,4.96%,NLGN1;NLGN4X;NRXN1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6982517754350702,1.6122466174843997,0.08,0.9925315595159654,1.0,7/18,16.32%,PDE7B;PDE4D;KSR1;EPHA5;DGKQ;RAPGEF2;ADCY2
prerank,PanglaoDB_Augmented_2021__Acinar Cells,0.7529532060478692,1.6116163118537552,0.03125,0.9691241428118214,1.0,4/12,4.93%,CPA1;TSPAN8;GIPC2;AKR1C3
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6981101065861944,1.6109749750209323,0.034482758620689655,0.9469819918754687,1.0,9/25,15.54%,ARC;IGF1R;WNT7A;WASL;CHRNA7;ITGA3;CTNND2;FYN;DOCK10
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.8958987250464233,1.6087987305005775,0.034482758620689655,0.9409916731208651,1.0,3/10,4.91%,NLGN1;NLGN4X;IL1RAPL1
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.8681039163129537,1.6078093355343452,0.05405405405405406,0.9237805072639249,1.0,4/8,8.55%,AKNA;CEP120;WNT7A;PCM1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.7586247683954946,1.60776056130867,0.05714285714285714,0.9006859945823268,1.0,8/17,16.25%,SOX11;SHANK2;LIMD1;MAPK14;NF2;MOB3B;WWC2;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.8117203527498488,-1.6075245510278409,0.0,0.15951769059100643,0.96,5/17,14.02%,EMD;DCTN1;NEMP1;TMEM43;CHMP4B
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.7780540927820434,1.6064990883536894,0.04,0.8878561263100002,1.0,4/11,15.66%,PPARG;PLIN5;ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.810291879417898,1.6052506163927596,0.03333333333333333,0.8781349467819928,1.0,3/11,8.14%,OSBPL7;GRAMD1B;RORA
prerank,PanglaoDB_Augmented_2021__Basophils,-0.748547724486931,-1.6018471227909274,0.0,0.16691339487100512,0.97,2/39,0.52%,CD44;F13A1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.743054677124154,-1.6005297429113217,0.0,0.16500760527788333,0.98,16/37,16.34%,RPS14;RPS24;RPS27;RPS25;RPS15;RPS16;RPS28;MRPS7;NOB1;EMG1;NOP14;RPS27L;SURF6;RPS7;RPS6;RIOK2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.7360568542134012,-1.5999121509444443,0.0,0.16256791526910022,0.98,5/37,4.16%,B2M;FTL;FTH1;NUBP1;CP
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.9128211706923683,-1.5994328610077786,0.0,0.15984137526108594,0.98,1/11,0.01%,CD44
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.9331072203871026,-1.5993834073647064,0.0,0.15584534087955879,0.98,1/10,0.01%,CD44
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),0.9486664707052981,1.5989254341846564,0.0,0.9120826714475676,1.0,1/6,2.08%,FKBP7
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),-0.8218540714780641,-1.5982269483432852,0.0,0.15557103427001467,0.98,2/18,0.66%,DUOX1;VEGFA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9485010943541501,-1.5956007681454925,0.0,0.16257798201721277,0.99,2/6,2.84%,VEGFA;HES1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.7534866210161288,1.5926708413282054,0.0,0.9427843113764485,1.0,5/21,8.13%,IL15;RAB27A;RAB31;MERTK;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.6592159582492332,1.5922465166512827,0.0,0.9251638724162334,1.0,10/20,19.31%,STN1;POT1;GNL3L;TNKS;CTC1;ERCC4;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.8731292554994384,1.591680231387956,0.05263157894736842,0.9096127095687825,1.0,3/7,6.71%,SOX11;GPNMB;FGL1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.816637954551436,-1.5900875882910566,0.0,0.1739295281213968,0.99,2/24,2.75%,CD44;FLOT1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.889045891647601,1.5878902958839434,0.08333333333333333,0.9176812731999633,1.0,4/5,9.62%,SIRT1;PLA2R1;MAPK14;MAPKAPK5
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),0.80852567155418,1.5864571781910635,0.0,0.9144860226468506,1.0,2/12,3.79%,TOP1MT;ABL1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.6312884063420257,1.5863888343914112,0.038461538461538464,0.8958230425928333,1.0,14/32,13.72%,SEMA3B;SOX11;ERBB4;TCOF1;SEMA4D;SEMA6C;ANXA6;RADIL;SOX8;SEMA3A;PHACTR4;SEMA6A;KLHL12;SOX10
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.7111441588946382,1.5860113280186205,0.0,0.8800046855553115,1.0,8/20,19.37%,KAT2B;SALL1;CHD7;SMOC1;KAT2A;BMPR1B;MEGF8;GREM1
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.879720630796932,-1.5840963207136727,0.014925373134328358,0.18637174785596716,0.99,2/11,2.82%,CRYM;PIPOX
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.879720630796932,-1.5840963207136727,0.014925373134328358,0.18637174785596716,0.99,2/11,2.82%,CRYM;PIPOX
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,-0.723837680935052,-1.583537442872038,0.0,0.18476509485720888,0.99,11/63,9.69%,CD44;F13A1;ITGA4;TAF7;IL3RA;PROCR;FPR3;LMO2;MAFF;RNASE1;MGST1
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.7079716839724669,-1.582211863035166,0.011627906976744186,0.18613245911147128,0.99,5/57,3.65%,CD44;POLR2I;FGF1;SFRP1;POLR2G
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.7954753977862379,-1.5780568596057956,0.039473684210526314,0.19731707141000837,1.0,1/18,0.01%,CD44
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.7067683585339687,1.5774424657063715,0.0,0.927984852334667,1.0,4/17,9.86%,ACACB;CPT1A;ACACA;CERT1
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6164015632661748,1.5771725180990164,0.045454545454545456,0.91129179408336,1.0,14/37,19.37%,SMAD9;CRIM1;PPARG;SMAD7;UBE2D1;SPART;CHRD;SMAD1;BMPR1B;VWC2;SMAD5;LEMD3;BMPR1A;GREM1
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.8663277348869469,-1.5770568037624282,0.0,0.19755274117385685,1.0,4/13,7.74%,CD44;TGFB1;CEMIP;HAS2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6812513695611636,1.575787285296229,0.07692307692307693,0.9059736686157582,1.0,6/21,10.52%,NCS1;HOMER1;IL1RAPL1;NTNG2;ZNF804A;CTNNA2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.872812783910674,-1.5755084521233993,0.0,0.19842164534665474,1.0,3/11,4.19%,ROMO1;RPL30;RARRES2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.6308735391543014,1.575194290572477,0.05263157894736842,0.8944693906880011,1.0,9/20,19.31%,STN1;POT1;GNL3L;CTC1;ERCC4;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.5476863073658389,1.572903813819843,0.0,0.9008222350897511,1.0,9/41,11.03%,HDAC9;MIER3;HDAC10;SIRT1;TBL1XR1;HDAC11;TRERF1;SMARCAD1;HDAC4
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",-0.8371558241531559,-1.5726690198213165,0.02666666666666667,0.20429695484211413,1.0,2/18,2.67%,CD44;PLET1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.9289277353501822,1.5725391805003193,0.038461538461538464,0.8871446612908287,1.0,1/6,0.09%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.855145393696678,1.5714895843852714,0.029411764705882353,0.8645634683207486,1.0,2/8,4.73%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.855145393696678,1.5714895843852714,0.029411764705882353,0.8645634683207486,1.0,2/8,4.73%,IRS1;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),0.7759110498703387,1.5707874741927101,0.0,0.8557520279048644,1.0,1/11,0.44%,SOX11
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.7430783149788013,1.5706029972496212,0.0,0.8437374624789516,1.0,5/14,14.50%,NLGN1;TSHZ3;NRXN1;RELN;CACNG2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.8980714317683828,-1.569529475038336,0.0,0.21025526262597097,1.0,1/13,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.8606237446337368,-1.5676805978192434,0.0,0.2134120209671453,1.0,4/11,7.67%,PPIF;NOL3;CLU;PRELID1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.9169725707239802,-1.5675093085924938,0.0,0.21005500317099754,1.0,1/6,4.19%,RARRES2
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.7137325714111978,-1.5670786856219265,0.0,0.20798853365744302,1.0,34/67,16.82%,B2M;MX1;HERC6;HLA-C;PSMB9;ISG15;TRIM5;EPSTI1;IFITM3;IFI35;TRIM25;IFIT3;PLSCR1;PSMB8;PARP14;PROCR;IRF1;RSAD2;USP18;OAS1;PARP9;PSMA3;OGFR;LPAR6;IFIT2;TAP1;WARS1;UBE2L6;IL7;ADAR;EIF2AK2;SP110;IFI44;PSME1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.6553324953409215,1.5665037365008239,0.0,0.8559477387754907,1.0,5/23,6.82%,ZNF358;MBNL1;SALL1;WNT7A;MYH3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.5753783703701856,1.5662031563685703,0.05555555555555555,0.8440758663199734,1.0,11/33,15.43%,ERBB4;EPHA3;ABL1;FER;ABL2;EGFR;ABI1;RELN;FLT1;TTBK1;FYN
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.8598581511393482,1.5654435721777795,0.06060606060606061,0.8366248429723062,1.0,3/7,11.23%,TRERF1;UBR5;NEDD4
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),0.8318595933864297,1.5651852806849804,0.0,0.825191723405813,1.0,1/8,0.16%,TOP1MT
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.7927011338212036,1.562953164289569,0.058823529411764705,0.8286357262329149,1.0,2/9,6.49%,SALL1;WNT7A
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),0.8131785033777224,1.5629235562027153,0.06896551724137931,0.8160806394718102,1.0,1/6,5.76%,PLIN5
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.8729850901698087,-1.562826725091022,0.014925373134328358,0.2186195687596167,1.0,3/9,3.54%,TAF7L;TAF7;TAF11
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.7608252354969913,-1.562364281695344,0.013157894736842105,0.21605254799092388,1.0,9/37,5.69%,CD44;ITGA4;A2M;JUN;TGFB1;HAX1;IFNGR2;IL3RA;IRF1
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.6274744041819816,-1.5603774435236237,0.0,0.21911422793411126,1.0,91/302,15.50%,RPS14;DENND3;PAPPA;RPS8;RPS23;RPL12;TNC;RPL31;RPLP1;RPS24;RPS2;RPL30;SCG3;SCG2;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;RPL11;RPL27A;CP;RPS3A;RPS11;RPS12;RPS18;MRPS18C;RPS15;RPL13A;RPL23A;RPL14;RPS16;COPS5;RPL23;RPL7A;RPS28;RPL41;CKAP4;CHGB;USP6;RPL15;DUSP12;MRPS7;APH1A;UBL5;MRPL27;PAPPA2;RPS21;GPC3;RPL36;ICMT;MRPL51;RPL4;FN1;RPL18;RPS13;PIGH;RPL9;RPLP0;CST3;RPS4X;SERPIND1;WARS1;NUCB1;RPS20;MSRB2;RPL18A;UBA52;SPG7;SPCS2;RPL35;PARP4;RSL24D1;APOE;SARS1;RPS7;FSTL3;RPS6;C3;UBE2L6
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.9093165403298447,-1.5581353810208856,0.0,0.220982865846168,1.0,2/8,7.32%,ROMO1;TIMM8B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.688278505065073,-1.5571902279205796,0.011627906976744186,0.2207808995793749,1.0,11/65,7.30%,CD44;VEGFA;HES5;HES1;ENPP2;TGFB1;HAX1;AGT;PARP14;EFNA1;IL5
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.7743958830568951,1.5571489177340978,0.047619047619047616,0.843044059299374,1.0,3/9,16.33%,GLTP;CERT1;ABCA2
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.6975068635500755,-1.5542731067909499,0.0,0.23019913457619462,1.0,4/61,2.11%,CD44;CD63;ITGA4;ECM2
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.9013634152282393,-1.5536082245961553,0.0,0.22894805232306314,1.0,3/11,5.13%,CD44;TGFB1;CEMIP
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7825400834340556,1.5533339175424117,0.0,0.8568726502241573,1.0,3/10,6.20%,IRS1;IGF1R;PLCB1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.6214264397350715,1.5529872511277816,0.0,0.8461917661126974,1.0,5/32,11.31%,USP51;RFWD3;ABL1;SMG1;UBE2N
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.7296120802962794,-1.5526105608578455,0.0,0.22786419910961506,1.0,4/29,13.66%,DALRD3;WDR6;TRMT10C;TRMT5
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.9547921098264645,-1.54835047554307,0.0,0.2399937916895267,1.0,1/6,0.19%,APIP
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.6547151659521082,-1.5446053997859082,0.0,0.25014351303745197,1.0,26/108,13.02%,CD44;GADD45B;VEGFA;TRIP10;TNC;SLC2A3;EIF1;HES1;JUN;TUBB2A;IFNGR2;TRIB1;IRF1;EFNA1;KDM6B;JAG1;MAFF;STAT5A;CEBPD;PNRC1;BTG1;ID2;IFIT2;TAP1;JUNB;NR4A3
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.9239244108665976,-1.5441436293057844,0.014285714285714285,0.24781405344484664,1.0,2/9,2.64%,PPIF;COX7A2
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8515911927093786,1.543963187406715,0.0,0.9011141790342317,1.0,4/7,12.22%,GRID2;OPHN1;AGTPBP1;PROX1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.8593958557673581,-1.541650369473297,0.0,0.25310779704319786,1.0,1/15,0.01%,CD44
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6885119848892635,-1.5411280139832704,0.0,0.24670273220064626,1.0,12/50,8.75%,NDUFA1;NDUFS5;NDUFB2;NDUFB11;NDUFA12;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;ECSIT;TMEM126B;FOXRED1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6885119848892635,-1.5411280139832704,0.0,0.24670273220064626,1.0,12/50,8.75%,NDUFA1;NDUFS5;NDUFB2;NDUFB11;NDUFA12;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;ECSIT;TMEM126B;FOXRED1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.6317897895279365,-1.5378369810133896,0.0,0.2571792407298168,1.0,47/298,9.35%,CD44;DUOX1;B2M;IFI6;HLA-F;HLA-B;MX1;F13A1;IFIT1;VEGFA;TXNDC17;OPRM1;IL20RA;HLA-C;PSMB9;ISG15;IL12RB2;RPS27A;TRIM5;NDN;IFITM3;IFI35;TRIM25;SNRPA1;IFIT3;IFIT5;TGFB1;PSMB8;ALOX5;IFNGR2;IL3RA;IRF1;HLA-A;OAS3;GSTO1;MT2A;CEACAM1;IL5;RSAD2;STAT5A;CEBPD;OAS1;PIK3CB;FN1;CAMK2A;PSMA3;OSMR
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.7218959998957986,-1.5343171966455331,0.0,0.269397238735465,1.0,9/48,7.30%,CD44;VEGFA;SFRP1;ENPP2;TGFB1;HAX1;AGT;EFNA1;IL5
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.9277682430108403,1.5320533191454,0.0425531914893617,0.9791151133562731,1.0,2/5,4.96%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.9277682430108403,1.5320533191454,0.0425531914893617,0.9791151133562731,1.0,2/5,4.96%,CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),-0.7971254029004945,-1.5319715243454974,0.013888888888888888,0.27603191103667557,1.0,7/24,8.64%,EPN1;VEGFA;FGF1;ALOX5;CEACAM1;PIK3CB;GLUL
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8989686105092682,1.5305264603873308,0.0,0.9759672733217197,1.0,3/6,3.15%,ZSWIM6;ERBB4;SALL1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.8195060320473442,1.529812706318377,0.06451612903225806,0.9694616756004852,1.0,5/9,11.13%,ABL1;IGF1R;EGFR;MAPK3;AATK
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.6569110243983749,1.528701995451605,0.1,0.9663266710593748,1.0,5/22,5.92%,ACACB;CPT1A;PPARG;RPS6KB1;ACACA
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.7122332267058856,-1.5275369956731477,0.0,0.2908482106656361,1.0,7/54,6.06%,B2M;HLA-F;HLA-B;HLA-C;PSMB9;PSMB8;HLA-A
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.9029444734671255,1.5270812755353687,0.02631578947368421,0.9693870630893068,1.0,2/8,4.96%,NLGN1;NRXN1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.7770075498622362,-1.5262895082803125,0.0,0.2940826333538066,1.0,10/33,8.71%,CD44;MX1;IFIT1;NAAA;IFITM3;IFIT3;PLSCR1;IGSF6;OAS1;FN1
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.9081848788128295,1.5260393631798443,0.04,0.9645827925643432,1.0,4/5,9.11%,NLGN1;BTRC;RORA;FBXW11
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.7006470786462664,-1.5257781790095184,0.0,0.29241084577401744,1.0,7/56,6.06%,B2M;HLA-F;HLA-B;HLA-C;PSMB9;PSMB8;HLA-A
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.8483761295230796,1.524757082107267,0.047619047619047616,0.9622073170502777,1.0,2/5,11.17%,FUT9;WNK1
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.5917280301693305,1.5247158348648657,0.047619047619047616,0.9504068815386711,1.0,4/20,7.63%,PKP2;SOX11;SMAD7;TGFBR2
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.595585918716458,1.5243474446980327,0.0,0.9411494252873563,1.0,3/27,1.31%,PHLDB2;CRB2;RACGAP1
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.8176188967852065,1.5238642679787866,0.030303030303030304,0.9339707279331947,1.0,2/10,10.34%,PC;VAPA
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.7925110148787894,-1.5227897759105014,0.0,0.30082463384646246,1.0,2/21,2.05%,CD44;IL12RB2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.8255173226854544,-1.5223930145071207,0.015625,0.29890005463913233,1.0,4/16,8.80%,B2M;HES5;HES1;MED1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),0.6917617861811733,1.5221227699255337,0.06060606060606061,0.9337293020415378,1.0,4/13,19.80%,ERI1;TENT2;XRN1;MTPAP
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.811297462224007,1.5220064605976071,0.027777777777777776,0.9230212305404355,1.0,3/8,11.17%,GPNMB;FGL1;WNK1
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),0.8693692751514586,1.5217034595698449,0.0,0.9139953946290428,1.0,1/6,4.55%,LIG4
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.8079409608948706,-1.5210685138648796,0.0125,0.300320522075597,1.0,2/27,1.61%,CD44;LFNG
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6815590831631614,1.5179627041111987,0.04,0.9300418168585247,1.0,7/23,14.12%,CRB2;NLGN1;IL1RAPL1;GRID2;NECTIN3;ALCAM;TENM3
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),-0.9140944064543152,-1.5179526103434913,0.0,0.31339902165653144,1.0,2/9,3.15%,CD44;ENPP2
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,-0.6356636305284684,-1.5144862962179082,0.0,0.3271547168721665,1.0,18/118,9.48%,CD44;GADD45B;ETV4;COCH;SLC2A3;CDKN1C;IFITM3;PLSCR1;IL3RA;CTSZ;SCN9A;CKAP4;GSTO1;XBP1;MAFF;GPX4;PTRH2;PRAF2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6602881000310911,-1.5137546678082114,0.0,0.32619022919235635,1.0,23/72,18.54%,NDUFA1;NDUFS5;SURF1;COX18;NDUFB2;NDUFB11;NDUFA12;NDUFC1;NDUFB9;NDUFA6;NDUFAF1;ECSIT;TTC19;TMEM126B;FOXRED1;NDUFS7;DMAC1;AIFM1;COA3;UQCC3;NDUFB7;NDUFA3;SDHAF4
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),0.8664856591233089,1.5136104939777013,0.05555555555555555,0.9566935166693057,1.0,1/6,2.87%,NR1H2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.6887546780259121,-1.5134564464356455,0.011627906976744186,0.3243675657859059,1.0,6/53,3.45%,SLC28A2;RIMS1;LIN7B;PPFIA4;NAAA;DVL1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6191356476325292,1.5127897530019077,0.037037037037037035,0.941762507570766,1.0,3/17,14.10%,TP63;MAPK8;BCL2
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6191356476325292,1.5127897530019077,0.037037037037037035,0.941762507570766,1.0,3/17,14.10%,TP63;MAPK8;BCL2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.6800487873500315,-1.512611901703515,0.011904761904761904,0.32442776215891256,1.0,7/69,6.41%,CD44;VEGFA;PFN2;CAMK1;TGFB1;HAX1;HDAC6
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.6880220908132404,1.5099127887845036,0.0,0.9576176879713011,1.0,6/19,7.55%,PKP2;NEDD4L;FGF12;ANK2;GPD1L;CACNA2D1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.6190438738825855,-1.5078031668900578,0.0,0.34495222419769794,1.0,81/303,14.76%,RPS14;RPS8;SRSF7;RPS23;RPL12;RPL31;POLR2I;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RBM3;RPLP2;RBM8A;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;POLR2G;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;MRPS18C;RPS15;RPL13A;RPL23A;RPL14;RPS16;COPS5;RPL23;RPL7A;RPS28;RPL41;RBMS2;DHX38;RPL15;MRPS7;NUP155;MRPL27;RPS21;RPL36;MRPL51;RPL4;RPL18;RPS13;CDC40;PTMA;SRSF5;RPL9;CASC3;RPLP0;PRPF4;NCBP1;RPS4X;HNRNPA2B1;WARS1;PPP5C;RPS20;UPF3B;MAGOHB;SEC13;RPL18A;RPL35;RSL24D1;SARS1;THOC5;RPS7
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),0.8282266405340946,1.5065336536779403,0.03225806451612903,0.9470788491104766,1.0,2/5,11.38%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),0.8282266405340946,1.5065336536779403,0.03225806451612903,0.9470788491104766,1.0,2/5,11.38%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.8282266405340946,1.5065336536779403,0.03225806451612903,0.9470788491104766,1.0,2/5,11.38%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.822520547859075,1.5050663096803303,0.03125,0.9476918995471103,1.0,4/8,17.09%,HECW2;NEDD4L;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.881183460241631,-1.5029819680172274,0.03571428571428571,0.3637651407188731,1.0,2/7,4.27%,VEGFA;TGFB1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.6845616795667089,1.5024896970206574,0.0,0.9581765899811986,1.0,8/17,14.89%,DUSP4;PPM1E;DUSP7;PPM1A;PDP1;PPM1F;PPM1D;DUSP16
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.8241247416679003,1.5023173342859264,0.04,0.9512455639428024,1.0,2/9,0.34%,PHLDB2;CRB2
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.8268402982720939,-1.5016831140350801,0.0,0.36775539861113815,1.0,4/12,7.92%,VEGFA;KDM6B;TTN;MEF2C
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.49458850684359174,1.5011559698809651,0.0,0.9491422017229177,1.0,33/115,15.74%,DUSP4;PPM1E;EYA4;UBLCP1;DUSP7;PPP2R2C;PPM1A;PTPRK;BTRC;PTPN13;SSH1;PPP4R2;PTPRC;EYA2;PDP1;FBXW11;PPP2R5E;PPP3CA;PPM1F;TAB1;MTMR3;PTPRS;PPM1L;PTPRU;PTPN4;PPM1D;CDC14B;PTPRG;PTPRN2;DUSP16;PPP2R2B;MTM1;DUSP26
prerank,MSigDB_Hallmark_2020__Apoptosis,-0.6305384686398713,-1.4984904403005477,0.011111111111111112,0.38125690987776883,1.0,7/98,5.69%,CD44;GADD45B;IFITM3;VDAC2;JUN;CLU;IRF1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),-0.7576079328636415,-1.4980486031621423,0.013513513513513514,0.3801194935698704,1.0,3/23,5.95%,GADD45B;VEGFA;RASGRP1
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.7668836263973224,1.4962037419627476,0.06666666666666667,0.9807631084976259,1.0,3/11,10.46%,RNF139;BAG2;LRRK2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),0.8551224625106658,1.4961911317208652,0.043478260869565216,0.9709082446947591,1.0,3/6,13.96%,SLC2A9;PRPS1;PNP
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.8227481974179724,1.4953953987039386,0.05555555555555555,0.9683672511039083,1.0,1/10,0.08%,VAPB
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.791614997373437,-1.494952118454379,0.028985507246376812,0.393088416269245,1.0,5/15,7.54%,RPS14;RPS27;RPS15;RPS28;MRPS7
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.9436720669553746,-1.4941516953542653,0.015873015873015872,0.39264814119655156,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.8196982739316265,-1.4939035451392193,0.0,0.3897457686548386,1.0,2/14,0.66%,GADD45B;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.8589759038613383,-1.4937150677529432,0.027777777777777776,0.38638258258182856,1.0,5/11,12.75%,ESRRB;HES5;HES1;JAG1;ZFP36L2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.7757322500192786,-1.492214020320294,0.013888888888888888,0.39121136727830713,1.0,5/21,9.02%,HES5;HES1;ATP6AP2;BHLHE41;HES4
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6079481104561569,1.4907179437050444,0.0,0.9925529687385607,1.0,6/25,11.34%,DSE;VCAN;CSGALNACT1;CHST3;UGDH;HEXB
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.6832517424802159,-1.4904993021594304,0.022727272727272728,0.397304776129123,1.0,24/60,17.24%,IFI6;MX1;IFIT1;ISG15;TRIM5;IFITM3;AGBL5;IFIT3;PLSCR1;IFIT5;IRF1;OAS3;RSAD2;OAS1;RNASE1;DDIT4;IFIT2;NLRC5;NLRP1;SKP2;EIF2AK2;TRIM52;STAT1;CGAS
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.8360071866613396,1.4904516432529598,0.03333333333333333,0.9842095191289391,1.0,1/6,8.85%,JADE3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6657065812908493,-1.4902527131515078,0.03896103896103896,0.3945601522213897,1.0,21/54,16.34%,RPS24;DHX37;RPL35A;RBIS;RPL38;RPS25;RPL11;RPS15;RPL14;RPS16;RPS28;RPF2;GLUL;EMG1;NOP14;WDR12;SURF6;RPS7;RPS6;MRPL36;RIOK2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.8097891513676406,1.4897465845187825,0.07142857142857142,0.9810251518427123,1.0,4/8,17.09%,HECW2;NEDD4L;NEDD4;PRKCE
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.6209300929375022,-1.4889312118544327,0.0,0.39823237609848594,1.0,72/249,14.76%,RPS14;RPS8;RPS23;RPL12;RPL31;POLR2I;RPLP1;RPS24;RPS2;RPL30;RPL35A;RPL3;RPL34;RPL13;RPL19;RPS27A;RPL32;RPLP2;RPL29;RPL10A;RPL10;RPS27;RPS9;RPL38;RPL37;RPS25;POLR2G;RPL11;RPL27A;RPS3A;RPS11;RPS12;RPS18;MRPS18C;RPS15;RPL13A;RPL23A;RPL14;RPS16;COPS5;RPL23;RPL7A;RPS28;RPL41;POLE3;RFC2;RPL15;MRPS7;MRPL27;RPS21;RPL36;MRPL51;RPL4;RPL18;RPS13;PTMA;RPL9;RPLP0;GCNT1;RPA3;RPS4X;DONSON;WARS1;PPP5C;RPS20;RPL18A;RFC4;RPL35;RSL24D1;APOE;SARS1;RPS7
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5268277413122016,1.4887435918165957,0.07142857142857142,0.9793576126413326,1.0,27/101,13.32%,ASXL3;SYNDIG1;CSRNP3;LRRC4C;RGS7BP;ADGRB3;NLGN1;ASTN1;ZNF536;MAP2;LRRC3B;ADGRL3;ANK2;NOVA1;RUNX1T1;GUCY1A2;MAPK10;CACNA2D1;NPAS3;CLVS2;ADGRA1;SLC35F1;FBXL7;ADCYAP1R1;MEGF10;NFASC;TMEM200C
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),0.8458099670540535,1.487874540662063,0.03225806451612903,0.9754165329143366,1.0,2/8,4.17%,OSBPL7;GRAMD1B
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.6617824955037557,-1.4862941031686754,0.011904761904761904,0.40928242885895394,1.0,6/47,4.27%,B2M;VEGFA;FGF1;SFRP1;CDKN1C;TGFB1
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.7609148302656547,1.4858035532459142,0.03333333333333333,0.9821124045196086,1.0,3/9,13.68%,HSPA1A;BAG5;DNAJA4
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.8924367588187789,1.4841967782549739,0.02631578947368421,0.9875508856555979,1.0,3/6,5.76%,LMO3;SIRT1;PLIN5
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.9161286755982829,-1.4834745485872065,0.014492753623188406,0.42027091452214277,1.0,1/6,4.90%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.8246874422248832,-1.4830973537367242,0.03389830508474576,0.4191092292215563,1.0,5/9,14.68%,PFDN6;CLU;CRYAB;VBP1;APOE
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.8799560077819344,1.4829112346094908,0.0,0.987845540888107,1.0,3/6,5.65%,PDE4B;ANK2;PDE4D
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6908685433843473,1.482327923470568,0.0,0.9824454368710903,1.0,4/12,16.31%,PLA2G15;SERAC1;CDS2;LPCAT1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.8679800289271595,1.480666249360805,0.07142857142857142,0.98498137129063,1.0,1/5,2.71%,RYK
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.5016980713290642,1.4806281766765184,0.0,0.9762994762028366,1.0,39/114,15.05%,DPYSL5;NOVA2;ERC2;CSRNP3;LRRC4C;ADGRB3;STIM2;ASTN1;EPHA3;ZNF536;PCLO;CADM2;ROBO1;NRXN1;ADGRL3;ANK2;NOL4;SLC8A2;LSAMP;NOVA1;LRRTM3;NPAS3;SOX5;NXPH1;CLVS2;ADGRA1;CTNNA2;FUT9;SLC35F1;GRIK3;ADCYAP1R1;PROX1;KIF1B;TTBK1;BCL2;KCNQ2;ATRNL1;CTNND2;ROBO2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),-0.7754174998959629,-1.4805892570190549,0.0641025641025641,0.42873535271866253,1.0,5/16,4.31%,SYCE2;STAG3;ZCWPW1;RNF212B;IHO1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),0.7676806376684695,1.4800022820929897,0.06666666666666667,0.9720944313520637,1.0,1/10,0.18%,DPYD
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.770603147947136,-1.4797609084818326,0.029411764705882353,0.4294217594206073,1.0,2/16,0.26%,SLC28A2;B2M
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,-0.6228540969434655,-1.4795855837225769,0.0,0.4261568321706552,1.0,13/128,4.27%,CD44;GADD45B;VEGFA;GLIPR1;TNC;SCG2;PFN2;ECM2;SFRP1;PPIB;COL5A3;JUN;TGFB1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.7903693827682222,1.4779245997903234,0.1,0.9810776254275047,1.0,4/8,20.46%,FERMT1;FBLIM1;JAM3;RAP1B
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7850980559723252,1.4773837991816894,0.10344827586206896,0.9753132396092693,1.0,4/10,13.82%,SOX11;PKD2;RELN;DLL1
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.701295802978003,1.4770235939839689,0.0,0.9703072840605064,1.0,4/12,14.81%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.6346314761492197,-1.4762554694946128,0.01098901098901099,0.4423755247066647,1.0,43/108,17.76%,B2M;HLA-B;MX1;IFIT1;HERC6;PSMB9;ISG15;EPSTI1;IFITM3;IFI35;TRIM25;IFIT3;PLSCR1;SSPN;PSMB8;PARP14;IRF1;HLA-A;OAS3;MT2A;APOL6;RSAD2;USP18;PSMA3;OGFR;BTG1;RNF213;IFIT2;PFKP;TAP1;NLRC5;WARS1;UBE2L6;IL7;ADAR;EIF2AK2;SP110;IFI44;TNFAIP6;PSME1;STAT1;P2RY14;CASP3
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.7434281754907442,1.4762271764069386,0.11428571428571428,0.9674734607218685,1.0,4/10,15.43%,BBS4;FBXW11;CTNNA2;SPEF2
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),-0.8980444157761055,-1.4760704911976532,0.017241379310344827,0.43958952961219716,1.0,1/7,1.63%,SLC2A3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.7870976770120501,-1.4752468368428238,0.0625,0.4404524435167501,1.0,2/13,3.56%,EMD;CAMK1
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.8584678068070539,1.4742953218454709,0.024390243902439025,0.9751531767610594,1.0,4/7,12.73%,ERC2;FCHSD2;ERC1;KIF1B
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),-0.8984017666862614,-1.4738272148099405,0.06060606060606061,0.4453157085237733,1.0,1/6,0.35%,DENND3
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.8145826182045911,1.4735925792221305,0.05555555555555555,0.9725825556925931,1.0,3/6,9.81%,SPSB4;MARCHF7;XIAP
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.9331556046574966,-1.4734095564773724,0.0,0.44363142848892606,1.0,5/6,6.06%,B2M;HLA-F;HLA-B;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.7858860714212178,-1.4725617792929209,0.0547945205479452,0.44339159840733583,1.0,3/11,3.54%,TAF7L;TAF7;TAF11
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.9274506794348762,-1.4722813877739336,0.017857142857142856,0.440724079475911,1.0,2/5,2.75%,CD44;FLOT1
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.8524896391427241,-1.4698199940505103,0.0,0.45212675978694866,1.0,3/9,9.19%,VEGFA;CEACAM1;SH3GL2
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.8436464270463496,1.4675170431522309,0.08823529411764706,1.0,1.0,2/6,5.29%,ACADS;MMAA
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.9109037703968074,-1.4669550676941232,0.017543859649122806,0.4644819345059014,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.905693811796617,-1.4666062079698305,0.016666666666666666,0.46219963946422893,1.0,3/8,6.06%,HLA-F;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.6003414175515548,1.4663437856154744,0.0,1.0,1.0,7/27,11.95%,RPA1;HDAC10;LIG4;RAD51B;RAD54B;RECQL5;HMGB1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),-0.6940147906135259,-1.4660237286108033,0.012345679012345678,0.46095301079420636,1.0,9/36,23.17%,DVL1;GABARAPL2;RPL23;MAP1LC3B2;DVL2;CAV1;VIPAS39;HSPA8;DVL3
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8155319491654601,1.4657603834012742,0.07692307692307693,1.0,1.0,1/5,3.60%,BOK
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.7301017860383544,1.4655950437334249,0.06666666666666667,0.9966612393124384,1.0,3/12,13.80%,ZFYVE27;RAB10;ATL2
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.8325314360019791,1.4649257197138994,0.07317073170731707,0.9937739963682145,1.0,3/6,4.96%,PCDH15;MYO7A;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.6149566812520089,1.4648051933318678,0.0,0.9863037385041103,1.0,11/22,25.50%,SEMA4D;CRIM1;PPARG;LIMD1;CHRD;GREM1;CDK6;SUFU;TRPM4;NOTCH1;TMEM64
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6182524972295573,1.4647196337141042,0.05,0.9791956856993734,1.0,7/24,6.49%,SYNDIG1;NLGN1;SEMA4D;IL1RAPL1;NRXN1;GRID2;WNT7A
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.46672774331719197,1.4642265864982216,0.0,0.9747190863167142,1.0,28/110,14.06%,RIT2;GABRG1;NEGR1;CSRNP3;LRRC4C;RGS7BP;ADGRB3;ASTN1;DPF1;ZNF536;CADM2;LRRC3B;NRXN1;SLC8A2;LSAMP;LRRTM3;ATXN1;NXPH1;CLVS2;ADGRA1;CA10;VSTM2B;ADCYAP1R1;NFASC;GABRB1;GABRA1;TTBK1;KCNC2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.7853509850225698,1.4637266805745124,0.05128205128205128,0.970194603941584,1.0,4/12,4.60%,SYNDIG1;RAB27A;NLGN1;SYNJ1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8005699917918071,1.4630955963043517,0.05555555555555555,0.9675114270940162,1.0,3/5,8.40%,LMNA;FOXO1;ATP2B4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.7867989780245328,1.4626057327611601,0.07692307692307693,0.9642847664543525,1.0,2/5,19.07%,FOXP1;MTOR
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.890111657429852,-1.4622133279741303,0.08196721311475409,0.48122076002283726,1.0,2/6,4.93%,COA6;NDUFA12
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.8918967300058367,1.4620036824893419,0.027777777777777776,0.9607596093327454,1.0,3/6,10.49%,CHRM3;ATP2B4;CHRNA7
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.8187482648523285,1.461867408044233,0.02564102564102564,0.9538302725168528,1.0,2/7,4.19%,PHLDB2;FERMT1
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.7759217354192037,1.4617867736721932,0.09090909090909091,0.9470067271027296,1.0,3/8,13.96%,GABRG1;GABRA1;GABRG3
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),-0.7105703499808986,-1.4611416737467509,0.0,0.4802645925167704,1.0,4/31,5.41%,CD44;A2M;FLOT1;CTSL
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),-0.7105703499808986,-1.4611416737467509,0.0,0.4802645925167704,1.0,4/31,5.41%,CD44;A2M;FLOT1;CTSL
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.5728388984669548,1.4605188810625012,0.047619047619047616,0.9493692692352916,1.0,5/30,7.67%,RIPOR2;LZTR1;SPRY4;ABL2;KANK1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.6447260752753551,1.4604289341821717,0.04,0.943019915261468,1.0,8/15,19.31%,STN1;POT1;GNL3L;CTC1;HNRNPC;TERF1;TERF2;XRN1
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.8225274600571637,1.4603038612924801,0.16279069767441862,0.9296043037693232,1.0,4/6,14.08%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.8225274600571637,1.4603038612924801,0.16279069767441862,0.9296043037693232,1.0,4/6,14.08%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),-0.7066743101773149,-1.4601330267820294,0.037037037037037035,0.48295714501137393,1.0,7/32,6.06%,PDCD1LG2;ISG15;IL12RB2;BTN3A1;ZFPM1;RASGRP1;HLA-A
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),0.7977942516735974,1.4601027069429622,0.09090909090909091,0.9239811178150154,1.0,2/6,10.65%,ABCC11;ABCC5
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),0.7165933714078252,1.4596155366988235,0.045454545454545456,0.9211747768776823,1.0,2/10,5.76%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.9231347606852232,-1.4590735925374272,0.03278688524590164,0.48071327748563547,1.0,2/5,2.84%,HES5;HES1
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.9231347606852232,-1.4590735925374272,0.03278688524590164,0.48071327748563547,1.0,2/5,2.84%,HES5;HES1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.6789976510702957,-1.4587235052171557,0.05263157894736842,0.47918425687967425,1.0,14/40,18.07%,CRNKL1;NOL3;SNRPD1;SNRPD2;CELF4;SRSF10;SRSF5;LUC7L3;SNRNP200;NCBP1;PRPF6;SRPK1;USP39;SF3A3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.9333881067431479,-1.457520662026939,0.0,0.4808106638087452,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.9333881067431479,-1.457520662026939,0.0,0.4808106638087452,1.0,1/7,0.01%,CD44
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.6146987804190379,-1.4569828954747526,0.011764705882352941,0.4802978110922283,1.0,25/111,11.73%,RPS14;CRNKL1;RPL3;NOL3;RPL10;RPS27;RPL38;RPL11;RPS15;RPL23A;RPS28;PRPF18;SNRPD1;SNRPD2;MRPS7;RPF2;CELF4;SNRPB;SRSF10;SRSF5;RPLP0;LUC7L3;SNRNP200;NCBP1;PRPF6
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.8840071980175519,-1.4569103283043776,0.05970149253731343,0.47694271680882594,1.0,2/8,1.59%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.859546150107242,1.4561827207715066,0.06060606060606061,0.9355675134831735,1.0,2/6,9.62%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.711995657407496,-1.4561183394006538,0.043478260869565216,0.4782684646703821,1.0,6/24,8.45%,ISG15;FLOT1;POLR3D;IRF1;OAS3;OAS1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.7300041766924706,-1.4560981844272252,0.02666666666666667,0.4746001953475027,1.0,8/25,13.16%,B2M;HLA-F;HLA-B;HLA-C;HLA-A;ERAP1;TAP1;SEC13
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.7445262253098345,1.4560860014545407,0.06060606060606061,0.9295915255496021,1.0,5/12,15.44%,TRPS1;SOX5;KAT2A;ZBTB16;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.6083030709946933,1.4559922188030288,0.10714285714285714,0.9242361394371058,1.0,5/26,8.64%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.9155269323542432,-1.45564584602273,0.03333333333333333,0.4740891427438481,1.0,2/5,5.10%,TGFB1;AGT
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.49451756884704245,1.4556130595525676,0.0,0.9203384462171048,1.0,20/61,22.78%,EPHA3;ABL1;RICTOR;RAC3;FAM107A;ABL2;RHOBTB1;EPHA5;PIK3CA;ARHGAP44;CCDC88A;GPM6B;EPS8;MTOR;CRK;MLST8;PTK2B;ARHGAP35;TAOK2;TWF1
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),-0.7703598051515714,-1.454902711651569,0.016666666666666666,0.47477851310964164,1.0,3/17,4.03%,CDC37;FLOT1;YBX3
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.8196358754208781,-1.4532262769492341,0.0821917808219178,0.4795672381177504,1.0,4/8,12.75%,SFRP1;XBP1;ID2;ZFP36L2
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),0.793189261213541,1.4530662539854602,0.0,0.9317987211651195,1.0,3/8,8.99%,LEPR;SIRT1;BBS4
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.7541829085723197,-1.452441182351212,0.045454545454545456,0.48020386359042483,1.0,3/17,7.32%,ROMO1;COX18;TIMM8B
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.8076004808702085,1.4516194723379636,0.09090909090909091,0.9354482840535993,1.0,2/6,9.50%,MDGA2;MDGA1
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.721836060124954,1.4513979999044708,0.07692307692307693,0.9305132045619088,1.0,3/10,7.63%,SOX11;DSCAML1;TGFBR2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.6954037988472381,-1.4506053025239767,0.08536585365853659,0.48677906504365215,1.0,9/33,8.45%,MX1;IFIT1;ISG15;IFITM3;PLSCR1;IFIT5;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6696050082031413,-1.4496904293968667,0.02631578947368421,0.4889337193948669,1.0,12/39,10.31%,RPS14;DHX37;RPL3;RPL10;RPS27;RPL11;RPS15;RPL23A;RPS28;MRPS7;RPF2;RPLP0
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6916439402135699,-1.449607877338134,0.02631578947368421,0.485680329436684,1.0,7/40,9.15%,CD44;AGRN;TGFB1;PRELP;CEMIP;GPC3;FUCA1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.876909086330258,1.4481488703157008,0.0625,0.9430098129059784,1.0,2/5,5.65%,PDE4B;PDE4D
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.8316829798813219,-1.448088833884704,0.0,0.49242715417167865,1.0,1/11,1.23%,LHFPL5
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.7159529794673833,1.4476619369143644,0.08823529411764706,0.939424956398862,1.0,3/11,13.27%,PATL1;LIMD1;LSM14A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.5870393571170018,1.4475557713566052,0.030303030303030304,0.93354405383209,1.0,4/19,8.99%,VCAN;CSGALNACT1;CHST3;UGDH
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.7160740703729284,1.447153734922958,0.08333333333333333,0.92845144177782,1.0,5/11,22.51%,TTLL1;CEP41;TTLL11;TTLL9;TTLL5
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.7628653433043654,-1.4456069125352229,0.04,0.5044295359434975,1.0,5/17,9.73%,HLA-F;HLA-B;RASGRP1;HLA-A;CD160
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),-0.8466086643691381,-1.4455034178683397,0.04285714285714286,0.5011930402376653,1.0,2/11,0.61%,PPIF;IFIT1
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.8530749865373971,-1.444644738673898,0.0,0.5015220108897833,1.0,1/11,0.14%,FLG
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),-0.7841902619822695,-1.4442369298957536,0.047619047619047616,0.5000998518961189,1.0,4/16,6.06%,B2M;HLA-F;HLA-B;HLA-A
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.6057030981834998,1.4441906585778894,0.04,0.9414310499604215,1.0,12/37,14.47%,LGR5;ADGRB3;ADRA1A;CALCRL;CALCB;ADGRL3;GNG2;ADCY6;GNAQ;RAPGEF2;RXFP1;LPAR1
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.7895292404717065,1.4438880138223074,0.14285714285714285,0.9380522244185764,1.0,2/6,9.15%,AK3;CMPK1
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),-0.8350927249137585,-1.4438049391883885,0.045454545454545456,0.4986981556217877,1.0,5/8,11.58%,OPRM1;RETREG1;SCN9A;NIPSNAP1;P2RX4
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),0.7761646827038862,1.4436557130220313,0.0625,0.9275827389691008,1.0,3/8,5.04%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),0.7761646827038862,1.4436557130220313,0.0625,0.9275827389691008,1.0,3/8,5.04%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.6377019306085803,-1.4430293240523586,0.07228915662650602,0.49886575611446393,1.0,15/56,19.30%,ISG15;FLOT1;POLR3D;POLR3H;POLR1C;IRF1;OAS3;GAPDH;OAS1;POLR3E;STAT1;CGAS;HSPD1;TRIM56;IFIH1
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.8055613711794941,-1.4426140145111845,0.014285714285714285,0.4974926945091421,1.0,3/16,2.61%,COA6;SURF1;COX18
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.8483493385997708,-1.4424137726080408,0.03333333333333333,0.49534695975802845,1.0,4/9,7.28%,HLA-F;HLA-B;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.880837610399589,-1.4420970240479372,0.0625,0.49396153210077154,1.0,1/6,2.94%,GTF3C6
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.7617120912642021,1.4420722006742261,0.06451612903225806,0.9308254223914229,1.0,3/10,12.59%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.7955082057708065,1.441365687296176,0.10256410256410256,0.9295495192266552,1.0,2/7,5.37%,PKP2;GPD1L
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),-0.6300313519318352,-1.4407272791662769,0.01098901098901099,0.4997918130512482,1.0,9/65,11.73%,CD44;SCG2;TACR1;TGFB1;FPR3;TPST1;MMP25;TAC4;PRDX5
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),0.7029929554505085,1.4406797053647402,0.03333333333333333,0.9277099584582067,1.0,5/13,16.46%,INTS6L;INTS7;INTS6;INTS8;INTS11
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.8949890553531072,-1.4399535994363775,0.014492753623188406,0.5005555118545374,1.0,3/8,1.71%,MX1;IFIT1;ISG15
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.5062623915548939,1.4398022995249535,0.0,0.9277192552670259,1.0,17/51,13.55%,MAPK11;ARHGEF6;MAP3K5;TAB3;BTRC;MAPK1;MAP4K2;MAP3K11;MAPK10;FBXW11;MAPK14;MAPK3;TAB1;MAP3K7;UBE2N;TAB2;MAPK8
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.7074580839876177,1.4381648422606301,0.075,0.9334557416005779,1.0,2/11,6.74%,ZDHHC2;SPTBN1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.9306833285028732,-1.4374378019621001,0.03333333333333333,0.5122581992616482,1.0,2/5,1.59%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.8533050446984014,-1.4360898821629133,0.04225352112676056,0.5170253068453278,1.0,1/8,2.94%,GTF3C6
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.7576911407756214,1.4356068451529083,0.09090909090909091,0.9442415674368734,1.0,4/8,20.49%,MBNL1;MYH3;MEGF8;FBXW4
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.6823246076125971,1.4347782720686681,0.1,0.9421673732296212,1.0,8/14,22.54%,RIPOR2;ABL2;KANK1;ITGA3;CCDC125;TNFAIP1;KCTD13;ARHGAP35
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7694103344373533,1.4346475496396567,0.08108108108108109,0.9313942664700406,1.0,7/10,20.46%,RAPGEF6;MAP4K4;RAPGEF2;RAP2B;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7694103344373533,1.4346475496396567,0.08108108108108109,0.9313942664700406,1.0,7/10,20.46%,RAPGEF6;MAP4K4;RAPGEF2;RAP2B;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),-0.9231219670279611,-1.4337083062227267,0.0,0.5299240955026234,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),0.7320462320617969,1.4335830537327212,0.08108108108108109,0.9312879673240364,1.0,4/9,18.12%,DGKB;DGKQ;DGKG;DGKE
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.5994037048489425,1.4324268117787669,0.05,0.9334815086302342,1.0,8/37,11.41%,IL15;NOVA2;PLCL1;NR1H2;MAP2K6;NOVA1;ADAMTS5;IP6K1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),-0.9566665004005794,-1.4320657422184744,0.0,0.5369887203903706,1.0,1/5,1.68%,PDCD1LG2
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.6747419761928604,1.4320111086669474,0.09375,0.9304395922281209,1.0,4/16,11.53%,NLGN1;NLGN4X;NRXN1;LHFPL4
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6569518116508022,-1.4319230091982298,0.03896103896103896,0.5341585669871887,1.0,20/47,20.74%,RPL35A;RPL3;RPL10A;RPL10;RPL11;RPL23A;RPL14;LAS1L;RPL7A;RPF2;RPLP0;WDR12;SURF6;RSL24D1;RSL1D1;MALSU1;RPL6;RPL5;NIP7;GTF3A
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.6685862581217308,-1.4319195059326306,0.0759493670886076,0.5306210930336313,1.0,4/35,4.16%,FTL;FTH1;NUBP1;CP
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.7303668523670394,1.4316793662777023,0.03225806451612903,0.9268895855102752,1.0,4/11,11.06%,IRS1;SIRT1;NNMT;ARPP19
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.7009690572786814,1.431148950064186,0.09090909090909091,0.9241045887922434,1.0,6/10,24.53%,IRS1;PPARG;PRKCE;AKT2;PPM1K;PPARD
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.8068041969691296,1.4303049523470552,0.12121212121212122,0.9231477304560658,1.0,2/5,4.01%,PRR5L;RICTOR
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7042574344173337,1.4295223020382979,0.10810810810810811,0.9213994174432347,1.0,5/15,15.54%,ARC;WNT7A;WASL;CTNND2;DOCK10
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8162511925869469,1.428587017128778,0.07142857142857142,0.9225094666325301,1.0,2/6,10.29%,PARD3;MYRF
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.9062508808301448,-1.4274930058573758,0.06666666666666667,0.5568321050959818,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.5881639218315677,1.4270957365552275,0.125,0.9252814132461683,1.0,3/28,5.24%,DUSP4;DUSP7;PTPN13
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8976458119513309,-1.4269295435470266,0.0,0.5563954845700034,1.0,4/6,7.28%,HLA-F;HLA-B;HLA-A;CEACAM1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),-0.6988336155489165,-1.4263548221057052,0.06944444444444445,0.5561731906740713,1.0,5/25,7.93%,VEGFA;CD63;FLOT1;LRPAP1;SFRP4
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.7955681282254434,-1.4252828634350412,0.029850746268656716,0.5609810341471048,1.0,2/13,1.80%,LIPI;HSD17B14
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.6006661282464747,1.425156959894882,0.08695652173913043,0.9315265431313843,1.0,12/21,19.19%,ABHD17C;ABL1;ABHD17B;PDLIM5;IL1RAPL1;MDGA1;CTNNA2;NEDD4;ARHGAP22;CDKL5;SLITRK4;YWHAZ
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.7964796224189425,1.424940204315832,0.15384615384615385,0.9270691272642453,1.0,2/5,12.22%,CHD7;PROX1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.4792825361136071,1.4247281751115255,0.0,0.9229231229530849,1.0,30/87,15.93%,LGR5;DPYSL5;NOVA2;ERC2;CSRNP3;LRRC4C;ASTN1;ZNF536;PCLO;CADM2;ADGRL3;ANK2;GAL3ST3;NOL4;SLC8A2;IGDCC4;UNC5D;CLVS2;SLC35F1;GALNT13;LHFPL4;GRIK3;ADCYAP1R1;MEGF10;TMEM200C;STOX2;KCNQ2;CTNND2;RHBDL3;CAMKV
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),0.8375247925777713,1.4239014364827054,0.02857142857142857,0.9233034847976115,1.0,2/6,8.29%,PKD2;BMP7
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.7994003375200954,1.4237528291750088,0.022222222222222223,0.9188838337882924,1.0,5/11,8.56%,AKR1C2;AKR1C3;FDX1;AKR1C1;STARD3
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.918712128439058,-1.4236492173736477,0.0,0.568765460618136,1.0,1/7,0.26%,B2M
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6414113705700389,1.4228752262778213,0.045454545454545456,0.9186867716257678,1.0,5/17,11.06%,STYXL1;PPP4R4;PPP1R8;MFHAS1;ARPP19
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.9161299130841337,-1.4222898946342688,0.05172413793103448,0.5750692055109861,1.0,2/5,8.38%,SLC3A1;SLC7A6
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.7304970572825614,1.421118858039216,0.08888888888888889,0.9260274986836353,1.0,2/7,8.94%,WASL;MSN
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7508761425354096,1.4209802746607803,0.08823529411764706,0.9213302584376601,1.0,1/10,0.09%,PKP2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7451972830330285,1.4203762035566654,0.08695652173913043,0.9191134746116606,1.0,4/7,19.37%,PLCB1;WASL;SLIT2;GREM1
prerank,PanglaoDB_Augmented_2021__Mller Cells,-0.6028986776370446,-1.420214475056504,0.011235955056179775,0.5844962934723371,1.0,18/116,11.96%,CD44;VEGFA;CRYM;HES1;CLU;AGT;CRYAB;GSTM5;PAMR1;GLUL;COL4A1;FNDC4;ITM2B;LMOD1;COL6A1;RDH10;DBI;PCDHB4
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.9388289799757308,-1.4200679848165445,0.0,0.5783950795530016,1.0,4/5,6.06%,HLA-F;HLA-B;HLA-C;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.9388289799757308,-1.4200679848165445,0.0,0.5783950795530016,1.0,4/5,6.06%,HLA-F;HLA-B;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.6824719181423546,1.419807934656965,0.14814814814814814,0.9176706445078947,1.0,7/13,18.89%,RIPOR2;DAPK2;MCU;JAM3;THBS4;MOSPD2;SLIT2
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),0.8146110655825999,1.4197676385898723,0.05714285714285714,0.912766237143947,1.0,1/8,1.01%,MOXD1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.8395996416971816,1.4195670604159576,0.03333333333333333,0.9091508718238348,1.0,1/5,1.65%,AKNA
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7012877289833255,1.4188274638675358,0.0967741935483871,0.9085231739356385,1.0,6/13,20.49%,MBNL1;MYH3;BMPR1B;NIPBL;MEGF8;FBXW4
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.6771728047368778,-1.4187055122911987,0.06097560975609756,0.5843826062564489,1.0,2/32,0.26%,APIP;B2M
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8917097120395436,1.4176065071807606,0.0,0.910590087122044,1.0,2/5,3.79%,MAP2;ABL1
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),-0.9285066504246084,-1.415348029648826,0.0,0.603635399811273,1.0,2/5,6.06%,HLA-B;HLA-A
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.7406164044216399,1.4149445172174362,0.125,0.9220315681374324,1.0,1/7,0.18%,DPYD
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.8472274357260108,1.4144861997383913,0.16216216216216217,0.9205390199222695,1.0,1/5,4.92%,ROBO1
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,-0.6957101142425954,-1.414004793667185,0.06578947368421052,0.6098874496820378,1.0,9/24,14.16%,F13A1;VEGFA;PDE6B;TGFB1;ALOX12;TBXAS1;VWF;MYO1F;PILRA
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.48726577992322634,1.413717565439192,0.09090909090909091,0.9205049813388207,1.0,11/66,8.64%,KCNJ6;KCNH5;KCNF1;KCND2;KCNQ3;KCNMB3;KCND3;SLC9A9;PKD2;SLC24A3;KCNN2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7108902867115043,1.4133582349967257,0.1388888888888889,0.9176812731999633,1.0,2/11,10.96%,ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.70048208331838,1.4132212240235003,0.06060606060606061,0.9131429903960836,1.0,2/12,10.27%,SLC25A18;GPD2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),0.8536122296274773,1.4128595491506875,0.2,0.910230000655053,1.0,3/5,13.55%,MAPK14;MAPK3;MAPK8
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.7655456178621305,-1.4125418746696143,0.03225806451612903,0.6158673217496519,1.0,3/15,4.27%,DUOX1;RARRES2;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.7571964729918772,1.4120847221977617,0.06976744186046512,0.9094660176497937,1.0,4/8,11.95%,MAPK11;PLCB1;MAPK14;HMGB1
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.6031634714617993,1.4119398651439683,0.05,0.9054317055909412,1.0,7/23,13.96%,NAV3;PDE4B;PDE4D;SPTBN1;PTPRC;MAP3K7;PNP
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.6366571145180036,-1.4118677976860337,0.022988505747126436,0.6173442431592644,1.0,26/67,17.68%,IFI6;MX1;IFIT1;ISG15;TRIM5;IFITM3;AGBL5;IFIT3;PLSCR1;IFIT5;IRF1;OAS3;RSAD2;OAS1;RNASE1;ZDHHC1;DDIT4;IFIT2;NLRC5;NLRP1;SKP2;EIF2AK2;TRIM52;STAT1;CGAS;AKAP1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.6200307039615146,1.41167895823693,0.047619047619047616,0.9019051000554967,1.0,6/26,6.59%,DAPK2;STYXL1;DEPTOR;SGMS1;TRAF1;CRADD
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.5739546638808223,1.4115184865869248,0.08,0.8981831019613971,1.0,15/29,20.71%,GRIK2;HOMER1;PLCB1;GRID2;GNAQ;GRIA3;GRIN2B;GRIK3;GRIK4;GRIN1;CPEB4;GRIK1;GRM5;GRM8;GRM7
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.5940632215853869,1.4114666231084385,0.13043478260869565,0.8937307420109968,1.0,3/19,4.02%,STYXL1;PPP4R4;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.5834008077949325,1.4114084354276057,0.1,0.8896296603420636,1.0,7/24,18.61%,FYCO1;LIG4;SYNJ1;C2CD5;P2RX7;STX18;AKT2
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.8067964811392927,-1.4103241533298618,0.05063291139240506,0.6243201908729312,1.0,5/10,11.93%,SFRP1;SFRP4;GPC3;WNT5B;RNF213
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.6884938918918434,-1.4098935114491535,0.011764705882352941,0.6239008800567558,1.0,1/32,0.04%,EPN1
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.7057878892526926,1.4098111592405205,0.11627906976744186,0.8949272397329738,1.0,1/7,0.44%,SOX11
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.7739093650238864,1.4097261723445131,0.04,0.8909372293844071,1.0,3/12,5.15%,EHD1;NR1H2;PPARG
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.8258031151384206,-1.4096976675087296,0.1076923076923077,0.6213347936269596,1.0,1/8,0.58%,PPIF
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),0.6892711930793636,1.4091132854488497,0.09375,0.8899243637471345,1.0,5/13,16.46%,INTS7;INTS6;MTREX;INTS8;INTS11
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7748876260387284,1.409061240140919,0.06451612903225806,0.8854747419283988,1.0,2/8,6.31%,BOK;FZD3
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4917587150890702,1.408408260321613,0.0,0.8856175233358066,1.0,8/36,17.03%,SMPD4;LARGE1;CTSA;ESYT2;GLTP;HEXB;ABCA2;ARSA
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.749545133889563,1.4070460297406593,0.10344827586206896,0.8896167905830776,1.0,3/10,11.38%,NEDD4L;SLC12A1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.8499071219565321,-1.4069127096646816,0.015384615384615385,0.6390961410741376,1.0,2/9,4.27%,DDRGK1;TGFB1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.7059297729408982,1.4061945776397258,0.12121212121212122,0.890328360340554,1.0,5/11,22.54%,EPHA3;NRCAM;MEGF8;SEMA5A;ARHGAP35
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.6891596320914268,1.4058320741266839,0.09375,0.8879475071381506,1.0,2/14,4.14%,SOX11;DSCAML1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),-0.9275371115905497,-1.4054305765802528,0.07142857142857142,0.6462052870005962,1.0,1/5,0.12%,ART4
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.6188284082215205,-1.4053275864803614,0.012345679012345678,0.643084002924061,1.0,21/67,22.69%,POLR2I;COPS6;RPS27A;UVSSA;POLR2G;COPS5;RFC2;RPA3;CDK7;UBA52;RFC4;RFC1;HMGN1;UBC;RFC3;XPA;LIG1;POLD2;COPS7A;XRCC1;RBX1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.6348507662980267,-1.404994628028784,0.04,0.6416336888645944,1.0,16/51,17.92%,B2M;IFIT1;ITGA4;DVL1;CAMK1;LRPAP1;CTSZ;ZFPM1;IFIT2;DDX11;RACK1;GTF2F1;BAX;CAV1;MITD1;PEX14
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7362738803885461,-1.404868348464568,0.0759493670886076,0.6386677845353231,1.0,8/15,24.14%,ATP5F1E;DMAC2L;ATP5PF;ATP5MC3;ATP5ME;ATP5PB;ATP5PD;ATP5MC1
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.7088837733273592,-1.4037997677771938,0.012195121951219513,0.6419686766590428,1.0,1/29,0.04%,EPN1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.802829011126546,1.4031284846490808,0.07894736842105263,0.8968479998000068,1.0,3/8,13.94%,FNBP1L;SNX33;PACSIN2
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.6271294066312649,-1.40310956979643,0.045454545454545456,0.6433038607028385,1.0,7/55,6.74%,FTL;MT1E;FTH1;MT1M;NUBP1;CP;MT2A
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.48424739761611235,1.402087706610936,0.0,0.897659603504784,1.0,12/73,8.64%,KCNJ6;KCNH5;KCNF1;KCND2;KCNQ3;KCND3;SLC9A9;SLC12A8;PKD2;SLC12A1;SLC24A3;KCNN2
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6300846947562071,1.4020234807551863,0.038461538461538464,0.8935402786929253,1.0,2/18,5.96%,PKP2;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.7951265983596882,-1.401779966113332,0.06944444444444445,0.6485948611464768,1.0,2/11,5.02%,DDRGK1;ATAD5
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.8323328264034696,1.4016640271027332,0.05128205128205128,0.8911897692138743,1.0,1/6,2.67%,RFWD3
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.7689226502186309,1.4013518202665216,0.1111111111111111,0.8884315194671583,1.0,1/7,1.17%,SHANK2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.7878689175171774,1.4006124697280034,0.20512820512820512,0.8888395580796196,1.0,2/6,15.17%,CNOT6L;CNOT2
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.795493188005509,-1.4000288400659535,0.1044776119402985,0.6589092722026425,1.0,2/6,8.80%,ZFPM1;MED1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.8621473343887576,-1.4000235695088827,0.04411764705882353,0.6553880575272074,1.0,1/7,2.94%,GTF3C6
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),-0.5961153872303464,-1.3999238538463639,0.022988505747126436,0.6525793646632679,1.0,19/87,17.92%,B2M;IFIT1;FLOT1;DVL1;CAMK1;RPL11;PRMT8;LRPAP1;CTSZ;ZFPM1;IFIT2;DDX11;RACK1;GTF2F1;TRIB3;BAX;CAV1;MITD1;PEX14
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6107815545890871,1.3989085176399427,0.11538461538461539,0.8940734873001812,1.0,6/24,8.66%,NLGN1;NLGN4X;PLD2;SYNJ1;WNT7A;OPHN1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.4786067879355143,1.3987612707204857,0.0,0.8907751403111088,1.0,20/75,13.94%,PLD1;RIT2;RNF139;HIP1;SEPTIN4;ABL1;STXBP5;MAPK1;PICALM;ABL2;PTPRC;OPHN1;NSF;RAB10;MAPK3;LRRK2;CDH13;MAP2K2;NRP1;PACSIN2
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.7997306951394948,-1.398706087559856,0.05970149253731343,0.6579244029915393,1.0,5/10,11.58%,MT1E;MT1M;MT2A;HVCN1;P2RX4
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),0.8173055700681495,1.3982743868526883,0.125,0.8893370963511995,1.0,3/5,16.58%,ATPSCKMT;SCN11A;MGLL
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),-0.7857976893853573,-1.3981739035953291,0.058823529411764705,0.6587721121704423,1.0,3/11,6.25%,NOP10;PUS3;GAR1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.7308444087502374,1.3978410791387745,0.15384615384615385,0.887282220548158,1.0,2/9,2.93%,ACADVL;ACADS
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6873765893445823,-1.3977748971269217,0.08433734939759036,0.657535981387444,1.0,4/25,9.06%,ART4;PARP2;PARP14;PARP9
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.8803163871415479,-1.3976426656298262,0.017543859649122806,0.6552598172804839,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),-0.7346069392896991,-1.3974271074299025,0.09090909090909091,0.6532703483810057,1.0,5/14,16.67%,DUOX1;GRN;HRAS;MYLK;PTN
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.5609575205944439,1.3973993412550396,0.07142857142857142,0.8851070509775479,1.0,4/22,7.07%,PHLDB2;ARAP1;ARHGAP28;TMEFF2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8404948528272276,-1.3966759544261191,0.04477611940298507,0.6544722701969099,1.0,5/9,12.32%,B2M;HLA-F;HLA-A;ERAP1;TAP1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),-0.6583647519343858,-1.3965455059572642,0.09210526315789473,0.652076531592833,1.0,5/27,7.93%,B2M;VEGFA;CD63;CLU;SFRP4
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.7566846049781243,1.3964994925514946,0.15151515151515152,0.8866292540802021,1.0,4/7,14.81%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.6203089342641239,1.396460201037235,0.10526315789473684,0.8827505910081738,1.0,8/33,11.41%,IL15;NOVA2;PLCL1;NR1H2;MAP2K6;NOVA1;ADAMTS5;IP6K1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7380330209567929,1.396170454185583,0.14814814814814814,0.8759891365721031,1.0,4/8,11.38%,SLC8A2;CACNA2D1;ATP2B4;SLC8A1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7380330209567929,1.396170454185583,0.14814814814814814,0.8759891365721031,1.0,4/8,11.38%,SLC8A2;CACNA2D1;ATP2B4;SLC8A1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.836950422029695,1.395833176735882,0.06666666666666667,0.8748002981717016,1.0,4/5,13.32%,CHRM3;DOCK5;DOCK4;ZDHHC21
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.7133939565048606,1.3956342560696635,0.05263157894736842,0.8717912940235649,1.0,3/8,16.87%,PIKFYVE;MAP2K2;PINK1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.746184783537168,1.3954288926369114,0.09523809523809523,0.869079424251838,1.0,4/8,8.43%,IRS1;AKR1C2;AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.8666022772033957,-1.3951552453608755,0.05,0.6583411017639447,1.0,1/5,3.31%,PAH
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.7639686061391477,1.394450750154155,0.07894736842105263,0.8702224949334479,1.0,4/7,14.82%,PPARG;UNC119B;ZDHHC17;VMP1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.44281237786960603,1.3938620384711506,0.0,0.8690137259054731,1.0,32/113,14.72%,RIT2;GABRG1;KCND2;ADGRB3;KCNQ3;ASTN1;MAP2;SATB2;KCND3;CADM2;PCP4;LRRC3B;NRXN1;CDH20;SLC8A2;LRRTM3;GRIA1;NXPH1;CLVS2;SEZ6L;ADGRA1;CA10;CTNNA2;VSTM2B;GRIA3;GRIN2B;ADCYAP1R1;GABRA1;TTBK1;KCNC2;KCNQ2;NGB
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.5448295990507437,1.393731301982943,0.0,0.86581750738219,1.0,8/34,6.49%,SOX11;SYNDIG1;NLGN1;LIG4;IL1RAPL1;NRXN1;GRID2;WNT7A
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.8500833839796085,-1.393240895704854,0.07246376811594203,0.6700084845885834,1.0,2/8,4.85%,VEGFA;EIF2B2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.6652083806740029,1.3929649157435289,0.13333333333333333,0.8668935260682606,1.0,2/15,2.87%,YJEFN3;NR1H2
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.8179314931038709,-1.3926251017636917,0.06451612903225806,0.671181415433675,1.0,2/9,7.98%,PPIB;STAT5A
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8737749181773756,1.3924192788488203,0.06818181818181818,0.8665076325722209,1.0,1/5,0.27%,CHRM3
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.5179434466338068,1.3919658604303555,0.14285714285714285,0.8651391730662773,1.0,15/68,8.66%,PKP2;TLN2;SHANK2;NLGN1;RYK;PKP4;SDK2;NRXN1;ADGRL3;CDH20;CDH9;CDH10;NRCAM;CDH18;OPHN1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6653629388777139,-1.391886779590257,0.05063291139240506,0.6689901203730398,1.0,5/30,13.86%,POLR2I;POLR2G;CDK7;NCBP1;GTF2F1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6653629388777139,-1.391886779590257,0.05063291139240506,0.6689901203730398,1.0,5/30,13.86%,POLR2I;POLR2G;CDK7;NCBP1;GTF2F1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5296380329842673,1.3915142976836272,0.07142857142857142,0.8637826651717392,1.0,5/40,4.39%,POU6F2;CRYGS;PCDH15;EYA4;MYO7A
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.6844883924811971,1.3903836854559928,0.12121212121212122,0.8650442931400542,1.0,2/12,1.84%,RANGAP1;BARD1
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),-0.6877024004385703,-1.3901460944521782,0.06944444444444445,0.6773046547890619,1.0,6/21,18.65%,TAF11;JUN;SAP30;CTDP1;SAP30BP;SNW1
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),0.7285412413838611,1.389564093784958,0.15384615384615385,0.8648028399840392,1.0,3/7,19.02%,NR1H2;PRKN;ITGAV
prerank,PanglaoDB_Augmented_2021__Chondrocytes,-0.6085762087838311,-1.3888268488477595,0.022222222222222223,0.683868102839365,1.0,31/90,22.86%,GADD45B;VEGFA;TNC;SFRP1;COL9A3;CRYAB;HAS2;PAMR1;FN1;COL4A1;LMOD1;COL15A1;COL6A1;ATF4;ACAN;NRP2;RUNX2;ADAMTS2;COL10A1;AEBP1;SCRG1;COL4A2;STAT1;COL14A1;CALD1;THBS2;PDGFRB;THY1;PDZRN3;RHOJ;C1S
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.7937255638296912,1.3886221810424635,0.11363636363636363,0.8670181464286526,1.0,2/7,7.97%,RFX3;FOXO1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.8181763790555796,1.3885348419443266,0.11627906976744186,0.86348999716265,1.0,3/5,15.66%,PPARG;ABHD5;OSBPL8
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.5286535659079145,1.3884884849006145,0.0,0.8603762711164424,1.0,8/40,11.03%,HDAC9;MIER3;HDAC10;SIRT1;TBL1XR1;HDAC11;TRERF1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.6542177817580915,1.3883898159229968,0.07142857142857142,0.8534659583735068,1.0,2/14,6.03%,PHLDB2;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.6542177817580915,1.3883898159229968,0.07142857142857142,0.8534659583735068,1.0,2/14,6.03%,PHLDB2;FAM107A
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.7385230230220132,1.3869203690257628,0.20512820512820512,0.8571999791176464,1.0,3/7,20.98%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.7241635108119127,1.3864816780951967,0.16129032258064516,0.8559281256978961,1.0,5/9,21.53%,ZKSCAN3;SIRT1;TERF2;CDK6;AKT3
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.8672241077248515,-1.3861681155473986,0.1,0.6977760227339369,1.0,2/5,11.49%,PDHX;PDHB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6420966079694126,1.3860740698012695,0.08695652173913043,0.8551058492553686,1.0,6/15,13.96%,PDE4B;PDE4D;SPTBN1;PTPRC;MAP3K7;PNP
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.6429145254369406,-1.385685124174129,0.03529411764705882,0.6978229524607048,1.0,15/85,14.84%,CD44;TNC;PLCD4;SLC6A6;SFRP4;PAMR1;FN1;OSMR;COL4A1;LMOD1;COL6A1;P2RX4;ACTA2;RUNX2;ADAMTS2
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7495438784000066,1.3856214820994524,0.17142857142857143,0.8538533201552091,1.0,4/8,22.36%,OXSR1;WNK1;SH2B3;PTK2B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.4925187265570166,1.3850559763776713,0.0,0.8531708456631425,1.0,12/44,11.68%,ATR;NAF1;MAPK1;STN1;POT1;GNL3L;TNKS;MAP3K4;CTC1;MAPKAPK5;MAPK3;HNRNPC
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.7367421809193914,1.3848731350161472,0.14285714285714285,0.8503265488380198,1.0,3/12,9.30%,SHANK2;LIMD1;MAPK14
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.7420341706947279,-1.3847652020274746,0.0821917808219178,0.7007384265247781,1.0,2/15,2.82%,CRYM;PIPOX
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.48090314990631144,1.3847148159251834,0.0,0.8475673345209914,1.0,5/153,2.13%,CPA1;ATG4A;MMP16;CTSV;ADAM10
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7412412480618661,1.3845135628768732,0.11764705882352941,0.8452606760209747,1.0,4/10,14.53%,OPHN1;MSN;RAB10;RAP2A
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.61763693673368,1.3844355510484734,0.15625,0.8422999861046989,1.0,2/9,6.28%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.7723690767465626,1.3844129350828098,0.11904761904761904,0.8389978435255471,1.0,3/7,12.19%,ADAM10;SLC29A4;ANTXR2
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.8873888038925868,-1.3843086151355297,0.017543859649122806,0.7008106202198171,1.0,2/6,10.36%,VEGFA;MESD
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.834167001759447,1.3840182030023562,0.0975609756097561,0.833379887773393,1.0,1/5,0.28%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.834167001759447,1.3840182030023562,0.0975609756097561,0.833379887773393,1.0,1/5,0.28%,PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.8431310444303106,-1.3837846174954958,0.09090909090909091,0.7013689492306915,1.0,1/6,0.58%,PPIF
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.749427291901013,-1.3836774397603753,0.07462686567164178,0.6985307409676954,1.0,4/13,13.74%,ATP6AP2;GRN;ATP6V0A4;ATP6V0E2
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.8945398172643287,1.3828501718076245,0.045454545454545456,0.8363525703957937,1.0,1/5,1.34%,LMO3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.7273163937148353,1.3822005456389066,0.10714285714285714,0.8354049930448789,1.0,1/9,0.18%,DPYD
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.7905094645306336,1.3821735131755801,0.18604651162790697,0.8321363932949657,1.0,5/6,20.86%,PADI2;ROBO1;SLIT3;SLIT2;SH2B3
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.727329341706807,-1.382155789830272,0.07894736842105263,0.7061239929542895,1.0,3/16,11.04%,ESRRB;BACH1;ID2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.7673839571923585,-1.3818050712923715,0.05172413793103448,0.7047691288583217,1.0,2/13,2.75%,VEGFA;FLOT1
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),0.8589898986017619,1.381260513061934,0.046511627906976744,0.834008160210664,1.0,3/5,9.66%,TOX;OPHN1;CHD5
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.7388110290755348,-1.3812444514541453,0.08,0.7055354171032592,1.0,8/14,24.14%,ATP5F1E;DMAC2L;ATP5PF;ATP5MC3;ATP5ME;ATP5PB;ATP5PD;ATP5MC1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,-0.5813664300643859,-1.3811823241308347,0.0,0.7022973095803996,1.0,50/174,19.64%,PDHX;NDUFA1;ATP5F1E;SURF1;UQCRQ;COX7A2;NDUFB2;COX4I1;VDAC2;NQO2;SLC25A6;NDUFC1;ISCA1;UQCR10;NDUFA6;TIMM8B;COX7C;GPX4;COX5B;ATP5PF;UQCRB;ACO2;PDHB;SUPV3L1;ATP6V1F;NDUFS7;CYC1;LDHA;COX7B;SLC25A5;ATP5MC3;HADHA;PMPCA;ISCU;COX6C;VDAC1;MRPS22;AIFM1;BAX;COX11;NDUFB7;VDAC3;HSPA9;NDUFA3;ATP5ME;AFG3L2;FH;ATP6V1D;MRPS11;MRPS30
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),0.6205720549276137,1.3809258456967606,0.13333333333333333,0.8324887353659591,1.0,4/24,8.09%,RPA1;ATR;ESR1;TNKS
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.8652460700165292,1.3809100961965664,0.05714285714285714,0.8292112206597939,1.0,2/5,2.11%,BAIAP3;NLGN1
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.714212374855967,1.3807062112624249,0.058823529411764705,0.8267234273459,1.0,2/10,8.13%,SOX11;PTPRC
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),-0.8271280974234745,-1.3803544491244901,0.03125,0.7046039732054642,1.0,1/7,0.66%,VEGFA
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.8936992112107076,-1.3803375187137819,0.03333333333333333,0.701362813945774,1.0,2/5,7.30%,LAGE3;OSGEP
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.8283620492303698,-1.3797639107760082,0.03333333333333333,0.7013898261084336,1.0,1/7,0.66%,VEGFA
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),-0.8250047271287446,-1.3792885707240525,0.03125,0.7015718094578075,1.0,1/9,4.37%,ARHGEF18
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.8587981514014373,1.3791161093688056,0.11428571428571428,0.8302847767497621,1.0,2/5,5.11%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.7463612361906106,-1.3779924757103779,0.078125,0.7074680199820971,1.0,5/14,16.82%,DDRGK1;PRELID1;APH1A;GRN;PSME1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.7724411724046166,-1.3771543016503762,0.05555555555555555,0.7096563233510812,1.0,3/13,6.06%,ROMO1;RARRES2;HLA-A
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.6468450814420621,-1.376634528909176,0.041666666666666664,0.710446654593806,1.0,7/32,12.71%,ISG15;FLOT1;POLR3D;IRF1;OAS3;OAS1;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.8197473808895338,-1.376552713335407,0.04054054054054054,0.7075364769887429,1.0,1/11,0.58%,PPIF
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6325645741109119,1.3762038531788423,0.08571428571428572,0.8408742913482167,1.0,4/11,19.79%,FMNL3;NCKAP1;FMNL2;IKBKB
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.49613731341340206,1.3760724368501638,0.0,0.8381378720110148,1.0,15/122,8.11%,CPA1;TCF7L1;LDB2;CALCRL;PCDH7;ACER3;GRIK2;CREB3L1;RAB27B;CDH9;LSAMP;CDC42BPA;SYNPO2;UNC13B;HS3ST1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.6321269077906897,1.3757507190122116,0.0967741935483871,0.836984877946881,1.0,7/25,10.52%,ZDHHC2;MCTP1;GRIK2;SLC8A2;ARC;NETO1;SLC4A10
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.6331638978623931,1.3757274402014261,0.125,0.8339386259834316,1.0,8/16,18.03%,SCD5;ACACA;FASN;ACSL4;ACSL3;HSD17B4;SLC25A1;FAR1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),-0.7911979319415858,-1.3755263272631875,0.0684931506849315,0.7124975550861563,1.0,2/12,2.44%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.8665445996267918,1.3753570634156183,0.07142857142857142,0.8329253949299846,1.0,1/5,4.96%,NRXN1
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.8177734663836249,-1.3750356418068153,0.04411764705882353,0.7101931795212382,1.0,2/8,5.10%,VEGFA;AGT
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.8177734663836249,-1.3750356418068153,0.04411764705882353,0.7101931795212382,1.0,2/8,5.10%,VEGFA;AGT
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7547166642180039,1.3748839273180868,0.16666666666666666,0.8320914991038539,1.0,3/7,19.44%,NSF;SNCA;RAB29
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7630950709576719,1.374617699899435,0.06666666666666667,0.826809579431477,1.0,3/9,12.59%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.7630950709576719,1.374617699899435,0.06666666666666667,0.826809579431477,1.0,3/9,12.59%,SYNJ1;INPP1;OCRL
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.6955241253432544,-1.3745893844965824,0.14084507042253522,0.7099911693582777,1.0,4/17,9.73%,B2M;HLA-F;HLA-A;CD160
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.6022714593618034,-1.3744709484032087,0.0,0.7076711402864272,1.0,26/119,15.46%,CD44;ADAMTS16;TNC;ITGA4;HRNR;ECM2;COL5A3;AGRN;SPINK5;COL9A3;MMP24;MARCOL;FN1;COL4A1;MMP25;COL15A1;COL6A1;COL9A2;VWF;THSD4;ACAN;MMP19;ADAMTS7;ADAMTS3;ADAMTS2;COL10A1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7076575017113645,1.3743712863750932,0.1111111111111111,0.8249902545422398,1.0,3/13,5.11%,DSE;VCAN;CSGALNACT1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.7778131304166324,1.3738870655676938,0.06666666666666667,0.8235226491442752,1.0,5/8,14.82%,PPARG;UNC119B;ZDHHC17;ZDHHC3;VMP1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7532150724911894,1.3735395813607838,0.09090909090909091,0.8216170046611514,1.0,3/7,12.39%,SOX11;BMP7;PHACTR4
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.9223233102263646,1.3723458494011533,0.06666666666666667,0.8236958738047081,1.0,2/5,4.96%,NLGN1;NRXN1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.752865734429089,1.3720390363307913,0.14705882352941177,0.8216366185292266,1.0,3/8,16.00%,SPRED2;NNMT;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7643672574074115,1.3717792473201351,0.16666666666666666,0.8192595846450449,1.0,2/7,14.79%,RAP1GDS1;MCU
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.6359635640116083,-1.371578213885415,0.11627906976744186,0.7253631073196053,1.0,10/45,8.45%,MX1;IFIT1;ISG15;TRIM5;IFITM3;PLSCR1;IFIT5;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.7009185449376246,-1.370475911537885,0.11428571428571428,0.7306586160408332,1.0,4/15,7.99%,PBLD;TGFB1;OVOL2;VEPH1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),-0.631676583950158,-1.3701018869844441,0.04878048780487805,0.7302201197781331,1.0,20/58,21.51%,SRSF7;RBM8A;FLOT1;SIDT2;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;HNRNPA2B1;UPF3B;MAGOHB;THOC5;RTRAF;CHTOP;RFTN1;SLBP;SRSF2;NUP188
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.7837091086756147,-1.3694244331184082,0.016129032258064516,0.7325607377520403,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.8214035142157458,1.3693909725599616,0.13953488372093023,0.8279049078652438,1.0,2/6,8.56%,FDX1;STARD3
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.7044606528421149,-1.368719584448233,0.05555555555555555,0.734443978278557,1.0,3/20,4.16%,B2M;FTL;CP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.8023645025910092,-1.368680821125763,0.07272727272727272,0.7315337167319494,1.0,1/7,0.36%,HLA-F
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.7445420588922478,1.3685486364494595,0.15,0.8291036291520781,1.0,3/8,14.76%,FCHSD2;WASF3;NCKAP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),-0.8121840381229534,-1.3676208490478894,0.06779661016949153,0.7363586086910131,1.0,3/8,7.72%,B2M;RPS27A;PGK1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.7868447371475911,-1.3669862159604074,0.08196721311475409,0.7385583003667234,1.0,3/8,11.04%,HES5;HES1;ID2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),-0.5871536782095768,-1.3668801413577023,0.022988505747126436,0.7359184802312635,1.0,8/90,6.31%,CD44;EVC;HES5;DDRGK1;RPL13;PPIB;PRELP;HHIP
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.8486121265862288,-1.366610696428116,0.0684931506849315,0.734723838149001,1.0,3/6,14.86%,ZFAND2B;CDH3;MYORG
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.735120863830585,-1.3663048233461834,0.07894736842105263,0.7335043327150675,1.0,7/16,15.73%,MT1E;MT1M;MT2A;SLC30A4;HVCN1;P2RX4;KHK
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.8435017255076913,-1.3658813557177896,0.09230769230769231,0.7329297298283102,1.0,1/5,2.15%,PHF1
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.693703594468478,1.3655208014419469,0.12903225806451613,0.8390219439637406,1.0,2/9,10.46%,RNF139;LRRK2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),-0.6078736625582774,-1.3655068863720365,0.03296703296703297,0.7326407833857618,1.0,20/74,18.13%,F13A1;VEGFA;CD63;F8;SCG3;A2M;TUBA4A;RARRES2;TGFB1;CLU;TTN;FN1;CALM1;VWF;BRPF3;PCYOX1L;CHID1;CYB5R1;APLP2;VCL
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.5444528224827899,1.3652958221571052,0.2,0.8370537219650903,1.0,12/56,8.29%,EMILIN3;SOX11;SPSB4;DPYSL5;NLGN4X;TOX3;CNTNAP2;MYCN;GAL3ST3;GRID2;UNC5D;BMP7
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.7333433961862437,-1.3652730143303011,0.05555555555555555,0.7314113140651816,1.0,6/19,6.06%,ISG15;IL12RB2;BTN3A1;ZFPM1;RASGRP1;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.8061050479009844,1.3643724225280662,0.15789473684210525,0.8391870295309786,1.0,3/7,10.53%,ILRUN;TRAF3IP1;PCBP2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.7126856241010575,-1.3640569764295618,0.08,0.7360348640415633,1.0,10/24,18.59%,FLG;SPINK5;OVOL2;JAG1;MED1;KRT10;ASAH1;USH2A;CASP3;CLIC4
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.6741095832706585,1.3637266537052044,0.12903225806451613,0.8398388120164971,1.0,4/12,14.59%,KAT2B;NAA50;NAA11;NAA16
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.8648961054143169,-1.3636316331188063,0.03508771929824561,0.7358747743450904,1.0,1/7,0.66%,VEGFA
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.5750631363327376,1.363487535270821,0.041666666666666664,0.8375102384193863,1.0,4/19,7.62%,IL15;FER;NMI;PKD2
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.6952412094738472,1.3634753996246374,0.15,0.8345515197769305,1.0,1/8,0.47%,GINS1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.5861546753260435,1.3634299720308278,0.047619047619047616,0.8316140105871088,1.0,7/23,14.59%,KAT2B;SIRT1;FOXO1;NAA50;NAA11;DSCC1;NAA16
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.7480463714304985,1.3629694474759926,0.0625,0.8313736364301926,1.0,3/10,13.26%,SOX11;PTPRC;LTBP3
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.5935247874559664,-1.3627265526183885,0.010638297872340425,0.7388535142358622,1.0,25/120,15.46%,CD44;ADAMTS16;TNC;ITGA4;ECM2;COL5A3;AGRN;SPINK5;COL9A3;MMP24;MARCOL;FN1;COL4A1;MMP25;COL15A1;COL6A1;COL9A2;VWF;THSD4;ACAN;MMP19;ADAMTS7;ADAMTS3;ADAMTS2;COL10A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.5202454444477891,1.3624393271125927,0.1,0.8309749753724357,1.0,9/52,11.14%,PLD1;TBC1D14;FER;IFT140;ATG5;DYNC2LI1;CAPZB;TBC1D1;RABGAP1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.48099931362922194,1.3622565883865865,0.1111111111111111,0.8286659771257254,1.0,28/113,15.60%,SYNDIG1;PCDH15;LRRC4C;ADGRB3;ASTN1;ZNF536;VCAN;MAP2;CDO1;LRRC3B;ADGRL3;ANK2;SLC8A2;LRRTM3;NXPH1;CLVS2;ADGRA1;CA10;VSTM2B;SLC35F1;ADCYAP1R1;MEGF10;NFASC;SOX10;TTBK1;CTNND2;FYN;TMEM178A
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.8114265117440185,-1.3622143839339194,0.045454545454545456,0.7390947096211167,1.0,1/9,2.64%,COX7A2
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.6258599404598902,1.3622029319553417,0.09090909090909091,0.8259496514937148,1.0,14/25,18.46%,ABHD17C;ABHD17B;PDLIM5;HOMER1;TANC2;IL1RAPL1;ARC;LRRK2;SRCIN1;ARHGAP22;ARHGAP44;SIPA1L1;CDKL5;PPFIA2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),-0.7925329852847787,-1.3621421556497286,0.07017543859649122,0.7364623873457369,1.0,3/10,6.06%,B2M;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.7320433907332421,-1.3621219266993685,0.125,0.7333417840095261,1.0,4/12,13.70%,B2M;HLA-A;RSAD2;CD55
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6752387941836411,-1.3620814293556613,0.02666666666666667,0.7307559493719622,1.0,10/24,17.47%,ZNHIT3;RPL10A;LAS1L;RPL7A;RPF2;DDX18;RPL35;WDR12;RSL1D1;NIFK
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.711432185296023,1.362055466050885,0.11764705882352941,0.8206793541434669,1.0,2/7,6.20%,IL15;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.711432185296023,1.362055466050885,0.11764705882352941,0.8206793541434669,1.0,2/7,6.20%,IL15;PLCB1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.7493463130880603,-1.3617497369262561,0.12307692307692308,0.7301495308642934,1.0,1/11,0.13%,DUOX1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),0.5750589927293281,1.3617165210839426,0.08,0.8198534535235612,1.0,8/25,17.74%,MAPK11;HSPA1A;ABCB10;MAPK14;FOXO3;ZNF16;MTURN;ACVR1B
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.9067662512003845,-1.3609790302537943,0.05357142857142857,0.733548013491673,1.0,2/6,5.96%,ZFPM1;OLFM1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7632594751444475,1.3609736800344872,0.20588235294117646,0.8214875362647135,1.0,3/6,11.06%,SIRT1;NNMT;ARPP19
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.6376736174412839,1.3605510114591204,0.12121212121212122,0.8211328916221295,1.0,4/15,25.92%,SNF8;PRKN;STAM;SMPD3
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.6340287948903187,1.3602838417170169,0.1,0.8194324388067135,1.0,4/14,5.32%,PDGFC;BCAR1;ABL1;FER
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.7516662532921455,1.359768631241451,0.16216216216216217,0.8196041008707156,1.0,1/7,0.44%,SOX11
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.7076184220860305,-1.3596335181587857,0.1038961038961039,0.7395289865534733,1.0,2/21,3.97%,FANCB;ZCWPW1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.510942108383676,1.3596242044969875,0.047619047619047616,0.8171480908701865,1.0,8/56,10.51%,ABHD3;NUDT19;ACADVL;ACADS;MMAA;ACAA2;PLA2G15;HADH
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.7300421334370184,1.3595175687700751,0.1724137931034483,0.8146575793771381,1.0,6/10,21.53%,ZKSCAN3;SIRT1;MARCHF5;TERF2;CDK6;AKT3
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.8202293224787185,1.3586139384501155,0.175,0.8159690431517356,1.0,1/5,11.79%,PTPRS
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.8701707473183589,1.3586128375650173,0.13043478260869565,0.8131936382430562,1.0,2/5,9.81%,SLC15A2;XIAP
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.4988321933816364,1.358275999439223,0.0,0.8118594929027984,1.0,37/119,13.06%,GABRG1;SEPTIN4;LRRC4C;RGS7BP;ADGRB3;BTBD17;ASTN1;KCND3;CADM2;LRRC3B;NRXN1;CDC42EP4;CDH20;MAGI2;FAM107A;HEPACAM;LSAMP;LRRTM3;MAPK10;ZEB2;SLC1A2;GRIA1;EGFR;NPAS3;RFTN2;DPP6;CLVS2;ADGRA1;CA10;CTNNA2;DLG2;GRIA3;GRIN2B;ADCYAP1R1;P2RX7;KIF1B;NFASC
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7021405272121289,1.3575813649874124,0.18181818181818182,0.8127114485449649,1.0,2/12,10.96%,ATF7IP;TRIM28
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.5583977543985246,-1.3574955939926245,0.022222222222222223,0.7516602722406747,1.0,24/217,9.28%,CD44;APIP;IFI6;PPIF;VEGFA;DDRGK1;NOL3;RPS27A;SFRP1;ANGPTL4;RPL10;IFIT3;RPS3A;HMGN5;COPS5;HAX1;HTR2B;XBP1;CRYAB;PRELID1;GPX4;MED1;ANKLE2;PTMA
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.6509034925708722,1.3573068130128203,0.12,0.8112869919883611,1.0,5/14,14.80%,HDAC9;SIRT1;SMARCAD1;HDAC4;SIRT6
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,-0.7785497775025445,-1.356113264528463,0.07575757575757576,0.7598738387309322,1.0,4/15,6.60%,SLC28A2;SLC3A1;PBLD;ACSM3
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.5143124269801801,1.3558579602618244,0.047619047619047616,0.8150519779224653,1.0,11/51,7.44%,PKP2;TLN2;NLGN4X;PKP4;CADM2;SDK2;CDH20;CDH9;CDH10;CDH18;NECTIN3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.7308636692162152,-1.3552519454244216,0.1044776119402985,0.7639866420021644,1.0,3/14,7.93%,VEGFA;CD63;SFRP4
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),0.8229042308330752,1.3547000859740888,0.12121212121212122,0.8169873906750691,1.0,3/6,10.59%,AKR1C3;H6PD;DGKQ
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5961602326303549,1.3543407773589589,0.12903225806451613,0.8158126998072089,1.0,8/16,18.96%,HSPA1A;DCUN1D2;DCUN1D5;ZMIZ1;WASHC1;DCUN1D1;PINK1;PRKN
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.8102968744848974,-1.3540418153480234,0.12162162162162163,0.769711894630557,1.0,1/7,3.99%,JUN
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),-0.8376057894950486,-1.353056827429097,0.07575757575757576,0.7743411677281001,1.0,3/7,8.54%,EPN1;ALOX5;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6457793521895021,1.3522194969003056,0.17391304347826086,0.8230103476733606,1.0,8/19,19.79%,PHLDB2;SLIT1;FAM107A;ROBO2;CORO1C;ARHGAP6;CLASP2;IKBKB
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),-0.8167210683602713,-1.3521575547278548,0.0,0.7783123490326468,1.0,2/6,4.27%,HLA-F;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.9017257934811498,1.3518779873342872,0.10256410256410256,0.8219723647266509,1.0,1/5,1.34%,LMO3
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.6346307025042685,-1.3513008616759499,0.0945945945945946,0.7813407215014233,1.0,14/41,21.20%,ROMO1;ATP5F1E;DMAC2L;TIMM8B;ATP5PF;SPG7;ATP5MC3;UQCC3;HSPA9;ATP5ME;AFG3L2;MICOS13;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.7246810991722523,1.3512988657918952,0.2,0.8213369151542873,1.0,2/7,5.76%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.6803954914900732,1.3508309572934263,0.16129032258064516,0.8214451094516436,1.0,2/9,11.38%,GSTM2;SLC8A1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),0.733674122330125,1.350725900611303,0.05,0.8191449341633872,1.0,3/9,11.31%,POGLUT2;GALNT16;GALNT13
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.8611268094795764,-1.3501888041431502,0.08955223880597014,0.7864177722551396,1.0,2/5,8.40%,HSD17B14;EPHX2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.8443319298728044,1.3497907709756878,0.10526315789473684,0.8206308943276166,1.0,2/5,9.86%,GLTP;CERT1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.47316877130553703,1.349717262029919,0.0,0.8185436193291558,1.0,38/131,16.20%,RIT2;LRRC4C;STYXL1;EPHA3;NCS1;CAMSAP2;PDLIM5;CSMD3;TOX;TANC2;IL1RAPL1;ROR2;NTNG2;MAGI2;ARC;DCC;ABL2;KANK1;ZNF804A;ADCY6;LRRC7;RELN;LRRK2;CTNNA2;FUT9;SRCIN1;BAG5;PTPRS;SEMA3A;PRKD1;KIF13B;RAPGEF2;TENM3;LPAR1;ARHGAP44;RAP1A;CCDC88A;SIPA1L1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.5997497012200722,1.3495697650599128,0.125,0.8166645273607717,1.0,10/31,13.08%,LRRC4C;NLGN1;NLGN4X;NRG3;GRIK2;ARC;GRID2;RELN;GRIK3;GRIK4
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6864009130690115,1.3494784384787102,0.15151515151515152,0.8143125992298308,1.0,3/13,14.80%,ATF7IP;TRIM28;SIRT6
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.724407133320168,1.3486311394102084,0.10810810810810811,0.8151181662096834,1.0,3/11,10.52%,GRIK2;SLC8A2;SLC4A10
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.6088955058251344,-1.3483458817598997,0.046511627906976744,0.796970864022635,1.0,7/49,9.19%,EPN1;IFI6;HAP1;AGT;RHBDF1;CEACAM1;SH3GL2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.528503144674253,1.3481137235694738,0.0625,0.8149066055171567,1.0,25/71,16.85%,LGR5;ASXL3;HID1;B4GALNT3;LRRN1;AHCYL2;TSPAN8;PRIMA1;TOX3;PBX1;SH3BGRL2;GPC4;APCDD1;BMP7;NEBL;CDS1;SEMA6A;AMOT;COBL;FRZB;NEO1;NDRG2;FREM1;PPP1R9A;ZNF704
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),-0.8855545551469546,-1.3479199699362399,0.05084745762711865,0.7973497502237881,1.0,1/5,3.26%,NAAA
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),-0.7192907834042349,-1.3475571782290892,0.12162162162162163,0.796669451097461,1.0,5/12,14.68%,PFDN6;CLU;CRYAB;VBP1;APOE
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.6885520217582628,-1.346851508694722,0.13636363636363635,0.7988316963469284,1.0,9/22,22.69%,COPS6;RPS27A;COPS5;UBA52;UBC;XPA;DDB2;COPS7A;RBX1
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.6855142893370181,1.3463274614190361,0.1935483870967742,0.8197879532796072,1.0,3/8,8.13%,PBX1;TOX;PTPRC
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.7803375806239674,-1.3457183332113822,0.09523809523809523,0.8045013246944664,1.0,2/10,4.71%,COPS6;COPS5
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.5948231868687881,1.345234074559228,0.14285714285714285,0.8229144285023602,1.0,3/34,1.53%,DUSP4;LMO3;SPRED2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.5680459148584214,-1.3451549378618608,0.022988505747126436,0.805445510223988,1.0,16/108,14.78%,CD44;VEGFA;EMD;SFRP1;TGFB1;OVOL2;HAS2;MEF2C;MED1;PDCD5;ZFP36L2;RACK1;STMN2;RUNX2;ADAMTS7;VIL1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6832307845861157,1.34496141035354,0.0967741935483871,0.8217732364699227,1.0,4/12,10.06%,NUTF2;NUP98;BANF1;RBM15B
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),-0.6735707175962682,-1.344427042889516,0.16216216216216217,0.8080834523754927,1.0,3/19,7.07%,DUOX1;ENPP4;XBP1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.7100184456195302,-1.344371479505525,0.06756756756756757,0.802232474963672,1.0,2/17,3.65%,POLR2I;POLR2G
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.7100184456195302,-1.344371479505525,0.06756756756756757,0.802232474963672,1.0,2/17,3.65%,POLR2I;POLR2G
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.8683617051270852,-1.3442760419651196,0.01694915254237288,0.7998080538586324,1.0,4/5,9.79%,HTR2B;HTR2C;HTR4;HTR1F
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.858458421267043,-1.3441684129315354,0.0967741935483871,0.797402354152087,1.0,1/5,4.08%,PUS3
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.8278552012986915,-1.3437459772789442,0.029850746268656716,0.7977959054026739,1.0,3/9,8.80%,ETV4;SFRP4;MED1
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),-0.8590172507097831,-1.3434084974633875,0.056338028169014086,0.7970168467978382,1.0,3/7,7.50%,VEGFA;TTN;JAG1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7022393966641025,-1.34303858946166,0.078125,0.7971022520748189,1.0,6/14,19.03%,C2ORF49;FAM98B;CSTF2;RTRAF;TRPT1;CPSF1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.7230926413820192,1.341901862528601,0.1111111111111111,0.8337227039093941,1.0,1/10,0.18%,DPYD
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.7082675458128567,1.3414140501929366,0.16,0.8325071057150616,1.0,2/8,3.77%,SGMS1;SMPD4
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.7545539890040169,-1.3411828923241809,0.08450704225352113,0.807786030516407,1.0,4/11,16.24%,HTR2B;PIK3CB;APOE;S100A1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.670031885543777,-1.341046331161238,0.15584415584415584,0.8053043865935495,1.0,8/24,13.63%,RPS14;RPS8;DHX37;RPS16;RPS21;KRI1;NOP14;UTP3
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5059338290517637,1.3402227784912402,0.08333333333333333,0.8348921442351018,1.0,4/38,4.39%,POU6F2;CRYGS;EYA4;MYO7A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.6330454891155226,-1.3400400048452008,0.08235294117647059,0.8100865676569635,1.0,9/28,19.55%,RBM47;FPR3;CEBPD;RNASE1;TYMP;NRN1;C3;STEAP4;CLDN18
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.5638650704000322,1.3399532934425953,0.038461538461538464,0.83306785997299,1.0,7/19,15.38%,HS6ST3;EXT2;UGDH;EXTL3;GPC1;EXT1;HS2ST1
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),-0.8772342572417261,-1.3399476147225515,0.05172413793103448,0.8078867362741408,1.0,1/5,0.26%,B2M
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.4392452946329521,1.3398049975410904,0.0,0.8311140747738065,1.0,25/116,14.30%,DAPK2;ERBB4;ATR;PEAK1;PRKX;ABL1;GRK5;MAP3K9;FER;IGF1R;MAP3K11;CDK12;OXSR1;EGFR;MAPKAPK5;PIKFYVE;MAPK3;LRRK2;SMG1;AATK;PRKD1;LMTK2;MAP2K2;FLT1;STK24
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.8054773436950058,1.3395429218668349,0.17777777777777778,0.8295471621275349,1.0,4/5,16.18%,SLCO1A2;SLC16A2;SLCO5A1;SLCO3A1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.821646003076555,1.3395405826908349,0.15151515151515152,0.8269629030554865,1.0,3/5,15.91%,SEC16A;LRRK2;GBF1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.7883907740330042,-1.338700229547437,0.046153846153846156,0.8137968222924256,1.0,3/10,6.74%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.6488989543141015,-1.3378981658943032,0.06944444444444445,0.8173247633795448,1.0,12/33,20.01%,RPS14;RPS8;DHX37;RPS16;RPS28;NOB1;NOP14;UTP3;RIOK2;HEATR1;MRPS11;DCAF13
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7506456587029184,-1.3376311579508113,0.0684931506849315,0.8159288704846711,1.0,2/14,2.61%,SURF1;COX18
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),-0.9256976547628706,-1.3367613398356097,0.07462686567164178,0.8188277255338559,1.0,2/5,7.02%,PAH;BCAT2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.6573448208304087,1.3367129661024453,0.2,0.8363093930741636,1.0,2/12,5.76%,EHD1;PLIN5
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),0.6057922570622774,1.336638726434631,0.15625,0.8341377791709931,1.0,6/11,28.61%,KEAP1;PKD2;MDFI;SUFU;FAF1;G3BP2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.759022394753199,1.3365992361637251,0.16666666666666666,0.8317945523188708,1.0,2/8,6.14%,FYCO1;IGF1R
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.8487468103892295,1.3365126406659813,0.08333333333333333,0.8295579696677874,1.0,3/5,5.15%,SIRT1;CTBP1;PPARG
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.8193490777444499,1.336476549516744,0.10256410256410256,0.8271971962125695,1.0,2/6,5.55%,LAMA3;LAMC1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),-0.7194674075636511,-1.3359951559683187,0.12162162162162163,0.8182412009301424,1.0,6/15,15.87%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),-0.7194674075636511,-1.3359951559683187,0.12162162162162163,0.8182412009301424,1.0,6/15,15.87%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.6344356129006422,-1.3359824892070504,0.0641025641025641,0.8153616839303074,1.0,8/31,17.94%,RPS14;VEGFA;ZFPM1;MED1;ID2;SLC25A5;CASP3;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.7917405437352244,1.3356642872885216,0.17391304347826086,0.8278756509861317,1.0,5/5,20.86%,PADI2;ROBO1;SLIT3;SLIT2;SH2B3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),-0.6427222844016087,-1.3355254456653922,0.08641975308641975,0.8153763968698564,1.0,4/33,3.45%,RIMS1;LIN7B;NAAA;DVL1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.8587105190811959,-1.3354189075619127,0.109375,0.812966417371719,1.0,1/6,2.15%,PHF1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.6525079874970819,-1.3350387089843143,0.08108108108108109,0.813135232360719,1.0,11/25,21.20%,ATP5F1E;DMAC2L;ATP5PF;SPG7;ATP5MC3;UQCC3;ATP5ME;AFG3L2;MICOS13;ATP5PB;ATP5PD
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.6758446385813764,-1.3345668168594356,0.0410958904109589,0.814317861951902,1.0,7/33,8.45%,ROMO1;RPL30;ISG15;RARRES2;HLA-A;OAS3;OAS1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.7309539154412114,1.334433602684629,0.08333333333333333,0.8315198457552334,1.0,3/9,4.96%,NLGN1;PCLO;NRXN1
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.5066951732104612,1.3336859214527539,0.1875,0.8320443828189482,1.0,20/52,18.40%,CRB2;SOX11;SMAD9;ELAPOR2;CRIM1;PPARG;SMAD7;UBE2D1;TWSG1;XIAP;SPART;CHRD;ITGA3;SMAD1;BMPR1B;VWC2;RBPJ;SMAD5;LEMD3;BMPR1A
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7833241827515749,1.3330012411527727,0.11428571428571428,0.8325203273676807,1.0,2/9,5.43%,LIMD1;PUM2
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),-0.795452949598648,-1.332544547682532,0.09230769230769231,0.8273973977238757,1.0,1/8,0.66%,VEGFA
prerank,PanglaoDB_Augmented_2021__Neutrophils,-0.7068607443486649,-1.3324820030392774,0.11764705882352941,0.8249788838785644,1.0,10/16,20.01%,ARG2;IGSF6;OAS3;CEACAM1;TBXAS1;MYO1F;PILRA;MYLK;ADPGK;DOCK8
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.5764550987608009,1.3323912386491594,0.0967741935483871,0.8327670146107311,1.0,6/17,13.71%,CAMSAP2;PDE4DIP;MAPK1;MAPK3;MYO5A;MAP2K2
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),-0.8589010865362342,-1.3320098023639662,0.1016949152542373,0.8262213046114754,1.0,1/5,1.53%,DDRGK1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6828565438781772,-1.3316882190537946,0.07894736842105263,0.8261112403046209,1.0,6/19,22.69%,RPS27A;UBA52;UBC;XPA;DDB2;RBX1
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.6237219080016517,-1.3316079557822025,0.07407407407407407,0.823808476437808,1.0,10/32,21.47%,SLC6A6;SLC7A6;SLC16A4;SLC6A9;SLC3A2;SLC7A8;SLC16A1;SLC36A4;SLC17A5;SLC16A3
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.8627843459519525,-1.3314547190890669,0.03125,0.8221180945236569,1.0,3/7,6.74%,MT1E;MT1M;MT2A
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.7833523659076848,-1.331098190316107,0.06060606060606061,0.8217407793473324,1.0,6/13,14.48%,FTL;IGSF6;TYMP;MYO1F;PILRA;CHIT1
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.7977865753399086,1.3310210004787326,0.1875,0.8359914509785242,1.0,5/7,18.89%,SALL1;PKD2;BMP7;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),-0.8202558453859266,-1.3308860697769531,0.07352941176470588,0.8202950099976342,1.0,1/7,1.03%,LIPI
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6853631573213074,-1.3297364514368517,0.1232876712328767,0.8257409940121961,1.0,8/19,19.68%,NUBP1;ISCA1;CIAO2B;NDOR1;ISCU;MMS19;HSPA9;CIAO1
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.7430206505841406,1.3295902355724647,0.1,0.8401416131703854,1.0,4/7,18.61%,IRS1;PRKCE;SNCA;AKT2
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.8768086224243756,-1.3294825428817016,0.018518518518518517,0.8242633712096783,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),-0.6443858769061628,-1.3289643451540591,0.0875,0.8255574445182383,1.0,4/32,3.45%,RIMS1;LIN7B;NAAA;DVL1
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5584670436881751,1.3283883243024344,0.19047619047619047,0.8430105745022146,1.0,5/25,7.36%,LAMA3;PEAK1;PTPRK;LAMC1;THSD1
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.8093769401824302,-1.3283445845270963,0.13333333333333333,0.827287310537122,1.0,2/8,16.50%,ACMSD;PGP
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.5769018992439958,1.328337983953402,0.07692307692307693,0.8405835964040986,1.0,4/22,9.30%,MAPK11;HSPA1A;ABCB10;MAPK14
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),-0.8602520981249255,-1.3280542357141696,0.1111111111111111,0.8262905568959045,1.0,1/5,6.70%,KDM6B
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),0.7895209081714221,1.3280334114666594,0.11904761904761904,0.8390631155456545,1.0,2/7,4.73%,LIG4;SIRT1
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.6632731848715642,-1.327685666182085,0.10126582278481013,0.8259907968358803,1.0,6/31,8.71%,S100A6;FTH1;EMD;SFRP1;AGT;FN1
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.8048145519626686,-1.3276699907526868,0.09375,0.8231895724117636,1.0,2/9,4.69%,ART4;PRMT8
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.5315318264783265,1.327339085973933,0.14285714285714285,0.8394194065151552,1.0,4/26,9.11%,RNF139;SIRT1;BTRC;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),-0.8648968549451371,-1.327279119733484,0.1,0.823395953220314,1.0,2/5,1.84%,F8;A2M
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.6897239221331553,-1.32703738880149,0.08450704225352113,0.8218521921199539,1.0,6/21,16.51%,DUOX1;ALOX5;VIL1;HRAS;MYLK;CAV1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.7336406737099722,-1.327024503427636,0.12121212121212122,0.8191479467059247,1.0,2/11,6.31%,OPRM1;HHIP
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.6739935105632655,-1.3268434967042322,0.10606060606060606,0.8173847131183044,1.0,5/21,14.39%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7471362558624968,1.3264396033175823,0.1388888888888889,0.8415027956944529,1.0,4/8,18.96%,IL1RAPL1;STXBP6;SNCA;PRKN
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7788275929858182,1.3255829403868724,0.22857142857142856,0.8423802819669398,1.0,4/7,14.08%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.738348756858729,-1.325207219033434,0.12903225806451613,0.8264796133006697,1.0,7/14,20.19%,EMC3;EMC7;EMC6;MMGT1;EMC10;BAG6;CAMLG
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.7209970711040636,-1.3251808380273302,0.09722222222222222,0.8240027216954046,1.0,2/13,7.74%,OLFM1;HAS2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.5887971672080976,-1.3251410030842412,0.11363636363636363,0.8215423979269642,1.0,16/54,20.30%,SRSF7;RBM8A;DHX38;CDC40;SRSF5;CASC3;NCBP1;CSTF2;SUPV3L1;UPF3B;MAGOHB;CSTF1;THOC5;CHTOP;CPSF1;SRSF2
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.7690554694647604,1.3246172288613556,0.13953488372093023,0.844266396213658,1.0,1/7,3.60%,BOK
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6085942548060835,1.3246087957381691,0.10714285714285714,0.841834490230089,1.0,1/13,0.18%,DPYD
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.7902775885925163,-1.3245018725162163,0.08450704225352113,0.8240255455131721,1.0,4/9,18.26%,ISG15;RPS27A;UBA52;UBC
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.6373482023063037,-1.3243027813189199,0.0875,0.8228625458092537,1.0,7/37,6.15%,HLA-B;HLA-C;FTL;PDCD1LG2;NAAA;HLA-A;IGSF6
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7138146450606931,1.3239786636720394,0.13157894736842105,0.8417392683700612,1.0,1/9,2.06%,IRS1
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.8629992420899004,-1.32371457990974,0.030303030303030304,0.8240746672439289,1.0,1/7,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.8275656644737679,-1.3234354275357811,0.078125,0.8232373310964546,1.0,1/8,1.45%,TUBB4B
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.5432291636864222,1.3224634967333868,0.10714285714285714,0.8465381383327388,1.0,5/25,8.13%,IL15;RAB27A;DYSF;MERTK;PTPRC
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),-0.809404032259328,-1.3223419444631261,0.07575757575757576,0.8277698221398838,1.0,3/7,9.15%,PDXDC1;ENPP2;FUCA1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.619996227569498,-1.3220591301527904,0.1125,0.8271365700492925,1.0,13/43,16.97%,B2M;SCG2;SFRP1;CDKN1C;TGFB1;ALOX5;CEACAM1;MED1;CNMD;AIMP1;APOE;CAV1;STAT1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.5243610021179772,1.3220275711711549,0.13043478260869565,0.8458634480715501,1.0,8/45,7.38%,PKP2;TLN2;PKP4;CDH20;SMAD7;CDH9;CDH10;CDH18
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),-0.8307326781326372,-1.3212450694040547,0.12280701754385964,0.8299990393585558,1.0,2/6,16.26%,PUS3;DKC1
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6444974172206616,1.320575484020193,0.25,0.8489718622641971,1.0,6/15,7.11%,NLGN1;NLGN4X;PCLO;IL1RAPL1;WNT7A;LRRTM3
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.7705157647313072,-1.320426543775112,0.09523809523809523,0.8331568645026951,1.0,4/9,7.65%,TAF7;TGFB1;SELENOS;AP2A1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.7964197976753631,1.320192206635798,0.225,0.847947530413579,1.0,2/5,12.97%,TGFBR2;ACVR1
prerank,MSigDB_Hallmark_2020__Apical Junction,0.5143805791201367,1.3200227209466981,0.16666666666666666,0.8461085184568641,1.0,29/129,10.95%,MAPK11;CERCAM;NEGR1;LAMA3;SHROOM2;ARHGEF6;IRS1;THBS3;VCAN;TRAF1;ADAM23;PPP2R2C;CADM2;ITGA2;TUBG1;TNFRSF11B;MYH9;MAP4K2;NECTIN3;CNTN1;EGFR;PTPRC;WASL;MSN;MAPK14;PARD6G;HADH;NF2;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.5841625215114327,1.3194157160663678,0.07692307692307693,0.8463902374166163,1.0,4/19,7.07%,PHLDB2;ARAP1;ARHGAP28;TMEFF2
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.568577856647351,-1.3188967389254864,0.1,0.8431276759393186,1.0,18/94,18.79%,RPS14;IFIT1;VEGFA;TUBB2A;IMP3;XBP1;FKBP14;DDIT4;DCTN1;NOP56;NOP14;ATF4;H2AX;DKC1;HSPA9;WFS1;TSPYL2;POP4
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8462294932771217,1.3188702564079247,0.16129032258064516,0.8463697540020528,1.0,2/5,9.15%,AK3;CMPK1
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6990803629740905,-1.3185749953679662,0.046875,0.8428948790573273,1.0,6/15,19.03%,C2ORF49;FAM98B;CSTF2;RTRAF;TRPT1;CPSF1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.8195534029120304,-1.3185195669574403,0.12121212121212122,0.8405127421730111,1.0,1/7,1.59%,SCG2
prerank,GO_Biological_Process_2021__artery development (GO:0060840),-0.6438806346702033,-1.3183837145319763,0.11428571428571428,0.8386883636122905,1.0,2/16,2.84%,VEGFA;HES1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.7086457079768095,1.318373254761177,0.16666666666666666,0.8440235287295833,1.0,4/9,20.05%,SPRY4;KANK1;CORO1C;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.7086457079768095,1.318373254761177,0.16666666666666666,0.8440235287295833,1.0,4/9,20.05%,SPRY4;KANK1;CORO1C;ACTN4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),-0.7946008504911588,-1.3183077110924732,0.1694915254237288,0.8338939709689642,1.0,1/7,4.03%,YBX3
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),-0.7946008504911588,-1.3183077110924732,0.1694915254237288,0.8338939709689642,1.0,1/7,4.03%,YBX3
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.7955407233983002,1.3181884230663232,0.17142857142857143,0.842306937150996,1.0,4/7,13.32%,ADRA1A;PDE4D;RAPGEF2;ZDHHC21
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.8295681249135498,1.3168425804198876,0.15789473684210525,0.8452276171508083,1.0,2/5,10.59%,H6PD;DGKQ
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.7974397977764418,1.3167012418313613,0.11627906976744186,0.8436443263128593,1.0,4/6,18.89%,ALCAM;NRP1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.47915833221340054,1.31617544232452,0.07142857142857142,0.8434630625837167,1.0,11/73,7.63%,PKP2;CRB2;HDAC9;ERBB4;FBXW7;KAT2B;SALL1;PDLIM5;FGF12;PKD2;TGFBR2
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),-0.7086686926831217,-1.3161613026045125,0.1388888888888889,0.8475350404915003,1.0,6/16,15.87%,C4BPA;CLU;CPB2;CD55;C3;CD46
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.8305088456200489,-1.3160837442313775,0.03225806451612903,0.8453800040609547,1.0,1/5,2.44%,FGF1
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.839543637658452,-1.315948213838881,0.08620689655172414,0.8438741502180859,1.0,1/6,6.70%,KDM6B
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),0.7012627923679056,1.3153362462564508,0.16666666666666666,0.8447983014861996,1.0,2/12,5.86%,VTI1A;TMED5
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),-0.8527746640411151,-1.3153122398541808,0.11764705882352941,0.8459509527531678,1.0,1/7,0.61%,IFIT1
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.5875303375313101,1.3150986212036708,0.08695652173913043,0.8431875393103284,1.0,8/21,11.88%,PKP2;KCND3;FGF12;ANK2;DMD;CACNA2D1;SLC8A1;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.6891029859680499,1.3147683358883706,0.06451612903225806,0.8422136999322279,1.0,2/8,13.68%,HSPA1A;DNAJA4
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.7529528047985765,-1.3145828236642345,0.0847457627118644,0.8480146936370857,1.0,1/13,0.13%,DUOX1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.7648419534921069,-1.3145270479197304,0.1267605633802817,0.8457844453965131,1.0,5/11,16.97%,CDC37;IFNGR2;PARP9;HSP90AB1;STAT1
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6695426045605668,1.3143971511646628,0.2,0.8409948158294928,1.0,2/11,11.38%,NEDD4L;SLC8A1
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.6888458542133694,-1.3143144343089068,0.16216216216216217,0.8447480220034074,1.0,4/17,8.05%,ANGPTL4;RBM47;ABCC3;CEBPD
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.45893423900196095,1.3139371804089397,0.0,0.8404903970520048,1.0,19/78,15.43%,ERBB4;BCAR1;EPHA3;RYK;ROR2;FER;TNK2;IGF1R;MERTK;EGFR;ABI1;EPHA5;LMTK2;PTPRU;FRS2;FLT1;PTPRG;MTSS1;FYN
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7160468137734592,-1.3136696147379134,0.07575757575757576,0.8470715062612495,1.0,4/13,18.65%,TAF11;JUN;CTDP1;SNW1
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.6513062196823619,1.3132369868742815,0.17647058823529413,0.8408190473988617,1.0,1/9,2.12%,ADRA1A
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.5878980462343965,1.3131443143745873,0.12,0.8389931314386443,1.0,4/12,12.90%,LPXN;CBFB;FOXP1;SLC39A10
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.8597539153384095,1.3126305490023678,0.13157894736842105,0.8390351007226994,1.0,1/5,2.71%,RYK
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6116125637970683,1.3121787354916346,0.06451612903225806,0.8384592656775833,1.0,4/18,11.23%,NEDD4L;ANK2;NETO1;NEDD4
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.6540962414824998,1.3107466762948372,0.1935483870967742,0.8423209344634026,1.0,1/10,2.58%,PRKX
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),-0.6597759022531993,-1.3106240265352065,0.1095890410958904,0.8659460494860545,1.0,2/25,3.97%,DUOX1;CFTR
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7550972934777291,1.3103826571633175,0.1,0.8415345353671012,1.0,3/7,15.43%,IGF1R;ITGA3;FYN
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5590984244042512,1.310361978841247,0.1111111111111111,0.8394457008813145,1.0,4/21,2.98%,COL7A1;LAMA3;PLOD1;ATP2C1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.7690238268359061,-1.310268838104991,0.07936507936507936,0.8661998551200526,1.0,1/9,1.27%,FANCB
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.6195687618087645,1.310067829860734,0.16666666666666666,0.838467768504283,1.0,2/18,3.12%,LZTR1;SPRY4
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.4776441168219365,1.3100124643211084,0.05,0.8364797940387341,1.0,9/49,8.88%,BAIAP3;SOX11;RAB27A;SYTL4;STXBP5;RAB27B;RAB9A;UNC13B;FRMD4A
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.6317418683574116,-1.3100050311110027,0.07692307692307693,0.8653859508589855,1.0,6/42,5.10%,S100A6;ITGA4;A2M;PAH;ARX;AGT
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.5233411365506537,-1.3097895969653732,0.021505376344086023,0.8641321359475614,1.0,34/277,12.08%,CD44;APIP;IFI6;PPIF;VEGFA;DDRGK1;NOL3;RPS27A;SFRP1;ANGPTL4;RPL10;RETREG1;BEX3;IFIT3;RPS3A;HMGN5;COPS5;HAX1;HTR2B;ALOX12;XBP1;CRYAB;PRELID1;MEF2C;PTRH2;MED1;ANKLE2;PTMA;GRN;WNK3;PRDX5;BDNF;RNF213;SUPV3L1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.8117009192314218,-1.3094918921936287,0.07462686567164178,0.8633049257438591,1.0,2/8,8.80%,ETV4;MED1
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.7282079427176738,1.3092338557950733,0.19444444444444445,0.8370543132634062,1.0,3/9,18.08%,AK3;NT5C1A;AMPD2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7788143081747201,-1.3091634049418712,0.1323529411764706,0.8630723723605188,1.0,3/8,9.06%,PARP2;PARP14;PARP9
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.8115795881316954,-1.3091429856005674,0.13114754098360656,0.860636987444634,1.0,2/5,14.68%,LRPAP1;APOE
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6602180777609342,-1.308914258591328,0.13333333333333333,0.8595349371168846,1.0,8/20,19.68%,NUBP1;ISCA1;CIAO2B;NDOR1;ISCU;MMS19;HSPA9;CIAO1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),-0.6295014765092259,-1.3085074884570689,0.12,0.8603870240623438,1.0,4/32,4.02%,PFN2;DNAJC9;PLSCR1;GABARAPL2
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.8203217177992964,-1.3084244280529107,0.03076923076923077,0.8583216005149151,1.0,1/7,0.19%,APIP
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.6699866054343477,1.307607985274949,0.12121212121212122,0.842634685541498,1.0,2/8,3.15%,TG;SALL1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.6943293180162486,-1.3072993064611245,0.14492753623188406,0.8650519782923093,1.0,4/17,21.48%,SELENOS;DERL2;SYVN1;TMEM129
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.7723270507204727,-1.3070583650649912,0.11392405063291139,0.8643358902779653,1.0,3/11,4.85%,VEGFA;COL9A3;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.5245029751537181,1.3067332745730273,0.10526315789473684,0.8439147216337725,1.0,4/22,8.79%,SOX11;TNKS;RSF1;ILRUN
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.7348118002401596,1.3066882623490612,0.1935483870967742,0.8419334628377484,1.0,3/9,7.63%,CHD7;WNT7A;TGFBR2
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.646018657550588,1.3065989152796351,0.17647058823529413,0.8400830112209811,1.0,3/11,4.82%,BARD1;ZC3H3;PAPOLA
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.575880490859664,-1.3065905208196686,0.1,0.8652355535528808,1.0,12/60,9.73%,B2M;HLA-F;HLA-B;ITGA4;HLA-C;PLSCR1;SPINK5;IRF1;HLA-A;RSAD2;ERAP1;CD160
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),-0.765901486434622,-1.3065230879313428,0.14285714285714285,0.8632522582433045,1.0,2/11,8.45%,MX1;OAS1
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.7815428977194105,-1.3064783738409327,0.125,0.8584389880012651,1.0,5/9,19.72%,SYCE2;STAG3;REC8;BAG6;TEX11
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.7815428977194105,-1.3064783738409327,0.125,0.8584389880012651,1.0,5/9,19.72%,SYCE2;STAG3;REC8;BAG6;TEX11
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),0.5866273760498294,1.3064249807858028,0.15151515151515152,0.8384022842082143,1.0,7/17,20.27%,USP51;KAT2A;USP15;ATXN7;USP49;USP22;USP3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.7801825157081188,-1.305737867161859,0.1724137931034483,0.861032911819779,1.0,5/10,17.42%,EMC3;EMC7;EMC6;MMGT1;EMC10
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.5030801118529862,1.304451192162177,0.10526315789473684,0.8446621586889169,1.0,20/54,19.37%,SMAD9;SPRY4;CREB3L1;CRIM1;PPARG;SMAD7;UBE2D1;ATP2B4;SPART;NEDD4;GPC1;CHRD;SMAD1;BMPR1B;VWC2;SMAD5;LEMD3;BMPR1A;SLIT2;GREM1
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5613834579336132,1.3044313590579415,0.15384615384615385,0.8425806829981418,1.0,4/26,5.37%,PKP2;STIM2;ANK2;GPD1L
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.7273830465058746,-1.3038346163870704,0.12307692307692308,0.8718106758749152,1.0,2/14,3.70%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.6874708549933054,-1.3033537222180003,0.11764705882352941,0.8725070873257045,1.0,7/17,25.83%,PSMB9;PSMB8;PSMA3;PSMA7;PSMB6;PSMB1;PSMB3
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.691334793013149,1.3032808970372483,0.09090909090909091,0.8453074721359369,1.0,3/10,14.53%,OPHN1;MSN;RAP2A
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),-0.7137089008480679,-1.3032460847397085,0.14516129032258066,0.8707258282566999,1.0,3/13,11.40%,VEGFA;AGT;WNT5B
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),-0.6309613167983777,-1.3028147791417852,0.14473684210526316,0.8712334265635308,1.0,5/25,10.24%,PPIF;NOL3;CLU;PRELID1;PDCD5
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),0.6306401922159666,1.3022007391337107,0.16216216216216217,0.8473871982886596,1.0,3/12,25.92%,SNF8;STAM;SMPD3
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.7538242028450743,1.3020447210179353,0.24242424242424243,0.8456699265184705,1.0,3/6,16.74%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.744285022463982,-1.3020074871396348,0.22058823529411764,0.8743377514525695,1.0,5/10,19.25%,BUD23;UTP15;DIMT1;RIOK2;HEATR1
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),-0.6332541274255113,-1.3014896274159786,0.14473684210526316,0.8756025318087775,1.0,9/32,20.12%,ANKRD53;RAB11A;ZW10;CENPC;CHMP4B;MIS12;EML3;RMDN1;KIF22
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7764968388275343,-1.3014829882542214,0.14285714285714285,0.8730878382817774,1.0,2/7,6.41%,CLU;HDAC6
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.7072270326207118,-1.301239507050736,0.125,0.872421865337331,1.0,6/13,20.38%,PRPF8;SRSF10;PRPF6;USP4;PRPF31;DDX20
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.5054672599843516,1.3008709956631292,0.2,0.8482491330358359,1.0,13/52,13.82%,YJEFN3;TP63;FBXW7;KAT2B;TSPAN15;BMP2K;EGFR;POFUT1;BEND6;TSPAN5;ZMIZ1;TSPAN14;DLL1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.7592741213390616,1.3006369948536782,0.11764705882352941,0.8467739852020166,1.0,4/6,14.81%,PUM2;ANKRD17;ZCCHC3;USP15
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),-0.8634249810302741,-1.3003355432738022,0.1,0.8736637362644658,1.0,2/5,2.35%,B2M;RPS27A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),-0.8634249810302741,-1.3003355432738022,0.1,0.8736637362644658,1.0,2/5,2.35%,B2M;RPS27A
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.6040724767633556,-1.3002924286134765,0.0975609756097561,0.871390581289318,1.0,18/52,15.73%,SLC28A2;TREH;CDH19;DEGS2;CEACAM1;ASPN;TMC4;EPHX2;RBP2;GSTM3;NR5A2;CD55;FAHD1;CA1;PDZK1;VIL1;CBR1;KHK
prerank,MSigDB_Hallmark_2020__Myc Targets V1,-0.5353338191485512,-1.2997146024727861,0.010416666666666666,0.8726191479970463,1.0,66/176,26.96%,SRSF7;RPS2;RPL34;H2AZ1;SNRPA1;APEX1;RPL14;COPS5;SNRPD1;POLE3;SNRPD2;PGK1;RPL18;CAD;BUB3;IFRD1;RPLP0;DDX18;NCBP1;CSTF2;HNRNPA2B1;HDGF;NOP56;CYC1;LDHA;RACK1;CCT7;RFC4;VBP1;PRPF31;VDAC1;RPS6;SRPK1;EIF3J;PSMA7;HSP90AB1;RSL1D1;PPM1G;VDAC3;RPL6;CDK4;HSPD1;ILF2;POLD2;SET;FBL;SRSF2;SNRPG;CBX3;LSM7;ERH;IMPDH2;HDDC2;PSMC4;MRPS18B;HNRNPR;SERBP1;HNRNPA3;ABCE1;NOLC1;PSMB3;RANBP1;PSMD7;SF3A1;EIF1AX;PRDX4
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.6989005835911893,1.2994390801359463,0.20512820512820512,0.8496498736379595,1.0,3/8,12.78%,XKR6;RHOBTB1;MEGF10
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5619641881686168,-1.2993499031723372,0.022988505747126436,0.8725590538128438,1.0,27/92,22.77%,POLR2I;COPS6;RPS27A;UVSSA;POLR2G;COPS5;RFC2;FAN1;RPA3;CDK7;FANCC;PNKP;UBA52;RFC4;RFC1;MMS19;HMGN1;UBC;RFC3;XPA;DDB2;LIG1;POLD2;COPS7A;XRCC1;RBX1;POLE
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.65834968599304,1.2986106813254954,0.11764705882352941,0.8498569319374284,1.0,3/12,10.36%,PLOD1;EGLN3;P3H2
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6497560388089739,1.2971847304980868,0.20689655172413793,0.8531380574912313,1.0,2/10,5.11%,DSE;CSGALNACT1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.5827786609515486,-1.2970483147552607,0.08433734939759036,0.8870824156496676,1.0,16/54,19.73%,DXO;RPS27A;IHO1;PNRC2;RFC2;RNASE1;FAN1;RPA3;UBA52;RFC4;RFC1;UBC;RFC3;XPA;DDB2;POLD2
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.7270367440903058,1.2970233889036193,0.28888888888888886,0.8516267055409954,1.0,1/5,0.44%,SOX11
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.5572937802309147,-1.296864725291566,0.06315789473684211,0.8856617762843767,1.0,16/119,10.65%,CD44;VEGFA;COL5A3;RARRES2;WIF1;CKAP4;HHIP;ASPN;GSTM5;PAMR1;FN1;P4HTM;COL4A1;LMOD1;COL15A1;COL6A1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.6080722737835599,-1.2966896510474497,0.0898876404494382,0.8841356989353616,1.0,20/60,21.17%,TNC;TGFB1;CRYAB;PAMR1;FN1;COL4A1;LMOD1;COL15A1;COL6A1;KRT10;SRPX;ACTA2;ADAMTS2;TNFAIP6;COL4A2;COL14A1;CALD1;THBS2;PDGFRB;THY1
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.7500068147691484,-1.2966402092058464,0.18181818181818182,0.8820072384873766,1.0,3/10,14.33%,ZW10;BUB3;MIS12
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6533151667387542,-1.2963398924252494,0.125,0.8815380063131072,1.0,4/19,10.19%,BUD23;NOP10;GAR1;DIMT1
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.672002607581634,-1.296136612154562,0.16,0.8805088493195203,1.0,8/24,15.97%,ISG15;CDC37;OAS3;USP18;OAS1;NLRC5;CACTIN;HSP90AB1
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.6432679548788436,-1.2958382220338316,0.11842105263157894,0.8797995918340352,1.0,5/25,19.52%,GABARAPL2;ATG14;CALM1;MAP1LC3B2;VIPAS39
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.6323220020143306,1.2951084919433955,0.23333333333333334,0.8566289124566571,1.0,3/15,4.48%,SEMA3B;SEMA4D;SEMA6C
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.6990250270536663,-1.2944565557884276,0.08108108108108109,0.8873513184646503,1.0,5/18,15.10%,SURF1;UQCR10;UQCRB;NDUFS7;MTFR1L
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.6528881199540453,1.294347888811438,0.14285714285714285,0.8573952222129135,1.0,4/11,16.08%,RIPOR2;OXSR1;WNK1;LRCH1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.8319805597181409,-1.2940860847196682,0.10344827586206896,0.887831984188861,1.0,2/5,11.00%,DDRGK1;SVBP
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.7562068465474332,-1.2940769526193119,0.15714285714285714,0.8854616270580752,1.0,2/8,5.63%,NAAA;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.569725172263459,1.2937993013862619,0.06896551724137931,0.8576952849529421,1.0,6/19,14.08%,PLCB1;ANKRD17;EGFR;LSM11;UBE2E2;ADAM17
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.7106394096327107,1.2937380289316092,0.2857142857142857,0.8556497735127211,1.0,2/7,6.37%,ARC;GRID2
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.4153903231976076,1.293401082519232,0.0,0.8548412380546333,1.0,26/99,14.06%,RIT2;GABRG1;CSRNP3;ASTN1;GLS;NRXN1;NOL4;SLC8A2;MAGI2;LSAMP;LRRTM3;SLC1A2;GRIA1;KCTD16;NXPH1;CLVS2;ADGRA1;CA10;CTNNA2;FUT9;DLG2;GRIN2B;ADCYAP1R1;GABRA1;TTBK1;KCNC2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.508746232378631,1.2927156011413987,0.17391304347826086,0.8560630577730763,1.0,10/43,13.54%,VAPB;SGMS1;ACER3;SPTLC2;CERT1;VAPA;PPM1L;ST3GAL4;PRKD1;CERS6
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),-0.6791273436102896,-1.2916305527897423,0.1506849315068493,0.9005911415553816,1.0,1/16,1.99%,TUFT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8232291426685958,-1.291589121446946,0.16417910447761194,0.8983314762892177,1.0,4/7,12.32%,B2M;HLA-A;ERAP1;TAP1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.7117887079847751,1.2913010640916225,0.18518518518518517,0.8600242698054223,1.0,3/9,11.03%,HDAC9;SMARCAD1;HDAC4
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.6173589397334671,-1.2912557516857597,0.10975609756097561,0.8978939183308102,1.0,6/41,10.22%,POLR2I;FANCB;POLR2G;H1-4;POLQ;MAGEF1
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.7816672345858567,-1.290843884161302,0.1875,0.8988233125519419,1.0,3/8,14.33%,ZW10;BUB3;MIS12
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.7768607477132152,-1.2907365047357975,0.027777777777777776,0.8969820778723633,1.0,3/15,2.57%,FTH1;EMD;SFRP1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7196191109269884,1.2905720180615599,0.15384615384615385,0.8565365012597608,1.0,3/8,10.79%,RAB27B;HSPB1;DLG2
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7196191109269884,1.2905720180615599,0.15384615384615385,0.8565365012597608,1.0,3/8,10.79%,RAB27B;HSPB1;DLG2
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7196191109269884,1.2905720180615599,0.15384615384615385,0.8565365012597608,1.0,3/8,10.79%,RAB27B;HSPB1;DLG2
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.45232109116825775,1.2904736327946793,0.0625,0.8547942204353871,1.0,22/92,14.16%,BAIAP3;ASXL3;FAM149A;CSRNP3;RGS7BP;LEPR;SORBS2;ASTN1;TOX3;NRXN1;NOL4;MAPK10;CNTN1;UNC5D;UNC5B;ADGRA1;GRIA3;PROX1;NFASC;LCORL;PCDH17;FRZB
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.6287072304550095,1.2903721867868827,0.13793103448275862,0.848945255875247,1.0,3/10,13.11%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6287072304550095,1.2903721867868827,0.13793103448275862,0.848945255875247,1.0,3/10,13.11%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6287072304550095,1.2903721867868827,0.13793103448275862,0.848945255875247,1.0,3/10,13.11%,NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),-0.7369493186690818,-1.290271625216089,0.1111111111111111,0.8980621148917858,1.0,4/11,23.17%,DVL1;DVL2;CAV1;DVL3
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.794229851207756,-1.2900055728800568,0.11267605633802817,0.8976518744829024,1.0,2/8,6.40%,SLC2A3;GSTO1
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),0.7532342069853617,1.28968855114149,0.21212121212121213,0.8494816476635486,1.0,1/6,1.53%,SPRED2
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.7128378209068562,-1.2892248224322533,0.125,0.9008359679623477,1.0,1/15,0.37%,ESRRB
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7023826972304216,1.2888256082261793,0.23529411764705882,0.8505372872077129,1.0,2/8,5.65%,ADRA1A;PDE4D
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.5723009938722746,1.2884505330730034,0.07142857142857142,0.8505092580229143,1.0,7/23,10.49%,ZDHHC2;ABL1;YTHDF1;FAM107A;ARC;RELN;CHRNA7
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.5005077254266667,1.2879730906921314,0.09523809523809523,0.8507410339101119,1.0,6/26,16.09%,ST6GAL2;GAL3ST3;FUT9;ST3GAL4;MAN2C1;FUT8
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.7024836437823573,-1.2874985541578532,0.12857142857142856,0.910928827241957,1.0,4/15,21.48%,SELENOS;DERL2;SYVN1;TMEM129
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.7706689909664872,1.2870719367401253,0.1891891891891892,0.8520447694686902,1.0,2/5,12.80%,RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),-0.8054709021029185,-1.2870267741669463,0.20689655172413793,0.9118730153195403,1.0,1/5,0.13%,DUOX1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),-0.7841834090616946,-1.2865760059746278,0.19298245614035087,0.9125529895366915,1.0,1/5,11.23%,NCBP1
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),-0.6188167256365459,-1.2864264520875084,0.14473684210526316,0.9109894798187523,1.0,11/36,23.44%,SURF1;UQCR10;UQCRB;NDUFS7;NR4A3;COQ10A;MTFR1L;SDHAF4;ETFRF1;NDUFS4;MTLN
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),-0.7284089257326616,-1.286256823149002,0.2222222222222222,0.9071591271789244,1.0,2/10,16.26%,CCT7;DKC1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),-0.7284089257326616,-1.286256823149002,0.2222222222222222,0.9071591271789244,1.0,2/10,16.26%,CCT7;DKC1
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.8294278117862354,1.2861835435389042,0.23684210526315788,0.8537481196648703,1.0,1/5,2.18%,CEP120
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),-0.5886457898031306,-1.286087426807308,0.06976744186046512,0.9058574533823771,1.0,6/75,6.28%,CD44;OPRM1;TGFB1;HTR2B;RASGRP1;HTR2C
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.6025290512178786,-1.284699380114608,0.11940298507462686,0.9128942675438292,1.0,9/37,12.71%,CDC37;POLR3D;IFI35;PLSCR1;IRF1;USP18;ERAP1;PARP9;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),-0.8276641520923511,-1.2845674718073528,0.13793103448275862,0.9112017721529431,1.0,4/7,15.87%,C4BPA;A2M;CD55;CD46
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.7871070227649033,-1.2845156848967836,0.05970149253731343,0.9090518972394143,1.0,2/8,4.94%,VDAC2;BLOC1S2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.5802771324035085,1.284376472404067,0.14814814814814814,0.858720236119753,1.0,7/32,12.37%,IFT140;DYNC2LI1;PCM1;TRAF3IP1;IFT172;KIF3C;SSX2IP
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5923809388149666,1.2839760027781677,0.19047619047619047,0.8579745955047955,1.0,2/18,1.84%,RANGAP1;BARD1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.525523863312806,-1.2838224068572945,0.010309278350515464,0.9114584742298123,1.0,50/275,19.27%,CD44;B2M;HLA-B;CD63;GLIPR1;HLA-C;FTL;TUBB4B;FTH1;HRNR;SLC2A3;PGRMC1;ALOX5;ATP6AP2;ENPP4;CTSZ;CKAP4;CEACAM1;HVCN1;GGH;AGA;FUCA1;MGST1;GRN;CST3;MMP25;TMBIM1;RAB3D;STOM;CYSTM1;ACTR1B;CD55;CHIT1;PYGL;C3;ASAH1;HSP90AB1;TNFAIP6;HGSNAT;SRP14;FUCA2;COMMD9;VCL;PTGES2;GSN;APEH;AP2A2;ATP6V1D;ILF2;PGAM1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.811530045326631,-1.283636760504074,0.10344827586206896,0.9105210380364839,1.0,3/6,16.59%,BUD23;EMG1;NSUN5
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.5255389790233606,-1.2836259454830028,0.010309278350515464,0.9082426225572494,1.0,50/274,19.27%,CD44;B2M;HLA-B;CD63;GLIPR1;HLA-C;FTL;TUBB4B;FTH1;HRNR;SLC2A3;PGRMC1;ALOX5;ATP6AP2;ENPP4;CTSZ;CKAP4;CEACAM1;HVCN1;GGH;AGA;FUCA1;MGST1;GRN;CST3;MMP25;TMBIM1;RAB3D;STOM;CYSTM1;ACTR1B;CD55;CHIT1;PYGL;C3;ASAH1;HSP90AB1;TNFAIP6;HGSNAT;SRP14;FUCA2;COMMD9;VCL;PTGES2;GSN;APEH;AP2A2;ATP6V1D;ILF2;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.7920595578461016,-1.2834037488799865,0.09230769230769231,0.9073394526538764,1.0,3/6,14.68%,PRELID1;DBI;APOE
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.6309038840781245,-1.2832687177326931,0.12941176470588237,0.9060435075029117,1.0,5/35,5.22%,EMD;CAMK1;ECT2;TGFB1;ZIC1
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.778227461149351,1.2832543122688607,0.2558139534883721,0.859247894623694,1.0,2/6,7.62%,SALL1;PKD2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),0.6976215584797376,1.2828428796197302,0.225,0.8586142613018487,1.0,3/7,24.41%,NT5C1A;PNP;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6814249089987338,-1.2826692569811855,0.10666666666666667,0.9081136598955895,1.0,4/16,17.24%,FANCB;POLQ;MAGEF1;CGAS
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.6906107748324606,1.282426272000775,0.2,0.8580566381461276,1.0,2/8,8.99%,OR3A2;BBS4
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.5239538423537133,-1.281322464385256,0.01020408163265306,0.9147308193578397,1.0,50/277,19.27%,CD44;B2M;HLA-B;CD63;GLIPR1;HLA-C;FTL;TUBB4B;FTH1;HRNR;SLC2A3;PGRMC1;ALOX5;ATP6AP2;ENPP4;CTSZ;CKAP4;CEACAM1;HVCN1;GGH;AGA;FUCA1;MGST1;GRN;CST3;MMP25;TMBIM1;RAB3D;STOM;CYSTM1;ACTR1B;CD55;CHIT1;PYGL;C3;ASAH1;HSP90AB1;TNFAIP6;HGSNAT;SRP14;FUCA2;COMMD9;VCL;PTGES2;GSN;APEH;AP2A2;ATP6V1D;ILF2;PGAM1
prerank,MSigDB_Hallmark_2020__Hypoxia,-0.5397302496980548,-1.2812659138423934,0.06593406593406594,0.9127408140620528,1.0,31/124,16.52%,VEGFA;MT1E;SLC2A3;PPFIA4;ANGPTL4;CDKN1C;JUN;CP;PDK1;XPNPEP1;EFNA1;GLRX;MT2A;GAPDH;MAFF;SLC6A6;PGK1;GPC3;PNRC1;SAP30;PHKG1;BTG1;DDIT4;PRDX5;PFKP;LDHA;SRPX;LXN;PDK3;CAV1;FOS
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.6678880899839602,1.281126931443706,0.18421052631578946,0.8608845869255095,1.0,1/10,2.06%,IRS1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.5274115621589872,1.2809245726542877,0.0967741935483871,0.8595621437904604,1.0,3/22,3.64%,CHRM3;KCNJ6;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.7573305980989642,1.280762197742066,0.2558139534883721,0.8580650934263938,1.0,1/5,0.25%,IL15
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7513638073630993,1.2804120147329157,0.19444444444444445,0.8573336085391423,1.0,3/6,16.60%,CPEB2;UNK;CPEB4
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6333960591459552,1.2797619133592355,0.26666666666666666,0.8576863944313977,1.0,6/13,22.36%,RIPOR2;OXSR1;WNK1;LRCH1;SH2B3;PTK2B
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.5361267885980936,-1.2791805853246927,0.020833333333333332,0.92523336608908,1.0,34/174,15.46%,CD44;ADAMTS16;TNC;ITGA4;A2M;ECM2;PPIB;FLOT1;COL5A3;AGRN;TGFB1;SPINK5;COL9A3;P4HA3;CTSL;MMP24;MARCOL;HAS2;FN1;COL4A1;MMP25;COL15A1;COL6A1;OPTC;COL9A2;VWF;THSD4;ACAN;MMP19;ADAMTS7;ADAMTS3;ADAMTS2;COL21A1;COL10A1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.46328660714438613,1.2786012154706579,0.05,0.859726609224371,1.0,8/51,7.46%,IL15;RAB27A;RXRA;SGK1;BOK;NEDD4L;C2CD5;MERTK
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),-0.7588239182480732,-1.2784572373264234,0.07407407407407407,0.9282241515191486,1.0,2/11,2.84%,HES5;HES1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.6589080568855055,1.2765566185403752,0.2222222222222222,0.8665613327490401,1.0,2/9,5.76%,NR1H2;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.7715159329245298,-1.2763637574094062,0.18461538461538463,0.9407159288883756,1.0,2/8,11.04%,SFRP1;ID2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.5830580427136434,-1.2763553660661255,0.1111111111111111,0.9383100057965894,1.0,8/37,16.53%,CDC37;CDKN1C;CDKN2C;CCNI2;CDK7;CNPPD1;HSP90AB1;CCNK
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7475473641786479,1.2762771979214087,0.16666666666666666,0.8636123574548789,1.0,4/5,20.18%,MAP4K4;IQSEC1;MAPRE2;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7475473641786479,1.2762771979214087,0.16666666666666666,0.8636123574548789,1.0,4/5,20.18%,MAP4K4;IQSEC1;MAPRE2;PIK3R1
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.7904379164912184,-1.2762616784527532,0.18032786885245902,0.9363262182814854,1.0,4/6,20.08%,ZNHIT3;NOP58;PRPF31;FBL
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4833725978258253,1.2762417881882684,0.22727272727272727,0.8617390081000773,1.0,2/23,3.60%,TP63;BOK
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.619531461643722,1.2758176034636353,0.23684210526315788,0.8612950543172583,1.0,4/11,23.37%,NFIB;SPTBN4;MYCBP2;SZT2
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.536013371571124,1.2757231186656794,0.16,0.8595777565584707,1.0,4/21,7.65%,EPHA3;BRINP3;ADNP2;ABL2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),-0.8340368621903643,-1.2754951886442951,0.13333333333333333,0.9397284772508531,1.0,2/5,14.68%,PROCR;APOE
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.6021377337852558,1.275465937511368,0.17857142857142858,0.8585754675540489,1.0,5/15,22.95%,CBLB;RGPD3;NUP35;IPO5;NUP54
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),-0.6289726626989928,-1.2749526806843807,0.1111111111111111,0.941115344120398,1.0,6/27,6.88%,VEGFA;HES1;ZFPM1;HTR2B;OLFM1;TTN
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.6576859886614289,1.2746950180029761,0.18181818181818182,0.8594820566487082,1.0,3/9,5.04%,ABHD17C;ABHD17B;ABHD10
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.6484582507589379,1.274661721864701,0.2631578947368421,0.857745928925433,1.0,8/24,12.45%,SEMA3B;MAP2;DIP2B;SEMA4D;SEMA6C;PTPRS;SEMA3A;SEMA6A
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.43483764233838545,1.2743612840260323,0.13333333333333333,0.8567549717585904,1.0,14/49,13.94%,RIT2;HIP1;MCTP1;EPHA3;NEDD4L;ABL1;PICALM;ABL2;SNX33;OPHN1;PRKD1;CDH13;DLL1;PACSIN2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7011431603257989,1.2741532388986392,0.08823529411764706,0.8553834793121923,1.0,2/7,13.78%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.6964113155189919,-1.2730059848747943,0.15492957746478872,0.9513419490622471,1.0,3/12,11.75%,CAD;TK2;TYMP
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.7495953350645952,-1.2729532359652618,0.12307692307692308,0.9492235747209613,1.0,3/10,14.68%,CLU;LRPAP1;APOE
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),-0.7549188115939713,-1.2727868725659985,0.17142857142857143,0.9483704376046068,1.0,2/10,3.39%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.6980260544092187,1.2725352367979368,0.2413793103448276,0.8560360922292042,1.0,2/10,1.45%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.6980260544092187,1.2725352367979368,0.2413793103448276,0.8560360922292042,1.0,2/10,1.45%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.6980260544092187,1.2725352367979368,0.2413793103448276,0.8560360922292042,1.0,2/10,1.45%,RIPOR2;DAPK2
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.7022258206607265,-1.2724529140138496,0.13924050632911392,0.948127110096409,1.0,2/17,2.44%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.7045501739175283,-1.271938821014214,0.18309859154929578,0.9493144805069472,1.0,3/14,7.73%,DUOX1;ALOX12;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),-0.7991272535708693,-1.271847050981473,0.15151515151515152,0.9473830238803386,1.0,4/7,15.97%,ACMSD;TGFB1;AP2A1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.556289112855245,1.2718419461898962,0.07407407407407407,0.8564828880971168,1.0,5/25,5.15%,YJEFN3;RXRA;NR1H2;SIRT1;PPARG
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),-0.7796728804476958,-1.2717851432497405,0.15714285714285714,0.9453410019751523,1.0,1/6,0.92%,HES5
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.6964974999260813,-1.2717431654333082,0.1774193548387097,0.9433291226291803,1.0,3/16,5.07%,VEGFA;SFRP1;S100A10
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.7451945238503696,-1.2714040648962817,0.140625,0.9433405274595483,1.0,2/9,6.31%,OPRM1;HHIP
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.6839859905531994,-1.2712123793279835,0.18181818181818182,0.9424968501008225,1.0,2/13,4.95%,IFI6;CLU
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),-0.8102428617182121,-1.271129157464207,0.15517241379310345,0.9408044244951447,1.0,1/6,1.65%,HAP1
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.528820761178387,1.270939042420707,0.14285714285714285,0.857619835292045,1.0,4/21,7.95%,PBX3;PBX1;SMOC1;MEIS1
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.7730297807560866,1.2708952122949186,0.24390243902439024,0.855850938747363,1.0,2/6,9.54%,CPT1A;CPT1C
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.5637620166932525,1.2707773713530381,0.18518518518518517,0.854227981550626,1.0,8/20,10.46%,ABL1;PDE4B;MAPK1;GNG2;ATP2B4;ADCY6;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),-0.7294683930290002,-1.2707638510249606,0.1388888888888889,0.9386880014121503,1.0,3/10,6.56%,FLG;HRNR;ALOX12
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),-0.7294683930290002,-1.2707638510249606,0.1388888888888889,0.9386880014121503,1.0,3/10,6.56%,FLG;HRNR;ALOX12
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.7192297859958058,-1.2706491343098962,0.14285714285714285,0.9372733174006513,1.0,2/11,2.61%,ISG15;COX18
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),-0.716113494296978,-1.2703941051872243,0.16176470588235295,0.9366904830169331,1.0,3/16,3.70%,TRIM5;IFITM3;TRIM25
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6438143032433666,1.2703467583045898,0.1111111111111111,0.8537123924743641,1.0,6/14,12.22%,TAFA1;TOX;SLC16A2;LRRK2;TRIM71;PROX1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.6189492522280104,-1.2703174684020235,0.14814814814814814,0.9349544853018338,1.0,5/26,10.43%,NOL3;CELF4;SRSF10;SRSF5;LUC7L3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6392076512641105,1.2700151987907295,0.17647058823529413,0.852993399378085,1.0,3/8,18.66%,FGD4;DNM3;SRGAP2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4689110475365365,1.2699081496498246,0.05555555555555555,0.8512512197788201,1.0,18/59,19.16%,TRAPPC12;TBC1D14;IFT140;ATG5;DYNC2LI1;MSN;TBC1D12;PIKFYVE;TBC1D1;RABGAP1;MTMR3;ATG3;NPRL2;CDKL5;STX18;RNF4;NPM1;TBC1D5
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.7508808551904084,1.2698207993280628,0.2702702702702703,0.8475862568136894,1.0,3/6,13.25%,CDC42EP4;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.7508808551904084,1.2698207993280628,0.2702702702702703,0.8475862568136894,1.0,3/6,13.25%,CDC42EP4;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.7769683969135422,1.2696832866938574,0.19444444444444445,0.8460041214426078,1.0,3/5,18.89%,ROBO1;SLIT3;SLIT2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.8453216905119896,-1.2695907635593087,0.21052631578947367,0.937683345041758,1.0,1/5,2.08%,NOL3
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.6868209069824294,1.2692567640134893,0.2564102564102564,0.8458871034264117,1.0,4/6,30.03%,NIPBL;COL5A2;INTU;SKI
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.6745964269057207,-1.269079270673503,0.16455696202531644,0.9387221113133666,1.0,3/15,9.73%,ITGA4;SCG2;CD160
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),-0.7744680648080451,-1.268971520431476,0.11475409836065574,0.9375773346991454,1.0,2/7,16.51%,RANGRF;CAV1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7038989500574374,1.2687072653198823,0.2222222222222222,0.8464810326070161,1.0,2/9,11.38%,NEDD4L;SLC8A1
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.5128769962181783,1.2684594841171601,0.2222222222222222,0.8455196356030971,1.0,8/44,9.53%,VAPB;EXTL1;PREB;ACADVL;EDEM1;DNAJB11;LMNA;EXTL3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5172828491849485,1.2682048285824488,0.19047619047619047,0.8448993337726042,1.0,7/32,11.88%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2;WNK1;KCNIP2
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.6787800903406586,-1.2676893261792577,0.1282051282051282,0.9442385051398339,1.0,5/18,13.74%,DMAC2L;HVCN1;ATP6V0A4;ATP6V1F;ATP6V0E2
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.6938194591370066,1.267380401677678,0.2,0.8458611037516289,1.0,2/7,19.19%,RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.536389231075876,1.26729240811484,0.1111111111111111,0.8441364307657938,1.0,8/28,10.25%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPKAPK5;MAPK3
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.5876557569221061,1.2669918898781674,0.08,0.843489918342694,1.0,5/17,13.72%,LAMA3;PRKX;TRAF3IP1;SOX8;SOX10
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),0.701604897852717,1.2667085842165824,0.2,0.8429464179291626,1.0,1/5,2.87%,NR1H2
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),-0.7690114395936561,-1.2656893342848872,0.13114754098360656,0.9554552453700337,1.0,6/9,15.87%,HLA-A;JAG1;EMP2;CD55;BTN3A3;CD46
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6707837062021071,1.265508318501017,0.17857142857142858,0.844969682179434,1.0,3/8,11.30%,SEMA4D;NTNG2;MOV10
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.6776014264539028,-1.2652677063091826,0.20270270270270271,0.9559006020617367,1.0,2/14,2.57%,EVC;SFRP1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6360828789728583,1.2652541085123439,0.17391304347826086,0.8441262463659918,1.0,4/16,11.88%,KCND3;ATP7B;ATP2B4;KCNIP2
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7363097291168067,1.2650304024599106,0.19148936170212766,0.8430212955638184,1.0,3/5,21.29%,HS6ST3;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.5627043343313312,1.2649488114645713,0.29411764705882354,0.8414249828728021,1.0,6/18,21.09%,RAP1GDS1;ANXA6;SMDT1;MCU;LETM1;MICU3
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.5738018997286467,1.2645237938872347,0.18518518518518517,0.8409580360918057,1.0,9/18,23.72%,PEAK1;PTPRK;THSD1;ARHGEF7;TRIP6;TAOK2;CTTN;ACTN1;BCR
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.538430095487565,1.2642357225955811,0.10526315789473684,0.8402296436998831,1.0,11/31,17.77%,TP63;KAT2B;ROBO1;BMP2K;TSPAN5;ZMIZ1;TSPAN14;DLL1;ROBO2;RBPJ;MAML1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4163259633805341,1.2642149692794193,0.0,0.838419899866806,1.0,56/146,20.83%,SEMA3B;LAMA3;UNC5C;EPHA3;RYK;SEMA4D;DSCAML1;SEMA6C;GAB1;ROBO1;NRXN1;PLXNA1;SH3KBP1;SLIT1;MAPK1;VLDLR;SPTBN1;DCC;PLXNA3;NFIB;UNC5D;UNC5B;OPHN1;SLIT3;EPHA5;RELN;MAPK3;PALLD;GPC1;KLF7;PIK3CA;SPTB;SEMA3A;SEMA6A;ALCAM;FRS2;NRP1;SOS1;SPTBN4;ROBO2;FYN;PRKCA;NTN4;PLXNC1;GFRA1;NRXN3;LYPLA2;DSCAM;SLIT2;NCAM1;SEMA5A;PLXNA2;PIK3R1;EPHA7;ENAH;RANBP9
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.800462576672825,1.264113596117747,0.18181818181818182,0.8368804210976227,1.0,1/5,10.35%,ATP6V1A
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.6975733812561569,-1.264001114777869,0.18333333333333332,0.9624121164504682,1.0,2/14,2.75%,CDC37;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6769519541005828,-1.2639220078334055,0.22727272727272727,0.9606093718891956,1.0,5/12,22.38%,TRMT10C;RPUSD3;COA3;RMND1;RCC1L
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6940444448533478,-1.2636685891059658,0.2,0.9598697181722697,1.0,1/9,1.45%,TUBB4B
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),0.6610331009772844,1.2628701467235852,0.1388888888888889,0.8401250067537088,1.0,3/11,10.66%,RAD54B;NSMCE2;SMC6
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.6095136552817031,-1.262759928268594,0.125,0.9635710091838994,1.0,5/39,6.68%,B2M;HES5;OPRM1;HES1;BHLHE41
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.7167680484763216,1.2625856638437594,0.13513513513513514,0.8394047768866354,1.0,1/9,1.07%,ABHD3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.7544536898525436,-1.2624803592078526,0.12307692307692308,0.9633239506213146,1.0,2/8,6.03%,ZFPM1;EFNA1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.8142528660795894,1.261966652262331,0.22857142857142856,0.8399582692730069,1.0,2/5,13.19%,CDO1;MPST
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),-0.7802729526338565,-1.2618926787054,0.26865671641791045,0.9648674632116718,1.0,1/6,4.27%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5563193459575897,1.2616005810233248,0.10714285714285714,0.8392740343148956,1.0,5/16,5.22%,ASXL3;FBXW7;ACADVL;AKR1C3;PRMT3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.7722780891537419,1.2615589670125162,0.18421052631578946,0.8376196149312777,1.0,3/5,18.96%,HSPA1A;ADAM17;PRKN
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),-0.7348046654082647,-1.2613774082590576,0.1506849315068493,0.9660998191469907,1.0,2/8,10.05%,CLU;GRN
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),-0.7372186943542858,-1.2613361241822156,0.2608695652173913,0.9641054775332168,1.0,2/9,16.26%,CCT7;DKC1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6678673684702826,1.261163225196411,0.2222222222222222,0.8372023319619166,1.0,1/8,1.31%,RACGAP1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.7026119954611798,-1.2608959330933427,0.2,0.9648423802543454,1.0,3/12,9.73%,HLA-F;RASGRP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.617173259480241,1.2604603373105212,0.16216216216216217,0.8381433802646229,1.0,7/12,25.43%,SOX5;ZBTB16;BMPR1B;PKDCC;SOX6;GDF6;TAPT1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),-0.8355292093399023,-1.2603660964289245,0.14925373134328357,0.9668392711189994,1.0,1/5,4.75%,ALOX5
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.7746822158967471,-1.2600938281291638,0.14705882352941177,0.9668890423675178,1.0,3/7,14.68%,PRELID1;DBI;APOE
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6758942031558055,1.2600315535255544,0.1935483870967742,0.8379201393071015,1.0,3/9,13.70%,PPARG;NFIB;NFATC3
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.7610152039027931,1.2599388226697041,0.2926829268292683,0.8364436251844828,1.0,1/6,2.56%,FNBP1L
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.7038912943915477,1.2594325637798016,0.22857142857142856,0.8369630709952244,1.0,4/9,12.83%,RIT2;SLC8A2;LRRK2;CDH13
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),0.723442168810357,1.259376928230902,0.25,0.8353027777308472,1.0,2/5,15.52%,BCL11B;JAM3
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5772431273443233,1.2593281396260558,0.32,0.8336495646083223,1.0,6/15,12.55%,MCTP1;EPHA3;NR1H2;PICALM;SNX33;PRKD1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.47413095890932594,1.2591370504702992,0.125,0.8323541332735178,1.0,8/28,12.25%,RIPOR2;NEDD4L;PICALM;SNX33;ILRUN;MFHAS1;ANKRD13A;LATS1
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.5524692348942493,1.2590105808733523,0.13333333333333333,0.8310960210862425,1.0,5/14,19.02%,NR1H2;PPARG;ABHD5;OSBPL8;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.7027239710279882,1.258954130942109,0.14814814814814814,0.8294939792599652,1.0,2/8,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.6557464360651171,1.25888052785431,0.20833333333333334,0.8282155497842574,1.0,3/12,5.76%,FBXW7;NR1H2;PLIN5
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.5813870307678135,1.258822069315342,0.2608695652173913,0.8266579615672021,1.0,6/16,26.76%,ESR1;NIPBL;LRWD1;TASOR;MACROH2A1;RUVBL2
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),0.6688686760183271,1.2588182168771274,0.19047619047619047,0.8250122803164291,1.0,3/8,10.71%,NSMCE2;SMC6;ERCC4
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.8333039419203607,-1.258712512693502,0.16923076923076924,0.9739395339435766,1.0,1/5,4.75%,ALOX5
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.7475229883693983,-1.2583755290043799,0.18032786885245902,0.973841443513125,1.0,3/7,20.87%,HNRNPA2B1;DDX11;DHX36
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),0.6521262689937946,1.2581726155624695,0.17647058823529413,0.8252940468961579,1.0,3/9,10.59%,DGKB;PLA2G15;DGKQ
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5072210691688863,1.2579921146133968,0.24,0.8240665610390735,1.0,8/26,10.81%,CRB2;PARD3;OPHN1;MSN;LRRC7;ERBIN;DLG2;PARD3B
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.7711093801897284,1.2578074734384057,0.23809523809523808,0.8229696207781833,1.0,1/5,0.08%,VAPB
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.764840917381731,1.2575914486063071,0.21153846153846154,0.82190854760777,1.0,3/5,22.99%,PKD2;ABCC8;TRPM4
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.7259454780596382,1.2572768089829833,0.2702702702702703,0.8215387748004979,1.0,5/7,22.18%,DAPK2;MAP3K7;PIK3CA;MTOR;STK11
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.5704023013234257,-1.2567063682160673,0.11627906976744186,0.9829727230542873,1.0,9/47,13.94%,PPIF;COX18;SLC25A6;KIFBP;TIMM8B;TIMM44;TOMM7;SPG7;SLC25A5
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.6150944050024737,-1.2566417825405387,0.1,0.9810089012024082,1.0,10/36,13.70%,HLA-F;HLA-C;IFI35;IRF1;MMP25;TYMP;KIAA0040;TAP1;JUNB;CD55
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),-0.6685652199264724,-1.256579927833905,0.1791044776119403,0.9791657442432761,1.0,3/15,9.45%,GSS;PLSCR1;GAMT
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.7998791752812553,-1.2563868131880955,0.20967741935483872,0.9781845191632029,1.0,2/5,7.28%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6268754165937437,1.2552965659235948,0.1935483870967742,0.827775796543642,1.0,3/12,7.55%,PKP2;FGF12;CACNA2D1
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),0.6863090303892521,1.2552376724248535,0.34210526315789475,0.8264004339242225,1.0,2/6,21.33%,NOS1;RNLS
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.6480671005878168,1.255040795000486,0.2,0.8254031006941176,1.0,4/13,9.08%,FBXW7;SIRT1;PLIN5;FTO
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.5467257307431864,-1.255030966410468,0.08791208791208792,0.9848708843079912,1.0,16/69,21.79%,SEL1L2;TRIM25;SELENOS;DERL2;TMUB1;DNAJC10;SYVN1;USP19;FAM8A1;WFS1;RNF175;BAG6;FBXO6;TMEM129;ERLIN2;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),0.6602250446273676,1.2550099568338315,0.2571428571428571,0.8237286861385857,1.0,4/10,18.61%,IRS1;PLIN5;ABHD5;AKT2
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6504763757316843,-1.2548262688050316,0.13513513513513514,0.9842688681358837,1.0,3/18,7.50%,VEGFA;HES1;JAG1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.5752595468263264,1.2547150381566707,0.1935483870967742,0.823266272832459,1.0,6/13,24.50%,ATP2B4;PTBP1;LMCD1;CHP1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.5919399448497275,1.2545940618388656,0.18181818181818182,0.8219423452542032,1.0,5/15,17.89%,FBXW7;CBLB;TGFA;ADAM17;SOCS4
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.6384537912939159,1.2544774741313394,0.18181818181818182,0.8206546277600811,1.0,2/8,16.60%,ATP6V1A;CPEB4
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),-0.7036741096053382,-1.2543739199339499,0.18055555555555555,0.985291006440377,1.0,2/11,4.95%,HES5;CLU
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),-0.7002252138909326,-1.2538876144584672,0.22666666666666666,0.9864187633108972,1.0,7/16,18.59%,FLG;JAG1;MED1;KRT10;ASAH1;CASP3;CLIC4
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.7059232370448589,-1.2536771869691852,0.17647058823529413,0.9855055431767324,1.0,1/12,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.8167570085694928,-1.2534948424112002,0.22388059701492538,0.9844683904350777,1.0,1/6,0.66%,VEGFA
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7820911403661612,-1.2529783058871196,0.09523809523809523,0.985791159260883,1.0,5/10,17.38%,UQCRQ;UQCR10;UQCRB;CYC1;UQCC3
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.7439879091852111,1.2518751053522084,0.24324324324324326,0.8272339351103398,1.0,3/6,19.37%,PADI2;SLIT2;GREM1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7153137502839351,-1.2518544317488423,0.19047619047619047,0.991151885662584,1.0,1/11,5.32%,ARFIP2
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.6862887127874504,-1.2516131302560076,0.23076923076923078,0.9905815428882997,1.0,1/12,0.13%,DUOX1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.48347714888773463,1.25160708080598,0.16666666666666666,0.8263697231920166,1.0,16/76,9.41%,BANP;ZDHHC2;BARD1;ASB5;SF3B3;HECW2;NEDD4L;HACE1;FMN2;CTSA;FOXO1;EGFR;SNF8;TIPARP;NSF;EEF1A2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.559843121666855,1.2513104795023884,0.25,0.8252643618396184,1.0,10/24,19.15%,ABHD3;SLC44A1;STARD7;SLC44A5;PCYT1B;GPAT4;PCTP;LPCAT1;CEPT1;ACHE
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.782662621495464,-1.2512565539973675,0.1509433962264151,0.9905940560177396,1.0,1/5,4.21%,PBLD
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),0.5949995660156746,1.2509242343964744,0.21212121212121213,0.8249570831225326,1.0,5/15,15.44%,TRPS1;SOX5;CHADL;ZBTB16;BMPR1B
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.7583447688739765,1.250842094757757,0.22580645161290322,0.8234326424639165,1.0,3/6,17.02%,SNX33;SNX18;SPIRE1
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.736005332408037,1.250545206082688,0.21875,0.8224615589777494,1.0,1/5,4.86%,CHD7
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),-0.8089979145969695,-1.25051470093663,0.2222222222222222,0.9889021254577245,1.0,1/5,3.96%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),-0.8089979145969695,-1.25051470093663,0.2222222222222222,0.9889021254577245,1.0,1/5,3.96%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),-0.8089979145969695,-1.25051470093663,0.2222222222222222,0.9889021254577245,1.0,1/5,3.96%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.5754323769485478,-1.250432315747062,0.1590909090909091,0.9871211326935037,1.0,14/71,16.82%,ESRRB;HES5;PSMB9;HES1;PSMB8;LDB1;LMO2;JAG1;PSMA3;ZFP36L2;PSMA7;EIF2AK2;PTN;PSME1
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.5865624137383759,1.250176932316917,0.13793103448275862,0.8221921569708454,1.0,5/17,20.18%,IRS1;ARPP19;OSBPL8;AKT2;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.6797944174806505,1.2500455409077074,0.2222222222222222,0.8209852977390865,1.0,3/7,21.33%,PDE4D;SPTBN4;RNLS
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),0.7495594819029148,1.2499951902683328,0.24444444444444444,0.819481158588571,1.0,3/6,24.28%,METTL4;MTG2;MTG1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.6475235985419538,1.2491003630639674,0.3055555555555556,0.821330147957074,1.0,2/9,8.13%,NAV3;PTPRC
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.7884536506210331,-1.2488092252741012,0.2112676056338028,0.9956407115631329,1.0,1/7,0.27%,IFI6
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.725519098360223,1.2487718307289037,0.24324324324324326,0.8210049951618467,1.0,3/7,14.53%,OPHN1;MSN;RAP2A
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.5823475373356379,1.2486470683555784,0.17142857142857143,0.8197501232789908,1.0,2/14,3.97%,STYXL1;PPP4R4
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8214651734717097,-1.248528211722118,0.10526315789473684,0.9954807667139635,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.6531223844343117,-1.2483908644193369,0.14473684210526316,0.9942682824316043,1.0,8/27,12.71%,ISG15;A2M;OAS3;USP18;OAS1;GRN;NLRC5;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.6923600965883313,1.248106262277905,0.21212121212121213,0.8185416705939464,1.0,4/6,29.66%,HDAC4;FBP1;GIT1;PFKFB1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.6923600965883313,1.248106262277905,0.21212121212121213,0.8185416705939464,1.0,4/6,29.66%,HDAC4;FBP1;GIT1;PFKFB1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5877369690117805,1.2470853639367943,0.2,0.820881624683636,1.0,5/18,18.12%,DGKB;PLA2G15;DGKQ;DGKG;DGKE
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.5823660793323253,-1.2469571679410547,0.1643835616438356,1.0,1.0,4/30,7.92%,EVC;SGCA;EMD;MEF2C
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.7609823761975637,1.2463176620377092,0.225,0.8218715381770436,1.0,4/6,23.31%,ARFIP1;LRRK2;PRKN;USP7
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7983443880256519,-1.2460843933172607,0.14705882352941177,1.0,1.0,2/7,13.00%,SUPV3L1;TRMT10C
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.5834142309417122,-1.2458295283037628,0.10588235294117647,1.0,1.0,8/40,13.26%,EVC;SFRP1;ZIC1;HHIP;GPC3;FUZ;ULK3;RACK1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.742309961010838,-1.2457420361846563,0.2028985507246377,1.0,1.0,4/8,16.21%,COPS5;XBP1;RACK1;BAX
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.46959915776159616,1.2449535139292038,0.16666666666666666,0.8252957960156511,1.0,12/45,14.47%,RIT2;RIPOR2;ABL1;ROBO1;ABL2;KANK1;OPHN1;GPR174;NRP1;ITGA3;STARD13;LPAR1
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.7514842637453847,-1.2446838023279287,0.21212121212121213,1.0,1.0,3/8,15.86%,SIDT2;HNRNPA2B1;RTRAF
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.7321902207405796,1.244258648540094,0.27906976744186046,0.826213695825985,1.0,4/5,22.44%,ABCC5;ABCC4;SLC19A1;LRRC8A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5509317746015303,1.2439182874905683,0.23809523809523808,0.8259136500076539,1.0,4/26,7.92%,NLGN1;FMNL3;RAC3;RHOBTB1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.46424028642939125,1.2433695378498815,0.18181818181818182,0.8264424421666478,1.0,25/90,18.27%,FMNL3;PCLO;PLD2;LIMD1;SH3KBP1;FGD4;ZRANB1;RAC3;ARC;SH3D19;BIN1;RHOBTB1;CAPZB;WASF3;SYNE3;BRWD3;PALLD;SEMA6A;MAST3;PACSIN2;FMNL2;MICAL1;LARP4;DIAPH1;ARHGAP10
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.3788728535941676,1.2430103753080735,0.0,0.8260546246511631,1.0,96/354,19.19%,DAPK2;ERBB4;FAM20B;MAP3K5;ATR;ADAM10;PEAK1;PRKX;EPHA3;RYK;STK36;SGK1;ABL1;GRK5;RICTOR;MAP3K9;CTBP1;FER;RPS6KB1;MAPK1;SMAD7;IGF1R;MAP4K2;PRKG2;MAP2K6;CDC42BPA;MAP3K11;CDK12;OXSR1;BMP2K;GRK6;MAPK10;MERTK;SIK3;TGFBR2;ABL2;EGFR;TNKS;ABI1;MAP3K1;BAZ1B;MAPK14;MAPKAPK5;RELN;MAPK3;LRRK2;MAP3K7;DGKQ;SMG1;AATK;WNK1;CSNK1E;PRKACB;CDK14;PRKG1;MAP4K4;LATS1;TBCK;ERC1;MAST3;PRKD1;LMTK2;ACVR1;CSNK1G3;CDK18;MAPK8;SRPK2;FLT1;TTBK1;STK24;DMPK;USP15;LMTK3;PNCK;ACVR1C;CSNK1G1;FYN;BMPR1B;CAMKV;PRKCA;PINK1;NLK;PRKCE;CSK;UHMK1;CDKL5;ACVR1B;MAML1;PXK;BRAF;BMPR1A;AKT2;VRK1;MTOR;RPS6KA2;YWHAZ
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.8017597967289501,-1.2426828850114693,0.22807017543859648,1.0,1.0,1/5,9.45%,GAMT
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.544133376125412,1.2419212329942573,0.1724137931034483,0.8281709807691726,1.0,12/26,13.78%,SEMA3B;ERBB4;SEMA4D;SEMA6C;ANXA6;RADIL;SOX8;SEMA3A;PHACTR4;SEMA6A;SOX10;NRP1
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.6313649519265017,1.2418539286626107,0.21428571428571427,0.8267234273459,1.0,3/8,19.19%,GBF1;VRK1;YWHAZ
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),-0.6323104360592442,-1.241557622228953,0.22972972972972974,1.0,1.0,2/26,4.26%,B2M;GORASP1
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.642911478079189,-1.240848552125698,0.13043478260869565,1.0,1.0,9/18,18.82%,RPL3;RPL10;RPL11;RPL23A;RPF2;RPLP0;RSL24D1;RPL6;RPL5
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.5424066934554927,1.2404284776628198,0.2,0.8303552319718088,1.0,4/19,8.66%,NLGN1;NLGN4X;SYNJ1;OPHN1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.45622599358418275,1.2404067739318831,0.0625,0.8288212556739146,1.0,17/70,15.81%,ERBB4;EPHA3;RYK;ROR2;IGF1R;MERTK;EGFR;PTPRC;EEF1A2;EPHA5;RELN;LMTK2;TAB2;RAPGEF2;FLT1;ZNF16;RAP1A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.683045920275792,-1.2400401192196113,0.2535211267605634,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.5982895120702872,1.2396235553345494,0.16666666666666666,0.8301269561144483,1.0,3/19,3.55%,AHCY;NOX4;CDO1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.5966604844794497,1.2396029866654885,0.1875,0.8285119231258989,1.0,2/11,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),-0.6312333880873664,-1.2394197359711903,0.17567567567567569,1.0,1.0,6/21,14.33%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC;MIS12
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.8049359366700557,1.2391985529722562,0.14634146341463414,0.828474557477306,1.0,1/5,4.10%,INAVA
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.6472263874857107,-1.2390797035613736,0.22535211267605634,1.0,1.0,3/20,5.07%,VEGFA;SFRP1;S100A10
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.5713871834349918,-1.2384373505203516,0.14285714285714285,1.0,1.0,7/45,16.51%,B2M;FLOT1;RPL11;BDNF;APOE;TRIB3;CAV1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),-0.5623660384587356,-1.2383009667915532,0.14634146341463414,1.0,1.0,2/46,0.26%,APIP;B2M
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.5253944733426857,-1.2379875952002464,0.14772727272727273,1.0,1.0,8/118,7.28%,CD44;APIP;OPRM1;TGFB1;HTR2B;RASGRP1;HTR2C;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),-0.5360845237324144,-1.2377791235053515,0.16279069767441862,1.0,1.0,10/127,6.28%,CD44;VEGFA;OPRM1;FGF1;TRIM5;TGFB1;SEMA4C;HTR2B;RASGRP1;HTR2C
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.5227141428421052,-1.2377235115411187,0.16091954022988506,1.0,1.0,28/115,23.98%,POLR2I;SURF1;POLR2G;MRPL40;POLR1C;NME3;EIF1B;RFC2;GPX4;DAD1;RPA3;TK2;UPF3B;GTF2F1;RFC4;EDF1;SF3A3;RFC3;DDB2;GUK1;LIG1;ELOA;RBX1;RNMT;IMPDH2;POLR1D;MPG;SNAPC4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.7293252819345264,-1.2367356155517664,0.14705882352941177,1.0,1.0,2/11,6.22%,KIF20B;OBSL1
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.660531617134191,1.2365666791752687,0.22727272727272727,0.8363371738314914,1.0,2/9,3.74%,CRB2;ITGA2
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5423939867865885,-1.236061962843951,0.15384615384615385,1.0,1.0,9/61,16.21%,VEGFA;PFN2;FLOT1;TGFB1;CLU;WARS1;RACK1;VIL1;BAX
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.7285397260177656,1.2358896475294023,0.1111111111111111,0.836777601663508,1.0,2/10,2.91%,DSE;VCAN
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.508002035084985,1.2358485856975867,0.08333333333333333,0.8353068577975232,1.0,15/47,22.68%,EPHA3;ABL1;RICTOR;RAC3;FAM107A;RHOBTB1;EPHA5;ARHGAP44;CCDC88A;GPM6B;MTOR;CRK;MLST8;ARHGAP35;TAOK2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.3804124901637677,1.2356374416224263,0.0,0.8347080506603097,1.0,47/130,21.53%,ATR;PRKX;SGK1;RICTOR;RPS6KB1;MAPK1;TGFBR2;TNKS;MAPK14;MAPKAPK5;PIKFYVE;LRRK2;DGKQ;SMG1;WNK1;CSNK1E;LATS1;MAST3;PRKD1;LMTK2;CSNK1G3;MAPK8;MAP2K2;SRPK2;TTBK1;DMPK;PNCK;CSNK1G1;CAMKV;PRKCA;PINK1;NLK;PRKCE;UHMK1;AKT2;VRK1;MTOR;RPS6KA2;RPS6KA3;IKBKB;HIPK3;PDPK1;SGK3;TTBK2;CAB39;EIF2AK3;AKT3
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.8317950877907079,-1.235391604510829,0.11666666666666667,1.0,1.0,2/5,14.68%,SELENOS;APOE
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.5290914546746379,-1.2353130891455413,0.125,1.0,1.0,9/95,4.19%,B2M;IFI6;MX1;IFIT1;ISG15;TRIM5;IFITM3;TRIM25;RARRES2
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.7519301131977871,-1.2351392979499523,0.1746031746031746,1.0,1.0,2/7,9.56%,VEGFA;COL4A1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.40844700963509806,1.235113380254191,0.08333333333333333,0.8344573879155474,1.0,22/106,13.10%,RIT2;HIP1;WFDC1;BCAR1;NRG3;SGK1;CAMSAP2;ABL1;SEMA4D;MLLT3;FAM107A;METTL4;PICALM;ABL2;OPHN1;DCUN1D5;NEDD4;BAG5;LATS1;LAMTOR2;CDH13;RAPGEF2
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.8049450485644647,-1.2349659085886022,0.2054794520547945,1.0,1.0,2/6,11.54%,CHCHD10;DCTN1
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.6450262594336112,1.2341683330113629,0.2916666666666667,0.8360773987860893,1.0,3/13,11.29%,SPRY4;CREB3L1;GPC1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6874806259440257,1.233838544794058,0.3055555555555556,0.8355666859934603,1.0,5/9,20.46%,RAPGEF2;RAP2B;RAP2A;RAP1A;RAP1B
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),-0.8104196247819515,-1.2333208546543362,0.2033898305084746,1.0,1.0,1/5,1.65%,HAP1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.5482617292462604,1.233162004833646,0.09090909090909091,0.836347391819064,1.0,3/25,7.61%,TCF7L1;TLE1;PYGO2
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.7993736960197095,-1.2331617285676812,0.171875,1.0,1.0,1/6,1.80%,HSD17B14
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),-0.731574489274435,-1.2328044844859187,0.16923076923076924,1.0,1.0,2/9,1.59%,VEGFA;SCG2
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),0.6866811515531235,1.232364962724637,0.275,0.8379545209405314,1.0,4/7,24.41%,NT5C1A;PNP;AMPD2;HPRT1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.6774494728928959,-1.2320703168494818,0.15492957746478872,1.0,1.0,4/14,14.68%,F8;A2M;CPB2;APOE
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,-0.5131294210902387,-1.232066855398139,0.12195121951219512,1.0,1.0,17/89,11.25%,VEGFA;GDAP1L1;SCG3;SCG2;ENPP2;ARX;INA;CHGB;SCG5;HPCA;CACNA1B;CELF4;SST;SH3GL2;CCK;KCNC1;TMEM179
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.6710075125171396,1.232013352030504,0.21212121212121213,0.8373860597756929,1.0,7/10,29.90%,ACVR1;ACVR1C;ACVR1B;ACVR2A;GDF6;TGFBR1;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.6626614350846415,-1.2318672052083615,0.2033898305084746,1.0,1.0,3/14,7.78%,FLOT1;IFI35;RSAD2
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.6859352465432272,1.2318136342375454,0.21428571428571427,0.8363069155645229,1.0,4/10,13.78%,SOX11;FZD3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.5546177375145481,-1.231806682770632,0.15730337078651685,1.0,1.0,7/63,9.16%,VEGFA;ELOB;PSMB9;RPS27A;PSMB8;BACH1;PSMA3
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.7653241812639408,-1.231612035249103,0.125,1.0,1.0,1/8,7.98%,STAT5A
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),-0.7779032439040591,-1.2316020341020375,0.18333333333333332,1.0,1.0,1/5,4.39%,SPINK5
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),-0.5064424503457106,-1.2314228771749758,0.054945054945054944,1.0,1.0,19/221,8.18%,CD44;VEGFA;DDRGK1;PFN2;SPDYA;FGF1;FLOT1;ENPP2;CAMK1;RARRES2;TGFB1;HAX1;AGT;CEMIP;RASGRP1;EFNA1;HDAC6;IL5;TOM1L1
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),-0.6365258696261857,-1.231321290790717,0.20833333333333334,1.0,1.0,5/17,13.23%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),-0.6365258696261857,-1.231321290790717,0.20833333333333334,1.0,1.0,5/17,13.23%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7434949114673569,-1.230533892310978,0.16393442622950818,1.0,1.0,1/6,2.57%,SFRP1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6696379429630535,-1.2303018565066461,0.17142857142857143,1.0,1.0,7/16,9.69%,GSTK1;GSTM4;GSTO1;AKR1A1;GSTM5;GSTM3;MGST1
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6696379429630535,-1.2303018565066461,0.17142857142857143,1.0,1.0,7/16,9.69%,GSTK1;GSTM4;GSTO1;AKR1A1;GSTM5;GSTM3;MGST1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.7686064891383775,-1.2300376091312946,0.23076923076923078,1.0,1.0,1/7,0.66%,VEGFA
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.7571616822493421,1.2298742987721156,0.275,0.8395821270025092,1.0,3/5,20.98%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.7571616822493421,1.2298742987721156,0.275,0.8395821270025092,1.0,3/5,20.98%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),0.7537620738519308,1.2296831225888498,0.3333333333333333,0.8389582278924231,1.0,1/5,1.53%,SPRED2
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.6623255063739044,-1.2296599673345283,0.25,1.0,1.0,3/14,12.71%,FLOT1;IRF1;CACTIN
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.6917354299506269,-1.2294923898117358,0.23880597014925373,1.0,1.0,1/8,2.84%,HES1
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),-0.6948182036855428,-1.2292251070424995,0.17142857142857143,1.0,1.0,2/15,3.09%,OPRM1;GALR1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.6541820996423914,-1.2287677676510427,0.22950819672131148,1.0,1.0,4/11,13.07%,HES5;HES1;OCIAD2;CRLF3
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.6199561671117122,-1.2286149268229747,0.1875,1.0,1.0,4/33,12.58%,POLR2I;POLR2G;PTMA;PPP5C
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.46640861092232216,1.228451939838864,0.07142857142857142,0.8418712245847993,1.0,22/66,18.71%,RIPOR2;ARAP1;NLGN1;CEP120;FNBP1L;CDC42EP4;DEF8;WASL;BBS4;CDC42EP1;ANLN;AUTS2;PIK3CA;P2RX7;WASHC1;NRP1;NCKAP1;CCDC88A;EPS8;RALA;DOCK11;GPM6A
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7466953024731551,1.228180913061581,0.22857142857142856,0.8413300337008676,1.0,3/5,21.78%,SMAD7;RC3H2;MALT1
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.7998022569967637,-1.22781579639401,0.25,1.0,1.0,3/7,7.10%,ROMO1;RPL30;GAPDH
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5568013526849597,1.2276606592659065,0.2222222222222222,0.8411289177258984,1.0,7/17,21.23%,NAV3;CAMSAP2;CLASP1;HDGFL3;ATXN7;CLASP2;TTBK2
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.6666196530914769,-1.2275605770015035,0.23529411764705882,1.0,1.0,4/18,12.37%,DUOX1;TMC4;VWA2;RAB3D
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.6787453979648428,-1.2274903749036963,0.22857142857142856,1.0,1.0,6/12,28.71%,DDRGK1;RACK1;WFS1;UFL1;PPP1R15B;BFAR
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.5993478141429646,1.2265786065530533,0.15,0.8432903993504615,1.0,5/17,8.99%,RANGAP1;BARD1;TAF3;PML;BBS4
prerank,PanglaoDB_Augmented_2021__Ionocytes,-0.5826976112842341,-1.226445901739389,0.18292682926829268,1.0,1.0,6/38,8.87%,FMO6P;MROH9;IL20RA;CFTR;CFAP52;VWA2
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.552313740888033,-1.2263259996892726,0.18604651162790697,1.0,1.0,16/53,19.30%,HLA-C;RBM47;CTSZ;OAS3;ABCC3;CEBPD;OAS1;GRN;TMBIM1;TYMP;JUNB;NFIC;MAPK13;TNFRSF1A;TAPBP;IFIH1
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.5588683108266794,1.2260707170730543,0.15151515151515152,0.8440686238621666,1.0,3/12,11.85%,MAPK14;GLO1;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6973737457354303,-1.2257212486318119,0.16666666666666666,1.0,1.0,6/15,21.58%,HTR2B;PIK3CB;CDH3;APOE;S100A1;PARK7
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5422563630724112,-1.2256676470870147,0.17647058823529413,1.0,1.0,6/61,9.28%,SLC28A2;SLC2A3;SLC4A3;SLC6A6;ABCC3;SLC6A9
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),0.792898067107957,1.225363147798992,0.25,0.844619842587784,1.0,3/5,12.23%,LARGE1;PPP3CA;CFLAR
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6180256384391467,1.2251975282960283,0.16666666666666666,0.8436312152175647,1.0,7/15,18.40%,ROBO1;TGFBR2;ZFPM2;ACVR1;NRP1;ROBO2;BMPR1A
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7429003583220186,-1.2251775036975177,0.23529411764705882,1.0,1.0,5/11,14.72%,COX4I1;COX7C;COX5B;COX7B;COX6C
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.4048903567954603,1.2250994942785336,0.08333333333333333,0.8424509157133113,1.0,30/120,15.74%,DUSP4;PPM1E;UBLCP1;DUSP7;PPM1A;PTPRK;BTRC;PTPN13;SSH1;PPP4R2;PTPRC;PDP1;FBXW11;PPP2R5E;PPP3CA;PPM1F;TAB1;ALPL;MTMR3;PTPRS;PPM1L;PTPRU;PTPN4;PPM1D;CDC14B;PTPRG;PTPRN2;DUSP16;MTM1;DUSP26
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.5183315065372809,-1.2249642796400835,0.12087912087912088,1.0,1.0,16/138,9.56%,CD44;VEGFA;PPFIA4;NOL3;ANGPTL4;AGRN;GMPPA;HAX1;GLRX;AKR1A1;PGK1;GPC3;MPI;DSC2;SAP30;TPST1
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.7184071219985768,1.2245307649414026,0.2619047619047619,0.8429185000235421,1.0,3/6,20.98%,B4GALT3;FA2H;UGT8
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),-0.537449055201535,-1.2244153584457669,0.12790697674418605,1.0,1.0,9/55,17.19%,CDC37;SPDYA;CDKN1C;CDKN2C;CCNI2;CDK7;CNPPD1;CCNK;CDKN2A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.6471108885136707,1.223868849285863,0.24390243902439024,0.843523370252999,1.0,3/8,8.93%,RIPOR2;PADI2;WASL
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.690062287029088,-1.223472307609069,0.1527777777777778,1.0,1.0,3/15,6.74%,MT1E;MT1M;MT2A
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),-0.7662351382825259,-1.2234455971427436,0.16176470588235295,1.0,1.0,2/9,3.39%,TRIM5;IFITM3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.7512495217059318,-1.2234089117277218,0.1864406779661017,1.0,1.0,2/6,7.92%,DDX5;MEF2C
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),-0.5295435114744921,-1.2228941897427517,0.11827956989247312,1.0,1.0,24/113,18.13%,F13A1;VEGFA;CD63;F8;RIMS1;SCG3;A2M;TUBA4A;RARRES2;TGFB1;CLU;TTN;FN1;CALM1;VWF;SYT11;BRPF3;PCYOX1L;CHID1;CYB5R1;SYT4;APLP2;STEAP2;VCL
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),0.6733844002706046,1.2222598054350815,0.2631578947368421,0.8471232913856824,1.0,5/9,11.96%,SERTAD2;PADI2;ARID1A;ARID1B;ZMIZ1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.6592585784201224,1.2222592429091486,0.26666666666666666,0.84555744426667,1.0,2/7,12.80%,RPS6KB1;ACSL3
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),-0.7248708172884177,-1.2218942671853468,0.23214285714285715,1.0,1.0,3/8,14.68%,HTR2B;HTR2C;APOE
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.6683257438470679,-1.2218165662017222,0.30158730158730157,1.0,1.0,2/11,7.92%,KDM6B;MEF2C
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),-0.6334738064233575,-1.2217162314539298,0.19736842105263158,1.0,1.0,3/16,8.16%,SCN9A;CACNA1G;CACNA1C
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6453222320194417,-1.2211916331500308,0.2318840579710145,1.0,1.0,3/14,15.26%,DDX5;CELF4;SCNM1
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),-0.739662618977338,-1.2211839660966197,0.22950819672131148,1.0,1.0,1/7,2.98%,GSS
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),-0.739662618977338,-1.2211839660966197,0.22950819672131148,1.0,1.0,1/7,2.98%,GSS
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.7717401138197577,-1.2210126454982395,0.15517241379310345,1.0,1.0,1/8,4.27%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.5364125492240497,-1.2209820217704133,0.25316455696202533,1.0,1.0,15/62,17.92%,IFIT1;DVL1;CAMK1;JUN;LRPAP1;CTSZ;ZFPM1;IFIT2;DDX11;RACK1;GTF2F1;BAX;CAV1;MITD1;PEX14
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.7823401637660066,-1.2204698582406297,0.11940298507462686,1.0,1.0,2/6,9.76%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.5910974559232699,-1.2203878445835248,0.21176470588235294,1.0,1.0,3/25,7.07%,VEGFA;RRAGA;XBP1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.6115118810987742,-1.2203310402118785,0.21794871794871795,1.0,1.0,8/29,17.37%,DVL1;TGFB1;SEMA4C;FUZ;LMO4;PLXNB2;DVL2;MTHFD1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.8361625507548007,-1.220247279117678,0.1724137931034483,1.0,1.0,2/5,12.58%,PLSCR1;PPP5C
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.5468697204938016,1.2201922541307637,0.15625,0.8500804384279292,1.0,4/16,12.17%,ADAM10;NUP98;NUP93;P2RX7
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5388786355124617,1.2195881582364032,0.21739130434782608,0.8503916696564856,1.0,5/22,5.04%,ABHD17C;HDAC10;ABHD17B;SIRT1;ABHD10
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6968350440883052,-1.2194473365333367,0.16176470588235295,1.0,1.0,4/13,13.94%,PPIF;CAMK2A;SPG7;SLC25A5
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.7033310568385308,1.2193305974151907,0.25,0.8497375545320259,1.0,5/8,11.96%,SERTAD2;PADI2;ARID1A;ARID1B;ZMIZ1
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),0.6569626805611529,1.2188801206459596,0.3333333333333333,0.8496907976795216,1.0,3/7,25.33%,PIKFYVE;ARL8B;RAB34
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6861586870443122,-1.2186922788609589,0.17857142857142858,1.0,1.0,3/17,10.75%,PPIF;PPIB;PPWD1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.5252310918478234,1.2185453013318257,0.1724137931034483,0.8490129145081924,1.0,2/16,7.78%,RYBP;RNF2
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.6327153282872262,1.2180268281321505,0.21052631578947367,0.8494060140483677,1.0,2/12,7.94%,RPA1;RECQL5
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5494329371191069,1.2177891036097765,0.2413793103448276,0.8487584721284808,1.0,2/15,5.44%,AGMO;TEX2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),-0.62504990285324,-1.2172830091577844,0.20833333333333334,1.0,1.0,5/19,13.23%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),-0.6429065054379706,-1.2169966427280912,0.17391304347826086,1.0,1.0,2/16,9.47%,LIPI;ABHD12B
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5423058959813067,-1.2169670158896884,0.15476190476190477,1.0,1.0,6/60,9.28%,SLC28A2;SLC2A3;SLC4A3;SLC6A6;ABCC3;SLC6A9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.7492333357397767,-1.2169168400342232,0.15873015873015872,1.0,1.0,2/7,7.92%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.5762119482652769,-1.216616568970595,0.20253164556962025,1.0,1.0,4/28,11.37%,VEGFA;SFRP1;S100A10;EMP2
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.6908400593097115,-1.2165595501223945,0.2571428571428571,1.0,1.0,3/11,19.75%,ZW10;BUB3;KNTC1
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6908400593097115,-1.2165595501223945,0.2571428571428571,1.0,1.0,3/11,19.75%,ZW10;BUB3;KNTC1
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6908400593097115,-1.2165595501223945,0.2571428571428571,1.0,1.0,3/11,19.75%,ZW10;BUB3;KNTC1
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6908400593097115,-1.2165595501223945,0.2571428571428571,1.0,1.0,3/11,19.75%,ZW10;BUB3;KNTC1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),-0.7398095800583862,-1.216367357541568,0.2537313432835821,1.0,1.0,3/6,20.74%,ABHD12B;ALDH4A1;CHAC2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6314861175100496,1.2160580939574315,0.2571428571428571,0.8528630948642254,1.0,4/9,14.17%,AKR1C3;FAM107A;BCL2L11;NR3C1
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6484878613166619,1.21588463574328,0.3103448275862069,0.8516666600110483,1.0,5/8,22.46%,FUT9;ZDHHC21;NFAT5;IRAK1;ETS1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.6943134402895164,1.2156946396967183,0.358974358974359,0.8507465544280584,1.0,2/5,13.70%,NFATC1;NFATC3
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.6311915804470231,-1.215459737268773,0.21739130434782608,1.0,1.0,4/19,14.02%,TMEM50A;TMEM50B;LEPROTL1;CHMP4B
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),-0.7821758073087244,-1.2150127355785383,0.14666666666666667,1.0,1.0,2/7,3.78%,B2M;ARG2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6753012487105514,-1.2149198598530115,0.2564102564102564,1.0,1.0,4/14,15.73%,EIF2B2;SELENOS;ZBED3;KHK
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.6910379379277624,1.214890993953861,0.24242424242424243,0.8520288820557874,1.0,3/5,17.75%,ATP2B4;NOSIP;SNCA
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.6883098930564174,-1.2134711724458072,0.24193548387096775,1.0,1.0,2/11,3.69%,FLOT1;IFI35
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5092269297272526,1.2134220107572566,0.18181818181818182,0.8558539984565946,1.0,28/79,24.19%,PHLDB2;EPHA3;ABL1;RICTOR;RAC3;MAPK1;FAM107A;RHOBTB1;TRAF3IP1;EPHA5;MAPK3;P2RX7;CLASP1;ARHGAP44;CCDC88A;GPM6B;IQCJ-SCHIP1;DIAPH1;MTOR;CRK;CYLD;MLST8;BICD1;ARHGAP35;TAOK2;TJP1;BAIAP2;PTK2
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.6852380859832385,-1.2131493725432738,0.25333333333333335,1.0,1.0,3/13,7.28%,IFI6;RHBDF1;CEACAM1
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5727720021378206,-1.2128025565562122,0.16666666666666666,1.0,1.0,10/32,20.38%,SNRPD1;SNRPD2;PRPF8;SNRPB;SRSF10;PRPF6;USP4;PRPF31;SNRPG;DDX20
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),-0.7958199409261754,-1.2127968772461593,0.15517241379310345,1.0,1.0,2/7,11.37%,CD63;EMP2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.6010463721605666,-1.2125815357273952,0.1780821917808219,1.0,1.0,6/27,16.67%,HES5;HES1;BHLHE41;TYMP;NSUN5;PTN
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.6750465147602104,-1.2125630345129241,0.2054794520547945,1.0,1.0,3/16,6.74%,MT1E;MT1M;MT2A
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.43653896147180465,1.212169019832886,0.1111111111111111,0.8583938916512909,1.0,31/105,14.16%,LDB2;ASXL3;SYNDIG1;CSRNP3;RGS7BP;ASTN1;VCAN;MAP2;CDO1;PBX1;ADGRL3;ANK2;PRDX6;MPDZ;SLC16A2;RUNX1T1;GUCY1A2;MAPK10;CACNA2D1;WASF3;LRFN5;EDIL3;PRICKLE2;FBXL7;PRKG1;ADCYAP1R1;MEGF10;NFASC;TMEM200C;STOX2;FRZB
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.6801916124826726,-1.212004088780261,0.22666666666666666,1.0,1.0,1/9,1.76%,NPM2
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5254091758937658,1.2118808250113855,0.18518518518518517,0.8575763068141719,1.0,7/17,15.38%,HS6ST3;CSGALNACT1;EXT2;UGDH;EXTL3;EXT1;HS2ST1
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.6236699640254812,-1.21170849797084,0.29333333333333333,1.0,1.0,3/24,9.39%,ART4;GLUL;CAD
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.6417396855329092,-1.2116922741126994,0.25,1.0,1.0,6/21,20.90%,ABRAXAS1;DONSON;BRCA1;TAOK3;FZR1;BRCC3
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.4746152016833257,1.211550044187156,0.13636363636363635,0.8568964332158259,1.0,11/48,7.14%,SHANK2;NLGN1;NLGN4X;RYK;SDK2;NRXN1;ADGRL3;GRID2;WNT7A;LRRTM3;NRCAM
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.6262939281608917,-1.2115012821471696,0.2,1.0,1.0,3/15,8.71%,S100A6;AGT;FN1
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.701252642533045,-1.2112990634639296,0.22058823529411764,1.0,1.0,5/11,26.09%,COQ10A;COQ3;UBIAD1;COQ6;COQ8B
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.701252642533045,-1.2112990634639296,0.22058823529411764,1.0,1.0,5/11,26.09%,COQ10A;COQ3;UBIAD1;COQ6;COQ8B
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),-0.8302330741134545,-1.21128601750509,0.18181818181818182,1.0,1.0,3/5,7.73%,DUOX1;ALOX12;NOXA1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),-0.6993031695703809,-1.211243121049591,0.27419354838709675,1.0,1.0,1/9,1.68%,PDCD1LG2
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.5101941199375664,1.2109627972837316,0.13636363636363635,0.8576988124309696,1.0,7/29,15.62%,SOX11;TP63;BMP7;PRKD1;ACVR1;BMPR1B;ZHX3
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.6930348727905771,1.2108855403358072,0.2391304347826087,0.8564302922620375,1.0,1/5,1.23%,HIP1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.5339125380617619,1.2108169978960086,0.15384615384615385,0.8552199294311573,1.0,11/52,13.54%,VAPB;SGMS1;ACER3;SMPD4;LARGE1;SPTLC2;CERT1;VAPA;PPM1L;PRKD1;CERS6
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.644425208016075,1.2107646750130119,0.2631578947368421,0.8539068432116972,1.0,5/10,31.64%,WASHC1;JMY;ARPC2;ACTR3;IQGAP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.563696580020951,-1.2107586588369879,0.16279069767441862,1.0,1.0,12/52,17.42%,VEGFA;SCG2;ALOX5;HTR2B;STAT5A;CNMD;AIMP1;NRP2;APOE;CAV1;STAT1;EMC10
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.6189316800576418,-1.2107568319548319,0.189873417721519,1.0,1.0,4/25,7.62%,ZBTB32;SP140;ALOX5;HVCN1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.6328415326913321,1.2107084700831292,0.36,0.8524915829265901,1.0,4/8,11.03%,HDAC9;HDAC10;SIRT1;HDAC4
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),0.7422898428621144,1.2102947147131344,0.2558139534883721,0.852628004061301,1.0,1/5,9.42%,PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.6691054278237696,-1.2100441358675202,0.17391304347826086,1.0,1.0,4/24,13.86%,POLR2I;POLR2G;CTDP1;GTF2F1
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.779675667430056,-1.2099572961145184,0.1791044776119403,1.0,1.0,4/7,20.57%,OAS3;OAS1;APOD;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),-0.6217624880499757,-1.2097124987216716,0.18461538461538463,1.0,1.0,4/24,7.50%,VEGFA;TGFB1;SPINT2;JAG1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.716912664748239,1.2096707114991412,0.35135135135135137,0.8527905595007137,1.0,3/5,22.74%,SPTBN1;ANK3;PEX16
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.8031543841968234,-1.2088472953697946,0.18571428571428572,1.0,1.0,3/6,19.07%,CAMK2A;CAV1;ACTN2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.702624456608066,-1.2084905114253006,0.26865671641791045,1.0,1.0,3/11,9.73%,HLA-F;RASGRP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.702624456608066,-1.2084905114253006,0.26865671641791045,1.0,1.0,3/11,9.73%,HLA-F;RASGRP1;CD160
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.4699810827062353,1.208406220997049,0.1875,0.8555831397893682,1.0,11/47,11.96%,TAF1A;SERTAD2;KAT2B;PADI2;ARID1A;H1-10;ARID1B;BAZ1B;TAF1B;KAT2A;ZMIZ1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.5625628408174739,-1.2083821531044248,0.22077922077922077,1.0,1.0,19/39,25.89%,APEX1;ADPRS;POLQ;RFC2;RPA3;PNKP;RFC4;RFC1;PARG;RFC3;XPA;LIG1;POLD2;MBD4;XRCC1;POLE;MPG;NTHL1;OGG1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.6589428074485975,-1.2083053916127156,0.22857142857142856,1.0,1.0,4/14,8.45%,IFITM3;PLSCR1;IRF1;OAS1
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.6174887086006613,-1.2082383884693888,0.24390243902439024,1.0,1.0,7/28,20.90%,ABRAXAS1;DONSON;NABP2;BRCA1;TAOK3;FZR1;BRCC3
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5620609959622085,-1.2082312587658002,0.1728395061728395,1.0,1.0,5/44,7.98%,VEGFA;ITGA4;SCG2;HTR2B;STAT5A
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.7086734145412805,-1.207734797399926,0.22033898305084745,1.0,1.0,2/6,21.43%,DDX11;CTCF
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.7172427725325143,-1.2074612077335143,0.22058823529411764,1.0,1.0,1/7,3.61%,ENTPD7
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.48745811084330354,1.2070000116253035,0.125,0.85876370534647,1.0,14/34,18.94%,NLGN1;HOMER1;TSHZ3;NRXN1;OPHN1;RELN;LRRK2;GRIK3;CACNG2;CDH2;GRIK1;TPRG1L;GRM5;GRM8
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5228975853275555,1.2066329324171838,0.25,0.858570346840264,1.0,10/25,15.34%,PKP2;FGF12;GPD1L;ATP2B4;NKAIN2;WNK1;NEDD4;P2RX7;SPTBN4;NOS1
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),-0.7563975406394096,-1.2062353354500708,0.203125,1.0,1.0,3/9,8.80%,CTSL;LMO2;MED1
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),-0.7563975406394096,-1.2062353354500708,0.203125,1.0,1.0,3/9,8.80%,CTSL;LMO2;MED1
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.53422927778511,1.2058095495170778,0.17391304347826086,0.8594084847958973,1.0,5/22,7.55%,PKP2;KCND3;ANK2;BIN1;CACNA2D1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),0.7842368143786644,1.2057315427942812,0.32432432432432434,0.8581329031366617,1.0,2/5,18.43%,MGLL;LYPLA2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.6195341398024057,1.2055077291603593,0.27906976744186046,0.8572305403609972,1.0,5/10,25.09%,TGFBR2;ACVR1;BMPR1A;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.6856729793511765,1.2053539761662397,0.24324324324324326,0.855041606997766,1.0,2/6,13.78%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.6856729793511765,1.2053539761662397,0.24324324324324326,0.855041606997766,1.0,2/6,13.78%,BCAR1;NRP1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6893516058233007,1.2052667297237287,0.3235294117647059,0.8537301796965755,1.0,2/8,4.73%,DIP2B;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6147350499539124,1.204716967891031,0.2571428571428571,0.854280290296932,1.0,2/9,3.84%,ATR;PDS5A
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),-0.7577348013948682,-1.2044454328638734,0.1935483870967742,1.0,1.0,3/7,7.80%,ALOX5;ALOX12;GPX4
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),-0.6289408173360134,-1.2042613068111705,0.25,1.0,1.0,5/21,16.31%,PIGO;PIGC;PIGH;PIGG;PIGL
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.6091673711143324,1.204012678691251,0.2702702702702703,0.8550634634080018,1.0,4/10,10.07%,BCO1;AKR1C3;AKR1C1;BCO2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.6518969347913705,-1.2039386815220852,0.26229508196721313,1.0,1.0,3/11,22.27%,AGT;AEBP1;RUNX1
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.5289676218058083,1.2030435177526422,0.2,0.8568343216926568,1.0,4/28,6.47%,THAP4;NOX4;GLS;SRR
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7669538176730967,-1.2029973094383042,0.3157894736842105,1.0,1.0,1/6,0.37%,ESRRB
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.665305322644938,1.2029751887523437,0.2647058823529412,0.8555288891736015,1.0,3/10,11.95%,ESR1;ATF7IP;HMGB1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.7035597350562368,-1.2028012276275495,0.29850746268656714,1.0,1.0,2/7,13.84%,DVL1;DVL2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.6373457012891305,1.2026968881484874,0.2391304347826087,0.8547214696971023,1.0,2/10,4.60%,RAB27A;SYNJ1
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6781330159444972,1.2024878602973823,0.175,0.8522867307971702,1.0,4/7,15.60%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6781330159444972,1.2024878602973823,0.175,0.8522867307971702,1.0,4/7,15.60%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.6655864684403056,1.201643665076015,0.29411764705882354,0.8519064995824659,1.0,1/6,3.43%,PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.6655864684403056,1.201643665076015,0.29411764705882354,0.8519064995824659,1.0,1/6,3.43%,PARD3
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),-0.7220527978439146,-1.2009741910942835,0.203125,1.0,1.0,1/7,5.62%,ZFPM1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.5968717987739793,-1.200935159439497,0.2,1.0,1.0,4/24,7.67%,PPIF;NOL3;CLU;PRELID1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.6387137595272586,-1.2009263556044583,0.1875,1.0,1.0,4/15,14.45%,PSMB9;BEX3;USP50;DELE1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),0.5328072470440057,1.2002927990584917,0.23076923076923078,0.8554124780584733,1.0,4/19,11.01%,KANSL3;JADE3;KAT8;MCRS1
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.58919011251894,1.2002120539605163,0.22580645161290322,0.8543050988189793,1.0,5/15,16.05%,INTS6L;INTS7;INTS6;EXOSC7;INTS8
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.6575075471304939,1.199984471401147,0.2222222222222222,0.8536890850229715,1.0,2/7,10.89%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4092739713021254,1.1997970452926432,0.08333333333333333,0.8529470878910808,1.0,29/100,14.26%,CRB2;LRFN4;LRRC4C;NLGN1;ATP2C1;IGSF11;DSCAML1;SDK2;IL1RAPL1;ROBO1;ADGRL3;CDH20;GPC4;CDH9;GRID2;CDH10;CDH18;NECTIN3;TGFBR2;UNC5D;LRFN5;CLDN12;PALLD;PTPRS;ALCAM;CDH13;ACVR1;TENM3;FLRT3
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.7653021435325364,-1.1997908296330453,0.3384615384615385,1.0,1.0,2/6,7.92%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.7440510508768388,-1.1996396864990593,0.11290322580645161,1.0,1.0,2/8,9.76%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6286049199112874,-1.199620673898226,0.17105263157894737,1.0,1.0,10/24,20.91%,HES5;TRIB1;ID2;APOD;NR4A3;OGN;STAT1;PDGFRB;IL18;NDRG4
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.6363541674080098,-1.1992554011141896,0.2375,1.0,1.0,5/24,15.35%,RPL13;PPIB;SFRP4;LRRC17;PLS3
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7337618027351261,-1.1990230164043618,0.29310344827586204,1.0,1.0,3/8,22.01%,TRMT10C;TRMT5;HSD17B10
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.7050883060955979,-1.1983384821512202,0.2318840579710145,1.0,1.0,6/15,12.71%,ISG15;OAS3;USP18;OAS1;NLRC5;CACTIN
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),-0.5770027230347424,-1.1982893643552928,0.2,1.0,1.0,8/35,17.94%,IL12RB2;SNRPA1;GSTO1;RPLP0;HNRNPDL;HNRNPA2B1;CA1;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.6271250593480893,-1.1982667681297103,0.2,1.0,1.0,8/22,16.97%,SCG2;ALOX5;MEF2C;CNMD;AIMP1;APOE;CAV1;STAT1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4765619694909283,1.1982380561569899,0.21739130434782608,0.855864727578386,1.0,11/37,20.44%,DOCK5;SPRY4;ABL1;RAC3;KANK1;NRP1;ARHGEF7;CORO1C;WASHC2C;ACTN4;CRK
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),-0.7487660056974924,-1.1977194860158686,0.24242424242424243,1.0,1.0,1/8,0.93%,OPRM1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),-0.7084723908702026,-1.1973042849392626,0.23529411764705882,1.0,1.0,1/9,2.05%,IL12RB2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),0.7074289515408186,1.1970886497882092,0.3181818181818182,0.8579809781520766,1.0,1/5,9.08%,MAP3K4
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),-0.5597920180686142,-1.1968841415810056,0.1917808219178082,1.0,1.0,9/41,16.67%,PFN2;ENPP2;RAB11A;HDAC6;CEACAM1;GLUL;EMP2;VIL1;PTN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),-0.624557397547429,-1.1968216728523924,0.23076923076923078,1.0,1.0,7/23,20.52%,HES5;JUN;ID2;NR4A3;STAT1;PDGFRB;IL18
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.5503772253312803,-1.1966470913835372,0.21518987341772153,1.0,1.0,8/51,7.07%,PPIF;NOL3;CREB3;YBX3;SELENOS;CLU;RTKN2;XBP1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.7100004450959557,1.1966071807525942,0.2894736842105263,0.8581020313535767,1.0,1/7,0.22%,YJEFN3
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.6294282223143071,-1.1964975098540407,0.25,1.0,1.0,3/19,14.22%,M6PR;CLU;AP4M1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),-0.7287182760805613,-1.1963817584787875,0.23809523809523808,1.0,1.0,1/9,0.66%,VEGFA
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.6972531878312735,1.1962587390568395,0.3181818181818182,0.8576629077564858,1.0,3/8,6.49%,NLGN1;GRID2;WNT7A
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.656969266566373,1.1962025138585772,0.3333333333333333,0.856412447991701,1.0,4/7,19.67%,SLC8A2;ATP2B4;LETM1;ATP2B1
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.7216248969248258,-1.195774801414244,0.26153846153846155,1.0,1.0,3/8,19.82%,ZFPM1;PRKCQ;RARA
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6697900797787965,1.1955452921203804,0.3225806451612903,0.8572709167418294,1.0,2/7,10.49%,WNT7A;CHRNA7
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.710436061866505,1.1954769028555838,0.2727272727272727,0.8560759735685609,1.0,5/6,28.79%,FAR1;HDHD5;CPNE3;CPNE7;CPNE1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6179741164659236,1.1952894159008778,0.20689655172413793,0.8553905059478724,1.0,2/9,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.5992110241794247,1.1950296968515397,0.23076923076923078,0.8548587246405535,1.0,3/8,17.53%,ITGA3;MYO1E;TBC1D8B
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),-0.5978587565933347,-1.1944976244396461,0.2222222222222222,1.0,1.0,5/24,8.54%,B2M;FLOT1;CLU;LRPAP1;PIK3CB
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.5988286436382528,1.1931479901538637,0.32,0.8599455033495936,1.0,4/11,7.06%,SYTL4;DYSF;MYH9;ANXA6
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.43573255859525045,1.1929906507259893,0.2,0.8592318485095503,1.0,41/120,17.72%,MMP16;IRS1;RXRA;ATP2C1;INPP4B;GRK5;PDLIM5;BCKDHB;PPARG;LAMC1;APBB2;MAGI2;SMAD7;CDON;VLDLR;IGF1R;CDC42BPA;TGFBR2;ATXN1;NFIB;ATP2B4;PLCB4;MAPK14;SDC2;ZMIZ1;SCAF8;NRP1;RASA2;NR3C1;LPAR1;PRDM2;FYN;SPOP;NIPBL;AMPH;SIPA1L1;PRKCA;MGLL;PRKCE;COL5A2;MGMT
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.7418100821145002,-1.19275166402608,0.2318840579710145,1.0,1.0,4/6,25.60%,LMOD1;TMOD3;PGM5;FLII
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.6082652099112715,-1.1926221240589376,0.23376623376623376,1.0,1.0,3/22,7.10%,IFITM3;RPL13A;GAPDH
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.803053438794378,-1.1924912011188087,0.21428571428571427,1.0,1.0,2/6,0.52%,FLG;F13A1
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.6502667882837929,-1.1923297365855565,0.2631578947368421,1.0,1.0,4/12,16.67%,HES1;TGFB1;ID2;PTN
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.582421325645833,-1.1920415061160252,0.25316455696202533,1.0,1.0,5/35,13.86%,POLR2I;IFITM3;POLR2G;CTDP1;GTF2F1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.6943759681628625,1.1916713563308978,0.2564102564102564,0.8622609226918936,1.0,3/5,28.77%,SNX33;RAB34;MAPKAPK2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6737737535580681,-1.1914356621806819,0.30303030303030304,1.0,1.0,2/12,3.04%,DDRGK1;RETREG1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.593124495757419,1.1913733718728179,0.21052631578947367,0.86157084368154,1.0,1/9,0.30%,BAIAP3
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),-0.6299405480648342,-1.1913649446988333,0.24,1.0,1.0,5/19,10.80%,IFIT1;HDAC6;CAMK2A;PARP9;TMBIM1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.6920396792659761,-1.1910236270541257,0.25757575757575757,1.0,1.0,2/12,13.02%,AGT;NR4A3
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.5828533528335056,1.1906424804060096,0.2413793103448276,0.8623341780190792,1.0,9/15,23.11%,FNBP1L;MYO7A;WASL;MYO5A;SUN2;MYO1E;ACTN4;MYO6;MYO5C
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5768424493142863,-1.1905718791099724,0.21518987341772153,1.0,1.0,6/32,12.30%,ITGA4;RPL23;CACNB1;XBP1;TRIM41;DDX11
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.45300014438490477,1.1904253256645434,0.16666666666666666,0.8614464577689923,1.0,12/58,11.38%,VAPB;STIM2;ATP2C1;NEDD4L;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.49368767908990663,-1.1901934512302013,0.14772727272727273,1.0,1.0,13/99,13.48%,VEGFA;SPDYA;CAMK1;ECT2;CLU;AGT;EFNA1;TOM1L1;MTCP1;EMP2;CALM1;STRADB;MAP2K1
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.5918916632205122,-1.190173245896919,0.25301204819277107,1.0,1.0,9/24,11.27%,OPRM1;TACR1;CHRM2;AGT;HTR2B;HTR2C;FPR3;GRM1;LPAR6
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),-0.6215848520316919,-1.1893473512420383,0.19117647058823528,1.0,1.0,3/24,4.19%,VEGFA;CREB3;RARRES2
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5933620714883092,1.1891447850399626,0.24324324324324326,0.864152456450855,1.0,4/12,20.01%,AGMO;AGPS;FAR1;DHRS7B
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.5925818320376686,-1.1890442519305737,0.24324324324324326,1.0,1.0,11/30,20.19%,EMC3;EMD;EMC7;EMC6;MMGT1;CCDC47;TRAM1L1;SEC61G;EMC10;BAG6;CAMLG
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.4096250293692837,1.1889077206635363,0.06666666666666667,0.8636878706043428,1.0,29/125,10.79%,ASXL3;TLN2;ZDHHC2;ERC2;CSRNP3;RGS7BP;ADGRB3;PRKX;ASTN1;ZNF536;GDAP1;MAP2;CADM2;CALCB;NRXN1;ANK2;MAGI2;LSAMP;NOVA1;GCNT2;LRRTM3;MAPK10;KCTD16;LRFN5;CLVS2;NKAIN2;ADGRA1;CA10;DLG2
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.47472724869966426,1.1888964356700746,0.2,0.8622555524109691,1.0,13/58,11.31%,SEM1;RMI1;RPA1;RFWD3;RAD51B;RAD54B;RECQL5;SAMHD1;NSMCE2;SMC6;ERCC4;HELQ;UBE2N
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.6641924973129305,-1.1887510272095176,0.2923076923076923,1.0,1.0,1/9,0.66%,VEGFA
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),-0.6803149208439021,-1.1880760851376597,0.2835820895522388,1.0,1.0,1/9,5.62%,ZFPM1
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),-0.7737464512702625,-1.1873757840778392,0.21666666666666667,1.0,1.0,4/5,21.60%,BBOF1;CCDC39;CCDC40;E2F4
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.5426008082269113,1.1872921253478175,0.22727272727272727,0.8659888756849061,1.0,5/26,8.64%,KCNJ6;KCNMB3;ANK2;GNG2;KCNN2
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6667757422020698,1.1868383993442777,0.30952380952380953,0.8660932911972187,1.0,1/6,2.19%,PDIA2
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),0.7223698369553326,1.1866047164621114,0.3409090909090909,0.8640049774376183,1.0,4/5,27.78%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),0.7223698369553326,1.1866047164621114,0.3409090909090909,0.8640049774376183,1.0,4/5,27.78%,AGPS;FAR1;DHRS7B;GNPAT
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.6207553628844017,-1.1865006715745012,0.189873417721519,1.0,1.0,6/22,17.24%,B2M;ARG2;NEK6;RSL1D1;CDKN2A;CGAS
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6965251807942702,-1.1864149865324287,0.28,1.0,1.0,6/11,25.26%,IFITM3;ADAR;EIF2AK2;KLHL20;IFNAR1;AXL
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.5396294652016991,-1.1864035563617201,0.1875,1.0,1.0,16/64,20.87%,ISG15;POLR3D;TRIM25;POLR3H;POLR1C;IRF1;GAPDH;NLRC5;POLR3E;UBE2L6;CGAS;TRIM32;TRIM56;IFIH1;HERC5;DHX36
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.6411858463783012,-1.1858090551950011,0.25757575757575757,1.0,1.0,4/13,13.07%,HES5;HES1;OCIAD2;CRLF3
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.7842385477864164,-1.185780585834548,0.28125,1.0,1.0,1/5,9.39%,CAD
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.6205658691144288,-1.1852818342746492,0.2463768115942029,1.0,1.0,6/17,22.38%,TRMT10C;RPUSD3;COA3;MALSU1;RMND1;RCC1L
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),0.610341400031035,1.185139852084814,0.25,0.8674890230463045,1.0,3/8,8.99%,NINL;PCM1;BBS4
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.5574960328219175,-1.1846937912292335,0.225,1.0,1.0,10/35,21.83%,ROMO1;SLC25A6;TIMM8B;TIMM44;TOMM7;AIFM1;HSPD1;TOMM20;TOMM40;AIP
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.41623796857529327,1.1844587682087055,0.07142857142857142,0.8679594139737887,1.0,18/93,11.31%,USP51;HDAC9;EYA4;MIER3;HDAC10;PADI2;SIRT1;TBL1XR1;HDAC11;TRERF1;EYA2;NAA50;BAZ1B;KAT8;PHF20L1;KAT2A;HDAC4;UBE2N
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5398680473129155,1.1843490042942146,0.3235294117647059,0.8668313452128484,1.0,2/12,3.15%,SOX11;SALL1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.4766949612931297,1.1843231067464854,0.24,0.8655352747281846,1.0,4/25,8.99%,VCAN;CSGALNACT1;CHST3;UGDH
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.6513074966445718,1.1841255971551188,0.23529411764705882,0.865051532973782,1.0,3/7,16.74%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.6001341469436111,1.1836685951950534,0.3,0.8646427126728196,1.0,2/11,11.38%,SLC9A9;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),0.7157586815823549,1.1835405090452573,0.4,0.8636006184131736,1.0,2/5,13.18%,EGFR;FRS2
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),0.6969758778071466,1.1835394870829514,0.2903225806451613,0.8621963897653472,1.0,3/6,22.86%,SENP1;SENP6;SENP7
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),-0.6651999104843664,-1.1834441409003817,0.3181818181818182,1.0,1.0,2/8,1.82%,VEGFA;CDHR1
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.571324219354096,-1.183284578359403,0.2,1.0,1.0,16/51,26.97%,PSMB9;RPS27A;PSMB8;PSMA3;UBA52;PSMA7;PSME1;GMNN;UBC;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6848386115160754,1.1831648571811826,0.14814814814814814,0.8620374820654856,1.0,2/11,2.91%,DSE;VCAN
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.7346050165631529,-1.1827667301300562,0.2631578947368421,1.0,1.0,2/7,11.04%,TGFB1;ID2
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.6162897355438274,-1.1823301124209595,0.23943661971830985,1.0,1.0,3/19,3.31%,SLC3A1;FMO3;PAH
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.6870528034664922,-1.1822848598903875,0.25757575757575757,1.0,1.0,4/9,24.14%,ATP5MC3;ATP5PB;ATP5PD;ATP5MC1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.7429718058926379,-1.1822405186380365,0.2833333333333333,1.0,1.0,3/5,20.09%,CCDC39;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.7429718058926379,-1.1822405186380365,0.2833333333333333,1.0,1.0,3/5,20.09%,CCDC39;DNAH11;CCDC40
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5212581747814473,1.1822095638462191,0.24,0.8641379879901794,1.0,7/26,13.78%,SEMA3B;SEMA4D;SEMA6C;PLXNA3;SEMA3A;SEMA6A;NRP1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.5202524690172211,1.1819392104301936,0.1875,0.863564204025417,1.0,6/22,18.78%,SYNJ1;MTMR10;MTMR3;OCRL;MTM1;MTMR8
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.6411185581098883,-1.1818514968751777,0.22857142857142856,1.0,1.0,2/18,6.88%,NCAPD3;TTN
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.7761849824219353,-1.1817464787645686,0.25,1.0,1.0,3/6,16.79%,LDB1;NUP155;NUP107
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.6475524014702186,1.1816702717699654,0.37037037037037035,0.8628954309567173,1.0,4/9,15.52%,SHROOM2;INSC;SHROOM3;JAM3
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7275664542140466,1.181402376201371,0.24324324324324326,0.8625913907644494,1.0,3/6,23.31%,UHRF2;UHRF1;USP7
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.6763266068066299,-1.181390885327083,0.2361111111111111,1.0,1.0,8/13,25.37%,PSMB8;PSMA3;CST3;SVBP;CAV1;NRDC;A2ML1;CSTB
prerank,MSigDB_Hallmark_2020__Angiogenesis,-0.6334113771500369,-1.1811876713260325,0.24285714285714285,1.0,1.0,3/17,7.50%,VEGFA;LRPAP1;JAG1
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.4246164035782815,1.1808221116447422,0.11764705882352941,0.863157109814991,1.0,18/67,14.12%,RIT2;STYXL1;EPHA3;TOX;ROR2;MAGI2;VLDLR;ABL2;BMP7;ZNF804A;LRRC7;RELN;FUT9;PRKD1;COBL;RAPGEF2;CAPRIN1;TENM3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),-0.6708251617577103,-1.1805247316017728,0.29577464788732394,1.0,1.0,2/13,2.69%,SCG2;PPIB
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.5881948941006842,-1.180378765684863,0.27848101265822783,1.0,1.0,7/26,17.37%,TGFB1;SEMA4C;FUZ;LMO4;PLXNB2;DVL2;MTHFD1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.5881948941006842,-1.180378765684863,0.27848101265822783,1.0,1.0,7/26,17.37%,TGFB1;SEMA4C;FUZ;LMO4;PLXNB2;DVL2;MTHFD1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.7492989551838976,-1.1797069294278992,0.25757575757575757,1.0,1.0,1/6,1.61%,LFNG
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4605468714904506,1.1796590093506025,0.22727272727272727,0.8651666486579759,1.0,21/71,15.15%,SPOCK3;MCTP1;NAV3;SRGAP1;PTPRK;ROBO1;MAGI2;SMAD7;TP53INP1;TMEFF2;KANK1;ZMYND8;MITF;NF2;CHRD;PTPRU;RAP2B;STK24;FOXO3;RAP2A;ARID2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.677364751260709,-1.1795197893463165,0.2875,1.0,1.0,3/12,11.15%,NAAA;GDE1;RDH10
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.8012739004957421,-1.1793778126499013,0.24561403508771928,1.0,1.0,1/5,3.96%,PLSCR1
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,-0.5496723217274343,-1.1792382420626903,0.22666666666666666,1.0,1.0,9/38,12.68%,FTL;SELENOS;GLRX;NDUFA6;GPX4;MGST1;PTPA;PFKP;JUNB
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.6167081914263596,-1.1791327748676543,0.2898550724637681,1.0,1.0,4/22,7.78%,OPRM1;SFRP1;RHBDF1;RSAD2
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.702613730661059,1.1788450015869354,0.23076923076923078,0.8664480771443214,1.0,3/6,19.90%,FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.6254060555736203,-1.1787880195888314,0.28378378378378377,1.0,1.0,3/16,6.03%,ZFPM1;OLFM1;EFNA1
prerank,MSigDB_Hallmark_2020__Myogenesis,-0.5018777594341233,-1.1787781551896455,0.20212765957446807,1.0,1.0,20/112,16.75%,GADD45B;SGCA;PPFIA4;GABARAPL2;AGRN;SSPN;TGFB1;CLU;CRYAB;MEF2C;MYL6B;IFRD1;COL15A1;APOD;PLXNB2;PTP4A3;MYLK;AEBP1;CRAT;COL4A2
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.6290553973523156,-1.178646231246302,0.2463768115942029,1.0,1.0,4/15,13.41%,EMD;NUP155;NEMP1;TMEM43
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.5787413105834914,-1.1785922173015622,0.21052631578947367,1.0,1.0,10/44,11.90%,LIPI;GSTM4;ALOX5;ALOX12;ACSM3;XBP1;GPX4;EPHX2;HACD4;ELOVL2
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),-0.6371692074433256,-1.178558934713854,0.30985915492957744,1.0,1.0,2/16,4.85%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7528010654364657,1.1784277493337918,0.3142857142857143,0.8664525104139096,1.0,2/5,16.31%,SERAC1;LPCAT1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",-0.5638685269157763,-1.1783540516361686,0.19230769230769232,1.0,1.0,17/30,25.89%,APEX1;ADPRS;RFC2;RPA3;PNKP;RFC4;RFC1;PARG;RFC3;LIG1;POLD2;MBD4;XRCC1;POLE;MPG;NTHL1;OGG1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.443206358964529,1.1780502714132248,0.13333333333333333,0.8661931678746614,1.0,6/27,13.48%,BANP;SF3B3;FMN2;EGFR;HDAC4;HMGCR
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6254336499227237,1.1777228788986251,0.3,0.8661501141332225,1.0,3/8,5.83%,SPRED2;ATR;PLA2R1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.6109613950690864,-1.1775852633492037,0.2631578947368421,1.0,1.0,7/17,25.51%,FGF1;LPCAT3;APOE;SREBF1;ERLIN2;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),-0.5799086383735397,-1.177467847098935,0.23076923076923078,1.0,1.0,8/33,17.94%,IL12RB2;SNRPA1;GSTO1;RPLP0;HNRNPDL;HNRNPA2B1;CA1;HSPA9
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.7171896239304024,1.17733426927643,0.25,0.8660832958808845,1.0,2/6,3.79%,RIT2;ABL1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),-0.6137763533817691,-1.1771408889819768,0.2876712328767123,1.0,1.0,6/17,27.01%,GAPDH;PGK1;LDHA;PGAM1;ENO4;PFKFB2
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.6595912976338483,1.1770060728485243,0.3611111111111111,0.8658735077266431,1.0,3/9,18.92%,KDM3B;JMJD1C;KDM4C
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),-0.7557851381543562,-1.176824110918019,0.2463768115942029,1.0,1.0,1/6,8.71%,FN1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.698465136538972,1.1766753755044557,0.35,0.8654499540302049,1.0,2/5,19.15%,LIMD1;ACHE
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.5786182304906863,1.1766522718542072,0.24242424242424243,0.8642189520950777,1.0,3/15,7.69%,THAP4;PPA2;DDO
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.444959359918451,1.1764607060619485,0.13043478260869565,0.8633956074543305,1.0,5/60,5.64%,MYRFL;MMP16;ADAM10;PHEX;KLKB1
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),-0.6368247487844668,-1.1763684177869487,0.20588235294117646,1.0,1.0,6/17,20.26%,VEGFA;TGFB1;HAS2;CAV1;RASA1;PDGFRB
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.6503059920927288,1.1760682683153854,0.3055555555555556,0.8634522399567772,1.0,3/8,12.01%,ICE2;SNAPC1;ELL
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.7096857202146288,1.17559677916541,0.3142857142857143,0.8637217710964201,1.0,1/5,8.99%,BBS4
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,-0.5007124525725,-1.1754078110270658,0.16483516483516483,1.0,1.0,8/123,7.07%,CD44;PPIF;HES1;RETREG1;OVOL2;RASGRP1;OLFM1;XBP1
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.6937925654513881,-1.1751335035688637,0.30985915492957744,1.0,1.0,1/7,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.633111544503312,-1.1749035754024189,0.22857142857142856,1.0,1.0,2/14,7.72%,TGFB1;ASPN
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),0.6503530700522043,1.174647802388514,0.21875,0.8652196250123848,1.0,1/6,9.36%,MECP2
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.5643499784416117,-1.174595303537641,0.23255813953488372,1.0,1.0,16/42,28.34%,PSMB9;PSMB8;PSMA3;PSMA7;PSME1;OAZ2;AZIN1;NQO1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.597413442923409,-1.174479585750759,0.21621621621621623,1.0,1.0,8/23,21.64%,ROMO1;PEX1;TIMM44;AIFM1;PEX14;HSPD1;TOMM20;TOMM40
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.7195978517468175,1.1739891419258968,0.375,0.8658395347188234,1.0,3/5,14.91%,DCX;AGTPBP1;ARL3
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),0.7738669632867445,1.1739705858485388,0.22727272727272727,0.8645252790221482,1.0,2/5,15.63%,ANXA6;PPP1R12B
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6798006027529707,-1.1736285234224837,0.2714285714285714,1.0,1.0,2/13,9.53%,SRSF7;SRSF10
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.676496965430472,-1.1735791367700454,0.22950819672131148,1.0,1.0,4/11,21.43%,ZW10;BUB3;MIS12;CTCF
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.71850506315265,-1.1734885245872937,0.2753623188405797,1.0,1.0,3/7,21.96%,DARS2;WARS2;GARS1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.5979233441474401,1.1725529298217103,0.3076923076923077,0.8672852546719071,1.0,4/10,15.60%,NFATC1;PPP3CA;NFATC3;NFAT5
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.5591826627816769,1.1724248855550383,0.2,0.8664191579908386,1.0,3/19,3.88%,CRB2;SOX11;ELAPOR2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.6565107291974656,-1.172365333163943,0.25,1.0,1.0,4/11,9.03%,RIMS1;FLOT1;MEF2C;CAMK2A
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.5721909236980354,1.1720416933816102,0.24,0.8661420966599722,1.0,4/23,2.56%,RIPOR2;ARAP1;NLGN1;FNBP1L
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6498018490593306,1.1719112762433244,0.35714285714285715,0.8653039090526393,1.0,5/8,27.78%,AGPS;FAR1;DHRS7B;CHPT1;GNPAT
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.5283650727430232,-1.1714067306113574,0.24096385542168675,1.0,1.0,16/63,20.30%,SRSF7;RBM8A;DHX38;CDC40;SRSF5;CASC3;NCBP1;CSTF2;UPF3B;MAGOHB;CSTF1;THOC5;CHTOP;CPSF1;SLBP;SRSF2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.42175596566125895,1.1711600126642392,0.16666666666666666,0.866549139452949,1.0,10/58,6.06%,BAIAP3;ZDHHC2;SHANK2;NLGN1;ADRA1A;GRIK2;TSHZ3;NRXN1;SLC8A2;ARC
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.5884501531258302,1.1710294866806057,0.32,0.8656428988315534,1.0,4/23,4.92%,SEMA3B;SEMA4D;SEMA6C;ROBO1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.7528553641190368,1.1709116032699942,0.28125,0.8633501720477341,1.0,2/6,13.63%,IWS1;SETD2
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.7528553641190368,1.1709116032699942,0.28125,0.8633501720477341,1.0,2/6,13.63%,IWS1;SETD2
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.5943530080009043,1.170857306268305,0.38235294117647056,0.8623601668775052,1.0,1/8,3.43%,PARD3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.7116213730706548,-1.170591507780528,0.25806451612903225,1.0,1.0,2/8,12.52%,SELENOS;SYT11
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.6738829559217526,-1.170470797863672,0.2571428571428571,1.0,1.0,6/10,25.54%,JAG1;CD55;BTN3A3;CD46;IL18;GNL1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7602887049167518,-1.1704699524465103,0.288135593220339,1.0,1.0,1/5,8.08%,SMC1A
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.7518412928329661,-1.1702643591198278,0.3188405797101449,1.0,1.0,1/5,5.99%,DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.7518412928329661,-1.1702643591198278,0.3188405797101449,1.0,1.0,1/5,5.99%,DOLPP1
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),0.6008280746792973,1.1700060657668734,0.3333333333333333,0.8633219299718917,1.0,2/7,18.92%,RIOX2;KDM4C
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.6722374062198916,-1.1694399902493975,0.2727272727272727,1.0,1.0,1/10,1.06%,ITGA4
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.5527134567975547,1.169248257214052,0.30303030303030304,0.8645355129855897,1.0,4/16,6.06%,SHANK2;TSHZ3;SLC8A2;ARC
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.5876723443815092,-1.1691130440984814,0.25,1.0,1.0,6/36,8.80%,FLG;HRNR;COL5A3;ALOX12;JAG1;MED1
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.792001180550254,-1.1689230667968522,0.3275862068965517,1.0,1.0,2/5,14.73%,SLC22A4;PDZK1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.5008197855044636,1.1687580552620214,0.13636363636363635,0.8646583697810605,1.0,8/26,12.78%,MAPK11;HDAC9;ABL1;CDON;MAPK14;PTBP1;CTNNA2;MEGF10
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.5553416753303777,-1.1685846814631993,0.22727272727272727,1.0,1.0,17/45,28.34%,PSMB9;PSMB8;PSMA3;PSMA7;PSME1;OAZ2;AZIN1;NQO1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;BHMT;PSMA4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.7805253680016481,-1.168362124479862,0.1864406779661017,1.0,1.0,4/5,16.54%,FLOT1;TGFB1;MEF2C;USP19
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.6698727594408892,-1.1682226606216806,0.25757575757575757,1.0,1.0,1/9,11.65%,LPCAT3
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.7007465079901316,-1.1679498853325732,0.36666666666666664,1.0,1.0,3/8,13.84%,NOXA1;CD55;DVL2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),-0.6713054709440537,-1.167825864012758,0.34285714285714286,1.0,1.0,1/14,0.26%,B2M
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),-0.7357309157412038,-1.1672988000859696,0.23636363636363636,1.0,1.0,1/5,4.27%,TGFB1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.4242040190017717,1.1665951596294744,0.16666666666666666,0.8700226437672784,1.0,21/82,16.30%,SYNDIG1;RGS7BP;ASTN1;ZNF536;PRIMA1;NRXN1;ADGRL3;ANK2;FAM107A;CNTN1;GRIK3;ADCYAP1R1;MEGF10;NFASC;INTS6;SOX10;PCDH17;FRZB;NDRG2;GPM6B;FREM1
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),0.6919239358008008,1.1662755757052312,0.2972972972972973,0.8695833347412526,1.0,1/7,8.71%,USP30
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.7037849895994471,-1.166138993572297,0.234375,1.0,1.0,1/7,3.62%,RAB11A
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),-0.588154557954795,-1.16610531284849,0.24691358024691357,1.0,1.0,7/32,12.75%,CDKN1C;TGFB1;ZW10;TOM1L1;BTG1;NABP2;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.7049917637761811,-1.1659800908180882,0.2647058823529412,1.0,1.0,3/10,22.09%,CAMK1;BRCA1;SPHK2
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),-0.5611544787972081,-1.1658345980858071,0.25925925925925924,1.0,1.0,7/28,18.34%,SLC6A6;GLUL;SLC22A4;SLC1A6;SLC7A8;SLC12A4;SLC29A2
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.6716368877299769,1.165759816703999,0.45454545454545453,0.8687547301336632,1.0,4/6,24.50%,PTBP1;LMCD1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.6716368877299769,1.165759816703999,0.45454545454545453,0.8687547301336632,1.0,4/6,24.50%,PTBP1;LMCD1;CAMTA1;AKAP6
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.623299516909229,-1.1654134644486789,0.2727272727272727,1.0,1.0,3/13,14.82%,PHKG1;CALM1;PYGL
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.6399633997239207,1.1652931654599181,0.4,0.8691914872052566,1.0,1/8,4.32%,LARGE1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.7802866737083779,-1.1649404461974957,0.2982456140350877,1.0,1.0,2/6,7.64%,ARG2;AZIN2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.6962032721565445,-1.1647242299446718,0.3333333333333333,1.0,1.0,2/7,20.52%,AGT;IL18
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),-0.7139201783750745,-1.1645910882926116,0.2698412698412698,1.0,1.0,5/9,24.29%,CEACAM1;CD160;PHPT1;THY1;PTPN2
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.5200226690664643,1.1645832809117178,0.30303030303030304,0.8697643990486496,1.0,1/15,0.44%,SOX11
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.6904427198866422,1.1645217916368846,0.3333333333333333,0.8685966750664633,1.0,2/5,8.40%,DMD;ATP2B4
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.7561980675358558,-1.1639420680253656,0.3611111111111111,1.0,1.0,1/6,9.03%,CAMK2A
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),-0.7563337568097304,-1.163572916302311,0.19696969696969696,1.0,1.0,2/7,6.56%,ALOX5;ALOX12
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.380970362795791,1.1633719204573718,0.18181818181818182,0.8707450662388241,1.0,35/145,16.14%,GABRG1;ITPR2;RGS7BP;ASTN1;MPPED1;SEMA4D;DSCAML1;TSPAN15;NRXN1;FAM107A;VLDLR;HDAC11;HEPACAM;LRRTM3;FASN;SLC1A2;ADGRA1;CA10;MYRF;ANLN;SRCIN1;DLG2;VSTM2B;SOX8;ADCYAP1R1;ENPP6;KIF1B;KIF13B;ST18;SOX10;TTBK1;NDRG2;TMEM178A;PEX5L;GPM6B
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.7722116983104266,-1.163371115320742,0.3076923076923077,1.0,1.0,1/5,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.7722116983104266,-1.163371115320742,0.3076923076923077,1.0,1.0,1/5,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.7722116983104266,-1.163371115320742,0.3076923076923077,1.0,1.0,1/5,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.5304519719276566,1.1633322296966098,0.28125,0.8694881625876996,1.0,3/13,13.96%,SAMHD1;NT5C1A;PNP
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),0.6002402767625393,1.1632935167291156,0.23809523809523808,0.868280630849851,1.0,4/12,18.37%,PRR5L;MOV10;ZC3HAV1;CNOT7
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),0.5837984493223737,1.1632649745806578,0.36666666666666664,0.8670767638517228,1.0,3/10,8.99%,NINL;PCM1;BBS4
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5426657445039,1.162915575056672,0.19047619047619047,0.8671481230047011,1.0,3/18,11.95%,HSPA1A;AFAP1L2;HMGB1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.7616829237903154,-1.1628806626368011,0.2727272727272727,1.0,1.0,2/6,10.61%,RIMS1;SLC22A4
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.5557973220242336,-1.1625260877645263,0.25925925925925924,1.0,1.0,6/40,9.45%,LIPI;ACMSD;ALOX5;ACSM3;XBP1;GAMT
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6102174507252288,1.1625063989826125,0.2702702702702703,0.867037887052022,1.0,5/11,18.00%,ITGA2;PTPRC;OPHN1;NRP1;ANKS1A
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.7185977977112535,1.1624806722128957,0.3181818181818182,0.8657508002978903,1.0,3/5,26.36%,SETD2;SETD3;SETMAR
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.5790378756080792,1.1622736311437034,0.35714285714285715,0.8651231123253448,1.0,3/8,14.95%,DCUN1D2;DCUN1D5;DCUN1D1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),-0.7227229742994632,-1.162061272308274,0.25,1.0,1.0,2/6,7.28%,HLA-F;CEACAM1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.7375305385577173,-1.1619502634820458,0.42028985507246375,1.0,1.0,1/6,0.41%,MX1
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.7375305385577173,-1.1619502634820458,0.42028985507246375,1.0,1.0,1/6,0.41%,MX1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.6321429340600958,-1.161668485762041,0.29577464788732394,1.0,1.0,8/15,28.02%,SNRNP200;CACTIN;CWC15;WBP11;RBM22;PSIP1;WBP4;NCBP2
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7512196357458043,-1.1616514901552415,0.3181818181818182,1.0,1.0,1/8,1.85%,DXO
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.5529043621785967,-1.1611332930487392,0.21428571428571427,1.0,1.0,12/36,19.73%,ISG15;RPS27A;TRIM25;RFC2;RPA3;UBA52;RFC4;UBE2L6;RFC1;UBC;RFC3;POLD2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.7272129993947732,-1.1609861873655813,0.3384615384615385,1.0,1.0,1/7,0.41%,MX1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.45159359357833484,1.16094808491631,0.09090909090909091,0.8679505194068609,1.0,4/23,9.43%,RXRA;FDX1;STARD3;OSBPL5
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.6408652294747414,1.160916150941195,0.30952380952380953,0.8667580107747955,1.0,1/6,1.96%,FBXW7
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.38183278084113736,1.1607327351158376,0.23076923076923078,0.865996624782041,1.0,16/82,13.54%,VAPB;SGMS1;ACER3;SMPD4;TEX2;CTSA;ESYT2;GLTP;PLA2G15;SPTLC2;CERT1;VAPA;HEXB;PPM1L;PRKD1;CERS6
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.572054791034513,1.1607012284363456,0.3235294117647059,0.8648330897147517,1.0,8/13,23.11%,FNBP1L;MYO7A;WASL;MYO5A;MYO1E;ACTN4;MYO6;MYO5C
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.675088331102462,-1.1606466234898882,0.2903225806451613,1.0,1.0,1/7,2.84%,HES1
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.6858228820196296,1.1602628543097788,0.3333333333333333,0.8650415619452947,1.0,4/6,30.42%,PICALM;RAB22A;RAB5A;ALS2
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),-0.6820234983850096,-1.1601881977832833,0.2222222222222222,1.0,1.0,2/9,14.81%,BTBD18;MAEL
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),-0.7429538273747186,-1.1599396645752391,0.45,1.0,1.0,1/5,3.15%,ENPP2
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,-0.6176420664456961,-1.1597816470249764,0.3157894736842105,1.0,1.0,7/16,14.67%,PLET1;TRIM25;IGSF6;TYMP;MYO1F;PILRA;NR1D1
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),-0.6906378269049638,-1.159607029484802,0.2727272727272727,1.0,1.0,3/9,15.55%,ZFPM1;TTN;MYLK
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.5458374482952772,1.1595561086114754,0.35714285714285715,0.8656302326876796,1.0,4/11,14.42%,KEAP1;PKD2;LATS1;MDFI
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.5589086624111449,1.159542090826213,0.25925925925925924,0.8643606151102602,1.0,9/24,12.45%,SEMA3B;UNC5C;SEMA4D;SEMA6C;ROBO1;SLIT1;SLIT3;SEMA3A;SEMA6A
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7088264049040575,-1.159485810675099,0.296875,1.0,1.0,3/7,17.72%,KDM6B;JAG1;EDF1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.5947050703708141,1.1590778707280047,0.24324324324324326,0.8645911939186415,1.0,3/10,13.88%,SLC25A18;SLC1A2;SLC25A14
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.4949451828223572,1.1590133883097509,0.2,0.8635945164360495,1.0,3/20,7.67%,IRS1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.6172126274687506,-1.1589340222474636,0.3424657534246575,1.0,1.0,4/20,16.26%,PUS3;TRMT10C;PCIF1;DKC1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.5376816859503122,1.1588564838750368,0.14814814814814814,0.8627789459393395,1.0,6/19,19.75%,OSBPL7;AKR1C1;CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.7281395123543942,1.158851138467061,0.3170731707317073,0.8615210935801071,1.0,1/5,0.81%,SLC25A18
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.5014711324906244,-1.1586787018954718,0.1935483870967742,1.0,1.0,36/80,30.28%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL27;MRPL51;MRPS25;CHCHD1;MRPL19;MRPL16;MRPS22;MRPL36;APEH;MRPL48;MTRF1L;MRPS16;MRPS11;MRPS30;PTCD3;MRPL32;GSPT2;MRPL52;MRPS18B;ABCE1;MRPS33;MRPS14;MRPL21;MRPS34;MRPL43;MRPS23;MRPL34;MRPL35;MRPL44;MRPS15;MRPL9
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),-0.5862391076104163,-1.15853159059047,0.23943661971830985,1.0,1.0,5/24,16.31%,PIGO;PIGC;PIGH;PIGG;PIGL
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),-0.7388132146455844,-1.1584463227049646,0.2676056338028169,1.0,1.0,2/8,3.78%,B2M;ARG2
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.6320411080510698,1.1584220798160236,0.35294117647058826,0.8613992781858657,1.0,1/7,5.76%,PLIN5
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7520822056210301,1.1582356449734033,0.4,0.8606570824187273,1.0,1/5,0.09%,PKP2
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.45559816231210915,1.158179083916114,0.21739130434782608,0.8596293038833723,1.0,11/29,14.53%,ADGRB3;HECW2;NEDD4L;SEMA4D;IL1RAPL1;FBXW8;NEDD4;SDC2;RAPGEF2;CAPRIN1;RAP2A
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),0.5367814921311366,1.1579621585104645,0.30303030303030304,0.8591571550714506,1.0,5/12,16.74%,STN1;POT1;CTC1;TERF1;TERF2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.5885573471781695,-1.157704062413217,0.3283582089552239,1.0,1.0,5/20,14.13%,VEGFA;CREB3;XBP1;ATF4;RUNX2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.4446172481632569,1.1575693889137975,0.15,0.8589291819761816,1.0,10/42,12.90%,KCNJ6;SLC8A2;SLC9A9;SLC12A8;CACNA2D1;SLC12A1;ATP2B4;SLC8A1;SLC39A8;SLC39A10
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),0.574637405309754,1.1574047484177195,0.2962962962962963,0.8580627511272464,1.0,1/9,2.67%,RFWD3
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),-0.48936052572649846,-1.1573821076429323,0.24705882352941178,1.0,1.0,8/65,7.93%,ROMO1;VEGFA;CD63;TGFB1;AGT;CHCHD2;PRELID1;SFRP4
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),-0.5578184651358115,-1.15737432191509,0.22784810126582278,1.0,1.0,11/34,23.09%,PDHX;GAPDH;PGK1;PDHB;LDHA;NR4A3;VDAC1;SLC16A1;PGAM1;SLC16A3;ENO4
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),0.6799298929232713,1.1572340381066957,0.2972972972972973,0.8573309041205988,1.0,2/5,5.67%,HSPA1A;ACAA2
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7444973176189154,-1.157097125631034,0.3382352941176471,1.0,1.0,3/7,22.01%,TRMT10C;TRNT1;HSD17B10
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),-0.5788757854034438,-1.157079816562263,0.2702702702702703,1.0,1.0,6/24,13.23%,CENPH;CENPX;RNF8;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.4934235208314154,-1.1568783349504235,0.18681318681318682,1.0,1.0,18/81,21.79%,SEL1L2;TRIM25;SELENOS;DERL2;TMUB1;DNAJC10;SYVN1;ERLEC1;CCDC47;USP19;FAM8A1;WFS1;RNF175;BAG6;FBXO6;TMEM129;ERLIN2;TRIM13
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.5074037579633778,1.1563152610082965,0.2962962962962963,0.8588425793827409,1.0,5/19,6.49%,SYNDIG1;NLGN1;PCLO;PLD2;WNT7A
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.666410226206287,-1.1555742428273046,0.273972602739726,1.0,1.0,7/14,19.30%,IFIT1;FLOT1;SLC3A2;CAV1;CGAS;RFTN1;IFIH1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.5835225409857432,-1.1550191962571672,0.3055555555555556,1.0,1.0,8/21,20.26%,OBSL1;TTN;LMOD1;TMOD3;OBSCN;ACTN2;PGM5;PDGFRB
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.7293534652098019,-1.154975870552002,0.3090909090909091,1.0,1.0,3/6,14.33%,CENPH;CENPC;MIS12
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.5385727002320421,-1.1546654935678544,0.2564102564102564,1.0,1.0,11/41,21.83%,ROMO1;SLC25A6;TIMM8B;TIMM44;TOMM7;PMPCA;AIFM1;HSPD1;TOMM20;TOMM40;AIP
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.581380202370308,-1.154483247565208,0.2692307692307692,1.0,1.0,8/20,27.60%,UTP15;DDX11;ATF4;NCL;HEATR1;UBTF;DHX33;MARS1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.7362511176305221,-1.1543138437576466,0.31666666666666665,1.0,1.0,1/6,0.66%,VEGFA
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7685943838088432,-1.154070264032963,0.3220338983050847,1.0,1.0,1/5,4.08%,POLR3H
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.5666712267009236,-1.1540059945051209,0.25316455696202533,1.0,1.0,7/38,16.03%,DXO;DDX5;LSM5;SUPV3L1;ZFP36L2;NUDT12;RNH1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.7523784305774905,1.1538581835385753,0.3,0.86478213271874,1.0,3/5,19.90%,FYCO1;KIF13A;KIFAP3
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),0.4144777774606957,1.1537855021318566,0.22727272727272727,0.8638026616557256,1.0,9/40,11.31%,SPRED2;EYA4;ATR;SIRT1;PLA2R1;EGFR;EYA2;TRIM28;UBE2N
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,-0.5126670630915559,-1.1536347551687343,0.21686746987951808,1.0,1.0,22/74,20.55%,RARRES2;CRYAB;ASPN;PAMR1;RNASE1;GSTM3;COL4A1;LMOD1;COL15A1;COL6A1;ACTA2;MYLK;MYLIP;SAT2;COL4A2;MATN2;COL14A1;CALD1;THBS2;RASD1;PDGFRB;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4591988090893645,1.1533061918065113,0.18181818181818182,0.8635917816813383,1.0,8/30,10.25%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPKAPK5;MAPK3
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.632778563972916,-1.153282101346881,0.26666666666666666,1.0,1.0,4/16,6.74%,MT1E;MT1M;JUN;MT2A
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.6810656188217565,1.153026049046153,0.2682926829268293,0.8630538243347919,1.0,2/7,3.22%,SGCZ;NOX4
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.6275037113396481,1.153010948008855,0.37142857142857144,0.861797559670549,1.0,3/9,2.12%,BAIAP3;NLGN1;ADRA1A
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.5088434873255745,1.1529141183434308,0.25,0.8608716865274962,1.0,13/35,21.11%,RIPOR2;ARAP1;NLGN1;FNBP1L;CAPZB;WASL;NRP1;ARHGAP44;RALA;DOCK11;GPM6A;PIK3R1;TENM1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.517781729441043,1.1529088617150052,0.2222222222222222,0.8596222356036536,1.0,4/31,8.82%,PHLDB2;EPHA3;FAM107A;TRAF3IP1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.5028258579501267,1.1528551932693363,0.3333333333333333,0.8584850037826098,1.0,5/23,10.05%,NLGN1;CNIH2;ARC;GSG1L;RELN
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6959035588995449,1.1526574423123184,0.34210526315789475,0.8577848248993019,1.0,3/6,24.28%,TSHZ3;MTG2;MTG1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.522142615311196,-1.152647574671764,0.19101123595505617,1.0,1.0,20/66,23.20%,TNC;ITGA4;COL5A3;SNED1;PAMR1;COL4A1;LMOD1;COL15A1;COL6A1;ACTA2;ADAMTS2;AEBP1;COL4A2;COL14A1;THBS2;PDGFRB;THY1;RHOJ;C1S;MADCAM1
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.7458597323986302,-1.1524643154368486,0.3387096774193548,1.0,1.0,2/5,13.43%,GALM;GALE
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.7288470809643403,-1.1523690165144158,0.2833333333333333,1.0,1.0,1/6,9.20%,CDH3
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.6015032947914809,1.1521191149037624,0.25,0.8581911627853832,1.0,1/8,5.65%,PDE4D
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5657152076091971,1.1516660216400931,0.3333333333333333,0.8583800732054631,1.0,3/12,13.63%,IWS1;CPSF6;SETD2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),-0.7372172562514476,-1.151642535564935,0.35,1.0,1.0,2/7,9.45%,HDAC6;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),-0.5418097934632389,-1.1516055083690282,0.25,1.0,1.0,8/48,11.60%,EPN1;SPINK5;ALOX5;PGK1;PIK3CB;NAXE;CD160;CNMD
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.6606403888431314,-1.151228124953777,0.34375,1.0,1.0,6/14,19.82%,ZFPM1;CEACAM1;LRRC17;FSTL3;TCTA;RARA
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.4358575314587891,1.15121708031508,0.2857142857142857,0.8579637983464261,1.0,10/31,19.04%,SGMS1;ACER3;SMPD4;PLA2G15;SPTLC2;CERS6;ABCA2;FA2H;PLPP2;SGPL1
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.7473623278057064,-1.150820232223179,0.3064516129032258,1.0,1.0,2/5,16.19%,SLC6A9;SLC7A8
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.38881240848395615,1.150523146750745,0.0,0.8587993896558571,1.0,51/163,17.58%,SHROOM2;RACGAP1;SORBS2;BCAR1;ABL1;RICTOR;PDLIM5;CDC42EP4;FGD4;MYH9;BCL2L11;KIF15;CDC42BPA;MAP3K11;SPTBN1;BIN1;PKD2;CNTRL;PPP4R2;CAPZB;PCM1;ABI1;OPHN1;WASL;CDC42EP1;ANLN;RABGAP1;PALLD;RAPGEF6;KIF3C;CLIP2;LATS1;FARP1;KIF1B;CLASP1;DOCK4;SASS6;SHROOM1;RASA2;PCNT;SUN2;SOS1;ARHGEF11;ARHGEF12;ARHGEF7;CCDC88A;SMC4;MYO1E;SSH2;ARFGEF1;ARHGAP5
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.6119910179353558,-1.150454895930679,0.2535211267605634,1.0,1.0,4/13,14.02%,TMEM50A;TMEM50B;LEPROTL1;CHMP4B
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),0.7102853897633928,1.1500949577093076,0.3333333333333333,0.8577757078199973,1.0,2/5,18.40%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),0.7102853897633928,1.1500949577093076,0.3333333333333333,0.8577757078199973,1.0,2/5,18.40%,RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.571237213841771,-1.1499866934049927,0.3026315789473684,1.0,1.0,8/25,16.51%,NOSTRIN;HTR2B;PIK3CB;CALM1;DNM2;APOE;S100A1;CAV1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5732444058344168,-1.1498019490911513,0.25,1.0,1.0,6/23,22.69%,RPS27A;UBA52;UBC;XPA;DDB2;RBX1
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6605365623064694,-1.1495549761091395,0.26865671641791045,1.0,1.0,2/11,7.50%,TGFB1;JAG1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.5035404600337615,1.1494468863114753,0.2608695652173913,0.858779741770018,1.0,7/21,19.07%,PRR5L;RICTOR;RPS6KB1;SMG1;CCDC88A;PINK1;MTOR
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.6443582041526881,-1.1489814207320659,0.23529411764705882,1.0,1.0,1/11,4.27%,TGFB1
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.6171125517699926,1.148816486088954,0.3142857142857143,0.8594378653323894,1.0,2/11,6.82%,IFT140;DYNC2LI1
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.5064725484482036,-1.1487853543018396,0.2159090909090909,1.0,1.0,32/73,30.28%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL27;MRPL51;MRPS25;CHCHD1;MRPL19;MRPL16;MRPS22;MRPL36;MRPL48;MRPS16;MRPS11;MRPS30;PTCD3;MRPL32;MRPL52;MRPS18B;MRPS33;MRPS14;MRPL21;MRPS34;MRPL43;MRPS23;MRPL34;MRPL35;MRPL44;MRPS15;MRPL9
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),-0.6125598414836684,-1.1486697050025276,0.28169014084507044,1.0,1.0,2/18,4.85%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.4786315403754972,1.1486652833576503,0.2413793103448276,0.8588309644086056,1.0,4/28,6.04%,SEPTIN4;STYXL1;BOK;BCL2L11
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.7215422378629501,-1.1482589277099864,0.36507936507936506,1.0,1.0,2/6,17.50%,SPINK5;USH2A
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5894527972746169,1.1482375071127435,0.2903225806451613,0.8589954275522222,1.0,3/11,9.05%,LAMA3;TRAF3IP1;RAB10
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),-0.662573840881496,-1.1478844037744025,0.2878787878787879,1.0,1.0,1/11,1.68%,PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6213663877689142,-1.1476612399447197,0.3287671232876712,1.0,1.0,3/18,9.53%,SRSF7;RPS13;SRSF10
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),-0.6493802826066265,-1.1472855513132556,0.29577464788732394,1.0,1.0,5/11,13.31%,MX1;IFIT1;OAS1;ZDHHC1;NLRP1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),-0.7194395871472117,-1.1471393121932358,0.3333333333333333,1.0,1.0,1/7,4.83%,DNAH17
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.6656044733357069,-1.1470217969358858,0.2777777777777778,1.0,1.0,2/11,9.76%,ITM2A;ITM2B
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.6341759547661566,-1.146790471910857,0.3424657534246575,1.0,1.0,5/16,16.51%,MEF2C;MYL6B;MYORG;SELENON;CAV1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4314714664956438,1.1467510495474635,0.23076923076923078,0.8624683974270329,1.0,33/99,18.76%,PHLDB2;CRB2;GPNMB;LRRC4C;ADGRB3;HECW2;NEDD4L;SEMA4D;PDLIM5;TANC2;ZRANB1;ARC;SH3D19;CAPZB;LRRK2;SRCIN1;NEDD4;SDC2;CLASP1;KIF13B;DLL1;RAP2A;ARHGAP44;INF2;MARCHF5;FMNL2;SIPA1L1;CDH2;LARP4;PID1;PPFIA2;CLASP2;NF1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.47831849783309893,1.1467472690234102,0.25,0.8612415576013898,1.0,9/30,13.39%,RAB31;SPTBN1;NECTIN3;NSF;RAB10;GGA1;BLZF1;ARFRP1;KIF13A
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7091464730919683,-1.1466106982413575,0.3333333333333333,1.0,1.0,3/8,26.16%,TTC19;UQCC3;BCS1L
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7091464730919683,-1.1466106982413575,0.3333333333333333,1.0,1.0,3/8,26.16%,TTC19;UQCC3;BCS1L
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.7051275052641206,-1.145871207733937,0.3770491803278688,1.0,1.0,3/8,16.51%,ENPP4;APOE;CAV1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.573558898801821,1.1457453886675706,0.25806451612903225,0.8628281635817876,1.0,6/13,17.04%,CEP120;PCM1;SYNE3;FBXW11;SUN2;TMEM201
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.4906245935218086,1.1453998590029786,0.17857142857142858,0.862667163053067,1.0,9/23,23.08%,FER;CAPZB;AUTS2;PIK3CA;NCKAP1;SLIT2;PIK3R1;TWF1;ARPC2
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.7159931953881422,-1.1453304461937162,0.3,1.0,1.0,1/9,1.85%,DXO
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.6566343947994127,1.145277423760926,0.37209302325581395,0.8616575276353813,1.0,2/5,20.96%,PLAUR;ANK3
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.6862734091825857,1.1451716510183023,0.45161290322580644,0.8608203263299565,1.0,2/7,10.05%,NRXN1;RELN
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.5969646034577459,1.1449788689489058,0.32432432432432434,0.8602394977256774,1.0,2/6,9.36%,HSPA1A;MECP2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.6644803219446306,-1.144974796291286,0.2711864406779661,1.0,1.0,1/8,0.36%,HLA-F
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.5046514087018888,-1.1449533025394654,0.19101123595505617,1.0,1.0,33/74,30.28%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL27;MRPL51;MRPS25;CHCHD1;MRPL19;MRPL16;MRPS22;MRPL36;MRPL48;MTRF1L;MRPS16;MRPS11;MRPS30;PTCD3;MRPL32;MRPL52;MRPS18B;MRPS33;MRPS14;MRPL21;MRPS34;MRPL43;MRPS23;MRPL34;MRPL35;MRPL44;MRPS15;MRPL9
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.7340120168647344,-1.1449514304461557,0.3090909090909091,1.0,1.0,2/5,15.97%,CLU;HSP90AB1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4257478709443746,1.144864759807272,0.21428571428571427,0.8593432457362903,1.0,6/77,2.84%,TOP1MT;RMI1;RPA1;BARD1;ATR;RBMS1
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.629754612179371,-1.1447554166818799,0.30666666666666664,1.0,1.0,4/17,6.74%,MT1E;MT1M;JUN;MT2A
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.7713352065622734,-1.1447551022229872,0.26666666666666666,1.0,1.0,1/5,1.68%,PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.8067399725496833,-1.1446056019585322,0.3220338983050847,1.0,1.0,1/5,6.24%,OAS3
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.6885072987218298,-1.1445319167333066,0.29411764705882354,1.0,1.0,4/6,22.47%,PRELID1;ISCU;PARK7;IFNAR1
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),-0.7250020870510061,-1.1444254812476202,0.3333333333333333,1.0,1.0,4/6,27.52%,CCDC39;CFAP100;CCDC40;DNAH7
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4148058431766855,1.1444117210562927,0.18181818181818182,0.8595049026128364,1.0,33/92,15.94%,SHROOM2;SHANK2;BCAR1;TOX3;CDC42EP4;MPDZ;SLC29A4;SLC16A2;MAGI1;UNC13B;EGFR;MMP15;ADCY6;SHROOM3;SLC4A10;PRICKLE2;PARD3B;SDC2;CMTM4;FARP1;CHRD;PTPRU;COBL;FRZB;FLRT3;RNF128;NCKAP1;EPB41L1;CHMP1A;NEO1;TMEM178A;TEAD1;AMOTL2
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.57301072438075,1.1443365709268511,0.25,0.8573220953217658,1.0,5/13,12.38%,SHROOM2;RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.57301072438075,1.1443365709268511,0.25,0.8573220953217658,1.0,5/13,12.38%,SHROOM2;RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),-0.7517732783409239,-1.1440530073734296,0.4,1.0,1.0,1/5,9.19%,SH3GL2
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.5403145781805755,-1.143755090819328,0.27058823529411763,1.0,1.0,10/38,16.34%,BUD23;DXO;TGFB1;DDX5;UTP15;DIMT1;SUPV3L1;MAP2K1;HRAS;RIOK2
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.6607272003562806,1.1436866256002585,0.2903225806451613,0.858221567252125,1.0,4/7,13.78%,UNC5C;FZD3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.506051935417247,-1.1434664494161428,0.26506024096385544,1.0,1.0,20/80,20.32%,SRSF7;DXO;PRPF18;DDX5;LSM5;PRPF8;SNRPB;SRSF5;SRRM4;NCBP1;HNRNPA2B1;ZFP36L2;NUDT12;RNH1;KIN;USP39;SF3A3;SLBP;SRSF2;SNRPG
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5675345687388967,-1.1431074469807943,0.3125,1.0,1.0,5/31,12.30%,FANCB;ZCWPW1;PARP9;PNKP;DDX11
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6537706122535953,1.1428227174237615,0.3333333333333333,0.8595173188976887,1.0,2/8,7.55%,ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),-0.6938820668333604,-1.142690506531547,0.32786885245901637,1.0,1.0,4/7,25.77%,OCIAD2;LPCAT3;LRRC19;UBAP2L
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.5021515558271451,1.1423979967744748,0.15,0.859258400286294,1.0,6/31,13.57%,PHLDB2;EPHA3;FAM107A;TRAF3IP1;CLASP1;KLHL42
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.5797151068777606,-1.1422990171191116,0.2839506172839506,1.0,1.0,9/22,30.34%,EFNA1;HDAC6;CST3;BAG6;PLAT;CSTB;TIMP3;TIMP1;CAMK2N1
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.629087285911442,1.142270643514582,0.22580645161290322,0.8585187964143395,1.0,2/6,4.70%,CD247;CD96
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.6625385679582194,-1.1418362783295544,0.2571428571428571,1.0,1.0,2/12,11.37%,CD63;EMP2
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.5981293569065796,1.1417851614493606,0.2702702702702703,0.8592025652108342,1.0,1/8,0.38%,SPOCK3
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.4432449529196358,-1.1417508922292625,0.10309278350515463,1.0,1.0,37/461,7.94%,CD44;GADD45B;APIP;IFI6;PPIF;VEGFA;BEX2;TFPT;DDRGK1;NOL3;VAV3;RPS27A;SFRP1;ANGPTL4;RPL10;ECT2;STK17A;IFIT3;APEX1;JUN;RPS3A;RASGRF2;ARHGEF18;HMGN5;COPS5;HAX1;CLU;AGT;HTR2B;OLFM1;XBP1;CRYAB;PRELID1;BCL2L14;MEF2C;SFRP4;APH1A
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.7336521151225374,-1.1416225543768457,0.37037037037037035,1.0,1.0,1/6,4.90%,SELENOS
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.6656994565110466,-1.141470597362786,0.31746031746031744,1.0,1.0,2/9,10.51%,ITGA4;GCNT1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.5688938460455987,-1.1414102096988235,0.2857142857142857,1.0,1.0,12/26,22.66%,IL20RA;OVOL2;TMC4;CEBPD;BTG1;PROM1;SLC44A3;UXT;BTC;CD9;RUNX1;SYTL2
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6440598152115129,-1.1412686448991791,0.3333333333333333,1.0,1.0,6/12,25.75%,SFRP1;LOC400499;SRA1;RARA;PELP1;AR
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),-0.7569235770699971,-1.141119895066519,0.30985915492957744,1.0,1.0,2/6,12.11%,ZW10;NABP2
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.6871607424513251,-1.140958666415649,0.2857142857142857,1.0,1.0,2/10,11.57%,PDE6B;CALM1
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.48670271501526996,1.1408465191090955,0.3076923076923077,0.8611159069259792,1.0,7/25,10.49%,MAPK11;MAP3K5;BTRC;MAPK1;FBXW11;MAPK3;MAP3K7
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.45455443926607736,1.1406891557899292,0.16666666666666666,0.8604184925068891,1.0,11/57,12.98%,SOX11;TP63;SEMA4D;CRIM1;PPARG;LIMD1;SMOC1;BMP7;PRKD1;ACVR1;CHRD
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),0.4256511190153545,1.1403218692566477,0.1875,0.8602225638772971,1.0,15/54,18.96%,SH3RF1;UBE3D;UHRF2;OBI1;RAD18;SH3RF3;MARCHF7;TRIM71;RNF11;MARCHF5;UBE2D2;UHRF1;RNF4;RNF185;PRKN
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6573773237174929,1.139913373589088,0.3076923076923077,0.8601103213510695,1.0,1/8,0.16%,MYRFL
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.43278777143160463,1.139904745255093,0.2857142857142857,0.8589813034093783,1.0,11/61,10.38%,VAPB;COL7A1;SEC24D;PREB;CNIH2;GRIA1;NSF;SEC16A;BET1;VAPA;TGFA
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5476363965681431,-1.1398395086790845,0.2564102564102564,1.0,1.0,3/26,10.22%,FANCB;POLQ;MAGEF1
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.5505399623155679,1.1389210321422978,0.3611111111111111,0.8606744376488096,1.0,4/16,12.78%,XKR6;RHOBTB1;HMGB1;MEGF10
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,-0.5233954231176613,-1.1387587968321151,0.27380952380952384,1.0,1.0,17/54,20.26%,RARRES2;CRYAB;ASPN;PAMR1;COL4A1;LMOD1;COL15A1;ACTA2;ADAMTS2;MYLK;COL4A2;RBPMS;MATN2;COL14A1;CALD1;THBS2;PDGFRB
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.4794053792455909,1.138563894907509,0.2608695652173913,0.8604585384578359,1.0,8/32,15.73%,ZDHHC2;NEDD4L;SSH1;SNF8;PLAUR;CHRNA7;MAPK8;SPOP
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.5793991648016122,1.1385173040361747,0.23333333333333334,0.8593130410415262,1.0,2/10,1.37%,SOX11;GPNMB
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.6918614319688625,-1.1379359363991544,0.2857142857142857,1.0,1.0,3/8,15.79%,COL15A1;CNMD;POF1B
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.666632772091787,-1.1374815268749858,0.24324324324324326,1.0,1.0,2/10,11.58%,VEGFA;P2RX4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5729886338290942,1.13736872480433,0.32142857142857145,0.8612051469308423,1.0,2/11,7.55%,ANK2;CACNA2D1
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),-0.7338983633341775,-1.1370556672156962,0.3225806451612903,1.0,1.0,2/5,17.64%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.472992565252765,1.1370132183085835,0.16666666666666666,0.8611337074083797,1.0,8/31,12.30%,PLD1;DGKB;PLD2;GPD1L;DGKQ;ABHD8;GPAT4;AGPAT5
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.49452385775644736,-1.1369899410356226,0.25,1.0,1.0,35/88,30.28%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL27;MTIF3;MRPL51;MRPS25;CHCHD1;MRPL19;MRPL16;MRPS22;MRPL36;MRPL48;MTRF1L;MRPS16;MRPS11;MRPS30;PTCD3;MRPL32;MRPL52;QRSL1;MRPS18B;MRPS33;MRPS14;MRPL21;MRPS34;MRPL43;MRPS23;MRPL34;MRPL35;MRPL44;MRPS15;MRPL9
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6472634113455182,-1.136923706787075,0.3466666666666667,1.0,1.0,1/11,4.27%,TGFB1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.6939767171407247,1.1368405843840643,0.45,0.8603213756738906,1.0,2/5,15.05%,RAPGEF2;ROBO2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.6888817957674502,-1.1363331359553355,0.35,1.0,1.0,2/6,10.05%,EFNA1;GRN
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.7018049265309276,-1.1360850975594894,0.35,1.0,1.0,2/6,10.05%,ATP6AP2;GRN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),-0.7406018042218216,-1.1359390888414216,0.3018867924528302,1.0,1.0,1/5,9.03%,CAMK2A
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5589808551736472,1.135829906154758,0.3,0.8619987364185329,1.0,6/11,29.05%,BMP7;RBPJ;BMPR1A;TGFBR3;NOTCH1;TGFBR1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.6623598410518265,-1.1355508844604714,0.37333333333333335,1.0,1.0,1/12,2.15%,PHF1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.5602694965385093,-1.135375187968157,0.28205128205128205,1.0,1.0,3/28,5.44%,MX1;RIMS1;NAPA
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.48957002657110016,-1.1352726515477838,0.23863636363636365,1.0,1.0,8/67,5.95%,VEGFA;SPDYA;FGF1;CAMK1;TGFB1;CEMIP;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.7559499529021054,-1.1351170564173978,0.3148148148148148,1.0,1.0,1/5,16.50%,PGP
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.4848346044467665,1.1351030093086087,0.1724137931034483,0.8628913847761575,1.0,6/29,8.20%,RAB27A;SYTL4;STXBP5;RAB27B;RAB9A;SNF8
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.48898343688361223,1.1347809894239107,0.3333333333333333,0.8625105097995148,1.0,2/13,2.78%,SOX11;TCOF1
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.49302497034819764,1.1347390467710683,0.35,0.8613936366542286,1.0,5/31,7.65%,EPHA3;RXRA;BRINP3;ADNP2;ABL2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6227570013803079,-1.1344821920125858,0.34328358208955223,1.0,1.0,2/14,13.02%,AGT;NR4A3
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5043909656447523,-1.134134524786087,0.30120481927710846,1.0,1.0,7/52,16.59%,BUD23;DIMT1;WDR6;TRMT10C;TRMT5;PCIF1;NSUN5
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5806875421316042,1.1339546080996266,0.35294117647058826,0.8622834571192084,1.0,4/11,14.08%,ADAM10;OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.6859638574569467,1.1335990739817088,0.39473684210526316,0.8621091422389605,1.0,2/6,3.27%,ERC2;PCLO
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),-0.6265042282726492,-1.1335939516086795,0.30985915492957744,1.0,1.0,4/11,17.44%,BHLHE41;XBP1;BDNF;HDAC3
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.5827595977007165,-1.1333811817564208,0.3582089552238806,1.0,1.0,1/18,0.66%,VEGFA
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.6759027453409174,-1.1328416251167528,0.390625,1.0,1.0,4/10,13.70%,TRIM5;TRIB1;CACTIN;CD55
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.4920727596245775,1.132492717657008,0.16666666666666666,0.8642801213024928,1.0,3/21,7.67%,IRS1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),-0.7605766647649433,-1.1320338577294975,0.3230769230769231,1.0,1.0,2/5,10.24%,KCNK12;CHCHD10
prerank,PanglaoDB_Augmented_2021__Platelets,-0.5123540534911888,-1.1320043048338706,0.313953488372093,1.0,1.0,7/52,8.12%,F13A1;VEGFA;SLC2A3;HLA-A;ALOX12;OST4;TBXAS1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),-0.7245656003471371,-1.1319864006454416,0.3548387096774194,1.0,1.0,1/5,4.03%,YBX3
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.42514010665488555,1.1319654154889836,0.16666666666666666,0.8647755143129072,1.0,8/88,5.35%,BAIAP3;HID1;SHANK2;SORBS2;TOX3;DSCAML1;SH3BGRL2;ZSWIM5
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6968477267508898,1.1318407233706378,0.30303030303030304,0.8640494987276345,1.0,4/6,13.37%,DYSF;ANK2;BIN1;MYOF
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),-0.7134860819906602,-1.1317719638823296,0.3181818181818182,1.0,1.0,1/7,0.92%,HES5
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.3887804278319079,1.1316672893607427,0.18181818181818182,0.8633863712163734,1.0,34/134,18.12%,PLD1;DGKB;ABHD3;INPP4B;PLD2;SYNJ1;SLC44A1;STARD7;PTPN13;GPD1L;ETNK1;PIKFYVE;SLC44A5;DGKQ;CDS1;MTMR3;PCYT1B;ABHD8;PIK3CA;GPAT4;AGPAT5;OCRL;CDS2;FIG4;ABHD5;MTM1;PCTP;LPCAT1;PITPNM2;DGKG;PIP5K1B;CEPT1;FAR1;DGKE
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5621079334562993,-1.1312775464033697,0.30666666666666664,1.0,1.0,3/21,11.04%,PDE6B;RBM4B;ID2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5680029227425407,-1.1311693170535944,0.3333333333333333,1.0,1.0,10/20,29.51%,CEACAM1;CD160;PHPT1;TESPA1;CD226;THY1;PTPN2;NECTIN2;CD81;RPS3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.43673584686876354,1.1308260339336977,0.2,0.8647732549263666,1.0,19/45,19.07%,TAB3;LEPR;ZKSCAN3;TBC1D14;FOXK1;CTSA;EIF4G3;LRRK2;DAPL1;SMG1;PIK3CA;TAB2;WASHC1;BCL2;PINK1;SNCA;EIF4E;MTMR8;MTOR
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.4634740212232024,-1.13073621119612,0.25,1.0,1.0,40/221,15.68%,DUOX1;F13A1;IFIT1;VEGFA;OPRM1;IL20RA;IL12RB2;RPS27A;SFRP1;NDN;YBX3;TGFB1;RPL13A;ALOX5;HAX1;IFNGR2;IL3RA;IRF1;MT2A;XBP1;GAPDH;IL5;HAS2;STAT5A;CEBPD;OAS1;PIK3CB;FN1;OSMR;TCF7;JUNB;CACTIN;ZFP36L2;TXLNA;UBA52;ADAMTS7;NR1D1;SHMT1;IL7;ASAH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.5182940736269733,1.1305016811118365,0.2413793103448276,0.8646172407857011,1.0,5/21,5.96%,ADRA1A;PDE4B;ANK2;PDE4D;SMAD7
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.4535034636176418,1.1304961353169969,0.35294117647058826,0.8634504158993507,1.0,10/34,11.85%,IL15;RXRA;SIRT1;PPARG;MYH9;TGFBR2;PML;MAPK14;GLO1;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),-0.5594638354864542,-1.1304753523228392,0.2608695652173913,1.0,1.0,5/32,7.58%,RPL13A;CLU;ANKRD27;HDAC6;CRYAB
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6526592918696607,1.129868474850995,0.3,0.8641246976559791,1.0,3/5,13.96%,TGFBR2;CBFB;PNP
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),-0.5123982654261359,-1.1296043260995166,0.28735632183908044,1.0,1.0,12/69,18.26%,VEGFA;ELOB;PSMB9;RPS27A;PSMB8;BACH1;PSMA3;ATF4;UBA52;PSMA7;PSME1;UBC
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.5084801937356153,-1.129205342908663,0.2808988764044944,1.0,1.0,23/62,29.29%,PSMB9;RPS27A;PSMB8;PSMA3;BUB3;UBA52;SKP2;PSMA7;CDC26;PSME1;UBC;FZR1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;CDC23;PSMA4;ANAPC2;UBE2S
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.4655538843214273,1.1288780954664575,0.3181818181818182,0.8659266953779112,1.0,11/51,11.38%,VAPB;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;STIM1;SLC8A1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.5404723984904742,-1.1287384630940729,0.2631578947368421,1.0,1.0,12/33,19.73%,RPS27A;RFC2;FAN1;RPA3;UBA52;RFC4;RFC1;UBC;RFC3;XPA;DDB2;POLD2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.6187331181321272,-1.1287090238501472,0.34210526315789475,1.0,1.0,1/15,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6446069546362588,1.1286688376710783,0.2682926829268293,0.8653872510700338,1.0,2/7,5.76%,ACADVL;PLIN5
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),-0.5768268229344158,-1.128599850958336,0.2777777777777778,1.0,1.0,5/28,9.56%,VEGFA;HES1;TGFB1;HAS2;COL4A1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6253098288245864,-1.1285327732428478,0.2916666666666667,1.0,1.0,3/13,14.82%,PHKG1;CALM1;PYGL
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.6410361638421181,-1.128249091995861,0.352112676056338,1.0,1.0,2/13,7.85%,ROMO1;TIMM44
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.7092425835430272,-1.1276646106212629,0.26153846153846155,1.0,1.0,2/6,6.41%,HAP1;HDAC6
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.5538633544019776,-1.1276591177578459,0.26666666666666666,1.0,1.0,10/35,18.87%,ROMO1;PEX1;ZFAND2B;TIMM44;AIFM1;RTN2;SEC61G;PEX14;HSPD1;TOMM20
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.5696778827626257,-1.127606887198675,0.352112676056338,1.0,1.0,4/20,18.09%,PEX1;PEX11B;PEX14;DNM1L
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4746777239473544,1.1274604711353229,0.2916666666666667,0.8677459658577499,1.0,8/27,18.57%,NAV3;MAP2;CAMSAP2;CLASP1;HDGFL3;ATXN7;SNCA;CLASP2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.6686132079984254,-1.1273517551343566,0.3333333333333333,1.0,1.0,2/11,6.40%,PPIF;GSTO1
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.7041430897351042,-1.1269065932855995,0.29850746268656714,1.0,1.0,4/8,17.44%,BHLHE41;XBP1;BDNF;HDAC3
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),0.6826296331487713,1.1267368377321594,0.4117647058823529,0.8682702504726871,1.0,2/6,10.58%,SRR;SERINC5
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4927327380563063,-1.126378278597051,0.26506024096385544,1.0,1.0,9/66,16.53%,POLR2I;TAF11;POLR2G;CDK7;NCBP1;NABP2;GTF2F1;SRRT;CCNK
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6651959249239796,-1.1263698796189605,0.2857142857142857,1.0,1.0,3/7,22.99%,APEX1;TERF2IP;DCLRE1C
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),-0.610112488104618,-1.1258214278804433,0.37333333333333335,1.0,1.0,2/13,4.02%,DDRGK1;GABARAPL2
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.4729790877330224,1.125717497973938,0.18181818181818182,0.8705786662769878,1.0,8/32,12.30%,PLD1;DGKB;PLD2;GPD1L;DGKQ;ABHD8;GPAT4;AGPAT5
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.6491731013436448,-1.125247136695169,0.36923076923076925,1.0,1.0,1/10,3.61%,ENTPD7
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.4107804040687625,1.1246063513167015,0.20833333333333334,0.8722397780468737,1.0,11/33,13.55%,ARHGEF6;MAP3K5;TAB3;MAP4K2;MAP3K11;MAPK10;TAB1;MAP3K7;UBE2N;TAB2;MAPK8
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.7171445271500287,-1.1245677840320334,0.453125,1.0,1.0,2/6,15.63%,APOBEC2;ADAR
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6268652607504634,-1.1245450548727238,0.3382352941176471,1.0,1.0,6/14,17.47%,ZNHIT3;RPF2;DDX18;RPL35;WDR12;NIFK
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5571471757380108,-1.1244614562621529,0.32894736842105265,1.0,1.0,3/22,11.04%,PDE6B;RBM4B;ID2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.6667042622229853,-1.124326274798546,0.3283582089552239,1.0,1.0,2/9,10.49%,TGFB1;CST3
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.7597763469624864,-1.1241032004198304,0.2727272727272727,1.0,1.0,4/5,22.01%,SUPV3L1;TRMT10C;TRNT1;HSD17B10
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),-0.5975403513642419,-1.1239434656804244,0.3424657534246575,1.0,1.0,3/18,16.26%,NOP10;CCT7;DKC1
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.6035830458401671,-1.123828764299668,0.3380281690140845,1.0,1.0,6/20,23.54%,SLC6A6;SLC6A9;SLC3A2;SLC7A8;SLC36A4;SLC7A10
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.6453866054488397,1.1229179390657158,0.375,0.875397100714905,1.0,5/7,33.40%,KDM5A;RIOX2;KDM5B;KDM1A;KDM1B
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),-0.7177579178250545,-1.1226983321241986,0.2898550724637681,1.0,1.0,2/6,7.07%,TAF7;XBP1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.42991174489682865,1.1223878730785184,0.2,0.8759483515142641,1.0,4/30,7.67%,IRS1;SIRT1;RPS6KB1;KANK1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.7007504194899248,-1.1223795551121978,0.4084507042253521,1.0,1.0,4/8,24.29%,RFFL;CARD8;GSTP1;PTPN2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),-0.5235003200156418,-1.1223384737548001,0.3157894736842105,1.0,1.0,8/42,14.67%,PDCD1LG2;TGFB1;SELENOS;XBP1;MEF2C;TRIM41;CACTIN;NR1D1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.6744401411597265,-1.1222651090803053,0.3382352941176471,1.0,1.0,3/10,16.97%,IRF1;OAS1;STAT1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.5014984061118613,-1.1218730303783315,0.3058823529411765,1.0,1.0,13/56,17.42%,VEGFA;FGF1;AGT;CEACAM1;PIK3CB;GLUL;GRN;SVBP;EMP2;NRP2;APOE;PTN;EMC10
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.37389352586411573,1.1217568284648074,0.1111111111111111,0.8764981342688847,1.0,22/94,12.27%,LRFN4;SHANK2;LRRC4C;NLGN1;NLGN4X;RYK;UNC13C;SDK2;NRXN1;ADGRL3;GPC4;SLC8A2;APBB2;NRCAM;UNC13B;LRFN5;DNM3;LRRK2;CHRNA7;NEDD4;PTPRS;FARP1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),-0.6312642327361935,-1.1217482082949943,0.37333333333333335,1.0,1.0,3/16,8.16%,VEGFA;HES5;CACNA1C
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.5616643636005315,-1.1216831934846057,0.2962962962962963,1.0,1.0,4/29,14.50%,HAP1;BLOC1S2;DCTN1;KIF1A
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),-0.6515660097015974,-1.1214968502446254,0.352112676056338,1.0,1.0,4/9,21.98%,ALOX12;CEACAM1;APOE;CD9
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.5118703204188022,-1.1213702932674412,0.31645569620253167,1.0,1.0,18/65,21.51%,SRSF7;RBM8A;TGFB1;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;STRADB;UPF3B;MAGOHB;THOC5;CHTOP;RANBP17;SRSF2;PHAX;NUP188
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.6515665813127387,-1.1209531794500103,0.30985915492957744,1.0,1.0,2/15,2.75%,IFIT1;FLOT1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.49553509115446626,-1.1208698214601078,0.2891566265060241,1.0,1.0,9/65,16.53%,POLR2I;TAF11;POLR2G;CDK7;NCBP1;NABP2;GTF2F1;SRRT;CCNK
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.7465003542253279,-1.1205222459017135,0.36363636363636365,1.0,1.0,2/5,18.40%,IL5;GSN
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.7429919545320444,-1.1204257917903275,0.40350877192982454,1.0,1.0,1/5,3.62%,RAB11A
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.603264399037766,-1.1202446809027287,0.32432432432432434,1.0,1.0,4/15,14.58%,LHFPL5;TTN;PKD2L2;PKD1L1
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.49813612507536276,1.1201793871492653,0.2857142857142857,0.8795774121341552,1.0,3/19,1.00%,COL7A1;DUSP4;LAMA3
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7167981625762597,-1.1197454550716577,0.3283582089552239,1.0,1.0,2/6,15.49%,SLC25A5;SLC25A42
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.6128249106521377,-1.1196535487810702,0.32,1.0,1.0,2/14,1.71%,PDCD1LG2;ISG15
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.4968250996620296,1.1196064749021473,0.1875,0.8803796454857049,1.0,13/41,13.94%,FNBP1L;SYTL4;DYSF;ANK2;MYH9;SPTBN1;BIN1;ANXA6;SNX33;NSF;P2RX7;MYOF;PACSIN2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.5195248578938535,1.1195339138178917,0.25925925925925924,0.8795300482013299,1.0,2/17,1.37%,IL15;GPNMB
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.6345489532529723,-1.119361462074158,0.35135135135135137,1.0,1.0,2/8,18.21%,SELENOS;WFS1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.5860606021289437,-1.1190960029446295,0.3561643835616438,1.0,1.0,1/18,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.6309895464315007,-1.1188210496992352,0.36363636363636365,1.0,1.0,3/11,15.97%,CLU;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.6309895464315007,-1.1188210496992352,0.36363636363636365,1.0,1.0,3/11,15.97%,CLU;P2RX4;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.47540273901245156,-1.1185436636894062,0.27586206896551724,1.0,1.0,20/77,23.44%,VEGFA;FLOT1;CAMK1;TGFB1;CLU;GPC3;DCTN1;WARS1;RACK1;APOE;BAX;RHOC;FRMPD4;SLF1;CALY;PARK7;RUNX1;TMED9;BNIP3;MTLN
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),0.5233603645823324,1.1183479151303308,0.2857142857142857,0.8816799926691229,1.0,6/13,18.43%,SMPD4;PRDX6;ENPP6;PNPLA6;MGLL;LYPLA2
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.6587725746136784,1.1181487432360944,0.3611111111111111,0.8811084499202223,1.0,3/6,11.85%,ADAM10;DYSF;FOXP1
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),-0.7154885811150108,-1.118002177250236,0.4745762711864407,1.0,1.0,2/5,6.28%,HTR2B;HTR2C
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.43117110190284835,1.1177446874143038,0.2222222222222222,0.8812115208876559,1.0,20/80,15.94%,EMILIN3;EYA4;BCAR1;SALL1;IGDCC4;MPDZ;CHST3;MAGI1;CACNA2D1;PRTG;TUSC3;MEX3A;PTPRU;TENM3;PTPRG;NCKAP1;FIGN;EPB41L1;TEAD1;AMOTL2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,-0.48638773520804085,-1.1176699807082227,0.20224719101123595,1.0,1.0,9/110,11.37%,CD44;PPIF;OVOL2;OLFM1;XBP1;CACNA2D2;RAPGEFL1;ID2;EMP2
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),0.639499849741402,1.1173857664362465,0.3684210526315789,0.8809979831017889,1.0,3/5,28.08%,ZNF16;MTURN;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),-0.679672066199884,-1.1172575198392736,0.36507936507936506,1.0,1.0,2/8,20.47%,EFNA1;ATRAID
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7096258436489258,-1.1172567125042543,0.3235294117647059,1.0,1.0,2/6,9.28%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5816517286218862,1.1171075009090283,0.2857142857142857,0.8804098529773908,1.0,2/12,5.76%,NR1H2;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.6465886038895156,-1.11630750398907,0.38028169014084506,1.0,1.0,3/12,18.21%,SCG2;CAST;WFS1
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.7522762157786735,-1.116209406395062,0.3559322033898305,1.0,1.0,2/5,15.25%,MYORG;SELENON
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.7522762157786735,-1.116209406395062,0.3559322033898305,1.0,1.0,2/5,15.25%,MYORG;SELENON
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.6966664659216247,1.1157480253853298,0.35714285714285715,0.8831755041017876,1.0,2/5,19.37%,SMAD7;GREM1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.7304785612380074,-1.115688577769335,0.4032258064516129,1.0,1.0,3/5,22.01%,TRMT10C;TRNT1;HSD17B10
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.5699328021406538,-1.1155297246383469,0.39705882352941174,1.0,1.0,5/24,9.44%,LFNG;HES1;JAG1;APH1A;SAP30
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),-0.6068578891493448,-1.1155012060247287,0.3235294117647059,1.0,1.0,1/14,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.44095665927821626,1.1153680703271016,0.21052631578947367,0.8831374653073707,1.0,8/62,8.29%,DUSP4;LMO3;SPRED2;DUSP7;SPRY4;FOXO1;PTPRC;BMP7
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),-0.5084826210407946,-1.1153157228753359,0.23863636363636365,1.0,1.0,10/82,8.48%,B2M;PPIF;MT1E;MT1M;ECT2;JUN;MT2A;HVCN1;MEF2C;HPCA
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.6628798978994929,1.115122165096533,0.4117647058823529,0.8828831864389454,1.0,1/7,4.67%,SUV39H2
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7305432000267582,-1.1149734884461155,0.3448275862068966,1.0,1.0,3/6,19.20%,PGP;COQ3;GOT1
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.7330328669121302,-1.1144699076726023,0.3870967741935484,1.0,1.0,1/6,4.53%,RPS15
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.5828169242139889,-1.1144239564620102,0.2753623188405797,1.0,1.0,2/18,2.36%,VEGFA;TACR1
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.640741942478677,1.1143346086875956,0.43902439024390244,0.8843187421156983,1.0,6/8,24.72%,SOX5;ZBTB16;BMPR1B;PKDCC;SOX6;GDF6
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),-0.7505803397336034,-1.1143023405248365,0.3220338983050847,1.0,1.0,2/5,16.97%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),-0.7505803397336034,-1.1143023405248365,0.3220338983050847,1.0,1.0,2/5,16.97%,STAT5A;STAT1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.5716942194781861,-1.1138809129791403,0.33766233766233766,1.0,1.0,3/24,6.48%,SFRP1;HDAC6;DDX5
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.6941978356963682,-1.1135121520513815,0.4067796610169492,1.0,1.0,4/7,22.87%,CLU;APOE;ABCA1;ABCA5
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6149863205074443,1.113232234824883,0.36666666666666664,0.8862605500697812,1.0,1/10,2.19%,PDIA2
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6875856044181959,-1.1131629351697865,0.39344262295081966,1.0,1.0,1/6,1.79%,ACMSD
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.6872187296361528,-1.1131480378485896,0.34375,1.0,1.0,2/6,16.30%,SLC7A8;COX11
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5102241787915545,1.1128938886665245,0.25,0.8861207267395816,1.0,4/17,11.59%,SGCZ;DMD;SLC8A1;PIK3CA
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.5239329157909552,-1.1127669125830624,0.28735632183908044,1.0,1.0,6/34,13.74%,FTH1;CP;ATP6V0A4;ATP6V1F;DNM2;ATP6V0E2
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),-0.5938154598304335,-1.1123617664014622,0.323943661971831,1.0,1.0,5/16,19.34%,GAPDH;PGK1;PFKP;PGAM1;ADPGK
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.7121376383880507,-1.1120517527836025,0.39705882352941174,1.0,1.0,2/6,14.68%,NR1D1;APOE
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.7276840471956029,-1.1119557301905518,0.46153846153846156,1.0,1.0,1/6,0.41%,MX1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.6129673638790001,1.1116206912064048,0.358974358974359,0.8889355176064825,1.0,4/9,8.26%,BAG2;KLKB1;MYH9;PLGRKT
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.3596239264198306,1.1115356769841462,0.25,0.8879719309579301,1.0,37/134,13.06%,ASXL3;TAFA1;ZDHHC2;CSRNP3;LRRC4C;RGS7BP;ADGRB3;ASTN1;ZNF536;PCLO;MAP2;CADM2;STXBP5;TOX;NRXN1;ADGRL3;ANK2;LSAMP;NOVA1;GCNT2;GUCY1A2;TAFA5;MAPK10;CACNA2D1;CNTN1;KCTD16;CLVS2;ADGRA1;CA10;PLEKHA5;AHDC1;TSHZ1;PIK3CA;FLOT2;ADCYAP1R1;KIF1B;NFASC
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.6435249696895653,1.1112519012962405,0.36,0.887927993523806,1.0,1/9,1.84%,BARD1
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.6457300559413227,-1.1112435007251953,0.3287671232876712,1.0,1.0,4/10,14.16%,IGSF6;TBXAS1;MYO1F;PILRA
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.42888115013324374,1.1108473281428364,0.29411764705882354,0.8883129116200267,1.0,21/60,19.11%,SEPTIN4;FBXW7;INAVA;SMAD7;FAM107A;HSPBP1;UBE2D1;DCUN1D2;DCUN1D5;NDFIP2;XIAP;LRRK2;HDAC4;RCHY1;DCUN1D1;PINK1;TANK;TBC1D7;MYCBP2;PIAS1;BCL10
prerank,PanglaoDB_Augmented_2021__Adipocytes,-0.49081719742028207,-1.1107598823122855,0.3103448275862069,1.0,1.0,27/94,21.19%,TRIP10;ECM2;COL5A3;EPSTI1;RARRES2;AGT;MT2A;APOL6;BCAT2;CRYAB;ASPN;LMOD1;COL15A1;COL6A1;METRN;ACTA2;ADAMTS2;C3;METRNL;TFE3;STEAP4;GSN;COL14A1;THBS2;PDGFRB;CYP1B1;NQO1
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.628173722686,1.1106616534539786,0.3939393939393939,0.8867666677206888,1.0,2/9,14.94%,VTA1;CHMP1A
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.628173722686,1.1106616534539786,0.3939393939393939,0.8867666677206888,1.0,2/9,14.94%,VTA1;CHMP1A
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.6773848207066324,1.1104516361029741,0.4166666666666667,0.8862586189826444,1.0,3/5,30.96%,MOV10;AGO1;AGO3
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.5769041773879273,-1.1103585488658148,0.3176470588235294,1.0,1.0,9/21,30.76%,PHKG1;CALM1;NR1D1;PYGL;GBE1;PER2;PHKB;UGP2;PHKG2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.5539002628268394,-1.110168748125745,0.36363636363636365,1.0,1.0,5/28,17.78%,DDRGK1;RETREG1;MTIF3;ULK1;UFC1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.6272487039833686,1.110015228165489,0.34375,0.8868181914184592,1.0,4/7,22.36%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.6444553619927977,1.1099929791338135,0.38636363636363635,0.885769243211308,1.0,3/6,24.81%,USP15;USP7;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),-0.6420841485129185,-1.109534469257944,0.391304347826087,1.0,1.0,2/12,7.92%,SFRP1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.6101170367862734,1.1091301842638672,0.34210526315789475,0.8869081239121552,1.0,1/6,10.46%,LRRK2
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.5417950982094095,1.1090814017039508,0.3870967741935484,0.8859197006165642,1.0,5/16,15.64%,XKR6;MYH9;RHOBTB1;MEGF10;GULP1
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.6606085191250741,1.1086216696917979,0.38235294117647056,0.8860910768004991,1.0,2/5,11.92%,PLCB1;LHFPL2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6074393240457782,1.1084561762153675,0.3333333333333333,0.8853951865781124,1.0,4/8,22.21%,FBXW7;PIK3CA;STK11;ERRFI1
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.7146798796086864,-1.1084273236914328,0.45161290322580644,1.0,1.0,2/5,16.19%,SLC3A2;SLC7A8
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.6842889224703865,-1.1083447344184056,0.38235294117647056,1.0,1.0,4/8,16.26%,NOP10;GAR1;RPUSD3;DKC1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.4493192927814832,1.1083003400174745,0.32,0.8846626068420046,1.0,4/26,11.71%,LIMD1;PUM2;MOV10;TRIM71
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.5613074299342384,-1.1082089828651913,0.3246753246753247,1.0,1.0,2/25,4.08%,GTF3C6;POLR3H
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.6328796270663787,1.108050842291516,0.3333333333333333,0.884162466374195,1.0,1/6,3.26%,PADI2
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.5361827480536123,-1.1078622345699851,0.3472222222222222,1.0,1.0,4/28,10.05%,HES5;HES1;BHLHE41;GRN
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.7015894882216506,-1.1077187596098015,0.39705882352941174,1.0,1.0,3/7,28.32%,BCAT2;HMGCLL1;HMGCL
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.7324026484995356,-1.1075962695382016,0.36363636363636365,1.0,1.0,2/5,22.09%,BRCA1;SPHK2
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.6068590282051473,-1.1075155273559338,0.3064516129032258,1.0,1.0,4/11,30.34%,CHMP4B;SEC61G;SEC62;GET3
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7452769481230826,-1.107368427521184,0.4,1.0,1.0,2/5,24.79%,DBI;RABL3
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4596518581116652,1.1072322793262583,0.3448275862068966,0.8850068229462097,1.0,11/27,23.90%,DEPTOR;SIRT1;MAPKAPK5;SESN1;TNFAIP8L1;NPRL2;TBC1D7;ITFG2;STK11;SZT2;UBR1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.6167061817438464,-1.1069781791551092,0.42028985507246375,1.0,1.0,2/9,11.75%,TK2;TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.6167061817438464,-1.1069781791551092,0.42028985507246375,1.0,1.0,2/9,11.75%,TK2;TYMP
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.46256346863951636,-1.106498325533053,0.2375,1.0,1.0,19/81,21.93%,VEGFA;TGFB1;CLU;NAPA;HDAC6;CRYAB;WARS1;RACK1;APOE;STX1B;ULK1;EIF2AK2;BAX;GSN;RHOC;ABCA1;SLF1;PARK7;HSPA8
prerank,PanglaoDB_Augmented_2021__Podocytes,0.38189850880456877,1.1059900789932298,0.2,0.887554639690271,1.0,37/141,15.94%,CRB2;LAMA3;SRGAP1;BCAR1;DOCK5;ILDR2;LAMC1;APBB2;MAGI2;MPDZ;SH3D19;CHST3;CDC42BPA;QKI;MAGI1;MERTK;KANK1;UNC13B;EGFR;NFIB;ADCY6;NEBL;PRICKLE2;PARD3B;PALLD;TOB1;CDH13;SNX7;ITGA3;STARD13;NAV2;PTPRG;NCKAP1;EPB41L1;ETF1;TEAD1;AMOTL2
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5439251295156555,1.1059196825390358,0.22580645161290322,0.8865550873927314,1.0,8/12,29.16%,ACER3;IP6K1;IP6K2;CYP27A1;ITPKB;CYP2R1;PPIP5K2;IPMK
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6111483217544836,-1.1054471539943884,0.36764705882352944,1.0,1.0,3/12,11.57%,NAAA;DEGS2;CALM1
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.6262917990044057,1.1048937534825423,0.4772727272727273,0.888081314779371,1.0,6/8,24.92%,RAPGEF6;RAPGEF2;RAP2B;TJP1;AFDN;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.4823025348137433,1.1047142913426993,0.37037037037037035,0.8873318215329432,1.0,7/29,12.22%,SOX11;PCP4;TCF4;BRINP3;NRCAM;BEND6;PROX1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.6152489867208455,-1.1043178286241846,0.37333333333333335,1.0,1.0,6/12,19.68%,ISCA1;CIAO2B;CISD3;MAGEF1;MMS19;CIAO1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),-0.5213623419866878,-1.1040233638081713,0.36363636363636365,1.0,1.0,5/48,7.07%,LIPI;ALOX5;DOLPP1;ACSM3;XBP1
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.6654824526607936,-1.1038652987053805,0.3382352941176471,1.0,1.0,2/12,2.75%,IFIT1;FLOT1
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.5596505128928295,1.1038540602628126,0.41379310344827586,0.8887769102272416,1.0,2/13,2.12%,CHRM3;ADRA1A
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.7381994990151778,-1.1037794227427906,0.3684210526315789,1.0,1.0,2/5,13.15%,FANCB;REC8
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.5692476171917296,1.103666562860235,0.37037037037037035,0.8882569479348736,1.0,3/10,14.41%,VEZF1;KLRG1;KLRC2
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.5548285057547938,1.1034658490686848,0.32432432432432434,0.8875861585841952,1.0,5/16,20.09%,LARGE1;TMTC1;CRPPA;TMTC2;TMTC3
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.3339094179194486,1.1032935176825684,0.18181818181818182,0.8869550580679081,1.0,20/108,13.18%,HIP1;ERBB4;IRS1;ESR1;AKR1C2;RICTOR;GAB1;SIRT1;AKR1C3;MAGI2;IGF1R;GCNT2;STRN;NRG2;EGFR;MFHAS1;TGFA;PIK3CA;THEM4;FRS2
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.5305513967778773,1.1032399271549198,0.3,0.8860030619214299,1.0,3/14,8.20%,ZDHHC2;NEDD4L;SNF8
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.6311397551312119,-1.1031658137044045,0.34375,1.0,1.0,4/11,17.61%,TRIM5;TRIM25;CAV1;FUCA2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5265590469250387,1.1031408597055026,0.2692307692307692,0.8850913652742264,1.0,4/17,16.32%,LGR5;ADCY6;RXFP1;ADCY2
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6342835607349858,-1.1031131998790233,0.40298507462686567,1.0,1.0,3/11,4.31%,ZCWPW1;RNF212B;IHO1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),-0.574412103939248,-1.1030870846543261,0.37662337662337664,1.0,1.0,9/25,19.34%,PMM1;AKR1A1;OAS1;FUCA1;APOD;GALM;KHK;FUCA2;ADPGK
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.7152286888465209,-1.1030241060937005,0.41818181818181815,1.0,1.0,1/5,3.94%,LETM2
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.6463631161835034,-1.103019088241894,0.328125,1.0,1.0,2/12,4.71%,DDRGK1;COPS5
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.5331370271267823,-1.1028576529962555,0.31645569620253167,1.0,1.0,9/37,18.40%,B2M;RPS27A;APH1A;ITM2B;CST3;UBA52;UBE2L6;UBC;GSN
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),-0.7440499604930252,-1.1026133962578344,0.4,1.0,1.0,3/5,11.37%,FLOT1;S100A10;EMP2
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.5286876916129969,1.1026092944575752,0.3548387096774194,0.8854876090874334,1.0,4/9,16.74%,POT1;UBE2N;TERF1;TERF2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.5988890254610426,-1.102524730936098,0.323943661971831,1.0,1.0,6/16,20.57%,ARG2;SELENOS;SYT11;CACTIN;RARA;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.5988890254610426,-1.102524730936098,0.323943661971831,1.0,1.0,6/16,20.57%,ARG2;SELENOS;SYT11;CACTIN;RARA;GSTP1
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5479365788375455,1.102500106697979,0.35555555555555557,0.8846166586669155,1.0,1/10,7.19%,NETO1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.552640713745368,-1.1023156218421613,0.36363636363636365,1.0,1.0,5/24,13.23%,CENPH;CENPX;SMARCA5;ITGB3BP;CENPC
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),-0.6355012741854698,-1.1023018992036129,0.3076923076923077,1.0,1.0,3/11,23.15%,DCTD;TYMP;ERH
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.3426155862325442,1.1019171377595198,0.1,0.8849936276226469,1.0,17/121,9.66%,MAPK11;TP63;BANP;RMI1;RPA1;BARD1;ATR;BOP1;TAF3;SGK1;RICTOR;TP53INP1;MAP2K6;PML;MAPK14;MAPKAPK5;CHD5
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.48089853825229245,-1.1016921286950727,0.3258426966292135,1.0,1.0,24/82,23.91%,SRSF7;RBM8A;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;HNRNPA2B1;UPF3B;MAGOHB;SEC13;THOC5;NUP107;CHTOP;MCM3AP;CPSF1;NUP85;SLBP;SRSF2;NUP188;ALKBH5;SMG6;YTHDC1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.6782352759272707,-1.10164187532351,0.3333333333333333,1.0,1.0,2/7,16.20%,RPS27L;KAT5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.6078627658453407,-1.1015473040453692,0.37681159420289856,1.0,1.0,3/15,16.26%,NOP10;CCT7;DKC1
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.6148504255882075,-1.1014303975411828,0.31746031746031744,1.0,1.0,4/13,28.00%,RBP2;CBR1;UBIAD1;LGMN
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.6958865364913397,-1.1013175425189583,0.4107142857142857,1.0,1.0,1/5,11.57%,CALM1
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.6166418025450662,1.1010146349543526,0.4411764705882353,0.8868211665909224,1.0,3/8,19.19%,NRXN1;RELN;YWHAZ
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.6064679123909783,1.100822856068262,0.2962962962962963,0.8863471946451636,1.0,2/10,5.96%,PKP2;SMAD7
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.651795208200524,1.1007777613722625,0.4,0.8852915010100381,1.0,2/6,10.49%,NLGN1;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6215050145628055,-1.100364057836626,0.352112676056338,1.0,1.0,3/10,27.18%,DONSON;GMNN;ZRANB3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.6489019772731296,-1.1000533118867601,0.4057971014492754,1.0,1.0,2/8,16.20%,RPS27L;KAT5
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.6416285705336418,-1.100008835139381,0.4126984126984127,1.0,1.0,2/10,11.90%,HACD4;ELOVL2
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),-0.6416285705336418,-1.100008835139381,0.4126984126984127,1.0,1.0,2/10,11.90%,HACD4;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.45212474965110583,1.09978625230222,0.2962962962962963,0.8870366761768614,1.0,4/17,13.11%,NSMCE2;TGFA;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),-0.7060259553325368,-1.0997190095949207,0.32786885245901637,1.0,1.0,5/6,29.17%,RSAD2;RARA;IL18;DENND1B;CD81
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),-0.5990535499048107,-1.0996597375328148,0.37142857142857144,1.0,1.0,1/14,0.58%,PPIF
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5482062548051125,1.099241884967542,0.3333333333333333,0.8876708485357776,1.0,6/15,21.53%,EGFR;NRP1;SNCA;DSCAM;BCL10;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.6056566873181352,-1.0989410735886822,0.325,1.0,1.0,3/19,5.22%,ECT2;TGFB1;ZIC1
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.47550667788191886,-1.0988993670267395,0.3563218390804598,1.0,1.0,17/85,19.83%,ITGA4;DHX37;DHX16;DHX38;PRPF8;NOL6;SNRNP200;NEMP1;DDX11;HDGF;NOP14;USP19;NUP107;MCM3AP;HEATR1;DARS2;NUP85
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.6096629882058114,-1.0986033328275202,0.32786885245901637,1.0,1.0,2/13,8.54%,XPNPEP1;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.5750318172971564,-1.098560299735836,0.33783783783783783,1.0,1.0,4/18,14.97%,TGFB1;TMBIM1;PPP2R5A;LZTFL1
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),-0.70529859350598,-1.0983978077054626,0.359375,1.0,1.0,2/6,17.64%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.5962852486427009,1.0983413685132026,0.3333333333333333,0.8890902243941724,1.0,3/9,10.89%,KAT2B;SIRT1;KAT2A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.4514553714052959,-1.098246522027651,0.29347826086956524,1.0,1.0,53/225,19.03%,SRSF7;POLR2I;CRNKL1;RBM8A;SNRNP27;POLR2G;SNRPA1;DHX16;RBM4B;SNRPD1;DDX5;PNN;LSM5;PDCD7;DHX38;SNRPD2;UBL5;PRPF8;RNPC3;SNRPB;CDC40;SRSF10;SRSF5;CASC3;PPWD1;SNRNP200;PRPF4;PRPF38A;SNRNP25;NCBP1;CSTF2;HNRNPA2B1;PRPF6;BUD31;CACTIN;DNAJC8;UPF3B;MAGOHB;CSTF1;GTF2F1;PRPF31;SRRT;SRRM2;SYF2;RBM19;USP39;SMNDC1;SF3A3;CWC15;CWF19L1;WBP11;SNW1;CPSF1
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5647788005084025,1.098222783874167,0.32558139534883723,0.8883170233708341,1.0,3/10,14.76%,FCHSD2;WASF3;NCKAP1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.5070554799995683,-1.0980533393486194,0.34177215189873417,1.0,1.0,7/56,8.08%,GOLGA8B;ABRAXAS1;RAB11A;GOLGA8A;TUBGCP2;TUBGCP4;SMC1A
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7137849946976381,1.0978339832524022,0.3333333333333333,0.8885921863472223,1.0,1/5,3.49%,CNTNAP2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.684786950939386,-1.0973710367162097,0.36363636363636365,1.0,1.0,2/6,7.28%,ALOX12;CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.5372320136722869,1.0972018156477508,0.34375,0.8891279471511081,1.0,3/13,10.49%,ZDHHC2;RELN;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.6885437043707453,-1.097113158366146,0.42857142857142855,1.0,1.0,1/8,4.90%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.516026244267995,1.0969738408994796,0.40625,0.8886185424732258,1.0,3/13,11.23%,HECW2;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.41638618637960456,1.0967606201582416,0.18181818181818182,0.8881104033970275,1.0,30/105,19.29%,PLD1;MAPK11;RIT2;CDC42EP4;HACE1;KSR1;MAPK14;MAPKAPK5;CDC42EP1;TRIM28;RAPGEF6;PHACTR4;PRKD1;RRAS2;CDH13;RAPGEF2;RAP2B;RAP2A;NCKAP1;SOS1;NRAS;ARHGEF11;RAP1A;EPS8;RALA;ARHGAP5;ARHGAP6;NF1;RIPOR1;RALB
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.6111301028051107,-1.0967012538615213,0.3918918918918919,1.0,1.0,7/16,16.97%,CDC37;IFNGR2;PARP14;PARP9;NLRC5;HSP90AB1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),-0.6809827961790553,-1.0962073479393668,0.46774193548387094,1.0,1.0,3/5,30.52%,ANAPC2;CPLX2;ADCY8
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.7031546336606999,-1.0961261642252287,0.3770491803278688,1.0,1.0,2/5,15.68%,SLC6A6;ASAH1
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),-0.6828107086377828,-1.0960657319899894,0.4090909090909091,1.0,1.0,1/7,1.61%,LFNG
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),-0.6648369905929156,-1.095921228255293,0.46551724137931033,1.0,1.0,1/7,4.27%,TGFB1
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.44525040447761294,-1.0957351849608838,0.28421052631578947,1.0,1.0,59/265,19.03%,SRSF7;POLR2I;CRNKL1;RBM8A;SNRNP27;POLR2G;SNRPA1;DHX16;PRPF18;RBM4B;SNRPD1;DDX5;PNN;LSM5;PDCD7;DHX38;SNRPD2;UBL5;PRPF8;RNPC3;SNRPB;CDC40;SRSF10;SRSF5;CASC3;SRRM4;PPWD1;SNRNP200;PRPF4;PRPF38A;CDK7;SNRNP25;NCBP1;CSTF2;HNRNPA2B1;PRPF6;BUD31;CACTIN;DNAJC8;UPF3B;MAGOHB;CSTF1;GTF2F1;PRPF31;THOC5;SRRT;SRRM2;SYF2;CHTOP;RBM19;KIN;USP39;SMNDC1;SF3A3;CWC15;CWF19L1;WBP11;SNW1;CPSF1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.7468436970697547,-1.0950449980665466,0.43333333333333335,1.0,1.0,2/5,15.52%,RAB3D;IL7
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.5716175949286852,1.0948213224044454,0.3548387096774194,0.8925494275036938,1.0,4/11,19.75%,NUDT19;PLA2G15;FAAH;ACOT8
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.5528862627567815,-1.0946586946801269,0.39705882352941174,1.0,1.0,11/21,25.75%,SFRP1;TRIM25;GSTM3;LOC400499;CAV1;BRCA1;SRA1;RARA;PELP1;RBBP5;AR
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4552660490525746,-1.094389954338508,0.3076923076923077,1.0,1.0,11/109,6.22%,DDRGK1;SCG3;ISG15;ARL1;EMD;FSIP2;DVL1;RAB11A;RPL11;GABARAPL2;OBSL1
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.5919213448087071,-1.0943667048125385,0.40350877192982454,1.0,1.0,1/12,0.66%,VEGFA
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),-0.6719636489625419,-1.0943296262143245,0.43636363636363634,1.0,1.0,2/7,26.63%,ATP6V0A4;PDK2
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.478126691370593,-1.0941923390751158,0.3181818181818182,1.0,1.0,24/84,23.91%,SRSF7;RBM8A;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;HNRNPA2B1;UPF3B;MAGOHB;SEC13;THOC5;NUP107;CHTOP;MCM3AP;CPSF1;NUP85;SLBP;SRSF2;NUP188;ALKBH5;SMG6;YTHDC1
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7298151591243562,-1.0938254801665124,0.423728813559322,1.0,1.0,1/5,7.71%,ZFAND2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.5767396858812849,-1.093821244819141,0.39436619718309857,1.0,1.0,3/19,13.02%,AGT;P2RX4;NR4A3
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.6500519800962673,1.0936490854315135,0.35,0.8946004164272768,1.0,4/7,32.65%,ARL8B;PIP4K2B;PIP4K2A;ATP13A2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5379665792499936,1.093212555305727,0.2857142857142857,0.8947359264808538,1.0,3/13,10.89%,SGK1;ARC;KAT2A
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.49006120236355133,1.0931839894689275,0.43333333333333335,0.8936484734886853,1.0,4/17,18.37%,LIMD1;MOV10;CELF1;CNOT7
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),-0.7280992978942368,-1.0931555239939656,0.41935483870967744,1.0,1.0,4/5,22.93%,FN1;CDH3;HSP90AB1;LAPTM4B
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.6333537700993253,-1.0930795020423976,0.423728813559322,1.0,1.0,2/7,11.04%,HES1;ID2
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.4967686016180539,1.092840638382387,0.38235294117647056,0.8933222792551196,1.0,2/11,6.28%,LARGE1;CHST3
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.6118691833473211,-1.092796675000788,0.3924050632911392,1.0,1.0,3/15,15.38%,ANKRD53;DCTN1;TACC3
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.665607945184162,1.0926091084969345,0.46153846153846156,0.8929229735113201,1.0,2/5,19.11%,FOXP1;BCL10
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.35761119096619626,1.092377441606856,0.25,0.8928014946748333,1.0,41/144,14.64%,RIPOR2;DPYSL5;ERC2;CSRNP3;ADGRB3;NLGN1;ASTN1;ISOC1;ZNF536;MAP2;CADM2;CNTNAP2;TMEM170B;ADGRL3;ANK2;NOL4;GRID2;NOVA1;AATF;GNL3L;WRAP73;EDIL3;CLVS2;SLITRK5;RELN;DNM3;FUT9;ABCC5;SLC35F1;GALNT13;ADCYAP1R1;TBCK;KIF1B;MEGF10;TMEM200C;MAPK8;KCNQ2;FLRT3;SMAD1;FSD1;ATRNL1
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.5799431940366755,1.0922788965671242,0.42857142857142855,0.8919982742546511,1.0,5/11,16.05%,ERI1;INTS6L;INTS7;INTS6;INTS8
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.669153499984533,1.0922475793201087,0.391304347826087,0.8909760967964351,1.0,2/5,22.54%,EPS8;ARHGAP35
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5023435353201681,-1.0921350120336561,0.30952380952380953,1.0,1.0,7/60,13.86%,POLR2I;DXO;DDX24;POLR2G;NCBP1;HNRNPA2B1;GTF2F1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5843541687930252,-1.091711288071723,0.40540540540540543,1.0,1.0,5/17,17.37%,PRPSAP1;PPAT;SHMT1;PAICS;MTHFD1
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.7115038341179603,-1.0912348572712538,0.4090909090909091,1.0,1.0,1/10,1.65%,HAP1
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.7225385752403641,1.0912176649716465,0.42105263157894735,0.8926227297042737,1.0,2/5,16.49%,DEF8;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),-0.6584893160502924,-1.0911959342203648,0.42028985507246375,1.0,1.0,3/8,20.57%,CEACAM1;CARD8;GSTP1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5404682323754681,-1.0911285236782422,0.4025974025974026,1.0,1.0,7/25,20.26%,VEGFA;RARRES2;TGFB1;P2RX4;PTN;P2RY12;PDGFRB
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5669486963787667,-1.09060853832205,0.4142857142857143,1.0,1.0,4/16,16.14%,HAP1;CLU;APOE;RTN2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7056452552225859,-1.0901926672683016,0.42857142857142855,1.0,1.0,3/7,14.04%,PPIF;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.421394672926155,1.0901380618113725,0.15789473684210525,0.8946510075953656,1.0,10/45,11.23%,BARD1;ASB5;HECW2;NEDD4L;HACE1;FOXO1;SNF8;TIPARP;NSF;NEDD4
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),0.696342351238216,1.0899298691797497,0.5128205128205128,0.8939595155762364,1.0,3/5,13.77%,FGGY;RPE;RPIA
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.634938232457624,-1.0896598106627045,0.4153846153846154,1.0,1.0,3/11,18.09%,SLIRP;SUPV3L1;DNM1L
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.5407131518912736,1.0896264603793353,0.42857142857142855,0.8937277355124317,1.0,2/9,9.23%,NUP98;NUP93
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.582703002457012,-1.0895609653168477,0.3380281690140845,1.0,1.0,4/13,20.72%,VAV3;MEF2C;IL7;GPR183
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.5334814083765839,-1.0895453203787937,0.37333333333333335,1.0,1.0,11/31,19.73%,RPS27A;RFC2;RPA3;UBA52;RFC4;RFC1;UBC;RFC3;XPA;DDB2;POLD2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.39061990464946794,1.0893409312531868,0.4166666666666667,0.8934965214561086,1.0,13/85,8.29%,PKP2;FLRT2;SGCZ;HDAC9;ERBB4;KAT2B;SALL1;PDLIM5;CHD7;FGF12;PKD2;TGFBR2;BMP7
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),0.5916211305253186,1.0892656278588733,0.40476190476190477,0.8926079293738249,1.0,1/7,7.27%,TGFBRAP1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5554881608078948,-1.0891613788457044,0.3466666666666667,1.0,1.0,5/23,14.64%,RANGRF;SELENOS;DERL2;SEC13;SYVN1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.6922184114900711,-1.0890969075069197,0.4153846153846154,1.0,1.0,2/6,13.43%,GALM;GALE
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.413869385840252,1.0887792838174535,0.3,0.8927437206166307,1.0,12/41,14.08%,PLCB1;STOX1;ANKRD17;RAD51B;EGFR;LSM11;NSMCE2;MECP2;UBE2E2;ANAPC4;CDC16;ADAM17
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",0.5403651155657443,1.0886816369746901,0.44,0.8919858282615012,1.0,3/9,8.09%,ATR;POT1;TNKS
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5974613875100223,1.088343117551412,0.34146341463414637,0.8915575495022531,1.0,5/9,22.67%,MAP3K7;TNFRSF10B;MALT1;IRAK1;TRAF2
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,-0.5708158871355289,-1.0878289875544602,0.358974358974359,1.0,1.0,5/23,7.88%,CFTR;OVOL2;EFNA1;JAG1;TMC4
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.5803868586680476,-1.0875865946085377,0.32857142857142857,1.0,1.0,1/11,3.31%,PAH
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.40443315710560235,1.087454503360409,0.3,0.8927489929823289,1.0,9/44,7.98%,ZSWIM6;ARAP1;ERBB4;ABL1;ZSWIM5;YTHDF1;ABL2;NRG2;EGFR
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),-0.5276308981113442,-1.0867589749338809,0.31645569620253167,1.0,1.0,9/35,16.03%,DXO;SIDT2;LSM5;NCBP1;SUPV3L1;ZFP36L2;RNASEH2C;NUDT12;RNH1
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.43139692224621784,1.0866851320823707,0.3076923076923077,0.8938285557086347,1.0,14/44,16.32%,CALCRL;CD247;CALCB;MYH9;GNG2;VIPR2;ADCY6;MAPK14;PRKACB;ADCYAP1R1;RXFP1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6053360039936886,-1.0863881808266007,0.3333333333333333,1.0,1.0,5/15,19.25%,BUD23;UTP15;DIMT1;RIOK2;HEATR1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4428115590125336,-1.0863334180423287,0.2967032967032967,1.0,1.0,56/244,19.03%,SRSF7;POLR2I;CRNKL1;RBM8A;SNRNP27;POLR2G;SNRPA1;DHX16;RBM4B;SNRPD1;DDX5;PNN;LSM5;PDCD7;DHX38;SNRPD2;UBL5;PRPF8;RNPC3;CELF4;SNRPB;CDC40;SRSF10;SRSF5;CASC3;PPWD1;SNRNP200;PRPF4;PRPF38A;SNRNP25;NCBP1;CSTF2;HNRNPA2B1;PRPF6;BUD31;CACTIN;DNAJC8;UPF3B;MAGOHB;CSTF1;GTF2F1;PRPF31;SCNM1;SRPK1;SRRT;SRRM2;SYF2;RBM19;USP39;SMNDC1;SF3A3;CWC15;CWF19L1;WBP11;SNW1;CPSF1
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.702996619460899,-1.0862493129594912,0.4788732394366197,1.0,1.0,4/5,28.52%,SF3A3;SF3A1;SF3A2;SLU7
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.36006924448863675,1.086238354250801,0.16666666666666666,0.8938713301698035,1.0,31/115,13.82%,SOX11;SH3RF1;TAFA1;RACGAP1;NLGN4X;DCX;ASTN1;RYK;IL1RAPL1;ADGRL3;ADNP2;FZD3;WNT7A;NRCAM;NAV1;OPHN1;ATOH8;MDGA1;RELN;USP9X;FUT9;AUTS2;ACSL4;SEMA3A;ACSL3;RAPGEF2;CEP85L;DTNB;ELP3;NRP1;DLL1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),-0.6591138328193151,-1.086151273876633,0.3582089552238806,1.0,1.0,3/6,26.77%,DOCK8;TNFRSF14;APP
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),-0.7175945740828713,-1.0861378373463424,0.390625,1.0,1.0,2/5,12.50%,TAF7;NLRC5
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),-0.575998970812853,-1.0856113410855244,0.4189189189189189,1.0,1.0,4/15,19.27%,GAPDH;PGK1;PFKP;PGAM1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),-0.575998970812853,-1.0856113410855244,0.4189189189189189,1.0,1.0,4/15,19.27%,GAPDH;PGK1;PFKP;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.7099485910425862,1.0855054942194289,0.4090909090909091,0.895001289395275,1.0,2/6,10.25%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.6866992445377831,-1.08529061331898,0.38095238095238093,1.0,1.0,1/8,8.97%,CEP72
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.5763304623400064,1.084999226108949,0.35135135135135137,0.8952959383719322,1.0,4/9,7.11%,NLGN1;NLGN4X;WNT7A;LRRTM3
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.6695312650691159,-1.0847358224061168,0.45588235294117646,1.0,1.0,5/6,28.79%,HAS2;SYAP1;HYAL1;MARS1;CORO1B
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.5291601804804182,-1.0846469761037476,0.32,1.0,1.0,9/38,22.09%,HLA-B;SELENOS;XBP1;SYT11;MAPK13;HSPD1;IFIH1;C1QTNF4;SPHK2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4430198308619527,1.0846410108163027,0.2857142857142857,0.8951379327124372,1.0,7/50,7.63%,PHLDB2;CRB2;SPRED2;EPHA3;SMAD7;GCNT2;TGFBR2
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.5527667166695998,-1.0845444062572571,0.38461538461538464,1.0,1.0,16/33,33.40%,TFAM;MRPS7;MRPL51;MRPL16;MRPS16;MRPS11;PTCD3;QRSL1;MRPS18B;MRPS14;MRPS34;MRPS15;MRPL57;FASTKD2;MRPL47;MRPL23
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.6108803204274489,-1.084283036281438,0.4155844155844156,1.0,1.0,1/12,3.14%,STX10
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.6446687547455259,-1.084177166709649,0.34328358208955223,1.0,1.0,4/7,21.98%,ALOX12;CEACAM1;RDX;CD9
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.5779267144071724,-1.0838763001869074,0.40298507462686567,1.0,1.0,6/17,22.81%,BUD23;DIMT1;EMG1;NSUN5;FBL;MTERF4
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.5728564673422418,-1.083859292282578,0.39705882352941174,1.0,1.0,3/19,3.96%,POLR3D;IFI35;PLSCR1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.687869311195144,-1.0838522778468918,0.36065573770491804,1.0,1.0,2/5,15.11%,XBP1;USF1
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4460133362249498,1.083478677084671,0.25,0.8971470242930871,1.0,29/97,15.94%,SEMA3B;CSRNP3;PCDH7;PBX1;INSC;ADGRL3;ANK2;MPDZ;CHST3;RUNX1T1;MAGI1;CACNA2D1;EDIL3;ADCY6;PRICKLE2;FBXL7;TUSC3;FARP1;NFASC;TENM3;FRZB;NAV2;PTPRG;NCKAP1;FIGN;EPB41L1;GULP1;TEAD1;AMOTL2
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.6813582297065686,1.083421709195564,0.39473684210526316,0.8961756304430353,1.0,2/5,15.95%,MEGF10;THBS4
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.6655173864350581,-1.0824661791625232,0.3387096774193548,1.0,1.0,4/7,22.01%,HSD17B14;CYP3A5;CYP1B1;HSD17B10
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.621046858496928,1.0823734216304604,0.3548387096774194,0.8977103184994959,1.0,4/6,29.82%,HMGCR;MVK;PHYH;PDSS2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.6285743140457267,-1.0817847202265645,0.35294117647058826,1.0,1.0,6/9,36.44%,XBP1;MBTPS2;MBTPS1;ATF6B;CALR;DDIT3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.6109973585078355,-1.0816203618259708,0.45588235294117646,1.0,1.0,2/12,11.04%,HAX1;ID2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.656741162304899,-1.0813528247023436,0.39622641509433965,1.0,1.0,1/6,2.75%,FLOT1
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.6436852227177172,1.0812980061561122,0.4166666666666667,0.899493195037734,1.0,2/7,10.19%,PTPRC;CBFB
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.3958929826533427,1.0811853836567211,0.3181818181818182,0.8986482678561741,1.0,2/53,0.80%,GSTT2;GSTM2
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.5282963929723904,-1.0811477952679345,0.3253012048192771,1.0,1.0,13/38,19.73%,ISG15;RPS27A;TRIM25;RFC2;RPA3;UBA52;RFC4;UBE2L6;RFC1;BRCA1;UBC;RFC3;POLD2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.5189446917739681,-1.0809101784212758,0.3670886075949367,1.0,1.0,8/33,11.44%,TUFT1;OVOL2;RHBDF1;TOM1L1;TEAD3;CDH3;EMP2;ATP6V0A4
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),-0.5080741491437032,-1.080806333622314,0.3717948717948718,1.0,1.0,8/58,13.15%,MIF4GD;EIF1;POLR2G;EIF2B2;EIF1B;EIF5B;NCBP1;ATF4
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.39768999591389464,1.0807488474811031,0.3333333333333333,0.8986489134623351,1.0,12/62,9.47%,HDAC9;IRS1;KAT2B;SIRT1;PPARG;FER;RPS6KB1;C2CD5;RAB31;FOXO1;RAB10;CPEB2
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.7133976214475533,-1.0806474273265803,0.3728813559322034,1.0,1.0,1/5,2.08%,NOL3
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7398881604157772,-1.0802048779248679,0.5084745762711864,1.0,1.0,1/5,6.41%,HDAC6
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.496619009837186,-1.0801103983374503,0.3448275862068966,1.0,1.0,11/56,18.96%,ISG15;RPS27A;CTSL;CTSZ;HDAC6;UBA52;CHMP4B;ADAMTS7;NR1D1;UBC;BAG6
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),-0.49532614568509614,-1.0800709228302225,0.3950617283950617,1.0,1.0,5/46,3.70%,TRIM5;STX10;DVL1;CAMK1;TRIM25
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.6145868603239941,1.0799344451021369,0.40625,0.8998864779203364,1.0,3/9,22.54%,NRCAM;SEMA5A;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.6421257690453086,-1.079862460975127,0.4,1.0,1.0,3/8,12.75%,SPINK5;PRELID1;ZFP36L2
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),-0.5533698209054513,-1.0795402675058268,0.3783783783783784,1.0,1.0,4/19,16.51%,CLU;P2RX4;HSP90AB1;CAV1
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),-0.49257062549866604,-1.0786354066692452,0.26582278481012656,1.0,1.0,9/37,11.48%,PSMB9;SERPINE3;PSMB8;AGT;GAPDH;PRELID1;APH1A;PSMA3;SERPIND1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.6806144974336008,1.0786188547452689,0.48717948717948717,0.9023207178990085,1.0,1/5,9.22%,MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.49548329019271004,1.0785865611429652,0.2727272727272727,0.9013512644586756,1.0,5/24,15.80%,MAP2;DIP2B;DCC;PTPRS;WWC2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),-0.512358435898852,-1.0785856186191833,0.3218390804597701,1.0,1.0,19/62,20.05%,SGCA;EMD;SSPN;TTN;CRYAB;MYL6B;GAMT;LMOD1;CALM1;TMOD3;MYL12B;ACTA2;SNTB1;MYLK;CHRNE;UTS2;VCL;ACTN2;CALD1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.4008596258556031,1.0783667156955155,0.23529411764705882,0.90102716419627,1.0,13/85,11.03%,RANGAP1;HDAC9;KAT2B;PLOD1;HDAC10;SIRT1;SENP1;NUP98;ATPSCKMT;NSMCE2;NUP93;TRIM28;HDAC4
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.5688377337808068,-1.078285215738901,0.34782608695652173,1.0,1.0,12/23,26.53%,ALOX5;ALOX12;GPX4;TBXAS1;EPHX2;CBR1;FAAH2;PTGES2;CYP1B1;EPHX1;CYP2E1;DAGLA
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.5915984168100935,1.0780688951333386,0.36363636363636365,0.9007216766199855,1.0,1/6,4.10%,INAVA
prerank,MSigDB_Hallmark_2020__Spermatogenesis,-0.4887337283128519,-1.0778035848596976,0.4367816091954023,1.0,1.0,10/69,9.64%,PARP2;SCG3;IL12RB2;CFTR;ZPBP;ZC2HC1C;SCG5;PCSK1N;GSTM3;CCT6B
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.39357572951355435,1.0775263142140163,0.29411764705882354,0.9008267710400576,1.0,17/74,14.59%,PRR5L;HSPA1A;NOX4;ABL1;CAT;PRDX6;STOX1;ADNP2;KEAP1;PKD2;FOXO1;CPEB2;LRRK2;PIK3CA;PRKD1;FOXO3;MSRA
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.582601773716667,1.0773909854158572,0.3793103448275862,0.8999882878507188,1.0,3/8,19.19%,NOX4;MPST;BLMH
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5868157680111349,-1.0773779673158355,0.38372093023255816,1.0,1.0,2/20,2.44%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),-0.5084577494654747,-1.0773237194566583,0.3815789473684211,1.0,1.0,7/40,14.67%,PDCD1LG2;SELENOS;XBP1;MEF2C;TRIM41;CACTIN;NR1D1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.4380815096658347,1.077290144268612,0.2857142857142857,0.8992584591112955,1.0,3/24,9.05%,RNF139;INAVA;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.5904947761242296,-1.0770974365532786,0.3614457831325301,1.0,1.0,4/20,10.24%,ECT2;TGFB1;ZIC1;PDCD5
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6926316995986331,-1.0770691740955582,0.43333333333333335,1.0,1.0,3/6,16.51%,LIN7B;AP4M1;CAV1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.650261907099934,1.0770172956188038,0.41025641025641024,0.8989920278940435,1.0,4/6,26.76%,NIPBL;LRWD1;MACROH2A1;RUVBL2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.47344150075506836,-1.0770043331028538,0.36046511627906974,1.0,1.0,35/87,30.28%,GADD45GIP1;MRPL40;MRPS18C;MRPL50;MRPS7;MRPL27;MRPL51;MRPS25;RACK1;CHCHD1;MRPL19;ZNF598;MRPL16;MRPS22;MRPL36;MRPL48;MRPS16;MRPS11;MRPS30;GTPBP1;PTCD3;MRPL32;MRPL52;MRPS18B;MRPS33;MRPS14;MRPL21;MRPS34;MRPL43;MRPS23;MRPL34;MRPL35;MRPL44;MRPS15;MRPL9
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),-0.7285271550936051,-1.076797834912645,0.46296296296296297,1.0,1.0,3/6,16.51%,FLOT1;EMP2;CAV1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5002943053280853,1.0767212326547095,0.35714285714285715,0.8989745235926113,1.0,3/23,13.37%,SGCZ;ADCY6;MYOF
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),-0.6694980953035207,-1.0766606290598257,0.38596491228070173,1.0,1.0,1/6,2.84%,HES1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6275956979456169,-1.0764636087258503,0.4857142857142857,1.0,1.0,4/9,22.09%,RACK1;TNFRSF1A;ORMDL1;SPHK2
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.48828557876782597,1.0759685102939431,0.3333333333333333,0.9000022153925823,1.0,3/20,3.79%,RPA1;PMS1;ABL1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.4951606019175422,1.0755282714199976,0.34375,0.900107414765083,1.0,4/15,10.49%,MAP3K5;MAP3K11;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),-0.6532916880641294,-1.0754952761654326,0.4594594594594595,1.0,1.0,3/9,23.48%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.383982167854756,1.0753446954028973,0.3333333333333333,0.8995408031472787,1.0,43/182,13.18%,SEMA3B;LAMA3;UNC5C;EPHA3;RYK;PARD3;SEMA4D;DSCAML1;SEMA6C;GAB1;ROBO1;NRXN1;SH3KBP1;SLIT1;NTNG2;MAPK1;VLDLR;WNT7A;SPTBN1;DCC;NRCAM;UNC5D;UNC5B;OPHN1;SLIT3;RAB10;SLITRK5;EPHA5;RELN;MAPK3;USP9X;CTNNA2;AUTS2;ZDHHC17;PALLD;GPC1;KLF7;PIK3CA;SPTB;SEMA3A;SEMA6A;LMTK2;FRS2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.6794696576984942,-1.0745197838155585,0.45454545454545453,1.0,1.0,3/7,11.27%,HTR2C;GRM1;LPAR6
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.6288259440875922,-1.0744797742593248,0.4084507042253521,1.0,1.0,1/10,4.94%,BLOC1S2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.6288259440875922,-1.0744797742593248,0.4084507042253521,1.0,1.0,1/10,4.94%,BLOC1S2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.5589772928390336,-1.0744615441063277,0.3888888888888889,1.0,1.0,3/20,14.68%,PFN2;SVBP;APOE
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.403736738910242,1.0744504869797817,0.3125,0.9011114051655797,1.0,32/105,16.40%,PKP2;ZDHHC2;TSPAN17;EHD1;ZFYVE27;TSPAN15;ANK2;C2CD5;SPTBN1;EFR3A;NECTIN3;PACS1;DPP6;RAB10;SEC16A;TSPAN5;DPP10;ZDHHC3;RAPGEF6;FLOT2;KCNIP4;MYO5A;TSPAN14;RAPGEF2;RAB40C;PACS2;MAP7;RAP2A;SPTBN4;RAP1A;CCDC88A;PPIL2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.5099147978910806,-1.0744184595454593,0.3974358974358974,1.0,1.0,8/25,22.69%,RPS27A;RPA3;CDK7;UBA52;UBC;XPA;DDB2;RBX1
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.6187598628889881,1.0743999466126493,0.5,0.9002452164700715,1.0,2/9,6.08%,SLC15A2;VLDLR
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.5804525967354568,-1.0741056847979058,0.3888888888888889,1.0,1.0,5/15,19.56%,TGFB1;TMBIM1;PPP2R5A;LZTFL1;SAPCD2
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5203570687290727,-1.0740577227521704,0.34146341463414637,1.0,1.0,10/36,14.48%,F13A1;NAAA;PARP14;IGSF6;GPR34;CPM;NR4A3;MYO1F;NRP2;CHIT1
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.480152421407087,1.0730092761607515,0.2857142857142857,0.9026565990545783,1.0,5/23,11.68%,ARFIP1;STXBP5;NDFIP2;PPM1F;DISP1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),-0.6961852446445196,-1.0729755047555347,0.484375,1.0,1.0,4/8,13.75%,PRELP;OMD;ACAN;OGN
prerank,PanglaoDB_Augmented_2021__Pericytes,-0.4698651571797685,-1.072947387147566,0.37349397590361444,1.0,1.0,21/80,21.17%,VEGFA;PDE5A;ECM2;RARRES2;ZIC1;CRYAB;ASPN;PAMR1;COL4A1;LMOD1;COL15A1;COL6A1;ACTA2;ADAMTS2;COL4A2;STEAP4;P2RY14;COL14A1;THBS2;PDGFRB;THY1
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.568744919423424,1.0724952726835826,0.38235294117647056,0.9030043219023244,1.0,3/8,18.89%,SLIT1;SEMA3A;SLIT2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5436679380678335,1.0722959157796987,0.2962962962962963,0.9024727736638696,1.0,10/18,24.92%,PDE4D;MSN;RAPGEF6;RAPGEF2;RAP2B;RAP1A;RAP1B;TJP1;AFDN;RAB1A
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.6333330704145833,-1.0722903087277242,0.4027777777777778,1.0,1.0,1/11,1.34%,PARP2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.5534744288074611,-1.0721142570681346,0.44155844155844154,1.0,1.0,3/21,10.89%,NME3;GLRX;DCTD
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.5499844449451551,-1.0719487953295157,0.38095238095238093,1.0,1.0,9/15,15.80%,OPRM1;CHRM2;AGT;HTR2B;HTR2C;HTR4;HTR1F;CHRM5;TSHR
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),-0.6908794601203481,-1.0719288776673466,0.39473684210526316,1.0,1.0,2/8,5.95%,BTN3A1;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),-0.6788652898140696,-1.0712213859908917,0.4576271186440678,1.0,1.0,2/5,16.21%,PRELID1;BAX
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),-0.5336796852828555,-1.0710199875003785,0.43037974683544306,1.0,1.0,6/26,23.09%,GAPDH;PGK1;LDHA;ENOSF1;PGAM1;ENO4
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.5248417692079347,-1.070847528180499,0.38571428571428573,1.0,1.0,4/17,16.67%,HES5;TYMP;NSUN5;PTN
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),-0.4716393749114164,-1.0707670340080373,0.38095238095238093,1.0,1.0,6/50,10.45%,VEGFA;FGF1;ANGPTL4;XBP1;GRN;BTG1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.46239162846822623,-1.0696206101392534,0.38202247191011235,1.0,1.0,24/86,23.91%,SRSF7;RBM8A;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;HNRNPA2B1;UPF3B;MAGOHB;SEC13;THOC5;NUP107;CHTOP;MCM3AP;CPSF1;NUP85;SLBP;SRSF2;NUP188;ALKBH5;SMG6;YTHDC1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.7143810171174185,-1.069412090923561,0.47761194029850745,1.0,1.0,2/6,21.81%,SAPCD2;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),-0.5541112255976927,-1.069355383736311,0.4444444444444444,1.0,1.0,5/12,20.26%,MEF2C;CALM1;PTPA;HSP90AB1;PDGFRB
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.47824250435424165,1.0688639696492594,0.4,0.9107342903676073,1.0,9/26,12.97%,SOX11;SALL1;ROBO1;SMAD7;TGFBR2;SLIT3;PROX1;ZFPM2;ACVR1
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),-0.6726566865130416,-1.06880172601372,0.4444444444444444,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.4769742249503476,1.06873391804452,0.39285714285714285,0.9100897765070606,1.0,5/20,10.52%,MAPK11;ABL1;CDON;MAPK14;CTNNA2
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.5830885612069969,1.0687292942422246,0.4444444444444444,0.909044095057656,1.0,1/5,26.55%,MAPK8IP2
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.695832707834877,1.068335078161366,0.5,0.9092774131852832,1.0,1/5,0.19%,PLD1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,-0.4877451583736647,-1.0682486282627952,0.35802469135802467,1.0,1.0,8/56,8.69%,TREH;A2M;FGF1;ENPP2;CFTR;AGT;HTR4;SST
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.6200229364972532,-1.0681359736754688,0.42028985507246375,1.0,1.0,3/15,10.85%,ZCWPW1;BRME1;BTBD18
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),-0.6243526436402287,-1.0679336567874356,0.4722222222222222,1.0,1.0,1/11,7.98%,STAT5A
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.48718876435410896,-1.0678603716521253,0.36363636363636365,1.0,1.0,10/49,12.16%,CRYM;LHFPL5;SLC26A5;CEMIP;NDUFB9;TIMM8B;PJVK;ATP6V0A4;P2RX4;MYO3B
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.7018692973948697,-1.0673400799265147,0.5,1.0,1.0,2/5,20.67%,FUZ;NPHP1
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.6459348503684779,1.067106026053213,0.40625,0.9113791277419654,1.0,4/7,29.05%,RBPJ;BMPR1A;NOTCH1;TGFBR1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6220241354086823,1.067094476484575,0.34146341463414637,0.9103355972740663,1.0,1/5,4.55%,LIG4
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.6629158623249071,-1.0669242156368914,0.45614035087719296,1.0,1.0,3/5,19.08%,TGFB1;CST3;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.5270214398203357,-1.0668665338947483,0.3835616438356164,1.0,1.0,4/25,7.92%,ISG15;TGFB1;ALOX5;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.5270214398203357,-1.0668665338947483,0.3835616438356164,1.0,1.0,4/25,7.92%,ISG15;TGFB1;ALOX5;MEF2C
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.6064845386762507,1.0668250830216117,0.3939393939393939,0.910096094746287,1.0,1/6,9.15%,CMPK1
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.5908364522531521,1.066671761428224,0.34375,0.9094045958814831,1.0,2/6,10.66%,RAD18;SMC6
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.45856848902230113,1.066536719182092,0.3333333333333333,0.9086625443835932,1.0,4/23,11.79%,MAP2;DIP2B;DCC;PTPRS
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.47096681296815857,1.0664541450220624,0.37037037037037035,0.9078180193840758,1.0,7/20,21.23%,NAV3;CAMSAP2;CLASP1;HDGFL3;ATXN7;CLASP2;TTBK2
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.635272346844225,-1.0664380569761691,0.4507042253521127,1.0,1.0,1/7,4.95%,CLU
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.5929140034597532,-1.0663912276568661,0.4,1.0,1.0,3/12,14.55%,CD63;PIK3CB;ADAMTS3
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.4204579310837762,1.0662906481743797,0.2692307692307692,0.9072876671330531,1.0,7/21,16.56%,SHROOM2;FAM107A;PAWR;SHROOM1;MICAL1;ADD2;EPS8
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6714781001862659,-1.0662880342572802,0.4927536231884058,1.0,1.0,1/7,4.75%,ALOX5
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.620058316978288,-1.0661062933648835,0.38461538461538464,1.0,1.0,5/10,34.10%,RNF8;DTX3L;RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5563814983745313,1.065951279456451,0.4642857142857143,0.9070703980140558,1.0,2/10,10.89%,KAT2B;KAT2A
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.49178710886058735,-1.0657677194353716,0.4230769230769231,1.0,1.0,4/51,2.44%,IGFBPL1;PFN2;SEZ6L2;FGF1
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.6120609116796213,-1.065767378988802,0.4533333333333333,1.0,1.0,1/12,4.75%,ALOX5
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),-0.6196747067742283,-1.0655752208161635,0.4594594594594595,1.0,1.0,3/12,6.88%,VEGFA;OBSL1;TTN
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.3929882362694666,1.0653619673139259,0.23529411764705882,0.9075458457205843,1.0,11/35,20.04%,ZFYVE27;SEMA4D;ROBO1;PLXNA1;PLXNA3;TIAM2;ROBO2;PLXNC1;CDKL5;SLIT2;PLXNA2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.6507703373118112,1.0652780790258838,0.5,0.9067410758655817,1.0,3/5,19.36%,PRKCA;VRK1;DCAF1
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.34806832716738184,1.0652037062934376,0.2777777777777778,0.9058173018043504,1.0,24/106,10.09%,ASXL3;SMAD9;NOVA2;CSRNP3;LRRC4C;ADGRB3;ASTN1;CADM2;PCP4;STXBP5;NRXN1;FGF12;NOL4;SLC8A2;LSAMP;NOVA1;MAPK10;CNTN1;UNC5D;DPP6;CLVS2;SEZ6L;ADGRA1;CA10
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),-0.7427429242177889,-1.0651139365576823,0.3793103448275862,1.0,1.0,1/6,3.96%,PLSCR1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.40432694481051573,1.0650485064502027,0.30434782608695654,0.9052060752147216,1.0,14/52,19.16%,EVI5L;CEP120;TBC1D14;IFT140;ATG5;DYNC2LI1;BBS4;TBC1D1;RABGAP1;ATG3;CCDC88A;CDKL5;TBC1D7;TBC1D5
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.6429760586639485,-1.064922513282989,0.48333333333333334,1.0,1.0,2/7,25.01%,SEC61G;SEC62
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.6196836211017195,-1.0646959395285123,0.4117647058823529,1.0,1.0,7/15,30.71%,UTP15;ATF4;HEATR1;UBTF;FLNA;DHX33;SIRT7
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.6495975287900131,-1.064661223664578,0.39705882352941174,1.0,1.0,1/8,9.69%,MGST1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6183175831834675,-1.064650134059696,0.4084507042253521,1.0,1.0,1/9,0.61%,IFIT1
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.6129942442703802,1.0646004650081742,0.43333333333333335,0.9053886410627324,1.0,2/7,11.81%,BBS4;SOX8
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.41958566653716817,1.0645949439389182,0.3076923076923077,0.9043491592704674,1.0,7/21,16.56%,SHROOM2;FAM107A;PAWR;SHROOM1;MICAL1;ADD2;EPS8
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.5070542309804147,-1.064359714676175,0.4166666666666667,1.0,1.0,20/51,30.15%,PSMB9;PSMB8;PSMA3;PSMA7;CAV1;PSME1;OAZ2;AZIN1;NQO1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PDK2;PSMC3;PSMA4;PANK2;PSMC5
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.6319045544540524,-1.064160357058792,0.417910447761194,1.0,1.0,5/10,31.71%,APOE;ABCA1;ABCA5;SOAT1;ABCG1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5490019975148829,-1.064004747355687,0.4025974025974026,1.0,1.0,1/17,0.27%,IFI6
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),-0.5212780863072976,-1.063927016779221,0.4666666666666667,1.0,1.0,2/25,10.30%,TAF7;SMARCA5
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.567510654619434,-1.0638931600488628,0.410958904109589,1.0,1.0,3/16,9.21%,CDKN1C;CDKN2C;ANKLE2
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.7326248501296911,-1.063634719114507,0.47692307692307695,1.0,1.0,1/5,2.69%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.47500487047566725,-1.0633922133967535,0.37037037037037035,1.0,1.0,12/68,17.72%,B2M;FLOT1;HES1;RPL11;PARP9;NCBP1;DDX11;APOE;TRIB3;CAV1;GMNN;EDF1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.5561332705097932,-1.063340815394293,0.44,1.0,1.0,4/15,18.09%,PPIF;PDCD5;BAX;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.46651757990872444,1.0631299944324721,0.36,0.9071789796827175,1.0,1/24,0.08%,VAPB
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.7208568098724346,-1.06296671938612,0.4067796610169492,1.0,1.0,2/6,11.34%,AGBL5;AGBL3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.6051340524784063,-1.0627541719904368,0.4507042253521127,1.0,1.0,2/13,13.02%,JUN;NR4A3
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.6501184881801667,-1.0625505455142525,0.4264705882352941,1.0,1.0,1/10,4.53%,RPS15
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.5098058205662245,-1.0623762197194213,0.35,1.0,1.0,6/42,8.87%,IL20RA;HES1;OVOL2;EFNA1;TMC4;VWA2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),-0.71660375945905,-1.0623530756489554,0.484375,1.0,1.0,2/5,9.29%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),-0.6178835470722934,-1.0621139221787488,0.40540540540540543,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.31885159701761784,1.0613560923429342,0.0,0.9108778145346308,1.0,41/305,7.72%,IL1RAPL2;CHRM3;ZNF358;POU6F2;LDB2;SHANK2;DPYSL5;PDGFC;MBNL1;ERBB4;NLGN1;DCX;NAV3;PCDHA1;DPF1;RYK;VCAN;NPAS1;ADAM23;NDP;DOC2A;SCD5;DSCAML1;LIG4;CRIM1;CHD7;SDK2;ROBO1;NRXN1;FGF12;ADGRL3;VLDLR;ADAM22;LSAMP;NRCAM;NAV1;ZEB2;MERTK;PKD2;TRAK1;ATXN1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.4905982147537471,1.0610830592771914,0.3939393939393939,0.9105900871220441,1.0,4/16,16.56%,HACE1;CDH13;NCKAP1;EPS8
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.5243835160725613,-1.0609206572426524,0.36619718309859156,1.0,1.0,5/27,9.06%,VEGFA;HES5;HES1;PARP14;PARP9
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.6403860495176338,1.0609093992618508,0.45,0.9099433424325144,1.0,3/5,22.44%,ATP8A1;ATP8A2;ATP11B
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.6445935499562692,1.0605459635124845,0.5111111111111111,0.9096915543333531,1.0,3/6,16.54%,NTNG2;LAMB4;NTN4
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.5877612337010831,-1.060382003876286,0.4117647058823529,1.0,1.0,5/14,21.05%,PRPSAP1;PPAT;NMNAT3;MTHFD1;NMNAT1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.7105588800392337,-1.0603313665707126,0.4126984126984127,1.0,1.0,2/5,9.28%,LDB1;SLC6A9
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.5559112613509433,1.0603070794100753,0.3783783783783784,0.9092011039705257,1.0,3/12,2.25%,IL15;GPNMB;LEPR
prerank,GO_Biological_Process_2021__gas homeostasis (GO:0033483),-0.6927124291240132,-1.0600099303717447,0.5,1.0,1.0,2/5,27.48%,CAV1;SOD2
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.5544716477085039,-1.0597093313526644,0.4050632911392405,1.0,1.0,5/23,14.13%,HES5;TGFB1;MEF2C;WNT5B;RUNX2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.468035784930363,-1.059657027592618,0.3764705882352941,1.0,1.0,14/63,17.42%,VEGFA;SCG2;FGF1;SFRP1;HTR2B;XBP1;STAT5A;CDH3;GRN;NR4A3;NRP2;HRAS;PTN;EMC10
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5020146093479408,1.059583341476277,0.36666666666666664,0.9094969381957311,1.0,3/12,5.67%,HSPA1A;BOK;ACAA2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6232826993309875,1.0594488450837687,0.42857142857142855,0.9088714296649056,1.0,4/7,23.49%,CTSA;EEF1A2;SNCA;GFAP
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.6441802946101353,-1.0594228308315772,0.46153846153846156,1.0,1.0,2/8,8.45%,OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.6032747120060921,-1.0592895002037777,0.47297297297297297,1.0,1.0,6/15,20.55%,TGFB1;ATF4;SARS1;C3;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.6435917274986935,1.0592008811337401,0.4358974358974359,0.9086730943300788,1.0,2/5,29.71%,ARL8B;VPS41
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.43232998384281157,1.0589636782441842,0.2777777777777778,0.9081690160508357,1.0,7/31,12.00%,ZFYVE27;MAP2;ABL1;DIP2B;NRCAM;PTPRS;SEMA3A
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.5833233175441053,-1.0588212309904197,0.4925373134328358,1.0,1.0,2/10,11.75%,TK2;TYMP
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.5513411027989327,-1.0588127506166471,0.36363636363636365,1.0,1.0,2/19,5.82%,ITGA4;CACNB1
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.5488162367999917,1.0587412756737677,0.39473684210526316,0.9076660808062396,1.0,2/9,5.70%,NLGN1;DEF8
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.679707007236186,1.0587330016812344,0.5135135135135135,0.9066381463998905,1.0,1/5,0.40%,SLC16A10
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5505662829759532,1.0587230266788055,0.3125,0.9056633966499472,1.0,3/10,11.59%,GSTM2;SLC8A1;PIK3CA
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.5952652458313021,-1.058605073058237,0.4393939393939394,1.0,1.0,4/12,16.31%,PIGC;PIGH;PIGG;PIGL
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.6089094650254739,1.0585937068506397,0.42424242424242425,0.9049787251467648,1.0,2/6,11.88%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.5728188622106716,-1.0584397549066349,0.4507042253521127,1.0,1.0,3/16,15.16%,AGT;HTR2B;KCNMB4
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.660418745935005,-1.0581685528493776,0.4909090909090909,1.0,1.0,4/6,27.96%,ADPRS;CCS;SOD2;MT3
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.6794378247358968,-1.0575039849936465,0.4647887323943662,1.0,1.0,1/5,4.23%,PDE6B
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.631661596695422,-1.0574554552169162,0.453125,1.0,1.0,2/6,14.68%,AGT;APOE
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),-0.6901743936675778,-1.057418007870207,0.4605263157894737,1.0,1.0,3/6,20.77%,MTHFD1;GOT1;MTRR
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.4900373807475026,-1.0573307753084467,0.34523809523809523,1.0,1.0,4/34,7.92%,TGFB1;HTR2B;DDX5;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.6292169957904831,1.0571818644182283,0.4838709677419355,0.9085242830986342,1.0,1/7,2.15%,ESR1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5670169780273223,1.0571520144563027,0.3333333333333333,0.9075338080462494,1.0,6/10,26.38%,NDFIP2;PPM1F;TERF1;SNX3;MAPT;SNX12
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.6655648635512984,-1.0570686860255585,0.41818181818181815,1.0,1.0,4/5,32.68%,HSPD1;CD226;NECTIN2;WNT5A
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7091682054804513,1.0569208054200103,0.4838709677419355,0.9072712592891596,1.0,2/5,14.42%,DMD;DMPK
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.711044620661745,-1.0568023630526329,0.46,1.0,1.0,4/5,28.91%,RHCG;SLC12A4;RHCE;RHD
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),-0.6976730375673618,-1.0566496502480405,0.4666666666666667,1.0,1.0,2/5,6.24%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.5051995983769717,1.056479573700279,0.34285714285714286,0.9074476002381977,1.0,4/15,10.59%,SPRED2;PARD3;SMAD7;DGKQ
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.4993088037018878,-1.0563731373265213,0.47297297297297297,1.0,1.0,3/36,8.54%,PDXDC1;ENPP2;ERAP1
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5835280834122463,1.0562796402842267,0.48,0.906882641481807,1.0,3/10,18.53%,DSCAML1;PALLD;DSCAM
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.4309086898625764,1.0560695467227337,0.30434782608695654,0.9063189508707726,1.0,10/29,16.20%,NLGN1;PDLIM5;TANC2;ARC;RELN;LRRK2;SRCIN1;CAPRIN1;ARHGAP44;SIPA1L1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.4597844493303582,-1.0558237943677014,0.4318181818181818,1.0,1.0,25/87,23.91%,SRSF7;RBM8A;DHX38;NUP155;CDC40;SRSF5;CASC3;NCBP1;HNRNPA2B1;UPF3B;MAGOHB;SEC13;THOC5;NUP107;CHTOP;MCM3AP;CPSF1;NUP85;SLBP;SRSF2;ENY2;NUP188;ALKBH5;SMG6;YTHDC1
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.5482841814365664,1.0554867294009218,0.4117647058823529,0.9068149845844836,1.0,2/10,9.39%,EDEM1;SEC16A
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.4822650034470621,1.0553888367699367,0.2777777777777778,0.9060848107483124,1.0,6/15,17.56%,GPSM1;CPEB2;LRRK2;WNK1;LRCH1;ARFGEF1
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),-0.6975377149495361,-1.0553827028939957,0.4126984126984127,1.0,1.0,3/5,20.69%,ISG15;UBE2L6;HERC5
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.5140737325803318,1.0544827086137194,0.36363636363636365,0.907418165338454,1.0,5/15,19.75%,OSBPL7;CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4224315980366888,1.0544465435245836,0.375,0.9065047581536064,1.0,11/29,17.72%,USP51;FMN2;POT1;PPP4R2;UBR5;PML;SETD2;SIRT6;TRIP12;SPIRE1;MGMT
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),-0.740891436047456,-1.0543708094953081,0.4927536231884058,1.0,1.0,1/5,5.10%,AGT
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.5823058642722316,-1.0541792148741815,0.4225352112676056,1.0,1.0,3/14,14.82%,PHKG1;CALM1;PYGL
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.5321531343514364,1.0538459944473195,0.425,0.9072659853393368,1.0,2/10,5.76%,IRS1;PLIN5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.668586972861214,-1.0538352844056156,0.4788732394366197,1.0,1.0,3/7,17.45%,CACNA1G;SCAMP5;SYT4
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.517681511147665,1.0533460640532846,0.3793103448275862,0.9073572229074095,1.0,1/14,1.50%,SEC24D
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.5117541414385586,-1.0532921278869243,0.4025974025974026,1.0,1.0,3/29,11.37%,ECM2;PIK3CB;EMP2
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.5659485639235589,1.0532210990355946,0.3225806451612903,0.9066471995018337,1.0,1/10,0.38%,SPOCK3
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),-0.6852944705012693,-1.0531284154287406,0.5072463768115942,1.0,1.0,2/5,18.12%,HDAC6;TMEM39A
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.519441292495276,1.0530287357981893,0.34210526315789475,0.9060721168007566,1.0,7/16,13.08%,GRIK2;UNC13C;GRID2;UNC13B;GRIK3;NAPB;GRIK4
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.6555985227009025,-1.0526543203322765,0.4444444444444444,1.0,1.0,1/5,6.03%,EFNA1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.4138183378138163,1.0526348791097193,0.36363636363636365,0.9060977702939048,1.0,16/62,11.54%,SPSB4;SEPTIN4;FBXW7;INAVA;SMAD7;FAM107A;HSPBP1;UBE2D1;DCUN1D2;MARCHF7;DCUN1D5;NDFIP2;XIAP;LRRK2;UBE2N;RCHY1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.5284779783615574,1.052553972562837,0.42857142857142855,0.9044043635532496,1.0,9/14,32.97%,TNFAIP1;FHDC1;KCTD13;FAM171A1;ITGB5;SORBS1;PHACTR1;RHOA;ZYX
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.5284779783615574,1.052553972562837,0.42857142857142855,0.9044043635532496,1.0,9/14,32.97%,TNFAIP1;FHDC1;KCTD13;FAM171A1;ITGB5;SORBS1;PHACTR1;RHOA;ZYX
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.3940302465205082,1.0521373221760928,0.29411764705882354,0.9044151824250813,1.0,31/92,18.89%,PHLDB2;MCTP1;NAV3;SRGAP1;PTPRK;ROBO1;MAGI2;SMAD7;TP53INP1;TMEFF2;KANK1;ZMYND8;MITF;NF2;CLASP1;CHRD;PTPRU;RAP2B;STK24;PTPRG;FOXO3;RAP2A;ARID2;ACVR1C;CORO1C;MACIR;BMPR1A;CLASP2;SRGAP2;NF1;SLIT2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),-0.616280852023856,-1.0519922825714152,0.4722222222222222,1.0,1.0,8/16,27.52%,DNAH17;CCDC39;CFAP100;CCDC40;DNAAF2;DNAI4;TTC12;DNAH7
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.6450190124631161,1.0518694324516245,0.43333333333333335,0.9040778406664995,1.0,2/5,18.51%,MRPL18;NPM1
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.6163125343259241,1.0513679372933102,0.5625,0.9044864273004787,1.0,1/5,5.15%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6188544318660547,1.0513519355325869,0.40476190476190477,0.9035708046203274,1.0,5/6,36.91%,LARP6;EIF4G1;CDK9;EIF3E;EIF3D
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.5447360290108584,1.0512230865245722,0.4482758620689655,0.9029546168355017,1.0,1/13,0.47%,GINS1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.5925299634865007,-1.051221937075933,0.4492753623188406,1.0,1.0,3/14,14.94%,LRRC17;FSTL3;TCTA
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),-0.6420979947461514,-1.0511976854277485,0.42105263157894735,1.0,1.0,3/7,19.61%,ABHD12B;DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.5343986195378003,-1.0511328917379406,0.4235294117647059,1.0,1.0,4/25,11.82%,ECT2;TGFB1;ZIC1;APOD
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.32194726614970787,1.0508108248246666,0.2857142857142857,0.9031155169349864,1.0,35/108,20.18%,NLGN1;DCX;EHD1;RYK;ZFYVE27;PBX3;MAP2;CNTNAP2;PBX1;ATXN10;OPHN1;UGDH;EPHA5;VAPA;WNK1;NEDD4;HMGB1;RAPGEF2;TENM3;FLRT3;FRYL;ARL3;GPM6B;HDGFL3;UNK;ATP8A2;B4GALT5;PPP1R9A;UHMK1;THOC2;GPM6A;POU3F2;VSX1;TBC1D23;FRY
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.4977427453813807,-1.0507046578076138,0.44047619047619047,1.0,1.0,9/47,8.45%,MX1;IFIT1;ISG15;IFITM3;PLSCR1;IFIT5;OAS3;RSAD2;OAS1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5067025760919881,1.0504138633476823,0.391304347826087,0.9032266027686303,1.0,4/17,13.99%,SOX11;SMAD7;LATS1;ITGA3
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.6140216887865662,1.050142820941007,0.3953488372093023,0.9028927913729144,1.0,3/6,28.99%,PTAR1;PGGT1B;RABGGTB
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.37628517643795706,1.0499846720120372,0.3888888888888889,0.9022471522738773,1.0,18/61,13.02%,PLD1;MACC1;PDZD2;LPP;ESRRG;FGD4;PLA2R1;TSC22D2;BAZ2B;ATP10B;NEBL;RSPH3;PLEKHA5;WNK1;SLC8A1;TRHDE;GSTO2;COBL
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.4110464628107202,1.049956998257126,0.2916666666666667,0.901340008772572,1.0,18/64,17.62%,GALNT7;POGLUT2;PLOD1;LARGE1;TMTC1;TRAK1;GALNT16;POFUT1;C1GALT1;GALNT8;POMK;GALNT13;ST3GAL4;CRPPA;TET2;TMTC2;B4GALT5;GALNT11
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.6175112214329388,1.0496984871231485,0.40540540540540543,0.9009437025301053,1.0,2/6,22.97%,FYN;NECAB2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3944539506679233,1.0495378968505342,0.42105263157894735,0.9004498841186942,1.0,13/60,14.47%,LGR5;ADGRB3;CALCRL;GRK5;CALCB;ADGRL3;VIPR2;ADCY6;GNAQ;PRKACB;ADCYAP1R1;RXFP1;LPAR1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.6196185122249618,-1.0493352425175522,0.40625,1.0,1.0,2/10,10.51%,ITGA4;GCNT1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.5356890774860511,-1.0491926910749816,0.36,1.0,1.0,3/22,8.49%,ITGA4;CACNB1;CACNA1B
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5809233366543678,-1.0489986820676254,0.44776119402985076,1.0,1.0,2/13,12.19%,PPCS;DCAKD
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.5553290252674801,-1.0487467673471098,0.4,1.0,1.0,3/16,13.64%,HAP1;TLE6;ZBED3
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.6735507127825172,-1.0483635466553023,0.4864864864864865,1.0,1.0,2/5,19.76%,PDZK1;ATP8B1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),-0.6014891847011324,-1.0483023644476228,0.43243243243243246,1.0,1.0,2/10,16.26%,CCT7;DKC1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),-0.49035606945754573,-1.0482621505187573,0.43037974683544306,1.0,1.0,11/51,16.31%,PIGO;SELENOK;PIGC;GLUL;PIGH;ZDHHC1;ZDHHC8;ZDHHC15;ZDHHC22;PIGG;PIGL
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.380887331807834,1.0482247352542386,0.3333333333333333,0.9024630770480202,1.0,8/59,10.68%,VAPB;SMPD4;UBE2J2;RAB10;SEC16A;VAPA;LRRK2;TRAM1
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),-0.6532254490688056,-1.0480199517498885,0.45901639344262296,1.0,1.0,1/7,14.47%,BEX4
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5477590726441044,1.04769781548508,0.36666666666666664,0.9027867161182016,1.0,3/11,11.59%,GSTM2;SLC8A1;PIK3CA
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.4496392959849885,-1.0476960646830238,0.4186046511627907,1.0,1.0,25/88,18.07%,SRSF7;NOL3;RBM8A;SNRPA1;DHX16;PRPF18;SNRPD1;PDCD7;SNRPD2;PRPF8;RNPC3;SNRPB;SRSF10;LUC7L3;PRPF4;SNRNP25;NCBP1;PRPF6;MAGOHB;SCNM1;SRPK1;RP9;USP39;SMNDC1;SF3A3
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.5524474492561099,1.0475724877964048,0.4,0.9011463628329044,1.0,2/7,7.84%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.5524474492561099,1.0475724877964048,0.4,0.9011463628329044,1.0,2/7,7.84%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.5877912207511333,-1.0471793321907843,0.4262295081967213,1.0,1.0,2/10,13.64%,TLE6;ZBED3
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.5608095015217927,-1.04707986281006,0.4861111111111111,1.0,1.0,2/14,11.37%,VEGFA;EMP2
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.49283645138027987,1.0469968024430165,0.4,0.9015845296372765,1.0,4/10,11.40%,NOVA2;NOVA1;PCBP2;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.4275171425547236,1.0469162717183182,0.3076923076923077,0.9007674427117651,1.0,5/30,7.98%,BANP;SF3B3;FMN2;CTSA;EGFR
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),-0.437875923969455,-1.0468072223291072,0.39325842696629215,1.0,1.0,21/105,19.83%,ERCC6L;RPS27;ABRAXAS1;RAB11A;ZW10;CENPH;SMC1A;BUB3;ITGB3BP;DYNC1LI2;PTPA;NEK6;SEC13;CENPC;MIS12;MZT1;NUP107;DCTN6;KNTC1;RMDN1;NUP85
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.5115075529006146,-1.046561997220499,0.4074074074074074,1.0,1.0,12/35,19.73%,ISG15;RPS27A;TRIM25;RFC2;RPA3;UBA52;RFC4;UBE2L6;RFC1;UBC;RFC3;POLD2
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.6823462114349605,-1.0463978047996192,0.4603174603174603,1.0,1.0,3/5,28.51%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.6823462114349605,-1.0463978047996192,0.4603174603174603,1.0,1.0,3/5,28.51%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.42728469638379685,1.0463850558051175,0.34782608695652173,0.9011887974973487,1.0,3/27,8.07%,ATR;RFWD3;SAMHD1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.3983908733480887,1.0459248615398469,0.2222222222222222,0.9011703724384406,1.0,10/45,13.96%,GABRG1;GABRR1;SLC12A8;SLC12A1;XPR1;GLRA1;GABRB1;GABRA1;SLC25A14;GABRG3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.5608571983309192,-1.045348816815303,0.4155844155844156,1.0,1.0,6/14,19.16%,VAV3;LAT2;MEF2C;BLNK;BAX;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.4483837225211252,1.045282699480682,0.4444444444444444,0.9019800579935826,1.0,2/25,0.38%,CRB2;SPOCK3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.6983454548810413,-1.0448464471880732,0.4696969696969697,1.0,1.0,2/5,23.10%,BNIP3;YME1L1
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.40717720892913256,1.0447895528682862,0.36363636363636365,0.9021392266615197,1.0,15/86,10.49%,BAIAP3;LRRC4C;MCTP1;NLGN1;NLGN4X;NRG3;GRIK2;HOMER1;SLC8A2;ARC;GRID2;OPHN1;RELN;LRRK2;CHRNA7
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.6476918401247896,1.0446637939643202,0.5217391304347826,0.9014879724881921,1.0,1/5,1.10%,BCO1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.33711909407845564,1.0446110910266602,0.16666666666666666,0.9006439159806816,1.0,28/101,15.57%,ERBB4;FBXW7;EPHA3;RYK;ROR2;NAF1;MAPK1;IGF1R;POT1;DCUN1D2;MERTK;EGFR;TNKS;DCUN1D5;MAP3K4;MAPKAPK5;EPHA5;MAPK3;CHRNA7;SERINC5;UBE2N;HNRNPD;DSCC1;LMTK2;FLT1;ARRDC4;DCUN1D1;ZNF16
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.6375856368194677,-1.0445903664300666,0.4461538461538462,1.0,1.0,1/8,0.66%,VEGFA
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),-0.471169559904724,-1.0441439569653939,0.4418604651162791,1.0,1.0,13/67,20.12%,ANKRD53;NCAPD3;RAB11A;ZW10;TTN;SMC1A;REC8;CHMP4B;MIS12;EML3;KIF18B;SET;KIF22
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),-0.45800736171755263,-1.0440920821681092,0.4358974358974359,1.0,1.0,13/62,17.64%,TRIM5;PDE6B;ALOX5;IRF1;USP18;ERAP1;GRN;CALM1;P2RX4;NLRP1;CD55;CAV1;P2RY12
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.521103481894525,1.0440269198523113,0.4642857142857143,0.9011435099001389,1.0,5/13,18.76%,PKD2;BMP7;ROBO2;NIPBL;NF1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),-0.7171624796236871,-1.0438456151808246,0.46774193548387094,1.0,1.0,3/5,23.79%,PDGFRB;AAMP;PLAT
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.6841434397413106,1.043842819540395,0.5135135135135135,0.9005115832430809,1.0,2/6,2.34%,ZDHHC2;EHD1
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),-0.575274804877651,-1.0436744897311496,0.4305555555555556,1.0,1.0,2/18,3.70%,TRIM5;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.5562394525785282,-1.0436546090536416,0.37142857142857144,1.0,1.0,5/21,9.06%,VEGFA;HES5;HES1;PARP14;PARP9
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.530349167928025,-1.0436105428571123,0.4473684210526316,1.0,1.0,12/21,22.77%,RPS27A;RFC2;RPA3;UBA52;RFC4;RFC1;UBC;RFC3;LIG1;POLD2;XRCC1;POLE
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),-0.6483550408902373,-1.0435897204116975,0.49206349206349204,1.0,1.0,2/6,6.88%,HTR2B;TTN
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),-0.6418801218009775,-1.043331183508222,0.4647887323943662,1.0,1.0,1/12,0.26%,B2M
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6295014775950004,1.0431391514304877,0.45454545454545453,0.9016393848285761,1.0,1/8,2.34%,EHD1
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.5703537517193282,1.0427625907548719,0.425,0.9014594890760907,1.0,2/7,10.18%,FGGY;POMK
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.624358586191369,1.0425157460400791,0.5666666666666667,0.9011512025018776,1.0,2/6,4.73%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),-0.4172095592829169,-1.0422767789535903,0.33707865168539325,1.0,1.0,25/186,14.02%,EPN1;MX1;TRIP10;RIMS1;RPS27A;EMD;COX18;CFTR;CHRM2;M6PR;NAPA;AZIN2;AP2A1;NUP155;SH3GL2;LPCAT3;CLTA;MTCH1;NEMP1;DNM2;CLTB;TMEM43;DVL2;UBA52;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.6805947070306135,1.042193976365871,0.45714285714285713,0.9010204562572054,1.0,1/5,2.30%,DEPTOR
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4001700924916567,1.0421127603884373,0.36666666666666664,0.9002635467924246,1.0,8/33,13.96%,GABRG1;GABRR1;SLC12A8;SLC12A1;GLRA1;GABRB1;GABRA1;GABRG3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.3167645657469377,1.0420892440330185,0.25,0.899315712647911,1.0,36/181,12.32%,IL1RAPL2;SOX11;POU6F2;SHROOM2;PDGFC;DCX;VCAN;NPAS1;ADAM23;PBX3;CNTNAP2;DSCAML1;PBX1;LIG4;SYNJ1;CHD7;ADGRL3;ADAM22;NRCAM;PKD2;TGFBR2;ATXN1;MEIS1;NFIB;MDGA1;RELN;CA10;CHST8;POMK;MYRF;AATK;SOX8;GRIN2B;ZBTB16;PROX1;GLIS2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.5939379831611622,-1.0420470586596606,0.4444444444444444,1.0,1.0,5/15,8.40%,GSTM4;ALOX5;ALOX12;GPX4;EPHX2
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),0.5715872812457437,1.0419269145972505,0.4,0.8987866416258814,1.0,3/8,25.33%,PIKFYVE;ARL8B;RAB34
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.6362393123435743,1.0417161751418613,0.4444444444444444,0.8983547681219547,1.0,2/5,5.15%,RXRA;PPARG
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),0.5526523820012001,1.0415953207429274,0.4864864864864865,0.8977318874432227,1.0,4/9,19.36%,LIG4;HMGB1;TCF3;DCAF1
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),-0.5948979123267242,-1.0414305548245815,0.43283582089552236,1.0,1.0,2/10,12.19%,PPCS;DCAKD
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),-0.5948979123267242,-1.0414305548245815,0.43283582089552236,1.0,1.0,2/10,12.19%,PPCS;DCAKD
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),-0.5948979123267242,-1.0414305548245815,0.43283582089552236,1.0,1.0,2/10,12.19%,PPCS;DCAKD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.5131296222779866,-1.0413816715596576,0.39285714285714285,1.0,1.0,10/46,22.67%,ECT2;TGFB1;ZIC1;PARP9;CCT7;DKC1;HDAC3;PARK7;RBM22;DTX3L
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,-0.5852041094637788,-1.0410978573582044,0.47435897435897434,1.0,1.0,3/16,6.15%,HLA-F;ALOX5;IGSF6
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.5158419140709894,-1.0410915115517836,0.5,1.0,1.0,6/30,16.31%,PIGO;PIGC;PIGH;B3GNT5;PIGG;PIGL
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.4720589176404574,-1.0410352472357478,0.4375,1.0,1.0,9/51,12.16%,CRYM;LHFPL5;SLC26A5;CEMIP;NDUFB9;TIMM8B;PJVK;ATP6V0A4;MYO3B
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),-0.44727255138219874,-1.0408569355433395,0.42045454545454547,1.0,1.0,20/83,21.53%,ERCC6L;RPS27;ZW10;CENPH;BUB3;ITGB3BP;DYNC1LI2;PTPA;NEK6;SEC13;CENPC;MIS12;TACC3;NUP107;DCTN6;KNTC1;RMDN1;NUP85;BCCIP;STIL
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4570484640516769,1.0408432323805874,0.30303030303030304,0.8989317164920589,1.0,7/24,17.78%,KAT2B;NAA50;KAT8;PHF20L1;KAT2A;MRGBP;ATAT1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.6133559648215328,-1.0408271586593716,0.5277777777777778,1.0,1.0,5/11,29.51%,CLU;TRIM32;TPT1;CDKN2D;RPS3
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.36206063176397346,1.0408214696956513,0.3333333333333333,0.8980382277878785,1.0,34/136,14.25%,CHRM3;RIT2;GABRG1;GABRR1;KCND2;NLGN1;NLGN4X;KCNQ3;GRIK2;DOC2A;UNC13C;PDE7B;HOMER1;NRXN1;MAPK1;CHRNB3;NOVA1;SLC1A2;GRIA1;UNC13B;GLRA1;CHRNA7;DLG2;GRIA3;PRKACB;GRIN2B;KCNIP2;GRIK4;GABRB1;GABRA1;DLGAP1;APBA1;GABRG3;KCNQ2
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.4671971650003923,1.0407680935016441,0.2608695652173913,0.8971785261997,1.0,9/31,16.66%,ITPR2;ANK2;SLC8A2;ATP2B4;STIM1;SLC8A1;DMPK;NOS1;TMEM65
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),-0.48839721131401714,-1.0405143267187957,0.4444444444444444,1.0,1.0,10/43,16.51%,PLSCR1;MT2A;TTN;SLC30A4;HVCN1;SNCB;CALM1;PPP5C;KHK;CAV1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.5150970377661712,-1.0404843354763986,0.4430379746835443,1.0,1.0,8/28,19.75%,NPM2;RPS27A;ZW10;BUB3;UBA52;CDC26;UBC;KNTC1
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.6347370200249118,-1.0404657890572098,0.49230769230769234,1.0,1.0,3/7,21.53%,ENPP4;USF1;ANO6
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.4565676148419231,1.0404236591816811,0.36363636363636365,0.8971328826878519,1.0,9/22,15.05%,SOX11;ROBO1;SMAD7;TGFBR2;SLIT3;PROX1;ZFPM2;ACVR1;ROBO2
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.5046165803536268,-1.040136800555488,0.4230769230769231,1.0,1.0,3/26,4.16%,TRPC5;FTH1;CP
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.6930756671011229,-1.0398912398549027,0.5,1.0,1.0,3/5,12.72%,RPS21;KRI1;NOP14
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.6024535260573258,1.039640370046567,0.46875,0.8973120554838317,1.0,6/7,18.89%,SLIT1;SLIT3;SEMA3A;ALCAM;NRP1;SLIT2
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.6024535260573258,1.039640370046567,0.46875,0.8973120554838317,1.0,6/7,18.89%,SLIT1;SLIT3;SEMA3A;ALCAM;NRP1;SLIT2
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.6519426038809779,1.0395328793323422,0.5,0.8967266491578783,1.0,2/5,8.95%,PPARG;ADAM19
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.596072062552957,-1.0387997699368954,0.49206349206349204,1.0,1.0,5/10,26.52%,NR4A3;ATF4;RACK1;PARK7;NONO
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.4049861687871692,1.038792057468584,0.39285714285714285,0.8978076435445203,1.0,7/35,13.48%,DHCR7;RXRA;FDX1;STARD3;OSBPL5;CYP7B1;HMGCR
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.39324538748146537,1.038530105204209,0.3684210526315789,0.8974605797786527,1.0,13/44,19.18%,ABHD3;NR1H2;SLC44A1;STARD7;PLA2G15;SLC44A5;PCYT1B;GPAT4;PCTP;LPCAT1;CEPT1;ACHE;PLAAT1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.5839329102569306,-1.038512473186712,0.4444444444444444,1.0,1.0,4/15,18.09%,MX1;DNM2;MTFR1L;DNM1L
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.6951476725525851,-1.0385049035909408,0.5373134328358209,1.0,1.0,2/5,15.12%,SLC25A5;VDAC1
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.5598777411399622,-1.0384633363980447,0.5128205128205128,1.0,1.0,3/12,13.20%,NPM2;ATAD5;BRPF3
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.5803229575746709,-1.0383982385040396,0.46835443037974683,1.0,1.0,7/15,21.05%,PARP9;NAXE;QPRT;NUDT12;NMNAT3;NAMPT;NMNAT1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.448060930762654,1.0383326105011166,0.3225806451612903,0.8972250253245575,1.0,9/26,15.44%,FAM20B;CSGALNACT1;GAL3ST3;EXT2;UGDH;EXTL3;CHST8;EXT1;BMPR1B
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3988133055500195,1.038284364190947,0.37037037037037035,0.8963892449083045,1.0,9/32,16.41%,MAP3K5;SIRT1;PPM1F;GRIN2B;HMGB1;TTBK1;ACVR1C;FYN;GRIN1
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.6347488548615569,1.0377841987775938,0.4375,0.8967238220170954,1.0,2/5,9.11%,MAP2;FBXW11
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.43822694671891566,-1.0375026248661476,0.3763440860215054,1.0,1.0,22/179,13.86%,POLR2I;ELOB;TAF7;TFAM;GTF3C6;TAF11;POLR2G;NFE2L3;POLR3H;POLR1C;DDX5;XBP1;CEBPD;PTMA;GLIS3;SMARCA5;CDK7;NCBP1;PPP5C;ATF4;CTDP1;GTF2F1
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.6769729024078674,-1.037140031401397,0.5,1.0,1.0,3/7,23.54%,SLC6A6;SLC36A4;SLC7A10
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6741399851581453,-1.036915688438429,0.55,1.0,1.0,4/5,31.71%,APOE;ABCA5;LCAT;ABCG1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.6118049239279044,-1.0368391678428963,0.46296296296296297,1.0,1.0,3/5,27.96%,APOE;SNX17;MT3
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.6118049239279044,-1.0368391678428963,0.46296296296296297,1.0,1.0,3/5,27.96%,APOE;SNX17;MT3
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.6118049239279044,-1.0368391678428963,0.46296296296296297,1.0,1.0,3/5,27.96%,APOE;SNX17;MT3
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5568834504269211,-1.0367829032908864,0.5068493150684932,1.0,1.0,8/20,18.69%,RPS27A;RFC2;RPA3;UBA52;RFC4;RFC1;UBC;RFC3
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5369413642561711,1.0364544514431526,0.4782608695652174,0.8992346746506064,1.0,2/8,11.98%,ABCC5;SLC39A8
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.3366629547736475,1.03640255442833,0.3333333333333333,0.8984466934555654,1.0,48/139,21.53%,POGLUT2;ATR;PRKX;SGK1;RICTOR;RPS6KB1;MAPK1;TGFBR2;TNKS;GALNT16;MAPK14;MAPKAPK5;LRRK2;DGKQ;SMG1;WNK1;CSNK1E;GALNT13;NAA11;LATS1;MAST3;PRKD1;LMTK2;CSNK1G3;MAPK8;SRPK2;TTBK1;DMPK;PNCK;CSNK1G1;CAMKV;PRKCA;PINK1;PRKCE;UHMK1;AKT2;VRK1;MTOR;RPS6KA2;RPS6KA3;IKBKB;HIPK3;PDPK1;SGK3;TTBK2;CAB39;EIF2AK3;AKT3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.596226196128403,-1.0358241231681564,0.4852941176470588,1.0,1.0,2/15,5.10%,SFRP1;AGT
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5264804940639022,-1.0358037207371693,0.4675324675324675,1.0,1.0,5/19,23.62%,ATP6V0A4;ATP6V1F;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.562511593488016,1.0357075747129305,0.41379310344827586,0.8989984440954067,1.0,1/7,1.91%,ADGRB3
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.7120679238415313,-1.0355966070394138,0.5,1.0,1.0,1/5,12.75%,ZFP36L2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.40841462334659107,1.035566921342707,0.3181818181818182,0.8983224433659084,1.0,11/42,11.88%,KCNJ6;KCNMB3;NEDD4L;GNG2;BIN1;KCNN2;DPP6;DPP10;NEDD4;KCNIP4;KCNIP2
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6302664588453777,-1.0354259436411288,0.4126984126984127,1.0,1.0,2/5,14.93%,HAX1;SREBF1
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5234295038464778,1.0354158009353338,0.53125,0.8978049505605461,1.0,1/12,0.09%,PKP2
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.6708888731485937,1.035257661047414,0.5365853658536586,0.8973983898769927,1.0,1/5,11.85%,FOXP1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),-0.6655596831338841,-1.035149288193255,0.423728813559322,1.0,1.0,2/6,14.78%,ENPP2;VIL1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.4688082623186028,-1.0350740180801175,0.43037974683544306,1.0,1.0,5/38,7.73%,ROMO1;STK17A;ALOX5;AGT;NOXA1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.399768451733353,1.0348174677373072,0.36,0.897870547443545,1.0,19/63,16.32%,CALCRL;CD247;CALCB;FER;MYH9;GNG2;NMI;VIPR2;ILRUN;TRAF3IP1;ADCY6;MAPK14;PCBP2;PRKACB;ADCYAP1R1;RXFP1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5546292971658943,-1.0345414825642796,0.4142857142857143,1.0,1.0,4/16,11.71%,TGFB1;CEMIP;CALM1;WNK3
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),-0.4990753415312219,-1.0344485626207742,0.46835443037974683,1.0,1.0,3/19,4.27%,H2AZ1;SFRP1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),-0.5936129743262536,-1.0344217201578643,0.4594594594594595,1.0,1.0,3/10,22.00%,GRN;ELAPOR1;PIP4K2C
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),-0.6963791475903961,-1.0343315450334583,0.5238095238095238,1.0,1.0,3/5,20.83%,TMSB15B;GSN;TMSB10
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.6031114360280734,-1.034207189344315,0.44285714285714284,1.0,1.0,4/9,23.44%,ANGPTL4;APOE;IL18;MTLN
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6286657877229216,-1.0340617408009904,0.453125,1.0,1.0,2/7,6.24%,TRIM25;OAS3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.5846884253744494,1.034028836313019,0.3870967741935484,0.8994848857410108,1.0,1/10,0.09%,PKP2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.5402143391430265,1.0339041557561008,0.38461538461538464,0.8989370532876455,1.0,6/12,29.45%,UBA1;SENP6;DESI2;UBA2;NAE1;UBA6
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.4617523688041117,1.0338803721670666,0.34782608695652173,0.8980621927766748,1.0,8/25,13.96%,GABRG1;INSYN1;GRID2;GLRA1;LRRK2;GRIN2B;GABRA1;GABRG3
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.32565677040191154,1.0338312144129784,0.4,0.8972828202406229,1.0,36/135,14.90%,RIT2;SHANK2;PPM1E;ADGRB3;ASTN1;GPSM1;PKP4;CADM2;CNTNAP2;PCP4;LRRC3B;NRXN1;SLC8A2;GRID2;LRRTM3;NXPH1;SLC24A3;CLVS2;GNG4;SEZ6L;ADGRA1;CA10;PDE1A;CTNNA2;VSTM2B;GRIA3;TSHZ1;GRIK3;PRKG1;ADCYAP1R1;GABRA1;DLGAP1;TTBK1;KCNQ2;CACNG2;CTNND2
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.5799104541952607,-1.0333727626849714,0.4305555555555556,1.0,1.0,2/10,4.94%,VDAC2;BLOC1S2
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),-0.589770110622248,-1.0333465066089396,0.5,1.0,1.0,2/11,3.15%,PDXDC1;ENPP2
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.4558511503521816,-1.033150906312659,0.45555555555555555,1.0,1.0,21/68,27.35%,PSMB9;DVL1;PSMB8;AP2A1;PSMA3;DAAM1;DVL2;PSMA7;PSME1;AP2A2;SAPCD2;PSMB6;CELSR2;DVL3;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;AP2S1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),-0.4547229708874798,-1.0330446501659198,0.4588235294117647,1.0,1.0,8/63,10.05%,VEGFA;FGF1;ENPP2;RAB11A;AGT;HDAC6;PIK3CB;GRN
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.6384621743744627,-1.0324428671859327,0.49295774647887325,1.0,1.0,5/8,29.96%,WIZ;DBF4B;DBF4;CDC7;SSBP1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4133986388732812,1.0323245728204482,0.35,0.9003725421765876,1.0,8/24,11.84%,ITPR2;SLC8A2;CACNA2D1;PKD2;PTPRC;ATP2B4;SLC8A1;GRIN2B
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6125435585764487,-1.0322627657631205,0.5072463768115942,1.0,1.0,3/9,12.72%,RPS21;KRI1;NOP14
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.5431803788563312,-1.0321585953468597,0.44871794871794873,1.0,1.0,3/23,5.58%,SLC9B1;CFTR;SLC4A3
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.6376381586510509,1.031432878617812,0.4444444444444444,0.9015241144606398,1.0,2/6,10.89%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.48442668084572144,-1.0311313371085495,0.45121951219512196,1.0,1.0,13/48,22.09%,ARG2;SELENOS;CLU;RASGRP1;OAS3;OAS1;SYT11;CACTIN;IFIH1;RARA;GSTP1;C1QTNF4;SPHK2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6714111254059836,-1.0308779995255122,0.5333333333333333,1.0,1.0,2/5,28.32%,HMGCLL1;HMGCL
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),-0.508682866173945,-1.0307803547618535,0.43548387096774194,1.0,1.0,5/21,16.51%,HES5;HES1;OCIAD2;CRLF3;CAV1
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.5858350111716617,-1.0300418538963163,0.4305555555555556,1.0,1.0,3/10,20.77%,AKAP5;PHPT1;MTRR
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),0.5206235638086535,1.0299782201345475,0.3939393939393939,0.9046497020553358,1.0,6/11,19.92%,IWS1;NUP93;NXF1;THOC2;PCID2;POLDIP3
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.47295413652025725,-1.0299731693942402,0.4069767441860465,1.0,1.0,12/53,18.26%,DDRGK1;RPS27A;RETREG1;CFTR;HDAC6;PJVK;ATG14;DYNC1LI2;UBA52;ULK1;UFC1;UBC
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.3549071622659567,1.0297180703887825,0.42857142857142855,0.9044108439741068,1.0,23/106,13.82%,TCF7L1;ESR1;KAT2B;ZBTB1;HDAC10;PADI2;SATB2;HP1BP3;ARID1A;SUV39H2;SIRT1;HDAC11;SMARCA2;BAZ2B;SMARCAD1;RSF1;BAZ1B;KAT2A;HDAC4;CHRAC1;KDM5A;SETD2;PRDM16
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.4914992769924531,-1.0292658795065865,0.4642857142857143,1.0,1.0,14/46,28.34%,PSMB9;PSMB8;PSMA3;PSMA7;PSME1;PSMB6;RBX1;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.6015828678605226,1.029235461277276,0.48717948717948717,0.9044054310259477,1.0,2/7,7.56%,LEPR;SGIP1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.4348034245246639,-1.029210964379654,0.4666666666666667,1.0,1.0,33/137,23.10%,MX1;HAP1;COX7A2;TFAM;HAX1;SLC25A6;SLIRP;CHCHD2;TIMM8B;TIMM44;HIGD1C;TOMM7;CHCHD10;TYMP;SUPV3L1;IFIT2;DNM2;SPG7;MTFR1L;AIFM1;BAX;DNM1L;MGME1;HSPD1;AFG3L2;TOMM20;PARK7;TOMM40;AIP;HSD17B10;ATAD3B;BNIP3;YME1L1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),-0.5487544196896867,-1.0290295433810352,0.5142857142857142,1.0,1.0,8/20,18.69%,RPS27A;RFC2;RPA3;UBA52;RFC4;RFC1;UBC;RFC3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.5475380245824376,-1.0287623047272003,0.4533333333333333,1.0,1.0,1/18,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),0.5727829721406501,1.0286897623090823,0.48717948717948717,0.9051136700378958,1.0,2/6,36.92%,TASOR;INPP5K
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),-0.685185719869268,-1.02819447766274,0.47761194029850745,1.0,1.0,2/6,17.21%,SHMT1;PAICS
prerank,MSigDB_Hallmark_2020__Apical Surface,0.4075879368669329,1.0280498378128051,0.3684210526315789,0.9059909209794815,1.0,9/31,12.02%,SHROOM2;ADAM10;ADIPOR2;AFAP1L2;PLAUR;MDGA1;HSPB1;FLOT2;AKAP7
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.51866138837482,-1.0279380687658062,0.45454545454545453,1.0,1.0,3/25,6.41%,EMD;SFRP1;HDAC6
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),0.6225270859433494,1.027764350920705,0.48484848484848486,0.9055349180965658,1.0,4/6,37.08%,HACL1;PHYH;SLC25A17;ALDH3A2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),-0.6648877974809662,-1.027678135007271,0.5238095238095238,1.0,1.0,1/7,5.52%,CTSZ
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.4998744501089787,-1.027658281552247,0.4878048780487805,1.0,1.0,7/37,13.94%,ITGA4;LAT2;AKAP17A;RASGRP1;MEF2C;BLNK;SLC25A5
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),-0.44211539157362345,-1.0274688795080253,0.4523809523809524,1.0,1.0,16/78,21.46%,CDC37;CAMK1;CDKN2C;TRIB1;CCNI2;MTCP1;CDK7;CALM1;MAP2K1;CNPPD1;TRIB3;CCNK;TELO2;HERC5;THY1;BCCIP
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5350258141274079,-1.0267842604724562,0.43661971830985913,1.0,1.0,4/18,20.72%,VAV3;MEF2C;IL7;GPR183
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.47759816168913316,1.0267821732008338,0.3181818181818182,0.9069666960344966,1.0,5/13,22.95%,NUP98;NUP93;SEH1L;NUP35;NUP54
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.6834165001808372,-1.0265431053067944,0.45901639344262296,1.0,1.0,1/5,0.66%,VEGFA
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.6048593628778507,1.0264578559192432,0.48,0.9067269267723482,1.0,3/9,22.21%,CBLB;SOCS4;ERRFI1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),-0.6542146743056579,-1.0262816025839827,0.48333333333333334,1.0,1.0,3/6,14.67%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),-0.5544725771000855,-1.0261452248816645,0.5,1.0,1.0,5/18,15.58%,RANGRF;SLC4A3;SLC30A4;WNK3;RHCG
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6367655305603453,1.025995921863106,0.5384615384615384,0.9069661067057109,1.0,1/5,4.79%,SLC44A1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6022025159935042,-1.0256115896524933,0.5142857142857142,1.0,1.0,2/9,11.56%,PDHB;PPCS
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.524615338161921,1.0253502760445408,0.43333333333333335,0.907821521076111,1.0,6/10,23.31%,MAPK1;MAPK3;LRRK2;MAP2K2;DNAJC13;USP7
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.5493536802238728,-1.0249922421877826,0.5072463768115942,1.0,1.0,4/18,10.92%,SFRP1;OVOL2;EFNA1;FUZ
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),-0.5700772878157985,-1.0248357657427942,0.5070422535211268,1.0,1.0,1/12,2.98%,CREB3
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.6560670227468117,-1.0245904662320604,0.5657894736842105,1.0,1.0,3/7,20.33%,WIZ;DBF4B;DBF4
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.4596102217777674,-1.024304383523086,0.4186046511627907,1.0,1.0,5/60,7.89%,POLR2I;POLR2G;TGFB1;DND1;NUP155
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.6715243794658495,-1.0239730793690995,0.5084745762711864,1.0,1.0,2/5,20.17%,APOE;ABCA1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),-0.5877700880152568,-1.0238462605305036,0.5074626865671642,1.0,1.0,2/10,7.92%,TRIB1;MEF2C
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.5598817977699064,1.0234348951192012,0.3783783783783784,0.911832652418431,1.0,4/10,19.53%,PDE4D;ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5389062532953135,-1.023385393886909,0.48717948717948717,1.0,1.0,6/22,25.39%,EFNA1;RHBDF1;APOE;PSME1;PRKACA;ATP5IF1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),-0.5165357744387952,-1.023084422963722,0.4691358024691358,1.0,1.0,5/26,13.40%,ENTPD7;SIDT2;NCBP1;SUPV3L1;RNASEH2C
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),-0.43466962315909935,-1.0230107399102633,0.43820224719101125,1.0,1.0,20/86,18.96%,DDRGK1;SELENOK;FLOT1;CFTR;JUN;RASGRF2;SELENOS;SCAMP5;ATF4;DNAJC10;SYVN1;ERLEC1;TRIB3;CCDC47;AIFM1;BAX;USP19;UFC1;WFS1;BAG6
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),-0.5128971426496731,-1.0229122871152836,0.4117647058823529,1.0,1.0,7/24,20.26%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A;HSP90AB1;PDGFRB
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.54794966895061,1.0227171415241176,0.5,0.9127120868475374,1.0,3/9,14.17%,FAM107A;BCL2L11;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.4329044382971974,-1.0225374384560222,0.4731182795698925,1.0,1.0,14/116,16.82%,PSMB9;EMD;SFRP1;DVL1;PSMB8;TLE6;SFRP4;PSMA3;FUZ;DVL2;APOE;PSMA7;CAV1;PSME1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),0.6411966674360284,1.022517212926438,0.5,0.9112717145003775,1.0,1/7,8.94%,ADCY6
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),0.6411966674360284,1.022517212926438,0.5,0.9112717145003775,1.0,1/7,8.94%,ADCY6
prerank,MSigDB_Hallmark_2020__UV Response Up,-0.4351279540473298,-1.0218369970399306,0.36666666666666664,1.0,1.0,26/117,17.76%,HLA-F;PPIF;PARP2;CDKN1C;TUBA4A;IRF1;RASGRP1;OLFM1;POLE3;GGH;WIZ;CCK;PPAT;BTG1;SELENOW;ATP6V1F;TAP1;JUNB;CLTB;UROD;RFC4;HSPA13;H2AX;FOS;CYB5R1;CASP3
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),-0.626058234681855,-1.0217044844363965,0.4426229508196721,1.0,1.0,2/8,14.87%,RAB11A;STX1B
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.49564941994734096,-1.0216631844374413,0.4430379746835443,1.0,1.0,13/38,19.44%,FANCB;RPS27A;FANCI;CENPX;RNF8;FAN1;RPA3;FANCC;UBA52;UBC;XPA;ATRIP;MSH6
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.5230081230461927,-1.021112530982526,0.4520547945205479,1.0,1.0,3/25,6.88%,NCAPD3;H1-4;TTN
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.649380101918273,-1.0210735184997404,0.5362318840579711,1.0,1.0,1/7,5.95%,RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.6328155103847974,-1.020819543652585,0.5084745762711864,1.0,1.0,1/5,6.03%,EFNA1
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.561748659711359,1.0206193282690461,0.375,0.9148794107206806,1.0,4/10,11.52%,CD247;CD96;PTPRC;GPR174
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.6411117901832516,-1.0206003308300688,0.5294117647058824,1.0,1.0,3/5,28.92%,BEND3;KMT5C;SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.6411117901832516,-1.0206003308300688,0.5294117647058824,1.0,1.0,3/5,28.92%,BEND3;KMT5C;SMYD5
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.4736038112260033,1.0205767337189948,0.3953488372093023,0.9140358926472445,1.0,4/13,15.01%,PPP2R2C;PPP3CA;PPM1F;PPP2R2B
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.5591351408472506,1.0204153404571055,0.5,0.9135155641634886,1.0,3/6,31.40%,HEXB;NEU1;NEU3
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.34061689341904794,1.0203466879799807,0.3333333333333333,0.9127516207449377,1.0,19/129,10.97%,GABRG1;SYNDIG1;RGS7BP;ADGRB3;ASTN1;CADM2;LRRC3B;NRXN1;CDH20;SLIT1;FAM107A;SRR;SLC16A2;LRRTM3;SLC1A2;ADGRA1;CA10;VSTM2B;GRIA3
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),-0.6067979181071578,-1.020183468592807,0.53125,1.0,1.0,1/9,0.66%,VEGFA
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.6066708252600361,-1.0198878163554275,0.44594594594594594,1.0,1.0,2/8,20.10%,CD46;FBN2
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),-0.6232416013709516,-1.0198742516936143,0.5538461538461539,1.0,1.0,2/8,9.29%,P4HA3;P4HTM
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.509457145686583,1.0198321931056054,0.34375,0.9131808184482397,1.0,5/11,20.83%,PICALM;CHRNA7;FLOT2;ABCA2;RANBP9
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.5836533994484638,1.0197637906312658,0.47619047619047616,0.9123424660210012,1.0,2/9,5.46%,FLRT2;NTNG2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.5577579741692746,1.0197186401108926,0.4375,0.9115363105586537,1.0,3/7,11.23%,NEDD4L;WNK1;NEDD4
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.4384133919024592,1.0192799994516517,0.42857142857142855,0.9115085306629478,1.0,10/26,19.61%,INAVA;FER;SRR;ERBIN;FOXP1;TAB2;ADAM17;NOS1;SNCA;RPS6KA3
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.520897573917457,1.0189733388864954,0.43902439024390244,0.9113286604135612,1.0,4/10,25.09%,ACVR1;BMPR1A;MDM4;NOTCH1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.6285172470686251,1.0184994239465581,0.5277777777777778,0.9106663364347098,1.0,4/7,10.46%,ABL1;MAPK1;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.6285172470686251,1.0184994239465581,0.5277777777777778,0.9106663364347098,1.0,4/7,10.46%,ABL1;MAPK1;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.6220048296934082,1.0184626939537658,0.475,0.9099114626265609,1.0,1/5,8.13%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.46451806229081705,-1.0184497552209744,0.4177215189873418,1.0,1.0,6/57,7.67%,PPIF;SCG2;NOL3;CLU;RTKN2;PRELID1
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.5822930464943905,-1.01818275827036,0.44776119402985076,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.46925833907391423,1.0181728907173033,0.40625,0.909673322130225,1.0,4/18,5.15%,RXRA;NR1H2;SIRT1;PPARG
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,-0.4903257447434216,-1.0181139781373847,0.4444444444444444,1.0,1.0,17/61,19.95%,ERCC6L;FANCI;PRMT8;ATAD5;CENPH;PPAT;BEND3;RFC4;NCL;NUP107;PIF1;PAICS;RFC3;TRIM32;MSH6;KNTC1;SET
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5943464102273164,-1.0179717487153224,0.5362318840579711,1.0,1.0,6/10,31.89%,ENTPD7;SMPDL3A;ENTPD5;ENTPD3;ENPP1;ENTPD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.6596402269299901,-1.0177148851350324,0.4915254237288136,1.0,1.0,2/6,19.82%,PRKCQ;RARA
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.5524539900908738,-1.0174242035848373,0.41333333333333333,1.0,1.0,2/20,2.06%,HLA-F;SP140
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.5873701606405982,-1.017347587565307,0.5,1.0,1.0,5/10,22.15%,NR4A3;RACK1;TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.36793583939310215,1.017329113486062,0.5,0.9105710002876707,1.0,18/53,17.74%,MAPK1;CDC42BPA;OXSR1;TGFBR2;TNKS;GALNT16;LRRK2;WNK1;GALNT13;PRKD1;LMTK2;ACVR1;MAPK8;TTBK1;PRKCA;NLK;GALNT11;ACVR1B
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.5373955364537333,-1.0168040939169196,0.49382716049382713,1.0,1.0,2/22,2.69%,PPIF;PPIB
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.5723418934705353,1.0164114704697913,0.5227272727272727,0.9119507886669312,1.0,2/6,11.53%,NLGN1;LHFPL4
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),0.5599329369297963,1.0163714625304712,0.43243243243243246,0.9112127712083963,1.0,3/7,38.68%,TASOR;INPP5K;TOP2B
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.42442517500865473,1.0161125378003828,0.39285714285714285,0.9109742795070287,1.0,3/26,5.68%,DOCK5;ABL1;RAC3
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),-0.5281337948972655,-1.0151029735741743,0.5,1.0,1.0,5/20,16.82%,EFNA1;PRELID1;APH1A;USP50;PSME1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",-0.6385574581882989,-1.0148222500592379,0.5,1.0,1.0,1/6,3.62%,RAB11A
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.577323879146785,1.014749953503571,0.4722222222222222,0.9138119588016421,1.0,2/7,14.79%,BCAR1;MCU
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.5758102650892785,-1.014438141278071,0.47297297297297297,1.0,1.0,2/18,5.58%,SLC9B1;SLC4A3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.5033725860249181,1.0143136584605386,0.39285714285714285,0.9138273842306194,1.0,3/13,9.41%,PPARG;ZBTB20;EEF1A2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.6005915391467791,-1.0141869945304496,0.48717948717948717,1.0,1.0,3/10,14.32%,PARP14;PARP9;PARP4
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.5342228809071501,-1.013731720786974,0.4444444444444444,1.0,1.0,4/19,11.54%,DVL1;AGRN;CACNB1;DCTN1
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.624447500995658,1.013711196661504,0.46511627906976744,0.9143092245988126,1.0,1/5,8.70%,ADIPOR2
prerank,GO_Biological_Process_2021__protein localization to membrane raft (GO:1903044),-0.6962072994315758,-1.0134537366834877,0.5192307692307693,1.0,1.0,3/5,19.16%,FLOT1;CAV1;RFTN1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.5836550044603762,1.0132587498389185,0.5,0.9147900983865279,1.0,2/5,11.09%,SIRT1;AUTS2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.634614571351053,-1.013120111132793,0.53125,1.0,1.0,1/6,0.66%,VEGFA
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.4967305228551123,-1.0130102898377367,0.425,1.0,1.0,8/28,24.27%,PPIF;SPG7;SLC25A5;HSPA9;MICOS13;RCC1L;BNIP3;GHITM
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),-0.6403247640387023,-1.0130070892942902,0.5396825396825397,1.0,1.0,3/8,17.37%,PRPSAP1;PPAT;MTHFD1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.5725413702580214,1.0127832855747474,0.46875,0.9150747941449926,1.0,6/10,18.09%,MAGI2;SMAD7;ACVR1;IGSF1;ACVR1B;LEMD3
prerank,MSigDB_Hallmark_2020__Adipogenesis,-0.4178206669795231,-1.012402057217382,0.43157894736842106,1.0,1.0,40/163,22.16%,UQCRQ;ANGPTL4;ENPP2;SSPN;CDKN2C;UQCR10;RMDN3;GPX4;STAT5A;EPHX2;COL4A1;CHCHD10;COL15A1;ACO2;OMD;LPCAT3;STOM;CYC1;COX7B;SLC66A3;APOE;C3;CD302;MYLK;AIFM1;CRAT;ACADL;NDUFB7;APLP2;COQ3;PEX14;UBC;DGAT1;JAGN1;ABCA1;CMBL;GBE1;PTCD3;ARAF;MTCH2
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.3831042324615943,1.0123745212469737,0.42857142857142855,0.9154639301428964,1.0,9/40,9.05%,RAB27A;SEPTIN4;SYTL4;STXBP5;IL1RAPL1;RAB27B;RAB9A;NSF;RAB10
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.6416953184262707,-1.0123453475767343,0.5178571428571429,1.0,1.0,2/6,11.57%,ATG14;CALM1
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),-0.618045419673686,-1.0121931886308442,0.5671641791044776,1.0,1.0,2/6,10.61%,VEGFA;SLC22A4
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,-0.4570869083838831,-1.0121755595000759,0.42528735632183906,1.0,1.0,19/66,22.86%,ECM2;CRYAB;ASPN;SFRP4;PAMR1;COL4A1;LMOD1;COL15A1;ACTA2;ADAMTS2;MYLK;COL4A2;COL14A1;CALD1;THBS2;PDGFRB;THY1;RHOJ;C1S
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.5801953969538592,-1.012040325534022,0.5074626865671642,1.0,1.0,4/11,21.98%,ALOX12;CEACAM1;PRKCQ;CD9
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.415778380377381,1.0119467736571655,0.3939393939393939,0.9156125045757376,1.0,12/24,25.09%,DCX;NAV1;NCKAP5;TTLL3;CLASP1;SPAG16;ZNF207;TOGARAM1;CHP1;PSRC1;AAAS;GAS2L1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.4235162626568493,-1.0115488063844602,0.5111111111111111,1.0,1.0,23/106,17.42%,VEGFA;FGF1;SFRP1;ANGPTL4;SPINK5;ALOX5;XBP1;CEACAM1;PGK1;GLUL;NAXE;CD160;GRN;BTG1;EMP2;CNMD;WARS1;SARS1;RNH1;COL4A2;STAT1;BRCA1;EMC10
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),-0.5379313343054324,-1.0114683451470337,0.4782608695652174,1.0,1.0,1/16,1.43%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.6701971431754656,-1.0114205872625237,0.5915492957746479,1.0,1.0,4/6,27.91%,WIZ;DBF4B;DBF4;CDC7
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.496400562490242,-1.0106076921458336,0.43661971830985913,1.0,1.0,4/22,10.05%,POLR3D;IFI35;PLSCR1;GRN
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.5601132528882591,1.0106001012738117,0.5,0.9176771321511054,1.0,3/11,10.53%,ILRUN;TRAF3IP1;PCBP2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.569840296476595,-1.010414152611017,0.4838709677419355,1.0,1.0,2/10,15.87%,FN1;CD46
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.5275183438922948,1.0102986145084303,0.4782608695652174,0.9174642442182039,1.0,6/13,11.52%,CD247;CD96;BCL11B;PTPRC;RORA;GPR174
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.4686122371488093,1.0102418174624566,0.375,0.9167736485980962,1.0,3/11,13.96%,AK3;CMPK1;PNP
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5629953272009084,-1.0101647727164813,0.4117647058823529,1.0,1.0,1/13,0.27%,IFI6
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5629953272009084,-1.0101647727164813,0.4117647058823529,1.0,1.0,1/13,0.27%,IFI6
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.4980820833986896,1.0101315952144276,0.45,0.9161142821641175,1.0,8/21,14.17%,CD247;CD96;PPARG;PTPRC;RORA;KLRD1;GPR174;NR3C1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.46928876346375176,1.0096599481073814,0.4090909090909091,0.916574620127272,1.0,5/16,10.21%,GPD1L;PDE4D;DMD;SMAD7;PPM1F
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.38336504944834865,1.0096292839870815,0.34782608695652173,0.9157231004484842,1.0,12/48,16.66%,ITPR2;ANK2;PDE4D;SLC8A2;SMAD7;ATP2B4;STIM1;SLC8A1;KCNIP2;DMPK;NOS1;TMEM65
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),-0.5827444675929103,-1.0094833303655057,0.55,1.0,1.0,1/8,6.37%,GLRX
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),-0.5074266226440037,-1.0093796159722264,0.4125,1.0,1.0,8/22,18.50%,NOP10;GAR1;RFC1;HSP90AB1;DKC1;TERF2IP;PIF1;TELO2
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3253965215454123,1.0093548376231911,0.3333333333333333,0.9153495049260928,1.0,71/297,18.40%,DGKB;DAPK2;FAM20B;MAP3K5;ADAM10;PEAK1;RYK;STK36;SGK1;ABL1;GRK5;MAP3K9;FGGY;CTBP1;LIMD1;FER;MAPK1;TNK2;MAP4K2;PRKG2;CDC42BPA;MAP3K11;CDK12;OXSR1;BMP2K;GRK6;MAPK10;MERTK;SIK3;TGFBR2;MAP3K1;POMK;MAPK3;LRRK2;DGKQ;AATK;WNK1;CSNK1E;PIK3CA;PRKACB;CDK14;PRKG1;MAP4K4;LATS1;TBCK;PRKD1;LMTK2;ACVR1;CDK18;MAPK8;SRPK2;TTBK1;STK24;DMPK;LMTK3;ACVR1C;FYN;BMPR1B;PRKCA;PINK1;NLK;PRKCE;CSK;DGKG;CDKL5;ACVR1B;MAML1;PXK;DGKE;BRAF;BMPR1A
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.5046041105692537,-1.009227633025912,0.4492753623188406,1.0,1.0,4/22,25.59%,HDAC6;BAG6;YME1L1;STUB1
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.5967127281350606,-1.0090851895959045,0.453125,1.0,1.0,3/8,14.73%,ZFPM1;ATF4;THOC5
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),-0.5391788147223193,-1.0090182962660807,0.5066666666666667,1.0,1.0,2/11,17.56%,CHMP4B;MITD1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.5797115871997977,-1.0087845342182509,0.4864864864864865,1.0,1.0,5/14,20.55%,TGFB1;ATF4;C3;BRCA1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.5276653469288002,-1.0087398602451103,0.5066666666666667,1.0,1.0,4/23,6.04%,FGF1;ECT2;HTR2B;KIF20B
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5107907210412705,-1.0085156252359115,0.5189873417721519,1.0,1.0,7/28,20.69%,ISG15;TRIM25;NLRC5;CACTIN;UBE2L6;IFIH1;HERC5
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.5126169700689063,-1.0084494987591328,0.4533333333333333,1.0,1.0,4/22,21.07%,HACD4;ELOVL2;ACOT2;ACSBG1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.5741582791497475,-1.0082094361294367,0.5151515151515151,1.0,1.0,3/10,28.02%,NCBP1;DHX36;NCBP2
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),-0.6057264230627502,-1.0081105076180608,0.45161290322580644,1.0,1.0,1/9,3.97%,CFTR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),-0.6057264230627502,-1.0081105076180608,0.45161290322580644,1.0,1.0,1/9,3.97%,CFTR
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.3895755411349587,1.008043610703714,0.4375,0.9174149232380069,1.0,12/45,20.04%,LRRC4C;ROBO1;PLXNA1;PLXNA3;KIF13B;TIAM2;ROBO2;SIPA1L1;CDH2;PLXNC1;SLIT2;PLXNA2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4316751495200053,1.007781624081117,0.5263157894736842,0.9172334776599883,1.0,3/23,3.79%,MAP2;CAMSAP2;ABL1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),-0.5126284520892419,-1.0076186188894694,0.45,1.0,1.0,8/21,18.50%,NOP10;GAR1;RFC1;HSP90AB1;DKC1;TERF2IP;PIF1;TELO2
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.5755679719366946,-1.0075691758178094,0.47297297297297297,1.0,1.0,2/10,11.58%,FGF1;P2RX4
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6086604665400587,1.0072977012303832,0.4,0.9177497809082469,1.0,2/7,11.88%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.3452055811358022,1.0071787201262943,0.5,0.917049544113514,1.0,14/76,12.38%,HDAC9;IRS1;KAT2B;PPARG;FER;RPS6KB1;C2CD5;RAB31;FOXO1;ADCY6;RAB10;CPEB2;PRKACB;MYO5A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.45585686935326997,1.00717130500346,0.5,0.9161729861762807,1.0,5/24,8.14%,ESR1;SIRT1;PPM1A;TLE1;RORA
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.6825322655980771,-1.0071196143408006,0.5263157894736842,1.0,1.0,1/5,3.56%,CAMK1
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.47922132161636843,1.0070479309207407,0.37037037037037035,0.9154017177815855,1.0,3/13,12.66%,PLIN5;CDS1;CDS2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.4814101718819205,-1.006591062592549,0.4691358024691358,1.0,1.0,7/43,15.81%,DENND3;CTSL;CTSZ;AP2A1;CLTA;ADAMTS7;MYLIP
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.3320517774671559,1.0064536561914026,0.46153846153846156,0.9155039636176334,1.0,15/63,15.27%,MMP16;TSPAN17;ADAM10;PHEX;TSPAN15;DNAJB11;NAA50;ADAM19;TSPAN5;NAA11;NFU1;TSPAN14;ADAM17;NAA16;GLRX3
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),-0.6271963176597821,-1.0062362455739644,0.5333333333333333,1.0,1.0,1/7,3.96%,PLSCR1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.4403544347177938,-1.0061592571144402,0.5227272727272727,1.0,1.0,5/81,6.71%,APIP;B2M;ECT2;PRMT8;POLQ
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),-0.6125636102982004,-1.0060510722595422,0.5588235294117647,1.0,1.0,2/9,6.88%,OBSL1;TTN
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.4269154966014713,1.005956374089362,0.38461538461538464,0.9159160725871572,1.0,2/23,7.05%,USP51;POT1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.5606402560438006,1.0058684032586316,0.38461538461538464,0.9151915857733905,1.0,6/8,31.92%,LATS1;WWC2;WWC1;DUSP6;DUSP9;PTEN
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5523005767729627,1.0058337590174857,0.42857142857142855,0.9144685237124531,1.0,1/9,2.81%,FYCO1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.5121107127159682,-1.0058179994104548,0.4605263157894737,1.0,1.0,5/20,18.09%,MX1;DNM2;MTFR1L;PEX11B;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.666569964631476,1.0055220704605352,0.5476190476190477,0.914276855102913,1.0,4/5,33.35%,BICD1;APC;CEP250;MARK4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.5675975902037637,-1.0053510608713367,0.5394736842105263,1.0,1.0,1/8,4.75%,ALOX5
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.4562423467560541,1.0050872721812347,0.4642857142857143,0.9142914609964665,1.0,1/20,0.09%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.48396173077221605,-1.0049803504695705,0.4810126582278481,1.0,1.0,5/43,11.37%,ECM2;SFRP1;S100A10;FN1;EMP2
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.6716154520474082,-1.0048382288202906,0.47619047619047616,1.0,1.0,1/5,2.57%,SFRP1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.5461346079651193,1.0047567851000703,0.5428571428571428,0.9142913456472713,1.0,4/7,15.38%,CSGALNACT1;EXT2;EXT1;HS2ST1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.30779200440689697,1.0047397877165691,0.42857142857142855,0.9134545723638428,1.0,57/321,12.55%,TP63;HDAC9;DPF1;NR1H2;NPAS1;HDAC10;SALL1;ATF7IP;SP3;ZKSCAN3;CREB3L1;TSHZ3;SUV39H2;SIRT1;PTPRK;CTBP1;MBD2;PPARG;BTRC;LIMD1;ZHX2;KCTD1;TLE1;PSPC1;PLCB1;FOXK1;MTERF3;RFX3;RUNX1T1;YAF2;PHC2;SMARCA2;ATXN1;EED;FOXO1;TRERF1;BMP7;PRDM11;RSF1;PML;FBXW11;KAT8;ATOH8;MECP2;ZNF282;ZNF93;RBM15B;PPM1F;TRIM28;HDAC4;SOX8;FOXP1;ZBTB16;NKRF;PROX1;GLIS2;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.4921329134800178,1.0047199312296073,0.3333333333333333,0.9117419850073966,1.0,3/6,16.74%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.4921329134800178,1.0047199312296073,0.3333333333333333,0.9117419850073966,1.0,3/6,16.74%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),0.6042999400349818,1.00466165977204,0.4473684210526316,0.9110857753472985,1.0,2/5,20.14%,FAM91A1;TBC1D23
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.519589419414241,-1.004619802037301,0.5,1.0,1.0,4/16,11.57%,HAP1;CEMIP;GSTO1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.5186431597574918,-1.0045678348840161,0.44776119402985076,1.0,1.0,7/20,20.87%,RBM3;CELF4;NCBP1;NCL;SNW1;CIRBP;DHX36
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5660872232666554,1.004565212171049,0.4722222222222222,0.9103284995687647,1.0,3/7,25.09%,TGFBR2;RBPJ;NOTCH1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5005080414928306,-1.0044083693865933,0.47435897435897434,1.0,1.0,3/31,4.27%,HES1;JUN;TGFB1
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.5702530155143176,-1.0041063080882155,0.4714285714285714,1.0,1.0,1/14,3.65%,POLR2G
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.5316339581638758,-1.003665067227168,0.4714285714285714,1.0,1.0,4/21,17.07%,SFRP1;TMBIM1;RFFL;BRCA1
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.4768851619207801,1.0036399139929333,0.42424242424242425,0.9117344889095537,1.0,3/10,25.21%,HEXB;ABCA2;NEU1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),-0.6342601850488144,-1.0035701641254944,0.5409836065573771,1.0,1.0,5/6,32.46%,PRELID1;BAX;BNIP3;ARL6IP5;HEBP2
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.48329597304441657,1.003565635526301,0.4666666666666667,0.9111385732595284,1.0,5/15,16.41%,PKD2;GRIN2B;CPSF6;KCNC2;GRIN1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5696854216469459,-1.003254568945386,0.45588235294117646,1.0,1.0,3/13,18.09%,SLIRP;SUPV3L1;DNM1L
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.529261911998917,-1.0029524113647479,0.4666666666666667,1.0,1.0,3/15,14.39%,TGFB1;TMBIM1;PPP2R5A
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),0.5964210686969829,1.0028799937851862,0.48484848484848486,0.9121328477995011,1.0,2/5,18.96%,TRIM62;PRKN
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),-0.5488314786518765,-1.0028195001814997,0.463768115942029,1.0,1.0,3/16,7.50%,TGFB1;EFNA1;JAG1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5035528048393721,1.00229016004295,0.38461538461538464,0.9126300105349578,1.0,4/20,5.65%,PKP2;PDE4B;ANK2;PDE4D
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),0.3933917180921416,1.002244080242738,0.44,0.9118749115949722,1.0,1/27,0.32%,TAF1A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.584254987754648,-1.0019626143445488,0.4714285714285714,1.0,1.0,4/7,25.74%,HAX1;SREBF1;ATP5IF1;DNAJA1
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.5069214961135394,1.0018547462632859,0.47368421052631576,0.9119352847438463,1.0,5/10,29.90%,ACVR1;BMPR1A;MDM4;NOTCH1;SMAD2
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6463741908063863,-1.0016359291852264,0.5211267605633803,1.0,1.0,3/7,11.40%,SFRP1;PLEKHA4;WNT5B
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),0.6177594368352859,1.0015084159368939,0.475,0.9119664973714693,1.0,2/6,15.28%,PLIN5;ABHD5
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4540447839680818,-1.0011609312535263,0.5189873417721519,1.0,1.0,8/58,8.54%,VEGFA;FGF1;TGFB1;AGT;TRIB1;HTR2B;RASGRP1;PIK3CB
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.4638179909832385,1.000979914470205,0.3548387096774194,0.9124038652145925,1.0,2/26,0.80%,GSTT2;GSTM2
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),-0.6626022261387838,-1.0006632097619432,0.46551724137931033,1.0,1.0,1/5,14.47%,BEX4
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),-0.4755014154124506,-1.0004514530902415,0.4691358024691358,1.0,1.0,11/45,15.58%,VEGFA;GSTK1;SPINK5;OVOL2;KDM6B;JAG1;PGK1;VIL1;VDAC1;CBR1;RHCG
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.6069872144739914,-1.0004318912356072,0.5,1.0,1.0,2/7,14.68%,PPIB;APOE
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.5742444401672254,1.000246394417869,0.4523809523809524,0.9135360832932226,1.0,2/5,20.22%,BBS4;UBR3
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),-0.675295673716512,-1.0002327298885056,0.5625,1.0,1.0,1/5,6.88%,TTN
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),0.5856155086116155,1.0002276999123363,0.5757575757575758,0.9126679194019409,1.0,3/5,31.40%,HEXB;NEU1;NEU3
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.23850410959127782,1.0,1.0,0.912322196376666,1.0,215/1410,13.84%,MYRFL;ONECUT1;EBF1;TCF7L1;ZNF761;SOX11;ZNF358;TRPS1;POU6F2;TP63;ZNF280D;ZNF516;SMAD9;ZNF280B;HDAC9;CREM;CSRNP3;RYBP;ZNF189;ERBB4;MAP3K5;ESR1;ZBTB34;TCF12;RXRA;ZBTB1;DPF1;SIM2;ZNF536;NR1H2;NPAS1;HDAC10;SALL1;NFYC;GPBP1L1;TOX3;PBX3;SATB2;DMTF1;ATF7IP;NDP;ABL1;ZNF98;MED24;SP3;HP1BP3;ZXDB;MYCN;ETV3;LCOR;ZNF79;ZKSCAN3;ZNF354B;PBX1;PKNOX1;ARID1A;TCF4;ZBTB41;CREB3L1;TSHZ3;SUV39H2;ZNF2;BBX;TOX;SIRT1;PPM1A;CHD7;PTPRK;ESRRG;CTBP1;MBD2;ZNF283;KLF12;PPARG;PLAGL2;BTRC;LIMD1;TBL1XR1;VEZF1;ZHX2;KCTD1;BCL11B;APBB2;TLE1;MLLT3;SMAD7;TP53INP1;IKZF2;PSPC1;PLCB1;FOXK1;MED12L;CAMTA2;ZNF268;ZNF696;WNT7A;MTERF3;ZNF678;RFX3;ZBTB40;NCOA2;RUNX1T1;ZNF697;METTL4;YAF2;PICALM;PHC2;TGFBRAP1;ZEB2;PHF14;TRAK1;SMARCA2;ATXN1;AATF;KDM3B;BAZ2B;EED;MEIS1;FOXO1;EGFR;ARID1B;NPAS3;TRERF1;SOX5;RORA;ZBTB5;SNF8;NFIB;BMP7;NFATC1;ATP2B4;ZNF239;ZBTB20;ZBTB10;PRDM11;RSF1;PML;AFAP1L2;ZNF701;ZNF415;ZNF595;FBXW11;POFUT1;BAZ1B;KAT8;ATOH8;MAPK14;SUPT20H;MECP2;ZNF444;RFX7;CHD5;ZNF282;ZNF93;RBM15B;CBFB;BRWD3;PPM1F;MYRF;PHF20L1;TGFA;MITF;ZNF175;ZKSCAN7;DGKQ;ZNF699;ARID3A;KAT2A;ZNF250;TRIM28;HDAC4;SPIN1;TSHZ1;KLF7;HNRNPD;NFIA;SOX8;ZNF730;FOXP1;ZNF717;ZBTB16;CDK14;HMGB1;ZMIZ1;SLC39A8;ZNF433;NKRF;IRF2;PROX1;GLIS2;ZNF221;ERC1;ZFPM2;CAND2;PRRX1;ZNF266;ACVR1;SLTM;ST18;NAB1;KDM5A;JMJD1C;ZNF608;CDK18;LCORL;ZNF710;ETS2;NFATC3;MAP2K2;SOX10;RAI1;ELP3;PRDM16;SUB1;ZSCAN23
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5110490381973003,-0.9998877473925856,0.49382716049382713,1.0,1.0,3/25,7.92%,SFRP1;HTR2B;MEF2C
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.6056783820890632,0.9997521183996163,0.42857142857142855,0.9121794645061491,1.0,2/6,13.26%,SOX5;LTBP3
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.6476753503429967,-0.9994782473657279,0.5161290322580645,1.0,1.0,2/6,17.33%,APOE;PRKCQ
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.3952637378507487,0.9994205426380666,0.38095238095238093,0.9119648185553407,1.0,6/42,9.43%,DHCR7;RXRA;ACAA2;FDX1;STARD3;OSBPL5
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.5330959546276458,-0.9992419367905792,0.4444444444444444,1.0,1.0,6/15,16.19%,SLC6A6;SLC6A9;SLC22A4;SLC1A6;SLC3A2;SLC7A8
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.504747233116762,-0.9990240455145031,0.5308641975308642,1.0,1.0,9/24,18.50%,NOP10;ZBTB48;GAR1;RFC1;HSP90AB1;DKC1;TERF2IP;PIF1;TELO2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",-0.6656901769381334,-0.9986031918740914,0.5373134328358209,1.0,1.0,1/5,5.27%,PNRC2
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),-0.5111575399399781,-0.998577002166193,0.4520547945205479,1.0,1.0,3/19,7.50%,TGFB1;EFNA1;JAG1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.6326056748365049,-0.9984711603556012,0.5454545454545454,1.0,1.0,3/6,33.01%,SHANK1;LGMN;MAP1A
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),-0.5506438073326809,-0.9981449820992301,0.5652173913043478,1.0,1.0,5/11,21.58%,CAMK1;KAT5;TERF2IP;FAM161A;PARK7
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),-0.5780946394570403,-0.9978695912998076,0.5362318840579711,1.0,1.0,4/9,24.89%,ARG2;CYP1B1;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),-0.5780946394570403,-0.9978695912998076,0.5362318840579711,1.0,1.0,4/9,24.89%,ARG2;CYP1B1;NQO1;CYB5R3
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),-0.6059944503420314,-0.997561999730572,0.5079365079365079,1.0,1.0,4/9,15.87%,JAG1;CD55;BTN3A3;CD46
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.6013829254078029,-0.9970762660884026,0.5285714285714286,1.0,1.0,1/9,1.43%,RIMS1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.6608431192796381,-0.9970505984463588,0.5483870967741935,1.0,1.0,1/5,1.82%,NOP10
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5251433569124953,-0.9969600738214253,0.5,1.0,1.0,3/19,8.77%,PRMT8;FAM98B;SNRPB
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.3670377023247824,0.9968752431741719,0.3,0.9172461003793696,1.0,20/100,16.05%,SEMA3B;SHROOM2;BCAR1;NCS1;SALL1;MPDZ;CHST3;EGFR;GPC1;CMTM4;TNFRSF21;FARP1;KAZN;ALCAM;PTPRU;NAV2;EPB41L1;TEAD1;AMOTL2;FMNL2
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.34868711996178176,0.9964521788922833,0.5,0.9175889875370987,1.0,11/45,9.47%,KCND2;HP1BP3;SUV39H2;SIRT1;ACAA2;FMN2;EGLN3;LMNA;RORA;BMP7;CPEB2
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.53689985531859,0.9963096389451223,0.45454545454545453,0.9162017225430097,1.0,2/8,8.40%,PDE4B;ATP2B4
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.53689985531859,0.9963096389451223,0.45454545454545453,0.9162017225430097,1.0,2/8,8.40%,PDE4B;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),0.5790644741160331,0.9960439439836505,0.5365853658536586,0.9159698805384149,1.0,1/5,8.99%,BBS4
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),-0.606171080470828,-0.9960144347349759,0.5714285714285714,1.0,1.0,1/8,2.98%,CREB3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.4635352872593122,0.995453271316448,0.38235294117647056,0.9165567087115593,1.0,4/15,16.03%,RACGAP1;KAT2A;TRIP12;NIPBL
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3561645076111989,0.9953974884288236,0.3888888888888889,0.9158803964366521,1.0,13/70,11.31%,SEM1;RMI1;RPA1;RFWD3;RAD51B;RAD54B;RECQL5;SAMHD1;NSMCE2;SMC6;ERCC4;HELQ;UBE2N
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.6782228757723948,-0.9953859003620991,0.5645161290322581,1.0,1.0,2/5,14.53%,RACK1;ZNF598
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.597149191509085,-0.9953025367054931,0.5396825396825397,1.0,1.0,1/7,4.27%,TGFB1
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),-0.6077910444944266,-0.9952904158331497,0.5454545454545454,1.0,1.0,1/9,0.66%,VEGFA
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5296539718814426,-0.9951338566982533,0.49295774647887325,1.0,1.0,6/15,20.73%,RBM3;CELF4;NCBP1;NCL;SNW1;CIRBP
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.37955183111178287,0.9949187236598689,0.4166666666666667,0.9162942593688358,1.0,24/86,14.85%,FLRT2;NOVA2;RNF150;TACC2;ANK2;APBB2;MPDZ;CHST3;SLC16A2;RUNX1T1;GUCY1A2;NAV1;MAGI1;ZNF462;CACNA2D1;SLIT3;FBXL7;FARP1;ZNF532;NFASC;TENM3;PTPRG;NCKAP1;FIGN
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.3591911904395601,0.994544838129096,0.375,0.9163494889473605,1.0,4/31,10.25%,TAF1A;TCOF1;TAF1B;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.4528604407723259,0.994503798570962,0.42857142857142855,0.9156467103031359,1.0,7/20,18.57%,NAV3;CAMSAP2;PIK3CA;CLASP1;HDGFL3;ATXN7;CLASP2
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.6098989689890156,-0.9942896065220441,0.4583333333333333,1.0,1.0,1/7,7.50%,JAG1
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.5930773735219494,-0.994179645838873,0.5714285714285714,1.0,1.0,5/11,24.29%,CEACAM1;CD160;PHPT1;THY1;PTPN2
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,-0.4609657378669615,-0.9941070792860898,0.5294117647058824,1.0,1.0,12/46,26.05%,COL4A1;LMOD1;COL6A1;SRPX;ACTA2;ADAMTS2;COL4A2;CALD1;PDGFRB;PLAT;TIMP3;LIMS2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.6373937044814951,-0.993895281075638,0.6307692307692307,1.0,1.0,2/8,9.73%,ITGA4;CD160
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,-0.5557465337593738,-0.9934433161799178,0.532258064516129,1.0,1.0,8/11,22.61%,PTGR1;ABCC3;GPR39;SLC44A3;CLDN18;ATP8B1;BTC;LIPH
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.5671399532683936,-0.9933718613521797,0.5285714285714286,1.0,1.0,3/19,8.80%,ETV4;CTSL;MED1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.5683772651702378,0.9932258080636821,0.4482758620689655,0.91845973117101,1.0,2/8,9.41%,WDR81;EEF1A2
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),0.5391196569107677,0.993095674426184,0.4722222222222222,0.9178847367338471,1.0,3/8,17.62%,GALNT16;GALNT13;GALNT11
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.3511400772658731,0.9930860017704092,0.42857142857142855,0.9170113925504657,1.0,15/85,11.38%,VAPB;TRPC4;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ANXA6;SMDT1;ATP2B4;SLC24A3;PML;CHRNA7;STIM1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.3870361634033278,0.9930229663768777,0.3333333333333333,0.9162964112020181,1.0,6/44,11.51%,FYCO1;GPSM1;SIRT1;SPTLC2;MAP3K7;SESN1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5257363798115314,-0.9929256270206408,0.4722222222222222,1.0,1.0,7/20,18.82%,RPL11;GABARAPL2;RPL23;EFNA1;RPS7;HSP90AB1;RPL5
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.6417343086594758,-0.9926699376041475,0.5714285714285714,1.0,1.0,3/6,29.84%,ATF4;MT3;SESN2
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,-0.5172865205524064,-0.992564703560512,0.4626865671641791,1.0,1.0,3/23,7.88%,TMCO4;TRIM25;TMC4
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),-0.4896773710861108,-0.9924549696143983,0.5421686746987951,1.0,1.0,7/31,15.73%,EIF2B2;SELENOS;XBP1;RACK1;ZBED3;PDK3;KHK
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.4877378469617257,-0.9921772047107698,0.5342465753424658,1.0,1.0,6/23,16.51%,SCN9A;CACNA1G;CACNA1B;P2RX4;CACNA1E;CAV1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),-0.6542980103493289,-0.9921253484363025,0.5714285714285714,1.0,1.0,1/5,9.92%,TRIM41
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.44927098025869994,-0.9920693768529802,0.550561797752809,1.0,1.0,3/61,5.95%,DENND3;ARHGEF18;RASGRP1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),-0.4343052848217708,-0.9918019528340023,0.45348837209302323,1.0,1.0,19/84,19.75%,HES5;ELOB;RIMS1;HES1;TUBGCP2;TUBGCP4;ZW10;NDUFAF1;CHCHD10;FANCC;SPG7;VIL1;NIFK;TSPAN4;PEX14;DNM1L;AFG3L2;TAPBP;KNTC1
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6226473946168538,-0.9916645618924442,0.5072463768115942,1.0,1.0,1/5,6.56%,ALOX12
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.6067577528366269,0.9916230805858499,0.475,0.9178990907983322,1.0,4/5,25.18%,FOXO1;KCNC2;GUCY1B1;MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.6067577528366269,0.9916230805858499,0.475,0.9178990907983322,1.0,4/5,25.18%,FOXO1;KCNC2;GUCY1B1;MTR
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.604575462595481,0.9913175948399187,0.45161290322580644,0.9177250976648905,1.0,4/5,39.53%,CBLL1;GRB2;CBL;CTNNB1
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.4620604077727515,0.9911637158994463,0.35294117647058826,0.9174662837467582,1.0,7/33,16.16%,DHCR7;OSBPL7;AKR1C3;CYP7B1;OSBPL6;HMGCR;HSD17B4
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.44918720922158306,-0.9908242480180449,0.49411764705882355,1.0,1.0,8/53,15.97%,DDRGK1;RANGRF;TGFB1;PARP9;SYT11;RIC3;PDZK1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.5422643218623899,0.9908069153647645,0.5365853658536586,0.9174915254049455,1.0,4/7,19.07%,MAP4K4;IQSEC1;MAPRE2;MTOR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.5991705647499488,0.9907659864438119,0.5806451612903226,0.9167518151752149,1.0,1/6,5.15%,PPARG
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.60943011017008,-0.9907383184375065,0.5357142857142857,1.0,1.0,4/8,27.85%,TRMT10C;POP4;HSD17B10;RPP30
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.41379390918295744,0.9907277831336702,0.41935483870967744,0.9160276534594374,1.0,2/22,5.67%,DHCR7;ACAA2
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.45625452598694854,-0.9906830260988808,0.47674418604651164,1.0,1.0,8/47,12.89%,OPRM1;GALR1;PDE6B;SVOP;SLC6A6;SLC7A14;SRRM4;CDH7
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5821436049221858,-0.9904269330575648,0.4927536231884058,1.0,1.0,1/12,3.65%,POLR2G
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.348654467047266,0.9899530457867473,0.47619047619047616,0.9172276486441313,1.0,8/47,11.39%,KCTD8;GRK5;PLCB1;GRK6;GNG4;CAMKMT;DGKQ;ZDHHC3
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.3497779492275853,0.9895136091810343,0.3125,0.9173660187801728,1.0,21/103,8.96%,POU6F2;SPSB4;DPYSL5;ERC2;PPM1E;CSRNP3;ERBB4;DCX;BTBD17;ASTN1;PBX1;SIRT1;ADGRL3;GAL3ST3;NOL4;SLC8A2;VLDLR;GRID2;EGFR;UNC5D;CLVS2
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.34078892319039017,0.9894127463360349,0.45454545454545453,0.9166997705340835,1.0,28/117,16.42%,IL15;HDAC9;GPNMB;SPRED2;NOVA2;PLCL1;NR1H2;ELAPOR2;ROBO1;SMAD7;MAP2K6;NOVA1;EGFR;NFIB;ATP2B4;TWSG1;ADAMTS5;KLF7;IP6K1;HMGCR;ADAM17;N4BP1;PTPRG;ACVR1C;WWC2;SPRED1;PCTP;CORO1C
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.5284918974955595,0.9889959536844941,0.45161290322580644,0.9165987064170247,1.0,2/8,7.55%,NEDD4L;CACNA2D1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.5285313703038458,-0.9888524882222522,0.5138888888888888,1.0,1.0,5/17,18.72%,PFDN6;CLU;NDUFAF1;HSP90AB1;HSPD1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.4495133189346,-0.988835494391055,0.4691358024691358,1.0,1.0,7/62,13.86%,POLR2I;ELOB;POLR2G;CDK7;NCBP1;CTDP1;GTF2F1
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.6043395010715162,0.9887123347144474,0.46875,0.9163992371660538,1.0,2/6,7.87%,UNC13C;UNC13B
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.4028782866592274,0.9886872635836863,0.5294117647058824,0.9156231991357571,1.0,5/37,4.22%,CHRM3;LGR5;HID1;TSPAN8;SH3BGRL2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,-0.4350191849234512,-0.9886607693682675,0.45348837209302323,1.0,1.0,22/93,17.27%,F8;A2M;PCDH12;NOSTRIN;CDKN1C;USHBP1;S100A10;PROCR;RNASE1;COL4A1;LMOD1;COL15A1;ELK3;VWF;SRPX;CD55;NRP2;MYLK;CD46;CAV1;RASGRP3;STAB2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.5724775363676482,-0.9885002796925266,0.4864864864864865,1.0,1.0,1/11,3.07%,CDKN1C
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.5476436407990021,-0.9882881456830066,0.5,1.0,1.0,1/15,1.85%,DXO
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),0.5554080195144111,0.9880342520388693,0.5263157894736842,0.9163669446929478,1.0,1/8,4.67%,SUV39H2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.5799718258304194,0.9878872297139635,0.42857142857142855,0.9158873452199932,1.0,2/5,15.05%,ROBO1;ROBO2
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.3145755800568052,0.9878806204415291,0.5,0.9150297727993753,1.0,19/90,14.88%,HID1;BCAR1;TMEM117;TSPAN15;CDC42EP4;HDAC11;PTGFRN;UNC13B;UNC5B;MMP15;WASL;ADCY6;CDS1;GPC1;CMTM4;PTPRU;COBL;RNF128;EPB41L1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4500118980746451,0.9877961246553826,0.46875,0.9143280153074989,1.0,5/19,21.37%,CNOT6L;CNOT2;CNOT9;CNOT7;PAN3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.518727414274931,-0.9877488934776544,0.5303030303030303,1.0,1.0,3/15,18.26%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.518727414274931,-0.9877488934776544,0.5303030303030303,1.0,1.0,3/15,18.26%,RPS27A;UBA52;UBC
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.45372051908601585,0.9875507556404864,0.5454545454545454,0.9140197384491276,1.0,4/13,8.13%,ITPR2;ANXA6;PKD2;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),-0.6807213699702868,-0.9873833547496699,0.6078431372549019,1.0,1.0,2/5,13.84%,NOXA1;DVL2
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.33702881379594335,0.9872448018720755,0.5333333333333333,0.9137680090949428,1.0,23/95,14.90%,KCNJ6;DPYSL5;NOVA2;ERC2;CSRNP3;ASTN1;HS6ST3;NRXN1;NOL4;SLC8A2;NXPH1;CLVS2;CHD5;LONRF2;ADGRA1;SRCIN1;LHFPL4;GRIK3;ADCYAP1R1;TTBK1;KCNQ2;ATRNL1;CTNND2
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.43579456060145494,0.9870827899425386,0.42105263157894735,0.9132651111344223,1.0,4/24,9.00%,SOX11;GRIK2;HOMER1;NSF
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3769930099601053,0.9869840852302036,0.4666666666666667,0.9126374486758319,1.0,12/51,12.83%,RIPOR2;ADAM10;SEMA4D;PLXNA1;ADAM22;GCNT2;PLXNA3;PTPRC;LPXN;NF2;SEMA6A;CDH13
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.5776091725909154,-0.9869658581640722,0.5606060606060606,1.0,1.0,1/10,4.27%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.47640760746734606,-0.9868131377555412,0.4594594594594595,1.0,1.0,4/32,8.32%,B2M;FLOT1;CLU;GPC3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.43272007496050524,-0.9867877359873851,0.5108695652173914,1.0,1.0,11/81,9.60%,PLAG1;MX1;LFNG;STAG3;ENTPD7;PDE6B;ZC2HC1C;IL5;RSAD2;GAMT;SNCB
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),-0.5550829722037424,-0.9863943333533343,0.5135135135135135,1.0,1.0,3/15,13.31%,TRPC5;GAPDH;NLRP1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.41696227934860763,-0.9862237393144633,0.5425531914893617,1.0,1.0,17/133,16.82%,PSMB9;EMD;SFRP1;DVL1;PSMB8;WIF1;TLE6;SFRP4;PSMA3;FUZ;RNF213;RACK1;DVL2;APOE;PSMA7;CAV1;PSME1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.5848828205892327,-0.9856176805035419,0.5074626865671642,1.0,1.0,1/7,15.63%,ADAR
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.595398379519552,-0.9856136543063613,0.5277777777777778,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.3020558167489368,0.9854829946108814,0.5,0.9155691917648856,1.0,68/326,13.82%,MYRFL;SOX11;TP63;ZNF516;RYBP;ERBB4;MAP3K5;ESR1;RXRA;NR1H2;SALL1;ATF7IP;NDP;MED24;SP3;MYCN;ZKSCAN3;ARID1A;TCF4;PPM1A;ESRRG;PPARG;BTRC;TBL1XR1;MLLT3;TP53INP1;PLCB1;FOXK1;WNT7A;RFX3;YAF2;PICALM;SMARCA2;FOXO1;EGFR;ARID1B;NPAS3;TRERF1;RORA;NFIB;BMP7;NFATC1;PRDM11;RSF1;PML;AFAP1L2;FBXW11;KAT8;ATOH8;MYRF;MITF;KAT2A;TRIM28;HDAC4;SPIN1;HNRNPD;SOX8;ZBTB16;ZMIZ1;GLIS2;CAND2;ACVR1;KDM5A;ETS2;MAP2K2;SOX10;RAI1;PRDM16
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.41824194948765414,-0.9853366934066762,0.5057471264367817,1.0,1.0,17/92,18.85%,DDRGK1;RPS27A;TRIM5;FLOT1;TRIM25;CLU;AGT;RTKN2;CAMK2A;UBA52;EIF2AK2;TERF2IP;CAV1;TRIM52;PRKCQ;UBC;TRIM32
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.44220769424110834,-0.9851150494491323,0.4942528735632184,1.0,1.0,9/57,15.77%,PMM1;TMEM258;DOLPP1;OST4;DAD1;MPDU1;ALG14;MCFD2;ALG10B
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.504998031614761,0.98507199993638,0.52,0.9157491252892292,1.0,1/13,0.28%,PHLDB2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3030375745189221,0.9847439455424764,0.6666666666666666,0.9157198053709158,1.0,46/292,14.39%,SPSB4;RNF144A;WDR81;FBXL4;UBE3D;FEM1A;FBXW7;MIB1;HECW2;RNF150;KLHL8;NEDD4L;SIRT1;BTRC;TBL1XR1;ZRANB1;HACE1;UBE2G1;UBE2D1;KEAP1;MVB12B;SPSB1;PML;FBXW11;NDFIP2;USP9X;PCBP2;UBE2H;NEDD4;RCHY1;FBXL7;ANAPC4;TRIM71;RNF11;FBXW5;PSMD6;PSMD13;UBE3C;COP1;CDC16;KLHL42;RNF217;FBXO11;ANAPC1;ADRM1;RNF128
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.35490701581262424,0.9846304683446557,0.2857142857142857,0.9151339398696586,1.0,30/154,13.10%,MAPK11;CRB2;SOX11;TP63;RIPOR2;LMO3;PCP4;ABL1;TCF4;BRINP3;PPARG;CDON;PLCB1;ZNF268;GCNT2;NRCAM;TGFBR2;SOX5;BMP7;WDFY2;RIN2;MAPK14;BEND6;CTNNA2;CDS1;GPC1;ZBTB16;PRKD1;ACVR1;RAPGEF2
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.6147416122073004,-0.9845953713089537,0.5909090909090909,1.0,1.0,1/6,15.63%,ADAR
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.4399238993854324,0.98455544120108,0.36,0.9144796508544115,1.0,5/29,9.11%,BAG2;BTRC;SH3D19;SNX33;FBXW11
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.5986813422048017,-0.9845131136548795,0.5217391304347826,1.0,1.0,4/8,28.05%,DERL2;ERLEC1;OS9;UBE2G2
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.5107458393154857,-0.9841894012607572,0.5769230769230769,1.0,1.0,3/24,12.36%,HES5;B9D1;ULK3
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.4958081319738571,-0.984161600916636,0.49333333333333335,1.0,1.0,6/20,19.07%,CFTR;GLRX;SLC6A9;WNK3;PDZK1;ACTN2
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5997480864953253,-0.9840038592701401,0.5194805194805194,1.0,1.0,4/9,19.81%,PARP9;NAXE;NUDT12;NAMPT
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),-0.49261389820895496,-0.9838116638930208,0.5584415584415584,1.0,1.0,7/26,19.39%,IGFBPL1;SCG5;VEPH1;TYMP;MTCH1;TSPYL2;GLRX2
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),0.48119042828706304,0.9838106532203604,0.45714285714285713,0.915243273860788,1.0,4/10,16.33%,ACER3;SPTLC2;QDPR;ABCA2
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),-0.4200638411076858,-0.9837737877966813,0.4827586206896552,1.0,1.0,18/99,14.40%,NACA;HAP1;CDC37;RPL11;SLC25A6;PEX1;TIMM8B;ZFAND2B;TIMM44;ICMT;ZDHHC24;TOMM7;ZDHHC1;GIPC1;ZDHHC15;SPCS2;AP4M1;ZDHHC22
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5544516829679971,0.9834171737009054,0.5365853658536586,0.9154643051793283,1.0,2/5,12.90%,FOXP1;SLC39A10
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.5030036061863252,0.9833883074392862,0.3548387096774194,0.9147144817616941,1.0,8/12,25.09%,KAT2B;PBX1;RBPJ;MAML1;WWC1;MAML2;CREBBP;NOTCH1
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.4670007894584228,0.9829164459438346,0.4642857142857143,0.91494944393539,1.0,2/10,11.34%,ACER3;HEXB
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.603192895666971,-0.9825141058014838,0.5689655172413793,1.0,1.0,5/7,18.82%,RPL11;RPL23;RPS7;USP44;RPL5
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.5410841511265958,0.982345532877322,0.5555555555555556,0.9155575957514711,1.0,1/11,0.27%,CHRM3
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6097945537833088,-0.9819157574990138,0.5873015873015873,1.0,1.0,3/7,22.09%,RACK1;TNFRSF1A;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.6097945537833088,-0.9819157574990138,0.5873015873015873,1.0,1.0,3/7,22.09%,RACK1;TNFRSF1A;SPHK2
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.5302892651589192,0.981127224668145,0.5384615384615384,0.9179480690589906,1.0,4/11,11.52%,CD247;CD96;PTPRC;GPR174
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),-0.6347105897642538,-0.981064672316795,0.5846153846153846,1.0,1.0,2/5,19.12%,TAP1;TAPBP
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.4279944116909221,-0.9810187070871954,0.5,1.0,1.0,9/78,11.23%,SRSF7;MBNL3;RBM3;RBM8A;DDX5;CELF4;SRSF10;SRRM4;NCBP1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.5945499422467645,-0.98099327463177,0.5384615384615384,1.0,1.0,2/7,17.92%,RPS7;PTTG1IP
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.36623251875534607,0.9809818885100501,0.5,0.9175025936208567,1.0,29/108,15.04%,PKP2;ZDHHC2;TSPAN17;EHD1;ZFYVE27;TSPAN15;ANK2;C2CD5;SPTBN1;EFR3A;PACS1;DPP6;RAB10;SEC16A;TSPAN5;DPP10;ZDHHC3;RAPGEF6;FLOT2;KCNIP4;MYO5A;TSPAN14;RAPGEF2;RAB40C;PACS2;MAP7;RAP2A;ARL3;SPTBN4
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.5747314478775438,-0.9805349058003504,0.5571428571428572,1.0,1.0,2/9,12.45%,DCTN1;NEK6
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.5388648645073434,0.9805303921879873,0.5405405405405406,0.9176099259023759,1.0,3/7,29.72%,WHRN;TMC2;KIT
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),-0.4599331430468263,-0.9800148577339934,0.524390243902439,1.0,1.0,5/40,6.19%,RBM3;RPL10;TGFB1;AGT;RBM4B
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.4228088661400343,-0.9799524937894503,0.5,1.0,1.0,8/60,10.01%,PAH;PLSCR1;CP;MRPS18C;ABCC3;GPC3;GLUL;CPB2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.5350997541035901,-0.979949984460023,0.5714285714285714,1.0,1.0,2/14,7.92%,ITGA4;MEF2C
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.5241643554247921,-0.9793827421057204,0.4666666666666667,1.0,1.0,1/14,3.48%,MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.5241643554247921,-0.9793827421057204,0.4666666666666667,1.0,1.0,1/14,3.48%,MMACHC
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4438379733319299,-0.9789767568372189,0.48148148148148145,1.0,1.0,7/63,13.86%,POLR2I;ELOB;POLR2G;CDK7;NCBP1;CTDP1;GTF2F1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.36217157828294466,0.9783315534232889,0.5294117647058824,0.9223219146495872,1.0,12/53,13.29%,ALG1;FAM20B;LARGE1;CSGALNACT1;GAL3ST3;COG3;GCNT2;SERP2;CHST8;FUT9;ST3GAL4;COG7
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),-0.42463751862564536,-0.9778043772999758,0.5212765957446809,1.0,1.0,9/97,9.16%,VEGFA;ELOB;PSMB9;RPS27A;SFRP1;PSMB8;BACH1;PGK1;PSMA3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.44854881277235154,0.9777199546980087,0.45161290322580644,0.9228791725343772,1.0,6/14,16.74%,NAF1;POT1;TNKS;ERCC4;TERF1;TERF2
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.4375170854176002,-0.9776583844460908,0.5,1.0,1.0,8/48,14.93%,ESRRB;FGF1;RAB11A;HTR2B;TLE6;CALM1;RACK1;CDK2AP2
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.5068546071360148,-0.9774776243577399,0.5454545454545454,1.0,1.0,4/19,12.54%,PFN2;RAP1GAP;TCHP;ARHGAP24
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.5410571023075805,0.9774715425481262,0.4666666666666667,0.9225546602740461,1.0,3/6,19.50%,MARCHF7;LRRK2;SASH1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.508727669688667,-0.977385511182453,0.44285714285714284,1.0,1.0,2/18,4.27%,HES1;TGFB1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.48990026341708026,-0.9772744275306015,0.4794520547945205,1.0,1.0,1/24,0.66%,VEGFA
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.6313249108149857,-0.9771571381232118,0.5441176470588235,1.0,1.0,6/7,29.72%,CENPC;MIS12;RMDN1;NUF2;BOD1;CHAMP1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.401686284123298,0.9771112388150801,0.6153846153846154,0.9228219522565019,1.0,6/22,11.38%,ADRA1A;SLC8A2;JPH1;CACNA2D1;SMDT1;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.6118733187290539,-0.9770929919771475,0.49206349206349204,1.0,1.0,1/9,2.57%,SFRP1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.46028506352528376,-0.9770122094092142,0.4942528735632184,1.0,1.0,14/50,26.97%,PSMB9;PSMB8;PSMA3;NABP2;PSMA7;PSME1;PSMB6;RBX1;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.4718235595690358,-0.9769952315235962,0.5647058823529412,1.0,1.0,3/26,7.92%,VAV3;XBP1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),0.5692436251584697,0.976887689447355,0.5384615384615384,0.9225942424118584,1.0,4/8,18.34%,SPRED2;DLL1;SPRED1;ZEB1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.6279634692608351,-0.9763208156313692,0.5245901639344263,1.0,1.0,3/7,33.10%,DONSON;ZRANB3;ZNF830
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),-0.48062093543416623,-0.9759352326103878,0.5396825396825397,1.0,1.0,4/23,7.41%,ZFPM1;KDM6B;TTN;CACNA1G
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.3673577502870111,0.9758221627553745,0.4,0.9242471185256163,1.0,11/49,14.97%,ABHD3;SMPD4;SYNJ1;PRDX6;PLCB1;PLA2G15;PIGQ;SERINC5;ENPP6;PIGX;PNPLA6
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),-0.599869406283098,-0.9757676574980215,0.5873015873015873,1.0,1.0,2/8,14.68%,AGT;APOE
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.35500390428834394,0.975753324674093,0.3888888888888889,0.9235934710076912,1.0,12/82,10.08%,ONECUT1;BCAR1;PRIMA1;PCLO;TOX3;FAM222A;SLC7A2;MAGI1;JPH1;BMP7;MMP15;SHROOM3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.3815879636491229,0.9756721352328982,0.45454545454545453,0.9229410184578061,1.0,6/34,8.86%,AEN;BOK;ABL1;SIRT1;BCL2L11;PML
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.4761294479560248,0.9755349876272585,0.55,0.9224676789953336,1.0,1/12,0.97%,ALG1
prerank,MSigDB_Hallmark_2020__Inflammatory Response,-0.4352975604352591,-0.9754453565954447,0.5393258426966292,1.0,1.0,9/78,9.35%,SLC28A2;TACR1;SELENOS;IFNGR2;IRF1;RASGRP1;HAS2;GPC3;OSMR
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.43442797889219875,0.975142140415856,0.4074074074074074,0.9225284804596633,1.0,1/20,0.30%,BAIAP3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.43367414454648034,-0.9750589949668759,0.5176470588235295,1.0,1.0,15/84,19.53%,PDHX;NAAA;BTD;PTGR1;ALOX12;HYI;GAMT;PDHB;LDHA;VDAC1;ACOT2;SLC16A1;ALDH4A1;MECR;CYP3A5
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.5173275209378311,-0.9750070510400302,0.5061728395061729,1.0,1.0,5/14,22.01%,ACMSD;ALDH4A1;HPD;MTRR;HSD17B10
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.5338048096463474,-0.9749412340010079,0.5571428571428572,1.0,1.0,4/17,17.28%,PLSCR1;ABHD12B;LPCAT3;OSBPL10
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.4682082199728921,0.9748762568488407,0.4666666666666667,0.9223705901318368,1.0,3/14,7.58%,SCD5;ACACA;FASN
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.5306604354038306,-0.9748583889656363,0.5352112676056338,1.0,1.0,2/15,12.10%,MYRIP;AIMP1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.40801161658485785,-0.974763430986177,0.5531914893617021,1.0,1.0,26/256,12.63%,ASB18;TNC;ELOB;SCG3;PSMB9;SCG2;COPS6;FBXW12;RAB11A;CP;ASB14;COPS5;PSMB8;OBSL1;CKAP4;CHGB;ASB16;GPC3;ICMT;FN1;PSMA3;CST3;FBXL13;SERPIND1;FBXO32;NUCB1
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4241835758076979,0.9746615872543438,0.48148148148148145,0.9219536589298194,1.0,4/19,11.91%,SHANK2;NLGN4X;LRRK2;GRIK3
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.6562535903225063,-0.9743484841931389,0.5178571428571429,1.0,1.0,1/6,1.77%,ZNHIT3
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),-0.6068915793915037,-0.9742369186491182,0.5873015873015873,1.0,1.0,3/7,14.67%,GRN;SYT11;NR1D1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.4865769314513761,-0.9740979754236119,0.5384615384615384,1.0,1.0,6/25,18.07%,PRPF8;SRSF10;PRPF4;PRPF6;SMNDC1;SF3A3
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.6036799540085787,-0.9738274018405464,0.6190476190476191,1.0,1.0,4/7,23.68%,ZDHHC8;APOE;ABCA1;PRKACA
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.5143508572303879,0.9735895810913763,0.4857142857142857,0.923705681628854,1.0,1/7,8.41%,SNX33
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.4546845229600764,-0.9734900066766051,0.5769230769230769,1.0,1.0,5/40,5.95%,VEGFA;FGF1;TGFB1;HTR2B;RASGRP1
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4081599607652841,-0.9731090568359877,0.5116279069767442,1.0,1.0,13/64,19.95%,HLA-F;RETREG1;MEF2C;GRN;BDNF;ATF4;CHMP4B;APOE;NRBP2;RASA1;WFS1;VPS35;SET
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6111716619082609,-0.9730516782104457,0.5517241379310345,1.0,1.0,2/6,18.09%,PEX11B;DNM1L
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.5593383424450279,-0.9729333674720332,0.5303030303030303,1.0,1.0,1/11,11.34%,ACO2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.4715487092028726,-0.9728502451611486,0.5135135135135135,1.0,1.0,4/22,17.81%,TGFB1;MED1;CAV1;CATSPERG
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.45591817037179716,-0.9723749694694761,0.5487804878048781,1.0,1.0,3/40,8.92%,ENPP2;GPX4;GDE1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.4222657600686442,0.9721712184138014,0.55,0.9265989390944366,1.0,5/25,13.88%,RACGAP1;XPR1;GLRA1;SLC4A10;SLC25A14
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),-0.659305008048672,-0.9721155282187017,0.5833333333333334,1.0,1.0,1/5,3.45%,DVL1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.569864461308267,-0.9718856605979097,0.4393939393939394,1.0,1.0,5/7,35.43%,HMGCLL1;HMGCL;ACAT1;SLC27A5;AACS
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.4332882840723498,0.9717811048842712,0.4444444444444444,0.9265468187477272,1.0,6/15,21.35%,PPP1R8;MFHAS1;ARPP19;URI1;ZCCHC9;CHP1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.4799618351868951,-0.9717080947446292,0.525,1.0,1.0,6/25,23.62%,ATP6V0A4;ATP6V1F;DNM2;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,PanglaoDB_Augmented_2021__NK Cells,0.42446800071652296,0.9715218719241672,0.4583333333333333,0.9261956078499527,1.0,8/28,11.90%,PCDH15;CD247;ITGA2;CD96;PTPRC;KLRD1;KLRG1;ZBTB16
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),0.4712480282441862,0.9709139897096574,0.5,0.9270814503530064,1.0,1/16,0.09%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.3401254610700326,0.9708696052038844,0.5384615384615384,0.926363874856627,1.0,18/82,13.18%,HIP1;ERBB4;IRS1;ESR1;AKR1C2;RICTOR;GAB1;AKR1C3;IGF1R;GCNT2;STRN;NRG2;EGFR;MFHAS1;TGFA;PIK3CA;THEM4;FRS2
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),-0.46782494180367895,-0.9706630852386003,0.4714285714285714,1.0,1.0,8/24,19.79%,IFI6;CLU;CAMK2A;IFIT2;BAX;DNM1L;HSPD1;VPS35
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4150552334587947,0.9704020106908465,0.5416666666666666,0.9267732776261091,1.0,12/34,15.54%,MAP2;ARC;WNT7A;WASL;CHRNA7;CTNNA2;KLF7;SDC2;BTBD3;FARP1;CTNND2;DOCK10
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.5127066702627896,-0.9702073776401343,0.4868421052631579,1.0,1.0,5/23,16.77%,EMD;COX18;CCDC47;TRAM1L1;SEC61G
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.5823346174647437,0.9694909825884037,0.4878048780487805,0.9282524011948483,1.0,1/5,10.25%,MAPK3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.4672305478805415,-0.9690917235528478,0.5342465753424658,1.0,1.0,5/32,14.39%,TGFB1;ANKLE2;CALM1;PTPA;PPP2R5A
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.511662020625872,0.9689579937725251,0.5,0.9285645930134777,1.0,2/14,5.68%,QRICH2;RAC3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.5623008899439415,-0.9687765822673088,0.5915492957746479,1.0,1.0,3/12,9.73%,ITGA4;SFRP4;CD160
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.4282998010821296,0.9685958873628437,0.4827586206896552,0.9287139131232288,1.0,4/16,11.37%,LIG4;YLPM1;SMG1;HNRNPD
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.4191533445227989,0.9685501287882333,0.3684210526315789,0.9279575603926398,1.0,9/22,20.00%,SLIT1;SLIT3;USP9X;AUTS2;SEMA3A;ALCAM;NRP1;SLIT2;SEMA5A
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),0.39967566874707866,0.9685247310697751,0.3793103448275862,0.9264084721672255,1.0,6/22,20.88%,PAPOLA;TENT2;SCAF8;CSTF3;MTPAP;CPSF2
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),0.39967566874707866,0.9685247310697751,0.3793103448275862,0.9264084721672255,1.0,6/22,20.88%,PAPOLA;TENT2;SCAF8;CSTF3;MTPAP;CPSF2
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.5483814464042117,0.9685223840079472,0.5428571428571428,0.9255753710231903,1.0,2/10,2.99%,RXRA;SGK1
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.6305669032428413,-0.9685102750229463,0.631578947368421,1.0,1.0,4/5,32.31%,CCS;SOD2;MT3;SOD1
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.4936130236250156,0.9682221563484443,0.5,0.9256863113072372,1.0,2/7,17.53%,MYO1E;TBC1D8B
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5816506213370733,0.9682098294540373,0.5,0.9248688069486279,1.0,2/6,15.29%,UBR5;TRIP12
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.46062150934071733,-0.9681023130194221,0.525,1.0,1.0,11/34,25.39%,RPS14;ZFPM1;SLC25A5;CASP3;HSPA9;RUNX1;UFL1;PTPN2;RPS19;SPI1;ATP5IF1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),-0.6074074693583638,-0.9680935431798131,0.5254237288135594,1.0,1.0,1/5,19.08%,TNFRSF1A
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",-0.6353587074910404,-0.9677732999155702,0.4925373134328358,1.0,1.0,2/5,12.54%,PLET1;ARHGAP24
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.6159191844203724,-0.967596072381924,0.5833333333333334,1.0,1.0,1/5,13.43%,GALE
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.4062262331052683,-0.9675605286829597,0.4891304347826087,1.0,1.0,19/77,19.44%,COPS6;PHF1;RPS27A;FAM50A;COPS5;LDB1;CENPH;POLE3;NUP155;GATAD1;UBA52;HMGN2;HDAC3;HMGN1;UBC;EZH1;XPA;MSH6;DDB2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.3872740482220919,-0.9671642350801755,0.5555555555555556,1.0,1.0,29/205,13.77%,VEGFA;CD63;RIMS1;DDRGK1;FGF1;RPL11;PLSCR1;TGFB1;HMGN5;CLU;RPL23;OVOL2;OLFM1;FAM98B;TTN;MEF2C;SFRP4;EPHX2;PIK3CB;FN1;MED1;CDH3;PDCD5;ID2;TADA3;WARS1;ATF4;MAP2K1;ACTA2
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.6417314712257342,0.9671486326107632,0.5555555555555556,0.9265661924971363,1.0,3/5,11.95%,TWSG1;CBFB;HMGB1
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.4474731024351884,-0.967123114971378,0.5476190476190477,1.0,1.0,7/51,21.51%,POLR2I;POLR2G;NUP155;SEC13;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.4474731024351884,-0.967123114971378,0.5476190476190477,1.0,1.0,7/51,21.51%,POLR2I;POLR2G;NUP155;SEC13;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.4201380550900735,0.9667240774608958,0.45454545454545453,0.926810233960252,1.0,7/26,10.25%,NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPKAPK5;MAPK3
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.47069196573719213,0.9666628578919175,0.47058823529411764,0.9261415027479332,1.0,6/19,15.69%,TBC1D14;TBC1D12;PIKFYVE;MTMR3;NPRL2;MTM1
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.4052872837772207,0.9665506791920644,0.5882352941176471,0.9256482289488892,1.0,6/31,10.71%,RPA1;ATR;STN1;POT1;CTC1;ERCC4
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),-0.5205885548278587,-0.9664880241894426,0.527027027027027,1.0,1.0,2/13,17.56%,CHMP4B;MITD1
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5800105011504029,-0.9663910355455765,0.5211267605633803,1.0,1.0,4/9,28.05%,DERL2;ERLEC1;OS9;UBE2G2
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),-0.6257356167479897,-0.966345186443029,0.6081081081081081,1.0,1.0,2/6,13.77%,HTR2B;ACTA2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),0.34854026973091934,0.9662037109784505,0.5555555555555556,0.9255844038841903,1.0,12/46,11.95%,EYA4;TOX;SIRT1;POT1;EGFR;EYA2;PML;MECP2;USP9X;TRIM28;UBE2N;HMGB1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.4355120301811377,0.9661428009629384,0.38235294117647056,0.9248917968790855,1.0,7/23,16.86%,SCD5;ACACA;FASN;ACSL4;ACSL3;ACSBG2;SLC25A1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.44802317898436583,-0.9661306938154224,0.5,1.0,1.0,12/43,21.40%,GAPDH;AKR1A1;PGK1;OAS1;APOD;GALM;ATF4;G6PC3;GOT1;PGAM1;ADPGK;G6PC2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.5185478564501619,-0.966032273050769,0.5571428571428572,1.0,1.0,2/19,9.56%,VEGFA;COL4A1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.4057082924223119,0.965702951201694,0.5416666666666666,0.9251228746780494,1.0,7/21,16.74%,YLPM1;PML;ERCC4;SMG1;HNRNPD;SIRT6;TERF2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.4751775504444589,-0.9656871953674413,0.5256410256410257,1.0,1.0,4/30,8.45%,CLU;RASGRP1;OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.28945051402146815,0.9654725930074344,0.75,0.9249528331988506,1.0,43/324,10.46%,MAPK11;RIT2;TP63;BANP;RACGAP1;RMI1;DAPK2;ARAP1;RPA1;BARD1;ARHGEF6;ATR;NLGN1;STYXL1;BOP1;TAF3;SGMS1;SRGAP1;TRAF1;SGK1;ZFAND6;RICTOR;SLC15A2;ARHGAP28;PTPN13;FGD4;RAC3;MAPK1;TP53INP1;MAP2K6;ARAP2;FAM13A;EGFR;OPHN1;PRDM11;PML;ARHGAP20;MAPK14;MAPKAPK5;XIAP;HSPB1;MAPK3;LRRK2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.5133682389771581,-0.965268989823253,0.5714285714285714,1.0,1.0,2/15,4.95%,IFI35;CLU
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.5352045612959118,0.9649226885993465,0.5641025641025641,0.9255704506476506,1.0,2/9,9.31%,SLC2A6;SLC2A9
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3235448618395193,0.9649191998782886,0.4375,0.9247469893926261,1.0,14/70,13.09%,HIP1;MAP3K5;BOK;SIRT1;ROBO1;PPARG;CRADD;SENP1;EGLN3;PPM1F;BCL2L13;HMGB1;CFLAR;ST18
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.4376694946905843,-0.9648292785279332,0.5571428571428572,1.0,1.0,13/50,19.03%,C2ORF49;PUS3;FAM98B;ELP5;CSTF2;TRMT10C;TRNT1;QTRT1;SARS1;RTRAF;TRPT1;QTRT2;CPSF1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),-0.46476490890784194,-0.9647393968117315,0.5679012345679012,1.0,1.0,6/30,14.93%,HAX1;ARIH2;UBL5;TOMM7;MICALL2;SREBF1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.6253870838431226,-0.9646957663406605,0.546875,1.0,1.0,3/6,30.23%,AXL;PPT1;APPL1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),-0.479131924553131,-0.9646689725286169,0.5641025641025641,1.0,1.0,7/27,18.96%,VEGFA;AGT;HAS2;STAT1;GREB1L;WFS1;BAG6
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),0.4448708423986244,0.9646038038774475,0.5263157894736842,0.9245510928895072,1.0,4/22,17.64%,RYBP;RNF2;BCOR;UHRF1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),-0.566960501527114,-0.9640908296979103,0.5694444444444444,1.0,1.0,1/11,3.61%,ENTPD7
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.5802110555044027,-0.9639107439715988,0.6031746031746031,1.0,1.0,1/9,14.10%,SPCS2
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),0.519953004452717,0.963787095947688,0.5454545454545454,0.9256465622897843,1.0,4/8,24.58%,WNT7A;COBL;CXXC4;TASOR
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.44784995821273343,0.9637031151757941,0.4827586206896552,0.9250778809217515,1.0,5/17,31.36%,TRIM71;DROSHA;DICER1;PARN;TENT4B
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),-0.5405706527069382,-0.9632885356381932,0.532258064516129,1.0,1.0,2/15,14.87%,STX19;STX1B
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.4433336404171952,-0.9631774041408209,0.5617977528089888,1.0,1.0,22/60,28.71%,PSMB9;PSMB8;LDB1;LMO2;PSMA3;PSMA7;EIF2AK2;PSME1;DHX36;LMO1;RUNX1;PSMB6;PDCD2;PSMB1;PSMC4;PSMD2;SPI1;PSMB3;PSMD7;PSMC3;PSMA4;SETD1A
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.636678479861222,-0.9626637508784671,0.6363636363636364,1.0,1.0,2/5,20.55%,RDH10;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.40129610577562963,-0.9625095555935007,0.6111111111111112,1.0,1.0,24/151,18.85%,VEGFA;DDRGK1;BEX1;RPS27A;TRIM5;FLOT1;TRIM25;COPS5;CLU;AGT;RTKN2;CAMK2A;TRIM41;ESR2;BUD31;DVL2;UBA52;EIF2AK2;TERF2IP;CAV1;TRIM52;PRKCQ;UBC;TRIM32
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.4331953138808597,-0.9625069085580756,0.5487804878048781,1.0,1.0,12/48,20.36%,SFRP1;CTSL;XBP1;LMO2;MEF2C;MED1;NR4A3;LOC400499;CAV1;SRA1;RARA;RDX
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.5921840462348834,0.9624994280254231,0.5,0.9273135253871009,1.0,1/8,0.28%,PHLDB2
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.46238230321061147,0.9624905618078543,0.4482758620689655,0.9265054411802185,1.0,2/16,3.27%,NLGN1;PCLO
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.5005107549699757,-0.9617500528200256,0.6,1.0,1.0,1/20,1.79%,PFN2
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.37257170290305486,0.9616748382627326,0.42857142857142855,0.9276748774026267,1.0,6/35,8.48%,PLCL1;IRS1;RPS6KB1;IGF1R;PLCB1;PLCB4
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.3973894606770337,-0.961219691379098,0.5684210526315789,1.0,1.0,16/143,12.61%,PDE4A;PFN2;SEZ6L2;RETREG1;SLC4A3;SCN9A;THEM6;ANO2;CFAP52;B9D1;KIFBP;HPCA;METRN;SCAMP5;PKIB;STOM
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.5579266921757696,0.9609092885966878,0.5217391304347826,0.9287494912880221,1.0,1/5,3.74%,ITGA2
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.6209461404303864,-0.9608815948969054,0.5714285714285714,1.0,1.0,4/5,37.57%,B3GALT5;B4GAT1;B3GNT7;B3GALNT1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.41484198325518884,0.9607774474539027,0.45454545454545453,0.9282600141715283,1.0,6/36,8.86%,SEPTIN4;STYXL1;BOK;BCL2L11;CRADD;PML
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.5952752178910706,-0.9605685498684038,0.5970149253731343,1.0,1.0,1/5,4.90%,SELENOS
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.6488633504376691,-0.9605660930376685,0.5873015873015873,1.0,1.0,2/5,30.23%,STAT3;APPL1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.449317940122124,-0.9603574099942693,0.5316455696202531,1.0,1.0,4/35,7.92%,ISG15;TGFB1;ALOX5;MEF2C
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.461539025140522,0.960326238876534,0.5172413793103449,0.9286047168173326,1.0,3/17,11.31%,BARD1;SMARCAD1;UBE2N
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),-0.48781253644081657,-0.9601736776275542,0.5974025974025974,1.0,1.0,5/24,14.13%,ARIH2;UBL5;TOMM7;PDCD5;MICALL2
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.515118573008688,0.9601399276920507,0.5405405405405406,0.9282880330468001,1.0,2/7,4.73%,LEPR;SIRT1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3564940497190409,0.9598972831318927,0.625,0.9280643347901515,1.0,14/53,16.33%,ESR1;RXRA;PPARG;FER;SRR;FOXO1;ALPL;ERBIN;FOXP1;TAB2;ADAM17;FOXO3;NOS1;ABCA2
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),-0.42562319496015527,-0.9598195041273175,0.5853658536585366,1.0,1.0,12/66,12.52%,HLA-B;ISG15;FLOT1;BTN3A1;ALOX5;AGT;HTR2B;GAPDH;IGF2BP2;SCAMP5;BTNL2;SYT11
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.5252552327346794,0.9594823901118583,0.47368421052631576,0.9283687224746827,1.0,3/8,4.93%,SGK1;SLC15A2;AKR1C3
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.4701285382642223,0.9594047788326483,0.5294117647058824,0.9277367450419288,1.0,4/12,17.57%,SIRT1;ATP2B4;RAPGEF2;PKIA
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.5779885485401262,0.9593886844289399,0.5714285714285714,0.9269346797614143,1.0,2/9,11.88%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.5949440281621557,-0.9591750313698874,0.6086956521739131,1.0,1.0,1/7,7.94%,APH1A
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.4302699062438784,0.959154533708614,0.4857142857142857,0.9267524279610975,1.0,3/14,13.37%,ATG5;ATG2B;ATG3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),-0.4915808501533173,-0.9591085921759979,0.5466666666666666,1.0,1.0,8/23,21.58%,PPIF;ECT2;HDAC6;RNF112;MAPK13;OSER1;CYP1B1;PARK7
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.5289151175538122,-0.9590220903954917,0.5757575757575758,1.0,1.0,1/10,2.84%,HES1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.5363092394360138,-0.9589371452610544,0.5967741935483871,1.0,1.0,5/18,20.52%,OAS3;OAS1;IL7;EIF2AK2;IL18
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.3946531969198843,0.9588465589281214,0.5,0.9268465621921411,1.0,2/22,1.00%,COL7A1;LAMA3
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.313572140835524,0.9579108397902681,0.5555555555555556,0.9281883081971746,1.0,12/124,5.14%,GSTT2;AHCY;ESR1;BCAR1;AKR1C2;CDO1;AOX1;PC;PDLIM5;SLC35D1;AKR1C3;CAT
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.616770588900851,0.9575677035371732,0.6086956521739131,0.9281891592938792,1.0,2/5,24.41%,AMPD2;HPRT1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.52116443482713,-0.957280581780905,0.5217391304347826,1.0,1.0,3/15,18.50%,RRAGA;LARS1;TELO2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.6155654253133663,-0.9572292344994807,0.5606060606060606,1.0,1.0,3/5,34.72%,PLAA;TRIM44;PPIA
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.5550401608935531,-0.9570201054712416,0.5671641791044776,1.0,1.0,2/11,7.92%,TGFB1;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.5502214941827043,0.9566347533219712,0.48148148148148145,0.9295011598914363,1.0,3/10,11.29%,SPRY4;CREB3L1;GPC1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.585006193062864,0.9566140782335724,0.5526315789473685,0.9287803592190809,1.0,2/5,12.44%,MAP3K7;ERC1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.4921984327687274,-0.956171878732452,0.5396825396825397,1.0,1.0,1/14,4.27%,TGFB1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.5720401144108551,-0.9560996647808312,0.5694444444444444,1.0,1.0,1/10,2.69%,PPIB
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.560940730872463,-0.9560553412941196,0.53125,1.0,1.0,4/9,17.48%,TLE6;RACK1;ZBED3;RBM19
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.518335644523549,-0.9560509438521897,0.5342465753424658,1.0,1.0,4/17,18.65%,CDKN1C;GIPC1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.518335644523549,-0.9560509438521897,0.5342465753424658,1.0,1.0,4/17,18.65%,CDKN1C;GIPC1;HSP90AB1;SNW1
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.4730866238167435,-0.9559308587996915,0.5205479452054794,1.0,1.0,8/29,23.51%,GAPDH;PGK1;ATF4;G6PC3;GOT1;PGAM1;G6PC2;SLC39A14
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5147236883495261,0.9558582443031175,0.47619047619047616,0.9301026403884254,1.0,3/10,9.08%,SIRT1;BMP7;FTO
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.44738108744950117,-0.9557727894110741,0.5058823529411764,1.0,1.0,10/42,15.49%,RIMS1;HAP1;RHBDF1;SCG5;MEF2C;CAMK2A;RAB3D;RAB15;KCNMB4;SEPTIN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.33625881050096323,0.9556828725745586,0.5,0.9298271971494161,1.0,22/147,10.38%,VAPB;COL7A1;SEC24D;TRAPPC12;COG6;PREB;VTI1A;ANK2;CNIH2;COG3;TMED5;SPTBN1;TRAPPC8;GRIA1;COG5;CAPZB;TMED3;NSF;SEC16A;BET1;VAPA;TGFA
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.5670299565137897,-0.9556697365687717,0.6129032258064516,1.0,1.0,6/9,35.73%,IL7;IFIH1;AXL;WNT5A;TRIM44;AGPAT1
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.28712524958701857,0.9556617297164244,0.6666666666666666,0.9291079974925437,1.0,67/383,13.38%,TP63;RNF139;HDAC9;ATR;DPF1;NR1H2;NPAS1;HDAC10;SALL1;ATF7IP;PDS5A;SP3;ZKSCAN3;CREB3L1;TSHZ3;SUV39H2;SIRT1;PTPRK;CTBP1;MBD2;PPARG;BTRC;LIMD1;ZHX2;KCTD1;TLE1;PSPC1;PLCB1;FOXK1;MTERF3;RFX3;RUNX1T1;YAF2;SYNCRIP;PHC2;SMARCA2;ATXN1;EED;FOXO1;TRERF1;BMP7;PRDM11;RSF1;PML;FBXW11;KAT8;ATOH8;MECP2;ZNF282;ZNF93;RBM15B;PPM1F;TRIM28;HDAC4;TRIM71;SOX8;FOXP1;ZBTB16;EIF4E2;NKRF;PROX1;GLIS2;ZFPM2;TOB1;NAB1;LSM14A;CAPRIN1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),-0.44235972088352105,-0.9551688781301628,0.6024096385542169,1.0,1.0,18/59,28.59%,SPDYA;CDKN2C;MAX;BACH1;CAMK2A;CDK7;CRLF3;CDKN2A;CDK4;DBF4;CDK16;POLE;EIF4EBP1;CCND1;CDKN2D;CDC7;TFDP1;CUL4B
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.4764049529795601,-0.9547694584745415,0.5256410256410257,1.0,1.0,8/24,19.30%,B2M;ARG2;RSAD2;SELENON;CDKN2A;CGAS;CDKN2AIP;IFIH1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5731376028961801,-0.9544565709235349,0.609375,1.0,1.0,2/9,20.08%,DKC1;FBL
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.34879997129504836,0.9544471146640676,0.5333333333333333,0.9314578357417975,1.0,15/82,8.83%,LDB2;ASXL3;CSRNP3;CNTN3;RGS7BP;SORBS2;TOX3;GLS;NOL4;RUNX1T1;MAGI1;MAPK10;CACNA2D1;FGF14;EDIL3
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.5986550735031364,-0.9543759768402612,0.5714285714285714,1.0,1.0,4/7,25.64%,RFC2;RFC4;RFC3;CHTF18
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.5986550735031364,-0.9543759768402612,0.5714285714285714,1.0,1.0,4/7,25.64%,RFC2;RFC4;RFC3;CHTF18
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.5076581641240052,0.9543200354325647,0.5,0.9308688991997103,1.0,4/7,20.04%,PLXNA1;PLXNA3;PLXNC1;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.42958586880585004,-0.954192443033689,0.5662650602409639,1.0,1.0,5/44,5.10%,VEGFA;SFRP1;FLOT1;S100A10;AGT
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),-0.46286342690374704,-0.9539923917077459,0.527027027027027,1.0,1.0,4/32,13.15%,XBP1;RRP8;ATG14;ATF4
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6017106922095377,-0.9539574379579177,0.5492957746478874,1.0,1.0,3/6,26.21%,SAT2;SAT1;AMD1
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.4246218481483276,-0.9537234701261569,0.5662650602409639,1.0,1.0,14/53,17.25%,GGNBP1;TAF7L;SPATA12;BCL2L14;SMC1B;FAM229A;MS4A5;ZMYND19;ODF2;SPATA20;MAEL;TSACC;BRCA1;TMEM53
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.5455427559756145,0.9537053561199391,0.525,0.9315189984625522,1.0,1/6,0.44%,SOX11
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.5385957640760652,0.9535295524348856,0.5151515151515151,0.9311653989448468,1.0,2/7,17.59%,STARD13;RBPJ
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),-0.4038193413680982,-0.9534954115290653,0.5604395604395604,1.0,1.0,18/112,17.53%,ESRRB;POLR2I;TAF7L;TAF7;TAF11;POLR2G;TEAD3;MED1;ESR2;CDK7;NR5A2;NR4A3;GTF2F1;NR1D1;HNF4G;HDAC3;TAF9B;NR0B1
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.476475256108061,0.9533899213882484,0.5172413793103449,0.9306953316291253,1.0,5/12,24.98%,NSF;KIF16B;SNCA;RAB29;LAMTOR1
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5624340279052203,0.9528810281525006,0.56,0.9311619208211508,1.0,3/10,11.88%,KCND3;KCNN2;KCNIP2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.37419292299913964,0.9526751491735971,0.6,0.9307965634354884,1.0,13/81,10.02%,ZDHHC2;RIPOR2;ADAM10;PRKX;PKP4;ABL1;SEMA4D;PLXNA1;ADAM22;PLXNA3;ABL2;LPXN;PPP3CA
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46066155140020604,-0.9525883479612524,0.5733333333333334,1.0,1.0,3/46,2.08%,IFI6;SCG2;NOL3
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.49364110329344546,0.9523101067280979,0.4827586206896552,0.930782171436685,1.0,4/9,15.72%,ZNF516;SPTLC2;SOX8;PGRMC2
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.37445289170504636,0.9522246812520294,0.4444444444444444,0.9301844215419013,1.0,14/43,16.32%,CALCRL;CD247;CALCB;MYH9;GNG2;VIPR2;ADCY6;MAPK14;PRKACB;ADCYAP1R1;RXFP1;ADAM17;FYN;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.5689448655786213,0.9520730609190834,0.5882352941176471,0.9298985734962014,1.0,4/6,22.99%,BCOR;GREM1;PTK2B;TRPM4
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.550701334190643,-0.952068673293555,0.5138888888888888,1.0,1.0,1/12,3.07%,CDKN1C
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.49868932853473286,0.9518218023965757,0.59375,0.9297944025468096,1.0,4/10,15.34%,ADGRB3;PTGFRN;ADAMTS5;NOS1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),-0.4302798407025428,-0.9518109217037206,0.5853658536585366,1.0,1.0,6/59,10.45%,VEGFA;FGF1;ANGPTL4;XBP1;GRN;BTG1
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.577186717700313,-0.9517702687079046,0.6612903225806451,1.0,1.0,3/9,21.58%,SLC25A5;VDAC1;PARK7
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),-0.5575382387017156,-0.9514959524836457,0.582089552238806,1.0,1.0,3/8,18.19%,TGFB1;EID2B;SRA1
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.46970472873672725,0.9510994602282571,0.475,0.9298191479156095,1.0,4/12,12.38%,RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.46970472873672725,0.9510994602282571,0.475,0.9298191479156095,1.0,4/12,12.38%,RAB27A;RAB27B;BBS4;MYO5A
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.502356131073623,0.9510679203870545,0.45,0.9290828112499488,1.0,2/9,7.68%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.5878129363952727,-0.9510635712201089,0.578125,1.0,1.0,1/7,6.04%,KIF20B
prerank,PanglaoDB_Augmented_2021__Melanocytes,-0.41236755157101346,-0.950957599101719,0.5529411764705883,1.0,1.0,16/98,16.75%,FLG;TNC;FILIP1L;RHBDF1;CRYAB;FN1;OSMR;COL4A1;COL6A1;SYNC;AFAP1L1;SRPX;NRP2;CAV1;PTN;COL4A2
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),-0.5402704810171561,-0.9508642462387205,0.6190476190476191,1.0,1.0,1/12,7.62%,HVCN1
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.5902970611934568,0.9508426205349916,0.5428571428571428,0.9287475527285634,1.0,2/6,11.36%,SIRT1;KLF7
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.39626267224947237,-0.9506862508373446,0.5617977528089888,1.0,1.0,20/125,16.51%,DUOX1;VEGFA;DDRGK1;FGF1;PLET1;TMSB15B;TGFB1;SEMA4C;CEMIP;XBP1;HAS2;ELP5;GRN;WNT5B;RACK1;VIL1;HRAS;MYLK;PHPT1;CAV1
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4144385765051553,0.9504093801536262,0.48484848484848486,0.9290442863413658,1.0,5/17,7.62%,GSTM2;PDE4D;DMD;JPH1;PKD2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.38662816355325685,0.9503650238724259,0.3888888888888889,0.9283105131392541,1.0,12/60,9.00%,BARD1;ASB5;HECW2;NEDD4L;SH3D19;HACE1;FOXO1;SNF8;TIPARP;SNX33;MSN;NSF
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.3134888035510238,0.9503284762355406,0.5555555555555556,0.927577999633627,1.0,31/117,15.54%,NLGN1;RYK;SGK1;MAP2;PARD3;CNTNAP2;DSCAML1;NTNG2;ARC;WNT7A;DCC;NRCAM;BMP7;WASL;RAB10;SLITRK5;LRRK2;CTNNA2;ZDHHC17;KLF7;SDC2;BTBD3;MAP4K4;FARP1;LMTK2;ALCAM;FLRT3;NCKAP1;CTNND2;SPTBN4;DOCK10
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.44687612947638,0.9502986732573553,0.4166666666666667,0.926846742583412,1.0,2/14,7.84%,SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),-0.629633923648256,-0.9502061275956771,0.625,1.0,1.0,2/5,20.57%,CARD8;GSTP1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),-0.47644267911335747,-0.9500548117533684,0.5555555555555556,1.0,1.0,5/37,13.40%,DENND3;SIDT2;NCBP1;SUPV3L1;RNASEH2C
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.5414379665831931,0.9498730762988491,0.5,0.9269899855414533,1.0,1/9,0.25%,IL15
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),-0.5770177478044902,-0.9498330764957468,0.6231884057971014,1.0,1.0,2/6,12.24%,CACNA1C;AKAP5
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.37536062196221887,0.9497537049611692,0.42105263157894735,0.9264016236472115,1.0,10/55,11.28%,DAPK2;BOK;ABL1;OSBPL7;KEAP1;ABL2;KAT8;HSPB1;LRRK2;MTMR3
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.5906019497743744,-0.9496048967616416,0.6029411764705882,1.0,1.0,3/8,17.44%,HAS2;MEF2C;HDAC3
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.6386316465026013,-0.9492896832927078,0.6206896551724138,1.0,1.0,3/5,18.40%,PLEKHH2;VIL1;GSN
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.3896914828822152,0.9490650702950659,0.6,0.9262526320268467,1.0,2/20,1.29%,ZDHHC2;ZDHHC11
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.3896914828822152,0.9490650702950659,0.6,0.9262526320268467,1.0,2/20,1.29%,ZDHHC2;ZDHHC11
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.5851969189122195,-0.9487349388140566,0.6,1.0,1.0,1/8,6.04%,KIF20B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),0.5320595243536272,0.9487204775989849,0.4666666666666667,0.9263319030460673,1.0,2/6,13.70%,NFATC1;NFATC3
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.5112538289610997,0.9484322022727429,0.5588235294117647,0.9262064455370411,1.0,3/7,16.01%,POT1;ERCC4;TERF1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4650868375206063,-0.9480128766951956,0.5316455696202531,1.0,1.0,4/31,8.45%,CLU;RASGRP1;OAS3;OAS1
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.5668786444703429,0.9480090669492388,0.574468085106383,0.9264772634289824,1.0,2/5,10.11%,COLGALT1;CHADL
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.6097146035064417,-0.9479920305962465,0.5833333333333334,1.0,1.0,1/5,8.64%,GLUL
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),-0.4821046980658652,-0.9479447729905249,0.5324675324675324,1.0,1.0,3/19,9.56%,HES1;MEF2C;COL4A1
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),-0.43420084319525276,-0.9478310867865622,0.5657894736842105,1.0,1.0,2/40,2.11%,VEGFA;ECM2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.41520554896245476,-0.9477922773705639,0.6413043478260869,1.0,1.0,16/103,17.07%,TXNDC17;PSMB9;SFRP1;YBX3;PSMB8;HAS2;PSMA3;CACTIN;ZFP36L2;ADAMTS7;NR1D1;ASAH1;PSMA7;PSME1;STAT1;BRCA1
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.45358145119660787,-0.9477749639788497,0.625,1.0,1.0,7/37,14.67%,RPL10;RARRES2;TGFB1;ZFPM1;TEAD3;ATF4;RNF112
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.5752342014009574,-0.947593074803237,0.5714285714285714,1.0,1.0,1/9,16.51%,CAV1
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.4856413147975486,-0.9469478597687195,0.5507246376811594,1.0,1.0,7/19,21.11%,RHBDF1;RSAD2;SYT11;APOE;SYT4;TNFRSF1A;ERP29
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.49427223504289397,-0.9469310354183407,0.5657894736842105,1.0,1.0,3/19,15.21%,PGRMC1;UROD;NFE2L1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.5520145114009751,-0.9469196007171168,0.6027397260273972,1.0,1.0,1/11,1.65%,HAP1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.432667264487811,0.9468673222686635,0.5384615384615384,0.9282794553091838,1.0,5/22,11.59%,MAP2;CAMSAP2;ABL1;CHRNA7;PIK3CA
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.5688612284984116,-0.9467983386711829,0.5942028985507246,1.0,1.0,5/8,30.76%,PYGL;GBE1;PHKB;UGP2;PHKG2
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.3151489703374028,0.9467921786390142,0.6,0.9276552378371052,1.0,55/318,13.94%,VAPB;TTC29;WDR81;TRAPPC12;FMNL3;TFB1M;FNBP1L;PCLO;PLD2;NDP;SMPD4;LIG4;LIMD1;SH3KBP1;FGD4;ZRANB1;YTHDF1;COG3;PLIN5;TMED5;GOLGA8N;ARC;SH3D19;RAB31;HACE1;MTX2;BIN1;PKD2;TRAPPC8;CAPZB;EPS15;WASF3;PPRC1;TMED3;SYNE3;WASL;SEC16A;PIKFYVE;BRWD3;VAPA;LRRK2;FBXW8;AGTPBP1;PALLD;BAG5;BLZF1;SEMA6A;MAST3;PRKD1;CLASP1;TMCC1;COG7;RHOT1;ATL2;PACSIN2
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.5470963772628773,0.9467655036924473,0.5161290322580645,0.9268919025257076,1.0,1/8,4.79%,SLC44A1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.5028989708089802,-0.9463003312135282,0.6493506493506493,1.0,1.0,5/21,18.97%,TGFB1;AP2A1;CLTA;MYLIP;AP2A2
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.6027328153195487,-0.9461300169006255,0.5416666666666666,1.0,1.0,1/8,7.93%,SFRP4
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4020154695666145,-0.9460222376402488,0.5913978494623656,1.0,1.0,14/95,16.82%,PSMB9;SFRP1;DVL1;PDE6B;PSMB8;AP2A1;SFRP4;CAMK2A;PSMA3;DAAM1;CALM1;DVL2;PSMA7;PSME1
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),-0.49250784696892225,-0.9458937634684054,0.5522388059701493,1.0,1.0,4/19,13.70%,TRIM5;IRF1;ERAP1;CD55
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),-0.5100623366688083,-0.9458654404411302,0.5789473684210527,1.0,1.0,6/17,21.90%,PFN2;TMSB15B;VIL1;GSN;TMSB10;HIP1R
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5445972811003199,-0.9455716091822945,0.5633802816901409,1.0,1.0,5/11,18.21%,ALOX5;CLU;LPCAT3;USP19;WFS1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),-0.5329936726857398,-0.9453458740947057,0.5774647887323944,1.0,1.0,1/12,2.98%,CREB3
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),0.5574304876026315,0.9448351531814408,0.6944444444444444,0.9304844674351481,1.0,3/6,10.59%,SIRT1;AKR1C3;DGKQ
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.45398799328953593,-0.9445151833227816,0.5609756097560976,1.0,1.0,6/38,14.68%,VEGFA;TGFB1;MEF2C;STAT5A;P2RX4;APOE
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.43901069657671293,-0.9443458760728723,0.5529411764705883,1.0,1.0,9/59,14.08%,VEGFA;FGF1;TGFB1;AGT;STAT5A;PIK3CB;GRN;P2RX4;NRP2
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.3735509541563821,0.9437898476075255,0.45454545454545453,0.9320099771899869,1.0,19/81,15.36%,PLD1;MAPK11;RIT2;PLD2;TNK2;KSR1;RIN2;MAPK14;MAPKAPK5;TRIM28;RAPGEF6;PRKD1;RRAS2;RAPGEF2;TIAM2;SOS1;ARL3;NRAS;RGL1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.5246263729019183,-0.9437752006511316,0.5974025974025974,1.0,1.0,1/19,0.82%,RPS23
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.36499145946103523,0.9437012244227705,0.5,0.9314101356802839,1.0,8/41,13.37%,SYTL4;DYSF;MYH9;WNT7A;ANXA6;PPP3CA;CFLAR;MYOF
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.5847735360287722,0.9436777077390638,0.5294117647058824,0.9306843069882526,1.0,1/5,7.63%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.5304426480321776,0.9435740001949062,0.5121951219512195,0.9302388793845796,1.0,1/5,0.44%,SOX11
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.4634956267629681,-0.9428485448257368,0.5833333333333334,1.0,1.0,3/25,14.78%,ENPP2;AVIL;VIL1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.46677159920740885,0.942761168638676,0.45161290322580644,0.9314424620274169,1.0,3/10,9.30%,RIPOR2;PLCB1;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.5392172534852111,-0.9425327821666896,0.5285714285714286,1.0,1.0,3/11,15.97%,RANGRF;RIC3;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.4830259966640566,-0.942360920010528,0.5714285714285714,1.0,1.0,6/17,21.58%,HAX1;HDAC6;SREBF1;VDAC1;DNM1L;PARK7
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.3965751998219123,-0.9423531491853279,0.5764705882352941,1.0,1.0,6/75,11.94%,VEGFA;FGF1;ECT2;TOM1L1;EMP2;STRADB
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),-0.5086564446057892,-0.9423091517304348,0.6323529411764706,1.0,1.0,9/19,31.81%,ALOX5;APOD;CHID1;ADCY7;PLD3;CUEDC2;STAT3;APPL1;PDCD4
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4874764093487611,-0.9421325634668921,0.6111111111111112,1.0,1.0,11/24,21.58%,CREB3;ALOX5;SELENOS;CLU;XBP1;LPCAT3;RACK1;SYVN1;WFS1;UBXN1;PARK7
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.3868036134173966,0.9420788674909265,0.52,0.932618673514786,1.0,9/30,19.98%,RAB27A;ARFGEF2;SNX33;WASHC5;TMCC1;CORO1C;HOOK1;SNX3;DNAJC13
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.5721611044426463,-0.9420339993756992,0.5925925925925926,1.0,1.0,4/6,27.44%,WNK3;PDZK1;ANO6;TRPC6
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),-0.39095287892867553,-0.9419536611108841,0.5978260869565217,1.0,1.0,39/151,22.27%,ISG15;IL12RB2;FLOT1;BTN3A1;POLR3D;POLR3H;TGFB1;POLR1C;AGT;ZFPM1;IRF1;HTR2B;RASGRP1;HLA-A;XBP1;GAPDH;SCAMP5;POLR3E;ATF4;C3;IL7;CD46;EIF2AK2;BRCA1;CGAS;PRKCQ;MAPK13;HSPD1;RFTN1;IFIH1;RARA;IL18;CYP1B1;CD226;DHX36;PARK7;C1QTNF4;SPHK2;RUNX1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.33341968057389587,0.9415837575902162,0.5294117647058824,0.9329068745881836,1.0,11/58,14.47%,PHLDB2;ARAP1;PPM1E;ABL1;ARHGAP28;TMEFF2;PPM1F;NF2;CLASP1;NRP1;LPAR1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5368155689669993,0.9414659014432013,0.5882352941176471,0.9322966665770827,1.0,2/7,11.88%,ANK2;KCNIP2
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.6181503697235256,-0.9413305928114986,0.6,1.0,1.0,1/5,13.83%,CTDP1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.5705526384132577,-0.9411381584891468,0.6119402985074627,1.0,1.0,3/12,23.48%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.39365741183090136,-0.9410606475272961,0.6363636363636364,1.0,1.0,33/156,18.07%,SRSF7;NOL3;RBM3;RBM8A;SNRPA1;DHX16;PRPF18;SNRPD1;RBMS2;LSM5;PDCD7;SNRPD2;PRPF8;RNPC3;SNRPB;SRSF5;SRRM4;LUC7L3;PRPF4;SNRNP25;NCBP1;HNRNPA2B1;PRPF6;MAGOHB;SCNM1;SRPK1;ADAR;DKC1;RBPMS;RP9;KIN;USP39;SF3A3
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.6091070452326642,-0.9406136606192782,0.5689655172413793,1.0,1.0,2/5,20.52%,RARA;IL18
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.3983814050816873,0.940599150897085,0.5,0.9333807296414091,1.0,8/23,18.96%,UBE2E2;UBE2H;ANAPC4;UBE2E3;CDC16;ANAPC1;RNF4;PRKN
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.5117685046789257,-0.940393981857095,0.5428571428571428,1.0,1.0,7/16,20.00%,RPL11;GORASP1;RPL23;RPS7;USP44;RPL5;FZR1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.4837494599899712,0.9402864487256934,0.5,0.9333392975972158,1.0,3/8,21.63%,SMG1;MTOR;MLST8
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),0.45858881155241576,0.9401541420026202,0.4583333333333333,0.9328311854173923,1.0,3/12,12.78%,SAXO2;PCM1;CLASP1
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.5454985118274845,-0.9397209880452132,0.5757575757575758,1.0,1.0,1/8,12.30%,DDX11
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.47769352680013605,0.939641452876686,0.5357142857142857,0.9334078936114915,1.0,4/10,19.87%,LRFN5;MFHAS1;CD200;GPR137B
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.4621060644482309,-0.939600989661598,0.5925925925925926,1.0,1.0,5/25,23.62%,ATP6V0A4;ATP6V1F;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.5165203096814059,-0.9390551401515935,0.578125,1.0,1.0,2/16,7.72%,CTSL;PGK1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.38417505233362753,-0.93896375932032,0.6595744680851063,1.0,1.0,29/243,11.37%,S100A6;ROMO1;VEGFA;HES5;DDRGK1;IL12RB2;SPDYA;FGF1;SFRP1;HES1;RPS9;TGFB1;HMGN5;AGT;RPL23;HTR2B;FAM98B;KIF20B;RTKN2;XBP1;DERL2;HAS2;MEF2C;FN1;OSMR;GRN;ID2;RPS4X;EMP2
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.45359787635388554,-0.9389484349547031,0.5897435897435898,1.0,1.0,3/31,6.48%,TGFB1;OLFM1;DDX5
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.4557282839466283,-0.9388074566041742,0.5641025641025641,1.0,1.0,3/30,6.48%,DDRGK1;HDAC6;DDX5
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5270811075753232,0.9387916208521107,0.5428571428571428,0.9344873789621273,1.0,2/9,13.87%,TRAPPC8;PACS2
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.5471766561694577,0.9387599628503195,0.5945945945945946,0.9337530871437433,1.0,1/6,12.66%,CDS2
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),-0.4826152363144203,-0.9385324970979146,0.5774647887323944,1.0,1.0,5/21,11.58%,OPRM1;RETREG1;SCN9A;NIPSNAP1;P2RX4
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5778460981013109,-0.9384456098703307,0.6065573770491803,1.0,1.0,4/7,32.77%,TPST1;TPST2;ENPP1;BPNT2
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.4653784247911479,0.9381413176260424,0.5714285714285714,0.9343527155436516,1.0,6/13,13.78%,SOX11;SOX8;SEMA3A;PHACTR4;SOX10;NRP1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.49625678182012345,0.9379115382241627,0.5384615384615384,0.9341222472623358,1.0,3/10,6.21%,AIFM2;MCTP1;STOX1
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),-0.4507270696155527,-0.9378642770587673,0.5844155844155844,1.0,1.0,7/35,16.97%,EIF2B2;XBP1;STAT5A;ZBED3;KHK;CAV1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.4934669754134941,-0.9375630159303651,0.6129032258064516,1.0,1.0,4/14,21.17%,CEMIP;P2RX4;CAV1;THY1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),-0.5154831113108046,-0.9373051688201587,0.5492957746478874,1.0,1.0,4/12,19.90%,CAMK1;KAT5;TERF2IP;FAM161A
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.4962989590910539,0.937035008242082,0.5833333333333334,0.9353355841363636,1.0,3/9,18.61%,ERBB4;LATS1;AKT2
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.5427294955524271,0.9367857833408972,0.6774193548387096,0.9343854713995281,1.0,3/10,17.63%,XPR1;SLC25A14;SLC20A2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.5427294955524271,0.9367857833408972,0.6774193548387096,0.9343854713995281,1.0,3/10,17.63%,XPR1;SLC25A14;SLC20A2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.41719353434047934,-0.936624739168017,0.5641025641025641,1.0,1.0,10/44,13.70%,TACR1;JPH3;HTR2C;FPR3;CACNA1C;GRM1;LPAR6;P2RX4;TAC4;CD55
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.5591313275928257,-0.9361583007650446,0.5671641791044776,1.0,1.0,2/10,14.87%,STX19;STX1B
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),-0.6068013790012714,-0.936106746598885,0.5454545454545454,1.0,1.0,2/5,13.70%,HLA-A;CD55
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.4087937240724577,0.93589942391302,0.4827586206896552,0.9356080674390176,1.0,1/16,0.25%,IL15
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.29949685804480164,0.9358250319067196,0.5,0.9349646976114252,1.0,37/181,15.09%,DAPK2;FBXW7;TAB3;LEPR;BOK;ABL1;OSBPL7;ZKSCAN3;TBC1D14;TP53INP1;FOXK1;SLC38A9;KEAP1;CTSA;ABL2;FOXO1;KAT8;EEF1A2;HSPB1;EIF4G3;ATP6V1A;LRRK2;CAPNS1;DAPL1;DHRSX;NEDD4;MTMR3;HMGB1;LAMTOR2;PRKD1;TAB2;WASHC1;MAPK8;BCL2;FOXO3;NPRL2;MID2
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),-0.3892825169355121,-0.9357104961365178,0.6373626373626373,1.0,1.0,21/133,17.44%,VEGFA;FGF1;FLOT1;CAMK1;RARRES2;TGFB1;RASGRP1;EFNA1;ANKLE2;ATG14;CALM1;PTPA;RACK1;DVL2;PPP2R5A;C3;HRAS;ALG10B;KAT5;TERF2IP;HDAC3
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.44090449949606836,-0.9356729107976531,0.581081081081081,1.0,1.0,6/30,17.76%,HAP1;CLU;EFNA1;APOE;RTN2;CASP3
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5691077736532395,0.9356130929139251,0.72,0.9346473783183523,1.0,2/6,12.69%,ARFGEF2;LMTK2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.42453572613441914,0.9352894907152913,0.5714285714285714,0.9345179185884765,1.0,3/23,8.51%,NR1H2;PLIN5;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3353173767594026,0.9349211672732286,0.75,0.9346382407368631,1.0,9/65,8.70%,ZNF516;PDGFC;LEPR;ACACB;ESRRG;ACACA;IGF1R;FASN;ADIPOR2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.6415636034990706,-0.9346057059266842,0.6212121212121212,1.0,1.0,1/5,21.81%,NUMA1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.5581594484145903,-0.9344190793292049,0.5714285714285714,1.0,1.0,2/11,11.90%,FADS2;ELOVL2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.37714788901271346,0.9343936785735437,0.52,0.9351448686140519,1.0,1/22,0.30%,BAIAP3
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),-0.5798428989017285,-0.9343489997802764,0.5901639344262295,1.0,1.0,3/7,14.67%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),0.5134179348227645,0.9340619433588749,0.5384615384615384,0.9352270968623783,1.0,3/9,19.07%,ICE2;ELL;MTOR
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.43717780053151994,0.9339478322345652,0.5357142857142857,0.9348486412886835,1.0,4/15,14.53%,PPM1E;PDE4B;PPM1F;RAP2A
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.4960606519591794,-0.9339402599858837,0.5733333333333334,1.0,1.0,3/17,15.21%,PGRMC1;UROD;NFE2L1
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.5309285688677764,-0.9338046396542969,0.6,1.0,1.0,1/12,1.34%,PARP2
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),-0.47643088754544827,-0.9337949748034032,0.6176470588235294,1.0,1.0,8/21,27.60%,MED1;ZFP36L2;VIL1;GAREM1;PDE8A;SYAP1;SOX9;MARS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.45202669049847977,0.9335963992570384,0.59375,0.9348439206408373,1.0,4/16,5.72%,GSTM2;ANK2;PDE4D;DMD
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.4200484789607301,0.9333784800286883,0.47368421052631576,0.93445398383294,1.0,4/27,11.95%,HSPA1A;PTPRC;AFAP1L2;HMGB1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.5751896807319996,-0.9333592607783562,0.6181818181818182,1.0,1.0,1/7,5.41%,PARP14
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.3980120155523853,0.9333550227721311,0.4166666666666667,0.9337294534596458,1.0,2/21,4.14%,SOX11;DSCAML1
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.46073143651845117,-0.9332085058750286,0.625,1.0,1.0,6/27,21.21%,KIF20B;OBSL1;TOM1L1;USP44;PDGFRB;BTC
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.6245899517901373,-0.9330252090239335,0.6290322580645161,1.0,1.0,1/5,3.31%,PAH
prerank,MSigDB_Hallmark_2020__p53 Pathway,-0.3767784989927418,-0.9329823753623481,0.6086956521739131,1.0,1.0,31/135,19.44%,PMM1;JUN;TGFB1;RPS12;S100A10;PROCR;RPL36;RPL18;FUCA1;HINT1;RRP8;BTG1;DDIT4;TAP1;STOM;RACK1;PLXNB2;RPS27L;ISCU;TRIB3;SLC3A2;HRAS;BAX;FOS;CCNK;CDKN2A;HDAC3;H2AJ;CDKN2AIP;TSPYL2;DDB2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.5050882578949052,0.932710156784415,0.5135135135135135,0.9343211593258502,1.0,5/8,23.74%,LANCL1;FYN;PINK1;PRKN;UBQLN1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),0.5503336181020871,0.9326265190790096,0.5555555555555556,0.9337590820632844,1.0,1/7,1.84%,BARD1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),-0.5041653127850035,-0.9325568778032536,0.6527777777777778,1.0,1.0,2/20,4.90%,PFN2;HAX1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.3511179349143737,0.932175623281667,0.52,0.9338915218918413,1.0,4/26,8.63%,USP51;H1-10;PPP4R2;SMARCAD1
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.4218513199124311,-0.932147305993625,0.6341463414634146,1.0,1.0,15/67,18.55%,NEFM;GDAP1L1;SCG2;IGFBPL1;JPH3;INA;CACNA1B;TMEM179;STMN2;ZDHHC22;KIF1A;BRCA1;SYT4;MPP2;NCAN
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.45914232040011815,0.9320565730053924,0.4838709677419355,0.9333802287871826,1.0,4/12,6.01%,TSPAN8;SLC26A3;CREB3L1;CDON
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.5536318267360953,-0.9319052354406736,0.6333333333333333,1.0,1.0,4/9,18.97%,AP2A1;CLTA;MYLIP;AP2A2
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.5536318267360953,-0.9319052354406736,0.6333333333333333,1.0,1.0,4/9,18.97%,AP2A1;CLTA;MYLIP;AP2A2
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.3543219944055154,0.9318694250938543,0.5333333333333333,0.9331789059643939,1.0,11/72,11.57%,HSPA1A;RPA1;ATR;BAG2;SIRT1;MAPK1;NUP98;NUP93;MAPK3;HSPH1;BAG5
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5969575015064637,-0.9317656192687958,0.6470588235294118,1.0,1.0,1/6,7.50%,JAG1
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),-0.4945310671199934,-0.9316133658813973,0.6451612903225806,1.0,1.0,3/23,4.11%,ITGA4;DVL1;AGRN
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.4297067792892124,0.9316028853238977,0.5416666666666666,0.9330396894274493,1.0,10/23,14.95%,FEM1A;FBXW7;ABL1;SMAD7;DCUN1D2;DCUN1D5;UBE2N;BAG5;ARRDC4;DCUN1D1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.3347581190217717,0.9314663245903023,0.4166666666666667,0.9326044296396593,1.0,28/87,19.50%,HSPA1A;SEPTIN4;FBXW7;BAG2;INAVA;PRMT3;SMAD7;FAM107A;HSPBP1;UBE2D1;GNL3L;NDFIP2;XIAP;LRRK2;UBE2N;RCHY1;BAG5;WASHC1;N4BP1;DCUN1D1;PINK1;TBC1D7;MYCBP2;SPOPL;PRKN;BCL10;IVNS1ABP;SASH1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5425534326332959,0.9314344769882653,0.6111111111111112,0.9319478647612316,1.0,3/7,25.23%,FOXP1;CDK6;CTNNBIP1
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),0.42378042137384153,0.9312818339837176,0.53125,0.93150189435537,1.0,2/19,4.55%,ATR;LIG4
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),-0.5843440293350739,-0.9311522594599957,0.6333333333333333,1.0,1.0,4/5,41.44%,TIMP3;TIMP1;LRP1;TIMP2
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.575088782150235,-0.9309547962821073,0.6166666666666667,1.0,1.0,3/6,9.32%,GSTM4;GSTO1;GSTM3
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3376651854047978,0.930907354029394,0.5454545454545454,0.9316354271246898,1.0,5/32,7.95%,SHROOM2;PBX3;PBX1;SMOC1;MEIS1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3454788970984301,0.9307600694766627,0.4444444444444444,0.9312396621389555,1.0,14/111,6.59%,TP63;HIP1;DAPK2;SEPTIN4;AIFM2;BCAR1;SGK1;ACER3;TOX3;ABL1;SIRT1;BCL2L11;TP53INP1;CRADD
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.4361825576837251,-0.9305254088861331,0.5747126436781609,1.0,1.0,19/56,28.71%,PSMB9;PSMB8;LDB1;LMO2;PSMA3;PSMA7;EIF2AK2;PSME1;LMO1;RUNX1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4;SETD1A
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),0.5340110145392346,0.930163889943622,0.4864864864864865,0.9318895413487823,1.0,1/7,4.72%,TOX
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),-0.513710416753118,-0.9299555775312904,0.5915492957746479,1.0,1.0,4/17,13.75%,PRELP;OMD;ACAN;OGN
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.4250818049760318,-0.9296952348351651,0.5595238095238095,1.0,1.0,9/49,18.13%,SFRP1;PLET1;LDB1;JAG1;PIK3CB;EMP2;CDKN2A;RASA1;VCL
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.3185514300234073,0.9290096884568209,0.6842105263157895,0.9335947774781295,1.0,7/53,9.23%,CRB2;SOX11;ELAPOR2;ZEB2;BMP7;TWSG1;NUP93
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.35911133544735274,0.928710049651529,0.4444444444444444,0.9334684064093245,1.0,11/47,14.10%,TAB3;LEPR;ZKSCAN3;TBC1D14;PLIN5;FOXK1;EIF4G3;DAPL1;TAB2;WASHC1;BCL2
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.3688837039124896,0.9284958387280121,0.5333333333333333,0.933072436906944,1.0,6/48,5.83%,LAMA3;ADAM10;BCAR1;ITGA2;ABL1;MYH9
prerank,GO_Biological_Process_2021__lung development (GO:0030324),-0.5158024766956752,-0.928495568019391,0.5975609756097561,1.0,1.0,2/18,2.44%,VEGFA;FGF1
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.4643938793232856,-0.9282459553482423,0.6103896103896104,1.0,1.0,2/23,1.85%,CD63;RANGRF
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.6117947008192799,-0.9279720744073542,0.639344262295082,1.0,1.0,1/6,0.61%,ROMO1
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.4582520017518213,-0.9279076408286088,0.5733333333333334,1.0,1.0,3/27,6.48%,JUN;TGFB1;DDX5
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4672577352674624,-0.927885465395008,0.6216216216216216,1.0,1.0,8/25,20.55%,VEGFA;SCG2;EMP2;GIPC1;PTP4A3;STAT1;LGALS8;CYP1B1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.4358054332205799,0.9276667481260378,0.5,0.9343436382386378,1.0,5/20,15.49%,LARGE1;TMTC1;DPY19L3;CRPPA;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.48186692712558277,-0.9274508451611647,0.6027397260273972,1.0,1.0,3/33,5.07%,PFN2;SFRP1;S100A10
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.5138343268839434,-0.9272847320538841,0.5942028985507246,1.0,1.0,4/11,22.09%,TAF7;BRCA1;SET;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.3494213553455494,0.9271262020977917,0.6470588235294118,0.9348781322568807,1.0,13/35,19.02%,MCTP1;EPHA3;NR1H2;DYSF;SNX33;NDFIP2;PPM1F;PRKD1;SNCA;PXK;PRKN;SNX3;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.5320471710218008,-0.9270366044273545,0.647887323943662,1.0,1.0,2/14,9.53%,SRSF7;SRSF10
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),-0.42017366639210085,-0.9266078177565835,0.5662650602409639,1.0,1.0,10/41,22.69%,RPS27A;SUPV3L1;DDX11;UBA52;PIF1;UBC;XPA;DDB2;RECQL;RBX1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.38788020760573294,-0.9265168743666633,0.611764705882353,1.0,1.0,18/105,16.67%,S100A6;IFIT1;HES5;ISG15;RBM3;ARX;ZIC1;INA;INAFM2;PLEKHH2;STMN2;KLHDC8A;ZDHHC22;KIF1A;APOE;IFI44;PROM1;PTN
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.5871900801616395,0.9264509716910935,0.6363636363636364,0.9358154704007675,1.0,1/5,5.96%,SMAD7
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),-0.5108709371738092,-0.9263856031122081,0.5652173913043478,1.0,1.0,3/11,21.79%,IFITM3;TRIM32;TRIM13
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),-0.39711967888344035,-0.9263116213977552,0.6630434782608695,1.0,1.0,11/122,9.20%,RSPO4;PSMB9;SFRP1;TGFB1;PSMB8;ATP6AP2;SFRP4;GPC3;PLEKHA4;PSMA3;CDH3
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.3829094782958153,0.9260637374453571,0.6,0.9360178476757403,1.0,2/29,1.56%,MAPK11;HSPA1A
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.4709387785945838,0.9255947861141364,0.5142857142857142,0.9362809645795098,1.0,3/10,16.41%,GLRA1;GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),-0.46893566627285377,-0.9253999894228255,0.6153846153846154,1.0,1.0,6/17,25.89%,PARP2;TERF2IP;MBD4;MPG;NTHL1;OGG1
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.4638019060979826,-0.9253662820101161,0.5903614457831325,1.0,1.0,1/27,2.15%,PHF1
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.5150300569809123,-0.9251403753845616,0.5737704918032787,1.0,1.0,2/9,17.35%,TGFB1;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.4799883123883393,0.9251350148761945,0.6857142857142857,0.9364948371371277,1.0,1/10,0.77%,ASXL3
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.32571357730866596,0.9249936474348449,0.625,0.9360986604384809,1.0,28/96,14.25%,ASXL3;NOVA2;CSRNP3;ADGRB3;DCX;ASTN1;NRXN1;ADGRL3;ANK2;MAGI2;GRID2;LSAMP;NOVA1;RUNX1T1;GUCY1A2;FMN2;GRIA1;CNTN1;UNC5D;CLVS2;CPT1C;CTNNA2;SLC35F1;ADCYAP1R1;NFASC;TMEM200C;PCDH17;KCNQ2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.33850983450613015,0.9249162371459528,0.631578947368421,0.9356056550462275,1.0,9/37,19.47%,CRADD;PML;ARID3A;PCBP4;CNOT6L;CNOT2;CNOT9;CNOT7;MDM4
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3264054699439152,0.9248183842731511,0.5882352941176471,0.93508910221218,1.0,11/45,20.80%,RFWD3;CRADD;PML;ARID3A;PCBP4;CNOT6L;CNOT2;CNOT9;CNOT7;MDM4;SDE2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.44682543839551797,0.9247690350298396,0.6206896551724138,0.9344274159656875,1.0,3/17,10.82%,PCM1;BBS4;NEDD1
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.5006900285829162,-0.9246865187808623,0.5675675675675675,1.0,1.0,3/19,9.69%,SLC35F3;SLC6A6;MGST1
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),-0.5863375955125846,-0.9245516725600066,0.6557377049180327,1.0,1.0,2/6,14.78%,STMN2;VIL1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.44873555954850913,-0.9244818571316367,0.6463414634146342,1.0,1.0,7/47,11.73%,PPIF;ROMO1;ECT2;JUN;HDAC6;PJVK;PRDX5
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.4411659313200467,-0.9238677153186305,0.5833333333333334,1.0,1.0,12/55,22.01%,CRYM;ACMSD;PIPOX;BCAT2;GLUL;ACAD8;SHMT1;ALDH4A1;GOT1;MTRR;SLC25A44;HSD17B10
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.4238610741916589,-0.9238041068925559,0.5844155844155844,1.0,1.0,13/46,21.07%,GSTM4;ALOX5;ALOX12;GPX4;EPHX2;FADS2;ELOVL2;ACOT2;FAAH2;ACADL;CYP1B1;GSTP1;ACSBG1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),-0.39885181904165307,-0.9237805162919938,0.6428571428571429,1.0,1.0,16/69,20.55%,IFI6;SELENOK;PDK1;DDX5;HINT1;RRP8;ATF4;DNAJC10;TRIB3;AIFM1;BAX;BRCA1;BAG6;MSH6;BCL2L2;CYP1B1
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5094500392362613,0.9233648423209464,0.5357142857142857,0.9373523703018495,1.0,2/10,9.15%,AK3;CMPK1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),-0.37591377937314385,-0.9228430399428547,0.6421052631578947,1.0,1.0,16/177,7.18%,ESRRB;ETV4;VEGFA;HAP1;PPIB;FLOT1;BTN3A1;TGFB1;LRPAP1;AGT;HTR2B;OLFM1;KDM6B;XBP1;GAPDH;TLE6
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.5433489186790134,0.9228206652860721,0.5454545454545454,0.93800154088891,1.0,1/6,4.19%,FERMT1
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5975080983441778,-0.9228034111867525,0.6461538461538462,1.0,1.0,2/5,21.51%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5975080983441778,-0.9228034111867525,0.6461538461538462,1.0,1.0,2/5,21.51%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5975080983441778,-0.9228034111867525,0.6461538461538462,1.0,1.0,2/5,21.51%,APOE;ERLIN2
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.31800017904316197,0.9221428819012142,0.5294117647058824,0.9387831427899862,1.0,21/102,10.04%,DHCR7;BCAR1;BOK;AOX1;PC;CDC42EP4;PLIN5;MPDZ;SH3D19;CHST3;FKBP5;SLC16A2;SLC7A2;MAGI1;UNC13B;EGFR;RORA;MMP15;ADCY6;KCTD3;CLDN12
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.47768658811445697,-0.9219073767724904,0.5652173913043478,1.0,1.0,2/15,7.74%,TGFB1;HAS2
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),-0.4002644814979556,-0.9217744946080753,0.6195652173913043,1.0,1.0,25/103,23.92%,PSMB9;RPS27A;PSMB8;POLE3;RFC2;PSMA3;RPA3;PNKP;UBA52;RFC4;GINS3;PSMA7;RFC1;PSME1;GMNN;UBC;MGME1;RFC3;POLD2;DBF4;RECQL;PSMB6;POLE;PSMB1;PSMC4
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),-0.48499407123030014,-0.9213662796245474,0.5714285714285714,1.0,1.0,1/14,1.43%,RIMS1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.5067658139466932,0.9213082860405658,0.525,0.9397938542838737,1.0,3/8,11.94%,FPGS;PRKG2;QDPR
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.42721826868872936,0.9211945315050307,0.5625,0.9392158453776217,1.0,6/17,24.68%,PDE4D;RAPGEF2;PEX5L;CDC34;PRKAR1B;RASD2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),-0.36401981180894893,-0.9210899877468867,0.6702127659574468,1.0,1.0,25/202,13.85%,GADD45B;TFPT;VAV3;RPS27A;SFRP1;ECT2;STK17A;JUN;RASGRF2;ARHGEF18;CLU;OLFM1;HDAC6;SFRP4;APH1A;PDCD5;ITGB3BP;PTPA;MTCH1;IFIT2;DNM2;ATF4;RACK1;OBSCN;UBA52
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.5236653164639868,0.9210334684222883,0.625,0.9388929831514687,1.0,2/8,13.19%,PON3;MPST
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.44981439416340185,0.9209204859994478,0.5666666666666667,0.9383892080013468,1.0,5/15,14.76%,ARFIP1;FCHSD2;WASF3;CTNNA2;NCKAP1
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.5991805022294335,-0.9209179278642581,0.65625,1.0,1.0,3/5,35.42%,C3;PANK2;MBOAT7
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),-0.6023322358914804,-0.9208407175665149,0.6,1.0,1.0,2/6,30.26%,FBN2;RARG
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.47195356173577574,0.9208138080407393,0.3684210526315789,0.9378862453917896,1.0,3/18,4.45%,SOX11;GRIK2;HOMER1
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.30048239484427214,0.920637669479388,0.8181818181818182,0.9376739200625056,1.0,20/75,20.15%,BAIAP3;VTI1A;TBC1D14;RAB9A;PIKFYVE;GGA1;ERC1;ARFRP1;VPS50;WASHC1;GBF1;SNX3;TBC1D5;WASHC2C;YKT6;RAB29;DENND5A;VPS54;TBC1D23;TRAPPC10
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.523583424238625,-0.9203982343771455,0.6486486486486487,1.0,1.0,5/12,23.44%,ANGPTL4;XBP1;APOE;IL18;MTLN
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.5509752445023098,0.9194438837213511,0.6,0.9396097539812307,1.0,1/5,3.60%,BOK
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.4647788384539223,-0.9194075304411626,0.6212121212121212,1.0,1.0,3/18,12.06%,HAP1;FUZ;SAXO1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5091854693296772,-0.9193913292990207,0.5263157894736842,1.0,1.0,1/14,2.08%,NOL3
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.3813081133874514,0.9193555159061486,0.5,0.9390346832517609,1.0,2/23,5.67%,DHCR7;ACAA2
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.4424446529295804,-0.9192919651822815,0.5822784810126582,1.0,1.0,4/31,16.51%,MX1;CEACAM1;DNM2;CAV1
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.5081174222738314,-0.9189346124932954,0.6212121212121212,1.0,1.0,3/9,8.54%,VEGFA;RSAD2;PIK3CB
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),-0.39529538814324555,-0.9189313079944924,0.6629213483146067,1.0,1.0,7/105,4.37%,TRIP10;ARHGAP15;A2M;VAV3;ECT2;RASGRF2;ARHGEF18
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3476654059547229,0.9185242824076784,0.5333333333333333,0.9400627867707451,1.0,9/50,11.38%,SGK1;NEDD4L;SLC8A2;PKD2;SLC12A1;SLC24A3;SCNN1D;SCN11A;SLC8A1
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),-0.5238587398777024,-0.9184566541492489,0.6619718309859155,1.0,1.0,2/12,18.58%,TYMP;MGME1
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3862343124787913,0.9180124527164732,0.5185185185185185,0.9405475595919075,1.0,8/38,11.42%,FBXW7;NEDD4L;PPARG;SLC4A7;ZBTB20;SLC4A10;WNK1;ABHD8
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4561045479203492,0.9179349107854614,0.64,0.9400332590756486,1.0,1/14,1.56%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.5937484104679308,-0.9177826677772795,0.65,1.0,1.0,1/7,16.51%,CAV1
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.4034587741512034,0.9177557433841974,0.42857142857142855,0.9397721615851982,1.0,2/18,2.77%,LEPR;ACADVL
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5502261901817241,-0.9175781591921611,0.6507936507936508,1.0,1.0,4/10,25.83%,APOD;CHID1;ADCY7;CUEDC2
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),-0.5238746834136957,-0.9175763820242206,0.5735294117647058,1.0,1.0,1/10,4.03%,YBX3
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),-0.5805843839748505,-0.9174555429300049,0.6666666666666666,1.0,1.0,2/5,29.59%,TIMP3;TIMP1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.4812550501678163,-0.9174270656947842,0.5753424657534246,1.0,1.0,3/23,5.10%,ROMO1;TGFB1;AGT
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.38493299481702076,0.9174020152910533,0.7037037037037037,0.9398116919716689,1.0,7/22,14.47%,ADRA1A;ESR1;ABL2;EGFR;GNAQ;FLT1;LPAR1
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),-0.5601547144376614,-0.9174007186747712,0.671875,1.0,1.0,2/6,22.82%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),-0.5601547144376614,-0.9174007186747712,0.671875,1.0,1.0,2/6,22.82%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),-0.5601547144376614,-0.9174007186747712,0.671875,1.0,1.0,2/6,22.82%,ARFGAP3;TMED9
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5344329139416939,0.9173542085048454,0.5666666666666667,0.9392632196393327,1.0,2/8,5.15%,RXRA;PPARG
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),-0.4403745753924541,-0.9173150518365378,0.6447368421052632,1.0,1.0,3/32,6.41%,PPIF;ECT2;HDAC6
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.6078876362739053,-0.9173147461635118,0.696969696969697,1.0,1.0,1/5,2.57%,SFRP1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.3753379821887734,0.9167609918069815,0.6428571428571429,0.9399265304927154,1.0,17/64,20.19%,PREB;CAMSAP2;PDE4DIP;MAPK1;STOX1;ZEB2;MSN;MAPK3;MYO5A;RHOT1;MTM1;PINK1;STX18;DIAPH1;PRKN;PRMT6;GOLPH3
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.41221021852409334,-0.9166915263870882,0.6022727272727273,1.0,1.0,4/58,4.27%,PPFIA4;DVL1;AGRN;TGFB1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.4619362251437031,0.9165312511970871,0.6666666666666666,0.9397861489708591,1.0,4/15,18.44%,PCM1;BBS4;NEDD1;C2CD3
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.45289818069162713,0.9163614152441386,0.5517241379310345,0.9395622016122034,1.0,1/9,1.22%,RIPOR2
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.5561847669302439,0.9162727832673607,0.5405405405405406,0.9389678374653596,1.0,3/6,32.03%,LYST;UBXN6;CHMP2B
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4852744053526755,-0.9162131085943246,0.5797101449275363,1.0,1.0,4/18,16.14%,HAP1;CLU;APOE;RTN2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.5048130158592258,-0.916174626350204,0.5588235294117647,1.0,1.0,1/11,1.43%,RIMS1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.5083832377159525,-0.9159657678368355,0.6268656716417911,1.0,1.0,4/12,20.87%,STAT1;HSPD1;IFIH1;DHX36
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.3360278615837345,0.9157375298342779,0.6086956521739131,0.9394978079078786,1.0,24/79,18.40%,SMAD9;SPRED2;HSPA1A;SIRT1;CRIM1;PPM1A;PPARG;MAGI2;SMAD7;UBE2D1;TGFBR2;SPART;ACVR1;CHRD;PRDM16;ADAM17;SMAD1;BMPR1B;SPRED1;IGSF1;VWC2;SMAD5;LEMD3;BMPR1A
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),-0.5339581688068604,-0.9156719058090191,0.59375,1.0,1.0,2/9,13.02%,GPC3;NR4A3
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5434511233811069,-0.9156408431424067,0.6,1.0,1.0,1/9,2.87%,TFAM
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.32860667481869693,0.915528923601603,0.625,0.9392746256353895,1.0,15/96,10.35%,HDAC9;IRS1;KAT2B;BCAR1;GAB1;PPARG;FER;RPS6KB1;C2CD5;IGF1R;RAB31;FOXO1;RAB10;CPEB2;ATP6V1A
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.333295108299121,0.9154211470995386,0.7777777777777778,0.9387535014593398,1.0,21/91,14.12%,RIT2;STYXL1;EPHA3;TOX;IL1RAPL1;ROBO1;PLXNA1;ROR2;MAGI2;PLXNA3;ABL2;ZNF804A;LRRC7;RELN;FUT9;FBXW8;PRKD1;RAPGEF2;CAPRIN1;TIAM2;TENM3
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.40605392153007847,-0.9151496301226588,0.6024096385542169,1.0,1.0,18/45,28.00%,RETREG1;MEF2C;GRN;BDNF;APOE;NRBP2;RASA1;WFS1;SET;PARK7;PRKCI;TGFB3;NONO;PTPRZ1;SOD2;PPT1;MT3;LGMN
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),-0.5723096171948958,-0.9150117490990172,0.625,1.0,1.0,1/5,2.84%,HES1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.559432472171039,-0.914958459520662,0.6206896551724138,1.0,1.0,1/7,4.27%,TGFB1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),-0.4024296627151003,-0.9147795565507008,0.6823529411764706,1.0,1.0,21/73,25.37%,RPL13A;HDAC6;GAPDH;IGF2BP2;CST3;RACK1;APOE;SHMT1;NCL;EIF2AK2;PCIF1;MALSU1;BAG6;ATRAID;DHX36;ILF3;PAIP2;PLAT;BTG2;CNOT8;CSTB
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.3720490606853338,-0.9147642402450147,0.6276595744680851,1.0,1.0,26/150,17.69%,MIF4GD;EIF1;RBM3;RPL10;RPL13A;EIF2B2;EIF1B;RBM4B;GAPDH;IGF2BP2;EIF5B;NCBP1;RPS4X;UPF3B;RACK1;PLXNB2;RPS27L;ZNF598;UPF3A;SHMT1;NCL;EIF2AK2;PCIF1;NSUN5;EIF2A;MALSU1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.317306658483769,0.9145758261202304,0.4666666666666667,0.9399500319260535,1.0,9/110,6.03%,SEMA3B;SYNDIG1;EXTL1;ZCCHC24;ASTN1;PRIMA1;ANK2;LAMC1;FAM107A
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.39447974792761553,0.9143671219427499,0.53125,0.9397389353281395,1.0,3/15,8.99%,TAF3;PML;BBS4
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.4096607458817323,-0.9143465445463705,0.6741573033707865,1.0,1.0,28/94,28.59%,PSMB9;RPS27A;PSMB8;PSMA3;SMARCA5;RPA3;CDK7;UBA52;H2AX;PSMA7;PSME1;GMNN;UBC;XPA;DDB2;PSMB6;RBX1;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;SOX9;ANP32B;ASF1A;PSMA4;CUL4B
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.40947419923316003,0.914257110427017,0.6,0.9393020083352129,1.0,3/22,7.84%,KCNJ6;SLC12A8;SLC12A1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.3773708297841026,0.9136925075016105,0.55,0.9398529779190883,1.0,6/18,18.96%,SYT12;SYT9;SYT17;SNCA;STX1A;PRKN
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.4240174644494955,0.9136843208768191,0.5121951219512195,0.9391314235445556,1.0,5/14,9.87%,RXRA;SLCO1A2;NCOA2;AKR1C1;ABCC11
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.5346563847563437,-0.9135789835667825,0.6666666666666666,1.0,1.0,2/9,11.37%,CEACAM1;EMP2
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.4774853910783348,-0.913477679405656,0.6666666666666666,1.0,1.0,2/18,6.50%,TUBGCP2;TUBGCP4
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.48626118348169234,0.9133007969195199,0.5,0.9395510283357518,1.0,4/9,15.27%,LMNA;FOXO1;ATP2B4;GLRX3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.3785514403718469,0.9127446910595934,0.5,0.9399343713874134,1.0,5/22,12.17%,PANX1;INAVA;HSPB1;HMGB1;P2RX7
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.49290404584392766,-0.9127356074720944,0.6438356164383562,1.0,1.0,4/15,18.76%,SLC6A6;SLC22A4;SLC7A8;SFXN3
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5319936233635618,-0.9125717471619326,0.6721311475409836,1.0,1.0,1/9,7.07%,XBP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.4739161988560518,0.9122879153291862,0.5833333333333334,0.9402459696439776,1.0,1/11,2.18%,CEP120
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.38212635148865554,-0.9122398166351521,0.7111111111111111,1.0,1.0,7/83,7.28%,SPDYA;TAF7;DVL1;ECT2;TRIB1;TTN;CEACAM1
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),-0.5696912955193463,-0.9122072906104194,0.589041095890411,1.0,1.0,2/8,16.67%,IHO1;PTN
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),-0.5826177278257414,-0.9121779392317269,0.6617647058823529,1.0,1.0,1/5,5.62%,ZFPM1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),0.5654121309714139,0.912092219263786,0.7083333333333334,0.9399173372202146,1.0,2/9,11.66%,AGMO;GPAT4
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.4208748994684217,-0.9119301243354557,0.6404494382022472,1.0,1.0,20/77,22.86%,VEGFA;MEG3;CRYAB;PAMR1;FN1;COL4A1;LMOD1;COL6A1;SRPX;ACTA2;ADAMTS2;COL4A2;VCL;COL14A1;CALD1;THBS2;PDGFRB;THY1;PDZRN3;C1S
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.5682662514923401,0.9118320932479026,0.6097560975609756,0.9397076003912493,1.0,2/5,18.57%,CLASP1;CLASP2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),-0.3974824614071956,-0.9118045612530293,0.675,1.0,1.0,6/68,6.22%,SFRP1;RAB11A;ECT2;IHO1;KIF20B;OBSL1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4132746523015222,-0.9116621119499433,0.6625,1.0,1.0,12/35,24.35%,NARS1;AIMP1;WARS1;SARS1;LARS1;CARS1;DARS2;WARS2;RARS1;GARS1;VARS1;QRSL1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.38960665696722163,0.9111208568388834,0.5555555555555556,0.9407993076139755,1.0,6/33,9.70%,FNBP1L;ARFGEF2;EPS15;SNX33;WASL;WASHC5
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.4218125118242039,0.9109323905214095,0.625,0.9405419301540936,1.0,7/22,20.18%,IRS1;C2CD5;ARPP19;OSBPL8;BRAF;AKT2;PIK3R1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.5395912523182659,0.910581075654122,0.6097560975609756,0.9406274384102112,1.0,5/6,21.54%,ATP2C1;ACSL3;CNST;CSK;PKDCC
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4010087812684363,-0.9104854443638545,0.6555555555555556,1.0,1.0,4/67,5.95%,GADD45B;VEGFA;SEMA4C;RASGRP1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.31787694485999507,0.9104623407917765,0.5555555555555556,0.9401581951388517,1.0,16/78,16.50%,CALCRL;SLCO1A2;MYH9;SLC29A4;ATP8A1;ABCB9;ABCC11;LRP1B;DISP1;ABCA10;ARRDC4;CHMP1A;TOM1;PCTP;ABCA2;CEP290
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.5550963126919658,-0.9103868917485229,0.609375,1.0,1.0,1/7,8.54%,PIK3CB
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),0.5652442880392659,0.9102626907743608,0.5714285714285714,0.9397604366994692,1.0,2/5,9.05%,INSYN1;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.5639174720505777,0.9102598134375312,0.65,0.93904519493448,1.0,4/6,19.07%,MAP4K4;IQSEC1;MAPRE2;MTOR
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.534872402487741,-0.9098346307783306,0.581081081081081,1.0,1.0,3/9,25.35%,PRELID1;IFNAR1;TRAP1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",-0.379547605636866,-0.9098121479627183,0.6444444444444445,1.0,1.0,25/136,18.65%,ESRRB;POLR2I;TAF7;TFAM;TAF11;POLR2G;POLR3H;POLR1C;RRN3;TEAD3;MED1;SMARCA5;ESR2;CDK7;NR5A2;TAF1D;NR4A3;GTF2F1;NR1D1;HNF4G;HDAC3;TAF9B;NR0B1;POLR1G;SNW1
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),-0.5156472157721352,-0.9097600392324259,0.589041095890411,1.0,1.0,1/11,1.68%,PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.41016552381964,0.909734862475253,0.631578947368421,0.9394141514559516,1.0,9/24,11.23%,HECW2;NEDD4L;FGF12;GPD1L;DMD;NETO1;FGF14;WNK1;NEDD4
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.4428383607352776,-0.909189263080008,0.6233766233766234,1.0,1.0,3/25,20.60%,RAB11A;CHMP4B;VPS36
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),0.5257419050507095,0.9088839745951597,0.5714285714285714,0.9405941970969739,1.0,1/7,2.87%,NR1H2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.29831478259946514,0.9086022736270449,0.8571428571428571,0.9402561149798523,1.0,34/302,8.14%,ONECUT1;TCF7L1;SOX11;POU6F2;ZNF280D;ZNF516;ZNF280B;CREM;RYBP;ESR1;ZNF536;HDAC10;NFYC;GPBP1L1;DMTF1;ABL1;ZNF98;SP3;HP1BP3;ZNF2;CHD7;ESRRG;LIMD1;APBB2;PSPC1;ZNF268;ZNF678;RFX3;NCOA2;YAF2;TGFBRAP1;SMARCA2;ATXN1;RORA
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.5037370530522195,-0.9085735558954713,0.6081081081081081,1.0,1.0,4/10,30.38%,DDX11;NCL;MARS1;PWP1
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),-0.6109532750570464,-0.9085020356767308,0.6607142857142857,1.0,1.0,3/5,21.53%,EMP2;MYLK;ANO6
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5194523110634892,-0.9084982734774618,0.6507936507936508,1.0,1.0,2/8,16.67%,GRN;PTN
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4937787924203797,-0.9082930990669309,0.6756756756756757,1.0,1.0,1/15,2.32%,SPDYA
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.6396399484386466,-0.9081909151220812,0.6615384615384615,1.0,1.0,1/5,10.88%,ATG14
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),-0.4030591818741009,-0.9080010960487775,0.6477272727272727,1.0,1.0,12/77,13.75%,GSTK1;GSTM4;GSS;PRELP;GSTO1;AKR1A1;GSTM5;GSTM3;MGST1;OMD;ACAN;OGN
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.3833689640313862,0.9080000329046107,0.5862068965517241,0.9409168768350286,1.0,4/23,10.49%,MAP3K5;MAP3K11;MAP3K4;MAP3K7
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.465778260276853,-0.9078855098757159,0.6533333333333333,1.0,1.0,3/26,6.19%,RBM3;RPL10;RBM4B
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4672120111760649,-0.9078221530493374,0.6081081081081081,1.0,1.0,1/23,0.66%,VEGFA
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),-0.5433180299892839,-0.9077173007542573,0.6428571428571429,1.0,1.0,4/9,25.51%,LPCAT3;SREBF1;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.35316744890134844,0.9071767513698689,0.6875,0.9418934670248486,1.0,9/45,13.96%,GABRG1;GABRR1;SLC12A8;SLC12A1;GLRA1;SLC4A10;GABRB1;GABRA1;GABRG3
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.5519330233080283,0.9067808933708847,0.6216216216216216,0.9420594010083063,1.0,2/6,17.72%,LIG4;MGMT
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.47389382158073423,-0.9067352756124945,0.6029411764705882,1.0,1.0,2/20,4.27%,JUN;TGFB1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),-0.5721193083777603,-0.9067210138984505,0.6666666666666666,1.0,1.0,3/8,16.85%,PDK1;PDK3;PDPR
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),-0.5721193083777603,-0.9067210138984505,0.6666666666666666,1.0,1.0,3/8,16.85%,PDK1;PDK3;PDPR
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.5136346953134044,-0.9066333808178566,0.618421052631579,1.0,1.0,3/11,4.22%,OPRM1;AGRN;CHRM2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.27111574612511363,0.9064041652951264,1.0,0.942061032998488,1.0,72/405,14.29%,SPSB4;SH3RF1;RNF144A;RNF139;FBXL4;TSPAN17;UBE3D;BARD1;FBXW7;ASB5;DTX4;RFWD3;LZTR1;MIB1;H2BC5;HECW2;UHRF2;KLHL8;NEDD4L;FBXO17;UBOX5;OBI1;KLHL21;SIRT1;BTRC;HACE1;TRIM62;UBE2G1;RAD18;SH3RF3;UBE2J2;UBE2D1;KEAP1;RNF135;MARCHF1;TNKS;UBR5;SPSB1;MARCHF7;FBXO15;FBXW11;HERC2;CBFB;USP9X;KLHL13;PELI2;UBE2E2;FBXO28;USP5;FBXW8;UBE2H;NEDD4;UBE2N;RCHY1;FBXL7;TRIM71;RNF11;CAND2;UBE2E3;FBXW5;PSMD6;PSMD13;UBE3C;CDC16;UBE2QL1;ATG3;KLHL12;KLHL42;RNF217;FBXO11;BCL2;TPP2
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.4336784615573447,-0.906288159113214,0.6666666666666666,1.0,1.0,4/38,4.27%,VEGFA;HES5;DVL1;TGFB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.3627327981080848,0.9062170654497246,0.5833333333333334,0.9416528765374479,1.0,10/31,18.61%,ABL1;PPA2;STOX1;BCO2;LRRK2;SPART;BCL2;PINK1;PID1;AKT2
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.5456802303942049,-0.906199495094992,0.6557377049180327,1.0,1.0,1/7,12.30%,DDX11
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.49932255513689705,-0.9060313656985028,0.6338028169014085,1.0,1.0,2/15,14.43%,LAS1L;WDR12
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.5695682185657666,-0.9056547292391534,0.640625,1.0,1.0,1/6,6.41%,HDAC6
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.46532718319030564,-0.9049939359094059,0.6049382716049383,1.0,1.0,1/22,0.27%,IFI6
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.500218223806941,-0.9048963800909442,0.6363636363636364,1.0,1.0,4/15,16.03%,SFRP1;EMP2;WARS1;RNH1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4038468331352002,0.9047560054222745,0.4583333333333333,0.9442988038243194,1.0,2/21,2.67%,PEAK1;EPHA3
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),-0.4529371202011247,-0.9037763334974885,0.6493506493506493,1.0,1.0,6/17,21.79%,RPS27A;DERL2;UBA52;SYVN1;UBC;TRIM13
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.39109457183098406,-0.903103270636701,0.6931818181818182,1.0,1.0,18/77,19.12%,B2M;RPS9;RPS3A;TGFB1;IFNGR2;HLA-A;IGSF6;RPL9;GCNT1;TAP1;WARS1;IL7;EIF3J;STAT1;BRCA1;CDKN2A;HLA-DMA;TAPBP
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,-0.5732456403232042,-0.9029359541535245,0.7301587301587301,1.0,1.0,6/7,27.42%,IGSF6;MYO1F;ITGAL;PSTPIP1;SPI1;AOAH
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.33783531933207617,0.9028522095887384,0.6153846153846154,0.9478524157438952,1.0,10/45,13.25%,SNX31;EHD1;ANKRD50;SNF8;EPS15;RAB11FIP4;SNX27;LMTK2;VPS50;WASHC1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.4355749556534607,-0.9026653360152256,0.6447368421052632,1.0,1.0,7/44,21.93%,DENND3;CEACAM1;NR1D1;APOE;BAG6;FBXO6;HSPA8
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5055790697579315,0.9024755774434644,0.5652173913043478,0.9480013777285591,1.0,2/10,2.87%,HDAC9;NR1H2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.5406257457025845,-0.9023506422985353,0.6875,1.0,1.0,3/9,13.15%,DDX5;MED1;ATF4
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.40206749580687284,0.9023498130853914,0.6428571428571429,0.9475198361789005,1.0,5/17,16.20%,PRELID3B;OSBPL5;PITPNA;OSBPL8;PCTP
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4927900518137249,-0.9023397788795087,0.6470588235294118,1.0,1.0,4/17,16.51%,NOSTRIN;CALM1;DNM2;CAV1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.4135406177450591,-0.9018635179385124,0.6626506024096386,1.0,1.0,5/46,10.39%,MBNL3;RBM8A;DDX5;CELF4;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),-0.3625406476719523,-0.9011637072858101,0.717391304347826,1.0,1.0,48/270,16.14%,VEGFA;RIMS1;DDRGK1;FGF1;RBM3;FLOT1;BTN3A1;RPL11;PLSCR1;TGFB1;HMGN5;POLR1C;CLU;AGT;RPL23;OVOL2;HTR2B;OLFM1;FAM98B;DDX5;TTN;GAPDH;MEF2C;SFRP4;EPHX2;PIK3CB;FN1;MED1;CDH3;PDCD5;SMARCA5;ID2;RPS4X;TADA3;SCAMP5;WARS1;TAF1D;UPF3B;ATF4;MAP2K1;PLXNB2;ACTA2;RPS27L;RPS7;UPF3A;CD46;EIF2AK2;PCIF1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.40790626753681203,-0.9008121615810054,0.6744186046511628,1.0,1.0,9/57,14.40%,NACA;COX18;RAB11A;GORASP1;ICMT;ZDHHC24;ZDHHC1;ZDHHC15;ZDHHC22
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),-0.38837310409208126,-0.900739406889749,0.6808510638297872,1.0,1.0,16/112,17.33%,PSMB9;VAV3;LAT2;BTN3A1;PSMB8;EIF2B2;HLA-A;MEF2C;PIK3CB;PSMA3;BTNL2;BLNK;BTN3A3;PSMA7;PSME1;PRKCQ
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),-0.4603893347771333,-0.9005559956814266,0.5915492957746479,1.0,1.0,1/16,3.43%,SLC35F3
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.558111416246393,0.9005321562037653,0.6428571428571429,0.951074307699802,1.0,1/6,0.25%,IL15
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.38878629542532017,0.8998326447689711,0.42857142857142855,0.951791440413165,1.0,6/26,5.37%,CHRM3;NEDD4L;HOMER1;FGF12;ANK2;GPD1L
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.41846830483422864,-0.8997994098897069,0.675,1.0,1.0,9/54,17.46%,CFAP61;FMO6P;WDR93;JAG1;ATP6V0A4;RHCG;DNAH2;NEK5;P2RY14
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.4683065120799219,-0.8997678471490256,0.6973684210526315,1.0,1.0,3/22,8.12%,SLC2A3;GSTO1;TBXAS1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.507477950005382,-0.8995641181440217,0.6349206349206349,1.0,1.0,1/15,1.65%,HAP1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.5534222999012361,-0.8995271555833191,0.6885245901639344,1.0,1.0,2/10,16.05%,ACOXL;CRAT
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.42098603101288196,-0.8994679264686621,0.6081081081081081,1.0,1.0,9/39,23.01%,SCG2;ARFGAP3;SVBP;RAB3D;RAB15;ABCA1;WLS;PARK7;MON1A
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),-0.48499896872367787,-0.899240220383647,0.5769230769230769,1.0,1.0,1/13,1.43%,RIMS1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),-0.5392403903617626,-0.8985878082802063,0.6111111111111112,1.0,1.0,2/8,18.40%,EMP2;GSN
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.5098955814307846,-0.8981422088208075,0.6621621621621622,1.0,1.0,5/13,27.96%,SLC30A4;SLC39A6;SLC39A14;SLC39A7;MT3
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.44382882522279954,0.8977423366086488,0.5641025641025641,0.9558377822159944,1.0,1/9,2.67%,RFWD3
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.3453980686459367,0.8976195992993413,0.5833333333333334,0.955363287419075,1.0,19/82,13.31%,ESR1;KAT2B;ZBTB1;SATB2;ARID1A;SUV39H2;SIRT1;MBD2;SMARCA2;BAZ2B;ARID1B;SMARCAD1;RSF1;BAZ1B;KAT2A;HDAC4;HNRNPC;CHRAC1;KDM5A
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),-0.3802246776423075,-0.8974720107452064,0.7840909090909091,1.0,1.0,28/137,18.96%,PFN2;CDC37;PPIB;FLOT1;DVL1;RPL11;CLU;RPL23;EFNA1;GAPDH;CRYAB;WIZ;GRN;CDK7;SAXO1;MORC3;CCT7;ZBED3;SYVN1;RPS7;HSP90AB1;USP19;TAF9B;WFS1;TELO2;HSPD1;RPL5;BAG6
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.5582807777195143,0.8974461053585763,0.6060606060606061,0.9550639251487992,1.0,1/7,2.89%,PLOD1
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),-0.5938801414171331,-0.8972337805708891,0.6363636363636364,1.0,1.0,1/5,9.47%,ABHD12B
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),-0.47700259619367513,-0.8971199069508388,0.6438356164383562,1.0,1.0,2/15,12.24%,CACNA1C;AKAP5
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5028081246134246,0.8968639270156638,0.6666666666666666,0.95571765443008,1.0,3/8,18.41%,NOS1;PINK1;PID1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.43055978424954106,-0.8967423062394143,0.6,1.0,1.0,5/29,15.01%,SCG2;ARFGAP3;SVBP;RAB3D;RAB15
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.5681488999571201,-0.8962331736424106,0.5882352941176471,1.0,1.0,3/6,21.05%,QPRT;NMNAT3;NMNAT1
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5551761768688266,0.8960134343776908,0.6111111111111112,0.956892749360616,1.0,2/5,29.34%,TEX264;SPRTN
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.5495297534326298,-0.8958612215311827,0.6923076923076923,1.0,1.0,2/6,20.19%,MEF2C;CAMLG
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.414653142877264,0.8958177520129077,0.6,0.9566392961059255,1.0,6/23,13.99%,SOX11;SMAD7;TWSG1;XIAP;LATS1;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),-0.43387876268411274,-0.8958096319625986,0.654320987654321,1.0,1.0,3/36,4.11%,RIMS1;PPIB;AGRN
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),-0.46085862398413413,-0.8957491166400607,0.5974025974025974,1.0,1.0,4/21,13.26%,HHIP;GPC3;ULK3;RACK1
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.5136754748769521,0.8955944956645039,0.5853658536585366,0.9563978253433665,1.0,4/6,12.23%,RIPOR2;EHD1;MAPK14;CFLAR
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.3516662216562393,0.8952853124924014,0.5833333333333334,0.9563420317327332,1.0,16/66,16.33%,RXRA;SLCO1A2;PRELID3B;NCOA2;ATP8A1;GLTP;AKR1C1;OSBPL5;CERT1;ABCC11;ABCA10;PITPNA;OSBPL8;SLCO3A1;PCTP;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),-0.40071290704252993,-0.8948005189600597,0.6951219512195121,1.0,1.0,19/74,20.87%,RBM3;RPS9;POLR2G;YBX3;RPS4X;UPF3B;TRMT10C;RPUSD3;PLXNB2;RPS27L;UPF3A;PCIF1;NSUN5;COA3;RPL5;RMND1;CIRBP;EIF2S3;DHX36
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.34513814416065236,0.8947984261074352,0.5714285714285714,0.9569922500078442,1.0,7/29,10.59%,SPRED2;PARD3;MAPK1;SMAD7;STOX1;BMP7;DGKQ
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),0.5451328992037383,0.8947715846413262,0.6764705882352942,0.9563232118017424,1.0,1/7,7.78%,RNF2
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.5635063995896509,-0.8946568751836479,0.6666666666666666,1.0,1.0,3/5,26.00%,PRUNE1;PRUNE2;ATCAY
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4054041265455041,0.8944951124245315,0.5925925925925926,0.9561173935718007,1.0,4/23,3.98%,RNF139;FBXW7;BAG2;OSBPL7
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.3868354735538099,-0.8944842033569292,0.6703296703296703,1.0,1.0,17/112,17.35%,POLR2I;RBM3;DDX24;POLR2G;LAGE3;SIDT2;RBMS2;RNASE1;PRPF4;NCBP1;HNRNPA2B1;SUPV3L1;RNASEH2C;GTF2F1;ADAR;DKC1;RBPMS
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.41473731416413995,-0.894352956975701,0.6941176470588235,1.0,1.0,21/69,26.97%,PSMB9;CDKN2C;PSMB8;PSMA3;ZFP36L2;CDK2AP2;PSMA7;PSME1;CDKN2A;CDK4;PSMB6;RBX1;BRD7;PSMB1;PSMC4;PSMD2;PSMB3;RBL2;PSMD7;CDKN2D;PSMC3
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.5359790169485379,-0.8943527831655542,0.5882352941176471,1.0,1.0,1/11,4.75%,ALOX5
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4040165217751309,-0.8943421714154915,0.6296296296296297,1.0,1.0,12/38,23.42%,NARS1;AIMP1;WARS1;SARS1;LARS1;CARS1;DARS2;WARS2;RARS1;GARS1;VARS1;TARS3
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),-0.4096913971681884,-0.8943010342663208,0.6125,1.0,1.0,5/46,11.54%,RAB11A;TUBGCP2;TUBGCP4;HOOK2;DCTN1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.45709238226933857,0.8941636349439965,0.625,0.9561081711703204,1.0,6/11,25.26%,MAP2;RAPGEF2;B4GALT5;ARHGAP35;B4GALT6;MAPT
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),-0.47581512308032137,-0.8940188979081194,0.6533333333333333,1.0,1.0,5/15,16.94%,CFTR;SLC4A3;CA1;CA5B;CYB5R1
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.49616973836965295,-0.8938803609474628,0.6623376623376623,1.0,1.0,2/15,4.27%,SFRP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.4162081545533566,0.8934664453036995,0.6428571428571429,0.956791178017342,1.0,2/15,7.62%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),-0.4913025197022366,-0.8934590890174062,0.6,1.0,1.0,4/13,16.14%,NR4A3;TRIB3;C3;RTN2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.3733260297942457,0.8929100540652889,0.6551724137931034,0.9571964610541374,1.0,3/26,5.92%,STYXL1;PPP4R4;MAGI2
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),0.5195492120044073,0.8928114596733072,0.5454545454545454,0.9551306499157165,1.0,1/5,1.30%,SORD
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),0.5195492120044073,0.8928114596733072,0.5454545454545454,0.9551306499157165,1.0,1/5,1.30%,SORD
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),0.5195492120044073,0.8928114596733072,0.5454545454545454,0.9551306499157165,1.0,1/5,1.30%,SORD
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.4200180806324833,0.8927698602994489,0.6153846153846154,0.9544786365267603,1.0,6/16,26.36%,SUV39H2;SETD2;SETD1B;SETD3;KMT2D;SETMAR
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),-0.4389518727150563,-0.8926324105878255,0.6301369863013698,1.0,1.0,6/38,8.32%,PDXDC1;ITGA4;FAT2;SEMA4C;HTR2B;GPC3
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.4634479240625451,0.8925759341079615,0.5405405405405406,0.954241041862845,1.0,7/13,27.70%,GNL3L;HDAC4;ZMIZ1;PIAS1;RASD2;PIAS4;UBA2
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.43354867548119924,-0.8924933450089991,0.631578947368421,1.0,1.0,5/33,10.17%,SLC3A1;SLC38A4;SLC6A6;SLC7A6;SLC7A14
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.333294399600868,0.8923977887767868,0.7037037037037037,0.9532165607896298,1.0,11/51,17.09%,CD247;PLD2;ABL1;MAPK1;ABI1;WASL;MAPK3;PIK3CA;NCKAP1;FYN;PRKCE
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.333294399600868,0.8923977887767868,0.7037037037037037,0.9532165607896298,1.0,11/51,17.09%,CD247;PLD2;ABL1;MAPK1;ABI1;WASL;MAPK3;PIK3CA;NCKAP1;FYN;PRKCE
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4439953810728206,-0.8922472909021815,0.6794871794871795,1.0,1.0,4/34,8.77%,PRMT8;FAM98B;ICMT;SNRPB
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),0.4789981504183837,0.8919573945011992,0.5333333333333333,0.9534158622883772,1.0,1/6,3.55%,CDO1
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.47780859634796735,-0.8915233652847757,0.6666666666666666,1.0,1.0,2/12,8.80%,HSD17B14;MED1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.422852590777307,-0.8914276232874875,0.654320987654321,1.0,1.0,10/54,14.81%,SFRP1;RARRES2;TGFB1;ALOX5;ZFPM1;XBP1;ID2;ZFP36L2;NR1D1;TRIB3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.515193891713095,-0.8913653702260472,0.6486486486486487,1.0,1.0,4/13,27.55%,PARP9;PNKP;DTX3L;KMT5C
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.5423899339262283,-0.8903358237317565,0.6338028169014085,1.0,1.0,2/9,13.72%,GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.5423899339262283,-0.8903358237317565,0.6338028169014085,1.0,1.0,2/9,13.72%,GABARAPL2;MAP1LC3B2
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.3792008989116636,0.890146555130409,0.56,0.9564541572474287,1.0,2/25,5.67%,DHCR7;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.3949556389805413,-0.8898170695149755,0.7469879518072289,1.0,1.0,15/85,16.84%,PDCD1LG2;ISG15;TRIM25;SELENOS;ZFPM1;CEACAM1;FN1;APOD;NLRC5;SYT11;CACTIN;SARS1;UBE2L6;KAT5;CHID1
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),-0.48034433109770047,-0.8898001545851589,0.6901408450704225,1.0,1.0,2/12,2.57%,H2AZ1;SFRP1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.45882812953287655,-0.8897431603938007,0.6666666666666666,1.0,1.0,5/27,16.46%,ANKRD53;DCTN1;CHMP4B;TACC3;EML3
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.3617406475622304,-0.8897383084601773,0.7448979591836735,1.0,1.0,27/235,11.25%,NEFM;PDE4A;OPRM1;GDAP1L1;ZIC4;HAP1;CDHR1;SURF1;TACR1;PCP4L1;ARX;ISCA1;CACNB1;TCEAL3;HPCA;CACNA1B;CELF4;SST;GRIN2D;CAMK2A;SH3GL2;SNCB;CCK;KCNC1;TCEAL2;GRM1;TMEM179
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.47955671889606777,-0.8897306506330088,0.6103896103896104,1.0,1.0,4/21,18.65%,PHF1;BRCA1;CHTOP;SNW1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.38512624322291067,0.8896963163278493,0.6060606060606061,0.9566964431918333,1.0,6/19,10.38%,HIP1;ARAP1;FBXW7;AFAP1L2;PLAUR;TGFA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.48577983566751004,-0.8893812894683878,0.5735294117647058,1.0,1.0,6/16,14.76%,RPL37;RPS15;RPL23;DDX5;RPS20;RPS7
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.4306806386302255,-0.8893134981975099,0.6666666666666666,1.0,1.0,2/30,4.94%,HAP1;BLOC1S2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5182475493093105,-0.8890095128250199,0.6,1.0,1.0,5/10,37.91%,APOE;WDR45B;WDR45;WIPI1;ATG10
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.4650268481332582,-0.8889184977000604,0.6470588235294118,1.0,1.0,4/27,9.28%,OPRM1;MEF2C;CAMK2A;SLC6A9
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.37309952848232897,0.8882598451842338,0.6,0.9584363934527221,1.0,7/37,8.43%,HDAC9;EHD1;NR1H2;GRAMD1B;SIRT1;RORA;AKR1C1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.37309952848232897,0.8882598451842338,0.6,0.9584363934527221,1.0,7/37,8.43%,HDAC9;EHD1;NR1H2;GRAMD1B;SIRT1;RORA;AKR1C1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),-0.3494843611232648,-0.8882542827559962,0.7956989247311828,1.0,1.0,27/221,13.85%,GADD45B;TFPT;VAV3;RPS27A;SFRP1;ECT2;STK17A;JUN;RASGRF2;ARHGEF18;CLU;OLFM1;SFRP4;APH1A;PTRH2;GRN;PDCD5;BTG1;ITGB3BP;PTPA;MTCH1;IFIT2;DNM2;ATF4;RACK1;OBSCN;UBA52
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.41076652740197234,-0.8882006480149025,0.6708860759493671,1.0,1.0,8/51,10.39%,MBNL3;FAM50A;AKAP17A;OAS3;IGF2BP2;OAS1;MED1;SRRM4
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.4323055209660233,-0.887882858079758,0.6,1.0,1.0,4/25,13.63%,KIF20B;IGSF10;CAMK2A;PLXNB2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),-0.4265863899209656,-0.8877469628861336,0.6455696202531646,1.0,1.0,1/27,1.65%,HAP1
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),-0.5280588839935489,-0.8875623397685917,0.6857142857142857,1.0,1.0,2/10,12.11%,ZW10;NABP2
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.5176483816810692,0.8872885292107267,0.7096774193548387,0.9595897284232471,1.0,5/8,18.89%,SALL1;PKD2;BMP7;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),-0.40803091513883477,-0.8871385791593598,0.6533333333333333,1.0,1.0,9/39,22.92%,PPIF;PDCD5;CHCHD10;BAX;DNM1L;VPS35;PARK7;HIP1R;BNIP3
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.3760236329138756,0.8871122374444742,0.5909090909090909,0.959190198354952,1.0,1/19,1.56%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.45764756266137613,-0.8870996145542607,0.631578947368421,1.0,1.0,3/22,13.71%,ANKRD53;DCTN1;STMN2
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.561272693046805,-0.8868578496594696,0.6349206349206349,1.0,1.0,1/5,8.80%,MED1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.4060546091895819,-0.8867540574798607,0.6538461538461539,1.0,1.0,5/42,12.68%,CDKN1C;TGFB1;IFNGR2;ID2;JUNB
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),-0.3987245564200787,-0.8866372968831565,0.7011494252873564,1.0,1.0,17/66,20.44%,HLA-F;CTSL;HLA-A;AP2A1;SH3GL2;DCTN1;DYNC1LI2;CLTA;DNM2;SEC13;ACTR1B;DCTN3;DCTN6;HLA-DMA;AP2A2;KIF22;MFSD6
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),-0.6023797125474343,-0.886618237791941,0.7101449275362319,1.0,1.0,1/5,9.19%,SH3GL2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),-0.4776524210991274,-0.8866158929823982,0.6323529411764706,1.0,1.0,1/12,0.66%,VEGFA
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.49054240548135686,-0.8865132631447168,0.6710526315789473,1.0,1.0,4/16,21.87%,AGT;KCNMB4;S100A1;KCNQ1
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.40251009274292693,-0.8865076656458875,0.7078651685393258,1.0,1.0,19/75,28.34%,TXNDC17;PSMB9;PSMB8;PSMA3;PSMA7;PSME1;STAT1;TNFRSF1A;PSMB6;TNFRSF14;PSMB1;PSMC4;CD27;PSMD2;PSMB3;PSMD7;PSMC3;TMSB4X;PSMA4
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.4500921159154173,0.8864857402047871,0.6060606060606061,0.9598739476499429,1.0,4/12,14.17%,AKR1C3;TRERF1;BMP7;NR3C1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.4635592184262874,0.886465372708334,0.5277777777777778,0.9591559480360878,1.0,1/8,4.93%,AKR1C3
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.502562537657397,-0.8863685254732747,0.647887323943662,1.0,1.0,2/11,9.20%,MED1;CDH3
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.5461081802352675,-0.886180574137791,0.609375,1.0,1.0,1/8,1.77%,ZNHIT3
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.3831436548664266,0.885793452313684,0.6,0.9598045472811766,1.0,6/20,7.38%,NLGN1;ATP2C1;CDH20;CDH9;CDH10;CDH18
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,-0.38031518348720755,-0.8852938291483672,0.6956521739130435,1.0,1.0,33/134,24.22%,H2AZ1;TGFB1;CDKN2C;KIF20B;SNRPD1;POLQ;MT2A;SMC1A;SAP30;BUB3;SRSF10;FANCC;CBX1;ODF2;H2AX;TACC3;HMGN2;NCL;DKC1;CDK4;KIF22;SRSF2;DBF4;CTCF;STIL;E2F4;NUMA1;HSPA8;ILF3;POLE;STMN1;YTHDC1;DR1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5176145761170153,-0.885263388327867,0.6301369863013698,1.0,1.0,1/12,2.87%,TFAM
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.40737311366966655,0.8849372008099617,0.6818181818181818,0.9610661749144371,1.0,8/26,10.49%,NLGN1;NLGN4X;NRXN1;SLC8A2;WNT7A;RELN;LRRK2;CHRNA7
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.33411133027487244,0.8846854436152604,0.5555555555555556,0.9607579358623543,1.0,11/72,8.99%,DHCR7;ACACB;RXRA;NFYC;PPARG;TBL1XR1;ACACA;NCOA2;FASN;RORA;BBS4
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.4926813414484589,-0.8846588122958537,0.6363636363636364,1.0,1.0,2/12,7.50%,DDX5;JAG1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),-0.565972525872206,-0.8846346245584286,0.7352941176470589,1.0,1.0,2/8,21.51%,SREBF1;ERLIN2
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),-0.565972525872206,-0.8846346245584286,0.7352941176470589,1.0,1.0,2/8,21.51%,SREBF1;ERLIN2
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.43070592086214027,-0.8846200357538512,0.7093023255813954,1.0,1.0,7/37,17.52%,RBM3;RPL10;RBM4B;PARP9;ATG14;PCIF1;EIF2A
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.5410527181093121,-0.8845652838454876,0.6376811594202898,1.0,1.0,1/8,12.01%,DONSON
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.562730246343441,0.8845541775165314,0.6153846153846154,0.9602571564536203,1.0,1/5,3.64%,NEDD4L
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.2993306712315494,0.884533801976251,0.7777777777777778,0.9595529291676096,1.0,58/251,14.53%,SEMA3B;LDB2;PRR5L;GPNMB;PDGFC;ERBB4;MCTP1;ADAM10;NAV3;SRGAP1;BCAR1;PRKX;SGK1;SEMA4D;SEMA6C;PTPRK;ROBO1;PLXNA1;ROR2;FER;NTNG2;MAGI2;SMAD7;FAM107A;TP53INP1;IGF1R;ZNF268;HACE1;GCNT2;TMEFF2;PLXNA3;KANK1;LMNA;ZMYND8;EGFR;PPP3CA;PPM1F;MITF;CTNNA2;SRCIN1;NF2;SEMA3A;MAP4K4;SEMA6A;AMOT;CDH13;ACVR1;CHRD;PTPRU;WASHC1;RAP2B;ELP3;FLT1;ADAM17;STK24;SUN2;FOXO3;RAP2A
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),-0.49356706544954765,-0.8844169151995104,0.6268656716417911,1.0,1.0,3/11,19.07%,TTN;OBSCN;ACTN2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.4806938296532557,0.8843146839162411,0.6111111111111112,0.9586574117652527,1.0,2/8,13.71%,ERI1;EXOSC7
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.4806938296532557,0.8843146839162411,0.6111111111111112,0.9586574117652527,1.0,2/8,13.71%,ERI1;EXOSC7
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.4478904999657062,-0.884287415344595,0.64,1.0,1.0,7/23,21.53%,HES1;MEF2C;CCDC39;AHI1;CCDC40;NDRG4;STIL
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.3879551870291956,0.8842542933739245,0.6666666666666666,0.9581144554822479,1.0,5/21,17.01%,SGMS1;SMPD4;SPTLC2;CERS6;FA2H
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.5817791144203057,-0.8841255183561126,0.7121212121212122,1.0,1.0,2/6,22.04%,ADAR;ADAT2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.3654872006147147,0.8841184504615575,0.6818181818181818,0.9576514924847395,1.0,7/36,9.05%,AKR1C2;OSBPL7;GRAMD1B;AKR1C3;GNG2;ADCY6;GLRA1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.34533149778135636,0.884065950692164,0.5555555555555556,0.9569970937233634,1.0,24/94,14.59%,PRR5L;HSPA1A;NOX4;ABL1;PTPRK;AKR1C3;CAT;FER;PRDX6;MAPK1;PLA2R1;ADNP2;KEAP1;PKD2;FOXO1;EGFR;CPEB2;MAPK3;LRRK2;PRKD1;ERCC6L2;MAPK8;FOXO3;MSRA
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.5147825156803547,0.88387275572121,0.59375,0.9560410872570009,1.0,3/7,12.34%,SLC1A2;DISP1;SIGMAR1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.5147825156803547,0.88387275572121,0.59375,0.9560410872570009,1.0,3/7,12.34%,SLC1A2;DISP1;SIGMAR1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.4081510957698775,-0.8838388935200479,0.7209302325581395,1.0,1.0,13/47,25.32%,CDC37;IFNGR2;USP18;RACK1;IL7;HSP90AB1;STAT1;TNFRSF1A;RUNX1;RNASEL;PTPN2;AXL;ABCE1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.3989547438466953,-0.8837347834331712,0.6511627906976745,1.0,1.0,8/59,14.67%,PDCD1LG2;SELENOS;TRIB1;XBP1;MEF2C;TRIM41;CACTIN;NR1D1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.4781159282892129,-0.8835011092765186,0.6417910447761194,1.0,1.0,3/29,9.06%,TGFB1;GLUL;PARP9
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),-0.4200993538714293,-0.8832385483222386,0.6282051282051282,1.0,1.0,15/48,28.59%,SPDYA;CDKN2C;MAX;CAMK2A;CDK7;CRLF3;CDKN2A;CDK4;DBF4;POLE;EIF4EBP1;CCND1;CDKN2D;CDC7;CUL4B
prerank,PanglaoDB_Augmented_2021__Tuft Cells,-0.4635338563200271,-0.8831391699555408,0.7,1.0,1.0,6/16,28.57%,ALOX5;AVIL;SPI1;SOX9;AOAH;TUBB
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.48409384301030745,-0.8831279734338782,0.6557377049180327,1.0,1.0,2/12,9.09%,RPL23;SMARCD1
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.403436424964122,0.8830629599564309,0.5882352941176471,0.9572951043229614,1.0,2/16,11.71%,PUM2;TRIM71
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.44030142558264973,0.8829429461672335,0.72,0.956755621758107,1.0,2/12,16.03%,LIG4;NIPBL
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),-0.37757011276947916,-0.8829088206368269,0.7142857142857143,1.0,1.0,30/114,23.54%,COX7A2;RPL38;PFDN6;TGFB1;CLU;NDUFAF1;GPX4;HIGD1C;NSG2;CLTA;CLTB;OTUD6B;CENPC;CCDC39;VBP1;CHMP4B;MIS12;AIFM1;HSP90AB1;NUP107;HSPD1;TESPA1;CCDC40;CALY;COG4;DNAAF2;HIP1R;VAMP1;HOPX;DNAI4
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4748923097866655,-0.8825803284080921,0.6527777777777778,1.0,1.0,2/18,10.42%,RNASE1;LACTB2
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),-0.38027477251103114,-0.8825572924840424,0.7191011235955056,1.0,1.0,11/74,18.33%,SFRP1;CFTR;RRAGA;XBP1;MEF2C;P2RX4;TSHR;LARS1;BRCA1;P2RY12;MAPK13
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.49635019543713743,0.8818671428246235,0.6111111111111112,0.9585026376875544,1.0,4/8,31.98%,STARD13;NOTCH1;MEOX2;RHOA
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),-0.3586547604770508,-0.8817579017687772,0.7628865979381443,1.0,1.0,36/198,19.02%,GADD45B;GADD45GIP1;BEX2;SFRP1;JUN;TGFB1;CDKN2C;RPL23;IRF1;KIF20B;RASSF1;RRP8;ID2;CDK7;WDR6;RNF167;NEK6;JUNB;CRLF3;RACK1;MAP2K1;WDR12;RNF112;SKP2;HRAS;NUDT6;HSP90AB1;CDC26;BRCA1;CDKN2A;GMNN;SRA1;CDK4;TSPYL2;TRIM32;ZBTB49
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4053309132336495,-0.881048103311179,0.6704545454545454,1.0,1.0,14/63,16.75%,PPIB;COL5A3;COL9A3;P4HA3;COL4A1;COL15A1;COL6A1;OPTC;COL9A2;ADAMTS3;ADAMTS2;COL21A1;COL10A1;COL4A2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),-0.5769742743280428,-0.880974672548619,0.7272727272727273,1.0,1.0,3/5,17.19%,MEF2C;PIK3CB;CDKN2A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),-0.504282725888852,-0.8808861300216613,0.6470588235294118,1.0,1.0,3/10,20.91%,TRIB1;PDGFRB;NDRG4
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3076549253982605,0.8805998030924678,0.8,0.9604382990502033,1.0,20/111,12.55%,VAPB;GSTM2;ABHD3;SGMS1;ACER3;CDO1;LARGE1;SLC44A1;STARD7;DMD;SPTLC2;CERT1;VAPA;SLC44A5;PCYT1B;GPAT4;PPM1L;GSTO2;ST3GAL4;PRKD1
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.5249035777878454,-0.8803817119783459,0.6507936507936508,1.0,1.0,1/9,1.63%,SLC2A3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.3914849754717606,-0.880349617118715,0.6309523809523809,1.0,1.0,9/55,15.86%,TAF7;CDKN1C;DVL1;TRIB1;CEACAM1;WARS1;PPP2R5A;TRIB3;RTRAF
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.5274539140184389,-0.8802514717548283,0.6621621621621622,1.0,1.0,4/9,29.57%,NR1D1;GBE1;PER2;UGP2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.5274539140184389,-0.8802514717548283,0.6621621621621622,1.0,1.0,4/9,29.57%,NR1D1;GBE1;PER2;UGP2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.36461391479152894,-0.8796412523560908,0.6666666666666666,1.0,1.0,8/63,11.70%,VEGFA;HSD17B14;SEZ6L2;SCG5;SST;SH3GL2;GLIS3;SCAMP5
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.4847930755614155,-0.8795678152360638,0.7105263157894737,1.0,1.0,5/23,18.90%,ADAM21;COL9A3;NR0B1;FSHR;MEA1
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.5384176006068195,-0.8795552854248193,0.676923076923077,1.0,1.0,3/8,13.48%,TGFB1;DDX5;MAP2K1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.4088557277492268,0.8793178362129622,0.6551724137931034,0.9623260855846513,1.0,3/11,15.43%,IGF1R;ITGA3;FYN
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.35190926638652387,0.8792665984522701,0.7,0.9616833412856497,1.0,13/38,18.40%,SMAD9;SMAD7;BMP7;MAPK3;USP9X;ACVR1;CHRD;SMAD1;USP15;BMPR1B;MEGF8;SMAD5;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.5330537136752274,-0.879240875140316,0.7258064516129032,1.0,1.0,1/6,6.68%,BHLHE41
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),-0.492694804585602,-0.8788603809963567,0.6935483870967742,1.0,1.0,3/11,17.64%,RARRES2;P2RX4;P2RY12
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3106759821352241,0.878721989603928,0.75,0.9620069795250995,1.0,54/210,18.87%,ARHGEF6;EHD1;FNBP1L;STK36;SEPTIN6;FGD4;RABL2B;IFT140;RFX3;CDC14A;PCM1;OPHN1;TRAF3IP1;BBS4;CEP41;DNM3;TTLL3;UNC119B;RAPGEF6;IFT172;P2RX7;MAP4K4;SSX2IP;OCRL;TCTN2;CDH13;RAPGEF2;EXOC2;RAP2B;NRP1;CDC14B;PCNT;RAP2A;MTSS1;TMEM138;ARL3;EXOC6;CEP89;RAP1A;GBF1;ARHGEF7;CCDC88A;SPAG16;CEP290;RAB3IP;EXOC4;TTC39C;GALNT11;MACIR;ATAT1;CEP20;ABCC4;SRGAP2;RILPL2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34798913980562224,0.8781386341176354,0.4666666666666667,0.9627115251158128,1.0,3/40,6.92%,TP63;FBXW7;UBE2J2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.43377871051927774,0.8780902792411492,0.6551724137931034,0.9621035617897477,1.0,2/20,5.20%,PKP2;ANK2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.5467423457827123,-0.8780673157399357,0.7258064516129032,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.5328438067123681,-0.8780474197545443,0.6615384615384615,1.0,1.0,2/10,25.31%,BTBD18;ZSCAN21
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.38587430004215806,-0.877924202372851,0.6666666666666666,1.0,1.0,20/69,27.35%,PSMB9;DVL1;PSMB8;AP2A1;PSMA3;DAAM1;DVL2;PSMA7;PSME1;AP2A2;PSMB6;CELSR2;DVL3;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;AP2S1
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),-0.6007683215130023,-0.8779158189226431,0.6851851851851852,1.0,1.0,5/5,39.95%,NLRP1;LGMN;ADGRV1;CAPN1;CAPN7
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.5475303407292861,-0.8778217529194878,0.6527777777777778,1.0,1.0,1/7,9.39%,CAD
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.49486157799177316,-0.8777919687190782,0.7777777777777778,1.0,1.0,3/11,20.87%,DND1;ZFP36L2;DHX36
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.4043298361919677,0.8776633569151909,0.696969696969697,0.962045338569564,1.0,5/15,17.02%,MYH9;SNX33;SNX18;GULP1;SPIRE1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.47273704763801977,-0.8775867044068623,0.6666666666666666,1.0,1.0,5/14,30.71%,DDX11;NCL;MARS1;PWP1;SIRT7
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),-0.43478464143721923,-0.8774407431797174,0.6493506493506493,1.0,1.0,3/21,13.96%,RARRES2;CLMP;CCDC39
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.4271827184459409,-0.8773830326221649,0.6133333333333333,1.0,1.0,6/31,13.05%,OPRM1;CHRM2;HTR4;HTR1F;AKAP5;CHRM5
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.39016628604310916,-0.8773651023957018,0.7051282051282052,1.0,1.0,19/80,23.92%,VEGFA;ISG15;TGFB1;CLU;IL5;RPA3;USP50;WARS1;RACK1;BAX;XPA;RHOC;DDB2;ABCA1;SLF1;PARK7;RBX1;MTLN;PSMC4
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.5455441785417622,-0.8772837736984656,0.6923076923076923,1.0,1.0,2/7,22.55%,MTIF3;EIF2D
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.3925141885475306,-0.8771374046238476,0.717948717948718,1.0,1.0,6/61,6.93%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),-0.5641799154534572,-0.8770562848200162,0.7017543859649122,1.0,1.0,1/5,11.17%,PLS1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.37343467530096325,0.8770073316375576,0.59375,0.9627930460926523,1.0,5/26,9.00%,COG6;VTI1A;COG3;COG5;NSF
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.511889257309331,0.8769825408323884,0.6052631578947368,0.9614241666315895,1.0,2/6,21.35%,ATP2B4;CHP1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.511889257309331,0.8769825408323884,0.6052631578947368,0.9614241666315895,1.0,2/6,21.35%,ATP2B4;CHP1
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),-0.44489922892792527,-0.8761075100079861,0.6756756756756757,1.0,1.0,3/21,6.88%,VEGFA;HES1;TTN
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.31735582530165163,0.8759830287500167,0.7857142857142857,0.9629300388677199,1.0,16/61,14.81%,SMAD9;PARD3;SIRT1;PTPRK;SMAD7;GCNT2;TGFBRAP1;TGFBR2;LPXN;TWSG1;USP9X;MAP3K7;ZMIZ1;ACVR1;SMAD1;USP15
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.4812874320352325,0.8758836782366295,0.6388888888888888,0.9624808541325991,1.0,2/8,7.55%,PDE4B;CACNA2D1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.5312905774628218,-0.8757412129326332,0.696969696969697,1.0,1.0,1/7,5.62%,ZFPM1
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.43832631993333215,0.8756334446233793,0.6666666666666666,0.9622999531095842,1.0,3/12,8.93%,TNK2;BMP2K;WASL
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.33764018617412855,0.8755922044768236,0.6190476190476191,0.9616847695774211,1.0,5/27,5.33%,MAP2;CAMSAP2;ABL1;ARHGAP28;FCHSD2
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.4781688677599557,-0.8753434882656841,0.6376811594202898,1.0,1.0,3/16,9.47%,ENPP2;GDE1;ABHD12B
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.5845266286482345,-0.8743960086267593,0.7068965517241379,1.0,1.0,3/7,33.23%,RANBP1;KIF25;KIF11
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.39073049305744756,-0.8739879865670478,0.6976744186046512,1.0,1.0,8/52,15.43%,ABRAXAS1;RAB11A;ZW10;SMC1A;CTDP1;CHMP4B;MIS12;MZT1
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.359201981119453,0.8739100580088563,0.5789473684210527,0.9647670107838917,1.0,13/35,20.64%,BCAR1;GAB1;REPS2;EGFR;TGFA;ERBIN;PIK3CA;ADAM17;SOS1;KIF16B;BRAF;PIK3R1;PDPK1
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.3380728458508803,0.8738288259156715,0.631578947368421,0.9642510413658638,1.0,6/48,11.23%,ATR;ZBTB1;SIRT1;PTPRK;ERCC4;NEDD4
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5522626763677395,0.8737982554396033,0.6511627906976745,0.9636024268951917,1.0,1/5,1.32%,NUTF2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.3591821824945971,0.8730744733688278,0.6842105263157895,0.9644100933295799,1.0,5/29,4.73%,AEN;ZNF385B;BOK;FHIT;SIRT1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.4149970711483353,0.872835281695209,0.45,0.9642285672450398,1.0,5/30,10.89%,EVI5L;STYXL1;KAT2B;LRRK2;KAT2A
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.35750578434787855,0.8727505367549123,0.6363636363636364,0.9636701525997315,1.0,11/45,14.79%,CHRM3;MCTP1;ANK2;EGFR;PTPRC;PPP3CA;LRRK2;SLC8A1;P2RX7;DMPK;MCU
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.28848605182305803,0.8727288414074672,0.6666666666666666,0.9629906327882304,1.0,29/131,16.82%,NLGN1;EHD1;RYK;SGK1;ZFYVE27;MAP2;CNTNAP2;CAMSAP2;ARC;WNT7A;BMP7;ATXN10;OPHN1;WASL;VAPA;LRRK2;NEDD4;HMGB1;MAP4K4;RAPGEF2;FLRT3;FRYL;NCKAP1;CTNND2;DOCK10;GPM6B;HDGFL3;WHRN;PPP1R9A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.3588811106846294,0.8727262088989584,0.8064516129032258,0.9622788880485494,1.0,3/24,4.08%,ZNF385B;BOK;FHIT
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.5581022347255945,-0.8726407819595922,0.6875,1.0,1.0,1/5,2.57%,SFRP1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),0.42916166202572886,0.8722050848552771,0.6666666666666666,0.9626528864104296,1.0,4/17,11.68%,GLTP;ABCB9;CERT1;DISP1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.39747323389469313,-0.8720504837361623,0.6823529411764706,1.0,1.0,12/68,17.19%,CDKN1C;TGFB1;CDKN2C;SH3GL2;ANKLE2;ATG14;WARS1;CACTIN;ZBED3;DNAJC10;TERF2IP;CDKN2A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3303060433456841,0.8720338725622224,0.7619047619047619,0.9622742449256251,1.0,7/45,11.07%,RYBP;ZFYVE19;YAF2;RNF2;EED;BMP7;TOM1L2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.3234364581578947,0.8720065396280394,0.6666666666666666,0.961586707069215,1.0,11/54,13.99%,PLD1;ASB5;DOCK5;DMD;SYNPO2;PRKG1;PRRX1;WASHC1;DLL1;IQSEC1;ITGA3
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.4951028626502646,-0.8719390699169987,0.6363636363636364,1.0,1.0,1/8,10.85%,BTBD18
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.5509242096519154,-0.8715654372192984,0.65625,1.0,1.0,1/5,15.20%,GINS3
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.5509242096519154,-0.8715654372192984,0.65625,1.0,1.0,1/5,15.20%,GINS3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.5023865012677106,-0.8713616808476748,0.6615384615384615,1.0,1.0,2/11,16.51%,CHRM2;CAV1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.28422966996459137,0.8713274216307091,0.7647058823529411,0.9622696154891356,1.0,19/95,10.80%,RGS7BP;ADGRB3;ASTN1;ZNF536;MAP2;CADM2;HS6ST3;LRRC3B;ANK2;SLC8A2;LRRTM3;KCTD16;NXPH1;LRFN5;CLVS2;NKAIN2;ADGRA1;CA10;VSTM2B
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.5125874146792311,-0.8712717265033221,0.6307692307692307,1.0,1.0,1/8,12.24%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.5125874146792311,-0.8712717265033221,0.6307692307692307,1.0,1.0,1/8,12.24%,AKAP5
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.4650948858816428,-0.8710766634722656,0.6461538461538462,1.0,1.0,1/13,4.27%,TGFB1
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.34783760820826326,0.8709226542456592,0.6875,0.9624218054289084,1.0,12/58,13.48%,SEMA3B;GSTM2;DHCR7;PPARG;TP53INP1;FASN;PLAUR;CPEB2;ECH1;ANTXR2;ALCAM;HMGCR
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.5180228375206819,0.8708643773115667,0.6666666666666666,0.9618459523489756,1.0,4/7,28.28%,IRAK1;PIK3R4;IRAK2;TRAF6
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.5103438515982167,-0.8708548137898948,0.631578947368421,1.0,1.0,3/11,24.77%,APH1A;APEH;BACE1
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.5542012204007332,-0.8700072863316832,0.5964912280701754,1.0,1.0,1/5,5.52%,CTSZ
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.42719253682842107,-0.8699037069050527,0.6575342465753424,1.0,1.0,6/27,21.18%,TRPM3;SLC6A9;SLC3A2;SLC7A8;SFXN3;SLC36A4
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.27901950133073716,0.8690953868418266,1.0,0.9650065406131704,1.0,46/311,11.55%,SPSB4;RANGAP1;RNF144A;RNF139;TSPAN17;BARD1;FBXW7;ASB5;DTX4;RFWD3;LZTR1;MIB1;H2BC5;HECW2;UHRF2;KLHL8;NEDD4L;KLHL21;SIRT1;BTRC;HACE1;TRIM62;UBE2G1;RAD18;UBE2J2;NUP98;UBE2D1;DCUN1D2;KEAP1;RNF135;SPSB1;NSMCE2;DCUN1D5;FBXW11;NUP93;HERC2;USP9X;KLHL13;TRIM28;USP5;FBXW8;UBE2H;NEDD4;UBE2N;RCHY1;FBXL7
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5144909319416571,-0.8690659400107715,0.676923076923077,1.0,1.0,3/8,24.29%,APOD;NDRG4;PTPN2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.288843662222998,0.8688968819242684,0.6666666666666666,0.9648370547898083,1.0,19/130,11.95%,SEM1;RMI1;RPA1;BARD1;RFWD3;LIG4;RAD51B;RAD54B;RECQL5;SAMHD1;SMARCAD1;NSMCE2;BAZ1B;HERC2;SMC6;ERCC4;HELQ;UBE2N;HMGB1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.5536241235260624,0.8686192334353932,0.6666666666666666,0.9647008276588811,1.0,3/5,18.96%,LRRK2;D2HGDH;PRKN
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.403739912209168,0.8685373330997409,0.6666666666666666,0.964234944460281,1.0,3/16,6.62%,SOX11;LIG4;RFX3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.3690563820308199,0.8684238360695943,0.5454545454545454,0.9637587572371799,1.0,8/26,11.37%,NAF1;MAPK1;TNKS;PML;MAP3K4;MAPKAPK5;MAPK3;HNRNPD
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4663201887177751,-0.8684184017583001,0.703125,1.0,1.0,7/16,20.36%,PFN2;P2RX4;ARHGAP24;HRAS;CAV1;P2RY12;RDX
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.3857482238976614,-0.8683094769974813,0.7317073170731707,1.0,1.0,13/72,17.69%,HAP1;RPL13A;CLU;GAPDH;IGF2BP2;RACK1;APOE;SHMT1;NCL;EIF2AK2;PCIF1;RTN2;MALSU1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.5526250095429499,-0.86801713345101,0.6727272727272727,1.0,1.0,2/5,14.87%,NAPA;STX1B
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4140121287482632,0.8679691056448872,0.5161290322580645,0.9640078875659812,1.0,4/18,18.01%,DIP2B;MAPK3;NOS1;TADA2A
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.4160956279327655,0.8679630632077675,0.75,0.9633131427403959,1.0,3/14,4.33%,ESR1;PADI2;ARID1A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),-0.4248102801984134,-0.8676571401118783,0.6708860759493671,1.0,1.0,2/27,7.58%,YBX3;DND1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),-0.4971981687697017,-0.8674908839682065,0.6615384615384615,1.0,1.0,1/11,4.03%,YBX3
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.5262520596286202,0.8673558274078861,0.6333333333333333,0.9639897925503162,1.0,3/6,13.78%,FZD3;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),-0.5155032213460984,-0.8670962068099054,0.684931506849315,1.0,1.0,1/10,2.67%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.4874418795042435,-0.8668960823977138,0.6911764705882353,1.0,1.0,2/11,14.68%,PPIB;APOE
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.35511968732371724,0.8668416729743039,0.6818181818181818,0.9642272526436525,1.0,4/31,7.89%,RYBP;YAF2;RNF2;EED
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.30854896609491345,0.8667679047735316,0.7142857142857143,0.9637309161994402,1.0,17/65,11.84%,NLGN1;HOMER1;FGF12;ANK2;CNIH2;PDE4D;DMD;NETO1;JPH1;GRIA1;FGF14;GSG1L;LRRC7;RELN;DLG2;GRIA3;GRIN2B
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3722115148723529,-0.8666446953181742,0.7659574468085106,1.0,1.0,22/145,16.82%,TUBB4B;PSMB9;NPM2;RPS27A;TUBA4A;PSMB8;ZW10;CEP72;PSMA3;BUB3;ID2;DCTN1;NEK6;ZFP36L2;ODF2;UBA52;TUBB4A;PSMA7;DCTN3;RIOK2;CDC26;PSME1
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.48839275171931773,-0.8662153231754847,0.6666666666666666,1.0,1.0,1/17,0.66%,VEGFA
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.43465092686357365,0.8660035010903133,0.8333333333333334,0.9646683158025803,1.0,3/12,6.47%,CDO1;GLYAT;SRR
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.35884658933701985,-0.8659632146867092,0.7659574468085106,1.0,1.0,49/231,22.99%,FANCB;PARP2;RPS27A;ABRAXAS1;APEX1;FANCI;ADPRS;POLQ;RFC2;BACH1;SMC1A;PARP9;CENPX;RNF8;SMARCA5;FAN1;RPA3;FANCC;PNKP;NABP2;PPP5C;UBA52;RFC4;PARP4;ALKBH2;H2AX;KAT5;BRCA1;MMS19;UBC;MGME1;RFC3;XPA;ATRIP;MSH6;DDB2;LIG1;POLD2;MBD4;UBXN1;RECQL;BRCC3;FBXO6;PARK7;XRCC1;DTX3L;POLE;ALKBH5;DCLRE1C
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4013280672668778,-0.8657952330815387,0.7272727272727273,1.0,1.0,10/42,25.32%,ABRAXAS1;DONSON;RPS27L;BRCA1;TAOK3;FZR1;BRCC3;NEK11;MDC1;CCND1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.38645362318682813,-0.8656235875155598,0.7209302325581395,1.0,1.0,4/55,6.40%,SLC2A3;MMACHC;BTD;GSTO1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.42293029477106964,-0.865398100704835,0.7037037037037037,1.0,1.0,4/33,11.58%,VEGFA;TGFB1;STAT5A;P2RX4
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.40739810001835075,0.865145527646635,0.6,0.9658011066569927,1.0,2/19,3.64%,KCNJ6;NEDD4L
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),0.4969591904082672,0.8650323160998891,0.6206896551724138,0.9654357852456661,1.0,2/7,17.07%,LIG4;TCF3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),-0.5083417081387331,-0.8649682661586754,0.6825396825396826,1.0,1.0,4/11,19.10%,PLSCR1;SYT11;RACK1;FER1L5
prerank,MSigDB_Hallmark_2020__heme Metabolism,-0.36289044651583924,-0.8646446954284726,0.7303370786516854,1.0,1.0,22/152,15.41%,GYPE;H4C3;RAP1GAP;ISCA1;CROCCP2;SIDT2;BACH1;LMO2;NARF;GDE1;SLC6A9;DAAM1;MOSPD1;SLC22A4;HDGF;HEBP1;CAST;UROD;CA1;NFE2L1;C3;ANK1
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.4454316620165236,0.8645938142334387,0.65,0.965824139066804,1.0,1/9,0.77%,ASXL3
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.3034113049133675,0.8645101353652672,0.7,0.96537207527111,1.0,22/104,17.41%,CORO6;SHROOM2;HIP1;BCAR1;GAS2;MYO7A;RAC3;RHOBTB1;ABI1;WASL;NEBL;SHROOM3;PROX1;MYO5A;COBL;SHROOM1;MCU;CORO1C;EPS8;PPP1R9A;SPIRE1;MYO1E
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.38571492322736317,-0.8644327501589891,0.6891891891891891,1.0,1.0,8/54,17.95%,PUS3;OSGEP;ELP5;WDR6;DUS2;TRMT5;QTRT1;QTRT2
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.3807398812517673,-0.8643309590484649,0.7444444444444445,1.0,1.0,14/114,11.82%,F13A1;ETV4;SCG3;PDCD1LG2;LAT2;ANGPTL4;PSMB8;TRIB1;GLRX;SCG5;PCSK1N;FUCA1;ID2;APOD
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),-0.38438287590524156,-0.8639595058098964,0.6835443037974683,1.0,1.0,6/46,10.05%,POLR3D;IFI35;PLSCR1;AGT;MEF2C;GRN
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.36286767152805693,-0.863688509779915,0.7052631578947368,1.0,1.0,27/123,26.97%,PSMB9;RPS27A;APEX1;PSMB8;IGF2BP2;DND1;PSMA3;ZFP36L2;UBA52;PSMA7;PSME1;UBC;SET;CIRBP;DHX36;HSPA8;PSMB6;PSMB1;ANP32A;PSMC4;SERBP1;PSMD2;DIS3;PSMB3;EXOSC8;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.3868378212591972,-0.8633736358643576,0.7777777777777778,1.0,1.0,9/84,8.69%,DUOX1;FGF1;ENPP2;TMSB15B;TGFB1;SPINT2;LDB1;CEACAM1;SST
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.44144552641605767,0.863298656699714,0.7027027027027027,0.9672313080286724,1.0,3/9,11.88%,KCNMB3;STIM1;KCNIP2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.41258124598027873,-0.8631929072195045,0.7215189873417721,1.0,1.0,8/46,18.74%,CDKN1C;TGFB1;BTG1;RNF167;NUDT6;CDKN2A;GMNN;TSPYL2
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.3500793566547349,0.8630250730520533,0.5833333333333334,0.9669967050432716,1.0,11/47,14.10%,TP63;LAMA3;ACADVL;ITGA2;LMNA;BMP7;NNMT;HSPB1;MYOF;ITGA3;BCL2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.4216834490477617,0.8629824833178612,0.6666666666666666,0.9663597566263195,1.0,4/14,8.30%,HIP1;PICALM;SGIP1;EPS15
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.37659844047450014,0.8627314376255744,0.6086956521739131,0.9663001348095978,1.0,3/28,7.63%,CRB2;GCNT2;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.48377372920723816,-0.8627069021259463,0.684931506849315,1.0,1.0,5/11,21.53%,AZIN2;NR4A3;C3;AZIN1;ANO6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5271685635810422,-0.8626683816975199,0.696969696969697,1.0,1.0,3/8,18.72%,ISG15;CD46;HSPD1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.36126732156995284,0.8624311179755516,0.782608695652174,0.9661753937098693,1.0,6/37,6.04%,DAPK2;SEPTIN4;STYXL1;SGMS1;BOK;BCL2L11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.4828160845822623,0.862305953003987,0.6,0.9648846723273544,1.0,1/7,0.34%,CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.4828160845822623,0.862305953003987,0.6,0.9648846723273544,1.0,1/7,0.34%,CRB2
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.3849094378686972,0.8621248564926429,0.7142857142857143,0.9644467492211842,1.0,12/30,23.50%,PRR5L;EHD1;PCM1;NEDD4;PCNT;CEP290;STX18;RIPOR1;RAB29;TENM1;STK11;ZFAND1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,-0.39758020512771836,-0.8620754456230709,0.6625,1.0,1.0,12/52,15.68%,FMO3;ANKUB1;CP;FPR3;TMEM220;APOL6;HVCN1;CPM;RASSF4;C3;CD302;ASAH1
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),-0.5842116295612744,-0.8620540625478097,0.7241379310344828,1.0,1.0,2/5,16.04%,USP50;EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.2843757212130515,0.8620268733294745,0.8888888888888888,0.9638794250856665,1.0,63/316,13.18%,RIT2;SOX11;HIP1;PDGFC;SEPTIN4;ERBB4;TAB3;IRS1;NLGN1;ADRA1A;ESR1;STYXL1;RYK;AKR1C2;ATP2C1;BOK;RICTOR;SEMA4D;INAVA;GAB1;SIRT1;PPM1A;AKR1C3;ROR2;PUM2;BCL2L11;IGF1R;ANKRD17;SLC38A9;TRIM62;GCNT2;NMI;STRN;NRG2;EGFR;PTPRC;KSR1;UNC5B;NDFIP2;MFHAS1;CHD5;RELN;VAPA;TGFA;MAP3K7;PELI2;ZDHHC17;NEDD4;UBE2N;PIK3CA;HMGB1;ZCCHC3;LURAP1;CFLAR;THEM4;LAMTOR2;PRKD1;TFG;CDH13;TRAF5;TAB2;RAPGEF2;FRS2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.4041433024352867,0.8620257189879376,0.64,0.9631829804143619,1.0,4/21,5.15%,RXRA;NR1H2;SIRT1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.4264373409051151,0.8619986716061577,0.6060606060606061,0.9625416441679137,1.0,4/12,16.74%,TNKS;ERCC4;TERF1;TERF2
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),-0.43906065902975255,-0.8618939284044701,0.7083333333333334,1.0,1.0,6/25,22.61%,LIPI;APOE;CAV1;DGAT1;FABP3;LIPH
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.533749514374887,-0.8618084029262881,0.6716417910447762,1.0,1.0,1/8,2.33%,TAF7
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),-0.38632696269129957,-0.8613000411252264,0.75,1.0,1.0,11/85,13.26%,MT1E;MT1M;SFRP1;TGFB1;CDKN2C;MT2A;TCHP;BTG1;ESR2;CRLF3;RACK1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.31326926564003554,0.8610185340077013,0.8571428571428571,0.9641070320622264,1.0,8/38,17.03%,SMPD4;CTSA;ESYT2;GLTP;HEXB;ST3GAL4;ABCA2;ARSA
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),0.39615139899346663,0.8609429484512523,0.7083333333333334,0.9636064186322609,1.0,2/16,7.78%,RYBP;RNF2
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.48309865497974186,0.8602995301968833,0.5777777777777777,0.9643158082846643,1.0,1/5,3.72%,NDP
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),0.41632291739020155,0.8601142115729429,0.65625,0.9639236592238886,1.0,1/12,1.73%,AIFM2
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),0.5264769069842349,0.8600413328525974,0.6,0.9633595684401303,1.0,2/5,17.47%,SRPK2;PRIMPOL
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),-0.3824694926653042,-0.859978715046683,0.7471264367816092,1.0,1.0,7/77,7.80%,LIPI;NAAA;ALOX5;ALOX12;ACSM3;XBP1;GPX4
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.3426842715287136,0.8599646913078834,0.6666666666666666,0.9627747409704874,1.0,13/32,21.35%,GPSM1;MAP2;PLIN5;CPEB2;LRRK2;WNK1;NOS1;LRCH1;TERF2;ARFGEF1;URI1;ZCCHC9;CHP1
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.5262671690790892,0.8599638493508779,0.6774193548387096,0.9620830924496754,1.0,4/5,25.99%,PML;HABP4;ETS1;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5303014190801313,-0.8597684322011551,0.6885245901639344,1.0,1.0,3/6,42.11%,C1QBP;SEC14L1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.43304587333952793,-0.859716364587941,0.6493506493506493,1.0,1.0,3/37,5.07%,PFN2;SFRP1;S100A10
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.41745383297843874,0.8595782848859536,0.6,0.9621024915820882,1.0,4/12,15.67%,CABYR;RFX3;SPEF2;ODAD4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),-0.38219714362957313,-0.8594700165848759,0.7529411764705882,1.0,1.0,2/49,2.26%,B2M;KCNJ13
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),-0.35420712638110063,-0.859165198380687,0.7395833333333334,1.0,1.0,21/166,16.21%,RSPO4;CD63;EVC;RIMS1;HAP1;FGF1;SFRP1;ATP6AP2;XBP1;JAG1;CDH3;EMP2;BDNF;ULK3;VWF;ADAMTS3;MYORG;STX1B;C3;IL7;BAX
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.3838991244595108,0.8590633105412161,0.7272727272727273,0.9624658848234455,1.0,6/21,14.08%,FBXW7;ARC;RELN;TGFA;NRP1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.5218046098461236,0.8589240747384357,0.6052631578947368,0.9620874915143848,1.0,3/5,9.30%,RIPOR2;EHD1;MAPK14
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.4148985217599988,-0.8587006082865134,0.6712328767123288,1.0,1.0,6/28,10.05%,POLR3D;IFI35;PLSCR1;XBP1;RSAD2;GRN
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.38144231342511375,0.8586275630069354,0.6666666666666666,0.962031698822171,1.0,6/18,12.78%,SGCZ;DMD;RORA;MRTFA;NEBL;MEGF10
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),-0.5235073714686427,-0.8585474797551771,0.7313432835820896,1.0,1.0,5/7,40.16%,ATP1B1;ATP1B2;ATP1A1;ATP1B3;SLC9A1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.465842803867837,-0.8581571881149855,0.6417910447761194,1.0,1.0,2/13,13.84%,DVL1;DVL2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),-0.5550868221462992,-0.8580128246365423,0.7358490566037735,1.0,1.0,4/5,31.83%,HOOK2;AKTIP;SQSTM1;HOOK3
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.515178048988703,-0.8579151690174621,0.6567164179104478,1.0,1.0,1/8,7.35%,CLMP
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5455773877539869,0.8578239580671784,0.6842105263157895,0.9627376455346592,1.0,2/5,15.29%,UBR5;TRIP12
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.5787879234586677,-0.857636098784092,0.696969696969697,1.0,1.0,3/5,38.85%,TMEM167B;RAB11B;TMEM167A
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.4516877343032196,-0.8573645448162459,0.6666666666666666,1.0,1.0,3/18,11.57%,VEGFA;TOM1L1;CALM1
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),-0.51060930213219,-0.8572793566505986,0.6129032258064516,1.0,1.0,4/9,21.58%,CACNA1C;AKAP5;ISCU;PARK7
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.37797168975406964,-0.8568296635495083,0.7341772151898734,1.0,1.0,9/57,14.68%,PFN2;PFDN6;CLU;CRYAB;PLEKHH2;STMN2;TUBB4A;VBP1;APOE
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),-0.44984331129394084,-0.8567090126932659,0.6714285714285714,1.0,1.0,3/24,13.78%,ARL1;OBSL1;ZDHHC15
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.49885822492138576,-0.8565982886349405,0.7301587301587301,1.0,1.0,3/10,18.34%,GLUL;SLC1A6;SLC29A2
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.5856249741663124,-0.8564986673130075,0.7547169811320755,1.0,1.0,3/5,16.97%,MEF2C;COL4A1;STAT1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.4532301274362233,0.856471185662666,0.71875,0.9649755316522689,1.0,4/11,16.41%,PKD2;GRIN2B;CPSF6;GRIN1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.4073097556836006,0.8564071989565867,0.6,0.9644250301468825,1.0,6/26,12.31%,ACACB;ACOT9;GLYAT;ACACA;GPAT4;THEM4
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.34817135547156663,0.8563301642688244,0.6818181818181818,0.9639181335174087,1.0,4/32,7.89%,RYBP;YAF2;RNF2;EED
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.3176068976095741,0.856302660173658,0.7,0.9633584756560831,1.0,7/43,8.98%,HSPA1A;BAG2;ABL1;PRMT3;SMAD7;GNL3L;MARCHF7
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.3793574511167853,-0.8561133350433859,0.7647058823529411,1.0,1.0,6/101,6.54%,GOLGA8B;ARL1;GOLGA8A;GORASP1;OBSL1;ZW10
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5223873557452506,0.8560997127095941,0.6363636363636364,0.9630347816632949,1.0,1/5,5.20%,ANK2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4199888546322485,-0.8559032015804234,0.6753246753246753,1.0,1.0,7/29,23.54%,SLC38A4;SLC7A6;SLC7A8;SLC16A1;SLC36A4;SLC25A30;SLC7A10
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.4621732093227431,0.8558893734042563,0.6571428571428571,0.9627756394330766,1.0,2/8,12.80%,SGK1;ACSL3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.4621802057099427,-0.855827977193197,0.7083333333333334,1.0,1.0,8/20,20.72%,IRF1;IGSF6;FPR3;APOL6;TYMP;DDX60L;IFIH1;GPR183
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.43063623821327596,0.8557502116387815,0.7419354838709677,0.9623567546438913,1.0,7/10,25.09%,ERBB4;ZFPM2;RBPJ;BMPR1A;TGFBR3;AKAP6;NOTCH1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.3920005277940802,0.8556382964063907,0.7037037037037037,0.9619171330987951,1.0,6/19,15.35%,DMD;MYH3;SLC8A1;PIK3CA;NOS1;ARHGEF11
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3398358791678633,0.8553904356833542,0.8461538461538461,0.9617446101586112,1.0,9/42,11.59%,PDGFC;SEMA4D;GAB1;SIRT1;ROR2;IGF1R;UNC5B;NEDD4;PIK3CA
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.3603168716618398,0.8553368565699302,0.782608695652174,0.9611995350452199,1.0,2/29,2.67%,ATR;RFWD3
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.39607000885064586,0.8552556556626522,0.6818181818181818,0.9607403845033909,1.0,4/20,14.76%,QRICH2;RAC3;PACSIN2;NCKAP1
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.3520463895561056,0.8552203441751391,0.6060606060606061,0.9600904334621893,1.0,12/23,22.64%,ERBB4;GAB1;NRG2;EGFR;ERBIN;PIK3CA;SOS1;PRKCA;PTPRR;PIK3R1;PTPN12;CPNE3
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.44008282078785604,0.8551463099031497,0.6956521739130435,0.9596008347183863,1.0,4/13,10.49%,CHRM3;PLCB1;GNAQ;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),-0.5538122613882155,-0.8549916046205313,0.6865671641791045,1.0,1.0,4/6,36.14%,PIK3IP1;TSC2;STAMBP;DAB2IP
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.3783508222895002,-0.8549096898071971,0.7608695652173914,1.0,1.0,25/102,22.94%,NOSTRIN;FGF1;FILIP1L;CRYAB;MEF2C;PAMR1;FN1;COL4A1;SMARCA5;LMOD1;COL15A1;COL6A1;ACTA2;MYLK;PTN;COL4A2;COL14A1;CALD1;THBS2;RASD1;PDGFRB;THY1;RHOJ;C1S;HOPX
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.33683513401967746,0.8548442977410761,0.6666666666666666,0.9595580186406276,1.0,4/36,3.79%,NAV3;MAP2;CAMSAP2;ABL1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.5705773595089542,-0.8548167875229414,0.7222222222222222,1.0,1.0,3/6,18.72%,RASGRP1;MEF2C;HSPD1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),-0.5000228516378794,-0.8543538462871576,0.6666666666666666,1.0,1.0,3/9,14.67%,GRN;SYT11;NR1D1
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),-0.4923122713390313,-0.8542527552474458,0.7297297297297297,1.0,1.0,4/12,11.90%,ALOX5;ALOX12;FADS2;ELOVL2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.36118391337496,-0.8540434054002066,0.7415730337078652,1.0,1.0,12/118,10.97%,NEFM;GDAP1L1;SCG3;TRPM3;LRTM1;SVOP;RNPC3;CACNA1B;CELF4;KCNC1;SRRM4;GRM1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.3335024866069567,0.853862450905872,0.7894736842105263,0.9609481042395026,1.0,13/59,12.90%,VAPB;STIM2;ATP2C1;CALCB;ANK2;SLC8A2;ATP2B4;SLC24A3;CHRNA7;STIM1;SLC8A1;SLC39A8;SLC39A10
prerank,MSigDB_Hallmark_2020__Complement,-0.3595953472346079,-0.8538533906839474,0.7555555555555555,1.0,1.0,21/116,18.23%,F8;SCG3;PSMB9;PLSCR1;CP;XPNPEP1;CLU;CTSL;IRF1;RASGRP1;MAFF;FN1;CALM1;CPM;BRPF3;CD55;C3;CD46;COL4A2;CASP3;GMFB
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.4088039486718055,-0.8538001756488374,0.75,1.0,1.0,2/39,4.27%,MX1;TGFB1
prerank,MSigDB_Hallmark_2020__Coagulation,-0.3772648352067162,-0.8536523364796406,0.7011494252873564,1.0,1.0,11/66,16.24%,F8;A2M;CLU;MAFF;FN1;CPB2;VWF;MSRB2;ISCU;C3;S100A1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),0.3496764449105729,0.8536425443237635,0.7272727272727273,0.9608195462764649,1.0,4/31,8.98%,UBE3D;OBI1;RAD18;MARCHF7
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.543664285338352,-0.8534849847959008,0.7358490566037735,1.0,1.0,1/5,4.21%,PBLD
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4029698610459983,0.8534019793936687,0.6571428571428571,0.9607017687743485,1.0,3/16,5.72%,GSTM2;ANK2;DMD
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.32846859474189494,0.8533747999694469,0.6551724137931034,0.9600546009995609,1.0,9/31,15.59%,STIM2;HOMER1;ANK2;CACNA2D1;PKD2;STIM1;BCL2;NOS1;ORAI1
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.5132084466760434,-0.8532517608928857,0.6290322580645161,1.0,1.0,1/8,5.35%,BTD
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.33996439604776646,0.8530601533915128,0.7222222222222222,0.9599057790997265,1.0,5/26,12.17%,PANX1;INAVA;HSPB1;FOXP1;P2RX7
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),-0.4788954735700724,-0.8526857062252386,0.6944444444444444,1.0,1.0,1/13,2.69%,PPIB
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.5010138338845158,0.8521749586948452,0.6585365853658537,0.961153223827698,1.0,2/8,6.76%,NEDD4L;BIN1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.5151156675250714,0.8520730318635769,0.6206896551724138,0.9606762065051938,1.0,2/8,10.35%,FOXO1;ATP6V1A
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.5449536409786526,-0.8516186170191831,0.765625,1.0,1.0,1/6,4.84%,ARX
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.4477479221145492,-0.8515989520272792,0.6986301369863014,1.0,1.0,9/20,26.54%,PPIB;PDK1;RASGRP3;SSR4;CD9;ITGAL;MAN1A1;CD27;GUSBP11
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.5494779462159228,-0.851114892637209,0.7377049180327869,1.0,1.0,1/6,11.90%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.5494779462159228,-0.851114892637209,0.7377049180327869,1.0,1.0,1/6,11.90%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.5494779462159228,-0.851114892637209,0.7377049180327869,1.0,1.0,1/6,11.90%,ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.5494779462159228,-0.851114892637209,0.7377049180327869,1.0,1.0,1/6,11.90%,ELOVL2
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.505937467366105,-0.8510458825429231,0.6818181818181818,1.0,1.0,2/8,15.35%,PLS1;PLS3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),-0.5161518076021445,-0.8506455165772872,0.703125,1.0,1.0,3/7,17.19%,MEF2C;PIK3CB;CDKN2A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.46575253217195933,-0.850202314621297,0.6753246753246753,1.0,1.0,2/13,11.54%,PLS1;DCTN1
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5598928427199221,-0.8497053638176099,0.7014925373134329,1.0,1.0,3/7,22.09%,ALOX5;GSTP1;SPHK2
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.5065594808426894,0.849215479529147,0.6333333333333333,0.966240913468655,1.0,1/6,20.07%,ATPAF1
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.511631508096503,-0.8491900517949036,0.7083333333333334,1.0,1.0,3/11,23.48%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4586928472969529,-0.8490670970686538,0.7051282051282052,1.0,1.0,4/17,13.75%,TRIB1;MEF2C;APOD;OGN
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),-0.4533319423253911,-0.848963752991073,0.7352941176470589,1.0,1.0,2/17,8.63%,PMM1;MPI
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3529822299602983,-0.8489389999710631,0.7553191489361702,1.0,1.0,20/129,15.97%,VEGFA;DDRGK1;SFRP1;TGFB1;LRPAP1;PARP14;OVOL2;OLFM1;MEF2C;PTRH2;PARP9;SH3GL2;ID2;TCEAL1;RACK1;MAP2K1;APOE;HRAS;CD46;HSP90AB1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.5585275628597546,-0.8488862733860835,0.7538461538461538,1.0,1.0,3/6,25.32%,PEX14;APEH;ABCE1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4459308669945109,-0.8484022510981946,0.7567567567567568,1.0,1.0,1/21,0.66%,CD63
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),-0.594163413600845,-0.8476275223532779,0.7619047619047619,1.0,1.0,1/5,7.02%,BCAT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.34780839822529175,0.8473765119366221,0.6190476190476191,0.9690959992328229,1.0,4/20,12.17%,PANX1;INAVA;HSPB1;P2RX7
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.4504278574175625,-0.847048671037211,0.704225352112676,1.0,1.0,2/18,7.92%,FLOT1;MEF2C
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.3011776447438982,0.846762531512726,0.7333333333333333,0.969869422810211,1.0,36/152,15.04%,PKP2;ZDHHC2;TSPAN17;NLGN1;EHD1;ZFYVE27;ARL5A;TSPAN15;NRXN1;ANK2;MAGI2;C2CD5;SPTBN1;EFR3A;PACS1;DPP6;SYNE3;RAB10;SEC16A;TSPAN5;DPP10;LRRC7;DLG2;ZDHHC3;RAPGEF6;FLOT2;KCNIP4;MYO5A;TSPAN14;RAPGEF2;RAB40C;PACS2;MAP7;RAP2A;ARL3;SPTBN4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.46887492100562433,-0.846606249766765,0.6865671641791045,1.0,1.0,3/14,7.07%,CREB3;SELENOS;XBP1
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.47154228610701077,0.84654952973098,0.5675675675675675,0.9697986387135563,1.0,2/6,12.58%,FBXL7;CAND2
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),0.42661680310003913,0.846462239007374,0.5625,0.9692645640422423,1.0,2/13,5.92%,ACACB;ACACA
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.5000736349274917,0.8463339700323512,0.5555555555555556,0.9688154330478073,1.0,2/6,6.03%,ABL1;FAM107A
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.31509547495563545,0.8462477747556397,0.68,0.9682302138683705,1.0,6/44,11.01%,KANSL3;ZZZ3;JADE3;KAT8;CHD5;MCRS1
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.5477664182974556,-0.8461490251968474,0.711864406779661,1.0,1.0,1/5,7.28%,CEACAM1
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.5101328464368777,0.8458730177041949,0.7058823529411765,0.9683394382529301,1.0,2/5,11.79%,DCC;PTPRS
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.31603494647991176,0.8458338371288178,0.6666666666666666,0.9676818583463994,1.0,18/70,15.60%,PTPN20;IL1RAPL1;PTPN13;RPS6KB1;NCOA2;TGFBR2;TIPARP;SLIT3;LRRK2;ACVR1;PTPN4;MAPK8;ROBO2;ACVR1C;NOS1;BMPR1B;ZNF16;NFAT5
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),-0.4857296267346587,-0.8457454063811227,0.7049180327868853,1.0,1.0,4/10,16.40%,TMLHE;SHMT1;CRAT;ACADL
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.475528117610412,-0.845626884977218,0.6865671641791045,1.0,1.0,2/9,11.54%,RANGRF;DCTN1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.3758420184448934,0.8456242116879606,0.6,0.9674135039475927,1.0,6/31,7.10%,NLGN1;NLGN4X;IL1RAPL1;NRXN1;SPTBN1;PICALM
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.5373650387588349,-0.8455442701173198,0.7,1.0,1.0,1/5,14.97%,LZTFL1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.31971955750619885,0.8454833748916148,0.72,0.9670196766579515,1.0,21/50,22.64%,ERBB4;BCAR1;GAB1;REPS2;MAPK1;NRG2;EGFR;TGFA;ERBIN;PIK3CA;ADAM17;SOS1;PRKCA;KIF16B;BRAF;PTPRR;PIK3R1;PDPK1;PTPN12;PTK2B;CPNE3
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.3862061476137498,-0.845442916398612,0.7777777777777778,1.0,1.0,7/70,8.32%,RSPO4;EMD;SFRP1;WIF1;ATP6AP2;SFRP4;GPC3
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.49298780724438696,0.8452974677560294,0.6428571428571429,0.9666368802147409,1.0,2/6,10.60%,FHIT;PRPS1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.5033106090162567,0.8451501561431096,0.71875,0.9663384005006849,1.0,3/7,22.36%,GRIN1;CPEB4;PTK2B
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.41665170417565345,-0.8450607713344688,0.6455696202531646,1.0,1.0,6/22,21.53%,ENKUR;CCDC39;PKD1L1;DNAH11;CCDC40;STIL
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,-0.3795057677538281,-0.8450097166066055,0.6708860759493671,1.0,1.0,12/51,22.21%,ESRRB;FILIP1;KBTBD12;CTNNA3;PREX2;WIPF3;TMEM266;ACTN2;SYCP2L;LDB3;GREB1;CNTFR
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),-0.5163675674733088,-0.84475157433647,0.7313432835820896,1.0,1.0,1/6,7.92%,MEF2C
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.49393276898155086,-0.844666375842659,0.6428571428571429,1.0,1.0,4/9,29.24%,USP44;DYNC1LI1;LCMT1;XRCC3
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.3282563836739612,0.8445801086395792,0.6153846153846154,0.9668985006304804,1.0,15/79,18.78%,INPP4B;SYNJ1;PTPN13;PLCB1;MTMR10;PIKFYVE;CDS1;MTMR3;PIK3CA;OCRL;FIG4;MTM1;PITPNM2;PIP5K1B;MTMR8
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.43650159961441304,-0.8444559723147409,0.6428571428571429,1.0,1.0,3/12,11.84%,HAP1;DDIT4;BDNF
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.4309893381664709,0.8443123906134483,0.625,0.9666839197200152,1.0,7/15,21.99%,MAPK1;MSN;MAPK3;MAP2K2;SNX3;DNAJC13;RAB21
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.36652207468980547,0.843934192628041,0.6896551724137931,0.9668249654898763,1.0,2/15,7.67%,RIPOR2;KANK1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),-0.5611493619270239,-0.8435619575019453,0.746268656716418,1.0,1.0,1/5,4.75%,ALOX5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.4138522476911637,0.8431852338607086,0.78125,0.9678744012001633,1.0,3/13,5.72%,GSTM2;ANK2;DMD
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.47281803007568546,-0.8431680362972278,0.671875,1.0,1.0,2/11,16.51%,PARP14;CAV1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.33462028055802634,0.8431617514864775,0.7368421052631579,0.9672421389592627,1.0,3/26,8.77%,H2BC5;UBN1;RSF1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.39004612656650794,0.8431577980243705,0.59375,0.9665690407414762,1.0,2/16,7.68%,SLC25A18;SLC1A2
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.5498679657334684,0.843074992963533,0.6666666666666666,0.9647114641546884,1.0,1/5,4.28%,EDEM1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.5498679657334684,0.843074992963533,0.6666666666666666,0.9647114641546884,1.0,1/5,4.28%,EDEM1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.5498679657334684,0.843074992963533,0.6666666666666666,0.9647114641546884,1.0,1/5,4.28%,EDEM1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.37938665441536334,0.8427903745577422,0.7741935483870968,0.9646035926418127,1.0,3/21,7.68%,SLC25A18;SLC7A2;SLC1A2
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.49951738950832547,0.8427836722392111,0.6666666666666666,0.9639346581115478,1.0,2/8,11.88%,KCND3;KCNIP2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),-0.3401305576009366,-0.842707669815638,0.7692307692307693,1.0,1.0,17/165,10.05%,VEGFA;DDRGK1;FGF1;PLET1;ENPP2;TMSB15B;RAB11A;TGFB1;SEMA4C;CEMIP;KIF20B;HDAC6;XBP1;HAS2;FN1;ELP5;GRN
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.5509096926471764,-0.8422326616032539,0.7241379310344828,1.0,1.0,1/5,15.87%,CD46
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.36888014892995846,0.8419680752752641,0.6129032258064516,0.964959507480922,1.0,4/15,14.01%,GDAP1;USP30;MFN1;MIGA1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.43343893809415407,-0.8418494012274917,0.6891891891891891,1.0,1.0,7/19,18.96%,SELENOK;ATF4;DNAJC10;TRIB3;AIFM1;BAX;BAG6
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.4275492149956238,0.8417797906778453,0.7586206896551724,0.9648724451666928,1.0,5/11,19.55%,IRS1;FOXO1;FOXO3;PID1;GLDC
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.5357505632607356,0.8417607147745423,0.6938775510204082,0.9642980546180308,1.0,2/5,32.31%,DDX3X;EIF4G1
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.45799353423643535,-0.8415106487005299,0.7105263157894737,1.0,1.0,5/23,18.90%,ADAM21;COL9A3;NR0B1;FSHR;MEA1
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),-0.4288117001076515,-0.8414942436370075,0.7432432432432432,1.0,1.0,6/21,20.87%,HNRNPA2B1;SUPV3L1;DDX11;PIF1;RECQL;DHX36
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.4442891293790566,-0.8413415973735765,0.7222222222222222,1.0,1.0,2/26,3.56%,TAF7;CAMK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.36027235318202083,-0.8412779747178013,0.8172043010752689,1.0,1.0,32/129,28.75%,PSMB9;CDKN1C;TGFB1;PSMB8;KIF20B;OBSL1;PSMA3;BUB3;BTG1;NEK6;PSMA7;CDC26;PSME1;SRA1;FZR1;NEK11;CDK11B;PSMB6;PSMB1;PSMC4;EIF4EBP1;BTG2;CUL7;PSMD2;PSMB3;PSMD7;APP;PSMC3;CDC23;LGMN;PSMA4;ANAPC2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.4904963113643993,-0.8412094997616977,0.7301587301587301,1.0,1.0,2/10,17.92%,PEX1;PEX14
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.3989809278993467,-0.8407738912660007,0.6867469879518072,1.0,1.0,8/54,15.63%,IFIT1;POLR2I;POLR2G;NR5A2;CTDP1;GTF2F1;SRPK1;ADAR
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.5659619505707385,-0.8407621485333453,0.7142857142857143,1.0,1.0,3/5,20.52%,HLA-A;CD55;IL18
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3768041691488293,-0.8407491783763585,0.7738095238095238,1.0,1.0,5/64,9.79%,S100A6;CDHR1;DVL1;MEF2C;CCK
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.4795374953301218,-0.8405015217238442,0.7432432432432432,1.0,1.0,4/12,24.22%,SLC30A4;SLC39A6;SLC39A14;SLC39A7
prerank,GO_Biological_Process_2021__caveola assembly (GO:0070836),-0.5941907731036744,-0.8402983478321986,0.7592592592592593,1.0,1.0,2/5,16.51%,EMP2;CAV1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.4566199276672257,-0.8402130566113486,0.7101449275362319,1.0,1.0,3/15,17.81%,TGFB1;CAV1;CATSPERG
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.4407660833949212,-0.8401633334787565,0.7058823529411765,1.0,1.0,1/20,2.84%,HES1
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),0.29304981185004514,0.8401107792531186,0.75,0.9671756962741066,1.0,30/167,14.39%,SPSB4;RNF144A;WDR81;FBXL4;FEM1A;MIB1;RNF150;KLHL8;NEDD4L;BTRC;HACE1;UBE2G1;UBE2D1;KEAP1;SPSB1;NDFIP2;UBE2H;NEDD4;RCHY1;FBXL7;ANAPC4;RNF11;PSMD13;UBE3C;CDC16;RNF217;FBXO11;ANAPC1;ADRM1;RNF128
prerank,GO_Biological_Process_2021__cognition (GO:0050890),-0.4131398466554826,-0.8401005904762533,0.691358024691358,1.0,1.0,2/32,2.27%,CBR3;GPR155
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.41707830822923514,0.8394720057851509,0.7352941176470589,0.9679572637364844,1.0,2/11,4.73%,HP1BP3;SIRT1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.4666515499091325,-0.8394379161785241,0.7142857142857143,1.0,1.0,5/12,23.82%,TTN;MYL6B;ACTN2;TPM4;MYL6
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.4666515499091325,-0.8394379161785241,0.7142857142857143,1.0,1.0,5/12,23.82%,TTN;MYL6B;ACTN2;TPM4;MYL6
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.4756214244280754,0.8389792857490169,0.6590909090909091,0.9676968613054711,1.0,2/5,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.4756214244280754,0.8389792857490169,0.6590909090909091,0.9676968613054711,1.0,2/5,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.3111132278125949,0.8389652958126023,0.8,0.9670398196465131,1.0,10/36,19.14%,YLPM1;STOX1;SMARCAD1;SMG1;UBE2N;HNRNPD;SUB1;TERF2;WRNIP1;UBE2V2
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.38932710633836654,-0.8387650194533453,0.6351351351351351,1.0,1.0,7/31,18.08%,AGRN;RARRES2;GPC3;RBP2;RDH10;APOE;GPC2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.3799652692266507,-0.8387413394513438,0.7613636363636364,1.0,1.0,13/56,21.81%,NPM2;ECT2;PLSCR1;KIF20B;WIZ;DDX11;GIPC1;USP19;DBF4B;PDGFRB;DBF4;BTC;NUMA1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.3282295990732857,0.8381225892420707,0.8095238095238095,0.9679019531001464,1.0,10/51,10.43%,RACGAP1;SEPTIN4;SEPTIN6;SEPTIN11;SPTBN1;EFHC1;SNX33;BBS4;SNX18;ANLN
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,-0.4477872115513735,-0.8380030998468107,0.7222222222222222,1.0,1.0,4/20,13.70%,S100A10;MAFF;ABCC3;CD55
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.5678757505537636,-0.8379993427284157,0.71875,1.0,1.0,1/5,4.27%,TGFB1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),-0.35456610336519145,-0.8378334468955753,0.782608695652174,1.0,1.0,15/100,16.20%,PDCD1LG2;H2AZ1;SFRP1;CFTR;SELENOS;XBP1;MEF2C;MED1;MGST1;TRIM41;WNT5B;CACTIN;NR1D1;PDK3;KAT5
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.4681199130535154,0.8375669524588026,0.6333333333333333,0.9681023390061386,1.0,3/6,19.55%,GLYAT;RIDA;GLDC
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.4093865842667358,0.8371518859716862,0.7333333333333333,0.9682096217640498,1.0,3/12,6.71%,RIPOR2;GPNMB;FGL1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3366348477773748,0.8369061178429427,0.6,0.9680281594542971,1.0,13/65,11.59%,PDGFC;SEMA4D;GAB1;SIRT1;ROR2;PTPN13;MAPK1;IGF1R;EGFR;UNC5B;MAPK3;NEDD4;PIK3CA
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3631090919444954,-0.8368115863814355,0.782608695652174,1.0,1.0,10/107,9.20%,PSMB9;SFRP1;TGFB1;PSMB8;ATP6AP2;SFRP4;GPC3;PLEKHA4;PSMA3;CDH3
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),-0.3822639936360102,-0.8366323012284641,0.75,1.0,1.0,7/50,15.94%,SFRP1;RRAGA;XBP1;ATG14;ZFYVE1;SREBF1;ULK1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.41890561768425116,-0.83659538822417,0.6582278481012658,1.0,1.0,5/28,15.03%,JAG1;TCF7;WNT5B;DVL2;SKP2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),-0.5004163252271849,-0.836399235566292,0.6779661016949152,1.0,1.0,1/8,4.19%,RARRES2
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.566326400388925,-0.836208770043559,0.7213114754098361,1.0,1.0,2/6,9.39%,GLUL;CAD
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.35339514197736677,0.8360160760612609,0.7666666666666667,0.969185942629622,1.0,8/30,13.02%,TG;ZBTB1;SALL1;PKD2;MSN;PRKCSH;PROX1;COBL
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.29635467154891715,0.835916537339538,0.7777777777777778,0.9687055650623628,1.0,15/102,11.57%,USP51;HSPA1A;RPA1;AIFM2;ATR;BAG2;ABL1;SIRT1;MAPK1;NUP98;NUP93;MAPK3;SMG1;HSPH1;BAG5
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.3595147344495171,-0.8358689225040677,0.8255813953488372,1.0,1.0,11/85,16.19%,SLC3A1;SLC35F3;SLC38A4;SLC6A6;SLC7A6;SLC7A14;SLC22A4;SCAMP5;SLC3A2;RHCG;SLC7A8
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.36413729965374697,0.8358480168568858,0.68,0.9681332744222034,1.0,9/31,19.29%,TBC1D14;TBC1D12;PIKFYVE;LRRK2;MTMR3;NPRL2;MTM1;PINK1;RALB
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.47128330479315117,-0.8358122452729988,0.7297297297297297,1.0,1.0,1/11,2.57%,SFRP1
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3896077455051555,-0.8355613726032104,0.7701149425287356,1.0,1.0,19/58,21.53%,VEGFA;HES5;GSTK1;DVL1;TGFB1;SPINK5;PGK1;VIL1;VDAC1;CBR1;RHCG;STAT1;MTHFD1;AHI1;VCL;PPP2R3A;DNPH1;NDRG4;STIL
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),-0.5406309160281423,-0.8354787831578485,0.765625,1.0,1.0,4/7,25.34%,POLQ;MCM3AP;MSH6;PMS2
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),0.4565948678075751,0.8348414297290269,0.6774193548387096,0.9697717057174801,1.0,2/10,10.58%,SRR;SERINC5
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.4731085276572443,0.8346859229552968,0.6363636363636364,0.9693535448085582,1.0,5/9,27.70%,HDAC4;PIAS1;RASD2;PIAS4;UBA2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.4167046956623527,0.8344498500201137,0.782608695652174,0.9691412506380961,1.0,3/14,7.65%,ESR1;ABL1;ABL2
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.47835579614720236,-0.8342880396866317,0.746268656716418,1.0,1.0,3/11,19.03%,NCBP1;CSTF2;CPSF1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.28263508664498055,0.834078932958643,1.0,0.9691344004817849,1.0,36/334,7.72%,ONECUT1;TCF7L1;SOX11;POU6F2;ZNF280D;ZNF516;ZNF280B;CREM;RYBP;ESR1;TCOF1;ZNF536;HDAC10;NFYC;GPBP1L1;DMTF1;ABL1;ZNF98;SP3;HP1BP3;OBI1;ZNF2;CHD7;ESRRG;LIMD1;APBB2;PSPC1;ANKRD17;ZNF268;ZNF678;RFX3;NCOA2;YAF2;TGFBRAP1;SMARCA2;ATXN1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),0.3330191248466152,0.8340175930683666,0.6923076923076923,0.9685535230851032,1.0,6/42,4.19%,ADAM10;KAT2B;SORBS2;DTX4;MIB1;PBX1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.46998695192841355,-0.8336784980981184,0.7142857142857143,1.0,1.0,2/12,12.54%,PIK3CB;ARHGAP24
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.49541535634288025,-0.8334698954704339,0.7391304347826086,1.0,1.0,1/8,14.53%,HADHA
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.49320556238587604,-0.8334458476687271,0.7096774193548387,1.0,1.0,5/8,30.01%,GNE;NAGK;AMDHD2;GNPDA1;ST3GAL1
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.43896940481688124,-0.8334348457063722,0.726027397260274,1.0,1.0,12/25,23.88%,CFAP61;DNAH17;DNHD1;CFAP251;CCDC39;CFAP100;DNAH11;CCDC40;CFAP70;DNAAF2;DNAI4;DNAH9
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.45472964433786905,-0.8329748767080627,0.7605633802816901,1.0,1.0,2/15,5.02%,RAB11A;ATAD5
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.31884197440927114,0.8328935091632548,0.6956521739130435,0.970114362038715,1.0,5/44,10.51%,ACADVL;ACADS;ACAA2;ADIPOR2;HADH
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.3411843519673161,0.832657025823874,0.7647058823529411,0.9699123648732176,1.0,8/36,10.71%,RPA1;ATR;STN1;POT1;NSMCE2;CTC1;SMC6;ERCC4
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.45896523164760306,0.8325010178166262,0.6756756756756757,0.9696492654957277,1.0,4/9,31.06%,ELP3;GTPBP3;ELP4;TRMT9B
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),-0.45316068736765136,-0.8324758741176671,0.6666666666666666,1.0,1.0,3/15,15.55%,YBX3;WNK3;MYLK
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.44926456712268975,0.8324439412958539,0.7209302325581395,0.9690696218265855,1.0,3/7,24.05%,EGFR;OPN3;MMP2
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.4152122541800504,-0.8319867201641372,0.7058823529411765,1.0,1.0,9/32,20.57%,ALOX5;PTGR1;ALOX12;GPX4;FADS2;ELOVL2;FAAH2;CYP1B1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),-0.4109931540300138,-0.8316897645396986,0.7361111111111112,1.0,1.0,6/25,11.48%,SERPINE3;SPINK5;AGT;GAPDH;CST3;SERPIND1
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.27839656739228463,0.8316844743803943,0.7142857142857143,0.9698596743856459,1.0,23/174,13.94%,SPSB4;RNF139;UBE3D;FBXW7;HECW2;NEDD4L;SIRT1;BTRC;TBL1XR1;HACE1;UBE2G1;SPSB1;PML;FBXW11;PCBP2;NEDD4;TRIM71;FBXW5;PSMD6;PSMD13;COP1;KLHL42;SOCS6
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.42752042212248337,-0.8316564229235834,0.7534246575342466,1.0,1.0,10/24,24.98%,ARHGAP15;EPSTI1;TCF7;SEPTIN1;GPR171;KLRB1;ITGAL;PSTPIP1;ARHGEF1;CD27
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),-0.3681246528507162,-0.831470871699268,0.8043478260869565,1.0,1.0,13/87,17.33%,PSMB9;VAV3;LAT2;JUN;PSMB8;PIK3CB;PSMA3;CALM1;NR4A3;PSMA7;FOS;PSME1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.38035453519650486,0.8306401324614731,0.72,0.9710059570867129,1.0,5/15,18.96%,SYT12;SYT9;SYT17;SNCA;PRKN
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.3104786027446674,0.830256525007536,0.6666666666666666,0.9711611037907616,1.0,14/88,9.69%,SERTAD2;HSPA1A;WFDC1;MAP2;DIP2B;SIRT1;APBB2;DCC;SMARCA2;SLIT3;PRDM11;PML;CGRRF1;GNG4
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.32903092894888647,0.8302216075408565,0.7222222222222222,0.9705718140539765,1.0,17/63,13.23%,CORO6;ASB5;SORBS2;PDLIM5;CPT1A;PDE4D;DMD;VLDLR;SYNPO2;STRN;ADIPOR2;MITF;PDE1A;MYOM1;PRKG1;ZFPM2;ADPRHL1
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),-0.4263605557282757,-0.8302183899256782,0.6891891891891891,1.0,1.0,2/21,4.85%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.4444856437966553,-0.8299105187670451,0.7246376811594203,1.0,1.0,7/18,24.29%,SFRP1;PARP14;SH3BP5L;CAV1;THY1;SH3BP5;PTPN2
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.48327302119650706,-0.8298068278026832,0.7384615384615385,1.0,1.0,3/10,19.03%,NCBP1;CSTF2;CPSF1
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.5032934665552165,-0.8297795935784131,0.7258064516129032,1.0,1.0,1/8,4.27%,TGFB1
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3074923850022448,0.8297224602207076,0.8148148148148148,0.9709511795735191,1.0,8/52,11.59%,CD247;PLD2;ABL1;MAPK1;ABI1;WASL;MAPK3;PIK3CA
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.5189389672050518,-0.8295279815402924,0.7230769230769231,1.0,1.0,1/10,2.57%,SFRP1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3512412548569511,0.8294470876383235,0.7916666666666666,0.9709431510359471,1.0,8/31,14.17%,ESR1;PADI2;ARID1A;TRERF1;UBR5;NEDD4;ZMIZ1;NR3C1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.30346532848641733,0.8294176994155366,0.8125,0.970385731760408,1.0,8/50,11.38%,SLC8A2;SLC9A9;PKD2;SLC12A1;SLC24A3;SCNN1D;SCN11A;SLC8A1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.43790161935261795,0.8291878507263482,0.6923076923076923,0.9702255897002021,1.0,4/13,21.53%,BARD1;SMG7;IKBKB;PSEN1
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.5504799026117848,-0.8291520058201952,0.7796610169491526,1.0,1.0,2/6,31.45%,EZH1;DOT1L
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.530589909097166,-0.8289267764515915,0.7352941176470589,1.0,1.0,1/5,8.80%,MED1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.43028752862173614,-0.8288179444346464,0.7101449275362319,1.0,1.0,2/16,8.80%,JUN;MED1
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.5403393994975647,0.8287078649731869,0.7941176470588235,0.9704212755977619,1.0,1/5,20.07%,ATPAF1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.48515225814262086,-0.8286517672405037,0.7096774193548387,1.0,1.0,7/12,36.87%,TPST1;TPST2;ENPP1;BPNT2;SLC35B3;SLC26A2;SULT1C4
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.40576526946238617,0.828558693570876,0.7058823529411765,0.9700785647947263,1.0,5/24,18.51%,CEP120;SIRT1;FBXW5;CHMP1A;NPM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.5351552069985274,-0.8282113177987059,0.6833333333333333,1.0,1.0,1/6,7.78%,RSAD2
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.3824306635775052,0.8281289647525105,0.7272727272727273,0.9704973093795422,1.0,4/18,15.52%,LAMC1;DMD;CLDN12;JAM3
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.5047783894023494,-0.8280752689392945,0.7627118644067796,1.0,1.0,1/8,10.42%,LACTB2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.38215366047700816,-0.8279162361277687,0.7215189873417721,1.0,1.0,9/47,22.09%,COX7A2;NUP155;SEC13;BEND3;NUP107;PGAM1;NUP85;NUP188;SPHK2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.5114908191457281,-0.8277932144912735,0.7846153846153846,1.0,1.0,1/7,7.28%,CEACAM1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4342750299678899,-0.8277104934775156,0.7466666666666667,1.0,1.0,5/19,15.25%,CACNB1;JPH3;HPCA;CALM1;SELENON
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),-0.4443626770089071,-0.8276673756616069,0.7432432432432432,1.0,1.0,3/17,17.45%,RIMS1;SYT11;SYT4
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),-0.3416431746409937,-0.8273409784786917,0.8064516129032258,1.0,1.0,18/123,18.09%,ESRRB;VEGFA;ENPP2;DVL1;CAMK1;XBP1;TLE6;SLC6A6;KRT10;ZBED3;ZDHHC15;DVL2;APOE;VIL1;HSP90AB1;PTN;RBM19;DNM1L
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.3315012178434701,-0.8271621944431319,0.8877551020408163,1.0,1.0,59/328,20.26%,ROMO1;VEGFA;HES5;DDRGK1;IL12RB2;SPDYA;FGF1;SFRP1;FLOT1;HES1;RPS9;TGFB1;HMGN5;RPL23;HTR2B;FAM98B;KIF20B;RTKN2;XBP1;DERL2;SLC6A6;NOXA1;HAS2;FN1;CDH3;OSMR;GRN;NCBP1;RPS4X;EMP2;P2RX4;SUPV3L1;DVL2;HDGFL2;SLC25A5;ZFHX3;RPS6;HRAS;IL7;TSHR;HSP90AB1;TFE3;CAV1;PTN;GAREM1;CHTOP;POFUT2;TAF9B;DBF4B;CLEC11A;CDKN2AIP;CDK4;TRIM32;SAPCD2;CIAO1;NAMPT;RARA;PDGFRB;COPS9
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.2971544043261574,0.8269844098611595,0.8333333333333334,0.9720916908964046,1.0,10/46,21.37%,PATL1;DCP1B;EXOSC1;EXOSC7;CNOT6L;CNOT2;CNOT9;CNOT7;RC3H2;PAN3
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.4070848473749511,0.8266131594324363,0.7692307692307693,0.9722450545031915,1.0,2/14,6.83%,PPARG;CBLB
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.4238012197903753,0.8264722390540451,0.7666666666666667,0.9718919116788655,1.0,3/16,5.96%,ANK2;DMD;SMAD7
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.3729259984529994,-0.8264411780897213,0.7954545454545454,1.0,1.0,11/64,16.75%,TNC;SFRP1;HAS2;COL4A1;TCEAL9;SRPX;NRP2;ADAMTS7;PLS3;PTN;COL4A2
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.43987648848311456,-0.826427198841637,0.7037037037037037,1.0,1.0,1/19,4.27%,TGFB1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.35993820240006336,-0.8262805483101424,0.7558139534883721,1.0,1.0,8/66,18.97%,VAV3;EFNA1;AP2A1;APH1A;HRAS;RASA1;NGEF;AP2A2
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4278769060401916,0.8262073485272674,0.7419354838709677,0.9718023435587135,1.0,4/9,18.40%,ERBB4;ZFPM2;RBPJ;BMPR1A
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),-0.4091878849223304,-0.8258234128482601,0.7974683544303798,1.0,1.0,7/27,19.07%,RANGRF;LEPROTL1;BDNF;RIC3;HSP90AB1;GOPC;ACTN2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.4232432603296298,-0.8254380164378582,0.6756756756756757,1.0,1.0,10/21,26.34%,RASSF1;TRAPPC6A;TOR2A;CCS;GUK1;DNAJC4;SF3B5;RHOG;DOK1;RPS6KB2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.4540827698535783,0.8254148896813979,0.6744186046511628,0.9729162621986323,1.0,3/7,9.17%,APOLD1;VEZF1;ATOH8
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.34683881900923713,0.8253809762002838,0.7916666666666666,0.9723208491660642,1.0,5/26,12.20%,PHLDB2;FAM107A;AJAP1;NF2;MAP4K4
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),-0.45737761729509274,-0.8253580386934662,0.76,1.0,1.0,3/15,17.64%,P2RX4;APOD;P2RY12
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.42044036963124554,-0.8253236764980465,0.7125,1.0,1.0,7/25,31.66%,M6PR;AP4M1;LAMTOR4;SORL1;CD81;NCOA4;AP3M1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.33908631620330404,0.8253126664322936,0.7272727272727273,0.971837324165874,1.0,2/40,1.85%,IL15;FEM1A
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3961699016481159,-0.8252812497489396,0.7435897435897436,1.0,1.0,7/35,21.51%,NUP155;NOL6;SEC13;NUP107;TOMM20;NUP85;NUP188
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.4192666025870665,0.8250944261015193,0.6764705882352942,0.9716975746187256,1.0,2/10,11.34%,VCAN;HEXB
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.49670400789923136,-0.824932267341014,0.6716417910447762,1.0,1.0,1/8,13.15%,ATF4
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.38426501670210533,0.8249018635870528,0.7857142857142857,0.9714470770804,1.0,2/16,4.14%,SOX11;DSCAML1
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),-0.3766320963128641,-0.8242477880515119,0.7349397590361446,1.0,1.0,11/46,20.84%,SFRP1;DERL2;NCBP1;SUPV3L1;HDGFL2;TAF9B;WFS1;CDKN2AIP;TRIM32;RFTN1;DNPH1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.3315338824427033,0.8238463813111043,0.8,0.9728699169063283,1.0,9/54,11.59%,IRS1;BCAR1;GAB1;FER;C2CD5;IGF1R;FOXO1;ATP6V1A;PIK3CA
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),0.4657662126385682,0.8237632091153035,0.6571428571428571,0.9724074657931633,1.0,3/8,11.79%,SEMA4D;DCC;PTPRS
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.5402615887467614,-0.8236312708768796,0.7741935483870968,1.0,1.0,3/6,16.12%,CDH3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.5402615887467614,-0.8236312708768796,0.7741935483870968,1.0,1.0,3/6,16.12%,CDH3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.48267367335620526,-0.8236107895263767,0.7538461538461538,1.0,1.0,3/13,22.55%,CAV1;BAG6;RNFT1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.34916332652844156,0.8234799648298989,0.64,0.9724690043406388,1.0,3/19,8.70%,ACADVL;NR1H2;ADIPOR2
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.47500836847669253,0.8234389936029509,0.7142857142857143,0.9718867467476024,1.0,5/7,32.32%,TOPBP1;SETMAR;NAE1;STK33;HUS1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.5063350047041411,0.8233423407713782,0.75,0.9714861931920488,1.0,3/5,18.61%,ERBB4;LATS1;AKT2
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3832907585138148,-0.8231536733517645,0.7654320987654321,1.0,1.0,9/29,21.18%,SLC38A4;SLC6A6;SLC7A6;SLC22A4;SLC1A6;SLC3A2;SLC7A8;SFXN3;SLC36A4
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.46116993299338893,0.8230232553586164,0.6904761904761905,0.9708974898943932,1.0,2/7,7.62%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.46116993299338893,0.8230232553586164,0.6904761904761905,0.9708974898943932,1.0,2/7,7.62%,GSTM2;PKD2
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.38006742074464606,0.8224723311765096,0.75,0.9712206416509683,1.0,5/17,9.87%,RXRA;SLCO1A2;NCOA2;AKR1C1;ABCC11
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),-0.46823768691619905,-0.8222792447632423,0.7164179104477612,1.0,1.0,4/11,22.55%,USP19;BAG6;UBXN1;RNFT1
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.4093084325329427,0.8222352498778241,0.6896551724137931,0.9710621906097416,1.0,2/11,11.38%,ADRA1A;SLC8A1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),-0.3915336820504848,-0.8222121789554796,0.7195121951219512,1.0,1.0,6/35,15.94%,GABARAPL2;ATG14;MAP1LC3B2;CISD2;FUNDC2;ULK1
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),-0.47897305751871766,-0.821512880023189,0.7536231884057971,1.0,1.0,1/12,2.69%,PPIB
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.32245053548312963,0.8212527419110023,0.7,0.9721962326851152,1.0,8/47,10.89%,GPNMB;FAM107A;PLCB1;ANKRD17;PKD2;EGFR;LSM11;UBE2E2
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.27770856216789536,0.821099126380418,0.9166666666666666,0.9716969678919055,1.0,9/65,10.12%,CTSV;RACGAP1;SEC24D;KIF15;MARCHF1;CAPZB;PIKFYVE;AP1G1;AP1S1
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.41948332307582503,-0.820978267260442,0.76,1.0,1.0,3/21,17.53%,SFRP1;BRCA1;NR0B1
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.41755994155198256,-0.8207550344095749,0.6666666666666666,1.0,1.0,4/20,14.68%,CAMK1;MEF2C;KIF1A;APOE
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3405906082221527,-0.8204877524717281,0.8241758241758241,1.0,1.0,23/127,18.55%,NEFM;GDAP1L1;LHFPL5;JPH3;INA;NARF;HPCA;CACNA1B;SH3GL2;SNCB;KCNC1;TCEAL2;TMEM179;DCTN1;STMN2;KLHDC8A;ZDHHC22;KIF1A;RTN2;RBPMS;SYT4;MAP6;NCAN
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.4235276947668981,-0.8203899822967102,0.7432432432432432,1.0,1.0,7/19,35.40%,DND1;CIRBP;PABPC1;MEIOC;YBX1;EIF4ENIF1;DHX34
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.37777197823339037,0.8196471693754787,0.6756756756756757,0.9740295892974316,1.0,4/10,18.89%,ROBO1;NFATC1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.49839160689666995,0.8195574017426449,0.675,0.9735197699459546,1.0,3/6,14.08%,LIG4;PTPRC;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.44293768042416487,-0.8195463197757583,0.6842105263157895,1.0,1.0,3/13,28.17%,PAIP2;EIF4EBP1;RBM4
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.4506841169222525,0.8194883670712547,0.6666666666666666,0.9730905581179687,1.0,3/10,16.03%,CTBP1;NNMT;NIPBL
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),-0.4840903416993795,-0.8191592782790563,0.7,1.0,1.0,2/7,7.58%,TGFB1;DND1
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.37894438472962705,-0.8190959014460986,0.7468354430379747,1.0,1.0,6/55,8.44%,CFAP61;ENKUR;PCP4L1;RARRES2;CFAP52;USP18
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.5378009170532297,-0.8190353747513227,0.765625,1.0,1.0,3/5,43.43%,IDH3B;IDH2;IDH3A
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.3936214893211669,-0.8188411068876476,0.8051948051948052,1.0,1.0,4/30,7.92%,ISG15;TGFB1;ALOX5;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.3276009376568328,0.8188401991763189,0.6666666666666666,0.9737202555106514,1.0,10/35,13.99%,ZDHHC2;EPHA3;ATP2C1;SPTBN1;EGFR;ATP2B4;DPP10;ACSL3;CNST;ITGA3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.47127005377609327,0.81882619870312,0.7058823529411765,0.9731019060512235,1.0,1/5,4.89%,IMMP2L
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.5275578773987679,-0.8187726754034064,0.75,1.0,1.0,1/7,2.44%,FGF1
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.362026390190837,0.8186688914379501,0.7647058823529411,0.9727137130673129,1.0,6/29,8.51%,SIRT1;IGF1R;FOXK1;UNC13B;FOXO1;ZBTB20
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.44286085556760413,-0.8180054471468278,0.7428571428571429,1.0,1.0,1/14,0.41%,HLA-B
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.45074310973099524,0.8180027592093939,0.6896551724137931,0.9733424049765332,1.0,2/11,19.19%,RIPOR1;YWHAZ
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3486978670045627,0.8179428644523318,0.7222222222222222,0.9728450325062832,1.0,2/23,2.06%,WDR81;IRS1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),-0.4895980031102172,-0.817859267623503,0.7457627118644068,1.0,1.0,1/7,5.69%,IRF1
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),-0.41322389479768845,-0.8176676540162024,0.8051948051948052,1.0,1.0,7/28,14.40%,SELENOK;GLUL;ZDHHC24;ZDHHC1;ZDHHC8;ZDHHC15;ZDHHC22
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.37647037357892016,-0.8175427023040586,0.75,1.0,1.0,7/33,15.97%,PFDN6;CLU;CRYAB;AZIN2;VBP1;APOE;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.28470927433104426,0.8173462488712665,0.8947368421052632,0.9732837301500491,1.0,7/56,10.51%,ZNF516;PDGFC;LEPR;ESRRG;IGF1R;ADIPOR2;HADH
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),0.41797610425465204,0.8172571132832751,0.6785714285714286,0.9728168903853179,1.0,3/13,11.66%,AGMO;PLA2G15;GPAT4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.4348772299125896,-0.8171250615768688,0.7272727272727273,1.0,1.0,3/13,11.57%,HAP1;GSTO1;CALM1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),-0.5399146955874009,-0.8169290783668847,0.7818181818181819,1.0,1.0,1/5,7.89%,ABCC3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.29881646289031144,0.8168443337121434,0.6,0.9728773820780229,1.0,7/49,7.50%,HIP1;BOK;ROBO1;PPARG;CRADD;SENP1;EGLN3
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.4545170073153968,0.8167811890762882,0.6341463414634146,0.9722922537498732,1.0,4/6,23.24%,D2HGDH;SNCA;ANK3;FBP1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),-0.493933748490857,-0.8166810710479607,0.72,1.0,1.0,2/10,7.92%,RASGRP1;MEF2C
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.518089756600862,-0.8166320309201502,0.75,1.0,1.0,2/5,22.99%,TERF2IP;DCLRE1C
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.3708637104120679,-0.8163068152375561,0.759493670886076,1.0,1.0,7/57,10.17%,SLC3A1;SLC38A4;CEACAM1;SLC6A6;ABCC3;SLC7A6;SLC7A14
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),-0.4069194958888367,-0.8161618054373588,0.7391304347826086,1.0,1.0,7/25,18.21%,LETM2;SELENON;SLC7A8;SLC12A4;COX11;CAV1;WFS1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.4631389595066746,-0.8158366695826755,0.7076923076923077,1.0,1.0,2/8,10.30%,H1-4;SMARCA5
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),-0.465912150736288,-0.8156934441895648,0.7164179104477612,1.0,1.0,1/12,4.19%,RARRES2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.41968373867953124,-0.8155497093467122,0.75,1.0,1.0,2/25,6.50%,TUBGCP2;TUBGCP4
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.49476890425415,-0.8154728317834995,0.746031746031746,1.0,1.0,2/8,14.78%,PLEKHH2;VIL1
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),-0.5032693371897675,-0.8153422985572035,0.7727272727272727,1.0,1.0,4/9,34.94%,APOE;ERLIN2;SOD1;DKK3
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.3842571598684589,0.8151070507466609,0.6774193548387096,0.974576169122171,1.0,4/12,12.05%,PBX1;TOX;PTPRC;SNX27
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.4825942888688836,0.8149927779823247,0.7222222222222222,0.9742188104521258,1.0,2/6,4.73%,IL15;SIRT1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.3820366586736038,-0.8148310176083503,0.7792207792207793,1.0,1.0,3/39,6.88%,MYRIP;TGFB1;TTN
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.43995714299919947,0.8147095361212361,0.6842105263157895,0.974139451438302,1.0,5/10,22.36%,NEDD4L;BIN1;NOS1;CAB39;PTK2B
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.5405504501085716,-0.8143449337351117,0.7638888888888888,1.0,1.0,4/5,37.49%,HRAS;ZSWIM8;RELA;PNPT1
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.3730058134301162,0.8142256108218521,0.6956521739130435,0.9742880152280549,1.0,6/19,12.19%,TTLL1;CEP41;TTLL3;TTLL11;AGTPBP1;NAA11
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5388083616744366,-0.8142179111197476,0.7321428571428571,1.0,1.0,2/5,22.67%,APOE;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.4083151035937461,-0.8141371985933592,0.7746478873239436,1.0,1.0,8/26,21.58%,DDRGK1;RPL11;GIPC1;HSP90AB1;BAG6;CAMLG;UBXN1;PARK7
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),-0.5537533943220403,-0.8140741766874608,0.7580645161290323,1.0,1.0,2/5,22.51%,MEF2C;INPPL1
prerank,PanglaoDB_Augmented_2021__Leydig Cells,-0.35488413872253616,-0.8134506570218234,0.7831325301204819,1.0,1.0,17/73,22.86%,ADAM21;RARRES2;CRYAB;PAMR1;COL4A1;LMOD1;NR5A2;COL21A1;COL4A2;MATN2;COL14A1;CALD1;THBS2;ACSBG1;PDZRN3;PDE8A;C1S
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),0.3473285219393004,0.8131821191214827,0.7391304347826086,0.9754163425569564,1.0,6/18,11.37%,MAPK1;TNKS;MAP3K4;MAPKAPK5;MAPK3;HNRNPD
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.41713391107161635,-0.81310320272103,0.7857142857142857,1.0,1.0,1/19,3.26%,NAAA
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),-0.4824079589353242,-0.8131005216849939,0.71875,1.0,1.0,3/11,19.20%,GLUL;QPRT;GOT1
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,-0.39645631235972395,-0.812682295253304,0.7272727272727273,1.0,1.0,3/31,6.26%,VEGFA;SCG2;LDB1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.4492415238603179,0.8125194439189324,0.6428571428571429,0.9752465779277815,1.0,1/7,11.90%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.4492415238603179,0.8125194439189324,0.6428571428571429,0.9752465779277815,1.0,1/7,11.90%,EIF4E2
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.39590451682999994,0.8125061648992918,0.7777777777777778,0.9746333365233796,1.0,6/13,11.37%,MAPK1;TNKS;MAP3K4;MAPKAPK5;MAPK3;HNRNPD
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),-0.47507587535423657,-0.8123451732065408,0.7692307692307693,1.0,1.0,2/6,35.82%,LAPTM4B;LRP1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),0.480146763835548,0.8119210755875745,0.6428571428571429,0.9751661131410747,1.0,2/6,16.74%,ERCC4;TERF2
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.3758731355679701,0.8116430464946268,0.6857142857142857,0.9749385061833127,1.0,3/21,8.51%,RAB27A;CREB3L1;ZBTB20
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3962418417257576,-0.8115940170705751,0.7532467532467533,1.0,1.0,11/32,21.58%,DDRGK1;RPL11;RPL23;GIPC1;RPS7;HSP90AB1;RPL5;BAG6;CAMLG;UBXN1;PARK7
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.3976861873602354,-0.8115900270717941,0.7974683544303798,1.0,1.0,1/29,1.65%,HAP1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.3474691923742927,-0.8112202447491097,0.8666666666666667,1.0,1.0,11/100,8.69%,NEFM;SCG2;SEZ6L2;TRPM3;GNRHR;GMPPA;CHGB;AGA;CACNA1C;CELF4;SST
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.5301646905504029,-0.8112119897613537,0.7323943661971831,1.0,1.0,2/5,17.21%,SHMT1;PAICS
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.3369106092755622,0.8111947949275251,0.6470588235294118,0.975174595697458,1.0,11/29,14.13%,PRKX;ABL1;FERMT1;ZEB2;KANK1;LPXN;ANLN;PIK3CA;CDH13;NRP1;STARD13
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.3583195471751354,-0.811036455223175,0.7682926829268293,1.0,1.0,10/54,20.36%,ARHGAP15;VAV3;RAP1GAP;CAMK2A;PLXNB2;CAV1;CFAP100;NGEF;ARHGAP12;RDX
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),-0.501359420360568,-0.8109928495755782,0.6825396825396826,1.0,1.0,2/6,10.05%,IFI35;GRN
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.39404574245443447,0.8108719938153124,0.6666666666666666,0.9751344899835329,1.0,3/19,4.48%,SEMA3B;SEMA4D;SEMA6C
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.4771627609536719,-0.8105421587464327,0.7391304347826086,1.0,1.0,2/9,16.00%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.48190588878055396,-0.8103661922637826,0.71875,1.0,1.0,1/11,13.15%,ATF4
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),-0.5383624049386168,-0.810279121957338,0.7777777777777778,1.0,1.0,3/5,40.60%,STAT3;TYK2;P4HB
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.43969383443896115,-0.8100386390218748,0.7466666666666667,1.0,1.0,5/18,18.71%,POLE3;RRP8;BEND3;CDKN2A;EZH1
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.4850980302374545,0.8099993287163493,0.68,0.9761184786298982,1.0,1/5,0.80%,GSTM2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.37140394494431644,0.8099818573061125,0.7333333333333333,0.9755267608363681,1.0,4/19,10.15%,FAM20B;CSGALNACT1;GAL3ST3;CHST8
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.5350117270194464,-0.8099361987613585,0.7704918032786885,1.0,1.0,3/5,40.29%,RTF1;CTR9;PAF1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.5350117270194464,-0.8099361987613585,0.7704918032786885,1.0,1.0,3/5,40.29%,RTF1;CTR9;PAF1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.34383849028777086,0.8093395905803753,0.6956521739130435,0.9761060218340267,1.0,4/25,7.56%,FNBP1L;FCHSD2;PICALM;SGIP1
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.41617613629360617,0.8093198550455469,0.6097560975609756,0.975505261048081,1.0,2/7,4.98%,SIRT1;MBD2
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.4186889249594937,0.8090595642477544,0.7241379310344828,0.9752686551682878,1.0,2/8,16.03%,TGFBR2;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.3503497874713199,-0.8089908651703963,0.75,1.0,1.0,6/67,6.93%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.37900247918768415,-0.8086318217424608,0.7926829268292683,1.0,1.0,11/47,18.85%,SFRP1;YBX3;HAS2;CACTIN;ZFP36L2;ADAMTS7;NR1D1;ASAH1;BRCA1;CASP3;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),-0.5117530772292156,-0.8083489276392538,0.673469387755102,1.0,1.0,1/5,9.45%,TOMM7
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.36405700448688516,-0.8082080487480394,0.7625,1.0,1.0,6/58,11.06%,HLA-F;CLU;CTSZ;MEF2C;SNCB;DDIT4
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),-0.4593582322948262,-0.8080690293534215,0.7936507936507936,1.0,1.0,1/10,7.41%,CACNA1G
prerank,GO_Biological_Process_2021__myelination (GO:0042552),-0.39028269164495283,-0.8076233625481611,0.7402597402597403,1.0,1.0,2/36,4.85%,HES5;EIF2B2
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.4655060261706767,-0.8073395215974952,0.7692307692307693,1.0,1.0,3/8,30.68%,ID2;PTPN2;IL34
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.45203402049720065,-0.8073110535358653,0.7857142857142857,1.0,1.0,3/11,13.48%,HTR2B;ZFP36L2;MAP2K1
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.41486383958721945,0.8071492851095267,0.8484848484848485,0.9782121965683658,1.0,2/11,2.11%,RAB27A;NLGN1
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.4828092405868736,-0.8070969283274081,0.6842105263157895,1.0,1.0,1/9,0.66%,VEGFA
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.3737512489968425,0.8070938979429653,0.84,0.9776406605697718,1.0,8/20,14.60%,TAB3;INAVA;MAP2K6;TAB1;MAP3K7;UBE2N;TAB2;OTULIN
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.31483333383180323,0.8068595346605749,0.9,0.9774423282291446,1.0,2/32,4.92%,YJEFN3;ROBO1
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),-0.36403026023034607,-0.8066284190144295,0.7692307692307693,1.0,1.0,7/40,14.68%,ALOX5;IRF1;USP18;ERAP1;GRN;NLRP1;APOE
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3497511226005547,-0.8066087079598081,0.7777777777777778,1.0,1.0,20/85,20.73%,NPM2;RBM3;ATAD5;LDB1;XBP1;SLC6A9;RPS4X;NLRC5;UPF3B;BRPF3;PLXNB2;RPS27L;UPF3A;PCIF1;NSUN5;RPL5;BCAR3;NAMPT;PDGFRB;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.46618648434224313,-0.806027516841556,0.7272727272727273,1.0,1.0,3/10,15.39%,HAX1;BAIAP2L2;HRAS
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.4689344689740065,-0.805777766015478,0.746031746031746,1.0,1.0,3/9,16.12%,CDH3;GIPC1;ASIP
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),0.43881093642887214,0.8055958057175554,0.7058823529411765,0.9783189680875446,1.0,3/8,16.33%,ACER3;SPTLC2;ABCA2
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),0.43881093642887214,0.8055958057175554,0.7058823529411765,0.9783189680875446,1.0,3/8,16.33%,ACER3;SPTLC2;ABCA2
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.48100089135556023,-0.8055852400196121,0.8028169014084507,1.0,1.0,2/12,8.48%,CACNB1;HPCA
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,0.32862799119511354,0.8055750450643989,0.9473684210526315,0.9777488546558405,1.0,5/33,10.62%,SORD;NOX4;GLYAT;ALPL;FUT9
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.3191633426000515,-0.8049843770699894,0.9393939393939394,1.0,1.0,79/576,17.11%,PLAG1;ESRRB;ETV4;VEGFA;DDRGK1;BEX1;H2AZ1;TAF7;RPS27A;FGF1;HES1;CREB3;GALR1;DVL1;CAMK1;APEX1;PLSCR1;JUN;LAGE3;AGRN;TGFB1;COPS5;HAX1;ZFPM1;IRF1;DBP;LDB1;MLX;KDM6B;MAX;CHCHD2;XBP1;LMO2;JAG1;MAFF;MEF2C;MED1;SMARCD1;CEBPZ;CKAP2;GLIS3;SMARCA5;MOSPD1;BTBD18;CDK7;ELK3;NR5A2;PRPF6;NLRC5;JUNB;NR4A3;CRLF3;ATF4;SSBP4;SS18L2;ZBED3;DVL2;UBA52;GTF2F1;ZFHX3;RUNX2;NR1D1;FSTL3;SREBF1;USF1;HRAS;RTRAF;ATAD2;HNF4G;KAT5;TFE3;FIZ1;FOS;CCNK;SALL2;ZBED4;STAT1;BRCA1;PAXBP1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.38933810033857774,-0.8049525861402715,0.8125,1.0,1.0,6/27,20.21%,BLOC1S2;HDAC6;NR4A3;KXD1;MAP6;SPAG9
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.37947814324783996,0.804788394932629,0.8125,0.9787045255256792,1.0,4/22,11.29%,ZDHHC2;GPC4;SPTBN1;GPC1
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.30974254111894944,0.8046682013677184,0.7368421052631579,0.9782423688628202,1.0,4/38,10.24%,ATR;ABL1;MAPK14;INTS7
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.3568387577283756,-0.8044217970490475,0.8170731707317073,1.0,1.0,10/61,14.81%,ELOB;DDRGK1;DVL1;CLU;TRIB1;ARIH2;MAGEF1;RACK1;SUMO2;TRIB3
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,-0.3333858314355831,-0.8043679198432285,0.8555555555555555,1.0,1.0,29/161,21.98%,SLC2A3;TUBA4A;PDK1;M6PR;COPS5;GLRX;XBP1;GAPDH;SLC6A6;PGK1;PSMA3;IFRD1;FADS2;DDIT4;WARS1;LDHA;TRIB3;IDI1;HSPA9;RPN1;HSPD1;ATP6V1D;GOT1;NAMPT;PDAP1;SC5D;TOMM40;GBE1;CD9
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.4891678965621192,-0.8043358083422695,0.78125,1.0,1.0,2/6,17.37%,SHMT1;MTHFD1
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),-0.4991670324184059,-0.804325803810842,0.7397260273972602,1.0,1.0,1/8,11.82%,APOD
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),-0.418833776897523,-0.8043204223974942,0.7714285714285715,1.0,1.0,4/22,14.68%,TGFB1;MEF2C;SVBP;APOE
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.3533719861312319,-0.8042246298397591,0.8072289156626506,1.0,1.0,6/52,13.53%,ANKRD53;RAB11A;ECT2;KIF20B;CALM1;GIPC1
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.4107809864183588,0.8042158882821231,0.6666666666666666,0.9784837621231709,1.0,4/15,18.51%,SIRT1;FBXW5;CHMP1A;NPM1
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),0.37800715156166337,0.8041894079382502,0.7714285714285715,0.9778955124597335,1.0,1/14,2.05%,ATR
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3340717988218319,0.8040865668132794,0.7692307692307693,0.9774640355955113,1.0,6/28,9.87%,RXRA;SLCO1A2;SLC16A2;NCOA2;AKR1C1;ABCC11
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.4014182242621913,0.8037039216830643,0.8928571428571429,0.977676231707641,1.0,2/19,3.83%,ESR1;MED24
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.45513002407912073,-0.8036251810445953,0.6865671641791045,1.0,1.0,3/8,10.45%,SFRP1;STK17A;BTG1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.46516743763711443,-0.8036102331664087,0.75,1.0,1.0,7/12,27.02%,CEACAM1;TRIB3;ACADL;BRCA1;ERLIN2;WDTC1;SOX9
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.47418345732606626,-0.8035320024438777,0.7323943661971831,1.0,1.0,1/7,11.54%,DCTN1
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.41497131737578996,-0.8032300652099434,0.7368421052631579,1.0,1.0,4/23,14.81%,TGFB1;ZFPM1;ZFP36L2;TRIB3
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),-0.3483963109294424,-0.802963054593104,0.8311688311688312,1.0,1.0,6/63,5.10%,POLR3D;IFI35;PLSCR1;RARRES2;TGFB1;AGT
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.35643448981394504,-0.802594044536316,0.8241758241758241,1.0,1.0,12/87,17.33%,PSMB9;VAV3;LAT2;JUN;PSMB8;PIK3CB;PSMA3;CALM1;PSMA7;FOS;PSME1;PRKCQ
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.35512125105940084,-0.8021669619307507,0.8045977011494253,1.0,1.0,8/52,14.39%,RANGRF;TGFB1;TMBIM1;PLS1;ZDHHC8;WNK3;AKAP5;PPP2R5A
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.40271190546959057,-0.8021439297804097,0.7974683544303798,1.0,1.0,1/19,5.95%,RASGRP1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.45607609681716976,0.8019844002051658,0.7073170731707317,0.9803712880153707,1.0,2/5,25.10%,ACSS1;ACSS2
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.41361921604929713,-0.8018861528690079,0.8108108108108109,1.0,1.0,5/25,13.85%,RPS27A;CFTR;HDAC6;DYNC1LI2;UBA52
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.4784400185518972,-0.8017463733801272,0.746031746031746,1.0,1.0,3/8,18.20%,TBXAS1;CBR1;PTGES2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.4415347116647253,0.8016676985705193,0.75,0.9803380341014869,1.0,1/6,6.31%,FZD3
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),-0.4702137762893945,-0.8016482182987292,0.7534246575342466,1.0,1.0,3/9,29.14%,PTN;OMG;GAP43
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.4454436457380208,0.8015988339782046,0.6571428571428571,0.9798185658572939,1.0,2/7,10.58%,SRR;SERINC5
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.2938073386930619,0.8015484297445814,0.6666666666666666,0.9792997713721724,1.0,30/149,14.82%,VAPB;TRAPPC12;ARFGEF2;SMPD4;DYSF;COG3;TMED5;GOLGA8N;HACE1;SPTBN1;TRAPPC8;SNX33;TMED3;NUP93;SEC16A;WASHC5;VAPA;LRRK2;FBXW8;BAG5;BLZF1;PRKD1;CLASP1;TMCC1;COG7;MYOF;ATL2;DMPK;SUN2;VMP1
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.41359557115461554,0.8014928768062234,0.7647058823529411,0.9787525117033312,1.0,3/11,14.80%,LIG4;PML;SIRT6
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.40629159922462965,-0.8014907245471896,0.8181818181818182,1.0,1.0,7/33,12.71%,ISG15;PARP14;OAS3;USP18;OAS1;NLRC5;CACTIN
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.493200434799025,-0.8011068736093314,0.696969696969697,1.0,1.0,1/6,4.27%,TGFB1
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),-0.419695384214444,-0.8009679347286607,0.7272727272727273,1.0,1.0,4/14,22.84%,EFNA1;P2RY12;CYP1B1;ADAM9
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.3889896964492597,0.8009167373940907,0.6571428571428571,0.9791571737892646,1.0,1/9,1.93%,ERBB4
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.426124983670837,-0.8008874484613836,0.7777777777777778,1.0,1.0,3/18,13.06%,HTR2C;TYMP;NPTX1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.5290822215525692,-0.800813539227626,0.8032786885245902,1.0,1.0,3/5,22.09%,RARA;IL18;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.4266424585995921,-0.8008012919916063,0.7236842105263158,1.0,1.0,1/16,2.08%,NOL3
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.32339023634089364,0.8007105631647133,0.8571428571428571,0.9788532141284089,1.0,7/36,9.42%,ATR;PDS5A;OBI1;STN1;ANKRD17;EGFR;CTC1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.4179051508829005,0.8004531724230167,0.72,0.9786853594486365,1.0,3/10,13.77%,H6PD;RPE;RPIA
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.3587742701777259,0.800441682017984,0.75,0.9780817873788249,1.0,3/13,14.06%,FOXO1;RTF2;KCNC2
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.4356412490289433,0.8001142414365211,0.6666666666666666,0.9780211408063476,1.0,2/8,9.62%,PATL1;DCP1B
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.3218013744954176,-0.8001068899673003,0.89,1.0,1.0,34/236,16.71%,VEGFA;DDRGK1;DXO;PHF1;SFRP1;TGFB1;RPL13A;PARP14;OVOL2;OLFM1;LSM5;GAPDH;IGF2BP2;MEF2C;PTRH2;RPS13;PARP9;SH3GL2;ID2;TCEAL1;SYT11;ZFP36L2;RACK1;MAP2K1;APOE;SHMT1;HRAS;CD46;NUDT12;NCL;RNH1;EIF2AK2;PCIF1;CREBZF
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.46283972647865934,0.7998877194195124,0.6666666666666666,0.9777767489999312,1.0,2/5,10.46%,NLGN4X;LRRK2
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.3938590553379417,-0.7998051362368284,0.7702702702702703,1.0,1.0,7/26,20.32%,SNRPB;NCBP1;CSTF2;CSTF1;CPSF1;SLBP;SNRPG
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.4365976604157224,0.7993812920867489,0.7307692307692307,0.9774241850726376,1.0,4/8,30.96%,TRIM71;TNRC6C;AGO1;AGO3
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.4365976604157224,0.7993812920867489,0.7307692307692307,0.9774241850726376,1.0,4/8,30.96%,TRIM71;TNRC6C;AGO1;AGO3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.29016913320386467,0.7991497869167299,0.9333333333333333,0.9772482438602093,1.0,18/92,11.23%,AP1G2;CALCRL;FNBP1L;FCHSD2;AP4E1;VLDLR;RAB31;COLEC12;PICALM;SGIP1;EPS15;PIKFYVE;AP1G1;AP1S1;LRP1B;DNM3;HSPH1;NEDD4
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),-0.43870371112157225,-0.7991436965246358,0.7361111111111112,1.0,1.0,4/21,13.75%,PRELP;OMD;ACAN;OGN
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.3179811308470062,0.7990358414668519,0.75,0.9768023291252812,1.0,9/37,16.39%,PRELID3B;ATP11C;ATP8A1;ATP10B;OSBPL5;PITPNA;OSBPL8;PCTP;ATP8A2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.30659116998517755,0.7990082654510086,0.9,0.9762219751677251,1.0,13/40,19.06%,ZNF516;SIRT1;CTBP1;PPARG;FOXO1;BBS4;SOX8;PRDM16;OSBPL8;TCF7L2;PID1;AKT2;FAM120B
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.5052367641714532,-0.7988503619258982,0.7903225806451613,1.0,1.0,3/6,18.20%,TBXAS1;CBR1;PTGES2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.39966022488542213,0.7987192903156554,0.7586206896551724,0.976124247254381,1.0,5/10,20.71%,HOMER1;GRIK3;GRM5;GRM8;GRM7
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),-0.37219777853507025,-0.79817987981693,0.8354430379746836,1.0,1.0,5/38,11.65%,SPINK5;ALOX5;CLU;HHIP;LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3649197998345044,-0.798136613526798,0.7710843373493976,1.0,1.0,7/55,12.55%,VEGFA;CLU;HDAC6;CRYAB;SCAMP5;SYT11;DNM2
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.48568550036457603,0.7980333576410468,0.6857142857142857,0.9765852660590276,1.0,1/5,0.47%,THAP4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.45040888860915573,-0.7977794495282363,0.6764705882352942,1.0,1.0,1/12,1.63%,SLC2A3
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4312223340217172,-0.7977013180032441,0.7681159420289855,1.0,1.0,5/16,15.52%,SPINK5;XBP1;PRELID1;TCF7;IL7
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.4273584752229933,-0.7974807360244118,0.7972972972972973,1.0,1.0,5/18,17.62%,RPS21;KRI1;NOP14;WDR12;ERI2
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.4132882088221247,-0.7973112138003718,0.7464788732394366,1.0,1.0,5/18,20.84%,PRPSAP1;PPAT;MTHFD1;GUK1;DNPH1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.35500194420933684,0.7971138918811694,0.8,0.9775847045734524,1.0,1/15,2.18%,CEP120
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),-0.540327516408436,-0.796840844667134,0.7796610169491526,1.0,1.0,1/5,2.33%,TAF7
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.4010732898726341,0.7966447019115445,0.78125,0.9778229563827768,1.0,3/11,14.08%,ADAM10;ADAM19;ADAM17
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.47771128004119545,-0.7963872192350754,0.7611940298507462,1.0,1.0,1/9,4.90%,SELENOS
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.31555694010405627,0.7960417825875448,0.875,0.978416578533088,1.0,2/34,1.98%,CHRM3;MCTP1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.38743513941867613,0.7959535438491367,0.7777777777777778,0.9778950621455563,1.0,2/14,1.85%,LDB2;FEM1A
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.3505155490274864,-0.7958944318444525,0.8227848101265823,1.0,1.0,9/64,14.57%,TRPC5;TRPM3;CACNA1G;CACNA1C;SLC24A5;GRIN2D;P2RX4;SPG7;PMPCA
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),-0.4341836420556132,-0.7956868611764457,0.7297297297297297,1.0,1.0,3/14,15.16%,SCN9A;CACNA1G;KCNMB4
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),-0.4836342876254583,-0.7953067784374639,0.6923076923076923,1.0,1.0,3/6,26.77%,DCTN1;HSPA8;APP
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.33447907718533065,-0.7948475855820268,0.7901234567901234,1.0,1.0,28/82,29.14%,JPH3;INA;HPCA;SLC6A9;SNCB;KCNC1;TMEM179;SCAMP5;STMN2;KIF1A;MPP2;GNG3;MAP6;NCAN;LRRC4B;NDRG4;TMEM151A;TMEM59L;CELSR2;TMEM198;ACTL6B;BCAN;PPFIA3;TUBB2B;CADM4;DNER;SRRM3;GAP43
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),-0.4800285527265096,-0.7945138163825785,0.7538461538461538,1.0,1.0,4/9,31.81%,GSTP1;AIDA;DNAJA1;PDCD4
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.52925008381306,-0.7944927156700852,0.7719298245614035,1.0,1.0,1/5,23.23%,SUMF1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.38263150991029216,0.7939699088412215,0.7741935483870968,0.9807920091170972,1.0,2/12,6.96%,MLLT3;METTL4
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.3985667877540744,-0.7939268045752047,0.7317073170731707,1.0,1.0,2/20,3.56%,EMD;CAMK1
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.4423975758005013,0.7935547189307577,0.6744186046511628,0.9809124646514016,1.0,2/7,13.78%,OPHN1;NRP1
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.49343129805084374,-0.7935530129114727,0.8181818181818182,1.0,1.0,2/7,16.00%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.49343129805084374,-0.7935530129114727,0.8181818181818182,1.0,1.0,2/7,16.00%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.49343129805084374,-0.7935530129114727,0.8181818181818182,1.0,1.0,2/7,16.00%,H1-4;ATAD2
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),-0.4808095007124389,-0.79352031318163,0.7540983606557377,1.0,1.0,2/10,15.53%,HNRNPA2B1;SRRT
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.46109149321506815,-0.7932446875493003,0.7936507936507936,1.0,1.0,1/12,1.10%,TRPC5
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3447111278717637,-0.7932345232653788,0.8539325842696629,1.0,1.0,10/77,13.85%,RPS27A;SFRP1;JUN;TGFB1;ARHGEF18;OVOL2;MEF2C;PDCD5;ZFP36L2;UBA52
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.2799012392643889,0.7932123676529678,0.9166666666666666,0.9808505890458562,1.0,25/86,18.40%,SMAD9;PARD3;SIRT1;PTPRK;SMAD7;GCNT2;TGFBRAP1;TGFBR2;BMP7;LPXN;TWSG1;MAPK3;USP9X;MAP3K7;ZMIZ1;ACVR1;SMAD1;USP15;ACVR1C;BMPR1B;NLK;MEGF8;ACVR1B;SMAD5;BMPR1A
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.4667323679034328,-0.7929220773565241,0.78125,1.0,1.0,2/7,22.01%,MED1;HSD17B10
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.4011790216329879,0.7929179364785636,0.7419354838709677,0.9806833891035001,1.0,5/13,16.03%,PDS5A;PDS5B;NAA50;DSCC1;NIPBL
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3243292200495548,-0.7927599262869734,0.8979591836734694,1.0,1.0,43/234,20.55%,B2M;RPS27A;PPIB;COL5A3;COL9A3;P4HA3;TUBGCP2;TUBGCP4;TLE6;APH1A;COL4A1;ITM2B;LMOD1;CST3;COL15A1;COL6A1;HOOK2;OPTC;EMP2;DCTN1;AVIL;COL9A2;TMOD3;ZBED3;STMN2;UBA52;MYO1F;ADAMTS3;ADAMTS2;COL21A1;COL10A1;UBE2L6;POF1B;HSP90AB1;COL4A2;KIF18B;UBC;GSN;RHOC;ARHGAP12;COL14A1;PGM5;CYP1B1
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3035492424969818,0.792746915298149,0.84,0.9804302187442329,1.0,5/28,10.06%,NUTF2;GEMIN8;NUP98;ATXN1;RBM15B
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.5027205520257995,0.7927207112776403,0.7096774193548387,0.9798519952834022,1.0,1/6,5.44%,GAL3ST3
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.34170269253567065,-0.7925307931755851,0.8539325842696629,1.0,1.0,14/101,14.06%,HES5;DHX37;HAP1;ZIC1;TUBGCP2;GRIN2D;COL4A1;B3GNT5;DDIT4;APOD;UTP3;PLXNB2;DNAJC30;ZFHX3
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),-0.5037819294513599,-0.7925292512504749,0.7241379310344828,1.0,1.0,1/5,7.41%,CACNA1G
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.35214564459888975,0.7925115037675581,0.7692307692307693,0.9796283699796479,1.0,3/17,8.86%,AEN;SIRT1;PML
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),0.3241161819641848,0.7923268820693857,0.8235294117647058,0.979319010714323,1.0,8/38,11.31%,EYA4;SIRT1;EGFR;EYA2;UBR5;PML;TRIM28;UBE2N
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.3660230677974774,-0.7922793445705738,0.7432432432432432,1.0,1.0,9/37,20.55%,AGRN;RARRES2;GPC3;RBP2;RDH10;APOE;GPC2;CYP3A5;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.42462367254849837,-0.7920821213430456,0.7323943661971831,1.0,1.0,3/15,19.28%,SEMA4C;EIF2AK2;TAOK3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.43669364777381636,0.791935424355434,0.6176470588235294,0.979554486821899,1.0,3/10,14.59%,NAA50;NAA11;NAA16
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.30432871838477105,0.7915537036111087,0.7647058823529411,0.9796369347477667,1.0,15/47,17.74%,MAPK1;CDC42BPA;OXSR1;TGFBR2;TNKS;LRRK2;WNK1;PRKD1;LMTK2;ACVR1;MAPK8;TTBK1;PRKCA;NLK;ACVR1B
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.4612280021132781,-0.7911964890245331,0.7538461538461538,1.0,1.0,1/9,4.27%,TGFB1
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.460801398274818,0.7911564440009773,0.7428571428571429,0.9797669748972063,1.0,1/5,0.58%,SH3RF1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.43711430074836,0.7911145426345612,0.6086956521739131,0.9792485805200349,1.0,6/10,20.04%,PLXNA1;PLXNA3;SEMA3A;NRP1;PLXNC1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.31923473921649115,-0.79087537215887,0.9473684210526315,1.0,1.0,60/430,17.24%,ROMO1;VEGFA;HES5;OPRM1;FTH1;DDRGK1;IL12RB2;SPDYA;FGF1;SFRP1;HES1;RPS9;IFI35;IFIT3;JUN;TGFB1;CDKN2C;HMGN5;CLU;AGT;RPL23;IRF1;HTR2B;FAM98B;KIF20B;RTKN2;TMEM115;XBP1;DERL2;JAG1;HAS2;SFRP4;STAT5A;SST;FN1;OSMR;PDCD5;BTG1;FUZ;ID2;RPS4X;EMP2;WDR6;WARS1;JUNB;NR4A3;MAP2K1;SLC25A5;BEX4;RPS6;HRAS;IL7;NUDT6;TSHR;EIF2AK2;PTN;STAT1;CDKN2A;GAREM1;CHTOP
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.4068488115168075,0.7904928465476141,0.7586206896551724,0.9797883764698853,1.0,2/13,8.70%,PPARG;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.3979914155282169,0.7904476975561918,0.7777777777777778,0.9792230209161559,1.0,2/13,10.89%,KAT2B;KAT2A
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3126735292342894,-0.7896197949812015,0.9072164948453608,1.0,1.0,29/218,19.44%,TFPT;PSMB9;COPS6;RPS27A;ABRAXAS1;CFTR;MBD6;COPS5;PSMB8;USP6;USP18;PSMA3;USP50;TADA3;OTUD6B;USP4;USP28;UBA52;SKP2;PSMA7;USP19;PSME1;BRCA1;TAF9B;USP44;UBC;TOMM20;IFIH1;DDB2
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,-0.34409642198857143,-0.7895141331077004,0.8314606741573034,1.0,1.0,17/82,21.87%,SFRP1;ZIC1;OBSL1;CRYAB;PAMR1;COL4A1;FNDC4;LMOD1;COL6A1;PTN;COL4A2;SCARA3;COL14A1;CALD1;FAM13C;THY1;PDZRN3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.41956845515346713,0.7887564424369687,0.5666666666666667,0.9814558550266875,1.0,3/9,21.92%,SIRT1;DNMT3B;ZNF274
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.476027073042961,-0.7887292298316019,0.7272727272727273,1.0,1.0,4/8,26.77%,MT2A;ATOX1;SLC31A1;APP
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.3154932042597809,0.7886128667340577,0.8,0.9810613239889803,1.0,11/37,15.69%,HPSE2;GPC4;GCNT2;HS3ST1;EXT2;UGDH;GPC1;SDC2;EXT1;HS2ST1;GNS
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3216761207718616,0.7885362525127741,0.8076923076923077,0.9805912681672162,1.0,12/39,21.42%,DOCK5;ABL1;IL1RAPL1;RAC3;FBXW8;CAPRIN1;NRP1;ARHGEF7;CDKL5;CRK;CUX1;SS18L1
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.3446285531836101,0.7884659600789903,0.72,0.9800458311446345,1.0,5/18,18.77%,ATF7IP;METTL4;PPM1D;BAZ2A;DNMT3B
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.4621452873751629,-0.7883847578449465,0.8208955223880597,1.0,1.0,3/8,14.68%,OLFM1;DNM2;APOE
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.45096487809247,-0.788297128272274,0.782608695652174,1.0,1.0,3/14,4.27%,HES5;DVL1;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3617383059609963,-0.7882111971172728,0.8452380952380952,1.0,1.0,9/62,15.36%,PFN2;ANKRD53;CLU;LMOD1;DCTN1;STMN2;APOE;VIL1;BAIAP2L2
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.5323465312316296,-0.7881743340694981,0.7090909090909091,1.0,1.0,2/5,14.68%,XBP1;APOE
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.49360595550455644,-0.7881000708972175,0.8088235294117647,1.0,1.0,2/8,7.75%,HDAC6;ECSIT
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),-0.3972030781866981,-0.7877350498023555,0.7894736842105263,1.0,1.0,2/25,4.27%,SFRP1;TGFB1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.49148803293249055,-0.7876811073773435,0.8113207547169812,1.0,1.0,3/5,23.68%,TTN;RDX;PRKACA
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.3382091961485548,-0.7876761689790602,0.8736842105263158,1.0,1.0,13/141,8.87%,CD63;IGFBPL1;LFNG;TRIM5;PLSCR1;TGFB1;CLU;ZIC1;OVOL2;HHIP;ZFAND2B;VEPH1;VWA2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.4597352348993311,-0.7875730533501212,0.7887323943661971,1.0,1.0,1/9,4.27%,TGFB1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.49910674661925736,-0.7874323091053156,0.8088235294117647,1.0,1.0,1/7,12.28%,PFKP
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.2914192472505564,0.7872667812856561,1.0,0.981494217171798,1.0,12/52,15.01%,DEPTOR;RICTOR;SIRT1;SLC38A9;MAPKAPK5;DGKQ;PIK3CA;TBCK;LAMTOR2;TTI1;TNFAIP8L1;NPRL2
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.32661763890526696,0.7865462487632449,0.7777777777777778,0.9820491705288209,1.0,5/24,10.46%,RAB27A;SYT12;DOC2A;SYT9;LRRK2
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.3168682351777154,0.7864782449091735,0.8,0.9815417627484738,1.0,6/28,10.59%,IRS1;SIRT1;FOXK1;RORA;SDHAF3;DGKQ
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.4966171592726161,0.7864050984779025,0.6666666666666666,0.9810539426591469,1.0,1/5,16.03%,NIPBL
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.3260987412065542,-0.7863202594899655,0.8241758241758241,1.0,1.0,27/116,21.58%,NPM2;RBM3;CLU;ATAD5;LDB1;CDH3;SLC6A9;RPS4X;P2RX4;UPF3B;BRPF3;GIPC1;PLXNB2;RPS27L;NR1D1;SREBF1;UPF3A;HSP90AB1;ASIP;PCIF1;NSUN5;RPL5;BCAR3;PDGFRB;CIRBP;FABP3;PARK7
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.4676304959320041,-0.786311678382806,0.8115942028985508,1.0,1.0,3/12,20.26%,JAG1;MYLK;PDGFRB
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.3778225786330471,0.7859461245029171,0.7142857142857143,0.9813619772310833,1.0,3/14,8.13%,ITPR2;PKD2;PTPRC
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.4441497445537332,0.785561420109384,0.6666666666666666,0.9814520165044545,1.0,3/7,29.81%,ITGAV;CBLL1;GRB2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.4173929886706088,-0.7855479970666016,0.7894736842105263,1.0,1.0,10/26,27.02%,ADAM21;COL9A3;NUP107;NR0B1;FSHR;MEA1;BASP1;FGF9;AR;SOX9
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.31220289817862057,0.7853776912612892,0.8518518518518519,0.981182645431087,1.0,5/28,9.84%,KCND2;KCNMB3;DMD;GNAQ;SCN11A
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.4757176226525629,-0.7853310906436594,0.835820895522388,1.0,1.0,1/8,4.27%,TGFB1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.37520005515031857,0.7850601872218541,0.7333333333333333,0.9810836999231968,1.0,5/15,23.73%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.42347416576008035,0.7847687785898297,0.7857142857142857,0.980890446496497,1.0,2/9,12.83%,PPARG;CDH13
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.32637947117099453,0.7843703569149724,0.8888888888888888,0.9809428066454187,1.0,8/53,8.70%,IRS1;LEPR;SIRT1;PPARG;IGF1R;FOXK1;FOXO1;ADIPOR2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),-0.5129463754774297,-0.7843555634264848,0.7966101694915254,1.0,1.0,3/5,27.95%,LPCAT3;DGAT1;SOAT1
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.33775398946909957,-0.7840391234877513,0.8461538461538461,1.0,1.0,15/75,21.59%,NAAA;BTD;ACSM3;DNPEP;DBI;CPM;ATF4;SHMT1;ACOT2;GNE;AEBP1;MTHFD1;ACSM6;MTRR;ORMDL1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.35845018815521146,-0.7839255478074704,0.8181818181818182,1.0,1.0,8/56,14.06%,HES5;HES1;ECT2;MEF2C;MED1;ID2;BDNF;ZFHX3
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.38030552130743267,-0.7837412396741413,0.75,1.0,1.0,6/33,16.42%,SFRP1;RARRES2;XBP1;ID2;METRNL;TFE3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),-0.44591410050796165,-0.7833659718523598,0.7213114754098361,1.0,1.0,5/14,21.48%,PTTG1IP;VPS35;RDX;ATRAID;WDR91
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),-0.37769813506107897,-0.7829154213009988,0.8513513513513513,1.0,1.0,6/34,17.66%,FANCB;POLQ;MAGEF1;TERF2IP;CGAS;MMS19
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.43026279717028143,0.7828725948093578,0.6842105263157895,0.9823668915051748,1.0,1/5,8.94%,MSN
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.43026279717028143,0.7828725948093578,0.6842105263157895,0.9823668915051748,1.0,1/5,8.94%,MSN
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.3628460915889615,0.7827247026752502,0.7419354838709677,0.9820037660592572,1.0,6/16,26.46%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B;CREB1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.4206101349944111,-0.7826886174043357,0.8450704225352113,1.0,1.0,3/17,15.39%,CEMIP;PDZK1;HRAS
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),-0.3655828802188729,-0.7825999895367061,0.8928571428571429,1.0,1.0,3/36,7.74%,VEGFA;AGT;HAS2
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4588470684319138,-0.7824749701430626,0.765625,1.0,1.0,3/7,10.45%,SFRP1;STK17A;BTG1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.34084091216819185,-0.7822821801375814,0.8625,1.0,1.0,11/66,20.17%,GSTK1;PIPOX;PEX1;EPHX2;FADS2;PRDX5;NUDT12;IDI1;DIO2;BCAR3;ABCA1
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3992677202102181,-0.7822525423497437,0.8125,1.0,1.0,3/22,9.73%,HTR2B;PIK3CB;CD160
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),-0.41449091456006665,-0.7821763653709637,0.7792207792207793,1.0,1.0,7/20,25.52%,STMN2;VIL1;KIF18B;GSN;DSTN;STMN1;STMN4
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.4450441565749118,0.7820641573045598,0.7906976744186046,0.9824506666504792,1.0,2/7,17.75%,STXBP6;SNCA
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),-0.3249091172738339,-0.7820445758573247,0.9347826086956522,1.0,1.0,23/172,15.39%,VEGFA;FGF1;FLOT1;ECT2;RARRES2;TGFB1;RASGRP1;EFNA1;TTN;FN1;SH3GL2;ATG14;WARS1;CACTIN;ATF4;RACK1;PLXNB2;ZBED3;DVL2;PPP2R5A;DNAJC10;C3;HRAS
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),-0.5324208986536936,-0.7820182711999941,0.7894736842105263,1.0,1.0,2/5,16.97%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),-0.5324208986536936,-0.7820182711999941,0.7894736842105263,1.0,1.0,2/5,16.97%,TGFB1;STAT1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3944543905912006,-0.7811558934073837,0.6962025316455697,1.0,1.0,3/24,13.02%,JUN;MEF2C;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.47886229078918985,-0.780896504112955,0.7741935483870968,1.0,1.0,2/8,3.56%,FLOT1;CAMK1
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.3575434830749382,-0.7801066509266432,0.7682926829268293,1.0,1.0,6/41,18.08%,DVL1;GPC3;CEP72;BDNF;HSP90AB1;GPC2
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.4579166930840841,-0.780026970048242,0.765625,1.0,1.0,7/11,27.42%,IL5;MYO1F;NR1D1;ITGAL;PSTPIP1;SPI1;AOAH
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.28605525203014426,0.7799756373050989,0.875,0.9853712295634863,1.0,8/75,9.11%,PLD1;NR1H2;BTRC;RPS6KB1;YTHDF1;WNT7A;MSN;FBXW11
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.31407912121418385,0.7794055573381264,0.782608695652174,0.9856838317568912,1.0,8/32,16.08%,PAPOLA;IWS1;QKI;SLTM;SRPK2;KHDRBS2;CPSF4;KHDRBS3
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.32840317363835875,0.7792797556826777,0.7777777777777778,0.9852443702075244,1.0,9/35,18.77%,CDC42EP4;CDC42EP1;PHACTR4;CDH13;ARHGEF11;EPS8;ARHGAP5;ARHGAP6;RIPOR1
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.26646755126024235,0.779264818877662,1.0,0.9846552192032905,1.0,47/348,9.69%,SOX11;SERTAD2;RNF139;RIPOR2;GPNMB;HSPA1A;GNRH1;ERBB4;ADRA1A;ADAM10;KAT2B;WFDC1;NR1H2;NOX4;SEMA4D;SIRT1;DYSF;PTPRK;CTBP1;PLXNA1;ROR2;APBB2;ATG5;MYH9;MAGI2;TP53INP1;ADNP2;ADAM22;ZNF268;NMI;RAD18;ANXA6;PDS5B;PLXNA3;PKD2;LMNA;SMARCA2;STRN;BMP7;ABI1;SLIT3;PRDM11;LPXN;PML;CGRRF1;CHD5;GNG4
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.46870733081237004,0.7792395167638113,0.696969696969697,0.9840949584116166,1.0,3/6,13.78%,CHRNA7;SEMA3A;NRP1
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.33843111427709943,-0.7791106705237256,0.8765432098765432,1.0,1.0,20/82,22.69%,ELOB;DDRGK1;DVL1;RPL11;CLU;TRIB1;ARIH2;RACK1;GIPC1;SUMO2;TRIB3;HSP90AB1;BAG6;FBXO22;CAMLG;UBXN1;GNA12;PARK7;ARAF;RBX1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,-0.3336761926214602,-0.7790763194601505,0.8620689655172413,1.0,1.0,18/116,16.82%,H2AZ1;CBR3;APEX1;S100A10;ACSM3;GLUL;HSDL2;ACO2;PDHB;LDHA;UROD;ACOT2;UBE2L6;CBR1;CRAT;ACADL;IDI1;PSME1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3885120488674273,0.7790095222406482,0.7894736842105263,0.983966798676983,1.0,2/10,6.04%,BOK;BCL2L11
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.37816560904092267,-0.7789167264504224,0.8289473684210527,1.0,1.0,6/33,21.51%,NUP155;NOL6;SEC13;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.37816560904092267,-0.7789167264504224,0.8289473684210527,1.0,1.0,6/33,21.51%,NUP155;NOL6;SEC13;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.413145984017799,0.7788937719724202,0.6470588235294118,0.9836138618190656,1.0,5/10,13.82%,APOLD1;PRKX;AJAP1;KLF7;DLL1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.3850627432185627,-0.7787426961700865,0.7746478873239436,1.0,1.0,6/23,15.16%,RIMS1;MEF2C;CAMK2A;SYT11;STX1B;KCNMB4
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),-0.3362688840948834,-0.7786678647821652,0.8387096774193549,1.0,1.0,16/109,17.67%,EMD;CAMK1;ECT2;TGFB1;CEMIP;ZIC1;KIF20B;ARIH2;UBL5;TOMM7;AKAP5;MICALL2;PDZK1;HRAS;HDAC3;OAZ2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.3954987417845655,0.7786193684258832,0.8064516129032258,0.9833081988066477,1.0,6/11,18.76%,PKD2;PRKCSH;PROX1;COBL;NIPBL;NF1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.32265057124030433,0.7783780735512467,0.8,0.9831433279012097,1.0,13/64,12.57%,SOX11;HSPA1A;ACER3;AKR1C3;ATG5;ADNP2;RAD18;DCC;BMP7;LRRK2;CHRNA7;PRKD1;RRAS2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.41252980969355507,0.7781725504976822,0.7073170731707317,0.9829318886204456,1.0,4/10,21.85%,SERAC1;RELCH;STARD4;ARV1
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3568105023074039,-0.7781604254704759,0.8433734939759037,1.0,1.0,13/57,21.51%,SNRPD1;SNRPD2;NUP155;SNRPB;SEC13;RANBP6;NUP107;PTTG1IP;RANBP17;NUP85;SNRPG;DDX20;NUP188
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.32329437094146174,-0.7779116050201756,0.9368421052631579,1.0,1.0,25/224,13.75%,B2M;OPRM1;FTH1;EMD;SFRP1;HES1;CDKN1C;IFI35;IFIT3;TGFB1;CDKN2C;TRIB1;IRF1;TMEM115;SFRP4;SST;PDCD5;BTG1;FUZ;WDR6;APOD;WARS1;MORC3;MAP2K1;OGN
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.45597636797702235,0.7779012162949227,0.8,0.9827300621496492,1.0,3/7,22.44%,UGDH;LETM1;LRRC8A
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),-0.50118760637805,-0.7771741982034321,0.7833333333333333,1.0,1.0,1/6,11.82%,APOD
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),-0.50118760637805,-0.7771741982034321,0.7833333333333333,1.0,1.0,1/6,11.82%,APOD
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),-0.38406651320270646,-0.7764670150807931,0.7564102564102564,1.0,1.0,6/25,21.93%,HDAC6;HSPA14;HSPA13;BAX;HSPA9;HSPA8
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.42108850463158504,-0.7762203811018606,0.8676470588235294,1.0,1.0,3/16,17.81%,TGFB1;CAV1;CATSPERG
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",-0.3738294520658048,-0.7757400765160082,0.8148148148148148,1.0,1.0,8/22,24.90%,RPS27A;DERL2;UBA52;SYVN1;UBC;TRIM13;MAN1A1;EDEM2
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.32393455773291907,0.775704699004664,0.7857142857142857,0.9857238538473351,1.0,3/20,13.96%,PDE4D;NT5C1A;PNP
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),-0.39415072950866126,-0.7756971134647077,0.8082191780821918,1.0,1.0,3/21,14.68%,TGFB1;MEF2C;APOE
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.40831384655214353,0.7753222100581876,0.8275862068965517,0.9858286720679188,1.0,3/11,14.30%,RMI1;ERCC4;HFM1
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.33645159150229487,-0.7752633608272786,0.8351648351648352,1.0,1.0,27/104,26.97%,PSMB9;RPS27A;APEX1;PSMB8;IGF2BP2;PSMA3;ZFP36L2;UBA52;PSMA7;PSME1;UBC;SET;DHX36;GTPBP1;HSPA8;PSMB6;PSMB1;ANP32A;PSMC4;SERBP1;CNOT8;PSMD2;DIS3;PSMB3;EXOSC8;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.4419346963226104,-0.774964264801313,0.8059701492537313,1.0,1.0,3/10,22.27%,IRF1;CD46;RUNX1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.38708669415694663,-0.7748757018334976,0.8082191780821918,1.0,1.0,3/30,4.02%,DDRGK1;RPL11;GABARAPL2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),-0.32560383558872197,-0.7748145067106171,0.8602150537634409,1.0,1.0,19/164,15.93%,TUBB4B;SPDYA;TUBA4A;CDKN2C;CCNI2;MAX;CEP72;CAMK2A;CDK7;DCTN1;DNM2;ODF2;CRLF3;CTDP1;TUBB4A;CHMP4B;SKP2;TACC3;DCTN3
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),0.365571000791997,0.774491222629073,0.7142857142857143,0.9864839207098863,1.0,2/14,4.76%,GLS;FPGS
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.4332782900470993,0.7742638928620148,0.7894736842105263,0.986308363462017,1.0,3/9,19.53%,ADCY6;ADCY2;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3044574427957418,0.7740873080870382,0.8888888888888888,0.9859279859943274,1.0,9/46,12.53%,ATR;NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPKAPK5;MAPK3;DSCC1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.3558157320288582,-0.7739789954991356,0.7764705882352941,1.0,1.0,4/49,6.26%,VEGFA;SFRP1;S100A10;LDB1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.3386720896050629,-0.773769341329236,0.8674698795180723,1.0,1.0,11/74,16.51%,TAF7;CDKN1C;DVL1;TRIB1;CEACAM1;SH3BP5L;WARS1;TRIB3;ADAR;RTRAF;CAV1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.4131428522186006,-0.7735677437941003,0.7654320987654321,1.0,1.0,1/15,1.61%,LFNG
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.36423142954243265,-0.7733619553878406,0.810126582278481,1.0,1.0,9/47,20.76%,GABARAPL2;ATG14;ATG16L2;EMC6;ULK3;MAP1LC3B2;ULK1;RAB19;ELAPOR1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.38913552271074625,-0.7729606970776779,0.8461538461538461,1.0,1.0,2/28,5.74%,RIMS1;STX19
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.403503331065906,-0.7729312567329697,0.7972972972972973,1.0,1.0,3/20,15.39%,CEMIP;PDZK1;HRAS
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),0.32851966582858894,0.7729124813062489,0.8125,0.9870756007633502,1.0,5/27,10.46%,ZKSCAN3;MYO7A;ATP10B;CLVS2;LRRK2
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3542444688787213,0.7724588641938506,0.7931034482758621,0.9872257956554025,1.0,4/17,13.11%,HECW2;NSMCE2;ANAPC4;CDC16
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),-0.4471901323575111,-0.7723522191015555,0.7571428571428571,1.0,1.0,1/9,3.69%,IFI35
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.48290207819210385,0.7723155962508542,0.7105263157894737,0.9868920699439468,1.0,2/5,9.05%,PLCB1;GLRA1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.3765555855666126,-0.7722393449162929,0.8375,1.0,1.0,5/36,12.24%,RANGRF;PLS1;ZDHHC8;WNK3;AKAP5
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.3888709803681444,0.7720894269284312,0.696969696969697,0.9867539912694472,1.0,4/17,4.45%,BCO1;TSPAN8;TOX3;SLC26A3
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3126806998165843,0.7720422319429409,0.8260869565217391,0.9862165688610554,1.0,8/39,7.44%,CADM2;INAVA;CDH20;SMAD7;CDH9;CDH10;CDH18;NECTIN3
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.31541438802001004,0.7720266946433029,0.8,0.9856333859605528,1.0,9/37,18.37%,PRR5L;YTHDF1;FTO;MOV10;TOB1;RIDA;CELF1;ZC3HAV1;CNOT7
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.4209919727491171,0.7719435376738804,0.8275862068965517,0.9851901183560573,1.0,1/8,1.55%,GCNA
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.31632284355458024,0.7716802818723797,0.8,0.9849606966791562,1.0,8/26,18.24%,LIG4;SIRT1;MAPK14;INTS7;RAD1;OPN3;EEF1D;TANK
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.4188339137091339,-0.771653398667374,0.7878787878787878,1.0,1.0,3/15,14.68%,RHBDF1;RSAD2;APOE
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,-0.3569412053764332,-0.7714908768141108,0.7954545454545454,1.0,1.0,15/65,21.17%,CRYAB;PAMR1;FN1;COL4A1;LMOD1;COL6A1;ACTA2;MYLK;PTN;COL4A2;COL14A1;CALD1;THBS2;PDGFRB;THY1
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),-0.4889643355097145,-0.7714545034142667,0.7741935483870968,1.0,1.0,1/6,11.58%,P2RX4
prerank,PanglaoDB_Augmented_2021__T Cells,0.3382416025677951,0.7711790904295963,0.8636363636363636,0.9850652089866424,1.0,7/31,8.14%,CREM;CD247;TRAF1;CD96;MBD2;PTPRC;RORA
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3416362008913242,-0.7708843386856025,0.8333333333333334,1.0,1.0,10/82,17.74%,TUBB4B;RAB11A;TUBA4A;B9D1;CEP72;DCTN1;ODF2;TUBB4A;DCTN3;AHI1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3625650948875673,0.770817743237772,0.8125,0.9850584441035133,1.0,12/32,25.07%,HSPA1A;TRAF1;CFLAR;ADAM17;MADD;OTULIN;PRKN;IKBKB;CYLD;TRAF2;HIPK1;RBCK1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.5100859919890387,-0.7705678919190077,0.8285714285714286,1.0,1.0,1/7,9.39%,CAD
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.4207044714190897,0.770451164731258,0.875,0.9849313516133118,1.0,2/7,12.98%,TGFBR2;CHRD
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",-0.44501706231386895,-0.7704292025277415,0.7714285714285715,1.0,1.0,2/11,16.26%,CCT7;DKC1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3445680317850976,-0.7703098010276165,0.8295454545454546,1.0,1.0,13/73,16.75%,RHBDF1;TTN;CRYAB;TEAD3;FN1;COL4A1;LMOD1;COL6A1;SYNC;AFAP1L1;SRPX;CAV1;COL4A2
prerank,GO_Biological_Process_2021__regulation of entry of bacterium into host cell (GO:2000535),-0.49391582679055773,-0.7702854550112107,0.8148148148148148,1.0,1.0,2/5,17.61%,CAV1;FUCA2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.41104230371423156,0.7701189918291358,0.7333333333333333,0.9849339286085509,1.0,3/9,8.41%,NEDD4L;PICALM;SNX33
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),0.3996011908938432,0.7699439473752978,0.7941176470588235,0.9846776370554512,1.0,3/10,13.79%,NIPAL3;TUSC3;NIPAL2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.34724105873655314,0.7699111516036996,0.7741935483870968,0.9840982793060027,1.0,2/14,7.67%,RIPOR2;KANK1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.37786738869409287,-0.7695509475039619,0.759493670886076,1.0,1.0,7/25,20.72%,PDCD1LG2;VAV3;MEF2C;IL7;CD46;IL18;GPR183
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.4757042342746717,-0.769432623127679,0.8142857142857143,1.0,1.0,1/12,2.57%,SFRP1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.3899109339209941,0.7691600666694085,0.7096774193548387,0.9847754321582591,1.0,2/10,18.52%,PTPRC;GRM5
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.42085087038228053,-0.768986235604299,0.8227848101265823,1.0,1.0,6/17,26.82%,TOM1L1;NABP2;PARP4;PDGFRB;SMG6;SMG5
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.2936334770530133,0.7687278611269592,0.9333333333333333,0.9848796080607997,1.0,16/76,12.17%,RGS7BP;KCND3;NRXN1;CDH20;MAPK1;FAM107A;RTN1;PLXDC2;SLC1A2;SEZ6L;CA10;TGFA;LRRK2;GRIA3;SLC8A1;P2RX7
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.4172163404686847,-0.7687132491767831,0.8142857142857143,1.0,1.0,7/16,26.39%,ZFAND2B;SPCS2;SEC61G;SRP14;SRPRA;MAN1A1;SRP54
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.3411531276231243,0.7686514832066063,0.8095238095238095,0.9844579769889676,1.0,3/22,8.70%,ASXL3;ZBTB20;ADIPOR2
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.5295446290629254,-0.7684084131409241,0.859375,1.0,1.0,1/5,12.12%,DPY19L1
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.5295446290629254,-0.7684084131409241,0.859375,1.0,1.0,1/5,12.12%,DPY19L1
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.2862798261725436,0.7681521548995788,0.8888888888888888,0.9847834222906253,1.0,5/65,4.48%,HID1;BTBD17;TOX3;MYCN;SEMA6C
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),-0.3715948575383996,-0.7676428703041512,0.8452380952380952,1.0,1.0,4/46,8.48%,PPIF;ECT2;MEF2C;HPCA
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.4612386975959868,0.7675523273689839,0.7567567567567568,0.9850900453413692,1.0,2/6,13.20%,DOCK5;DOCK4
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),-0.43662882288053717,-0.7671972616780851,0.746031746031746,1.0,1.0,1/7,6.03%,EFNA1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.40301817141783414,-0.7670625614628441,0.8208955223880597,1.0,1.0,4/19,12.83%,CACNA1G;CACNA1C;CACNA1B;CACNA1E
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.38379820898739536,0.7669477002018339,0.8181818181818182,0.9857000712151163,1.0,1/8,1.42%,ZNF618
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.38375866305037476,0.7668064201047641,0.7,0.9853157709501593,1.0,3/11,19.13%,SERAC1;RELCH;STARD4
prerank,PanglaoDB_Augmented_2021__B Cells,0.310704407048183,0.7667225982009296,0.8571428571428571,0.9848767773512329,1.0,5/35,8.13%,EBF1;EAF2;EDEM1;FCHSD2;PTPRC
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),-0.3141680445660584,-0.7665831861227107,0.9375,1.0,1.0,23/175,16.70%,ROMO1;PDCD1LG2;H2AZ1;SFRP1;CFTR;JUN;RRAGA;SELENOS;XBP1;MEF2C;TRIM41;WNT5B;P2RX4;PRDX5;CACTIN;NR4A3;NR1D1;SHMT1;PDK3;TSHR;KAT5;FOS;LARS1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.30024546579721617,-0.7662849931345712,0.98,1.0,1.0,76/754,16.18%,ASB18;ART4;FLG;F13A1;TNC;ELOB;PARP2;SCG3;PSMB9;SCG2;ISG15;COPS6;FBXW12;CAMK1;RAB11A;STK17A;CP;TGFB1;PDK1;ASB14;COPS5;PSMB8;PARP14;TRIB1;OBSL1;CKAP4;GLRX;CHGB;USP6;DUSP12;UBL5;AGA;ASB16;GPC3;ICMT;MAN2A2;MPI;FN1;CAMK2A;DAD1;PARP9;PSMA3;PIGH;CST3;B3GNT5;CDK7;FBXL13;SERPIND1;WNK3;STRADB;FBXO32;KRT10;NEK6;PPP5C;NUCB1;MORC3;MAK;MAP2K1;CTDP1;UBA52;PARP4;MAP3K12;PPP2R5A;APOE;FSTL3;SKP2;C3;SRPK1;UBE2L6;PDK3;PHPT1;ALG10B;PSMA7;ULK1;EIF2AK2;PPM1G
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.33269232518201886,-0.766160225707528,0.8620689655172413,1.0,1.0,10/91,14.45%,SEZ6;SCG3;SVOP;CELF4;PMP2;CCK;SLC7A14;SRRM4;CACNA1E;RPH3A
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),-0.4534252308045633,-0.766059771505718,0.746031746031746,1.0,1.0,8/10,35.46%,TESPA1;CD226;NECTIN2;CD81;RPS3;CARD11;PRKD2;RELA
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3361640166926964,0.7658437827913581,0.8387096774193549,0.9857339016292835,1.0,7/25,11.30%,GNG2;PLCB1;FZD3;NFATC1;PPP3CA;MAP3K7;MOV10
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.37769271234266505,0.7654478526376791,0.8,0.9857267850401015,1.0,2/11,6.03%,RPS6KB1;FAM107A
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,-0.3326075115924935,-0.7653915662253424,0.8823529411764706,1.0,1.0,12/94,10.65%,HES5;ANGPTL4;RARRES2;CLU;AGT;OBSL1;RHBDF1;CRYAB;GAMT;LMOD1;CST3;COL6A1
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.45119767561337293,0.7653626024029019,0.7714285714285715,0.9852424599577847,1.0,3/8,8.43%,AKR1C2;AKR1C3;AKR1C1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),-0.4678269899009157,-0.7653232368529823,0.7777777777777778,1.0,1.0,1/7,5.22%,ZIC1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),-0.5058482172684448,-0.76490628388397,0.7692307692307693,1.0,1.0,3/6,19.16%,OAS1;SCARA3;RFTN1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4208922481695282,0.7646534793643811,0.8387096774193549,0.9857217496312303,1.0,3/6,22.86%,WNK1;JAM3;ACER2
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.43074596521126945,0.7644514840471317,0.7674418604651163,0.985384676523617,1.0,3/6,15.43%,HOMER1;GRIN2B;FYN
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.3798346145436204,-0.764375164258389,0.8082191780821918,1.0,1.0,4/23,18.13%,PIK3CB;FN1;P2RY12;VCL
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.44450427675559817,0.7641622618558751,0.7,0.9851212988883441,1.0,1/6,5.31%,SH3KBP1
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.43513631143444864,-0.7637457458708768,0.8260869565217391,1.0,1.0,2/11,8.16%,CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.4473008511200083,-0.763420432363132,0.7846153846153846,1.0,1.0,2/8,17.28%,LPCAT3;OSBPL10
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),-0.4758375846219509,-0.7633773259117722,0.7794117647058824,1.0,1.0,3/5,34.10%,RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.4528369415706562,-0.7632999083805295,0.8059701492537313,1.0,1.0,1/8,5.78%,HTR2B
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.3893301228482273,-0.7632920650425815,0.8,1.0,1.0,4/24,18.70%,OST4;DAD1;MCFD2;RPN1
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.4107474691913563,0.7631805422432992,0.7586206896551724,0.9861765384753511,1.0,1/8,3.71%,GAS2
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4045793451258375,0.7629673604513096,0.7586206896551724,0.9859038497518621,1.0,1/11,2.08%,EVI5L
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.3981697167955237,-0.7629659866861401,0.7857142857142857,1.0,1.0,2/17,6.03%,CLU;EFNA1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),-0.39539418200928045,-0.7627203502413759,0.8133333333333334,1.0,1.0,4/21,15.74%,HAX1;BAIAP2L2;HRAS;PHPT1
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.4376209687802754,-0.7625876601926146,0.8208955223880597,1.0,1.0,5/11,30.71%,NIFK;POLR1G;GTF3A;MARS1;SIRT7
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),-0.3477996911881467,-0.7625756361835618,0.8125,1.0,1.0,11/44,23.93%,DDRGK1;GABARAPL2;RHBDF1;APOE;HSP90AB1;USP19;PSME1;GNA12;ARAF;PRKACA;UFL1
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.4334893073971636,0.7624263396674446,0.8,0.9862441188789919,1.0,1/6,14.57%,PTPRN2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.38754588360256403,-0.7620521531653289,0.7922077922077922,1.0,1.0,4/25,18.70%,OST4;DAD1;MCFD2;RPN1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.44366345321405565,-0.7619733636436067,0.7727272727272727,1.0,1.0,2/8,15.73%,PPP1R3F;KHK
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),0.4103638941678487,0.7619126597975876,0.7878787878787878,0.9864377637187309,1.0,3/9,21.09%,SMDT1;MCU;MICU3
prerank,MSigDB_Hallmark_2020__E2F Targets,-0.3237331613106399,-0.7616785626834093,0.925531914893617,1.0,1.0,37/134,23.94%,H2AZ1;CDKN2C;ZW10;PNN;RFC2;SMC1A;SNRPB;LUC7L3;RPA3;DONSON;NOP56;SHMT1;GINS3;H2AX;TACC3;RFC1;ATAD2;NUP107;BRCA1;CDKN2A;PAICS;KIF18B;CDK4;CBX5;RFC3;LIG1;POLD2;SLBP;NAA38;KIF22;SRSF2;CTCF;ILF3;POLE;PSIP1;STMN1;ANP32E
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.38343547749633483,0.7616473742597887,0.6956521739130435,0.9862019443823192,1.0,1/10,8.33%,UBN1
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.4797424316547066,-0.7614271089908132,0.7285714285714285,1.0,1.0,1/6,3.63%,ECT2
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),0.46977500383515125,0.7612421794787777,0.7297297297297297,0.9863679981851321,1.0,3/5,18.53%,SDK2;SOX8;DSCAM
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.30411993214683486,0.7612236880600384,0.9166666666666666,0.9857767738745,1.0,14/68,11.38%,SLC25A18;PANX1;SLC15A2;SLC26A3;SLC8A2;SLC9A9;SLC1A2;SLC12A1;SLC24A3;KCNN2;GLRA1;CHRNA7;WNK1;SLC8A1
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.35086561636999203,0.7612131936756944,0.8695652173913043,0.9851771529658173,1.0,7/32,16.16%,DHCR7;OSBPL7;AKR1C3;CYP7B1;OSBPL6;HMGCR;HSD17B4
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.3399992692274995,-0.7611489364386883,0.8765432098765432,1.0,1.0,10/70,12.83%,TRPC5;TRPM3;SELENOK;CACNA1G;CACNA1C;SLC24A5;CACNA1B;CAMK2A;P2RX4;CACNA1E
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.31571691385969586,0.7608314292200073,0.8333333333333334,0.9853161959859905,1.0,8/63,7.98%,LDB2;ERBB4;EPHA3;RYK;ROR2;IGF1R;MERTK;EGFR
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),-0.3162479122523814,-0.7607582189981961,0.9278350515463918,1.0,1.0,20/189,16.82%,PSMB9;EMD;SFRP1;DVL1;TGFB1;PSMB8;ATP6AP2;TLE6;SFRP4;GPC3;PLEKHA4;PSMA3;CDH3;FUZ;ZBED3;DVL2;APOE;PSMA7;CAV1;PSME1
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3087585481002498,0.76069081583772,0.9444444444444444,0.9849178884720056,1.0,8/36,10.71%,NAF1;MAPK1;POT1;TNKS;MAP3K4;MAPKAPK5;MAPK3;ERCC4
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),0.43538910042359724,0.7605202391806046,0.7272727272727273,0.9845291638789951,1.0,3/7,25.29%,KMT2C;SETD1B;KMT2D
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.3810282396556128,-0.7600272686962848,0.8356164383561644,1.0,1.0,6/29,19.70%,ALOX5;ALOX12;EPHX2;LPCAT3;CYP3A5;PLPP5
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.34783827723984617,-0.7594821680529741,0.8941176470588236,1.0,1.0,5/47,9.73%,PLCH1;HTR2B;PLCD4;PIK3CB;CD160
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),-0.5044385697000591,-0.7594518017810236,0.7708333333333334,1.0,1.0,2/6,16.51%,CTSL;CAV1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.38364519906134764,-0.7589421498950967,0.8292682926829268,1.0,1.0,1/23,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.41012558388653864,-0.7586508822442292,0.8260869565217391,1.0,1.0,4/14,20.87%,STAT1;HSPD1;IFIH1;DHX36
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.3700853989933978,-0.7584534486357095,0.8571428571428571,1.0,1.0,5/27,18.13%,PIK3CB;FN1;DSC2;P2RY12;VCL
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.4180130964403898,-0.758215147764314,0.8405797101449275,1.0,1.0,3/15,11.39%,DOLPP1;MPDU1;ALG14
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.4094835843364763,-0.7577164397815588,0.8260869565217391,1.0,1.0,2/15,6.03%,CLU;EFNA1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.3527276440994431,0.7575714795562233,0.7692307692307693,0.9889514906064995,1.0,2/13,4.19%,LAMA3;FERMT1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.31748941460033286,0.7575411590074917,0.9615384615384616,0.9883790272207162,1.0,4/23,12.97%,SOX11;BMP2K;ZBTB16;ACVR1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.4631122513001659,-0.7573710189784087,0.8405797101449275,1.0,1.0,2/11,10.69%,MMP24;METRN
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.47101933455626516,-0.7573070776175824,0.8333333333333334,1.0,1.0,2/9,12.16%,ZIC1;MYO3B
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.3643747016911671,-0.7572456219684787,0.8333333333333334,1.0,1.0,10/44,16.75%,TNC;RHBDF1;TEAD3;CDH3;OSMR;COL4A1;ACTA2;MYLK;CAV1;COL4A2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.44094111197041813,-0.756808939525431,0.7941176470588235,1.0,1.0,1/9,1.85%,RANGRF
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.4128577468587455,-0.7565765710986818,0.7638888888888888,1.0,1.0,2/17,7.94%,TGFB1;APH1A
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.3943200372748108,0.7562642948449259,0.8260869565217391,0.989878113442796,1.0,1/15,0.47%,GINS1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.37844392109343855,-0.7561694267076534,0.8648648648648649,1.0,1.0,4/27,6.03%,SLC3A1;CFTR;S100A10;EFNA1
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.38787983126451375,-0.7559686592045496,0.8701298701298701,1.0,1.0,2/25,10.96%,ABRAXAS1;USP50
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.3750491331487036,0.7559226802328057,0.7586206896551724,0.989877645829506,1.0,2/11,8.81%,KIF19;NCKAP5
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.30506733333887526,0.7554850957157238,0.7407407407407407,0.9900041826451867,1.0,7/33,18.78%,SYNJ1;MTMR10;MTMR3;OCRL;MTM1;PLPP2;MTMR8
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.36962737039898075,-0.7554583566875304,0.8181818181818182,1.0,1.0,1/23,1.53%,DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.2648248094123768,0.7552616356150624,0.9166666666666666,0.9898404474343915,1.0,17/141,9.62%,SHANK2;ESR1;DEPTOR;SIRT1;PPM1A;LIMD1;GPD1L;PDE4D;TLE1;MAGI2;NMI;RORA;BMP7;ATP2B4;PLAUR;MAPK14;MAPKAPK5
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.368433724282318,-0.7551707763968786,0.8472222222222222,1.0,1.0,6/29,16.52%,CLU;GRN;DDIT4;ATF4;BAX;FOS
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),-0.4434302174214386,-0.7550347375814276,0.8333333333333334,1.0,1.0,1/11,4.19%,RARRES2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.341205953952647,0.7548799540180496,0.9259259259259259,0.989849064177005,1.0,4/17,14.01%,GDAP1;USP30;MFN1;MIGA1
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.48672423952118776,0.7548000187729025,0.7560975609756098,0.9894411285322758,1.0,1/5,4.67%,SUV39H2
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.34513262950014095,-0.7545422669801475,0.8333333333333334,1.0,1.0,3/49,3.65%,POLR2I;FGF1;POLR2G
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),-0.3513934828428367,-0.75429351547324,0.8641975308641975,1.0,1.0,12/58,26.97%,PSMB9;PSMB8;PSMA3;PSMA7;PSME1;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.3652617053841237,0.7539100777578466,0.8125,0.9901196606226257,1.0,1/11,1.42%,ZNF618
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.4578894784736157,0.7537840398867603,0.7435897435897436,0.9897663200350746,1.0,1/5,6.04%,BCL2L11
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.31417898040164804,0.753769761839397,0.9411764705882353,0.9891874337815149,1.0,9/39,18.24%,ATR;LIG4;SIRT1;MAPK14;INTS7;RAD1;NIPBL;EEF1D;TANK
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.3169106896466879,0.7536759284906966,0.9130434782608695,0.9887899139467864,1.0,15/27,27.47%,EFR3A;SMG1;IP6K1;PIK3CA;SOCS6;SOCS7;SOCS4;EFR3B;IP6K2;PIK3R1;PI4KB;TTC7B;ITPKB;PIP4K2B;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.4158778757665972,-0.7535436462913859,0.8,1.0,1.0,4/17,21.58%,TMBIM1;RFFL;BRCA1;PARK7
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),-0.3059104103414331,-0.7534698928654588,0.8977272727272727,1.0,1.0,8/139,7.84%,IFI6;MX1;TRPC5;PLSCR1;IRF1;TCHP;GAPDH;BCL2L14
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",0.4740963684671745,0.7533237950188296,0.7804878048780488,0.9887359364980238,1.0,1/5,2.13%,ADAM10
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.27233653774366995,0.7532464760706636,0.9375,0.9882489416354724,1.0,11/61,14.59%,CHRM3;ABL1;PHEX;ABL2;PPP4R2;MMP15;MCRS1;ATG3;CSNK1G3;FBXO11;MSRA
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32928537159815324,-0.7528797931404744,0.8863636363636364,1.0,1.0,2/50,2.33%,VEGFA;VAV3
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.4090918001021352,0.7527172735493791,0.896551724137931,0.9885380052506341,1.0,4/14,10.65%,SLC15A2;SLC29A4;ABCC11;ABCC5
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5095552188948869,-0.7522173934912938,0.8333333333333334,1.0,1.0,1/5,8.54%,PIK3CB
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3255655196920929,-0.7521073386465744,0.9047619047619048,1.0,1.0,6/97,8.71%,APIP;TRIM5;ATP6AP2;RASGRP1;CEACAM1;FN1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.38413358099130995,-0.752058437675895,0.8115942028985508,1.0,1.0,9/29,26.77%,IFI35;RTKN2;PTP4A3;EIF2AK2;TERF2IP;C1QTNF4;LRRC19;CD27;APP
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.4795449877430299,0.7519897356700619,0.75,0.9890970722014965,1.0,4/6,8.94%,AKR1C2;AKR1C3;GNG2;ADCY6
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.4453333944358631,0.7518621785451625,0.7575757575757576,0.988682788574172,1.0,4/6,18.51%,PPM1F;DUSP26;CORO1C;NPM1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.42074426045030355,-0.7518214835193575,0.9054054054054054,1.0,1.0,5/14,23.82%,MEF2C;MYL6B;CAV1;BASP1;MYL6
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.4765289005461509,-0.7517699156410254,0.8709677419354839,1.0,1.0,3/7,20.47%,SFRP1;EIF2AK2;ATRAID
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.2967595040833654,-0.7513022780584159,0.97,1.0,1.0,118/755,19.26%,PLAG1;ESRRB;ETV4;VEGFA;HES5;DDRGK1;BEX1;H2AZ1;TAF7;RPS27A;FGF1;ZBTB48;SFRP1;HES1;TFAM;CREB3;CDKN1C;GALR1;DVL1;CAMK1;APEX1;PLSCR1;JUN;LAGE3;AGRN;TGFB1;HMGN5;COPS5;HAX1;AGT;ZIC1;ZFPM1;IRF1;DBP;H1-4;LDB1;MLX;KDM6B;MAX;CHCHD2;XBP1;NIF3L1;LMO2;JAG1;MAFF;MEF2C;UTP15;MED1;PARP9;SMARCD1;CEBPZ;CHCHD10;CKAP2;GLIS3;SMARCA5;MOSPD1;ID2;ESR2;CDK7;ELK3;TADA3;NR5A2;PRPF6;NLRC5;DNM2;JUNB;NR4A3;CRLF3;ATF4;SSBP4;MAP2K1;SS18L2;ZBED3;ACTA2;DVL2;UBA52;GTF2F1;ZFHX3;RUNX2;MAP3K12;NR1D1;APOE;THOC5;FSTL3;SREBF1;USF1;HRAS;RTRAF;ATAD2;HNF4G;KAT5;TFE3;FIZ1;FOS;CCNK;SALL2;ZBED4;STAT1;BRCA1;PAXBP1;HDAC3;MMS19;EDF1;AHI1;HNRNPAB;HMGN1;NFIC;UBC;CCNC;ZNF711;SNW1;ZBTB49;TRIM56;TNFRSF1A;ILF2;DNAJC2;HEATR1;DRAP1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),0.43690479409407473,0.7511133881954324,0.6470588235294118,0.9894211145034779,1.0,3/8,32.61%,NAA16;NAA20;NAA30
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.3997081860923505,-0.7510176187211769,0.7971014492753623,1.0,1.0,4/18,21.81%,ZW10;DCTN1;SAPCD2;NUMA1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),0.3576558049587021,0.7507986153500953,0.78125,0.9892230250325476,1.0,3/12,15.49%,TRAPPC8;USP30;PEX5
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.43346195439787216,0.7506103340434256,0.6944444444444444,0.9888543617874272,1.0,2/10,9.43%,STARD3;OSBPL5
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.36584530268363147,-0.7501985050418702,0.9066666666666666,1.0,1.0,7/37,21.51%,NUP155;NOL6;SEC13;NUP107;NUP85;PHAX;NUP188
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.32404494110380155,0.7501967016279102,0.9090909090909091,0.9887916198997754,1.0,5/26,8.57%,LAMA3;PADI2;TOX3;PYGO2;NNMT
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),0.4187019160973219,0.7499716173852214,0.725,0.9886391601724641,1.0,4/7,18.09%,MAGI2;ACVR1;IGSF1;LEMD3
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),-0.38797012228275013,-0.7499402001400391,0.8378378378378378,1.0,1.0,10/28,26.19%,PRELP;OMD;ACAN;OGN;NCAN;CHAC2;TXN2;IDUA;HYAL1;BCAN
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.33091346915713177,-0.7498924218774619,0.8414634146341463,1.0,1.0,9/55,18.85%,VEGFA;OPRM1;OBSL1;METRN;SS18L2;PLXNB2;MAP6;SNW1;TRIM32
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.37706546965239324,0.7498906647454039,0.7407407407407407,0.9881817695599356,1.0,3/14,7.63%,OSBPL7;GRAMD1B;TGFBR2
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),-0.4356628590893453,-0.7498261933985937,0.7866666666666666,1.0,1.0,4/11,21.70%,DNAH17;CCDC39;DNAH2;DNAAF2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.3286871659462755,-0.7497388868037677,0.9,1.0,1.0,10/119,8.80%,ESRRB;HES5;SFRP1;HES1;TGFB1;OVOL2;ZFPM1;EFNA1;JAG1;MED1
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.34895772396102553,0.7494889587026752,0.8260869565217391,0.9882899453733055,1.0,2/15,13.09%,FER;ST18
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),-0.4835538758426182,-0.7494828366979717,0.8225806451612904,1.0,1.0,1/5,11.84%,BDNF
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.2528953874848471,0.7492977831759189,1.0,0.9880394641386527,1.0,29/141,15.24%,TAB3;ESR1;TRAF1;ATP2C1;ZFAND6;INAVA;SIRT1;PPM1A;TLE1;ANKRD17;TRIM62;RORA;NDFIP2;HSPB1;VAPA;MAP3K7;PELI2;ZDHHC17;UBE2N;LURAP1;CFLAR;PRKD1;TFG;TRAF5;TAB2;LPAR1;MID2;CXXC5;ZMYND11
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.27509635097279056,0.7492838592715722,0.8461538461538461,0.987457842495902,1.0,8/36,13.51%,MAP2;FER;EPHA5;PPM1F;PARD6G;LRRK2;CSNK1E;KIAA1614
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.3090173959627736,-0.7491988055018869,0.9560439560439561,1.0,1.0,7/114,9.56%,ESRRB;ITGA4;SFRP1;HES1;ZIC1;TEAD3;COL4A1
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.29192256542963263,0.7490976527559076,0.9230769230769231,0.9871096802883477,1.0,13/80,13.55%,ITPR2;MAPK1;ACACA;PLCB1;MAP2K6;MAPK10;EGFR;CAB39L;PIKFYVE;MAP3K7;UBE2N;THEM4;MAPK8
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.37617075931176003,0.749028435802373,0.8,0.9866277267298473,1.0,5/14,23.73%,ADCY6;PRKACB;ADCY2;ADCY9;PRKAR1B
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.36657793847777276,-0.748881528843834,0.8117647058823529,1.0,1.0,5/34,13.20%,LDB1;POLE3;TADA1;TADA3;BRPF3
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.3986178156316076,-0.7484117565846695,0.8571428571428571,1.0,1.0,4/19,15.52%,PARP14;PARP9;NLRC5;IL7
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),-0.4392445659407599,-0.7483784019136197,0.8428571428571429,1.0,1.0,2/10,11.71%,GLRX;WNK3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.3287420747505109,0.7483680789032338,0.85,0.9870762954339075,1.0,6/24,10.59%,ACADVL;SIRT1;FOXK1;FMO5;RORA;DGKQ
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.3839714480357172,-0.7482272287405117,0.8493150684931506,1.0,1.0,4/22,17.92%,PEX1;ATAD1;PEX11B;PEX14
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),-0.45829604694477133,-0.7481935098166316,0.8235294117647058,1.0,1.0,1/7,11.71%,WNK3
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.46809171238811564,-0.747640513625016,0.821917808219178,1.0,1.0,2/8,16.42%,METRNL;TFE3
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.41795047353954123,0.7475508883552574,0.8285714285714286,0.9877745502592907,1.0,3/9,8.94%,CERCAM;SEMA4D;MSN
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.30051774222675126,-0.7475412031291673,0.9680851063829787,1.0,1.0,28/208,19.44%,TFPT;PSMB9;RPS27A;ABRAXAS1;CFTR;MBD6;COPS5;PSMB8;USP6;USP18;PSMA3;USP50;TADA3;OTUD6B;USP4;USP28;UBA52;SKP2;PSMA7;USP19;PSME1;BRCA1;TAF9B;USP44;UBC;TOMM20;IFIH1;DDB2
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.35280101507642647,-0.7475232937492525,0.8765432098765432,1.0,1.0,10/36,27.18%,UVSSA;RRH;USF1;TRIM32;MSH6;DDB2;CIRBP;SLC24A1;CDKN2D;ZRANB3
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.49352481572524864,0.7472180753006349,0.9090909090909091,0.9874895472482703,1.0,2/6,10.25%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.3081021651778747,0.7465875157104882,0.8888888888888888,0.9878207654745177,1.0,9/26,18.52%,FBXW7;NOX4;RELN;TGFA;SRCIN1;ADAM17;FYN;DOCK3;GRM5
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.42297853158544574,-0.7465830914892719,0.8571428571428571,1.0,1.0,3/16,7.93%,CTSL;MAFF;SFRP4
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),-0.37012544211243187,-0.7465743896420478,0.8656716417910447,1.0,1.0,9/20,32.02%,HOOK2;KIF1A;MAP6;TUBA1B;CCDC186;TUBB;TUBA1A;HOOK3;TUBA1C
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.45081912215284947,0.7465533548437335,0.7894736842105263,0.9873041409989576,1.0,1/5,4.73%,SIRT1
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.31621597603477647,-0.7462164391221754,0.8705882352941177,1.0,1.0,3/87,4.04%,B2M;HSD17B14;TMEM50A
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),-0.44114565844901166,-0.7461299599577617,0.835820895522388,1.0,1.0,1/10,5.09%,LRPAP1
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.4443947732705686,0.7461033527721285,0.6578947368421053,0.9874300257844041,1.0,3/5,32.61%,NAA16;NAA20;NAA30
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.31183128100202057,0.7459690079907679,0.8125,0.9869944370347601,1.0,17/47,21.35%,PRR5L;SYTL4;ATP2C1;UNC13B;PCM1;FRMD4A;MYOM1;ACSL3;CNST;PCNT;CEP290;RIPOR1;ACHE;RAB29;GOLPH3;TENM1;CHP1
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.41559290633063434,0.7456167957572051,0.7631578947368421,0.9870135009435536,1.0,3/6,18.51%,SIRT1;HMGB1;NPM1
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.35302743182345947,0.7454004238411474,0.7631578947368421,0.9867922605561071,1.0,4/13,19.53%,ADCY6;ADCY2;AMPD2;ADCY9
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.34545000348395344,-0.744888738345165,0.8026315789473685,1.0,1.0,5/52,7.99%,RPS27A;PBLD;TGFB1;ASPN;VEPH1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.4624428496376479,-0.7445857238251857,0.8135593220338984,1.0,1.0,2/7,29.53%,TSN;MRPL44
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),-0.33000214898100566,-0.7445563105261777,0.9333333333333333,1.0,1.0,11/70,18.85%,RIMS1;SFRP1;DERL2;NCBP1;BDNF;SUPV3L1;HDGFL2;SYT4;TAF9B;CDKN2AIP;TRIM32
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.44506933026693296,0.7445052385928039,0.7142857142857143,0.9877275078463716,1.0,1/7,5.29%,MMAA
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.33101868246539534,-0.7443793290838833,0.891566265060241,1.0,1.0,4/57,5.78%,HLA-F;CLU;LRPAP1;HTR2B
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.38482504191874667,0.7443705247839056,0.8285714285714286,0.9872838873156602,1.0,3/9,18.96%,ADCK1;PID1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.2973275983890862,0.7440282305281309,0.7142857142857143,0.9871872490125194,1.0,38/124,19.16%,RANGAP1;ARAP1;EVI5L;DOCK9;RAP1GDS1;RGS7;PKP4;SEMA4D;TBC1D14;PICALM;SGSM1;TBC1D12;SNX18;ARHGAP42;TBC1D1;RABGAP1;RAPGEF6;MAP4K4;TBCK;RAPGEF2;TIAM2;ARHGAP22;DOCK10;MAPRE2;RAP1A;ARHGEF7;SIPA1L1;CORO1C;TBC1D8B;CDKL5;RABGAP1L;DOCK11;RALGAPA2;TBC1D7;SRGAP2;NF1;RALGAPA1;TBC1D5
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.4487255716672528,-0.7437241003753854,0.819672131147541,1.0,1.0,2/8,8.35%,MEF2C;SLC24A5
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.3246425191249491,0.7434715952460781,0.75,0.9873837068696611,1.0,4/26,14.94%,RAB27A;SNF8;VTA1;CHMP1A
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.3945480739469825,0.7432773129034888,0.7352941176470589,0.9871007914113411,1.0,1/8,5.44%,GAL3ST3
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.29894455618715526,-0.7432679970410858,1.0,1.0,1.0,61/463,18.71%,ZBTB32;RPS14;VEGFA;CRYM;HES5;TAF7;RPS27A;RPL10;HES1;CHD3;JUN;ZFP69;RPL23;ZFPM1;EFNA1;CGGBP1;LDB1;DDX5;MLX;BHLHE41;MAX;BACH1;TLE6;MEF2C;ZNF124;MED1;PARP9;ZNF568;SAP30;GLIS3;MOSPD1;TCF25;ID2;ESR2;HDGF;NR4A3;ATF4;BEND3;ZNF248;UBA52;ZFHX3;NR1D1;SARS1;TRIB3;AEBP1;KAT5;CAV1;ZNF749;STAT1;ZNF404;CBX7;HDAC3;TAF9B;NR0B1;ZNF875;NFIC;WFS1;UBC;CBX5;SNW1;EZH1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),-0.47086154898697324,-0.7432630055778946,0.8412698412698413,1.0,1.0,1/5,10.05%,GRN
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.36658395489755474,-0.7431292106887131,0.8356164383561644,1.0,1.0,4/39,7.84%,SCG2;NOL3;AGT;BCL2L14
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.4665545124405582,-0.7431013178284779,0.8214285714285714,1.0,1.0,1/7,8.80%,MED1
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.4709596536573898,-0.7430296739361011,0.8382352941176471,1.0,1.0,1/8,10.88%,ATG14
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.3826544718037579,0.7430123772460158,0.7307692307692307,0.9869600943695792,1.0,1/9,6.11%,SLC29A4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),-0.433935450086913,-0.7429573691352853,0.8305084745762712,1.0,1.0,3/8,32.72%,CACTIN;TMSB4X;ARRB1
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.42654270959423846,-0.7429233619223915,0.8461538461538461,1.0,1.0,1/11,2.57%,SFRP1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.40358010133136135,0.7428942397972184,0.8214285714285714,0.9865271018530292,1.0,2/9,15.43%,CABYR;SPEF2
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.4891368046163814,-0.7427156459579978,0.8421052631578947,1.0,1.0,1/6,11.04%,ID2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3232481408525512,-0.7423797016271112,0.9120879120879121,1.0,1.0,16/101,16.04%,HES5;CAMK1;TGFB1;ALOX5;DDX5;SLC6A6;CEBPD;ID2;EMP2;BDNF;ATF4;ZFHX3;RUNX2;NR1D1;HSP90AB1;EIF2AK2
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.32048136020220136,-0.7423469484154462,0.898876404494382,1.0,1.0,21/90,21.59%,KCNJ13;TAF7;TRPM3;SCN9A;CNGB3;PANX2;SLC6A6;SLC7A6;SLC6A9;KCNC1;SLC22A4;KCNMB4;SLC3A2;RHCG;SLC7A8;KCNAB3;SLC5A10;SLC36A4;KCNJ3;ANO6;SLC5A9
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.4767751222489009,-0.7406479420835601,0.7887323943661971,1.0,1.0,1/5,5.60%,MMP24
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),-0.356236454919034,-0.7405229694317742,0.8974358974358975,1.0,1.0,8/41,16.51%,SFRP1;DVL1;SFRP4;CDH3;TCF7;WNT5B;DVL2;CAV1
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.2461328676185092,0.7404904437380431,1.0,0.9887075079481535,1.0,50/262,16.41%,MAPK11;FLRT2;PDGFC;SPRED2;ERBB4;IRS1;BCAR1;EPHA3;RYK;HNRNPH1;ZFYVE27;GAB1;ROR2;FER;MAPK1;TNK2;IGF1R;PLCB1;MERTK;FOXO1;EGFR;ABI1;WASL;MAPK14;EPHA5;MAPK3;PTBP1;ATP6V1A;SDC2;PIK3CA;TRIM71;GRIN2B;PRKD1;LMTK2;RAPGEF2;FRS2;NRP1;FLT1;FLRT3;PTPRG;GTF2F2;MTSS1;NCKAP1;SOS1;SH2B2;FYN;SPRED1;ARHGEF7;SIPA1L1;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),-0.4576864013633375,-0.7403712314149089,0.7794117647058824,1.0,1.0,1/7,7.50%,JAG1
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),-0.3336311089158177,-0.7403182752304114,0.8372093023255814,1.0,1.0,8/78,9.28%,C4BPA;TGFB1;CLU;AGT;RASGRP1;LDB1;GPC3;SLC6A9
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.3088374756574999,-0.7401259828322542,0.9888888888888889,1.0,1.0,34/204,19.93%,HES5;ELOB;F8;RIMS1;NOL3;HES1;GORASP1;NAPA;CTSZ;TUBGCP2;TUBGCP4;ZW10;NDUFAF1;TRAPPC2L;FN1;CHCHD10;TCF7;FANCC;TRAPPC6A;SEC13;SPG7;VIL1;MCFD2;KAT5;HGSNAT;NIFK;TSPAN4;PEX14;DNM1L;AFG3L2;TNFRSF1A;TAPBP;KNTC1;TRAPPC4
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.3523958339314584,0.7400968586223245,0.875,0.9885395551516005,1.0,3/20,7.68%,SLC25A18;SLC7A2;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4421808947225899,-0.7398516577707195,0.8591549295774648,1.0,1.0,2/10,11.71%,GLRX;WNK3
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),-0.4254209936334489,-0.739321851544455,0.8260869565217391,1.0,1.0,1/10,0.66%,VEGFA
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.29013916234634285,-0.7392244736950512,1.0,1.0,1.0,193/1384,18.72%,ZBTB32;PLAG1;RPS14;ESRRB;ETV4;VEGFA;CRYM;HES5;ZIC4;DDRGK1;BEX1;ZNF610;H2AZ1;SP140;TAF7;RPS27A;FGF1;ZBTB48;RPL10;HES1;CREB3;GALR1;DVL1;ZNF883;CAMK1;CHD3;NFE2L3;APEX1;PLSCR1;JUN;LAGE3;AGRN;TGFB1;DACH2;ZNF790;ZFP69;COPS5;ZNF829;ARX;ZNF574;HAX1;RPL23;ZSCAN2;ZIC1;BRD9;OVOL2;ZNF232;ZFPM1;IRF1;DUXB;DBP;EFNA1;CGGBP1;LDB1;DDX5;MLX;BHLHE41;KDM6B;MAX;CHCHD2;XBP1;BACH1;TLE6;LMO2;JAG1;MAFF;ZNF546;MEF2C;STAT5A;CEBPD;WIZ;TEAD3;ZNF124;GMEB1;MED1;HES4;PARP9;SMARCD1;ZNF568;ZBTB25;ZNF213;ZNF132;SAP30;ZNF565;ZNF552;TADA1;ZSCAN31;IFRD1;CEBPZ;CKAP2;GLIS3;SMARCA5;ZNF81;ZNF7;MOSPD1;ZNF394;TCF25;TCF7;ID2;ESR2;CDK7;PROX2;ELK3;ZNF850;ZNF449;TADA3;NR5A2;PRPF6;ZSCAN5A;BUD31;ZNF226;MED29;HDGF;NLRC5;JUNB;ZNF235;ZNF726;NR4A3;CRLF3;ATF4;BEND3;SSBP4;ZNF480;SS18L2;ZBED3;ZSCAN29;ZNF248;CTDP1;DVL2;UBA52;GTF2F1;HDGFL2;ZFHX3;RUNX2;ZNF211;NR1D1;APOE;SARS1;TRIB3;FSTL3;CPHXL;SREBF1;ZSCAN30;USF1;NFE2L1;ZNF302;HRAS;ZNF665;AEBP1;RTRAF;CCNQ;ZNF426;ATAD2;SP110;HNF4G;KAT5;BAX;ZNF814;TFE3;ZSCAN1;FIZ1;CAV1;FOS;CCNK;ZNF749;CREBZF;SALL2;BRD3;ZBED4;ZNF197;STAT1;ZNF404;BRCA1;PAXBP1;CBX7;CDKN2A;HDAC3;TAF9B;NR0B1;AHI1;ZNF875;NFIC;ZNF793;SRA1;WFS1;UBC;CCNC;CDK4;CBX5;ZSCAN32;SNW1;EZH1;HSPD1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.3500817690361716,0.7390695896635279,0.7692307692307693,0.989477648920973,1.0,5/20,11.06%,SIRT1;NNMT;SDHAF3;DGKQ;ARPP19
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),-0.45015127184762077,-0.7389507066211333,0.8088235294117647,1.0,1.0,2/8,15.59%,TGFB1;PMVK
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.3557392456439745,-0.7389109495544385,0.881578947368421,1.0,1.0,6/43,11.06%,VEGFA;TUBB2A;TUBGCP2;MEF2C;CCK;DDIT4
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,-0.4180343668843158,-0.738685129355905,0.8260869565217391,1.0,1.0,4/14,8.03%,OVOL2;CEACAM1;TMC4;GGH
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),-0.4261675103035191,-0.7384907590322484,0.8266666666666667,1.0,1.0,2/9,22.00%,ELAPOR1;PIP4K2C
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.2632488341379454,0.7383399348199896,1.0,0.9898222508158581,1.0,18/96,14.42%,LDB2;SEC24D;KAT2B;WFDC1;NOX4;PDE4DIP;SMOC1;SYNPO2;MSRB3;SLIT3;NF2;ADAMTS5;FBXL7;PRKG1;PRRX1;ZBTB44;KIF1C;DMPK
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.4737189969760627,0.7382540186854702,0.78125,0.9893711745106897,1.0,2/6,10.25%,MAPK1;MAPK3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4066484977269287,-0.7382444153147514,0.8333333333333334,1.0,1.0,1/11,5.13%,CEMIP
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.40908494235753856,0.7380275558704461,0.8214285714285714,0.9890795904608604,1.0,2/8,15.43%,CABYR;SPEF2
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3123124711546201,0.7374573727923556,0.88,0.9894061660548867,1.0,4/30,9.11%,RNF139;BTRC;PLAUR;FBXW11
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),-0.2966384756270115,-0.7373718616003531,0.9777777777777777,1.0,1.0,27/178,13.53%,RIMS1;HAP1;LIN7B;NAAA;DVL1;CAMK1;CHRM2;NAPA;HTR2B;CACNB1;HTR2C;HTR4;CACNA1B;SST;GRIN2D;SNCB;HTR1F;GRM1;CALM1;PCDHB4;AKAP5;RIC3;CACNA1E;CHRM5;NPTX1;SLC1A6;GIPC1
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),0.39342627569594685,0.7373175373087052,0.6333333333333333,0.9890531593951921,1.0,1/6,1.01%,MOXD1
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.4669639271093196,-0.7366272013404781,0.8909090909090909,1.0,1.0,2/6,27.85%,POP4;RPP30
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.39827024263614524,0.7365708253369907,0.8888888888888888,0.9895292308884899,1.0,2/9,13.38%,RELN;CAPRIN1
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),-0.40624575399705287,-0.7365032822614066,0.7903225806451613,1.0,1.0,1/12,4.19%,RARRES2
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.43392578757248945,0.7364549873547995,0.8333333333333334,0.9891677565584067,1.0,2/6,7.56%,NLGN1;SGIP1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2868247073430904,-0.7362668303413095,1.0,1.0,1.0,83/661,15.87%,PLAG1;ESRRB;VEGFA;RIMS1;DDRGK1;MBNL3;ZNHIT3;PHF1;FGF1;SFRP1;TRIM5;BTN3A1;DVL1;CHD3;RPL11;FAM50A;PLSCR1;YBX3;TGFB1;HMGN5;CLU;AKAP17A;RPL23;PARP14;OVOL2;SPIN2A;OLFM1;FAM98B;CGGBP1;LDB1;HDAC6;MLX;KDM6B;TTN;BACH1;IGF2BP2;MEF2C;SFRP4;EPHX2;PIK3CB;FN1;PTRH2;MED1;PARP9;SH3GL2;CDH3;SAP30;SRSF10;HINT1;PDCD5;SRRM4;BTG1;HNRNPDL;TCF7;ATG14;ID2;ESR2;TADA3;NR5A2;BTNL2;TCEAL1;WARS1;DNM2;CACTIN;ATF4;ATXN7L3B;RACK1;ZNF100;MAP2K1;ACTA2;DVL2;ZFHX3;APOE;RPS7;STX1B;PTP4A3;BTN3A3;ZNF460;ZNF331;HRAS;SRRT;ZNF90;CD46
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.41044609906226315,-0.7361910262150224,0.8028169014084507,1.0,1.0,2/11,29.53%,ADAR;MRPL44
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),-0.302978543390112,-0.7360525504815637,1.0,1.0,1.0,19/149,15.72%,TRPC5;TRPM3;KCNK12;SCN9A;DMAC2L;SLC30A4;CACNA1G;HVCN1;SLC6A6;CACNA1C;SLC24A5;SLC6A9;KCNC1;ATP6V0A4;P2RX4;ATP6V1F;ATP6V0E2;RHCG;SLC39A6
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.36760637591973855,-0.7359529436406178,0.9090909090909091,1.0,1.0,1/21,2.44%,FGF1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.29021604128206185,0.7357086406425898,0.9375,0.9896520064980421,1.0,13/38,17.72%,EYA4;HDAC10;SIRT1;FMN2;EGFR;EYA2;TRIM28;UBE2N;HMGB1;FAM168A;EYA3;SPIRE1;MGMT
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.36696801234018706,-0.7356101539059405,0.782051282051282,1.0,1.0,1/18,7.07%,XBP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),-0.3229015095496558,-0.7355527817171253,0.8977272727272727,1.0,1.0,14/93,18.33%,PSMB9;RPS27A;SFRP1;PSMB8;HAS2;PSMA3;CACTIN;UBA52;ADAMTS7;NR1D1;PSMA7;PSME1;UBC;MAPK13
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.35063088031965517,-0.7350851588787072,0.8666666666666667,1.0,1.0,3/30,8.08%,ABRAXAS1;RAB11A;SMC1A
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),-0.3927040459562899,-0.7350086627382583,0.7681159420289855,1.0,1.0,9/14,26.77%,P2RX4;C3;HSP90AB1;IL18;TXN;ANO6;PSTPIP1;ENTPD5;APP
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.3244923232371548,-0.7349295408262474,0.9047619047619048,1.0,1.0,11/69,18.15%,NOL3;ECT2;PRMT8;POLQ;KCNC1;RNF213;BEND3;RNF112;HGSNAT;DNM1L;MPP2
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.33432830304722233,0.7348141029140791,0.75,0.9904524889153764,1.0,2/16,5.15%,NR1H2;PPARG
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),-0.45976269311982,-0.7347910881622578,0.8461538461538461,1.0,1.0,1/6,11.71%,WNK3
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.33769548924809684,-0.734748216307559,0.9431818181818182,1.0,1.0,2/48,5.95%,GADD45B;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.389228431488429,0.734626588450185,0.75,0.9901086989025448,1.0,4/10,13.04%,ABL1;ABL2;PDP1;RFK
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.2950656589265557,0.734359431964843,0.9583333333333334,0.9899498960757401,1.0,9/31,15.38%,GPC4;GCNT2;HS3ST1;EXT2;UGDH;GPC1;SDC2;EXT1;HS2ST1
prerank,MSigDB_Hallmark_2020__Protein Secretion,-0.31835428678403127,-0.7343298797091445,0.8901098901098901,1.0,1.0,9/89,12.00%,CD63;SSPN;M6PR;NAPA;ZW10;TOM1L1;SH3GL2;ARFGAP3;CLTA
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.3363450444437222,0.7342104256872022,0.8666666666666667,0.9896419419340291,1.0,6/27,18.43%,DGKB;DGKQ;MGLL;DGKG;DGKE;LYPLA2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3455453957210743,0.7341520392990976,0.9142857142857143,0.9892026574297134,1.0,3/15,14.10%,BOK;DCC;BCL2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.31980801263510994,-0.7340907205605267,0.9090909090909091,1.0,1.0,11/75,18.94%,FTL;FTH1;NAPA;AP2A1;SH3GL2;CLTA;DNM2;AP4M1;KLHL20;STEAP2;GOPC
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.4084393060636219,0.7339445926427189,0.868421052631579,0.988948147012727,1.0,2/8,18.29%,METTL4;WRNIP1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.4107259942330304,0.7337959732941529,0.71875,0.9886413196185225,1.0,1/8,4.10%,INAVA
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.38743262206182616,0.7337860754436951,0.7297297297297297,0.988080694818531,1.0,4/8,32.32%,TOPBP1;RAD9A;NAE1;HUS1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),0.2548874074067695,0.7337477844497996,1.0,0.9875470019981132,1.0,40/170,18.87%,TTC29;EHD1;FNBP1L;STK36;SEPTIN6;RABL2B;IFT140;RFX3;CDC14A;PKD2;PCM1;TRAF3IP1;BBS4;CEP41;TTLL3;UNC119B;IFT172;SSX2IP;OCRL;TCTN2;EXOC2;CDC14B;PCNT;TMEM138;ARL3;EXOC6;CEP89;GBF1;SPAG16;CEP290;RAB3IP;EXOC4;TTC39C;GALNT11;MACIR;ATAT1;CEP20;ABCC4;TTC17;RILPL2
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),-0.4660944440363066,-0.7337316428443987,0.8,1.0,1.0,2/6,13.15%,WNT5B;ATF4
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,-0.3663858353607097,-0.7335415528750492,0.8533333333333334,1.0,1.0,15/33,24.37%,TUBB4B;ANKUB1;ATP5MK;CFAP52;CDHR3;CCDC39;CFAP100;MAP3K19;CFAP77;FAM161A;CFAP70;VWA3A;DNAH9;DRC3;TTC21A
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.42417241664482597,0.7335018461247421,0.7435897435897436,0.9873815910292965,1.0,1/7,5.76%,PLIN5
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.37665597324064337,-0.7334188116356403,0.8428571428571429,1.0,1.0,3/19,7.07%,CREB3;SELENOS;XBP1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.4889300108172446,-0.7333456188908176,0.8955223880597015,1.0,1.0,1/5,15.39%,HRAS
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),-0.3795593177370996,-0.7332193517883695,0.8395061728395061,1.0,1.0,3/20,15.26%,MED1;AVIL;C3
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.38641709445888406,-0.7332004943093634,0.8157894736842105,1.0,1.0,4/24,14.64%,ITGA4;BLNK;SLC25A5;SYVN1
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.4283473809389352,0.7324477025006991,0.88,0.9883362017571945,1.0,5/11,17.10%,SLC26A3;ATG16L1;DLL1;RAP1A;KLF15
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3455277097353082,0.732296731205143,0.8484848484848485,0.9879431908881121,1.0,7/15,28.93%,HMGB1;ACVR1C;BLCAP;DFFB;DFFA;HMGB2;DICER1
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.3281085013772441,-0.732042213520508,0.9101123595505618,1.0,1.0,5/82,4.90%,MX1;ISG15;IFITM3;PLSCR1;HAX1
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.36826302405701605,0.7316368072179809,0.84375,0.9883108842043296,1.0,6/16,21.53%,ANKRD13D;PICALM;ANKRD13A;ABCA2;ITGAV;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.3818784356891441,-0.7316143760962831,0.8552631578947368,1.0,1.0,2/24,4.26%,RPS2;GORASP1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.24282269245011062,0.7315327987612842,1.0,0.9879270795095526,1.0,48/266,14.29%,RNF144A;FBXL4;UBE3D;BARD1;FBXW7;TRAF1;HECW2;NEDD4L;FBXO17;UBOX5;BTRC;HACE1;TRIM62;UBE2G1;UBE2J2;UBE2D1;RNF135;MARCHF1;TNKS;UBR5;SPSB1;FBXO15;FBXW11;CBFB;PELI2;UBE2E2;FBXO28;FBXW8;UBE2H;NEDD4;UBE2N;FBXL7;ANAPC4;TRIM71;UBE2E3;FBXW5;PSMD6;PSMD13;UBE3C;TRAF5;CDC16;UBE2QL1;KLHL42;RNF217;FBXO11;ANAPC1;BCL2;TPP2
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.3239524884413648,-0.7309193623780784,0.8777777777777778,1.0,1.0,15/58,21.17%,CRYAB;PAMR1;COL4A1;LMOD1;COL15A1;ACTA2;ADAMTS2;MYLK;AEBP1;PTN;COL14A1;CALD1;THBS2;PDGFRB;THY1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),-0.2988300936407721,-0.7307226549247179,0.96875,1.0,1.0,41/258,21.00%,ESRRB;POLR2I;ELOB;TAF7;TAF11;POLR2G;NFE2L3;DDX5;XBP1;CEBPD;TEAD3;SNRPB;MED1;GLIS3;ESR2;CDK7;NCBP1;NR5A2;CSTF2;NABP2;NR4A3;ATF4;CSTF1;CTDP1;GTF2F1;NR1D1;SRRT;HNF4G;CCNK;HDAC3;TAF9B;NR0B1;NFIC;SNW1;CPSF1;DRAP1;RARA;SLBP;SNRPG;PHAX;MNT
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.41912561490897576,0.7305840948387038,0.84375,0.9887220396048986,1.0,1/6,5.15%,PPARG
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.38661007352604554,-0.7299306597379419,0.8333333333333334,1.0,1.0,4/17,19.08%,BLOC1S2;DELE1;BAX;TNFRSF1A
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.2906060232178247,-0.7298092314564847,0.9583333333333334,1.0,1.0,40/312,20.76%,GOLGA8B;RPS23;DHX37;RAB11A;GABARAPL2;GOLGA8A;TUBGCP2;HDAC6;CFAP52;TUBGCP4;B9D1;LMOD1;ATG14;FUZ;ATG16L2;EMC6;AVIL;NEK6;TMOD3;TRAPPC6A;CENPC;MAK;MAP1LC3B2;CHMP4B;MIS12;ZFYVE1;LZTFL1;ULK1;HDAC3;EIF2A;AHI1;GSN;RAB19;ATP6V1D;FAM161A;PGM5;CFAP70;VPS36;CIRBP;ELAPOR1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.47556814052067703,-0.7296058205000313,0.8688524590163934,1.0,1.0,1/5,8.89%,GRIN2D
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.4947708620509995,0.7292329471818727,0.8823529411764706,0.9899609573989986,1.0,2/5,10.25%,MAPK1;MAPK3
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.2690338431763645,0.7287434714618747,1.0,0.9900302050854647,1.0,26/92,19.40%,ASB5;BCAR1;LAMC1;DMD;SH3D19;FOXK1;CHST3;EGFR;ADCY6;PARD3B;PALLD;GPC1;SOX8;IRF2;PTPRU;SNX7;NCKAP1;EPB41L1;FRMD6;TEAD1;AMOTL2;NTN4;COL5A2;NCAM1;KITLG;ITGA7
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4116291299869022,0.7286738301824592,0.875,0.9896027280760449,1.0,4/9,19.37%,MAPK1;MAPK3;MAP2K2;GREM1
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.3159652765572759,-0.7284963434810958,0.9565217391304348,1.0,1.0,3/75,5.95%,GADD45B;COPS5;RASGRP1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.4311383604073389,0.7283101710928725,0.8157894736842105,0.9896111474901307,1.0,1/6,5.80%,ATG5
prerank,PanglaoDB_Augmented_2021__Osteoclasts,-0.34303246343580074,-0.7282759836494199,0.8888888888888888,1.0,1.0,11/56,16.11%,F13A1;CTSZ;FPR3;CEBPD;RNASE1;CST3;RASSF4;VWF;NRP2;MMP19;TNFAIP6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.3586695623751263,0.7281367329345186,1.0,0.9893497661091261,1.0,7/12,25.90%,ERBB4;ZFPM2;RBPJ;BMPR1A;TGFBR3;NOTCH1;VGLL4
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.38336585435543563,-0.7278734837926973,0.821917808219178,1.0,1.0,9/17,34.40%,EIF3I;EIF2S3;EIF2D;DHX29;EIF4B;RBM4;EIF2S2;EIF5;MCTS1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.40593198948244236,-0.727842393770169,0.7857142857142857,1.0,1.0,3/13,22.92%,HDAC6;SHFL;BNIP3
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.25968500006265643,0.7275054897259813,0.9411764705882353,0.9896627485393014,1.0,19/79,15.43%,FEM1A;CALCRL;CD247;CALCB;PPARG;MYH9;GNG2;VIPR2;RORA;LRFN5;ADCY6;MFHAS1;MAPK14;PRKACB;ADCYAP1R1;RXFP1;ADAM17;OTULIN;FYN
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.4835099718732568,-0.7273468001441991,0.8461538461538461,1.0,1.0,1/5,10.89%,DCTD
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.32970779082405316,0.7273060819271451,0.8461538461538461,0.9893929476141531,1.0,8/21,18.96%,LRRK2;MCU;INF2;MARCHF5;PINK1;SPIRE1;RALA;PRKN
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.35045544700159176,-0.7271525229512023,0.9090909090909091,1.0,1.0,13/46,17.19%,ITGA4;ECT2;OVOL2;KIF20B;CEACAM1;TMC4;CDH3;CKAP2;NRP2;POF1B;PROM1;BRCA1;CDKN2A
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.41009940474000334,0.7267759683820505,0.7837837837837838,0.9895404739243966,1.0,1/5,8.94%,MSN
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),-0.3845121437240733,-0.7267474020615377,0.8656716417910447,1.0,1.0,4/18,24.05%,RAB11A;WFS1;PRKACA;ADCY7
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),-0.3451329684982205,-0.7267320666546455,0.8470588235294118,1.0,1.0,2/28,7.07%,RRAGA;XBP1
prerank,PanglaoDB_Augmented_2021__Neurons,-0.2968932650632621,-0.7264904847876849,0.9278350515463918,1.0,1.0,28/237,14.50%,NEFM;BEX2;GDAP1L1;HAP1;BEX1;NDN;IFIT3;MEG3;ZIC1;TCEAL3;RNPC3;HPCA;CACNA1B;CELF4;SH3GL2;DIPK1B;SNCB;CCK;KCNC1;TCEAL2;SRRM4;CACNA2D2;TMEM179;ARHGDIG;NRN1;STMN2;ZDHHC22;KIF1A
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),-0.36883317794143555,-0.7264889625630258,0.8795180722891566,1.0,1.0,3/29,12.55%,MX1;SNCB;DNM2
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),-0.4704400285450628,-0.7262411632057312,0.8620689655172413,1.0,1.0,1/6,7.89%,ABCC3
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.45791344948379614,0.7260920308730837,0.8,0.9899396295313163,1.0,3/7,15.81%,MAGI2;RAPGEF2;RAP1A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.3074275946715314,0.7257398816755316,0.8076923076923077,0.9898003030468361,1.0,8/34,10.43%,RACGAP1;SEPTIN6;SPTBN1;EFHC1;SNX33;BBS4;SNX18;ANLN
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.3070766875394064,0.7256020302281229,0.7368421052631579,0.9893662654253199,1.0,6/32,14.65%,YTHDF1;FTO;MOV10;TRIM71;RIDA;CELF1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.44007429023576455,-0.7253678664984212,0.8285714285714286,1.0,1.0,3/6,35.15%,MT3;PRKCB;PRKD2
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),-0.31394248566184946,-0.7250685030734636,0.8809523809523809,1.0,1.0,21/62,28.00%,RETREG1;MEF2C;GRN;BDNF;ATF4;APOE;BAX;NRBP2;RASA1;WFS1;SET;PARK7;BACE1;PRKCI;TGFB3;PTPRZ1;SOD2;PPT1;KCNB1;MT3;LGMN
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3299358689192039,-0.7249752825136015,0.8902439024390244,1.0,1.0,4/50,10.92%,SFRP1;TGFB1;CST3;FUZ
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),-0.3144148355508555,-0.724886823247355,0.946236559139785,1.0,1.0,25/102,26.97%,PSMB9;BTN3A1;PSMB8;EIF2B2;HLA-A;PIK3CB;PSMA3;BTNL2;BTN3A3;PSMA7;PSME1;PRKCQ;RFTN1;THY1;PSMB6;FYB1;PSMB1;PSMC4;PSMD2;PSMB3;DENND1B;PSMD7;EIF2B4;EIF2B5;PSMC3
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),-0.4504782253534598,-0.7247995903497733,0.7910447761194029,1.0,1.0,2/7,12.17%,MAFF;KRT10
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.30421535523866533,0.7247271003033763,0.9166666666666666,0.990128872672482,1.0,7/32,12.59%,INPP4B;SYNJ1;PLCB1;PLCB4;INPP1;IP6K1;OCRL
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.47109295227987336,-0.7246797943084503,0.8032786885245902,1.0,1.0,1/6,6.56%,ALOX12
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3568482329820412,-0.7245770524752557,0.8734177215189873,1.0,1.0,6/33,14.40%,SELENOK;GLUL;ZDHHC1;ZDHHC8;ZDHHC15;ZDHHC22
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.3949406125569752,-0.7241782446316033,0.8333333333333334,1.0,1.0,4/17,18.21%,SELENOK;CCDC47;BAX;WFS1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),-0.3023655328082388,-0.7237388742652627,0.9325842696629213,1.0,1.0,12/92,17.76%,H2AZ1;SFRP1;CFTR;TGFB1;MEF2C;MED1;P2RX4;NR4A3;KAT5;BRCA1;P2RY12;CASP3
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.2676131613412224,0.7228639441308341,1.0,0.9920687242991663,1.0,4/45,4.39%,FBXO17;ENGASE;LARGE1;MAN2A1
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),-0.4746104105052552,-0.7223723842872453,0.8275862068965517,1.0,1.0,2/5,18.71%,POLE3;EZH1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.25586557768827267,0.7223006681130879,1.0,0.992300770322651,1.0,15/99,13.56%,BAIAP3;WDR81;VTI1A;RAB9A;SNF8;EPS15;PIKFYVE;AP1G1;GGA1;ERC1;ARFRP1;LMTK2;VPS50;WASHC1;MON2
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.4224909225733978,0.7220754693673962,0.8,0.9921085666769299,1.0,1/6,5.76%,PLIN5
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.4507730219442313,-0.7219700941563794,0.8918918918918919,1.0,1.0,1/9,3.99%,JUN
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3340852083990196,-0.7214975896084889,0.891566265060241,1.0,1.0,10/57,14.85%,SFRP1;TGFB1;ZFPM1;RTKN2;ARIH2;JAG1;ZFP36L2;ATF4;RUNX2;FSTL3
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.2746678909059852,0.7212571911764719,0.875,0.9925046281222796,1.0,6/27,18.01%,CTBP1;MAPK3;UBE2N;NOS1;NIPBL;TADA2A
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3129231998728395,-0.7209430270745296,0.927710843373494,1.0,1.0,19/96,22.86%,ENPP4;PROCR;EPHX2;FN1;COL4A1;LMOD1;COL6A1;AFAP1L1;GXYLT2;SRPX;NR1D1;CAV1;COL4A2;SCARA3;COL14A1;CALD1;CYP1B1;PCOLCE2;C1S
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.32605371250474635,0.7208907009407091,0.875,0.9923298140158463,1.0,3/14,8.14%,SIRT1;FOXK1;RORA
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.3367834687985275,0.720828282044096,0.8333333333333334,0.9917924169030226,1.0,3/15,6.71%,RPS6KB1;YTHDF1;CDC123
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.37761367636955645,-0.7207678927456985,0.8636363636363636,1.0,1.0,1/21,1.65%,HAP1
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),-0.3020105712151544,-0.7206278087612715,0.9560439560439561,1.0,1.0,34/174,20.09%,SYCE2;HES5;ELOB;RIMS1;STAG3;HES1;DVL1;TGFB1;TUBGCP2;TUBGCP4;ZW10;NDUFAF1;HAS2;CHCHD10;PLS1;FANCC;LRGUK;REC8;SPG7;VIL1;PLS3;BAIAP2L2;NIFK;TSPAN4;PEX14;DNM1L;GSN;AFG3L2;BAG6;TAPBP;TEX11;KNTC1;CALD1;CCDC40
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),0.3123264944998331,0.7203410897470702,0.8260869565217391,0.9917736039740851,1.0,4/16,10.59%,ACADVL;FMO5;RORA;DGKQ
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.4432532124530514,-0.7202996617851591,0.8387096774193549,1.0,1.0,2/8,17.37%,SHMT1;MTHFD1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.27866595724299653,0.7202652424625681,1.0,0.9912889125257217,1.0,22/66,20.63%,RANGAP1;EVI5L;TBC1D14;SGSM1;TBC1D12;ARHGAP42;TBC1D1;RABGAP1;TBCK;TIAM2;ARHGAP22;SIPA1L1;CORO1C;TBC1D8B;RABGAP1L;RALGAPA2;TBC1D7;RALGAPA1;TBC1D5;RALGAPB;TBC1D9;CCDC125
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),-0.4596782475698057,-0.7200147944943113,0.8181818181818182,1.0,1.0,1/5,22.20%,RHOJ
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.4724259411492173,-0.7196203581839017,0.8867924528301887,1.0,1.0,2/6,16.51%,CALM1;CAV1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.39179749712412393,-0.7193151440361184,0.8181818181818182,1.0,1.0,1/15,1.85%,RANGRF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.3649371433474689,-0.7189291181713455,0.8243243243243243,1.0,1.0,8/26,26.77%,XBP1;MAPK13;HSPD1;IFIH1;C1QTNF4;SPHK2;SCIMP;APP
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),-0.4226352337554811,-0.7186325309782321,0.8,1.0,1.0,2/13,8.92%,ENPP2;GDE1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.3441942537705045,0.7180773675660191,0.8064516129032258,0.9935640802512554,1.0,2/14,4.28%,FBXO17;EDEM1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.4215367590555108,0.7176568350084519,0.8536585365853658,0.9935701345695224,1.0,2/5,23.13%,IKBKB;PPP1R12A
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),0.41357016235199395,0.7174228847039934,0.8461538461538461,0.9932402786087738,1.0,2/7,8.29%,AIFM2;BMP7
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),-0.3551076476565449,-0.7168123430066676,0.9090909090909091,1.0,1.0,5/32,15.94%,GABARAPL2;MAP1LC3B2;CISD2;FUNDC2;ULK1
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.36446509877693345,-0.7167405305801761,0.8387096774193549,1.0,1.0,2/18,11.84%,GSTM3;BDNF
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.44439738099740034,-0.7166197499439355,0.8,1.0,1.0,1/7,11.60%,CNMD
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.34382683097296257,0.7163995015624922,0.8484848484848485,0.994055660060742,1.0,7/18,27.10%,AUTS2;PIK3CA;NCKAP1;PIK3R1;ARPC2;ACTR3;WASF2
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.4871696331277676,0.7163590697027656,0.875,0.9935194316814112,1.0,4/5,36.98%,ELAVL4;TENT4B;METTL16;TENT4A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.3609636924365329,0.7163539495337977,0.78125,0.9929580243515977,1.0,1/13,2.25%,LEPR
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2857405628235264,0.7162442633371272,0.9523809523809523,0.992500378652782,1.0,4/26,13.71%,PATL1;DCP1B;EXOSC1;EXOSC7
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.2771591722133802,0.7162348775955372,0.9545454545454546,0.9919573752079667,1.0,10/49,17.64%,ATF7IP;MED24;MECP2;CBFB;TRIM28;MOV10;PPM1D;SUB1;TCF7L2;MED13
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.31147893201298726,0.7161769680306093,0.8928571428571429,0.9914149937602244,1.0,6/30,9.11%,FNBP1L;MYO7A;TANC2;TRAK1;WASL;FBXW11
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.40723684677748895,-0.7158611940820263,0.859375,1.0,1.0,1/10,4.27%,TGFB1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.38775519896532734,0.7157841797297598,0.8529411764705882,0.9913450449586256,1.0,1/6,4.73%,GLS
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3177949691917409,-0.7156793298611331,0.9418604651162791,1.0,1.0,14/73,19.55%,VEGFA;IL20RA;RHBDF1;RTKN2;TEAD3;OSMR;EMP2;AKAP5;THSD4;FSTL3;SCARA3;TMEM54;SLC44A3;CLDN18
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.2973167699137103,-0.7152924234856054,0.9473684210526315,1.0,1.0,18/156,13.26%,SFRP1;WIF1;LRPAP1;AGT;TRIB1;HHIP;TMEM25;SFRP4;GPC3;PIK3CB;TMBIM1;DDIT4;CNMD;APOD;BDNF;ULK3;CACTIN;RACK1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.3364175295466233,0.7152831629712888,0.8148148148148148,0.9915752482458068,1.0,3/14,12.25%,ILRUN;MFHAS1;LATS1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.44971047738251285,-0.7146764058091245,0.875,1.0,1.0,2/7,25.26%,IFNAR1;AXL
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.4612349716507748,-0.7144045710004581,0.8688524590163934,1.0,1.0,1/6,17.07%,BRCA1
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.295869450180938,0.7143183643931992,0.9411764705882353,0.9921736374641157,1.0,7/37,11.73%,ARID1A;MBD2;SMARCA2;ARID1B;SMARCAD1;HNRNPC;VPS72
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.3060719929314049,-0.7142579816513005,0.9186046511627907,1.0,1.0,19/117,16.51%,TAF7;SFRP1;DVL1;TGFB1;TRIB1;CEACAM1;SH3GL2;ATG14;DDIT4;CALM1;WARS1;CACTIN;RACK1;ZBED3;DNAJC10;TRIB3;RTRAF;TERF2IP;CAV1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.3715019409809287,-0.713886281175768,0.8873239436619719,1.0,1.0,5/25,20.87%,DND1;DKC1;PHAX;CIRBP;DHX36
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.48513727291365644,-0.7137938330113868,0.8225806451612904,1.0,1.0,2/5,19.53%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.48513727291365644,-0.7137938330113868,0.8225806451612904,1.0,1.0,2/5,19.53%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.48513727291365644,-0.7137938330113868,0.8225806451612904,1.0,1.0,2/5,19.53%,MGST1;CYP3A5
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.2774137029557512,0.7137099904153211,1.0,0.9923003399119367,1.0,14/65,14.16%,TCF7L1;RYK;BTRC;GPC4;ZRANB1;RAC3;FZD3;WNT7A;STRN;LRRK2;CSNK1E;CSNK1G3;KLHL12;FRZB
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),-0.3948132884239333,-0.7136036053205608,0.7910447761194029,1.0,1.0,3/14,17.72%,AP2A1;AP4M1;KLHL20
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.2891789750561514,-0.7133423740716359,0.9895833333333334,1.0,1.0,41/270,22.69%,SEL1L2;PSMB9;RPS27A;TRIM25;PSMB8;SELENOS;DERL2;KCTD2;ZFAND2B;PSMA3;BUB3;FBXL13;UBA52;TMUB1;DNAJC10;SYVN1;SKP2;PSMA7;KAT5;USP19;CDC26;RFFL;PSME1;FAM8A1;KLHL20;USP44;WFS1;UBC;RNF175;BAG6;FZR1;UBXN1;RMND5B;FBXO6;TMEM129;ERLIN2;TRIM13;SPSB3;ARMC8;PSMB6;RBX1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.3390166427279475,-0.7131652091796001,0.8941176470588236,1.0,1.0,7/63,14.67%,SFRP1;MYRIP;ALOX5;CACNA1C;CACNA2D2;CACNA1E;NR1D1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.3583119334936474,0.7124686409141259,0.8275862068965517,0.9930859251084662,1.0,4/14,12.26%,ESR1;KAT2B;PTBP1;PTBP2
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.44469043316706525,-0.7123843470851423,0.8450704225352113,1.0,1.0,2/7,26.64%,GSN;COL4A3
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),-0.3272168155930157,-0.7123805936655617,0.9176470588235294,1.0,1.0,4/47,11.54%,PFN2;ANKRD53;LMOD1;DCTN1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4240837935636161,0.7123351723409237,0.8064516129032258,0.9926474039395973,1.0,3/8,13.78%,DOCK5;DOCK4;NRP1
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),-0.42719432678154845,-0.7123249906856668,0.8382352941176471,1.0,1.0,3/10,22.49%,VIL1;GSN;DSTN
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.3321504157677251,0.7123172698916574,0.9,0.9920982456439292,1.0,2/24,2.31%,HSPA1A;NAV3
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.3024691529212848,0.7118639699471092,0.8695652173913043,0.992199069650803,1.0,7/27,13.55%,ABL1;POT1;ABL2;MAPK14;MAPK3;PHACTR4;MAPK8
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3031191238384976,0.7115757842734355,1.0,0.991924049951724,1.0,12/36,22.95%,BIN1;NUP98;NUP93;DMPK;SUN2;CHMP1A;ATXN7;LEMD3;SEH1L;NUP35;IRAG2;NUP54
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.45559745189007395,-0.7114454268808295,0.8153846153846154,1.0,1.0,1/5,12.71%,CACTIN
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.35781882945978727,-0.7112839452094332,0.8918918918918919,1.0,1.0,4/20,11.57%,HAP1;GSTO1;ANTKMT;CALM1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.28773552127648305,-0.711132802604786,0.9791666666666666,1.0,1.0,45/259,22.82%,HAP1;RANGRF;CDC37;ARL1;COX18;STX10;RPL11;TGFB1;ARL4C;ARFIP2;NAPA;STX19;HDAC6;USP6;SCG5;AP2A1;NUP155;ARFGAP3;STRADB;TMED1;SEC13;GIPC1;AP4M1;STX1B;RTN2;RANBP6;NUP107;PTTG1IP;SNX17;RAB19;RANBP17;VIPAS39;ARL17A;VPS35;NUP85;VPS36;WLS;ERP29;NUP188;TBC1D17;SRPRA;TBC1D16;EIF2D;ARL5B;TMED9
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4326833415085848,-0.7107729613616984,0.8656716417910447,1.0,1.0,1/9,4.26%,GORASP1
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.2944316332858838,0.7107353537016924,0.9,0.9924515797322383,1.0,9/22,18.60%,FAM107A;WASF3;WASL;WASHC5;COBL;SPIRE1;DIAPH1;ARHGAP6;TTC17
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.30962702773501016,-0.7107050402790467,0.946236559139785,1.0,1.0,15/117,18.46%,TUBB4B;PSMB9;RAB11A;TUBA4A;PSMB8;CEP72;PSMA3;DCTN1;ODF2;TUBB4A;PSMA7;DCTN3;PSME1;DBF4B;CDK4
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.31771224258133524,-0.7106728949962247,0.95,1.0,1.0,6/65,10.39%,MBNL3;FAM50A;AKAP17A;RPS13;SRSF10;SRRM4
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.4627012709313998,-0.7099801907179543,0.8709677419354839,1.0,1.0,1/6,7.28%,CEACAM1
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.37971432640862934,0.7098294980875509,0.9090909090909091,0.9929188020282462,1.0,3/9,13.02%,VLDLR;BMP7;COBL
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3679446808669993,-0.7098286981885421,0.8765432098765432,1.0,1.0,1/18,2.32%,SPDYA
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.4295799404639411,0.7096863290140374,0.7674418604651163,0.9924903973018744,1.0,1/5,3.66%,CTBS
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.40374480562121356,0.7090199735838777,0.8285714285714286,0.992795188715177,1.0,3/8,24.41%,PNP;AMPD2;HPRT1
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.3284287848796128,0.7089984079012697,0.8846153846153846,0.9922907057617688,1.0,3/19,13.63%,SUV39H2;ATPSCKMT;SETD2
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.38803982790180874,-0.7089676212704515,0.9142857142857143,1.0,1.0,3/15,11.60%,GSTM3;COL15A1;CNMD
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.400904628883348,0.7089567401207283,0.8085106382978723,0.9917442447770282,1.0,1/6,5.68%,RAC3
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.3096133996081152,0.7088936833164605,0.8928571428571429,0.9912919630975955,1.0,2/24,3.20%,ZFAND6;GDAP1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.44435835816061997,0.7086902393425277,0.7631578947368421,0.9909251999215807,1.0,2/5,16.49%,DLL1;PRKCA
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.4160494968838877,0.7082235631656901,0.9,0.9910855874184606,1.0,1/7,1.01%,MOXD1
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.36719056684912676,0.7080871709272434,0.8064516129032258,0.990659920396165,1.0,5/9,29.16%,IP6K1;IP6K2;ITPKB;PPIP5K2;IPMK
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),-0.36292991577440603,-0.7080490500679489,0.9210526315789473,1.0,1.0,2/22,6.56%,ALOX5;ALOX12
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.3601912904732129,-0.7078747527061026,0.84375,1.0,1.0,3/17,11.84%,HAP1;DDIT4;BDNF
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.34420920765919083,0.7078733743880238,0.8620689655172413,0.9904044574794063,1.0,4/15,10.89%,GPNMB;ABL1;FGL1;KAT2A
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.4187764835512885,0.7075968784618328,0.8571428571428571,0.9901832089084882,1.0,4/6,25.18%,FOXO1;KCNC2;GUCY1B1;MTR
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.38180377910294916,-0.7074334027778697,0.8253968253968254,1.0,1.0,4/14,13.53%,SLC6A6;PRAF2;SLC1A6;GIPC1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.31888260090063175,0.7072016786808223,0.9230769230769231,0.9900893581511404,1.0,5/28,7.39%,GSTM2;ANK2;PDE4D;DMD;JPH1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.30428672047868205,0.7069924390955722,1.0,0.9897245187648388,1.0,7/31,12.59%,INPP4B;SYNJ1;PLCB1;PLCB4;INPP1;IP6K1;OCRL
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),-0.36634929779932235,-0.7067921049093513,0.8823529411764706,1.0,1.0,2/17,5.10%,HAP1;AGT
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.42377899967030636,-0.7061758937622816,0.9,1.0,1.0,4/10,23.10%,SPG7;PMPCA;AFG3L2;YME1L1
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.390067252974651,0.7057322197081421,0.9166666666666666,0.9907317333452458,1.0,10/10,61.02%,ALMS1;ASAP3;AKAP13;ACTG1;ROCK1;ROCK2;RAC1;CDC42;SLC9A1;TSC1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.3419384322262425,-0.7056464528150769,0.8974358974358975,1.0,1.0,4/31,14.39%,VEGFA;TOM1L1;CALM1;PPP2R5A
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.28718007108971594,0.7050832976492067,0.95,0.9911623847270673,1.0,10/43,11.98%,SLC2A6;SLCO1A2;CA13;SLC16A2;SLC4A7;CA3;ABCC11;SLC4A10;ABCC5;SLC39A8
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.43232716275084115,-0.7050342236726729,0.8148148148148148,1.0,1.0,1/6,5.45%,PEX1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.43232716275084115,-0.7050342236726729,0.8148148148148148,1.0,1.0,1/6,5.45%,PEX1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.36456233948549127,-0.7044425252348243,0.8857142857142857,1.0,1.0,4/28,14.04%,HAP1;CRYAB;ANTKMT;DNAJC30
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.39752321137844404,-0.7044191797299333,0.8382352941176471,1.0,1.0,2/11,15.96%,H1-4;AIFM1
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.46596985678261077,-0.7043714953362377,0.90625,1.0,1.0,1/5,7.50%,JAG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.46596985678261077,-0.7043714953362377,0.90625,1.0,1.0,1/5,7.50%,JAG1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.3799100441957821,-0.7042706226576064,0.8082191780821918,1.0,1.0,6/13,36.14%,CNMD;CADM4;MT3;PRKCB;PRKD2;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.28462461946036266,0.7041725913808407,0.8947368421052632,0.9917194105640169,1.0,15/66,17.10%,GPSM1;SIRT1;TP53INP1;FOXO1;LRRK2;MAP3K7;DHRSX;SESN1;HMGB1;PRKD1;FOXO3;NPRL2;MID2;PINK1;TPCN1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.32110521605356507,-0.704161763211162,0.9176470588235294,1.0,1.0,12/66,16.42%,TGFB1;SH3GL2;ATG14;DBI;PTPA;PNKP;WARS1;CACTIN;ZBED3;BEX4;DNAJC10;TERF2IP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3417206373456434,-0.7040074608866902,0.922077922077922,1.0,1.0,2/28,6.75%,POLR2G;LSM5
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.40173873949781735,-0.7037798051710058,0.7966101694915254,1.0,1.0,2/9,13.70%,GRN;CD55
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.39997047594778146,0.7036846613750402,0.8048780487804879,0.9916503158244813,1.0,1/5,12.40%,ST3GAL4
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.26275432517114605,0.7035665068483766,1.0,0.9912011464951644,1.0,21/101,15.94%,SYNDIG1;TLN2;BCAR1;ANK2;MPDZ;CHST3;GUCY1A2;MAGI1;CACNA2D1;EDIL3;PRICKLE2;GPC1;FBXL7;NFASC;TENM3;FRZB;FIGN;EPB41L1;NOS1;TEAD1;AMOTL2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.35664513212957594,0.7034426259993365,0.8928571428571429,0.9907355971247354,1.0,5/14,17.84%,ANK2;CACNA2D1;NOS1;FYN;DIAPH1
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.43167157800294226,-0.7032026220949469,0.8611111111111112,1.0,1.0,2/7,11.37%,IL20RA;EMP2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),-0.4223187175730436,-0.7020906599112259,0.8636363636363636,1.0,1.0,2/9,21.58%,CDK16;PARK7
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.4054096472569955,0.7016145041790698,0.8260869565217391,0.9924307818690644,1.0,2/10,8.86%,RXRA;PML
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),-0.4593321859720154,-0.7014253996488956,0.8305084745762712,1.0,1.0,1/5,8.80%,MED1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),-0.31082715995479926,-0.7012858610078863,0.891566265060241,1.0,1.0,9/49,19.16%,RPS27A;CTSL;OAS1;UBA52;S100A1;SCARA3;UBC;HSPD1;RFTN1
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.4437165654813374,-0.7012848360675898,0.8615384615384616,1.0,1.0,3/7,19.44%,RNF8;HSPD1;MSH6
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),-0.3211039078722335,-0.7009747785639348,0.8732394366197183,1.0,1.0,2/37,3.74%,FLOT1;STK17A
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.3912771192298369,0.7009724428739773,0.8222222222222222,0.9928337223199547,1.0,2/7,18.41%,PINK1;PID1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.4129396681074792,-0.7008331022667198,0.8382352941176471,1.0,1.0,3/9,20.26%,RPL11;RPL5;COPS9
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),-0.29720426028506186,-0.7008067708356536,0.967032967032967,1.0,1.0,8/118,5.95%,ARHGAP15;VAV3;SFRP1;ECT2;AGRN;S100A10;RAP1GAP;RASGRP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.37299195716703454,0.7007901597388059,0.7741935483870968,0.9918860335463142,1.0,1/9,2.06%,IRS1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.37299195716703454,0.7007901597388059,0.7741935483870968,0.9918860335463142,1.0,1/9,2.06%,IRS1
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.4185820473681754,-0.7004177744147404,0.8461538461538461,1.0,1.0,5/10,26.21%,HDAC6;SAT2;OAZ2;SAT1;AMD1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.31399533078076247,-0.7001185693978323,0.9204545454545454,1.0,1.0,14/50,27.58%,H1-4;POLE3;SMARCD1;RNF8;SMARCA5;H2AX;MCM3AP;SET;CTCF;ANP32E;SUPT16H;SOX9;ANP32B;ASF1A
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),-0.40948841736350605,-0.7000901756953968,0.9047619047619048,1.0,1.0,2/8,12.04%,AGRN;MTCH1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3455688785069379,-0.6998804664908549,0.9305555555555556,1.0,1.0,2/29,3.97%,SFRP1;CFTR
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),-0.4560312945908893,-0.6998336106808946,0.9322033898305084,1.0,1.0,1/6,11.84%,BDNF
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.409561801996698,0.6997618941702466,0.875,0.9924906654952779,1.0,1/6,1.57%,ERC2
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.3376264867193316,-0.6997366161725392,0.8641975308641975,1.0,1.0,11/45,19.79%,ALOX5;SELENOS;FNDC4;LPCAT3;CACTIN;NR1D1;APOE;METRNL;TNFAIP6;TNFRSF1A;VPS35
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.2563789020409912,0.6996997176338404,1.0,0.9920427897289227,1.0,11/72,14.09%,ATR;ZBTB1;PTPRK;CAT;EGFR;MAP3K4;ERCC4;REV1;NEDD4;MAPK8;N4BP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),-0.3760105791305035,-0.699171003335636,0.8472222222222222,1.0,1.0,6/16,32.65%,SPHK2;YEATS4;MSL3;BRD8;TRRAP;NAA40
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.35007345504710324,-0.6989367052046243,0.9012345679012346,1.0,1.0,3/22,13.94%,PFN2;STMN2;TUBB4A
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.36832746769032726,-0.6988864388834548,0.8888888888888888,1.0,1.0,9/27,23.85%,SP140;STAG3;MYO1F;P2RY14;BCL7A;DOCK8;ITGAL;PSTPIP1;RCSD1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.41477447280581287,0.6987093456151566,0.8378378378378378,0.9914750191811639,1.0,3/5,25.62%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.41477447280581287,0.6987093456151566,0.8378378378378378,0.9914750191811639,1.0,3/5,25.62%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.41477447280581287,0.6987093456151566,0.8378378378378378,0.9914750191811639,1.0,3/5,25.62%,NSMCE2;SMC5;MACROH2A1
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.31707751143517837,0.6986954548827508,0.8888888888888888,0.9909363625382799,1.0,3/14,14.47%,ROBO1;GPR174;LPAR1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.23753223985563082,0.6985416088646821,1.0,0.9905996948387811,1.0,50/235,18.44%,NINL;DCX;EHD1;FNBP1L;STK36;TUBG1;SEPTIN6;RABL2B;IFT140;HAUS2;RFX3;DYNC2LI1;CDC14A;CNTRL;PCM1;TRAF3IP1;BBS4;CEP41;TTLL3;NEDD1;UNC119B;CSNK1E;IFT172;KIF3C;SSX2IP;OCRL;TCTN2;CLASP1;EXOC2;HAUS6;CDC14B;PCNT;TMEM138;SFI1;ARL3;EXOC6;CEP89;GORAB;GBF1;SPAG16;CEP290;RAB3IP;EXOC4;TTC39C;GALNT11;MACIR;ATAT1;CEP20;ABCC4;C2CD3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.3553833898539497,-0.6981738329371932,0.927710843373494,1.0,1.0,2/35,1.61%,ITGA4;LFNG
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),-0.37260048402023677,-0.6980317603728978,0.8552631578947368,1.0,1.0,3/20,10.69%,HES5;MMP24;METRN
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.34753198241841643,-0.6977871338269247,0.8860759493670886,1.0,1.0,2/25,6.04%,TGFB1;KIF20B
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.41642522143715555,0.697570239202843,0.8947368421052632,0.9911439735277268,1.0,5/9,28.48%,SESN1;ITFG2;STK11;SZT2;RNF152
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.39178359418446085,-0.6975110516277373,0.8125,1.0,1.0,1/9,4.39%,PDK1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.3075802857603437,-0.6974387977458507,0.9418604651162791,1.0,1.0,12/57,21.14%,POLR1C;SNRPB;CDK7;NCBP1;CSTF2;TAF1D;CSTF1;POLR1G;CPSF1;SLBP;SNRPG;UBTF
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.3938691733284653,-0.6969806312683664,0.8533333333333334,1.0,1.0,2/14,16.14%,TRMT10C;PCIF1
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.358235888745887,0.69666557201321,0.84375,0.9916038265368378,1.0,3/12,11.52%,CD247;PTPRC;GPR174
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.3354906849503327,-0.6965795857935104,0.8933333333333333,1.0,1.0,8/32,23.51%,GAPDH;PGK1;ATF4;G6PC3;GOT1;PGAM1;G6PC2;SLC39A14
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.36491762164004393,-0.6961687071416509,0.8571428571428571,1.0,1.0,3/21,20.08%,PRMT8;NTMT1;FBL
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.39885910620369636,-0.6961076507209865,0.8059701492537313,1.0,1.0,3/13,18.15%,MEF2C;GRIN2D;MPP2
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.3474452781212754,-0.6959060855518747,0.972972972972973,1.0,1.0,10/28,27.42%,IL3RA;BLNK;MYO1F;DOCK8;GPR183;ITM2C;ITGAL;PSTPIP1;SPI1;AOAH
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.3707357472923176,-0.6957708648280535,0.9166666666666666,1.0,1.0,2/18,9.11%,VEGFA;ZNF568
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.3923372857218472,-0.6957328042701592,0.8615384615384616,1.0,1.0,4/10,20.26%,CALM1;PTPA;HSP90AB1;PDGFRB
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.3399701409831014,0.6956888288934111,0.9354838709677419,0.9921553124738219,1.0,2/13,12.93%,ATP2B4;RTF2
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.2727710230643788,0.6955333656002259,1.0,0.9917433652315926,1.0,16/99,13.29%,ALG1;GALNT7;PLOD1;LARGE1;COG3;GCNT2;TRAK1;SERP2;POFUT1;POMK;FUT9;MGAT4C;TUSC3;SLC39A8;ST3GAL4;COG7
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.3784228381632265,0.695514624280282,0.7307692307692307,0.9912063633032855,1.0,2/8,15.52%,SMAD7;JAM3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.3810652702191998,-0.695187462161965,0.8873239436619719,1.0,1.0,6/19,21.53%,MEF2C;CCDC39;AHI1;CCDC40;NDRG4;STIL
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.32968073127234315,-0.6951801353602809,0.958904109589041,1.0,1.0,7/45,17.95%,NOP10;PUS3;ELP5;QTRT1;ADAR;NSUN5;QTRT2
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.32373646662132954,-0.6950858445562196,0.8625,1.0,1.0,5/41,14.22%,SFRP1;TGFB1;DDX5;RUNX2;ADAMTS7
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),-0.31420578588920123,-0.6950608188351934,0.9222222222222223,1.0,1.0,11/70,18.59%,PPIF;ECT2;TTN;MEF2C;HPCA;CALM1;SYT11;KCNMB4;CAV1;SYT4;CLIC4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.3491784765125432,-0.6949309117993309,0.9156626506024096,1.0,1.0,4/28,7.50%,TGFB1;SPINT2;CEACAM1;JAG1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.3526978157840085,-0.6934509060552936,0.8205128205128205,1.0,1.0,9/28,25.51%,TGFB1;APH1A;ERAP1;PRKCQ;AFG3L2;ADAM9;MBTPS2;BACE1;MBTPS1
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),-0.2936971968116767,-0.6933882898089565,0.9555555555555556,1.0,1.0,15/117,16.70%,SFRP1;GABARAPL2;RRAGA;XBP1;RRP8;ATG14;ATP6V1F;ATF4;SEC13;MAP1LC3B2;ATP6V0E2;ZFYVE1;SREBF1;EIF2AK2;LARS1
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.3111826371596663,-0.692966716507365,0.9425287356321839,1.0,1.0,1/65,0.18%,S100A6
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4315404030223289,-0.6929605794209366,0.890625,1.0,1.0,1/8,2.33%,TAF7
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.32001471861669334,0.6929391057086193,0.8387096774193549,0.9935719139264536,1.0,8/25,19.02%,ANKRD13D;PLIN5;AATF;ANKRD13A;ABCA2;PINK1;PRKN;ITGAV
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3848161133389462,-0.6927482598745653,0.8923076923076924,1.0,1.0,7/13,22.67%,RPL11;RPL23;RPS7;USP44;RPL5;PARK7;DTX3L
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.45633317716853994,-0.6924004962681224,0.8983050847457628,1.0,1.0,2/5,13.15%,MED1;ATF4
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.31207034381845233,0.6922366353944586,0.9259259259259259,0.9938536058772295,1.0,4/17,13.39%,SHROOM2;PIKFYVE;AP1G1;KIF13A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.32786967798820277,0.6917118511140109,0.8571428571428571,0.9933056311295766,1.0,1/18,1.68%,RPA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.32786967798820277,0.6917118511140109,0.8571428571428571,0.9933056311295766,1.0,1/18,1.68%,RPA1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.3900273071578386,-0.6916638415301922,0.8831168831168831,1.0,1.0,3/14,22.27%,PARP9;IFIH1;RUNX1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.2836446295939314,0.6913727835334578,0.9090909090909091,0.9931948162783263,1.0,6/54,7.98%,TCF7L1;PPARG;LAMC1;SH3D19;CHST3;EGFR
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.36508806753188794,0.6912012433273111,0.8888888888888888,0.9928089143863147,1.0,3/11,12.07%,PPARG;TAFA5;PRKG1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),-0.3665884078640258,-0.6909983639030893,0.8904109589041096,1.0,1.0,1/18,2.25%,ARL1
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.3642653518622516,0.6909856032470449,0.7931034482758621,0.9924401118910868,1.0,2/7,11.24%,NRXN1;AGTPBP1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.3429877470097417,-0.6909635382751722,0.9142857142857143,1.0,1.0,6/26,21.99%,AGT;EFNA1;SH3BP5L;CAV1;THY1;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.4201281020837976,-0.6909297841559244,0.8873239436619719,1.0,1.0,1/7,5.29%,SLIRP
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.29463076786179665,0.690742857671276,0.9642857142857143,0.9922549890139566,1.0,11/24,26.83%,PCM1;BBS4;CEP89;GORAB;CEP290;C2CD3;TOGARAM1;BBS10;PIBF1;DISC1;TMEM216
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.4145201151694905,-0.6906732596705588,0.9090909090909091,1.0,1.0,1/10,2.33%,TAF7
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),-0.34388711257840454,-0.6903114950869872,0.8641975308641975,1.0,1.0,5/23,22.15%,NOL3;ATF4;TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.40646721592244905,-0.6901487602313078,0.8125,1.0,1.0,1/7,12.45%,NEK6
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.4029624341487087,0.6900722979870542,0.7567567567567568,0.992411429989181,1.0,1/6,19.20%,MCM4
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,-0.30586056715786786,-0.6898744950960728,0.9545454545454546,1.0,1.0,11/77,17.88%,SEZ6L2;OBSL1;RHBDF1;GAPDH;TEAD3;COL4A1;SRPX;PLS3;COL4A2;SCARA3;FSHR
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),-0.28430577625862913,-0.6889804623779315,0.9789473684210527,1.0,1.0,39/207,20.37%,PARP2;RPS27A;APEX1;ADPRS;POLQ;POLE3;RFC2;BACH1;SMC1A;FAN1;RPA3;FANCC;PNKP;SUPV3L1;NABP2;UBA52;RFC4;PARP4;RFC1;KAT5;TERF2IP;PARG;BRCA1;GMNN;MMS19;TSN;UBC;RFC3;XPA;ATRIP;GLRX2;MSH6;DDB2;TOP3B;LIG1;POLD2;MBD4;DBF4;RECQL
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.4037642527576229,0.688880874014528,0.6944444444444444,0.9933748522704948,1.0,2/6,11.26%,HOMER1;STIM1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.3169944514815711,-0.6881886946222207,0.975609756097561,1.0,1.0,2/39,5.14%,HSD17B14;CYP3A43
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.2763288533366864,0.6881687161457092,0.9130434782608695,0.9935637644322115,1.0,9/28,29.16%,IP6K1;AGPAT5;LPCAT1;IP6K2;GPHN;ITPKB;PPIP5K2;GNPAT;IPMK
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.3045412856596519,-0.6880201445744043,0.9647058823529412,1.0,1.0,7/74,9.56%,FGF1;RARRES2;CRYAB;HAS2;FN1;OSMR;COL4A1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.30666645256760766,-0.687919208181394,0.963855421686747,1.0,1.0,13/69,21.51%,CLU;NUP155;SEC13;APOE;RANBP6;NUP107;ATAD1;PEX11B;PEX14;PTTG1IP;RANBP17;NUP85;NUP188
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.3749494731667374,-0.6879028438560337,0.8923076923076924,1.0,1.0,1/12,6.04%,KIF20B
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.36854031122836894,-0.6878827607880125,0.8933333333333333,1.0,1.0,4/15,20.77%,GGH;SHMT1;MTHFD1;MTRR
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.35863190309756154,0.6878597627853766,0.84375,0.9933867409975573,1.0,7/10,18.76%,MAPK14;MAPK3;STIM1;MAPK8;NOS1;ORAI1;NF1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.2880685068476653,-0.687600885739021,0.9888888888888889,1.0,1.0,14/137,13.50%,PLCH1;TGFB1;HTR2B;PLCD4;DUSP12;PGK1;GPX4;EPHX2;PIK3CB;GDE1;CALM1;PNKP;PFKP;G6PC3
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.4509376725206322,-0.6874856985372154,0.8253968253968254,1.0,1.0,2/5,18.02%,RPL23;MCM3AP
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.3782894453023652,-0.6873608874704762,0.9090909090909091,1.0,1.0,1/10,6.48%,DDX5
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),-0.3884044432953358,-0.6872744396847078,0.8823529411764706,1.0,1.0,4/13,11.37%,FLOT1;S100A10;NAXE;EMP2
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),0.3365274546343299,0.6869832799865031,0.9230769230769231,0.9938495796165359,1.0,1/14,1.17%,RAB27A
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),-0.28923578957108503,-0.6865281785932034,0.9787234042553191,1.0,1.0,23/150,18.85%,NUBP1;SFRP1;TGFB1;CDKN2C;AGT;TCHP;CEACAM1;DERL2;PAPPA2;OGFR;BTG1;ESR2;NCBP1;SUPV3L1;CRLF3;RACK1;HDGFL2;CDKN2A;PRKCQ;TAF9B;CDKN2AIP;TSPYL2;TRIM32
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.45207667202677626,0.6864201033999838,0.8863636363636364,0.9938386488954651,1.0,2/5,8.80%,TGFBR2;TWSG1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.37765047585091027,0.6864150158017236,0.8125,0.9932883506402627,1.0,4/8,21.35%,PLCB1;ABCA2;RAMP1;CHP1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3427688369657893,-0.6857896109346183,0.9230769230769231,1.0,1.0,4/21,18.01%,BTBD18;THOC5;CCNK;HMGN1
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.2970475121684421,0.6857562567180048,0.8666666666666667,0.9933523846080513,1.0,5/24,10.22%,PARD3;FRMPD2;STRN;CLDN12;PARD6G
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.3026390046477228,-0.6849987345363109,0.9529411764705882,1.0,1.0,9/57,16.51%,TRPC5;SELENOK;CACNA1C;CACNA1B;CAMK2A;CACNA1E;MMGT1;SLC3A2;CAV1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3535896247990936,-0.6849935125906821,0.8970588235294118,1.0,1.0,4/21,14.68%,OLFM1;STAT5A;DNM2;APOE
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),-0.30974266239385795,-0.6848614059228927,0.9318181818181818,1.0,1.0,7/54,13.16%,F8;GORASP1;NAPA;CTSZ;TRAPPC2L;TRAPPC6A;SEC13
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.30974266239385795,-0.6848614059228927,0.9318181818181818,1.0,1.0,7/54,13.16%,F8;GORASP1;NAPA;CTSZ;TRAPPC2L;TRAPPC6A;SEC13
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),-0.30974266239385795,-0.6848614059228927,0.9318181818181818,1.0,1.0,7/54,13.16%,F8;GORASP1;NAPA;CTSZ;TRAPPC2L;TRAPPC6A;SEC13
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),-0.3436481501976667,-0.684681466810829,0.8783783783783784,1.0,1.0,1/20,3.97%,CFTR
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),-0.35526599005801757,-0.6845791501430396,0.9358974358974359,1.0,1.0,5/24,16.97%,EIF2B2;STAT5A;CACNA1B;NLRP1;STAT1
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.4128989361702129,0.6844516879343767,0.8181818181818182,0.9942701115410956,1.0,5/5,58.73%,PARN;TENT4B;DIS3L2;SND1;TUT4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.32234991394026785,0.6842763930011949,0.9666666666666667,0.9938613219542201,1.0,6/18,12.92%,TAB3;MAP2K6;TAB1;MAP3K7;UBE2N;TAB2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.30552335409328757,-0.6840103504606561,0.925,1.0,1.0,10/43,21.58%,ISG15;RPL11;SVBP;USP4;CAV1;RPL5;CAMLG;UBXN1;COPS9;PARK7
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.4489415919527629,-0.6839072796978231,0.8529411764705882,1.0,1.0,1/5,0.86%,CRYM
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.4489415919527629,-0.6839072796978231,0.8529411764705882,1.0,1.0,1/5,0.86%,CRYM
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),-0.3232595790697039,-0.6835751991411457,0.9529411764705882,1.0,1.0,2/31,7.07%,RRAGA;XBP1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.4220894600819989,-0.6835512892318004,0.8709677419354839,1.0,1.0,3/8,29.77%,REXO4;MUS81;ISG20
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),-0.3239950481333448,-0.6834178205135116,0.9240506329113924,1.0,1.0,7/46,16.52%,ROMO1;JUN;PJVK;PRDX5;APOD;APOE;FOS
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),-0.36486022796911294,-0.6834044345365728,0.881578947368421,1.0,1.0,6/16,35.57%,RNF8;TTC21A;NECTIN2;CEP57;MEIOC;RFX2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.39591566953111723,0.6832982826494169,0.8205128205128205,0.9942975246725794,1.0,1/5,7.98%,ATG2B
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),-0.3279650350072777,-0.6832327595919845,0.9625,1.0,1.0,9/42,16.97%,SPINK5;ALOX5;PGK1;NAXE;CD160;CNMD;SARS1;COL4A2;STAT1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.31937280250331634,0.6831212397224246,0.88,0.9939222723520259,1.0,6/20,10.66%,SIRT1;NSMCE2;PML;MAPK14;MAPKAPK5;SMC6
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.30976846694638066,0.683079413856893,0.8666666666666667,0.9933985621396076,1.0,2/14,7.84%,SLC12A8;SLC12A1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.32022948706930215,-0.6829564364243764,0.9125,1.0,1.0,7/47,18.46%,JUN;MED1;RUNX2;BAX;CDKN2A;CCNC;CDK4
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.4594234311313106,-0.6827957267795421,0.896551724137931,1.0,1.0,1/5,1.65%,HAP1
prerank,MSigDB_Hallmark_2020__Pperoxisome,-0.3022512266074294,-0.6823227803122884,0.975,1.0,1.0,11/76,17.92%,GSTK1;EPHX2;CACNA1B;ESR2;CDK7;PRDX5;HRAS;CRAT;IDI1;PEX11B;PEX14
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3661108941285477,0.6822981783122187,0.88,0.9935697828201986,1.0,1/9,4.73%,SIRT1
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.3493831521325046,0.6820319257857403,0.7631578947368421,0.993302952453576,1.0,1/8,7.50%,OXCT1
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),-0.36712410071210916,-0.6811352048875887,0.8688524590163934,1.0,1.0,2/14,11.65%,DBI;LPCAT3
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.4149908919938649,0.6805822121732404,0.8536585365853658,0.9943410221859995,1.0,3/8,8.99%,CARNS1;SLC35D1;UGDH
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.2790072232684477,0.6804794394692436,1.0,0.9939007594676245,1.0,3/42,5.67%,ACADVL;ACADS;ACAA2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.3528422207480467,0.6796650418495526,0.8333333333333334,0.9940795747413724,1.0,4/14,13.29%,TOB2;FMN2;USP9X;DIAPH2
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.399648982980009,-0.6792489938637675,0.9014084507042254,1.0,1.0,2/8,19.07%,VIL1;ACTN2
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.302354925896884,0.6791813342532229,0.9473684210526315,0.9939944052974737,1.0,6/24,13.10%,PDE7B;PDE4D;KSR1;EPHA5;DGKQ;RAPGEF2
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),-0.45430031895856515,-0.6790547032748779,0.9384615384615385,1.0,1.0,1/5,21.18%,SLC36A4
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),-0.33772089612314277,-0.6789276595577901,0.875,1.0,1.0,5/28,18.26%,RPS27A;CTSL;UBA52;S100A1;UBC
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),0.4007759727029726,0.6788661306620697,0.7777777777777778,0.9937610303198687,1.0,4/7,21.53%,ADAM10;ADAM17;GALNT11;PSEN1
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.36109165302138446,0.6784356746282482,0.9354838709677419,0.9936020206457281,1.0,2/9,12.98%,TGFBR2;CHRD
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.35473489554604115,-0.6779724941058207,0.875,1.0,1.0,4/21,18.24%,ZW10;SMC1A;MIS12;KIF18B
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.3876016470306936,-0.6778006920388864,0.8873239436619719,1.0,1.0,3/13,15.49%,SLC22A4;PDZK1;SLC25A42
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3501606661346717,-0.6773475797010945,0.9166666666666666,1.0,1.0,3/20,19.63%,TGFB1;RBPMS;BMP8B
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),-0.33754093579564853,-0.6772937136807534,0.9436619718309859,1.0,1.0,6/25,25.68%,VAV3;LARS1;PEX11B;RDX;RAP1GAP2;LAMTOR4
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.32070436831134214,-0.6771213090693825,0.926829268292683,1.0,1.0,5/25,23.62%,ATP6V0A4;ATP6V1F;ATP6V0E2;ATP6V1D;ATP6V1E1
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.3552007947338252,-0.677056399870698,0.8441558441558441,1.0,1.0,5/18,16.40%,EPHX2;LPCAT3;APOE;SREBF1;ACADL
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.44552996383473287,-0.6769451332046906,0.9180327868852459,1.0,1.0,2/7,18.09%,CHMP4B;DNM1L
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),0.2611304771445525,0.6766654287519824,1.0,0.9949163188302,1.0,17/49,24.96%,RANGAP1;NUP98;NSMCE2;NUP93;TRIM28;NUP210;STX1A;PIAS1;SEH1L;NUP35;ZNF451;NUP42;NUP54;TRPM4;UBE2I;AAAS;PIAS4
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.37722792517420517,0.6766221512287731,0.8333333333333334,0.9933456733751796,1.0,4/9,33.18%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.37722792517420517,0.6766221512287731,0.8333333333333334,0.9933456733751796,1.0,4/9,33.18%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.37722792517420517,0.6766221512287731,0.8333333333333334,0.9933456733751796,1.0,4/9,33.18%,TERF1;ERCC1;WRN;SLX4
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.29699726657318226,-0.6766142818770564,0.9550561797752809,1.0,1.0,23/109,23.92%,PSMB9;ZFP69;PSMB8;MED1;PSMA3;ID2;NR1D1;APOE;SREBF1;PMVK;PSMA7;IDI1;PSME1;HDAC3;OAZ2;EDF1;AZIN1;NQO1;SC5D;SIN3B;PSMB6;PSMB1;PSMC4
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.30312286242299363,-0.6765773256190944,0.9761904761904762,1.0,1.0,15/86,20.63%,CDKN1C;SSPN;JAG1;CRYAB;PAMR1;RNASE1;COL4A1;LMOD1;NEK6;VWF;C3;COL4A2;GSN;CALD1;WLS
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.3512213464656865,-0.6764693601416584,0.9295774647887324,1.0,1.0,2/24,11.00%,PFN2;PLEKHH2
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.2665324863629533,-0.6751200002565992,1.0,1.0,1.0,79/640,18.71%,ZBTB32;RPS14;VEGFA;CRYM;HES5;TAF7;RPS27A;SFRP1;RPL10;HES1;CDKN1C;CHD3;JUN;TGFB1;ZFP69;RPL23;ZFPM1;IRF1;EFNA1;CGGBP1;LDB1;HDAC6;DDX5;MLX;BHLHE41;MAX;BACH1;TLE6;CRYAB;MEF2C;ZNF124;SCML1;MED1;PARP9;ZNF568;SAP30;GLIS3;MOSPD1;TCF25;ID2;ESR2;ELK3;PRDX5;HDGF;NR4A3;ATF4;BEND3;ZNF248;UBA52;ZFHX3;RUNX2;NR1D1;SARS1;TRIB3;MAEL;AEBP1;KAT5;CAV1;ZNF749;CREBZF;STAT1;ZNF404;BRCA1;CBX7;CDKN2A;GMNN;HDAC3;TAF9B;NR0B1;BCL7A;EID2B;PEX14;ZNF875;NFIC;WFS1;UBC;CBX5;SNW1;EZH1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.4005532457011958,0.6749608598161938,0.8484848484848485,0.9937596000278093,1.0,2/6,17.84%,GABRB1;DIAPH1
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.4005532457011958,0.6749608598161938,0.8484848484848485,0.9937596000278093,1.0,2/6,17.84%,GABRB1;DIAPH1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.40513074047646597,-0.6744784538341149,0.8636363636363636,1.0,1.0,3/11,13.48%,TGFB1;DDX5;MAP2K1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4082724043376443,-0.6744136623820545,0.8923076923076924,1.0,1.0,3/9,22.15%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.3119002098854837,0.6742355360324601,0.9166666666666666,0.9940031359656161,1.0,3/23,7.62%,GPNMB;FAM107A;PKD2
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),-0.335216923105662,-0.6737995158718688,0.9054054054054054,1.0,1.0,7/29,22.17%,ECT2;MICALL2;POF1B;VCL;RHOC;CLDN18;CLDN10
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),-0.27855119627558883,-0.6737299783935924,0.9791666666666666,1.0,1.0,44/265,21.67%,PARP2;PHF1;SPDYA;VAV3;APEX1;ADPRS;POLQ;POLE3;RFC2;BACH1;SMC1A;RNF8;FAN1;FANCC;PNKP;NABP2;DDX11;CBX1;USP28;RFC4;PARP4;H2AX;BAX;CCNK;BRCA1;CGAS;MMS19;KIN;CDKN2AIP;CBX5;RFC3;XPA;ATRIP;TAOK3;MSH6;DDB2;LIG1;MBD4;BCL2L2;RECQL;SLF1;FBXO6;PARK7;CBX3
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),-0.3016736628313659,-0.6735989881980896,0.9456521739130435,1.0,1.0,8/60,17.07%,ABRAXAS1;ECT2;RNF8;NABP2;USP28;H2AX;KAT5;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.36090490019823696,-0.6735963423128709,0.8333333333333334,1.0,1.0,4/15,19.86%,XBP1;IL7;CD46;TESPA1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.26529855012169623,0.6735907951248927,0.8888888888888888,0.9940496467330314,1.0,17/48,18.89%,ARHGAP28;CDC42EP4;FER;FCHSD2;BIN1;SSH1;KANK1;WASHC5;CDC42EP1;LATS1;NCKAP1;PRKCE;SSH2;ARFGEF1;KANK4;COTL1;SLIT2
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.3671273818665591,0.672177254160983,0.8108108108108109,0.9948990988063514,1.0,1/8,5.11%,CSGALNACT1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),-0.36078086745928745,-0.6719637163397878,0.9411764705882353,1.0,1.0,1/18,2.33%,VAV3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.35573007051380456,-0.6718128683851403,0.918918918918919,1.0,1.0,6/21,21.53%,MEF2C;CCDC39;AHI1;CCDC40;NDRG4;STIL
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.29243791769619515,-0.6716095865565244,0.9888888888888889,1.0,1.0,11/99,15.93%,TUBB4B;TUBA4A;BACH1;CEP72;CDK7;DCTN1;DNM2;ODF2;TUBB4A;SKP2;DCTN3
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.3363277837021052,-0.6714618677599251,0.88,1.0,1.0,6/24,25.59%,FGF1;HSP90AB1;HSBP1;DHX36;PRKACA;STUB1
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.4016035580159315,0.6711602609210702,0.8333333333333334,0.9954036710717767,1.0,1/5,9.08%,FTO
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.42477900846110395,-0.6708400178379497,0.9027777777777778,1.0,1.0,2/7,20.77%,MTHFD1;MTRR
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),0.42112502772194393,0.6705949683972733,0.8857142857142857,0.995465710426972,1.0,1/5,9.36%,MECP2
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.2958304515105283,-0.6705252391915065,0.9302325581395349,1.0,1.0,6/55,17.07%,ABRAXAS1;POLQ;RNF8;H2AX;KAT5;BRCA1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),-0.44774779762765904,-0.6701925572886666,0.8793103448275862,1.0,1.0,1/5,13.15%,ATF4
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),-0.2982408993352843,-0.6699689386868997,0.9743589743589743,1.0,1.0,6/56,13.70%,TRPC5;TACR1;FPR3;CACNA1C;TAC4;CD55
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.34212736033341984,-0.6690973604476402,0.9178082191780822,1.0,1.0,3/22,13.48%,TGFB1;DDX5;MAP2K1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.3362313159487281,0.6690564793444008,0.8387096774193549,0.9965829510494385,1.0,4/10,17.78%,ROBO1;PKD2;ROBO2;ADAMTS9
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.28803669808153703,0.6688708737238233,0.9459459459459459,0.9962027798357364,1.0,3/21,11.23%,MVB12B;SNF8;NEDD4
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),-0.428263666659984,-0.6687649971465357,0.8909090909090909,1.0,1.0,1/6,11.57%,CALM1
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.3034282038228801,-0.6677386514766921,0.9736842105263158,1.0,1.0,11/48,21.62%,SLC6A9;PRAF2;SLC1A6;SLC25A5;SLC3A2;SLC25A42;SLC35B4;SLC7A8;SFXN3;SLC36A4;SLC25A30
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.3907080060752551,0.6675087738567116,0.8157894736842105,0.9969343416283023,1.0,1/6,5.14%,CAT
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3906931023119474,-0.6675013446002684,0.8823529411764706,1.0,1.0,3/11,29.56%,NEK11;MDC1;MUS81
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),-0.4301455373575567,-0.6674710193427249,0.8524590163934426,1.0,1.0,1/5,7.98%,STAT5A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),-0.3562276543373251,-0.6674382680114612,0.9130434782608695,1.0,1.0,8/19,22.09%,CAMK2A;P2RX4;WNK3;MYLK;CAV1;WFS1;PDGFRB;SPHK2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.25701498243254883,0.6673221833943972,1.0,0.9965380592648537,1.0,9/62,10.89%,KAT2B;ZZZ3;NAA50;JADE3;KAT8;CHD5;PHF20L1;MAP3K7;KAT2A
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.28661451499413987,0.6671350130216365,1.0,0.9961830213697115,1.0,8/34,17.93%,FBXW7;SIRT1;PPARG;ZBTB20;ABHD8;ABHD5;ABCA2;ADCK1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),-0.30922937675130996,-0.6670811221839362,0.9302325581395349,1.0,1.0,13/61,20.41%,ALOX5;SELENOS;TRIB1;FNDC4;LPCAT3;CACTIN;NR1D1;APOE;METRNL;TNFAIP6;TNFRSF1A;VPS35;CARD8
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.32481350953779503,0.6669229243771012,0.918918918918919,0.9958038956729035,1.0,1/11,5.15%,PPARG
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),-0.3210488549971822,-0.6667506054215429,0.9565217391304348,1.0,1.0,8/36,25.33%,INA;ATP5PF;CALM1;S100A1;ATP5PB;BASP1;ZNF430;FGF9
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.2686196584727529,0.6657730411090209,0.9545454545454546,0.9962568574324039,1.0,13/38,19.05%,IGSF11;DSCAML1;SDK2;ROBO1;NECTIN3;PALLD;CDH13;TENM3;ROBO2;CDH2;CDH4;DSCAM;CADM1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.36739688376579416,-0.6656916204412733,0.8823529411764706,1.0,1.0,6/15,20.93%,BHLHE41;XBP1;BDNF;HDAC3;FBXO22;ATP11A
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.3806716437611474,-0.6653250543111748,0.9117647058823529,1.0,1.0,1/10,5.62%,ZFPM1
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),0.41660865515244966,0.6652130074436892,0.95,0.9955486309393075,1.0,1/5,8.20%,SNF8
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),0.41660865515244966,0.6652130074436892,0.95,0.9955486309393075,1.0,1/5,8.20%,SNF8
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3367831767773675,-0.6651964726962344,0.9333333333333333,1.0,1.0,3/26,10.85%,LDB1;RNF8;BTBD18
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),0.28669266091363127,0.6648024286538823,0.9354838709677419,0.9953172005699943,1.0,7/21,31.36%,MTREX;EXOSC7;XRN1;DIS3L;EXOSC6;PARN;TENT4B
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.34311919284097747,0.6645664989514981,0.8787878787878788,0.9949477100008195,1.0,1/14,2.77%,ACADVL
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.36499388372530456,-0.664372919253972,0.9027777777777778,1.0,1.0,5/12,28.05%,DERL2;ERLEC1;EDEM2;OS9;UBE2G2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),-0.3804688869384845,-0.6643712994362507,0.9104477611940298,1.0,1.0,5/11,30.71%,CTDP1;CHMP4B;PPP2R2D;UBE2S;SIRT7
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.4054256105167924,0.664217109874409,0.875,0.9947900408273974,1.0,3/5,30.37%,RPS6KA3;INO80;BCLAF1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.4051855740943531,0.6640786293066585,0.7906976744186046,0.9943968554498881,1.0,3/6,25.74%,ARL3;RAB29;WDR19
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),-0.37324841978547196,-0.6640423357527719,0.8421052631578947,1.0,1.0,2/13,17.94%,LDB1;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.3199592327688423,0.6636700218584627,0.92,0.994345251381352,1.0,3/22,7.62%,GPNMB;FAM107A;PKD2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.29835526472582374,-0.6635072780872615,0.9418604651162791,1.0,1.0,8/56,17.50%,ITGA4;EFNA1;MEF2C;FN1;ATF4;MICALL2;POF1B;USH2A
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.40216779485459153,-0.6632077811276073,0.8225806451612904,1.0,1.0,2/6,20.66%,MAP1S;UXT
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.3695877050391607,0.663155952819632,0.8378378378378378,0.9941475731001597,1.0,7/7,63.06%,PTPRB;DUSP10;PTPN1;PTPRT;PTPRO;PTPRQ;DUSP3
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.2784274509990403,0.6629803435252197,0.9523809523809523,0.9937878299788098,1.0,3/21,18.41%,FER;ST18;PID1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.29097936451418255,-0.6626810307207882,1.0,1.0,1.0,6/72,12.77%,PHF1;POLR1C;CGGBP1;HDAC6;SMARCA5;TAF1D
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.31598071362082286,-0.6625987597714716,0.9506172839506173,1.0,1.0,8/46,21.51%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.3183649928465155,-0.6625120642829726,0.9012345679012346,1.0,1.0,3/35,11.27%,RASGRP1;PIK3CB;LPAR6
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.3172229489802415,-0.6623002325095139,0.9210526315789473,1.0,1.0,4/29,12.77%,POLR1C;RRN3;CDK7;TAF1D
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),-0.29114308192766464,-0.66210749428816,0.9767441860465116,1.0,1.0,11/69,17.92%,NACA;ICMT;ZDHHC24;ZDHHC1;ZDHHC15;CHMP4B;ZDHHC22;ATAD1;PEX11B;SRP14;PEX14
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),-0.30572709500261874,-0.6618228384118892,0.9878048780487805,1.0,1.0,9/49,21.30%,ENTPD7;ACSM3;TPST1;HINT1;DBI;ACOT2;TPST2;ACSM6;GTPBP1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.3023037679505407,-0.6617228154188642,0.9879518072289156,1.0,1.0,14/64,19.08%,RBM3;CLU;EFNA1;RPS4X;UPF3B;RACK1;PLXNB2;RPS27L;UPF3A;PCIF1;NSUN5;CASP3;RPL5;TNFRSF1A
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),-0.2935074631738965,-0.661164699758995,0.9318181818181818,1.0,1.0,16/74,26.97%,PSMB9;RPS27A;PSMB8;PSMA3;UBA52;PSMA7;PSME1;UBC;PSMB6;RBX1;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.43740633273144286,-0.660948907919443,0.921875,1.0,1.0,1/5,18.58%,MGME1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.38826784054681734,-0.6606630815384327,0.9104477611940298,1.0,1.0,4/10,25.71%,ALKBH2;ALKBH5;MPG;ASCC2
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.38826784054681734,-0.6606630815384327,0.9104477611940298,1.0,1.0,4/10,25.71%,ALKBH2;ALKBH5;MPG;ASCC2
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.3689615501799705,0.6603990781709334,0.8235294117647058,0.9949580152688381,1.0,1/7,7.98%,ATG2B
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.3689615501799705,0.6603990781709334,0.8235294117647058,0.9949580152688381,1.0,1/7,7.98%,ATG2B
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.36393513420996537,-0.6602966809199884,0.9054054054054054,1.0,1.0,1/18,1.43%,RIMS1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),-0.4024736585266089,-0.6601372366445151,0.9054054054054054,1.0,1.0,3/10,15.79%,WNT5B;ACTA2;POF1B
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),0.34673149528329256,0.6599609423135367,0.8333333333333334,0.9948900457672696,1.0,1/11,4.73%,SIRT1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.30714101002626515,0.6599606389662052,0.8709677419354839,0.9943525578981355,1.0,4/12,18.89%,ROBO1;NFATC1;ROBO2;SLIT2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.3647049565183852,0.6597969606438852,0.9,0.9939774912450229,1.0,3/9,23.79%,PLIN5;SNCA;PCSK6
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.2724058967107083,-0.6595674152951881,0.979381443298969,1.0,1.0,37/213,21.25%,PSMB9;SCG2;RPS27A;FGF1;TGFB1;RASGRF2;PSMB8;IL3RA;HTR2B;RASGRP1;IL5;MEF2C;ICMT;PIK3CB;CAMK2A;PSMA3;CALM1;PPP5C;ZFP36L2;RASA3;MAP2K1;UBA52;HRAS;PSMA7;RASGRP3;PSME1;PRKCQ;RASA1;UBC;MAPK13;ACTN2;TAOK3;PDGFRB;IL18;NRG4;BTC;PEBP1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.37992811137732985,-0.6595341982769541,0.9253731343283582,1.0,1.0,2/11,15.49%,SLC25A5;SLC25A42
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.39881742724365343,-0.6595165914672227,0.8888888888888888,1.0,1.0,1/7,12.52%,SYT11
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.31732084630087487,-0.6593335310994981,0.9382716049382716,1.0,1.0,8/43,21.51%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.31732084630087487,-0.6593335310994981,0.9382716049382716,1.0,1.0,8/43,21.51%,EMD;NUP155;ANKLE2;SEC13;CHMP4B;NUP107;NUP85;NUP188
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.41218804388323776,-0.6590607838506628,0.90625,1.0,1.0,3/8,22.15%,TXN;PARK7;PDE8A
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3036915518382076,-0.6589971287294857,0.9743589743589743,1.0,1.0,7/46,20.27%,TGFB1;BLOC1S2;DELE1;BAX;CASP3;TNFRSF1A;BCL2L2
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.3031106383971123,-0.658876521634754,0.9523809523809523,1.0,1.0,8/64,15.93%,TUBB4B;TUBA4A;ATAD5;CEP72;DCTN1;ODF2;TUBB4A;DCTN3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3543089003962119,-0.6584863282387833,0.821917808219178,1.0,1.0,1/15,3.69%,IFI35
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.29296841824318437,0.6584595876956125,0.9130434782608695,0.9947674541498746,1.0,5/15,19.44%,PTPRC;FOXP1;SLC39A10;BCL10;RAB29
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.30085968365721316,0.6580234210168033,1.0,0.9946512342190856,1.0,6/18,12.92%,TAB3;MAP2K6;TAB1;MAP3K7;UBE2N;TAB2
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.4494699556155197,-0.6577644371892167,0.8545454545454545,1.0,1.0,1/5,8.18%,TOM1L1
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.4494699556155197,-0.6577644371892167,0.8545454545454545,1.0,1.0,1/5,8.18%,TOM1L1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),-0.32322590205021945,-0.6577363523245772,0.9242424242424242,1.0,1.0,5/20,18.13%,MESD;EMP2;RIC3;USP4;VCL
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.36084744980318967,-0.6577037167006925,0.9142857142857143,1.0,1.0,3/13,18.46%,RAB11A;DBF4B;CDK4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.30073463377277154,-0.6576506121134045,0.9615384615384616,1.0,1.0,12/74,18.65%,RPS27A;CDKN1C;PBLD;TGFB1;ASPN;VEPH1;GIPC1;UBA52;HSP90AB1;CAV1;UBC;SNW1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.33774265620543176,-0.6572928616624704,0.9605263157894737,1.0,1.0,5/36,12.83%,ALOX5;HTR2C;CACNA1C;CACNA2D2;CACNA1E
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.3957738866972414,-0.6569920185442705,0.8676470588235294,1.0,1.0,7/9,34.40%,EIF2S3;EIF2D;DHX29;EIF4B;EIF2S2;EIF5;MCTS1
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.2914849201761827,0.655592968007842,0.9166666666666666,0.9963286669196519,1.0,3/18,8.95%,ADAM10;MYH9;ADAM19
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.44266415424811556,-0.655390844819884,0.8620689655172413,1.0,1.0,1/5,27.48%,SOD2
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.2905257835311835,0.6550725277878776,0.92,0.9963005516446148,1.0,3/19,8.83%,ATP11C;ATP8A1;ATP10B
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.3240257826453508,0.6545690199105485,0.9333333333333333,0.996280536900739,1.0,3/15,12.23%,SGCZ;BMP7;CFLAR
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.26102729346703557,-0.6545162557774518,0.979381443298969,1.0,1.0,25/245,15.49%,CD63;ARMCX3;ARL1;COX18;STX10;RRAGA;ARL4C;ARFIP2;NAPA;STX19;HDAC6;USP6;SCG5;AP2A1;MESD;ARFGAP3;EMP2;TMED1;RIC3;SEC13;USP4;ZDHHC15;AP4M1;STX1B;SEPTIN1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.2711662511175739,-0.6542463821062227,1.0,1.0,1.0,16/106,21.79%,TRIM5;ECT2;TRIM25;IFIT5;HTR2B;GAPDH;NEK6;PPP5C;TERF2IP;TRIM52;TRIM32;RHOC;TNFRSF1A;WLS;DHX36;TRIM13
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),-0.3237749106026716,-0.6538518009214592,0.9324324324324325,1.0,1.0,7/29,17.07%,ACMSD;CEACAM1;TRIB3;ACADL;PGP;CAV1;BRCA1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.3973377872959007,0.6536945302220958,0.9166666666666666,0.9964460595698187,1.0,2/6,22.78%,SASH1;DDX3X
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),0.2884253385863714,0.6536840314935403,0.9032258064516129,0.9959100477034553,1.0,4/25,10.46%,ZKSCAN3;MYO7A;CLVS2;LRRK2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.3666375642551941,-0.653320743250655,0.9298245614035088,1.0,1.0,3/15,12.55%,RAB11A;SYT11;DNM2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.2666849462480148,0.6532689905586524,1.0,0.9957774739094394,1.0,5/37,11.23%,ATR;ZBTB1;PTPRK;ERCC4;NEDD4
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.3931130151987423,0.6531618989340671,0.9259259259259259,0.9953470851140108,1.0,3/8,18.05%,CSGALNACT1;FUT8;GFPT1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,-0.2917259463604338,-0.6530072509981107,0.987012987012987,1.0,1.0,11/53,19.73%,MBNL3;AGRN;LAS1L;TEAD3;HDGF;GIPC1;HNRNPAB;TMEM54;PPP1R14B;SAPCD2;POLD2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.3773919468045808,0.6525423670602568,0.8444444444444444,0.9948335968054347,1.0,6/6,62.28%,SLCO2B1;ABCG2;ABCC1;HMOX2;BLVRA;BLVRB
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.3773919468045808,0.6525423670602568,0.8444444444444444,0.9948335968054347,1.0,6/6,62.28%,SLCO2B1;ABCG2;ABCC1;HMOX2;BLVRA;BLVRB
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.4293632755779608,0.6521655387612041,0.8709677419354839,0.9946616852791177,1.0,3/5,20.81%,DLL1;NF1;CDK6
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.36203540962425534,-0.6519922726676988,0.958904109589041,1.0,1.0,4/15,20.74%,GTF3C6;NIFK;POLR1G;GTF3A
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3439315799583046,-0.6512671431786168,0.9315068493150684,1.0,1.0,3/19,13.53%,ECT2;KIF20B;GIPC1
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.349709171273638,0.65109293835673,0.9210526315789473,0.9952131650914353,1.0,1/7,2.11%,NLGN1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.367216183949882,0.6503697562577796,0.8888888888888888,0.9953544561544093,1.0,2/8,13.16%,CAT;PXDNL
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.3761876811854,0.6503311368885991,0.9615384615384616,0.9948614608801345,1.0,4/10,19.07%,SYNE3;FBXW11;SUN2;MTOR
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.36410408271922134,0.649998308779048,0.9090909090909091,0.9946738571002828,1.0,1/8,4.73%,SIRT1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.33536842639373127,-0.6495388845413674,0.9142857142857143,1.0,1.0,4/21,21.81%,ZW10;DCTN1;SAPCD2;NUMA1
prerank,PanglaoDB_Augmented_2021__Microglia,-0.3162533919112677,-0.6494559084421543,0.9605263157894737,1.0,1.0,7/29,17.64%,IGSF6;GPR34;TBXAS1;MYO1F;AEBP1;FOS;P2RY12
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.27684918080290116,-0.6492274807256595,0.967032967032967,1.0,1.0,18/95,22.58%,CDKN1C;CDKN2C;LDB1;NUP155;FN1;ANKLE2;ATG14;EMP2;NLRC5;SEC13;PLXNB2;NUP107;CDKN2A;PGAM1;NUP85;NUP188;NDUFS4;STAT2
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.304948952937061,-0.6488837698063178,0.9259259259259259,1.0,1.0,8/49,20.76%,GABARAPL2;ATG14;ATG16L2;EMC6;MAP1LC3B2;ULK1;RAB19;ELAPOR1
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),0.30545332357799426,0.6487334494014753,0.9230769230769231,0.9952000948267147,1.0,2/15,9.04%,FPGS;MTHFD2L
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.3301741750532255,-0.6486790387025759,0.9154929577464789,1.0,1.0,7/25,25.74%,RAB11A;USP6;POFUT2;ICA1;CLDN10;MBTPS1;DNAJA1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.31058943453660065,-0.6485674008015605,0.9518072289156626,1.0,1.0,5/41,19.08%,RPS27A;AZI2;UBA52;UBC;TNFRSF1A
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.4207327366284851,-0.6483269548394167,0.8769230769230769,1.0,1.0,3/7,20.72%,RNF8;MSH6;GPR183
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.34034827312853055,-0.6479696304842935,0.9130434782608695,1.0,1.0,4/22,21.81%,ZW10;DCTN1;SAPCD2;NUMA1
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.40608268156804506,0.6479032582654733,0.8809523809523809,0.9948491564932197,1.0,1/5,8.40%,ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.40608268156804506,0.6479032582654733,0.8809523809523809,0.9948491564932197,1.0,1/5,8.40%,ATP2B4
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.2833127702029346,0.6477702641435159,1.0,0.9944217925878369,1.0,3/24,9.44%,NUTF2;RANBP3;XPO7
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),-0.3970313218361871,-0.6477258693198514,0.8507462686567164,1.0,1.0,5/8,29.90%,STEAP4;STEAP2;ATOX1;SLC31A1;COX17
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.23669151377077022,0.6475446724593328,1.0,0.9941069033803958,1.0,15/67,20.19%,RACGAP1;SCYL1;COG3;KIF15;TMED3;NSF;KIF3C;COG7;KIF1C;GBF1;STX18;NBAS;COPB2;KIFAP3;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.27776904055153806,-0.6470014777103957,0.9772727272727273,1.0,1.0,14/87,20.01%,SFRP1;ECT2;AGRN;S100A10;RAP1GAP;RASGRP1;CALM1;RACK1;ZC3H15;HRAS;LARS1;RHOC;BCAR3;DOCK8
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.3201926446762834,0.6466816665784612,0.8857142857142857,0.9943041608915681,1.0,3/13,17.62%,PKD2;DLL1;GALNT11
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.28579816078573506,-0.6461359220212142,0.9659090909090909,1.0,1.0,10/57,21.51%,RAB11A;NUP155;SEC13;ZDHHC15;RANBP6;NUP107;PTTG1IP;RANBP17;NUP85;NUP188
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.3952685412723693,-0.645875348253267,0.8695652173913043,1.0,1.0,2/8,8.51%,AGA;MAN2A2
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.37159679096186954,-0.645813997323665,0.8591549295774648,1.0,1.0,3/13,8.89%,JPH3;CACNA1C;GRIN2D
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),-0.3422768592947603,-0.645799740066822,0.9066666666666666,1.0,1.0,3/20,16.82%,DDRGK1;ID2;PSME1
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.3951967325447324,-0.6457791642674716,0.9253731343283582,1.0,1.0,4/11,26.77%,IL7;EIF2AK2;IL18;APP
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.43399664648801317,-0.6447918939133702,0.9104477611940298,1.0,1.0,3/6,23.99%,FUCA1;FUCA2;GUSB
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.33039142544203604,-0.6445535855703555,0.9054054054054054,1.0,1.0,6/21,21.93%,HSPA14;HSPA13;BAX;HSPA9;HSPD1;HSPA8
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.38797093386846226,-0.644440075235122,0.863013698630137,1.0,1.0,1/8,5.82%,CACNB1
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.29639552452520823,-0.6435733172607458,0.9662921348314607,1.0,1.0,22/72,29.29%,PSMB9;PSMB8;PSMA3;BUB3;PSMA7;CDC26;PSME1;DBF4B;FZR1;DBF4;NEK11;PSMB6;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;CDC23;PSMA4;ANAPC2;UBE2S
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.3443379580717061,-0.6433114314257878,0.9102564102564102,1.0,1.0,4/19,22.01%,BCAT2;ACAD8;SLC25A44;HSD17B10
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.3443379580717061,-0.6433114314257878,0.9102564102564102,1.0,1.0,4/19,22.01%,BCAT2;ACAD8;SLC25A44;HSD17B10
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.2804123437412967,-0.6432767963912266,1.0,1.0,1.0,13/80,19.83%,DVL1;RPL11;NUP155;RPF2;CHCHD10;SEC13;MORC3;RANBP6;NUP107;PTTG1IP;XPA;RANBP17;NUP85
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.37692995298767207,0.6432152040860488,0.868421052631579,0.9967791492788638,1.0,1/6,13.63%,SETD2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.3235941366764273,-0.6431495036920496,0.8701298701298701,1.0,1.0,2/27,5.63%,ARG2;DEGS2
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.42411099237078376,-0.6429820906728055,0.9,1.0,1.0,3/5,29.23%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.42411099237078376,-0.6429820906728055,0.9,1.0,1.0,3/5,29.23%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.38411362232524054,-0.6429105354097412,0.9393939393939394,1.0,1.0,4/10,29.00%,TYMP;OARD1;ERH;MACROD1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.35802655122149196,-0.6423183502912271,0.9230769230769231,1.0,1.0,2/12,8.12%,PTGR1;TBXAS1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.3193983332054937,-0.6421966210060408,0.9102564102564102,1.0,1.0,7/26,22.01%,RBM3;CELF4;NCBP1;NCL;SNW1;CIRBP;RBM22
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.4111673693941744,-0.641755375108781,0.90625,1.0,1.0,1/6,8.40%,EPHX2
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.3349184165789878,-0.6413658164892533,0.9452054794520548,1.0,1.0,1/21,6.70%,KDM6B
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2567443781584091,0.6407482562747987,1.0,0.998197014987814,1.0,8/50,12.58%,NEDD4L;HACE1;UBE2G1;UBE2D1;UBR5;UBE2E2;UBE2H;UBE2E3
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.28241743706685646,-0.6405350554944031,0.9523809523809523,1.0,1.0,15/89,17.76%,VEGFA;SPINK5;LDB1;XBP1;NIF3L1;MEF2C;ID2;DDIT4;WNT5B;MAP2K1;RUNX2;RNF112;USH2A;NRBP2;CASP3
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),0.3425702591196477,0.6398186875010996,0.9444444444444444,0.9981203133184282,1.0,1/12,3.04%,FARS2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3357197114096563,-0.6396156469756522,0.961038961038961,1.0,1.0,7/22,28.06%,LDB1;THOC5;CCNK;HMGN1;SUPT16H;TCEA2;SUPT5H
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),-0.3173688145015987,-0.638929209265317,0.9285714285714286,1.0,1.0,4/29,15.97%,SH3GL2;NRP2;ULK1;HSP90AB1
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),-0.3783585359439638,-0.6387837310737884,0.9193548387096774,1.0,1.0,5/8,34.93%,SPINK13;GJA1;TIMP1;ZP3;CALR
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.31962089289827494,-0.6384475957351328,0.987012987012987,1.0,1.0,9/26,21.17%,PDCD1LG2;HLA-A;XBP1;IL7;CD46;PRKCQ;HSPD1;DOCK8;THY1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.34434736270255,-0.6380112289093179,0.971830985915493,1.0,1.0,6/22,21.53%,PLSCR1;ATP9B;ATP8B1;ABCA1;ATP11A;ANO6
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.2983116442232576,-0.6378069968135075,0.9367088607594937,1.0,1.0,3/38,8.71%,ITGA4;EFNA1;FN1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.3139025748874268,-0.6373577360586741,0.9876543209876543,1.0,1.0,4/30,17.65%,PLET1;JAG1;CDKN2A;RASA1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),-0.2729831514467064,-0.637303482431539,0.9767441860465116,1.0,1.0,22/90,24.38%,IFI35;ALOX5;SELENOS;AGT;USP18;FNDC4;GRN;LPCAT3;NLRP1;NR1D1;APOE;METRNL;TNFAIP6;MAPK13;TNFRSF1A;VPS35;IL18;PARK7;LRRC19;UFL1;PTPN2;TNIP1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.40011288691403807,0.6373029276026452,0.8837209302325582,0.9994481748157483,1.0,1/5,14.39%,RNF128
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.2682075379149258,0.6371925804462976,1.0,0.9990119796560806,1.0,3/32,8.29%,DUSP7;SPRY4;BMP7
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),0.3942819148936171,0.6370997924601685,0.8717948717948718,0.9985682770147655,1.0,5/5,60.59%,EXOSC6;PARN;EXOSC10;EXOSC5;EXOSC2
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),-0.28341987877466635,-0.6369158480278938,0.9767441860465116,1.0,1.0,11/91,15.94%,CFAP61;MNS1;RAB11A;BLOC1S2;ARFIP2;SH3GL2;ODF2;STMN2;MICALL2;APOE;ULK1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),-0.36627156745802353,-0.6365760816462235,0.8857142857142857,1.0,1.0,1/10,4.31%,IHO1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.357302953234805,-0.6360905114350074,0.9090909090909091,1.0,1.0,4/13,44.07%,AXL;P4HB;KPNA6;VPS4A
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.2860583295954818,0.6360493072202386,0.9696969696969697,0.9987783631997396,1.0,8/27,19.44%,EHD1;IFT140;BBS4;TCTN2;ARL3;ODAD4;INVS;RAB29
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),-0.3091423489364769,-0.6354642914516772,0.9866666666666667,1.0,1.0,3/35,10.21%,TRIM5;ARIH2;RNF8
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.33628607120497017,-0.6347698745926336,0.9166666666666666,1.0,1.0,6/20,18.08%,AGRN;GPC3;FUCA1;CHIT1;HGSNAT;GPC2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.33348496662499993,-0.6344453388344207,0.9452054794520548,1.0,1.0,4/18,17.30%,SH3GL2;BDNF;STMN2;RAB35
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),0.3102556524309147,0.6342300246820878,0.8,0.9996571221351019,1.0,7/7,68.99%,PRMT6;PRMT7;COPRS;PRDM4;PRMT1;PRMT5;CARM1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),0.39531619385342787,0.6340736297507048,0.9,0.9992774543381725,1.0,5/5,60.48%,ABCD2;SLC27A4;ABCD3;ABCD4;ACOX1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.25354442259433485,0.6335282987019997,1.0,0.9991209182283242,1.0,14/38,21.21%,FAM107A;WASF3;ABI1;WASL;WASHC5;COBL;MICAL1;SPIRE1;DIAPH1;ARHGAP6;TTC17;CFL2;ENAH;MICAL2
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.32886597735292367,-0.6335256452384433,0.9305555555555556,1.0,1.0,4/26,12.67%,GCNT4;GCNT1;B3GNT5;GXYLT2
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.3698654974768084,0.6335234699534648,0.9302325581395349,0.9985908806059219,1.0,2/7,11.94%,PRKG2;QDPR
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.31373778464094204,-0.6334695480117364,0.975,1.0,1.0,6/33,18.33%,SFRP1;HAS2;CACTIN;ADAMTS7;NR1D1;MAPK13
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.28335413186199326,-0.6333083432007025,0.9550561797752809,1.0,1.0,9/69,15.39%,RANGRF;CEMIP;PDCD5;PLS1;ZDHHC8;WNK3;AKAP5;PDZK1;HRAS
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3164177013070387,0.6329785387183678,0.8620689655172413,0.998387197577225,1.0,3/12,22.24%,SNCA;MRAP;BICD1
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.384894763609951,-0.6326548010688318,0.84375,1.0,1.0,3/9,14.94%,LRRC17;FSTL3;TCTA
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.3287173586979414,0.6326505710575866,0.90625,0.998088427053169,1.0,3/14,12.17%,CD247;PTPRC;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.3789706646367118,0.6325230342678154,0.9166666666666666,0.9976232804533175,1.0,2/7,18.76%,SLC16A2;NF1
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),-0.34464362462087467,-0.6324887900555473,0.8961038961038961,1.0,1.0,3/19,12.75%,LFNG;TCF7;ZFP36L2
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),-0.4132373502028769,-0.6319868227341342,0.9104477611940298,1.0,1.0,1/6,11.93%,PNKP
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.37184977676293823,-0.6319658938985797,0.9384615384615385,1.0,1.0,3/13,11.57%,GSTO1;SLC6A9;CALM1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),-0.406911706095628,-0.6317427793249644,0.9166666666666666,1.0,1.0,2/6,29.22%,UBXN1;AQP11
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.3332573585420783,-0.6315320885741694,0.9305555555555556,1.0,1.0,4/18,21.40%,LMO2;SST;SRP14;G6PC2
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.29478768678466116,0.6312131783687943,0.9259259259259259,0.9980471827389439,1.0,5/15,15.38%,CSGALNACT1;EXT2;FUT9;EXT1;HS2ST1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.26567573818195755,-0.6310572533586274,0.9887640449438202,1.0,1.0,7/153,6.03%,VEGFA;FGF1;FLOT1;RARRES2;TGFB1;RASGRP1;EFNA1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.29027390626440497,-0.6310003221867176,0.9880952380952381,1.0,1.0,9/72,14.68%,TGFB1;ALOX5;RHBDF1;TTN;RSAD2;CACNA1C;CACNA2D2;CACNA1E;APOE
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.29073337519369585,0.6307153892254949,0.9655172413793104,0.9978997238481827,1.0,1/17,1.31%,PRR5L
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.40698751122845833,-0.6302715911906089,0.9264705882352942,1.0,1.0,1/6,6.70%,KDM6B
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.3466077441720505,-0.6301344048104242,0.9242424242424242,1.0,1.0,1/13,10.35%,LMOD1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.38358413101759625,-0.6298803163264495,0.9622641509433962,1.0,1.0,1/8,11.14%,CDK7
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.34810984609808787,0.6295542907771056,0.8918918918918919,0.998275480717169,1.0,1/5,10.46%,LRRK2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.39696936151896856,-0.6293373382303327,0.9464285714285714,1.0,1.0,2/7,19.08%,VCL;TNFRSF1A
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),0.22631272523740076,0.6292766296274379,1.0,0.9979458749638391,1.0,11/58,15.01%,MAP3K5;MAPK1;SLC38A9;MAPK3;ATP6V1A;DAPL1;SESN1;LAMTOR2;PRKD1;MAPK8;NPRL2
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),-0.40610171204582857,-0.6286662066234343,0.8823529411764706,1.0,1.0,2/5,20.57%,OSMR;GSTP1
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.3918513072037424,0.6281854172708357,0.8823529411764706,0.9965281735694275,1.0,1/5,13.71%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.3918513072037424,0.6281854172708357,0.8823529411764706,0.9965281735694275,1.0,1/5,13.71%,EXOSC7
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.3918513072037424,0.6281854172708357,0.8823529411764706,0.9965281735694275,1.0,1/5,13.71%,EXOSC7
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.3918513072037424,0.6281854172708357,0.8823529411764706,0.9965281735694275,1.0,1/5,13.71%,EXOSC7
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.39260623222202806,0.6281358282828663,0.875,0.9960423560183016,1.0,1/6,2.27%,KAT2B
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.3816756950630688,0.6280119985763601,1.0,0.9955965299920361,1.0,1/8,4.46%,CREB3L1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.3756620567846062,0.627796635541741,0.9705882352941176,0.9946905105945184,1.0,2/8,22.33%,CACNG2;GPHN
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.3756620567846062,0.627796635541741,0.9705882352941176,0.9946905105945184,1.0,2/8,22.33%,CACNG2;GPHN
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",-0.39479400243921525,-0.62777057594838,0.8732394366197183,1.0,1.0,4/9,21.19%,RIC3;APOE;CHRNE;NQO1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.3317416931075845,-0.6272720445505513,0.9428571428571428,1.0,1.0,8/23,29.33%,HSPA14;HSPA13;HSPA9;HSPA8;SDF2;ENTPD5;DNAJC18;DNAJB5
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.28616574040084425,0.6271801879963345,1.0,0.994656039132151,1.0,7/24,16.01%,ABL1;SMAD7;POT1;ERCC4;BAG5;NPRL2;TERF1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.35185065940770416,-0.6271789717112806,0.9714285714285714,1.0,1.0,1/13,3.26%,NAAA
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.3751760159262237,-0.6269096322779335,0.9,1.0,1.0,1/6,12.06%,SAXO1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.3087863855123238,-0.6261354510216381,0.9459459459459459,1.0,1.0,4/35,10.22%,RPL11;CLU;RPL23;MAGEF1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.40367922620678454,-0.6254194245392474,0.9464285714285714,1.0,1.0,1/5,14.49%,ALKBH2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),-0.338610602392864,-0.6250205002661081,0.9444444444444444,1.0,1.0,8/14,32.74%,APOE;PTTG1IP;VPS35;RDX;ATP5IF1;CD81;VPS11;HSP90AA1
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.3112972952014904,0.6250116706493074,0.925,0.9957483458636371,1.0,8/15,21.20%,CNNM2;SLC8A1;TMTC2;GRIN1;SNCA;PRKN;ANK3;TRPM7
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),-0.29382684260178377,-0.6241288900472219,0.96,1.0,1.0,8/37,21.93%,HSPA14;HSPA13;HSP90AB1;BAX;HSPA9;HSPD1;DNAJC4;HSPA8
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.3312857062571326,-0.6239906267149983,0.9710144927536232,1.0,1.0,2/16,12.05%,SELENOS;PPP1R3F
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.3525825555184845,0.62334803841531,0.9032258064516129,0.996469371440711,1.0,2/6,24.19%,PIK3R1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.3030031516066822,0.62274744313351,0.875,0.996434020016968,1.0,6/15,18.96%,MCU;MARCHF5;PINK1;SPIRE1;RALA;PRKN
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),-0.30444916080154716,-0.6219807693652203,0.96,1.0,1.0,2/26,17.47%,MAEL;NIFK
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.37286507164679794,0.6212001033637284,0.8888888888888888,0.9971381948659889,1.0,2/6,13.18%,PTPRU;FRS2
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.34390643615491345,0.6210382036722093,0.9210526315789473,0.9967801557145114,1.0,4/7,21.99%,TANC2;KIF1C;PPFIA2;KIF5A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.393366449541703,-0.6209496165062408,0.9538461538461539,1.0,1.0,1/5,9.03%,CAMK2A
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.2999947436415855,-0.6206272833724935,0.9753086419753086,1.0,1.0,6/42,19.28%,ANKRD27;KIF20B;BDNF;DNM2;MAP1S;TAOK3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3501419362903091,-0.6205361178108364,0.9493670886075949,1.0,1.0,4/17,20.26%,TGFB1;ATG14;P2RY12;PDGFRB
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.32503284790953596,-0.6201951405657247,0.9605263157894737,1.0,1.0,5/17,23.68%,XBP1;RACK1;PDK3;SLC39A14;PRKACA
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.2864281435279487,0.6201551996472146,0.9615384615384616,0.9968625767644169,1.0,7/17,18.89%,TGFBR2;SLIT3;GLRA1;GRIN2B;ABCA2;GRIN1;SLIT2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.301604772114625,-0.619560678876219,0.9878048780487805,1.0,1.0,7/39,20.57%,SEMA4C;COPS5;RASGRP1;MAP2K1;EIF2AK2;TAOK3;GSTP1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),-0.3368055946472016,-0.6194610845201294,0.9508196721311475,1.0,1.0,3/13,22.09%,WNK3;PDGFRB;SPHK2
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.3071145707737389,0.6194092657372039,0.9090909090909091,0.9969213478093172,1.0,3/12,14.08%,ADAM10;ADAM19;ADAM17
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.40723009758878764,-0.619376116719522,0.9714285714285714,1.0,1.0,4/6,26.21%,HDAC6;SAT2;SAT1;AMD1
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.33313780753571376,-0.6187928943730178,0.9583333333333334,1.0,1.0,6/17,24.89%,ARG2;ASAH1;CYP1B1;NQO1;SPHK2;CYB5R3
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.3544425665525474,-0.6185278205407517,0.96875,1.0,1.0,6/13,32.04%,ANTKMT;DNAJC30;SPHK2;TMSB4X;ENO1;AK4
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.32609514644853316,-0.6182917410148691,0.972972972972973,1.0,1.0,6/22,20.72%,RARRES2;TGFB1;P2RX4;P2RY12;PDGFRB;GPR183
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),-0.26637037173069644,-0.6176486097528515,1.0,1.0,1.0,19/117,21.97%,TRIM5;FLOT1;YBX3;CGGBP1;KDM6B;IGF2BP2;HNRNPDL;CACTIN;ATXN7L3B;APOE;STX1B;RASA1;HNRNPAB;CDK4;ZNF711;TAPBP;ATRAID;CTCF;TBC1D16
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.35984579437279557,0.6170160812902876,0.8857142857142857,0.9983303298853221,1.0,2/5,14.59%,MSRB3;MSRA
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.32552476543248743,0.6168354267546535,0.972972972972973,0.9979096459040298,1.0,3/11,12.17%,SSH1;DGKQ;P2RX7
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),-0.36512242307210335,-0.616777311603756,0.8939393939393939,1.0,1.0,1/7,20.87%,DHX36
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.3878960339336582,0.6156143597123769,0.9743589743589743,0.9981795163339513,1.0,3/5,32.32%,TOPBP1;NAE1;HUS1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.34795091129236,-0.6154674263586276,0.9315068493150684,1.0,1.0,4/11,26.77%,MT2A;ATOX1;SLC31A1;APP
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.3482125897467661,-0.6150847570416826,0.9,1.0,1.0,4/14,17.24%,PARP9;ZDHHC1;STAT1;CGAS
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.3846643139582625,-0.6147488071431219,0.9142857142857143,1.0,1.0,1/5,26.50%,FLNA
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.3284495384356955,-0.6146744046568476,0.9571428571428572,1.0,1.0,5/19,22.07%,HSPA14;HSPA13;HSPA9;HSPA8;SDF2
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.31912477999754163,0.6146379289264335,0.8620689655172413,0.9983080185915091,1.0,2/13,8.41%,SH3D19;SNX33
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.3600988906100086,-0.6136213835163817,0.9090909090909091,1.0,1.0,6/10,25.40%,CEACAM1;TRIB3;ACADL;BRCA1;ERLIN2;WDTC1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.3808237222938027,0.6135501338746118,0.9655172413793104,0.9985303945894145,1.0,2/8,8.41%,SH3D19;SNX33
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.359934024126653,-0.6132629580030865,0.9444444444444444,1.0,1.0,3/9,18.40%,ARFIP2;VIL1;GSN
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.30462217291335536,-0.6131374514803554,0.9863013698630136,1.0,1.0,5/24,22.87%,CLU;APOE;CAV1;ABCA1;ABCA5
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.31649962579953356,0.6129837004842476,0.9375,0.9983923621653954,1.0,1/10,9.39%,SEC16A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.3306214404255908,0.6129725224955175,0.9090909090909091,0.9978788342769627,1.0,2/7,18.96%,ADCK1;PRKN
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.2798308694427407,-0.6129328808297915,1.0,1.0,1.0,7/52,20.25%,TTN;LMOD1;TMOD3;OBSCN;ALKBH4;ACTN2;PGM5
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),-0.3255852706969784,-0.6129131154629583,0.9367088607594937,1.0,1.0,3/15,18.40%,AVIL;VIL1;GSN
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),-0.3255852706969784,-0.6129131154629583,0.9367088607594937,1.0,1.0,3/15,18.40%,AVIL;VIL1;GSN
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.31313473696943833,-0.6122484097461578,0.9710144927536232,1.0,1.0,2/20,10.66%,GCNT1;B3GNT5
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.3795847091181609,-0.6121825845968025,0.9558823529411765,1.0,1.0,3/9,23.73%,JAG1;PROM1;BASP1
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),-0.2799534082164741,-0.612103905844849,0.9879518072289156,1.0,1.0,9/69,14.19%,AGRN;PRELP;CEMIP;HAS2;GPC3;OMD;ACAN;OGN;XYLT2
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.3706932173106663,0.6117088145872667,0.8936170212765957,0.9981323730512708,1.0,1/5,13.10%,RAPGEF2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.21567039068885654,0.611400691023257,1.0,0.9978696816944107,1.0,12/51,23.71%,CRADD;PML;ARID3A;PCBP4;CNOT6L;CNOT2;CNOT9;CNOT7;MDM4;ACER2;MYO6;CASP2
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.3694878837283505,0.6113383411904291,0.813953488372093,0.9973884838828302,1.0,1/5,10.46%,LRRK2
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.3781084963861865,0.6109313412776962,0.8780487804878049,0.9970952158967963,1.0,1/6,11.79%,PTPRS
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.38775951760259203,-0.61040449096787,0.9242424242424242,1.0,1.0,2/5,22.57%,RNF112;XRCC1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),-0.3453850581005474,-0.6101134083471411,0.9864864864864865,1.0,1.0,3/13,17.07%,CELF4;NR5A2;BRCA1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.3402005033739627,-0.6100333235409935,0.9142857142857143,1.0,1.0,4/17,17.24%,PARP9;ZDHHC1;STAT1;CGAS
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.3843965480856627,-0.6100041545239994,0.9516129032258065,1.0,1.0,2/7,17.16%,GLUL;ALDH4A1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.3014488588870824,-0.6098600064372555,0.9863013698630136,1.0,1.0,3/27,18.50%,RRAGA;LARS1;TELO2
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.314761733425141,-0.6095152386112007,0.9428571428571428,1.0,1.0,5/19,21.50%,VDAC2;VDAC1;SLC22A24;SLC17A5;SLC17A7
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),0.3663563829787234,0.6094201323006618,0.85,0.9976062143092468,1.0,5/5,63.38%,HSF1;NUDT16L1;CYREN;TFIP11;ERCC6
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.28078033017737003,-0.6093996924504712,0.9629629629629629,1.0,1.0,4/51,13.06%,OPRM1;MEF2C;CAMK2A;NPTX1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.3208621234882122,0.6086264603616611,0.975,0.9976329949926711,1.0,2/9,16.33%,GPC1;ABCA2
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.2651110668135155,0.6078121716917838,1.0,0.9975193959851135,1.0,6/26,26.36%,SUV39H2;WDR82;SETD1B;SETD3;KMT2D;SETMAR
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.28500709462414797,0.6076160975842867,1.0,0.9971175641812992,1.0,4/11,16.94%,DMD;SLC8A1;PIK3CA;CDH2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.3589886027399167,-0.6075565271284878,0.9705882352941176,1.0,1.0,3/10,17.74%,SFRP4;BTG1;AHI1
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.37687158542599497,-0.6075387770760086,0.927536231884058,1.0,1.0,1/7,18.58%,MGME1
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.4006871660104664,-0.6073162932987827,0.8955223880597015,1.0,1.0,1/5,9.81%,LRRC17
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.3130027119067144,0.606834270910144,0.875,0.9971134002102595,1.0,3/11,21.60%,ETNK1;CEPT1;CHKA
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.24205835341920773,0.606652111913171,1.0,0.9967277671446352,1.0,19/90,17.13%,ESR1;TAF3;SIRT1;BTRC;SMAD7;KEAP1;PKD2;RNF2;BMP7;ERBIN;HDAC4;PROX1;GLIS2;LRRC14;MDFI;OTULIN;MTURN;NFKBIL1;TCF7L2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),-0.275964059181691,-0.6065802267686915,0.9767441860465116,1.0,1.0,14/63,20.12%,CTSL;AP2A1;SH3GL2;DCTN1;DYNC1LI2;CLTA;DNM2;SEC13;ACTR1B;DCTN3;DCTN6;HLA-DMA;AP2A2;KIF22
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.2526400723740952,0.6060767689384202,0.96875,0.9966304363278936,1.0,6/25,20.18%,IRS1;ARPP19;OSBPL8;PID1;AKT2;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.35740630318825006,-0.6059674381483797,0.9295774647887324,1.0,1.0,1/12,10.21%,RNF8
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.2902203658849546,0.6054190284567029,0.9705882352941176,0.9966731941807597,1.0,2/14,8.13%,INAVA;PTPRC
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3451434582361511,-0.6048915656891448,0.972972972972973,1.0,1.0,1/12,3.61%,ENTPD7
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),-0.2427667258583833,-0.6048852945677132,1.0,1.0,1.0,26/270,15.01%,SCG2;ARL1;STX10;ARL4C;CLU;ARFIP2;NAPA;STX19;HDAC6;USP6;SCG5;AP2A1;ARFGAP3;SVBP;ATP6V0A4;SCAMP5;TMED1;ATP6V1F;RAB3D;DNM2;SEC13;ATP6V0E2;AP4M1;APOE;STX1B;RAB15
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.39700171981985044,-0.6043313015932201,0.9056603773584906,1.0,1.0,3/5,29.19%,MAP3K12;NEK11;RPS6KA5
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),-0.4107837982167436,-0.6036063274062724,0.9538461538461539,1.0,1.0,1/5,20.63%,WLS
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.2767857646387233,0.6034524164157441,1.0,0.9968751123178724,1.0,2/17,12.17%,ZBTB20;P2RX7
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.2767857646387233,0.6034524164157441,1.0,0.9968751123178724,1.0,2/17,12.17%,ZBTB20;P2RX7
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.383916607240188,-0.6029860338415578,0.9375,1.0,1.0,3/8,32.29%,CAV1;ENPP1;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),-0.28460177949348886,-0.6023860348904797,0.9767441860465116,1.0,1.0,6/47,15.39%,PFN2;HAX1;LMOD1;VIL1;BAIAP2L2;HRAS
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.3470208619066567,0.6016697245522356,0.9285714285714286,0.9972748670712661,1.0,3/5,31.70%,PIGU;PGAP1;PIGK
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.3367181133684458,-0.6015882813263771,0.9295774647887324,1.0,1.0,6/15,23.83%,H2AZ1;H2AX;KLRB1;TUBA1B;HOPX;STMN1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.3676755906638346,-0.600788765126229,0.9666666666666667,1.0,1.0,1/8,8.45%,OAS1
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.3595389389685236,0.6002268413012176,0.9,0.9977673395669144,1.0,7/7,64.06%,KCNMA1;SLC12A2;ATP1A2;ATP1B3;ATP1A1;ATP1B2;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.26658434707993156,-0.5999145507953562,1.0,1.0,1.0,6/54,17.19%,CDKN1C;AGT;PIK3CB;PKIB;APOE;CDKN2A
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),0.31668700183170345,0.5997051895461792,0.9736842105263158,0.9975689323976169,1.0,4/10,22.44%,ABCC5;ABCC4;SLC19A1;LRRC8A
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3224307378789152,-0.5996695790061342,0.984375,1.0,1.0,4/18,18.72%,RPS27A;UBA52;UBC;HSPD1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.3741129446528275,-0.5995338909290706,0.9482758620689655,1.0,1.0,1/7,10.87%,PJVK
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),-0.39428053795499896,-0.5993266695732334,0.9411764705882353,1.0,1.0,3/6,26.39%,CCDC39;CCDC40;SRP54
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.35253560892226027,0.5992047324215453,0.9285714285714286,0.9972854480427812,1.0,3/6,16.74%,POT1;TERF1;TERF2
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),-0.30591170530092016,-0.5980562938232628,0.9506172839506173,1.0,1.0,5/25,22.77%,POLE3;RPA3;GMNN;DBF4;POLE
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.287563689813491,-0.5973729713820957,0.9506172839506173,1.0,1.0,6/34,21.43%,H1-4;POLE3;SMARCA5;H2AX;EZH1;CTCF
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.34596480474694025,0.5965474327999024,0.9111111111111111,0.9985287986231032,1.0,1/7,2.54%,BCAR1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.38104161922242685,-0.5962090577655762,0.921875,1.0,1.0,3/8,28.06%,ANTKMT;XRCC1;TMSB4X
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.29462806334895364,-0.5960527094449612,0.9866666666666667,1.0,1.0,3/26,14.81%,PIK3CB;RACK1;TRIB3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),0.22695846872304534,0.5959320058612061,1.0,0.998330305542928,1.0,11/57,15.01%,MAP3K5;MAPK1;SLC38A9;MAPK3;ATP6V1A;DAPL1;SESN1;LAMTOR2;PRKD1;MAPK8;NPRL2
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.2678149024246007,0.5959223374361335,0.975,0.9978146390627922,1.0,13/13,73.24%,APBA1;BORCS5;DYNC1I1;CLIP3;COPG1;SPG11;ARHGAP21;DYNC1I2;CDC42;COPG2;BAG3;CAMSAP3;APP
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.27054689545584537,-0.5956676476610179,0.9880952380952381,1.0,1.0,9/59,21.51%,RPL23;NUP155;SEC13;RANBP6;NUP107;PTTG1IP;RANBP17;NUP85;NUP188
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.34152897070996635,-0.5954889889168218,0.9242424242424242,1.0,1.0,2/11,20.87%,ZFP36L2;DHX36
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.34152897070996635,-0.5954889889168218,0.9242424242424242,1.0,1.0,2/11,20.87%,ZFP36L2;DHX36
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.364901149428588,-0.5954379102299772,0.9047619047619048,1.0,1.0,2/7,23.51%,C3;SLC39A14
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.35213414686227656,-0.5950040122043517,0.958904109589041,1.0,1.0,2/12,18.65%,BRCA1;SNW1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.3401179003005146,0.594724854697154,0.8709677419354839,0.9981041469439855,1.0,3/8,30.21%,ST3GAL4;ST3GAL2;PARN
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),-0.2981634067171794,-0.5945183521086236,0.972972972972973,1.0,1.0,5/22,22.17%,ECT2;MICALL2;POF1B;CLDN18;CLDN10
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),-0.32123396645846086,-0.5941399402057511,0.9733333333333334,1.0,1.0,3/14,15.26%,SRRM4;MTCH1;C3
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3036621092785172,-0.5936311001452272,0.9722222222222222,1.0,1.0,3/25,15.63%,HNRNPA2B1;SRRT;ADAR
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.3461249994781475,-0.5936065017613824,0.927536231884058,1.0,1.0,2/10,15.87%,XBP1;CD46
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.31982566831350107,0.5935506632763433,1.0,0.9983701572074223,1.0,3/9,19.27%,CTBP1;NIPBL;PRMT6
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),-0.26585800502212065,-0.5932655118861604,1.0,1.0,1.0,10/48,21.17%,EFNA1;STMN2;APOE;STX1B;MYLIP;NGEF;PRAG1;OMG;ITM2C;THY1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.2746870236897538,-0.5930661998060693,0.9512195121951219,1.0,1.0,7/39,18.40%,GPX4;MSRB2;CHMP4B;MICALL2;VIL1;WASHC3;GSN
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.33899020509719924,0.5915448019515993,0.95,0.9988600329675877,1.0,2/7,18.35%,BIN1;SESTD1
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.37288096936815507,-0.5914668536463621,0.9545454545454546,1.0,1.0,3/7,28.51%,DPH6;DPH2;DPH7
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.26924931966186966,0.5910673442564675,0.96,0.9980778827976746,1.0,4/16,18.77%,ATF7IP;PPM1D;BAZ2A;DNMT3B
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.26924931966186966,0.5910673442564675,0.96,0.9980778827976746,1.0,4/16,18.77%,ATF7IP;PPM1D;BAZ2A;DNMT3B
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.3684097713045423,-0.5907394899253263,0.9827586206896551,1.0,1.0,1/6,18.09%,DNM1L
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.36664252717482326,-0.5904435910749566,0.9344262295081968,1.0,1.0,2/8,13.31%,TRIM41;NLRP1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.275556212580383,0.5882527144981923,0.9629629629629629,0.999007022527294,1.0,12/12,72.47%,TP53BP1;SHLD1;KMT5B;MAD2L2;TFRC;SLC15A4;SUPT6H;PAXIP1;RIF1;HMCES;SHLD2;KMT5C
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.30008075044056975,0.5880936106855655,0.9375,0.9985777090900609,1.0,3/16,16.09%,MAN2A1;PRKCSH;FUT8
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.26400112193773867,0.5876369528522885,0.95,0.9982953098953132,1.0,6/43,11.36%,IRS1;LEPR;PPARG;IGF1R;ADIPOR2;KLF7
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.37156549226098246,-0.5875479638225914,0.890625,1.0,1.0,1/6,13.20%,BRPF3
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3380242682649287,-0.5874190794184805,0.9833333333333333,1.0,1.0,2/9,20.91%,APOD;NDRG4
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.2594221459900429,-0.5874139594270772,1.0,1.0,1.0,10/100,15.93%,TUBB4B;TUBA4A;CEP72;CDK7;DCTN1;DNM2;ODF2;TUBB4A;SKP2;DCTN3
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),-0.4089109618661222,-0.5867225532611141,0.9259259259259259,1.0,1.0,1/5,8.64%,GLUL
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.36497327606219965,0.5860988662091137,0.8536585365853658,0.9987605975965074,1.0,3/7,20.86%,NF2;VHL;SH2B3
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.23691696157003272,0.5859451017723178,1.0,0.9983782795858634,1.0,17/80,15.94%,BCAR1;LAMC1;MPDZ;SH3D19;CHST3;MAGI1;CACNA2D1;EGFR;ADCY6;SNX7;TENM3;PTPRG;NCKAP1;FIGN;FRMD6;TEAD1;AMOTL2
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.3427427977977031,-0.5855196199599333,0.971830985915493,1.0,1.0,2/10,20.84%,HINT1;DNPH1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.33651004728132405,0.5851122167903241,0.8292682926829268,0.997768686184903,1.0,5/5,66.36%,PAPSS1;PAPSS2;SLC35B2;SLC26A2;SLC35B3
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.33651004728132405,0.5851122167903241,0.8292682926829268,0.997768686184903,1.0,5/5,66.36%,PAPSS1;PAPSS2;SLC35B2;SLC26A2;SLC35B3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.2701927747889875,-0.585105400638763,0.9746835443037974,1.0,1.0,6/37,22.00%,IL5;FUZ;SAXO1;ELAPOR1;NUMA1;PIP4K2C
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.362638644777705,-0.5848448662729626,0.9859154929577465,1.0,1.0,2/9,16.16%,NEK6;RSL1D1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.3829966702293906,-0.5848123782342212,0.8955223880597015,1.0,1.0,3/5,34.10%,RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),-0.3108363083786383,-0.5840712754937677,0.961038961038961,1.0,1.0,5/20,18.19%,TGFB1;MEF2C;BTG1;EID2B;SRA1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.34321375615538585,-0.5840201080475474,0.9428571428571428,1.0,1.0,2/12,18.91%,NDOR1;ETFRF1
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.35419283339490226,0.5840196605463793,0.975609756097561,0.9977642415454551,1.0,6/6,64.60%,LCLAT1;LPGAT1;PLAAT3;PLA2G12A;PLA2G4C;MBOAT7
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.3880277096217126,-0.5839448753740591,0.9354838709677419,1.0,1.0,1/6,10.61%,SLC22A4
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.3321516954300121,-0.5839109177373258,0.971830985915493,1.0,1.0,1/10,13.23%,OTUD6B
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.2990697885705892,-0.5838407475976383,0.9848484848484849,1.0,1.0,3/19,11.37%,ANKRD27;HOOK2;EMP2
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),0.3535811361879371,0.5836705350590946,0.9534883720930233,0.9973294211950043,1.0,2/6,22.83%,BCO2;ALDH8A1
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),-0.3190864628401522,-0.5834630003832576,0.9714285714285714,1.0,1.0,3/15,21.87%,TTN;GSN;KCNQ1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.3728480508652526,-0.5832556846320937,0.9090909090909091,1.0,1.0,1/6,12.55%,DNM2
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.32894931284173207,0.5830262695186097,0.925,0.997125489268542,1.0,7/7,67.12%,CHP1;RAB11FIP5;PKD1L3;IMPACT;TRPV1;SLC9A1;RAB11B
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.31621236396157876,0.5828040728050341,0.9142857142857143,0.9967221516108397,1.0,3/8,26.99%,B4GALT5;B4GALT6;ST3GAL2
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.35501933753914183,-0.5823608012716005,0.953125,1.0,1.0,3/6,30.88%,SFXN3;SLC7A10;SLC38A2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.30531674002598774,0.582308040507909,0.9411764705882353,0.9965340865789347,1.0,3/12,9.63%,ADRA1A;EGFR;GNAQ
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.3200325131160866,0.5822365869583838,0.8888888888888888,0.9960624377521713,1.0,8/8,68.02%,MAN2C1;NEU1;NEU3;MANBA;GBA3;NEU4;MAN2B2;MAN2B1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.31129940819676477,-0.5817851146775772,0.9459459459459459,1.0,1.0,4/18,18.15%,MEF2C;GRIN2D;INSYN2A;MPP2
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.2986993792491871,0.5813679668489375,0.8857142857142857,0.9960818766338074,1.0,9/9,70.15%,SETD2;SETD3;SETD4;SETD7;SETD6;EHMT1;SMYD2;CSKMT;KMT5A
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),-0.3515267285559228,-0.5813511313134212,0.9272727272727272,1.0,1.0,3/8,25.89%,MBD4;NTHL1;OGG1
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.37596677337968654,-0.581287918665099,0.9552238805970149,1.0,1.0,2/6,19.44%,RNF8;MSH6
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.263084182569658,0.5807693377556822,0.9565217391304348,0.9958331330863296,1.0,2/18,12.54%,ZC3H3;CPSF6
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.2381363852208107,0.5807061471227778,1.0,0.9953395918387808,1.0,7/35,15.43%,MAP3K5;AKR1C3;PICALM;LRRK2;GRIN2B;CELF1;FYN
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.3026316856899173,0.5792431757169636,1.0,0.9957497221279342,1.0,5/11,23.99%,SPTBN4;B4GALT5;MYCBP2;ARHGAP35;B4GALT6
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.2768898363046013,-0.5792073395683655,1.0,1.0,1.0,11/42,28.06%,IFI35;RTKN2;PTP4A3;EIF2AK2;TERF2IP;C1QTNF4;LRRC19;CD27;SPI1;APP;TMSB4X
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.2962621290545697,-0.5791241096259488,0.9736842105263158,1.0,1.0,5/20,21.58%,DCTD;NMNAT3;GUK1;NMNAT1;PARK7
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.2634397360749322,0.5786262916479081,1.0,0.9956086298140358,1.0,2/18,12.17%,ZBTB20;P2RX7
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.276352995891595,-0.577924957097576,0.972972972972973,1.0,1.0,6/41,16.65%,PPIB;FN1;ATG14;WARS1;PLXNB2;PARG
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.21719674701594024,0.5777917305776614,1.0,0.9954906199246666,1.0,23/96,18.94%,INPP4B;SYNJ1;PTPN13;EFR3A;PIKFYVE;PIGQ;SMG1;CDS1;MTMR3;IP6K1;PIK3CA;OCRL;SOCS6;FIG4;SOCS7;MTM1;PITPNM2;PIP5K1B;PIGU;SOCS4;EFR3B;MTMR8;IP6K2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.28924745023345544,-0.5775727665612069,0.9873417721518988,1.0,1.0,5/25,21.31%,DONSON;USP28;H2AX;ATRIP;FBXO6
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),-0.2940683351412581,-0.5775195670069335,0.9594594594594594,1.0,1.0,4/22,17.76%,TEAD3;DVL2;SAV1;CASP3
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.28361203334026386,0.5771047983919108,1.0,0.9953574458885077,1.0,1/17,3.20%,GDAP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.2720721978284297,-0.5759723757226356,1.0,1.0,1.0,7/42,21.51%,NUP155;SEC13;KHK;NUP107;PGAM1;NUP85;NUP188
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.3730833121590137,-0.5756187078933939,0.9714285714285714,1.0,1.0,2/5,29.24%,DYNC1LI1;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.3730833121590137,-0.5756187078933939,0.9714285714285714,1.0,1.0,2/5,29.24%,DYNC1LI1;XRCC3
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.3193559212959778,0.5751420090180943,0.9354838709677419,0.9957590925736739,1.0,3/10,14.17%,ESR1;BMP7;NR3C1
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.25509832943429395,-0.5750910673737438,1.0,1.0,1.0,21/76,30.15%,PSMB9;PSMB8;PSMA3;FBXL13;SKP2;PSMA7;PSME1;FBXO6;PSMB6;RBX1;PSMB1;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4;CUL4B;FBXO2;FBXO27;PSMC5
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),-0.2475692805131367,-0.5748085623987713,1.0,1.0,1.0,15/77,25.21%,RPL13A;GAPDH;IGF2BP2;RACK1;SHMT1;NCL;EIF2AK2;PCIF1;MALSU1;DHX36;ILF3;PAIP2;EIF4EBP1;BTG2;CNOT8
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),0.3678861221328081,0.5744145205946466,0.926829268292683,0.9956182829896835,1.0,3/5,26.02%,NOS1;CYP2U1;CYP2R1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.23876526996343034,0.5742176809284294,1.0,0.9952258077118121,1.0,7/58,14.31%,SLC2A6;NUP98;ZBTB20;NUP93;HDAC4;P2RX7;NUP210
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.31976357591429616,0.5737724300683571,0.975,0.9948947454604492,1.0,6/6,68.04%,CHPT1;PLA2G7;LPCAT2;PLA2G6;PLA2G4C;PAFAH1B1
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.2835843779211956,-0.5736411514123017,0.9873417721518988,1.0,1.0,5/32,18.50%,RRAGA;SEC13;LARS1;HDAC3;TELO2
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),-0.3516413625300629,-0.5731287964790106,0.9104477611940298,1.0,1.0,3/8,28.74%,PPP2R5A;PIP4K2C;PIK3IP1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.33301124423081796,0.5730161718556639,0.9714285714285714,0.9948384413646828,1.0,2/8,13.09%,PLAUR;ST18
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.2420481110486719,0.5728701494984155,1.0,0.9944545800793256,1.0,24/101,18.61%,PRR5L;IRS1;PLIN5;TP53INP1;SH3D19;FOXO1;SNX33;ZBTB20;MSN;LRRK2;DHRSX;MOV10;HMGB1;P2RX7;PRKD1;FOXO3;NPRL2;MID2;ABHD5;ZC3HAV1;TPCN1;SNCA;CNOT7;AKT2
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.27688352742568667,0.5720500582202412,0.96875,0.9943909417954273,1.0,3/16,10.69%,CBLB;PTPRC;SRCIN1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.2826917764790403,0.5717165740488511,0.9333333333333333,0.9940381424935166,1.0,2/11,12.01%,CDK12;ELL
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.3002510706537256,0.571579558193161,0.9545454545454546,0.9935791986317941,1.0,2/16,8.07%,FBXO17;SAMHD1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.3360608649562887,0.5710872569787812,0.9024390243902439,0.9933108074251401,1.0,3/5,25.26%,LRRK2;CLUH;MAPT
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),-0.3525412033026264,-0.5705325338722549,1.0,1.0,1.0,2/8,17.64%,P2RX4;P2RY12
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.32610493039735433,-0.5700238906287933,0.9726027397260274,1.0,1.0,1/13,3.61%,ENTPD7
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.28092212849427195,-0.5698726790452009,0.9868421052631579,1.0,1.0,12/34,35.11%,PPCS;DCAKD;IMPDH2;ADCY7;NPR2;ACAT1;PANK2;ADCY8;ADCY1;PPCDC;SLC35B3;SLC26A2
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.3170351931698274,-0.5696861362172283,0.9852941176470589,1.0,1.0,2/13,11.02%,MEF2C;ERVW-1
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.32242400633120605,0.5690607688577333,0.8857142857142857,0.9932761620777933,1.0,1/6,13.71%,EXOSC7
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.32242400633120605,0.5690607688577333,0.8857142857142857,0.9932761620777933,1.0,1/6,13.71%,EXOSC7
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.30045036504707245,-0.568997719647459,0.96,1.0,1.0,1/21,3.56%,CAMK1
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.3188031030661249,0.5686598704136624,0.9459459459459459,0.9930007403515635,1.0,6/6,68.13%,AKT2;INPP5K;CTTNBP2NL;AKT1;IRS2;PRKCB
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.3656914893617021,0.5676037595318877,0.868421052631579,0.9930367087680863,1.0,5/5,63.44%,LNPK;TMEM33;RAB3GAP1;RAB3GAP2;ATL3
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.29423888903087503,-0.5674573111957443,0.9736842105263158,1.0,1.0,4/18,23.10%,SPG7;PMPCA;AFG3L2;YME1L1
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.277447453275551,-0.5666192144421105,1.0,1.0,1.0,7/37,22.58%,HAX1;HDAC6;SREBF1;VDAC1;DNM1L;VPS35;STAT2
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.29830492205615966,0.5664346826438907,0.8823529411764706,0.993019551107914,1.0,1/8,10.25%,MAPK3
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.349759881787957,0.5663566987028372,0.9512195121951219,0.9925551670552966,1.0,6/6,65.04%,DDX3X;SSB;DHX9;DDX1;DCP1A;YBX1
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.3316913779454641,-0.5663073360900942,0.9242424242424242,1.0,1.0,1/10,8.80%,MED1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),-0.3453469101133352,-0.5659861166645456,0.967741935483871,1.0,1.0,2/8,16.51%,CALM1;CAV1
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.3322844152775312,0.565843409859278,1.0,0.9922882433764602,1.0,2/7,12.66%,CDS1;CDS2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.3166619408889103,-0.5653201731167355,0.971830985915493,1.0,1.0,2/15,14.67%,CACTIN;NR1D1
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.30812377687756154,0.5644954887909401,0.96875,0.9924608084721186,1.0,2/6,21.51%,BMPR1B;EIF2AK3
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),0.32743594220808697,0.564325382223304,0.9411764705882353,0.9919974102249526,1.0,5/8,26.76%,POT1;NIPBL;LRWD1;MACROH2A1;RUVBL2
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.3758842472955203,-0.5643160704906727,0.9375,1.0,1.0,1/6,8.54%,PIK3CB
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),-0.280032832584825,-0.5642379085709546,0.9764705882352941,1.0,1.0,5/23,23.68%,XBP1;RACK1;PDK3;SLC39A14;PRKACA
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.36097263677937885,0.5642146893391733,0.8947368421052632,0.9915496100131866,1.0,1/5,7.97%,FOXO1
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.35723941755938976,0.5636649050120863,0.9444444444444444,0.9913366613305531,1.0,1/5,6.28%,RAB31
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.3534970518672909,0.5636420581238246,0.9230769230769231,0.9908367437000284,1.0,1/5,13.98%,FLT1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.31633189059138955,-0.5635697039972701,0.9833333333333333,1.0,1.0,3/11,24.39%,SMARCD1;SET;SUPT16H
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.31633189059138955,-0.5635697039972701,0.9833333333333333,1.0,1.0,3/11,24.39%,SMARCD1;SET;SUPT16H
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.30073685221229035,-0.5633334807701444,0.9577464788732394,1.0,1.0,5/15,27.96%,HDAC6;BRCA1;PARK7;TRAP1;MT3
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.2793563213216742,-0.5633195987636943,0.9875,1.0,1.0,4/28,18.40%,PFN2;LMOD1;BAIAP2L2;GSN
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.2772175104995098,0.5630740416212029,0.9743589743589743,0.990631922648189,1.0,1/12,4.73%,SIRT1
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.35453605200945626,0.5629849542910528,0.95,0.9901706130040758,1.0,5/5,64.56%,NFKB1;SLC30A10;ROCK1;ROCK2;RELA
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),-0.30277096838396833,-0.5627233729961054,0.9859154929577465,1.0,1.0,1/18,3.15%,ENPP2
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),-0.37180085379090433,-0.5625812864365377,0.9206349206349206,1.0,1.0,1/5,11.40%,WNT5B
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),-0.2899160291631805,-0.5616505262612869,0.9726027397260274,1.0,1.0,5/23,25.74%,HDAC3;TAOK3;GSTP1;AIDA;DNAJA1
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),0.32220169929811593,0.5610596979821983,0.9411764705882353,0.9906530242040575,1.0,6/6,67.79%,NPM1;SDAD1;XPO1;NMD3;NUP88;RAN
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.35995461906374004,-0.5603950788922286,0.9565217391304348,1.0,1.0,1/5,7.98%,STAT5A
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),0.3319121168960511,0.5603575707781567,0.9285714285714286,0.990478773864809,1.0,1/6,8.94%,MSN
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.244085526353726,0.5602606832700319,0.9615384615384616,0.9900106989399609,1.0,10/25,23.71%,CRADD;MAP3K1;MAPK3;MAPK8;MAP3K2;TNFRSF10B;BCL10;HABP4;MAP2K4;CASP2
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),-0.2838726556321796,-0.5596196313721532,0.9863013698630136,1.0,1.0,4/21,19.89%,ACSM3;DBI;ACOT2;ACSM6
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),-0.2838726556321796,-0.5596196313721532,0.9863013698630136,1.0,1.0,4/21,19.89%,ACSM3;DBI;ACOT2;ACSM6
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.30776690452703864,-0.5594429087237119,1.0,1.0,1.0,2/17,12.71%,TRIB1;CACTIN
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),-0.3197055759342291,-0.558588323897234,0.9571428571428572,1.0,1.0,2/14,19.20%,MTHFD1;GOT1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.3262154573666323,0.5582228199370841,0.96875,0.9904698589147111,1.0,7/7,67.40%,ANKRD11;HDAC2;LRP6;GLI2;BMP2;HDAC1;EDA
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.28546253739046973,-0.5574879670174123,0.9743589743589743,1.0,1.0,5/24,21.31%,DONSON;USP28;H2AX;ATRIP;FBXO6
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),-0.32732603301214813,-0.5573224581621926,0.918918918918919,1.0,1.0,2/12,14.85%,SFRP4;FSTL3
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.30089185119896944,0.5565801779705462,1.0,0.9908080633050309,1.0,2/7,18.97%,NF1;CSRP1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.30437679011856505,-0.5563611921732884,0.948051948051948,1.0,1.0,4/12,32.58%,CD226;NECTIN2;KMT5C;SHLD2
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),-0.30814444045077255,-0.5552233791512641,0.9848484848484849,1.0,1.0,2/12,16.51%,PTRH2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.3338351107576736,0.5549467002864128,0.9302325581395349,0.9909426962660032,1.0,1/5,12.17%,P2RX7
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),-0.3553207013187244,-0.5548981790680293,0.9649122807017544,1.0,1.0,1/7,15.55%,MYLK
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),0.29823192527534453,0.5541920585351741,0.9473684210526315,0.9908214011327542,1.0,2/7,15.95%,MEGF10;THBS4
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),-0.3417073574165604,-0.5538328897234613,0.9178082191780822,1.0,1.0,2/7,25.49%,IDI1;DHDDS
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.32858554439846943,0.5533542651626521,0.8780487804878049,0.9906701495353807,1.0,1/5,11.85%,FOXP1
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.3485894896178967,-0.552994342846332,0.9848484848484849,1.0,1.0,2/6,29.44%,FH;MDH1
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.24331980452411628,0.5522164924773151,1.0,0.9905566285208947,1.0,4/13,16.74%,POT1;UNG;TERF1;TERF2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.33809516060508993,-0.5520181986367894,0.9672131147540983,1.0,1.0,2/7,17.18%,DIO2;SEPSECS
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.33809516060508993,-0.5520181986367894,0.9672131147540983,1.0,1.0,2/7,17.18%,DIO2;SEPSECS
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.28850313602989663,0.5518469187209997,0.9666666666666667,0.990150253002739,1.0,1/11,3.42%,MAP2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.3210783985257207,-0.5515923751735646,0.9393939393939394,1.0,1.0,3/10,21.17%,PRKCQ;HSPD1;THY1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.3167314876954347,0.5507522855349587,0.9714285714285714,0.9901947793383091,1.0,3/9,21.99%,MSN;PRKN;RAB21
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.2900439496003032,0.5497102350591742,0.9487179487179487,0.9902542700499245,1.0,2/6,22.97%,ABCA2;NECAB2
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.28763128764860857,-0.5490868445841993,1.0,1.0,1.0,4/17,22.58%,STAT5A;STAT1;IFNAR1;STAT2
prerank,GO_Biological_Process_2021__liver development (GO:0001889),-0.31929464542245223,-0.5483069464949668,0.9710144927536232,1.0,1.0,3/12,20.09%,XBP1;CCDC39;CCDC40
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.3451895117699654,-0.5470679550165566,0.9344262295081968,1.0,1.0,1/6,12.05%,PPP1R3F
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),-0.29150641470172184,-0.5467870927298657,0.987012987012987,1.0,1.0,4/19,17.45%,CACNA1G;SCAMP5;SYT11;SYT4
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.3214602922065109,-0.5464416472710609,0.958904109589041,1.0,1.0,1/13,10.21%,RNF8
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.33540048703741165,-0.5457185952154301,0.9830508474576272,1.0,1.0,3/10,29.23%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.33540048703741165,-0.5457185952154301,0.9830508474576272,1.0,1.0,3/10,29.23%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.33540048703741165,-0.5457185952154301,0.9830508474576272,1.0,1.0,3/10,29.23%,NAGK;AMDHD2;GNPDA1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3379186087042125,-0.5447903379446375,0.9253731343283582,1.0,1.0,2/7,25.35%,PARK7;TRAP1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),-0.31283209335522805,-0.5442146082556031,0.984375,1.0,1.0,4/10,25.26%,XBP1;IL7;CD27;AXL
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.3164893617021278,0.5434665780020805,0.9534883720930233,0.9924064045009942,1.0,5/5,68.36%,PPIP5K2;IPPK;ITPK1;IMPA1;PPIP5K1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.2615299148536344,-0.5431515730975532,1.0,1.0,1.0,10/40,22.35%,LAS1L;DDX18;SUPV3L1;NOP56;SLC29A2;CDK4;HSPD1;NIP7;CBX3;RABEPK
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),-0.2996635904395037,-0.5418777092571179,0.9436619718309859,1.0,1.0,3/14,19.07%,WNK3;SYT11;ACTN2
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),-0.2424215332449915,-0.541025425256623,1.0,1.0,1.0,17/72,29.19%,PSMB9;PSMB8;PSMA3;HRAS;PSMA7;PSME1;PSMB6;PSMB1;PRKACA;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4;RAF1;RPS6KA5
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),-0.2424215332449915,-0.541025425256623,1.0,1.0,1.0,17/72,29.19%,PSMB9;PSMB8;PSMA3;HRAS;PSMA7;PSME1;PSMB6;PSMB1;PRKACA;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4;RAF1;RPS6KA5
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),-0.2424215332449915,-0.541025425256623,1.0,1.0,1.0,17/72,29.19%,PSMB9;PSMB8;PSMA3;HRAS;PSMA7;PSME1;PSMB6;PSMB1;PRKACA;PSMC4;PSMD2;PSMB3;PSMD7;PSMC3;PSMA4;RAF1;RPS6KA5
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),0.2580676238899623,0.540733528592607,0.9411764705882353,0.992974523721338,1.0,1/12,8.57%,NNMT
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.3004666484013203,-0.5406831155264235,0.9876543209876543,1.0,1.0,4/19,20.26%,TGFB1;ATG14;P2RY12;PDGFRB
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),0.2577235772357723,0.5406247642181535,1.0,0.992515502599019,1.0,11/11,74.25%,EXOSC7;XRN1;DIS3L;EXOSC6;EXOSC10;EXOSC9;EXOSC5;EXOSC2;TRIR;EXOSC8;DIS3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.3318510217155594,-0.540394819653858,0.9692307692307692,1.0,1.0,3/10,21.58%,PARG;AKAP8;PARK7
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.32138634348211637,0.5397023528405357,0.9142857142857143,0.9924239249435975,1.0,9/9,67.88%,NOS1;CBARP;INPP5K;ATP1A2;TRIM27;SLC30A1;TMBIM6;PLN;CAV3
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.29234350869477205,0.5396094260080738,0.9459459459459459,0.991980608892535,1.0,3/9,19.75%,PON3;NPL;ACOT8
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),-0.3011560593667008,-0.5391346531403619,0.9733333333333334,1.0,1.0,4/13,22.84%,PDCD7;ZFP36L2;GOT1;ADAM9
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.32712765957446804,0.5389345190663102,0.9512195121951219,0.9917547136356744,1.0,5/5,67.30%,GTF2H2;GRK3;ARRB2;GRK2;ARRB1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.28129702881828267,-0.5368852509788719,1.0,1.0,1.0,3/15,16.21%,GRN;ATF4;BAX
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.3179340915351133,-0.5366149047396584,1.0,1.0,1.0,1/10,13.06%,NPTX1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.2400482085692216,0.5362936173414461,1.0,0.9922170447888176,1.0,10/23,27.12%,LRRK2;SMG1;PIK3CA;MTM1;PINK1;MTOR;QSOX1;RUBCN;SEC22B;SMCR8
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.32282817959150967,0.5360738906025551,0.9459459459459459,0.9919090369836446,1.0,2/6,22.54%,PIK3CA;ARHGAP35
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.25363864375969003,-0.5359449545751637,0.9871794871794872,1.0,1.0,6/38,21.51%,NUP155;SEC13;NUP107;PGAM1;NUP85;NUP188
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.25205330403771037,-0.5355267372563043,1.0,1.0,1.0,7/41,21.09%,GORASP1;STMN2;APOE;STX1B;MYLIP;PRAG1;ITM2C
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.3292988024352218,-0.5342280112170054,0.9420289855072463,1.0,1.0,2/9,13.02%,MEF2C;NR4A3
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2340870469818649,-0.5338707535165557,1.0,1.0,1.0,13/100,21.64%,GABARAPL2;TOMM7;ATG14;ULK3;MAP1LC3B2;CHMP4B;ZFYVE1;VDAC1;ULK1;TOMM20;VIPAS39;VPS36;TOMM40
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),-0.280916775979754,-0.5335505159837408,0.9871794871794872,1.0,1.0,5/19,34.10%,RNF8;DTX3L;RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.31990417298039214,-0.5333823918167008,0.9852941176470589,1.0,1.0,3/10,16.34%,NEK6;TACC3;RIOK2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.2118671314835156,0.5331947956402059,1.0,0.9923260053648265,1.0,11/48,19.73%,RPS6KB1;ANKRD17;PKD2;EGFR;PROX1;SRPK2;ADAM17;PRKCA;EIF4E;USP22;C6ORF89
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.3204580863706813,-0.5314492896331894,0.9538461538461539,1.0,1.0,4/8,33.59%,PTN;RUNX1;PRKCB;PURB
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.29617007303786697,-0.5310571968369747,0.9850746268656716,1.0,1.0,4/14,22.55%,XBP1;BAX;BAG6;RNFT1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.256189307747716,-0.5295877932510721,0.9864864864864865,1.0,1.0,6/37,21.51%,NUP155;SEC13;NUP107;PGAM1;NUP85;NUP188
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),-0.35052213057820714,-0.5295154660795138,0.9672131147540983,1.0,1.0,1/5,17.33%,PRKCQ
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.23444606820353978,0.5293931074002908,0.9565217391304348,0.9932204521892097,1.0,4/24,14.52%,SUV39H2;ATPSCKMT;SETD2;TET2
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.31847391185117907,-0.5292204394391002,0.9714285714285714,1.0,1.0,3/8,29.47%,VCL;PLEKHA7;CAMSAP3
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.2760737120847895,0.5281893091689088,0.9473684210526315,0.9931512328313221,1.0,4/9,31.06%,ELP3;GTPBP3;ELP4;TRMT9B
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.271041095858245,-0.5260475366850837,0.9855072463768116,1.0,1.0,4/18,30.89%,BAG6;STUB1;DNAJC18;RNF126
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.2911911846679401,-0.5246898504504649,1.0,1.0,1.0,3/13,29.53%,TSN;NRDE2;MRPL44
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.272085237624348,-0.5243449365825953,0.9852941176470589,1.0,1.0,1/18,11.72%,PTPA
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),-0.3654324050873322,-0.5243388193848747,0.9852941176470589,1.0,1.0,1/5,13.77%,ACTA2
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.2597474986910278,-0.5235625998286217,0.9880952380952381,1.0,1.0,4/38,17.33%,ZFPM1;MEF2C;NR4A3;PRKCQ
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.29572570961580746,-0.5231670263229767,0.9841269841269841,1.0,1.0,3/11,22.47%,NCBP1;SRPK1;CDK11B
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.3155714354789282,-0.5219547677840826,0.9861111111111112,1.0,1.0,2/7,19.44%,CHTOP;MSH6
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),0.280605836719616,0.521495012834157,0.9736842105263158,0.9950961904317314,1.0,6/6,71.95%,FAF1;G3BP2;NFKBIB;PSMD10;NFKBIA;TMSB4X
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.28866245974940996,-0.5212807626610453,0.9864864864864865,1.0,1.0,4/16,25.52%,STMN2;KIF18B;STMN1;STMN4
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.3067685364166964,-0.5198887623685923,0.9411764705882353,1.0,1.0,2/10,23.91%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.2583540484885723,0.5192107846719832,0.9666666666666667,0.995428727946766,1.0,1/12,7.68%,SLC1A2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.3312678703848777,0.5188884484116285,0.9736842105263158,0.9950902330905768,1.0,1/5,11.28%,MTMR3
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),-0.2472156343818421,-0.5183397135634247,1.0,1.0,1.0,4/29,21.93%,AGT;APOE;RDX;HSPA8
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),-0.28140665640498563,-0.5179081332690733,1.0,1.0,1.0,2/16,16.51%,PTRH2;CAV1
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.26207043277105657,0.5178512750954947,0.9666666666666667,0.9949159425175282,1.0,3/13,16.96%,ZNF93;MOV10;PIWIL4
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.2930387322924322,0.517843091971492,0.9487179487179487,0.9944216971412155,1.0,3/7,20.96%,PLAUR;PRKCA;ANK3
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.3113183774087588,-0.5160732559862063,0.9577464788732394,1.0,1.0,4/8,34.10%,SUPT5H;RNF20;RNF40;CTR9
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.3223208797240976,-0.5160592895600437,0.9117647058823529,1.0,1.0,2/5,20.09%,CCDC39;CCDC40
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.3033410853798909,-0.5157922550446099,0.9838709677419355,1.0,1.0,1/10,18.96%,BAG6
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.20650935714942142,0.5154526718838445,1.0,0.9947911148063562,1.0,9/41,23.26%,FPGS;MTHFD2L;SDHAF3;D2HGDH;AADAT;ACOT8;SLC19A1;ME3;ME2
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),-0.30206397786249906,-0.5151815085788696,0.9852941176470589,1.0,1.0,2/12,23.91%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.2799822655730436,0.5147531824616086,0.972972972972973,0.9945131079100173,1.0,8/8,72.02%,CHP1;RAB11FIP5;PKD1L3;IMPACT;TRPV1;SLC9A1;RAB11B;LGMN
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.2913204985308616,-0.5143278837927739,0.9850746268656716,1.0,1.0,3/12,23.68%,NPHP1;RUNX1;PRKACA
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.2893066397114894,-0.5126293148135945,0.9577464788732394,1.0,1.0,2/12,20.66%,MAP1S;UXT
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.3319252470002846,-0.5124779206245306,1.0,1.0,1.0,3/6,28.65%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.3319252470002846,-0.5124779206245306,1.0,1.0,1.0,3/6,28.65%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.3319252470002846,-0.5124779206245306,1.0,1.0,1.0,3/6,28.65%,RDX;DTX3L;SORL1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.2776300236406621,0.5105148787293238,0.9767441860465116,0.9952166328497869,1.0,5/5,72.25%,EHD3;ATP2A2;SLC9A1;PLN;SLC8B1
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.30873226950354604,0.5103925981059662,1.0,0.9947529388440441,1.0,5/5,69.14%,SLC38A6;SLC38A3;SLC38A1;SLC1A4;SLC38A2
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.2810391663713021,-0.5098423992130804,0.9743589743589743,1.0,1.0,4/15,22.32%,G6PC3;RBKS;G6PC2;PGLS
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.3122594788464381,-0.5095704625224929,0.9705882352941176,1.0,1.0,2/9,17.62%,RPS21;ERI2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),-0.2980622324484397,-0.5084419835822723,0.9692307692307692,1.0,1.0,2/10,18.12%,CHMP4B;TMEM39A
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.2580062006601289,0.5083907659225049,1.0,0.9949580795318159,1.0,2/13,11.99%,MTMR3;SMG7
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),-0.2880504263539899,-0.5069101698296514,0.9852941176470589,1.0,1.0,3/12,25.47%,AKAP5;FSHR;AKAP12
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.33822769512978357,-0.5068302672468169,0.96875,1.0,1.0,2/6,30.55%,TNIP1;SART3
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.2718737545917715,-0.5066907984729246,1.0,1.0,1.0,4/23,20.32%,SNRPB;NCBP1;SLBP;SNRPG
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.30520545960160556,-0.504231191088048,0.96875,1.0,1.0,2/7,29.96%,MGME1;SSBP1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.25461930981442565,-0.50223304655986,1.0,1.0,1.0,1/27,4.27%,TGFB1
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.2569105691056911,0.5022043860213622,1.0,0.9960760106029836,1.0,11/11,74.33%,RNF128;SZT2;SH3BP4;SH3GLB1;ATP13A2;RTN4;LMBRD1;MFSD1;LAMTOR5;CD81;LAMTOR4
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.2858104984515027,0.5020596810031793,0.972972972972973,0.9956570940423715,1.0,2/8,13.55%,CHRNA7;MAPK8
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.2922176130694728,-0.5003078995771981,0.9848484848484849,1.0,1.0,6/12,26.01%,LRGUK;CCDC39;CCDC40;DNAAF2;DNAI4;TTC12
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),-0.3077601130854167,-0.5001461556665251,0.9333333333333333,1.0,1.0,2/8,31.93%,LGMN;GRIN2A
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.3106128029975379,-0.4990089880691045,1.0,1.0,1.0,2/6,24.97%,CYP3A5;CYP2E1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.27031081454055605,-0.4968246027718216,0.9864864864864865,1.0,1.0,5/18,25.57%,OBSL1;SS18L2;DHX36;CUL7;LRP8
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.32225654453076924,-0.4961464758660716,0.9672131147540983,1.0,1.0,1/5,15.77%,ALG10B
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.297530736481677,-0.4955593882199182,0.9726027397260274,1.0,1.0,3/9,21.87%,CACNA1C;KCNJ3;KCNQ1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.25787354323518846,-0.4945469170071806,1.0,1.0,1.0,3/21,19.44%,H1-4;TERF2IP;MSH6
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.2876884422110554,0.49301855301570574,0.9705882352941176,0.9977524013090604,1.0,9/9,71.25%,GABRA1;PLXNB1;FGF13;GABRB3;GABRA2;LGI2;GABRB2;WNT5A;GABRG2
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.24810145512555148,-0.4924848575667639,1.0,1.0,1.0,3/25,18.13%,ARFIP2;P2RY12;VCL
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.2895672957228036,0.49092004064684996,1.0,0.997770360285342,1.0,2/8,13.26%,SOX5;LTBP3
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.2919621749408986,0.49054193145144004,1.0,0.9973438193768224,1.0,5/5,70.81%,ZNF274;ATRX;SMARCB1;PIH1D1;ZNF304
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.2684091293447747,-0.48733002376777235,0.9682539682539683,1.0,1.0,1/20,10.96%,USP50
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),-0.32700748153896875,-0.48711648455290446,0.9508196721311475,1.0,1.0,2/5,31.18%,GSN;HTRA2
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.30964473244607116,-0.4850960107879666,0.9841269841269841,1.0,1.0,2/7,29.17%,P2RY12;CD81
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.2899916491719447,-0.4844155665589539,0.972972972972973,1.0,1.0,2/7,23.05%,MTRR;TXN2
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.2478169738329611,-0.483485514644031,1.0,1.0,1.0,3/22,18.13%,ARFIP2;P2RY12;VCL
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.23438201018139343,0.48327799357001133,1.0,0.9988502419317267,1.0,4/9,24.03%,AP1G1;EHD3;CCDC91;SORT1
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.3104118267644813,-0.48204779865680475,0.9827586206896551,1.0,1.0,2/5,34.27%,NPR2;PDE2A
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.2999891119363268,0.4815207614711014,0.975,0.9988084264072258,1.0,2/6,16.74%,ERCC4;TERF2
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),-0.31828893583838935,-0.48051911297930494,0.9682539682539683,1.0,1.0,1/6,17.07%,BRCA1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.26631459344928154,-0.47721959057911034,1.0,1.0,1.0,4/12,30.99%,MBD4;NTHL1;OGG1;NT5C
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.3067375886524823,0.47446618887670106,0.9523809523809523,0.9999871680598229,1.0,5/5,69.34%,CTNNBIP1;CSF1;ZFP36L1;ACIN1;IL34
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.24514306817332238,0.4743695343256172,1.0,0.9995086213126959,1.0,2/9,21.26%,MTMR3;PHB2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.29670323059998915,0.47385227001669994,1.0,0.9986415764878765,1.0,1/5,12.54%,CPSF6
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.29670323059998915,0.47385227001669994,1.0,0.9986415764878765,1.0,1/5,12.54%,CPSF6
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.2922275082170232,-0.47098891973886364,0.9857142857142858,1.0,1.0,1/11,8.40%,ICMT
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),-0.2752125435880621,-0.47088831543946186,0.9861111111111112,1.0,1.0,4/12,25.51%,LPCAT3;SREBF1;MBTPS2;MBTPS1
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.2853987505027599,-0.47033019840701407,1.0,1.0,1.0,3/7,36.39%,SHFL;GSPT1;UPF1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.2778364018142927,0.4702853351302775,0.9696969696969697,0.9985141248491561,1.0,2/6,14.02%,CDC16;ANAPC1
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.2778364018142927,0.4702853351302775,0.9696969696969697,0.9985141248491561,1.0,2/6,14.02%,CDC16;ANAPC1
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),-0.29953603347788144,-0.46981389804166396,0.9473684210526315,1.0,1.0,1/7,17.45%,SYT4
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.30761584972330935,-0.4692804530198662,1.0,1.0,1.0,1/5,22.85%,PSIP1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),-0.2979192818792005,-0.46916140474733853,0.9830508474576272,1.0,1.0,2/5,26.52%,PARK7;NONO
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.24361594882748666,-0.4678806833186299,1.0,1.0,1.0,4/18,26.86%,PRDX5;DHX36;AR;ZNF76
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.22241806893593086,-0.4666925286295626,1.0,1.0,1.0,9/48,26.87%,ZFPM1;MEF2C;NR4A3;PRKCQ;HSPA9;RUNX1;RBBP5;SPI1;KMT2B
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.2976273823588245,-0.46539655495399357,0.9705882352941176,1.0,1.0,2/6,28.71%,KMT2B;SETD1A
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),-0.3076604018822305,-0.46246953642004607,0.9852941176470589,1.0,1.0,1/5,18.94%,GOPC
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.2864213947990545,0.46070661421550385,0.9523809523809523,0.9997927839392907,1.0,5/5,71.37%,GOLPH3;VPS13D;VPS13A;VPS13C;SORL1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.2728649855289996,0.4604058696138465,1.0,0.9993747179157922,1.0,1/7,11.70%,CYP7B1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.282417539777252,-0.45933651542302,1.0,1.0,1.0,1/6,14.22%,ADAMTS7
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),-0.2799914347320535,-0.45604368083774605,1.0,1.0,1.0,3/10,28.62%,MPDU1;B3GALT5;ST3GAL6
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),-0.2799914347320535,-0.45604368083774605,1.0,1.0,1.0,3/10,28.62%,MPDU1;B3GALT5;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.19952225769324744,-0.45580502765850617,1.0,1.0,1.0,16/94,26.62%,RRAGA;HDAC6;GAPDH;ATP6V0E2;ULK1;NRBP2;CASP3;ATP6V1D;VPS35;TRIM13;BNIP3;ATP6V1E1;PRKACA;LAMTOR4;SNX32;VPS26A
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.27992021276595747,0.4549061886215973,1.0,0.9998633235724796,1.0,5/5,72.02%,PIAS4;CYP2R1;CUBN;LRP2;LGMN
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.2250520184557144,0.45310773158557816,1.0,0.9997254791280709,1.0,5/12,28.93%,HMGB1;DFFB;DFFA;HMGB2;DICER1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.2531215367565571,0.4527841288487155,1.0,0.9992638977646812,1.0,6/6,74.70%,NPM1;XPO1;LSG1;TSC1;RAN;ABCE1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.25649942883688376,-0.4525484833116439,0.9848484848484849,1.0,1.0,3/16,23.48%,PPAT;PAICS;IMPDH2
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.28622090875507955,0.4520724582899261,0.9743589743589743,0.998846912325507,1.0,6/6,71.39%,PID1;NFKB1;PTPRT;SBNO2;RELA;ST3GAL6
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.27880447233248784,-0.45090240243164714,1.0,1.0,1.0,1/7,14.22%,ADAMTS7
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),-0.2714122648806828,-0.4493255776186765,0.9846153846153847,1.0,1.0,2/9,19.79%,RAB35;VPS35
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.24913591464597112,0.4489695171207791,1.0,0.9987538905893809,1.0,4/10,22.36%,ADAM17;SLIT2;CAMK1D;PTK2B
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.264472443447774,-0.4488321787124637,1.0,1.0,1.0,3/7,33.06%,ALG10B;MT3;GOLGA2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.26935252156078143,0.44483969447479127,1.0,0.9988888071434898,1.0,2/5,22.96%,NOS1;RAB6A
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.1854935550717139,0.44386706280928984,1.0,0.9985460818048576,1.0,13/49,23.31%,SIRT1;BMP7;ERBIN;LRRC14;OTULIN;MTURN;NFKBIL1;CD200;ANXA4;CYLD;CHP1;IRAK1;USP7
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.26090765947055783,-0.4418861001812762,1.0,1.0,1.0,1/11,16.50%,PGP
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),-0.23544616260625578,-0.4392808377314409,1.0,1.0,1.0,5/19,32.72%,BRCA1;SPHK2;BRD7;RPS6KA5;ARRB1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.2796315178290374,-0.4386545977128006,1.0,1.0,1.0,3/6,39.28%,DHX8;KLC1;TFIP11
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.20739057652827173,0.43755402971470725,1.0,0.9988278220199219,1.0,7/27,23.69%,SGMS1;AGPAT5;LPCAT1;FAR1;HDHD5;CPNE3;CPNE7
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.2666044346142317,-0.43602089240128833,1.0,1.0,1.0,3/6,30.15%,CLDN18;CLDN10;CLDN20
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),-0.28047332106839923,-0.4330849842789845,1.0,1.0,1.0,3/7,37.19%,CDC7;MUS81;MCMDC2
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.25286415567397336,-0.43110896427890544,0.9701492537313433,1.0,1.0,1/11,13.21%,BEND3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.24574035216816073,-0.4309428209452623,1.0,1.0,1.0,4/18,24.91%,ELOVL2;DGAT1;ACSBG1;HSD17B12
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.2446559399939021,-0.42921147829156503,1.0,1.0,1.0,1/9,10.96%,USP50
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.2107293051881647,-0.42275288663000105,1.0,1.0,1.0,7/25,31.29%,BEND3;PRXL2C;ENTPD5;APP;PFKFB2;TMSB4X;ENO1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),0.21702704772263465,0.4210188773380138,1.0,0.999960622663147,1.0,2/11,18.71%,D2HGDH;AADAT
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.2723490516294215,-0.413495022433281,1.0,1.0,1.0,1/5,24.38%,TNIP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.23124562500390575,-0.4111306449902926,1.0,1.0,1.0,2/16,18.65%,BRCA1;SNW1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.20885860424407657,-0.40625086064000293,1.0,1.0,1.0,9/23,34.42%,BEND3;RBBP5;KMT2B;SETD1A;CXXC1;ZNF335;WDR5;CTR9;MEN1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.21581670362158173,0.4024993622290662,1.0,1.0,1.0,11/11,78.44%,PTPRN2;CYB5R4;CAMK2G;RIMS2;SNX19;PTPRN;RAB11FIP5;RAB11FIP2;SELENOT;RAB11B;PARK7
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.25327248194527757,-0.39343336280157365,1.0,1.0,1.0,1/6,17.07%,BRCA1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.22886337674174995,-0.39199302925994345,1.0,1.0,1.0,3/14,24.91%,ELOVL2;ACSBG1;HSD17B12
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.2686810724523617,-0.391807807421656,1.0,1.0,1.0,2/5,26.97%,CCNK;PSMC3
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.23435537495382347,0.3887707994643989,1.0,1.0,1.0,6/6,76.57%,AKT2;BAD;STOML2;VCP;AKT1;MTLN
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.21573637335106977,0.3881203349121992,1.0,0.9999320769100354,1.0,3/10,23.90%,SESN1;MTOR;UBR1
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.21573637335106977,0.3881203349121992,1.0,0.9999320769100354,1.0,3/10,23.90%,SESN1;MTOR;UBR1
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.19726533628972648,0.3881127201973352,1.0,0.9994435903067574,1.0,11/11,80.29%,PNP;AMPD2;HPRT1;POLL;POLD3;AMPD3;DCK;ADK;DGUOK;GMPR2;POLD2
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),-0.18647559365060729,-0.3630088188365919,1.0,1.0,1.0,8/25,34.72%,HDAC3;TAOK3;GSTP1;AIDA;IGBP1;QARS1;MEN1;PPIA
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.18776956726741773,-0.3628076531508734,1.0,1.0,1.0,4/17,33.54%,CASP3;REXO4;MUS81;KPNA1
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.20596251794496045,-0.35213143323670865,1.0,0.9998960468944009,1.0,1/10,16.70%,LARS1
